(function(){const U=document.createElement("link").relList;if(U&&U.supports&&U.supports("modulepreload"))return;for(const v of document.querySelectorAll('link[rel="modulepreload"]'))f(v);new MutationObserver(v=>{for(const F of v)if(F.type==="childList")for(const Q of F.addedNodes)Q.tagName==="LINK"&&Q.rel==="modulepreload"&&f(Q)}).observe(document,{childList:!0,subtree:!0});function p(v){const F={};return v.integrity&&(F.integrity=v.integrity),v.referrerPolicy&&(F.referrerPolicy=v.referrerPolicy),v.crossOrigin==="use-credentials"?F.credentials="include":v.crossOrigin==="anonymous"?F.credentials="omit":F.credentials="same-origin",F}function f(v){if(v.ep)return;v.ep=!0;const F=p(v);fetch(v.href,F)}})();function BS(G){return G&&G.__esModule&&Object.prototype.hasOwnProperty.call(G,"default")?G.default:G}var GA={exports:{}},ai={};var MS;function _l(){if(MS)return ai;MS=1;var G=Symbol.for("react.transitional.element"),U=Symbol.for("react.fragment");function p(f,v,F){var Q=null;if(F!==void 0&&(Q=""+F),v.key!==void 0&&(Q=""+v.key),"key"in v){F={};for(var sE in v)sE!=="key"&&(F[sE]=v[sE])}else F=v;return v=F.ref,{$$typeof:G,type:f,key:Q,ref:v!==void 0?v:null,props:F}}return ai.Fragment=U,ai.jsx=p,ai.jsxs=p,ai}var RS;function il(){return RS||(RS=1,GA.exports=_l()),GA.exports}var oE=il(),uA={exports:{}},YN={};var sS;function ol(){if(sS)return YN;sS=1;var G=Symbol.for("react.transitional.element"),U=Symbol.for("react.portal"),p=Symbol.for("react.fragment"),f=Symbol.for("react.strict_mode"),v=Symbol.for("react.profiler"),F=Symbol.for("react.consumer"),Q=Symbol.for("react.context"),sE=Symbol.for("react.forward_ref"),q=Symbol.for("react.suspense"),k=Symbol.for("react.memo"),_E=Symbol.for("react.lazy"),IE=Symbol.for("react.activity"),CE=Symbol.iterator;function HE(EE){return EE===null||typeof EE!="object"?null:(EE=CE&&EE[CE]||EE["@@iterator"],typeof EE=="function"?EE:null)}var fE={isMounted:function(){return!1},enqueueForceUpdate:function(){},enqueueReplaceState:function(){},enqueueSetState:function(){}},zE=Object.assign,wE={};function $E(EE,z,yE){this.props=EE,this.context=z,this.refs=wE,this.updater=yE||fE}$E.prototype.isReactComponent={},$E.prototype.setState=function(EE,z){if(typeof EE!="object"&&typeof EE!="function"&&EE!=null)throw Error("takes an object of state variables to update or a function which returns an object of state variables.");this.updater.enqueueSetState(this,EE,z,"setState")},$E.prototype.forceUpdate=function(EE){this.updater.enqueueForceUpdate(this,EE,"forceUpdate")};function DE(){}DE.prototype=$E.prototype;function xE(EE,z,yE){this.props=EE,this.context=z,this.refs=wE,this.updater=yE||fE}var gE=xE.prototype=new DE;gE.constructor=xE,zE(gE,$E.prototype),gE.isPureReactComponent=!0;var PN=Array.isArray;function $N(){}var cE={H:null,A:null,T:null,S:null},pN=Object.prototype.hasOwnProperty;function xN(EE,z,yE){var FE=yE.ref;return{$$typeof:G,type:EE,key:z,ref:FE!==void 0?FE:null,props:yE}}function mO(EE,z){return xN(EE.type,z,EE.props)}function WO(EE){return typeof EE=="object"&&EE!==null&&EE.$$typeof===G}function vO(EE){var z={"=":"=0",":":"=2"};return"$"+EE.replace(/[=:]/g,function(yE){return z[yE]})}var bT=/\/+/g;function EO(EE,z){return typeof EE=="object"&&EE!==null&&EE.key!=null?vO(""+EE.key):z.toString(36)}function lT(EE){switch(EE.status){case"fulfilled":return EE.value;case"rejected":throw EE.reason;default:switch(typeof EE.status=="string"?EE.then($N,$N):(EE.status="pending",EE.then(function(z){EE.status==="pending"&&(EE.status="fulfilled",EE.value=z)},function(z){EE.status==="pending"&&(EE.status="rejected",EE.reason=z)})),EE.status){case"fulfilled":return EE.value;case"rejected":throw EE.reason}}throw EE}function rE(EE,z,yE,FE,sN){var rN=typeof EE;(rN==="undefined"||rN==="boolean")&&(EE=null);var KN=!1;if(EE===null)KN=!0;else switch(rN){case"bigint":case"string":case"number":KN=!0;break;case"object":switch(EE.$$typeof){case G:case U:KN=!0;break;case _E:return KN=EE._init,rE(KN(EE._payload),z,yE,FE,sN)}}if(KN)return sN=sN(EE),KN=FE===""?"."+EO(EE,0):FE,PN(sN)?(yE="",KN!=null&&(yE=KN.replace(bT,"$&/")+"/"),rE(sN,z,yE,"",function(mT){return mT})):sN!=null&&(WO(sN)&&(sN=mO(sN,yE+(sN.key==null||EE&&EE.key===sN.key?"":(""+sN.key).replace(bT,"$&/")+"/")+KN)),z.push(sN)),1;KN=0;var YO=FE===""?".":FE+":";if(PN(EE))for(var _O=0;_O<EE.length;_O++)FE=EE[_O],rN=YO+EO(FE,_O),KN+=rE(FE,z,yE,rN,sN);else if(_O=HE(EE),typeof _O=="function")for(EE=_O.call(EE),_O=0;!(FE=EE.next()).done;)FE=FE.value,rN=YO+EO(FE,_O++),KN+=rE(FE,z,yE,rN,sN);else if(rN==="object"){if(typeof EE.then=="function")return rE(lT(EE),z,yE,FE,sN);throw z=String(EE),Error("Objects are not valid as a React child (found: "+(z==="[object Object]"?"object with keys {"+Object.keys(EE).join(", ")+"}":z)+"). If you meant to render a collection of children, use an array instead.")}return KN}function pE(EE,z,yE){if(EE==null)return EE;var FE=[],sN=0;return rE(EE,FE,"","",function(rN){return z.call(yE,rN,sN++)}),FE}function MN(EE){if(EE._status===-1){var z=EE._result;z=z(),z.then(function(yE){(EE._status===0||EE._status===-1)&&(EE._status=1,EE._result=yE)},function(yE){(EE._status===0||EE._status===-1)&&(EE._status=2,EE._result=yE)}),EE._status===-1&&(EE._status=0,EE._result=z)}if(EE._status===1)return EE._result.default;throw EE._result}var VN=typeof reportError=="function"?reportError:function(EE){if(typeof window=="object"&&typeof window.ErrorEvent=="function"){var z=new window.ErrorEvent("error",{bubbles:!0,cancelable:!0,message:typeof EE=="object"&&EE!==null&&typeof EE.message=="string"?String(EE.message):String(EE),error:EE});if(!window.dispatchEvent(z))return}else if(typeof process=="object"&&typeof process.emit=="function"){process.emit("uncaughtException",EE);return}console.error(EE)},vN={map:pE,forEach:function(EE,z,yE){pE(EE,function(){z.apply(this,arguments)},yE)},count:function(EE){var z=0;return pE(EE,function(){z++}),z},toArray:function(EE){return pE(EE,function(z){return z})||[]},only:function(EE){if(!WO(EE))throw Error("React.Children.only expected to receive a single React element child.");return EE}};return YN.Activity=IE,YN.Children=vN,YN.Component=$E,YN.Fragment=p,YN.Profiler=v,YN.PureComponent=xE,YN.StrictMode=f,YN.Suspense=q,YN.__CLIENT_INTERNALS_DO_NOT_USE_OR_WARN_USERS_THEY_CANNOT_UPGRADE=cE,YN.__COMPILER_RUNTIME={__proto__:null,c:function(EE){return cE.H.useMemoCache(EE)}},YN.cache=function(EE){return function(){return EE.apply(null,arguments)}},YN.cacheSignal=function(){return null},YN.cloneElement=function(EE,z,yE){if(EE==null)throw Error("The argument must be a React element, but you passed "+EE+".");var FE=zE({},EE.props),sN=EE.key;if(z!=null)for(rN in z.key!==void 0&&(sN=""+z.key),z)!pN.call(z,rN)||rN==="key"||rN==="__self"||rN==="__source"||rN==="ref"&&z.ref===void 0||(FE[rN]=z[rN]);var rN=arguments.length-2;if(rN===1)FE.children=yE;else if(1<rN){for(var KN=Array(rN),YO=0;YO<rN;YO++)KN[YO]=arguments[YO+2];FE.children=KN}return xN(EE.type,sN,FE)},YN.createContext=function(EE){return EE={$$typeof:Q,_currentValue:EE,_currentValue2:EE,_threadCount:0,Provider:null,Consumer:null},EE.Provider=EE,EE.Consumer={$$typeof:F,_context:EE},EE},YN.createElement=function(EE,z,yE){var FE,sN={},rN=null;if(z!=null)for(FE in z.key!==void 0&&(rN=""+z.key),z)pN.call(z,FE)&&FE!=="key"&&FE!=="__self"&&FE!=="__source"&&(sN[FE]=z[FE]);var KN=arguments.length-2;if(KN===1)sN.children=yE;else if(1<KN){for(var YO=Array(KN),_O=0;_O<KN;_O++)YO[_O]=arguments[_O+2];sN.children=YO}if(EE&&EE.defaultProps)for(FE in KN=EE.defaultProps,KN)sN[FE]===void 0&&(sN[FE]=KN[FE]);return xN(EE,rN,sN)},YN.createRef=function(){return{current:null}},YN.forwardRef=function(EE){return{$$typeof:sE,render:EE}},YN.isValidElement=WO,YN.lazy=function(EE){return{$$typeof:_E,_payload:{_status:-1,_result:EE},_init:MN}},YN.memo=function(EE,z){return{$$typeof:k,type:EE,compare:z===void 0?null:z}},YN.startTransition=function(EE){var z=cE.T,yE={};cE.T=yE;try{var FE=EE(),sN=cE.S;sN!==null&&sN(yE,FE),typeof FE=="object"&&FE!==null&&typeof FE.then=="function"&&FE.then($N,VN)}catch(rN){VN(rN)}finally{z!==null&&yE.types!==null&&(z.types=yE.types),cE.T=z}},YN.unstable_useCacheRefresh=function(){return cE.H.useCacheRefresh()},YN.use=function(EE){return cE.H.use(EE)},YN.useActionState=function(EE,z,yE){return cE.H.useActionState(EE,z,yE)},YN.useCallback=function(EE,z){return cE.H.useCallback(EE,z)},YN.useContext=function(EE){return cE.H.useContext(EE)},YN.useDebugValue=function(){},YN.useDeferredValue=function(EE,z){return cE.H.useDeferredValue(EE,z)},YN.useEffect=function(EE,z){return cE.H.useEffect(EE,z)},YN.useEffectEvent=function(EE){return cE.H.useEffectEvent(EE)},YN.useId=function(){return cE.H.useId()},YN.useImperativeHandle=function(EE,z,yE){return cE.H.useImperativeHandle(EE,z,yE)},YN.useInsertionEffect=function(EE,z){return cE.H.useInsertionEffect(EE,z)},YN.useLayoutEffect=function(EE,z){return cE.H.useLayoutEffect(EE,z)},YN.useMemo=function(EE,z){return cE.H.useMemo(EE,z)},YN.useOptimistic=function(EE,z){return cE.H.useOptimistic(EE,z)},YN.useReducer=function(EE,z,yE){return cE.H.useReducer(EE,z,yE)},YN.useRef=function(EE){return cE.H.useRef(EE)},YN.useState=function(EE){return cE.H.useState(EE)},YN.useSyncExternalStore=function(EE,z,yE){return cE.H.useSyncExternalStore(EE,z,yE)},YN.useTransition=function(){return cE.H.useTransition()},YN.version="19.2.4",YN}var _S;function Qo(){return _S||(_S=1,uA.exports=ol()),uA.exports}var dE=Qo(),YA={exports:{}},Di={},HA={exports:{}},CA={};var iS;function Al(){return iS||(iS=1,(function(G){function U(rE,pE){var MN=rE.length;rE.push(pE);E:for(;0<MN;){var VN=MN-1>>>1,vN=rE[VN];if(0<v(vN,pE))rE[VN]=pE,rE[MN]=vN,MN=VN;else break E}}function p(rE){return rE.length===0?null:rE[0]}function f(rE){if(rE.length===0)return null;var pE=rE[0],MN=rE.pop();if(MN!==pE){rE[0]=MN;E:for(var VN=0,vN=rE.length,EE=vN>>>1;VN<EE;){var z=2*(VN+1)-1,yE=rE[z],FE=z+1,sN=rE[FE];if(0>v(yE,MN))FE<vN&&0>v(sN,yE)?(rE[VN]=sN,rE[FE]=MN,VN=FE):(rE[VN]=yE,rE[z]=MN,VN=z);else if(FE<vN&&0>v(sN,MN))rE[VN]=sN,rE[FE]=MN,VN=FE;else break E}}return pE}function v(rE,pE){var MN=rE.sortIndex-pE.sortIndex;return MN!==0?MN:rE.id-pE.id}if(G.unstable_now=void 0,typeof performance=="object"&&typeof performance.now=="function"){var F=performance;G.unstable_now=function(){return F.now()}}else{var Q=Date,sE=Q.now();G.unstable_now=function(){return Q.now()-sE}}var q=[],k=[],_E=1,IE=null,CE=3,HE=!1,fE=!1,zE=!1,wE=!1,$E=typeof setTimeout=="function"?setTimeout:null,DE=typeof clearTimeout=="function"?clearTimeout:null,xE=typeof setImmediate<"u"?setImmediate:null;function gE(rE){for(var pE=p(k);pE!==null;){if(pE.callback===null)f(k);else if(pE.startTime<=rE)f(k),pE.sortIndex=pE.expirationTime,U(q,pE);else break;pE=p(k)}}function PN(rE){if(zE=!1,gE(rE),!fE)if(p(q)!==null)fE=!0,$N||($N=!0,vO());else{var pE=p(k);pE!==null&&lT(PN,pE.startTime-rE)}}var $N=!1,cE=-1,pN=5,xN=-1;function mO(){return wE?!0:!(G.unstable_now()-xN<pN)}function WO(){if(wE=!1,$N){var rE=G.unstable_now();xN=rE;var pE=!0;try{E:{fE=!1,zE&&(zE=!1,DE(cE),cE=-1),HE=!0;var MN=CE;try{N:{for(gE(rE),IE=p(q);IE!==null&&!(IE.expirationTime>rE&&mO());){var VN=IE.callback;if(typeof VN=="function"){IE.callback=null,CE=IE.priorityLevel;var vN=VN(IE.expirationTime<=rE);if(rE=G.unstable_now(),typeof vN=="function"){IE.callback=vN,gE(rE),pE=!0;break N}IE===p(q)&&f(q),gE(rE)}else f(q);IE=p(q)}if(IE!==null)pE=!0;else{var EE=p(k);EE!==null&&lT(PN,EE.startTime-rE),pE=!1}}break E}finally{IE=null,CE=MN,HE=!1}pE=void 0}}finally{pE?vO():$N=!1}}}var vO;if(typeof xE=="function")vO=function(){xE(WO)};else if(typeof MessageChannel<"u"){var bT=new MessageChannel,EO=bT.port2;bT.port1.onmessage=WO,vO=function(){EO.postMessage(null)}}else vO=function(){$E(WO,0)};function lT(rE,pE){cE=$E(function(){rE(G.unstable_now())},pE)}G.unstable_IdlePriority=5,G.unstable_ImmediatePriority=1,G.unstable_LowPriority=4,G.unstable_NormalPriority=3,G.unstable_Profiling=null,G.unstable_UserBlockingPriority=2,G.unstable_cancelCallback=function(rE){rE.callback=null},G.unstable_forceFrameRate=function(rE){0>rE||125<rE?console.error("forceFrameRate takes a positive int between 0 and 125, forcing frame rates higher than 125 fps is not supported"):pN=0<rE?Math.floor(1e3/rE):5},G.unstable_getCurrentPriorityLevel=function(){return CE},G.unstable_next=function(rE){switch(CE){case 1:case 2:case 3:var pE=3;break;default:pE=CE}var MN=CE;CE=pE;try{return rE()}finally{CE=MN}},G.unstable_requestPaint=function(){wE=!0},G.unstable_runWithPriority=function(rE,pE){switch(rE){case 1:case 2:case 3:case 4:case 5:break;default:rE=3}var MN=CE;CE=rE;try{return pE()}finally{CE=MN}},G.unstable_scheduleCallback=function(rE,pE,MN){var VN=G.unstable_now();switch(typeof MN=="object"&&MN!==null?(MN=MN.delay,MN=typeof MN=="number"&&0<MN?VN+MN:VN):MN=VN,rE){case 1:var vN=-1;break;case 2:vN=250;break;case 5:vN=1073741823;break;case 4:vN=1e4;break;default:vN=5e3}return vN=MN+vN,rE={id:_E++,callback:pE,priorityLevel:rE,startTime:MN,expirationTime:vN,sortIndex:-1},MN>VN?(rE.sortIndex=MN,U(k,rE),p(q)===null&&rE===p(k)&&(zE?(DE(cE),cE=-1):zE=!0,lT(PN,MN-VN))):(rE.sortIndex=vN,U(q,rE),fE||HE||(fE=!0,$N||($N=!0,vO()))),rE},G.unstable_shouldYield=mO,G.unstable_wrapCallback=function(rE){var pE=CE;return function(){var MN=CE;CE=pE;try{return rE.apply(this,arguments)}finally{CE=MN}}}})(CA)),CA}var oS;function Sl(){return oS||(oS=1,HA.exports=Al()),HA.exports}var BA={exports:{}},ln={};var AS;function ll(){if(AS)return ln;AS=1;var G=Qo();function U(q){var k="https://react.dev/errors/"+q;if(1<arguments.length){k+="?args[]="+encodeURIComponent(arguments[1]);for(var _E=2;_E<arguments.length;_E++)k+="&args[]="+encodeURIComponent(arguments[_E])}return"Minified React error #"+q+"; visit "+k+" for the full message or use the non-minified dev environment for full errors and additional helpful warnings."}function p(){}var f={d:{f:p,r:function(){throw Error(U(522))},D:p,C:p,L:p,m:p,X:p,S:p,M:p},p:0,findDOMNode:null},v=Symbol.for("react.portal");function F(q,k,_E){var IE=3<arguments.length&&arguments[3]!==void 0?arguments[3]:null;return{$$typeof:v,key:IE==null?null:""+IE,children:q,containerInfo:k,implementation:_E}}var Q=G.__CLIENT_INTERNALS_DO_NOT_USE_OR_WARN_USERS_THEY_CANNOT_UPGRADE;function sE(q,k){if(q==="font")return"";if(typeof k=="string")return k==="use-credentials"?k:""}return ln.__DOM_INTERNALS_DO_NOT_USE_OR_WARN_USERS_THEY_CANNOT_UPGRADE=f,ln.createPortal=function(q,k){var _E=2<arguments.length&&arguments[2]!==void 0?arguments[2]:null;if(!k||k.nodeType!==1&&k.nodeType!==9&&k.nodeType!==11)throw Error(U(299));return F(q,k,null,_E)},ln.flushSync=function(q){var k=Q.T,_E=f.p;try{if(Q.T=null,f.p=2,q)return q()}finally{Q.T=k,f.p=_E,f.d.f()}},ln.preconnect=function(q,k){typeof q=="string"&&(k?(k=k.crossOrigin,k=typeof k=="string"?k==="use-credentials"?k:"":void 0):k=null,f.d.C(q,k))},ln.prefetchDNS=function(q){typeof q=="string"&&f.d.D(q)},ln.preinit=function(q,k){if(typeof q=="string"&&k&&typeof k.as=="string"){var _E=k.as,IE=sE(_E,k.crossOrigin),CE=typeof k.integrity=="string"?k.integrity:void 0,HE=typeof k.fetchPriority=="string"?k.fetchPriority:void 0;_E==="style"?f.d.S(q,typeof k.precedence=="string"?k.precedence:void 0,{crossOrigin:IE,integrity:CE,fetchPriority:HE}):_E==="script"&&f.d.X(q,{crossOrigin:IE,integrity:CE,fetchPriority:HE,nonce:typeof k.nonce=="string"?k.nonce:void 0})}},ln.preinitModule=function(q,k){if(typeof q=="string")if(typeof k=="object"&&k!==null){if(k.as==null||k.as==="script"){var _E=sE(k.as,k.crossOrigin);f.d.M(q,{crossOrigin:_E,integrity:typeof k.integrity=="string"?k.integrity:void 0,nonce:typeof k.nonce=="string"?k.nonce:void 0})}}else k==null&&f.d.M(q)},ln.preload=function(q,k){if(typeof q=="string"&&typeof k=="object"&&k!==null&&typeof k.as=="string"){var _E=k.as,IE=sE(_E,k.crossOrigin);f.d.L(q,_E,{crossOrigin:IE,integrity:typeof k.integrity=="string"?k.integrity:void 0,nonce:typeof k.nonce=="string"?k.nonce:void 0,type:typeof k.type=="string"?k.type:void 0,fetchPriority:typeof k.fetchPriority=="string"?k.fetchPriority:void 0,referrerPolicy:typeof k.referrerPolicy=="string"?k.referrerPolicy:void 0,imageSrcSet:typeof k.imageSrcSet=="string"?k.imageSrcSet:void 0,imageSizes:typeof k.imageSizes=="string"?k.imageSizes:void 0,media:typeof k.media=="string"?k.media:void 0})}},ln.preloadModule=function(q,k){if(typeof q=="string")if(k){var _E=sE(k.as,k.crossOrigin);f.d.m(q,{as:typeof k.as=="string"&&k.as!=="script"?k.as:void 0,crossOrigin:_E,integrity:typeof k.integrity=="string"?k.integrity:void 0})}else f.d.m(q)},ln.requestFormReset=function(q){f.d.r(q)},ln.unstable_batchedUpdates=function(q,k){return q(k)},ln.useFormState=function(q,k,_E){return Q.H.useFormState(q,k,_E)},ln.useFormStatus=function(){return Q.H.useHostTransitionStatus()},ln.version="19.2.4",ln}var SS;function rl(){if(SS)return BA.exports;SS=1;function G(){if(!(typeof __REACT_DEVTOOLS_GLOBAL_HOOK__>"u"||typeof __REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE!="function"))try{__REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE(G)}catch(U){console.error(U)}}return G(),BA.exports=ll(),BA.exports}var lS;function Pl(){if(lS)return Di;lS=1;var G=Sl(),U=Qo(),p=rl();function f(E){var O="https://react.dev/errors/"+E;if(1<arguments.length){O+="?args[]="+encodeURIComponent(arguments[1]);for(var n=2;n<arguments.length;n++)O+="&args[]="+encodeURIComponent(arguments[n])}return"Minified React error #"+E+"; visit "+O+" for the full message or use the non-minified dev environment for full errors and additional helpful warnings."}function v(E){return!(!E||E.nodeType!==1&&E.nodeType!==9&&E.nodeType!==11)}function F(E){var O=E,n=E;if(E.alternate)for(;O.return;)O=O.return;else{E=O;do O=E,(O.flags&4098)!==0&&(n=O.return),E=O.return;while(E)}return O.tag===3?n:null}function Q(E){if(E.tag===13){var O=E.memoizedState;if(O===null&&(E=E.alternate,E!==null&&(O=E.memoizedState)),O!==null)return O.dehydrated}return null}function sE(E){if(E.tag===31){var O=E.memoizedState;if(O===null&&(E=E.alternate,E!==null&&(O=E.memoizedState)),O!==null)return O.dehydrated}return null}function q(E){if(F(E)!==E)throw Error(f(188))}function k(E){var O=E.alternate;if(!O){if(O=F(E),O===null)throw Error(f(188));return O!==E?null:E}for(var n=E,t=O;;){var o=n.return;if(o===null)break;var S=o.alternate;if(S===null){if(t=o.return,t!==null){n=t;continue}break}if(o.child===S.child){for(S=o.child;S;){if(S===n)return q(o),E;if(S===t)return q(o),O;S=S.sibling}throw Error(f(188))}if(n.return!==t.return)n=o,t=S;else{for(var d=!1,V=o.child;V;){if(V===n){d=!0,n=o,t=S;break}if(V===t){d=!0,t=o,n=S;break}V=V.sibling}if(!d){for(V=S.child;V;){if(V===n){d=!0,n=S,t=o;break}if(V===t){d=!0,t=S,n=o;break}V=V.sibling}if(!d)throw Error(f(189))}}if(n.alternate!==t)throw Error(f(190))}if(n.tag!==3)throw Error(f(188));return n.stateNode.current===n?E:O}function _E(E){var O=E.tag;if(O===5||O===26||O===27||O===6)return E;for(E=E.child;E!==null;){if(O=_E(E),O!==null)return O;E=E.sibling}return null}var IE=Object.assign,CE=Symbol.for("react.element"),HE=Symbol.for("react.transitional.element"),fE=Symbol.for("react.portal"),zE=Symbol.for("react.fragment"),wE=Symbol.for("react.strict_mode"),$E=Symbol.for("react.profiler"),DE=Symbol.for("react.consumer"),xE=Symbol.for("react.context"),gE=Symbol.for("react.forward_ref"),PN=Symbol.for("react.suspense"),$N=Symbol.for("react.suspense_list"),cE=Symbol.for("react.memo"),pN=Symbol.for("react.lazy"),xN=Symbol.for("react.activity"),mO=Symbol.for("react.memo_cache_sentinel"),WO=Symbol.iterator;function vO(E){return E===null||typeof E!="object"?null:(E=WO&&E[WO]||E["@@iterator"],typeof E=="function"?E:null)}var bT=Symbol.for("react.client.reference");function EO(E){if(E==null)return null;if(typeof E=="function")return E.$$typeof===bT?null:E.displayName||E.name||null;if(typeof E=="string")return E;switch(E){case zE:return"Fragment";case $E:return"Profiler";case wE:return"StrictMode";case PN:return"Suspense";case $N:return"SuspenseList";case xN:return"Activity"}if(typeof E=="object")switch(E.$$typeof){case fE:return"Portal";case xE:return E.displayName||"Context";case DE:return(E._context.displayName||"Context")+".Consumer";case gE:var O=E.render;return E=E.displayName,E||(E=O.displayName||O.name||"",E=E!==""?"ForwardRef("+E+")":"ForwardRef"),E;case cE:return O=E.displayName||null,O!==null?O:EO(E.type)||"Memo";case pN:O=E._payload,E=E._init;try{return EO(E(O))}catch{}}return null}var lT=Array.isArray,rE=U.__CLIENT_INTERNALS_DO_NOT_USE_OR_WARN_USERS_THEY_CANNOT_UPGRADE,pE=p.__DOM_INTERNALS_DO_NOT_USE_OR_WARN_USERS_THEY_CANNOT_UPGRADE,MN={pending:!1,data:null,method:null,action:null},VN=[],vN=-1;function EE(E){return{current:E}}function z(E){0>vN||(E.current=VN[vN],VN[vN]=null,vN--)}function yE(E,O){vN++,VN[vN]=E.current,E.current=O}var FE=EE(null),sN=EE(null),rN=EE(null),KN=EE(null);function YO(E,O){switch(yE(rN,O),yE(sN,E),yE(FE,null),O.nodeType){case 9:case 11:E=(E=O.documentElement)&&(E=E.namespaceURI)?Y(E):0;break;default:if(E=O.tagName,O=O.namespaceURI)O=Y(O),E=C(O,E);else switch(E){case"svg":E=1;break;case"math":E=2;break;default:E=0}}z(FE),yE(FE,E)}function _O(){z(FE),z(sN),z(rN)}function mT(E){E.memoizedState!==null&&yE(KN,E);var O=FE.current,n=C(O,E.type);O!==n&&(yE(sN,E),yE(FE,n))}function HO(E){sN.current===E&&(z(FE),z(sN)),KN.current===E&&(z(KN),Si._currentValue=MN)}var vn,bI;function RT(E){if(vn===void 0)try{throw Error()}catch(n){var O=n.stack.trim().match(/\n( *(at )?)/);vn=O&&O[1]||"",bI=-1<n.stack.indexOf(`
    at`)?" (<anonymous>)":-1<n.stack.indexOf("@")?"@unknown:0:0":""}return`
`+vn+E+bI}var mI=!1;function un(E,O){if(!E||mI)return"";mI=!0;var n=Error.prepareStackTrace;Error.prepareStackTrace=void 0;try{var t={DetermineComponentFrameRoot:function(){try{if(O){var GE=function(){throw Error()};if(Object.defineProperty(GE.prototype,"props",{set:function(){throw Error()}}),typeof Reflect=="object"&&Reflect.construct){try{Reflect.construct(GE,[])}catch(SE){var iE=SE}Reflect.construct(E,[],GE)}else{try{GE.call()}catch(SE){iE=SE}E.call(GE.prototype)}}else{try{throw Error()}catch(SE){iE=SE}(GE=E())&&typeof GE.catch=="function"&&GE.catch(function(){})}}catch(SE){if(SE&&iE&&typeof SE.stack=="string")return[SE.stack,iE.stack]}return[null,null]}};t.DetermineComponentFrameRoot.displayName="DetermineComponentFrameRoot";var o=Object.getOwnPropertyDescriptor(t.DetermineComponentFrameRoot,"name");o&&o.configurable&&Object.defineProperty(t.DetermineComponentFrameRoot,"name",{value:"DetermineComponentFrameRoot"});var S=t.DetermineComponentFrameRoot(),d=S[0],V=S[1];if(d&&V){var X=d.split(`
`),RE=V.split(`
`);for(o=t=0;t<X.length&&!X[t].includes("DetermineComponentFrameRoot");)t++;for(;o<RE.length&&!RE[o].includes("DetermineComponentFrameRoot");)o++;if(t===X.length||o===RE.length)for(t=X.length-1,o=RE.length-1;1<=t&&0<=o&&X[t]!==RE[o];)o--;for(;1<=t&&0<=o;t--,o--)if(X[t]!==RE[o]){if(t!==1||o!==1)do if(t--,o--,0>o||X[t]!==RE[o]){var LE=`
`+X[t].replace(" at new "," at ");return E.displayName&&LE.includes("<anonymous>")&&(LE=LE.replace("<anonymous>",E.displayName)),LE}while(1<=t&&0<=o);break}}}finally{mI=!1,Error.prepareStackTrace=n}return(n=E?E.displayName||E.name:"")?RT(n):""}function II(E,O){switch(E.tag){case 26:case 27:case 5:return RT(E.type);case 16:return RT("Lazy");case 13:return E.child!==O&&O!==null?RT("Suspense Fallback"):RT("Suspense");case 19:return RT("SuspenseList");case 0:case 15:return un(E.type,!1);case 11:return un(E.type.render,!1);case 1:return un(E.type,!0);case 31:return RT("Activity");default:return""}}function tI(E){try{var O="",n=null;do O+=II(E,n),n=E,E=E.return;while(E);return O}catch(t){return`
Error generating stack: `+t.message+`
`+t.stack}}var rT=Object.prototype.hasOwnProperty,fT=G.unstable_scheduleCallback,PT=G.unstable_cancelCallback,we=G.unstable_shouldYield,zT=G.unstable_requestPaint,sT=G.unstable_now,Ee=G.unstable_getCurrentPriorityLevel,Ne=G.unstable_ImmediatePriority,tN=G.unstable_UserBlockingPriority,fI=G.unstable_NormalPriority,pI=G.unstable_LowPriority,eI=G.unstable_IdlePriority,VI=G.log,Oe=G.unstable_setDisableYieldValue,pT=null,NT=null;function UE(E){if(typeof VI=="function"&&Oe(E),NT&&typeof NT.setStrictMode=="function")try{NT.setStrictMode(pT,E)}catch{}}var nE=Math.clz32?Math.clz32:EN,uE=Math.log,YE=Math.LN2;function EN(E){return E>>>=0,E===0?32:31-(uE(E)/YE|0)|0}var kE=256,jE=262144,BE=4194304;function KE(E){var O=E&42;if(O!==0)return O;switch(E&-E){case 1:return 1;case 2:return 2;case 4:return 4;case 8:return 8;case 16:return 16;case 32:return 32;case 64:return 64;case 128:return 128;case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:return E&261888;case 262144:case 524288:case 1048576:case 2097152:return E&3932160;case 4194304:case 8388608:case 16777216:case 33554432:return E&62914560;case 67108864:return 67108864;case 134217728:return 134217728;case 268435456:return 268435456;case 536870912:return 536870912;case 1073741824:return 0;default:return E}}function SN(E,O,n){var t=E.pendingLanes;if(t===0)return 0;var o=0,S=E.suspendedLanes,d=E.pingedLanes;E=E.warmLanes;var V=t&134217727;return V!==0?(t=V&~S,t!==0?o=KE(t):(d&=V,d!==0?o=KE(d):n||(n=V&~E,n!==0&&(o=KE(n))))):(V=t&~S,V!==0?o=KE(V):d!==0?o=KE(d):n||(n=t&~E,n!==0&&(o=KE(n)))),o===0?0:O!==0&&O!==o&&(O&S)===0&&(S=o&-o,n=O&-O,S>=n||S===32&&(n&4194048)!==0)?O:o}function TN(E,O){return(E.pendingLanes&~(E.suspendedLanes&~E.pingedLanes)&O)===0}function QE(E,O){switch(E){case 1:case 2:case 4:case 8:case 64:return O+250;case 16:case 32:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:return O+5e3;case 4194304:case 8388608:case 16777216:case 33554432:return-1;case 67108864:case 134217728:case 268435456:case 536870912:case 1073741824:return-1;default:return-1}}function nN(){var E=BE;return BE<<=1,(BE&62914560)===0&&(BE=4194304),E}function SO(E){for(var O=[],n=0;31>n;n++)O.push(E);return O}function _N(E,O){E.pendingLanes|=O,O!==268435456&&(E.suspendedLanes=0,E.pingedLanes=0,E.warmLanes=0)}function qN(E,O,n,t,o,S){var d=E.pendingLanes;E.pendingLanes=n,E.suspendedLanes=0,E.pingedLanes=0,E.warmLanes=0,E.expiredLanes&=n,E.entangledLanes&=n,E.errorRecoveryDisabledLanes&=n,E.shellSuspendCounter=0;var V=E.entanglements,X=E.expirationTimes,RE=E.hiddenUpdates;for(n=d&~n;0<n;){var LE=31-nE(n),GE=1<<LE;V[LE]=0,X[LE]=-1;var iE=RE[LE];if(iE!==null)for(RE[LE]=null,LE=0;LE<iE.length;LE++){var SE=iE[LE];SE!==null&&(SE.lane&=-536870913)}n&=~GE}t!==0&&GN(E,t,0),S!==0&&o===0&&E.tag!==0&&(E.suspendedLanes|=S&~(d&~O))}function GN(E,O,n){E.pendingLanes|=O,E.suspendedLanes&=~O;var t=31-nE(O);E.entangledLanes|=O,E.entanglements[t]=E.entanglements[t]|1073741824|n&261930}function wN(E,O){var n=E.entangledLanes|=O;for(E=E.entanglements;n;){var t=31-nE(n),o=1<<t;o&O|E[t]&O&&(E[t]|=O),n&=~o}}function fO(E,O){var n=O&-O;return n=(n&42)!==0?1:OT(n),(n&(E.suspendedLanes|O))!==0?0:n}function OT(E){switch(E){case 2:E=1;break;case 8:E=4;break;case 32:E=16;break;case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:case 4194304:case 8388608:case 16777216:case 33554432:E=128;break;case 268435456:E=134217728;break;default:E=0}return E}function TT(E){return E&=-E,2<E?8<E?(E&134217727)!==0?32:268435456:8:2}function FT(){var E=pE.p;return E!==0?E:(E=window.event,E===void 0?32:NS(E.type))}function Kn(E,O){var n=pE.p;try{return pE.p=E,O()}finally{pE.p=n}}var WN=Math.random().toString(36).slice(2),aO="__reactFiber$"+WN,QO="__reactProps$"+WN,dT="__reactContainer$"+WN,QN="__reactEvents$"+WN,MI="__reactListeners$"+WN,VT="__reactHandles$"+WN,jT="__reactResources$"+WN,rn="__reactMarker$"+WN;function lO(E){delete E[aO],delete E[QO],delete E[QN],delete E[MI],delete E[VT]}function ZT(E){var O=E[aO];if(O)return O;for(var n=E.parentNode;n;){if(O=n[dT]||n[aO]){if(n=O.alternate,O.child!==null||n!==null&&n.child!==null)for(E=kN(E);E!==null;){if(n=E[aO])return n;E=kN(E)}return O}E=n,n=E.parentNode}return null}function wn(E){if(E=E[aO]||E[dT]){var O=E.tag;if(O===5||O===6||O===13||O===31||O===26||O===27||O===3)return E}return null}function RI(E){var O=E.tag;if(O===5||O===26||O===27||O===6)return E.stateNode;throw Error(f(33))}function sI(E){var O=E[jT];return O||(O=E[jT]={hoistableStyles:new Map,hoistableScripts:new Map}),O}function dO(E){E[rn]=!0}var lt=new Set,FR={};function kn(E,O){_I(E,O),_I(E+"Capture",O)}function _I(E,O){for(FR[E]=O,E=0;E<O.length;E++)lt.add(O[E])}var jR=RegExp("^[:A-Z_a-z\\u00C0-\\u00D6\\u00D8-\\u00F6\\u00F8-\\u02FF\\u0370-\\u037D\\u037F-\\u1FFF\\u200C-\\u200D\\u2070-\\u218F\\u2C00-\\u2FEF\\u3001-\\uD7FF\\uF900-\\uFDCF\\uFDF0-\\uFFFD][:A-Z_a-z\\u00C0-\\u00D6\\u00D8-\\u00F6\\u00F8-\\u02FF\\u0370-\\u037D\\u037F-\\u1FFF\\u200C-\\u200D\\u2070-\\u218F\\u2C00-\\u2FEF\\u3001-\\uD7FF\\uF900-\\uFDCF\\uFDF0-\\uFFFD\\-.0-9\\u00B7\\u0300-\\u036F\\u203F-\\u2040]*$"),FO={},zM={};function FM(E){return rT.call(zM,E)?!0:rT.call(FO,E)?!1:jR.test(E)?zM[E]=!0:(FO[E]=!0,!1)}function ke(E,O,n){if(FM(O))if(n===null)E.removeAttribute(O);else{switch(typeof n){case"undefined":case"function":case"symbol":E.removeAttribute(O);return;case"boolean":var t=O.toLowerCase().slice(0,5);if(t!=="data-"&&t!=="aria-"){E.removeAttribute(O);return}}E.setAttribute(O,""+n)}}function ze(E,O,n){if(n===null)E.removeAttribute(O);else{switch(typeof n){case"undefined":case"function":case"symbol":case"boolean":E.removeAttribute(O);return}E.setAttribute(O,""+n)}}function zn(E,O,n,t){if(t===null)E.removeAttribute(n);else{switch(typeof t){case"undefined":case"function":case"symbol":case"boolean":E.removeAttribute(n);return}E.setAttributeNS(O,n,""+t)}}function gT(E){switch(typeof E){case"bigint":case"boolean":case"number":case"string":case"undefined":return E;case"object":return E;default:return""}}function ZR(E){var O=E.type;return(E=E.nodeName)&&E.toLowerCase()==="input"&&(O==="checkbox"||O==="radio")}function XR(E,O,n){var t=Object.getOwnPropertyDescriptor(E.constructor.prototype,O);if(!E.hasOwnProperty(O)&&typeof t<"u"&&typeof t.get=="function"&&typeof t.set=="function"){var o=t.get,S=t.set;return Object.defineProperty(E,O,{configurable:!0,get:function(){return o.call(this)},set:function(d){n=""+d,S.call(this,d)}}),Object.defineProperty(E,O,{enumerable:t.enumerable}),{getValue:function(){return n},setValue:function(d){n=""+d},stopTracking:function(){E._valueTracker=null,delete E[O]}}}}function Fe(E){if(!E._valueTracker){var O=ZR(E)?"checked":"value";E._valueTracker=XR(E,O,""+E[O])}}function qR(E){if(!E)return!1;var O=E._valueTracker;if(!O)return!0;var n=O.getValue(),t="";return E&&(t=ZR(E)?E.checked?"true":"false":E.value),E=t,E!==n?(O.setValue(E),!0):!1}function gI(E){if(E=E||(typeof document<"u"?document:void 0),typeof E>"u")return null;try{return E.activeElement||E.body}catch{return E.body}}var je=/[\n"\\]/g;function XT(E){return E.replace(je,function(O){return"\\"+O.charCodeAt(0).toString(16)+" "})}function NO(E,O,n,t,o,S,d,V){E.name="",d!=null&&typeof d!="function"&&typeof d!="symbol"&&typeof d!="boolean"?E.type=d:E.removeAttribute("type"),O!=null?d==="number"?(O===0&&E.value===""||E.value!=O)&&(E.value=""+gT(O)):E.value!==""+gT(O)&&(E.value=""+gT(O)):d!=="submit"&&d!=="reset"||E.removeAttribute("value"),O!=null?rt(E,d,gT(O)):n!=null?rt(E,d,gT(n)):t!=null&&E.removeAttribute("value"),o==null&&S!=null&&(E.defaultChecked=!!S),o!=null&&(E.checked=o&&typeof o!="function"&&typeof o!="symbol"),V!=null&&typeof V!="function"&&typeof V!="symbol"&&typeof V!="boolean"?E.name=""+gT(V):E.removeAttribute("name")}function Te(E,O,n,t,o,S,d,V){if(S!=null&&typeof S!="function"&&typeof S!="symbol"&&typeof S!="boolean"&&(E.type=S),O!=null||n!=null){if(!(S!=="submit"&&S!=="reset"||O!=null)){Fe(E);return}n=n!=null?""+gT(n):"",O=O!=null?""+gT(O):n,V||O===E.value||(E.value=O),E.defaultValue=O}t=t??o,t=typeof t!="function"&&typeof t!="symbol"&&!!t,E.checked=V?E.checked:!!t,E.defaultChecked=!!t,d!=null&&typeof d!="function"&&typeof d!="symbol"&&typeof d!="boolean"&&(E.name=d),Fe(E)}function rt(E,O,n){O==="number"&&gI(E.ownerDocument)===E||E.defaultValue===""+n||(E.defaultValue=""+n)}function Pt(E,O,n,t){if(E=E.options,O){O={};for(var o=0;o<n.length;o++)O["$"+n[o]]=!0;for(n=0;n<E.length;n++)o=O.hasOwnProperty("$"+E[n].value),E[n].selected!==o&&(E[n].selected=o),o&&t&&(E[n].defaultSelected=!0)}else{for(n=""+gT(n),O=null,o=0;o<E.length;o++){if(E[o].value===n){E[o].selected=!0,t&&(E[o].defaultSelected=!0);return}O!==null||E[o].disabled||(O=E[o])}O!==null&&(O.selected=!0)}}function WR(E,O,n){if(O!=null&&(O=""+gT(O),O!==E.value&&(E.value=O),n==null)){E.defaultValue!==O&&(E.defaultValue=O);return}E.defaultValue=n!=null?""+gT(n):""}function jM(E,O,n,t){if(O==null){if(t!=null){if(n!=null)throw Error(f(92));if(lT(t)){if(1<t.length)throw Error(f(93));t=t[0]}n=t}n==null&&(n=""),O=n}n=gT(O),E.defaultValue=n,t=E.textContent,t===n&&t!==""&&t!==null&&(E.value=t),Fe(E)}function at(E,O){if(O){var n=E.firstChild;if(n&&n===E.lastChild&&n.nodeType===3){n.nodeValue=O;return}}E.textContent=O}var ZM=new Set("animationIterationCount aspectRatio borderImageOutset borderImageSlice borderImageWidth boxFlex boxFlexGroup boxOrdinalGroup columnCount columns flex flexGrow flexPositive flexShrink flexNegative flexOrder gridArea gridRow gridRowEnd gridRowSpan gridRowStart gridColumn gridColumnEnd gridColumnSpan gridColumnStart fontWeight lineClamp lineHeight opacity order orphans scale tabSize widows zIndex zoom fillOpacity floodOpacity stopOpacity strokeDasharray strokeDashoffset strokeMiterlimit strokeOpacity strokeWidth MozAnimationIterationCount MozBoxFlex MozBoxFlexGroup MozLineClamp msAnimationIterationCount msFlex msZoom msFlexGrow msFlexNegative msFlexOrder msFlexPositive msFlexShrink msGridColumn msGridColumnSpan msGridRow msGridRowSpan WebkitAnimationIterationCount WebkitBoxFlex WebKitBoxFlexGroup WebkitBoxOrdinalGroup WebkitColumnCount WebkitColumns WebkitFlex WebkitFlexGrow WebkitFlexPositive WebkitFlexShrink WebkitLineClamp".split(" "));function XM(E,O,n){var t=O.indexOf("--")===0;n==null||typeof n=="boolean"||n===""?t?E.setProperty(O,""):O==="float"?E.cssFloat="":E[O]="":t?E.setProperty(O,n):typeof n!="number"||n===0||ZM.has(O)?O==="float"?E.cssFloat=n:E[O]=(""+n).trim():E[O]=n+"px"}function yI(E,O,n){if(O!=null&&typeof O!="object")throw Error(f(62));if(E=E.style,n!=null){for(var t in n)!n.hasOwnProperty(t)||O!=null&&O.hasOwnProperty(t)||(t.indexOf("--")===0?E.setProperty(t,""):t==="float"?E.cssFloat="":E[t]="");for(var o in O)t=O[o],O.hasOwnProperty(o)&&n[o]!==t&&XM(E,o,t)}else for(var S in O)O.hasOwnProperty(S)&&XM(E,S,O[S])}function Ze(E){if(E.indexOf("-")===-1)return!1;switch(E){case"annotation-xml":case"color-profile":case"font-face":case"font-face-src":case"font-face-uri":case"font-face-format":case"font-face-name":case"missing-glyph":return!1;default:return!0}}var qM=new Map([["acceptCharset","accept-charset"],["htmlFor","for"],["httpEquiv","http-equiv"],["crossOrigin","crossorigin"],["accentHeight","accent-height"],["alignmentBaseline","alignment-baseline"],["arabicForm","arabic-form"],["baselineShift","baseline-shift"],["capHeight","cap-height"],["clipPath","clip-path"],["clipRule","clip-rule"],["colorInterpolation","color-interpolation"],["colorInterpolationFilters","color-interpolation-filters"],["colorProfile","color-profile"],["colorRendering","color-rendering"],["dominantBaseline","dominant-baseline"],["enableBackground","enable-background"],["fillOpacity","fill-opacity"],["fillRule","fill-rule"],["floodColor","flood-color"],["floodOpacity","flood-opacity"],["fontFamily","font-family"],["fontSize","font-size"],["fontSizeAdjust","font-size-adjust"],["fontStretch","font-stretch"],["fontStyle","font-style"],["fontVariant","font-variant"],["fontWeight","font-weight"],["glyphName","glyph-name"],["glyphOrientationHorizontal","glyph-orientation-horizontal"],["glyphOrientationVertical","glyph-orientation-vertical"],["horizAdvX","horiz-adv-x"],["horizOriginX","horiz-origin-x"],["imageRendering","image-rendering"],["letterSpacing","letter-spacing"],["lightingColor","lighting-color"],["markerEnd","marker-end"],["markerMid","marker-mid"],["markerStart","marker-start"],["overlinePosition","overline-position"],["overlineThickness","overline-thickness"],["paintOrder","paint-order"],["panose-1","panose-1"],["pointerEvents","pointer-events"],["renderingIntent","rendering-intent"],["shapeRendering","shape-rendering"],["stopColor","stop-color"],["stopOpacity","stop-opacity"],["strikethroughPosition","strikethrough-position"],["strikethroughThickness","strikethrough-thickness"],["strokeDasharray","stroke-dasharray"],["strokeDashoffset","stroke-dashoffset"],["strokeLinecap","stroke-linecap"],["strokeLinejoin","stroke-linejoin"],["strokeMiterlimit","stroke-miterlimit"],["strokeOpacity","stroke-opacity"],["strokeWidth","stroke-width"],["textAnchor","text-anchor"],["textDecoration","text-decoration"],["textRendering","text-rendering"],["transformOrigin","transform-origin"],["underlinePosition","underline-position"],["underlineThickness","underline-thickness"],["unicodeBidi","unicode-bidi"],["unicodeRange","unicode-range"],["unitsPerEm","units-per-em"],["vAlphabetic","v-alphabetic"],["vHanging","v-hanging"],["vIdeographic","v-ideographic"],["vMathematical","v-mathematical"],["vectorEffect","vector-effect"],["vertAdvY","vert-adv-y"],["vertOriginX","vert-origin-x"],["vertOriginY","vert-origin-y"],["wordSpacing","word-spacing"],["writingMode","writing-mode"],["xmlnsXlink","xmlns:xlink"],["xHeight","x-height"]]),Xe=/^[\u0000-\u001F ]*j[\r\n\t]*a[\r\n\t]*v[\r\n\t]*a[\r\n\t]*s[\r\n\t]*c[\r\n\t]*r[\r\n\t]*i[\r\n\t]*p[\r\n\t]*t[\r\n\t]*:/i;function ne(E){return Xe.test(""+E)?"javascript:throw new Error('React has blocked a javascript: URL as a security precaution.')":E}function qT(){}var qe=null;function GT(E){return E=E.target||E.srcElement||window,E.correspondingUseElement&&(E=E.correspondingUseElement),E.nodeType===3?E.parentNode:E}var Yn=null,Dt=null;function QR(E){var O=wn(E);if(O&&(E=O.stateNode)){var n=E[QO]||null;E:switch(E=O.stateNode,O.type){case"input":if(NO(E,n.value,n.defaultValue,n.defaultValue,n.checked,n.defaultChecked,n.type,n.name),O=n.name,n.type==="radio"&&O!=null){for(n=E;n.parentNode;)n=n.parentNode;for(n=n.querySelectorAll('input[name="'+XT(""+O)+'"][type="radio"]'),O=0;O<n.length;O++){var t=n[O];if(t!==E&&t.form===E.form){var o=t[QO]||null;if(!o)throw Error(f(90));NO(t,o.value,o.defaultValue,o.defaultValue,o.checked,o.defaultChecked,o.type,o.name)}}for(O=0;O<n.length;O++)t=n[O],t.form===E.form&&qR(t)}break E;case"textarea":WR(E,n.value,n.defaultValue);break E;case"select":O=n.value,O!=null&&Pt(E,!!n.multiple,O,!1)}}}var WM=!1;function We(E,O,n){if(WM)return E(O,n);WM=!0;try{var t=E(O);return t}finally{if(WM=!1,(Yn!==null||Dt!==null)&&(bM(),Yn&&(O=Yn,E=Dt,Dt=Yn=null,QR(O),E)))for(O=0;O<E.length;O++)QR(E[O])}}function Fn(E,O){var n=E.stateNode;if(n===null)return null;var t=n[QO]||null;if(t===null)return null;n=t[O];E:switch(O){case"onClick":case"onClickCapture":case"onDoubleClick":case"onDoubleClickCapture":case"onMouseDown":case"onMouseDownCapture":case"onMouseMove":case"onMouseMoveCapture":case"onMouseUp":case"onMouseUpCapture":case"onMouseEnter":(t=!t.disabled)||(E=E.type,t=!(E==="button"||E==="input"||E==="select"||E==="textarea")),E=!t;break E;default:E=!1}if(E)return null;if(n&&typeof n!="function")throw Error(f(231,O,typeof n));return n}var Hn=!(typeof window>"u"||typeof window.document>"u"||typeof window.document.createElement>"u"),Ie=!1;if(Hn)try{var UI={};Object.defineProperty(UI,"passive",{get:function(){Ie=!0}}),window.addEventListener("test",UI,UI),window.removeEventListener("test",UI,UI)}catch{Ie=!1}var Cn=null,iI=null,Qe=null;function xI(){if(Qe)return Qe;var E,O=iI,n=O.length,t,o="value"in Cn?Cn.value:Cn.textContent,S=o.length;for(E=0;E<n&&O[E]===o[E];E++);var d=n-E;for(t=1;t<=d&&O[n-t]===o[S-t];t++);return Qe=o.slice(E,1<t?1-t:void 0)}function Je(E){var O=E.keyCode;return"charCode"in E?(E=E.charCode,E===0&&O===13&&(E=13)):E=O,E===10&&(E=13),32<=E||E===13?E:0}function $e(){return!0}function JR(){return!1}function nT(E){function O(n,t,o,S,d){this._reactName=n,this._targetInst=o,this.type=t,this.nativeEvent=S,this.target=d,this.currentTarget=null;for(var V in E)E.hasOwnProperty(V)&&(n=E[V],this[V]=n?n(S):S[V]);return this.isDefaultPrevented=(S.defaultPrevented!=null?S.defaultPrevented:S.returnValue===!1)?$e:JR,this.isPropagationStopped=JR,this}return IE(O.prototype,{preventDefault:function(){this.defaultPrevented=!0;var n=this.nativeEvent;n&&(n.preventDefault?n.preventDefault():typeof n.returnValue!="unknown"&&(n.returnValue=!1),this.isDefaultPrevented=$e)},stopPropagation:function(){var n=this.nativeEvent;n&&(n.stopPropagation?n.stopPropagation():typeof n.cancelBubble!="unknown"&&(n.cancelBubble=!0),this.isPropagationStopped=$e)},persist:function(){},isPersistent:$e}),O}var vI={eventPhase:0,bubbles:0,cancelable:0,timeStamp:function(E){return E.timeStamp||Date.now()},defaultPrevented:0,isTrusted:0},KI=nT(vI),Lt=IE({},vI,{view:0,detail:0}),jn=nT(Lt),$R,ct,wI,ht=IE({},Lt,{screenX:0,screenY:0,clientX:0,clientY:0,pageX:0,pageY:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,getModifierState:Bn,button:0,buttons:0,relatedTarget:function(E){return E.relatedTarget===void 0?E.fromElement===E.srcElement?E.toElement:E.fromElement:E.relatedTarget},movementX:function(E){return"movementX"in E?E.movementX:(E!==wI&&(wI&&E.type==="mousemove"?($R=E.screenX-wI.screenX,ct=E.screenY-wI.screenY):ct=$R=0,wI=E),$R)},movementY:function(E){return"movementY"in E?E.movementY:ct}}),QM=nT(ht),Es=IE({},ht,{dataTransfer:0}),Ns=nT(Es),o_=IE({},Lt,{relatedTarget:0}),EM=nT(o_),JM=IE({},vI,{animationName:0,elapsedTime:0,pseudoElement:0}),dt=nT(JM),kI=IE({},vI,{clipboardData:function(E){return"clipboardData"in E?E.clipboardData:window.clipboardData}}),te=nT(kI),A_=IE({},vI,{data:0}),Os=nT(A_),S_={Esc:"Escape",Spacebar:" ",Left:"ArrowLeft",Up:"ArrowUp",Right:"ArrowRight",Down:"ArrowDown",Del:"Delete",Win:"OS",Menu:"ContextMenu",Apps:"ContextMenu",Scroll:"ScrollLock",MozPrintableKey:"Unidentified"},Ts={8:"Backspace",9:"Tab",12:"Clear",13:"Enter",16:"Shift",17:"Control",18:"Alt",19:"Pause",20:"CapsLock",27:"Escape",32:" ",33:"PageUp",34:"PageDown",35:"End",36:"Home",37:"ArrowLeft",38:"ArrowUp",39:"ArrowRight",40:"ArrowDown",45:"Insert",46:"Delete",112:"F1",113:"F2",114:"F3",115:"F4",116:"F5",117:"F6",118:"F7",119:"F8",120:"F9",121:"F10",122:"F11",123:"F12",144:"NumLock",145:"ScrollLock",224:"Meta"},CO={Alt:"altKey",Control:"ctrlKey",Meta:"metaKey",Shift:"shiftKey"};function Pn(E){var O=this.nativeEvent;return O.getModifierState?O.getModifierState(E):(E=CO[E])?!!O[E]:!1}function Bn(){return Pn}var ns=IE({},Lt,{key:function(E){if(E.key){var O=S_[E.key]||E.key;if(O!=="Unidentified")return O}return E.type==="keypress"?(E=Je(E),E===13?"Enter":String.fromCharCode(E)):E.type==="keydown"||E.type==="keyup"?Ts[E.keyCode]||"Unidentified":""},code:0,location:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,repeat:0,locale:0,getModifierState:Bn,charCode:function(E){return E.type==="keypress"?Je(E):0},keyCode:function(E){return E.type==="keydown"||E.type==="keyup"?E.keyCode:0},which:function(E){return E.type==="keypress"?Je(E):E.type==="keydown"||E.type==="keyup"?E.keyCode:0}}),Is=nT(ns),ee=IE({},ht,{pointerId:0,width:0,height:0,pressure:0,tangentialPressure:0,tiltX:0,tiltY:0,twist:0,pointerType:0,isPrimary:0}),NM=nT(ee),Me=IE({},Lt,{touches:0,targetTouches:0,changedTouches:0,altKey:0,metaKey:0,ctrlKey:0,shiftKey:0,getModifierState:Bn}),ts=nT(Me),zI=IE({},vI,{propertyName:0,elapsedTime:0,pseudoElement:0}),oI=nT(zI),OM=IE({},ht,{deltaX:function(E){return"deltaX"in E?E.deltaX:"wheelDeltaX"in E?-E.wheelDeltaX:0},deltaY:function(E){return"deltaY"in E?E.deltaY:"wheelDeltaY"in E?-E.wheelDeltaY:"wheelDelta"in E?-E.wheelDelta:0},deltaZ:0,deltaMode:0}),Gt=nT(OM),es=IE({},vI,{newState:0,oldState:0}),Ms=nT(es),FI=[9,13,27,32],Re=Hn&&"CompositionEvent"in window,an=null;Hn&&"documentMode"in document&&(an=document.documentMode);var l_=Hn&&"TextEvent"in window&&!an,$M=Hn&&(!Re||an&&8<an&&11>=an),Zn=" ",Rs=!1;function ss(E,O){switch(E){case"keyup":return FI.indexOf(O.keyCode)!==-1;case"keydown":return O.keyCode!==229;case"keypress":case"mousedown":case"focusout":return!0;default:return!1}}function TM(E){return E=E.detail,typeof E=="object"&&"data"in E?E.data:null}var ut=!1;function _s(E,O){switch(E){case"compositionend":return TM(O);case"keypress":return O.which!==32?null:(Rs=!0,Zn);case"textInput":return E=O.data,E===Zn&&Rs?null:E;default:return null}}function jO(E,O){if(ut)return E==="compositionend"||!Re&&ss(E,O)?(E=xI(),Qe=iI=Cn=null,ut=!1,E):null;switch(E){case"paste":return null;case"keypress":if(!(O.ctrlKey||O.altKey||O.metaKey)||O.ctrlKey&&O.altKey){if(O.char&&1<O.char.length)return O.char;if(O.which)return String.fromCharCode(O.which)}return null;case"compositionend":return $M&&O.locale!=="ko"?null:O.data;default:return null}}var is={color:!0,date:!0,datetime:!0,"datetime-local":!0,email:!0,month:!0,number:!0,password:!0,range:!0,search:!0,tel:!0,text:!0,time:!0,url:!0,week:!0};function se(E){var O=E&&E.nodeName&&E.nodeName.toLowerCase();return O==="input"?!!is[E.type]:O==="textarea"}function jI(E,O,n,t){Yn?Dt?Dt.push(t):Dt=[t]:Yn=t,O=A(O,"onChange"),0<O.length&&(n=new KI("onChange","change",null,n,t),E.push({event:n,listeners:O}))}var Yt=null,aT=null;function os(E){Ho(E,0)}function _e(E){var O=RI(E);if(qR(O))return E}function nM(E,O){if(E==="change")return O}var ER=!1;if(Hn){var WT;if(Hn){var bn="oninput"in document;if(!bn){var _T=document.createElement("div");_T.setAttribute("oninput","return;"),bn=typeof _T.oninput=="function"}WT=bn}else WT=!1;ER=WT&&(!document.documentMode||9<document.documentMode)}function AI(){Yt&&(Yt.detachEvent("onpropertychange",Ht),aT=Yt=null)}function Ht(E){if(E.propertyName==="value"&&_e(aT)){var O=[];jI(O,aT,E,GT(E)),We(os,O)}}function IM(E,O,n){E==="focusin"?(AI(),Yt=O,aT=n,Yt.attachEvent("onpropertychange",Ht)):E==="focusout"&&AI()}function ie(E){if(E==="selectionchange"||E==="keyup"||E==="keydown")return _e(aT)}function tM(E,O){if(E==="click")return _e(O)}function Xn(E,O){if(E==="input"||E==="change")return _e(O)}function r_(E,O){return E===O&&(E!==0||1/E===1/O)||E!==E&&O!==O}var ZO=typeof Object.is=="function"?Object.is:r_;function oe(E,O){if(ZO(E,O))return!0;if(typeof E!="object"||E===null||typeof O!="object"||O===null)return!1;var n=Object.keys(E),t=Object.keys(O);if(n.length!==t.length)return!1;for(t=0;t<n.length;t++){var o=n[t];if(!rT.call(O,o)||!ZO(E[o],O[o]))return!1}return!0}function SI(E){for(;E&&E.firstChild;)E=E.firstChild;return E}function Ct(E,O){var n=SI(E);E=0;for(var t;n;){if(n.nodeType===3){if(t=E+n.textContent.length,E<=O&&t>=O)return{node:n,offset:O-E};E=t}E:{for(;n;){if(n.nextSibling){n=n.nextSibling;break E}n=n.parentNode}n=void 0}n=SI(n)}}function As(E,O){return E&&O?E===O?!0:E&&E.nodeType===3?!1:O&&O.nodeType===3?As(E,O.parentNode):"contains"in E?E.contains(O):E.compareDocumentPosition?!!(E.compareDocumentPosition(O)&16):!1:!1}function eM(E){E=E!=null&&E.ownerDocument!=null&&E.ownerDocument.defaultView!=null?E.ownerDocument.defaultView:window;for(var O=gI(E.document);O instanceof E.HTMLIFrameElement;){try{var n=typeof O.contentWindow.location.href=="string"}catch{n=!1}if(n)E=O.contentWindow;else break;O=gI(E.document)}return O}function Ae(E){var O=E&&E.nodeName&&E.nodeName.toLowerCase();return O&&(O==="input"&&(E.type==="text"||E.type==="search"||E.type==="tel"||E.type==="url"||E.type==="password")||O==="textarea"||E.contentEditable==="true")}var P_=Hn&&"documentMode"in document&&11>=document.documentMode,Bt=null,NR=null,lI=null,bt=!1;function Ss(E,O,n){var t=n.window===n?n.document:n.nodeType===9?n:n.ownerDocument;bt||Bt==null||Bt!==gI(t)||(t=Bt,"selectionStart"in t&&Ae(t)?t={start:t.selectionStart,end:t.selectionEnd}:(t=(t.ownerDocument&&t.ownerDocument.defaultView||window).getSelection(),t={anchorNode:t.anchorNode,anchorOffset:t.anchorOffset,focusNode:t.focusNode,focusOffset:t.focusOffset}),lI&&oe(lI,t)||(lI=t,t=A(NR,"onSelect"),0<t.length&&(O=new KI("onSelect","select",null,O,n),E.push({event:O,listeners:t}),O.target=Bt)))}function ZI(E,O){var n={};return n[E.toLowerCase()]=O.toLowerCase(),n["Webkit"+E]="webkit"+O,n["Moz"+E]="moz"+O,n}var uT={animationend:ZI("Animation","AnimationEnd"),animationiteration:ZI("Animation","AnimationIteration"),animationstart:ZI("Animation","AnimationStart"),transitionrun:ZI("Transition","TransitionRun"),transitionstart:ZI("Transition","TransitionStart"),transitioncancel:ZI("Transition","TransitionCancel"),transitionend:ZI("Transition","TransitionEnd")},OR={},TR={};Hn&&(TR=document.createElement("div").style,"AnimationEvent"in window||(delete uT.animationend.animation,delete uT.animationiteration.animation,delete uT.animationstart.animation),"TransitionEvent"in window||delete uT.transitionend.transition);function rI(E){if(OR[E])return OR[E];if(!uT[E])return E;var O=uT[E],n;for(n in O)if(O.hasOwnProperty(n)&&n in TR)return OR[E]=O[n];return E}var PI=rI("animationend"),aI=rI("animationiteration"),nR=rI("animationstart"),ls=rI("transitionrun"),IR=rI("transitionstart"),rs=rI("transitioncancel"),DI=rI("transitionend"),mn=new Map,tR="abort auxClick beforeToggle cancel canPlay canPlayThrough click close contextMenu copy cut drag dragEnd dragEnter dragExit dragLeave dragOver dragStart drop durationChange emptied encrypted ended error gotPointerCapture input invalid keyDown keyPress keyUp load loadedData loadedMetadata loadStart lostPointerCapture mouseDown mouseMove mouseOut mouseOver mouseUp paste pause play playing pointerCancel pointerDown pointerMove pointerOut pointerOver pointerUp progress rateChange reset resize seeked seeking stalled submit suspend timeUpdate touchCancel touchEnd touchStart volumeChange scroll toggle touchMove waiting wheel".split(" ");tR.push("scrollEnd");function QT(E,O){mn.set(E,O),kn(O,[E])}var Se=typeof reportError=="function"?reportError:function(E){if(typeof window=="object"&&typeof window.ErrorEvent=="function"){var O=new window.ErrorEvent("error",{bubbles:!0,cancelable:!0,message:typeof E=="object"&&E!==null&&typeof E.message=="string"?String(E.message):String(E),error:E});if(!window.dispatchEvent(O))return}else if(typeof process=="object"&&typeof process.emit=="function"){process.emit("uncaughtException",E);return}console.error(E)},JT=[],mt=0,ft=0;function pt(){for(var E=mt,O=ft=mt=0;O<E;){var n=JT[O];JT[O++]=null;var t=JT[O];JT[O++]=null;var o=JT[O];JT[O++]=null;var S=JT[O];if(JT[O++]=null,t!==null&&o!==null){var d=t.pending;d===null?o.next=o:(o.next=d.next,d.next=o),t.pending=o}S!==0&&Ps(n,o,S)}}function Vt(E,O,n,t){JT[mt++]=E,JT[mt++]=O,JT[mt++]=n,JT[mt++]=t,ft|=t,E.lanes|=t,E=E.alternate,E!==null&&(E.lanes|=t)}function LI(E,O,n,t){return Vt(E,O,n,t),XI(E)}function qn(E,O){return Vt(E,null,null,O),XI(E)}function Ps(E,O,n){E.lanes|=n;var t=E.alternate;t!==null&&(t.lanes|=n);for(var o=!1,S=E.return;S!==null;)S.childLanes|=n,t=S.alternate,t!==null&&(t.childLanes|=n),S.tag===22&&(E=S.stateNode,E===null||E._visibility&1||(o=!0)),E=S,S=S.return;return E.tag===3?(S=E.stateNode,o&&O!==null&&(o=31-nE(n),E=S.hiddenUpdates,t=E[o],t===null?E[o]=[O]:t.push(O),O.lane=n|536870912),S):null}function XI(E){if(50<Ue)throw Ue=0,W_=null,Error(f(185));for(var O=E.return;O!==null;)E=O,O=E.return;return E.tag===3?E.stateNode:null}var $T={};function a_(E,O,n,t){this.tag=E,this.key=n,this.sibling=this.child=this.return=this.stateNode=this.type=this.elementType=null,this.index=0,this.refCleanup=this.ref=null,this.pendingProps=O,this.dependencies=this.memoizedState=this.updateQueue=this.memoizedProps=null,this.mode=t,this.subtreeFlags=this.flags=0,this.deletions=null,this.childLanes=this.lanes=0,this.alternate=null}function iT(E,O,n,t){return new a_(E,O,n,t)}function MM(E){return E=E.prototype,!(!E||!E.isReactComponent)}function Wn(E,O){var n=E.alternate;return n===null?(n=iT(E.tag,O,E.key,E.mode),n.elementType=E.elementType,n.type=E.type,n.stateNode=E.stateNode,n.alternate=E,E.alternate=n):(n.pendingProps=O,n.type=E.type,n.flags=0,n.subtreeFlags=0,n.deletions=null),n.flags=E.flags&65011712,n.childLanes=E.childLanes,n.lanes=E.lanes,n.child=E.child,n.memoizedProps=E.memoizedProps,n.memoizedState=E.memoizedState,n.updateQueue=E.updateQueue,O=E.dependencies,n.dependencies=O===null?null:{lanes:O.lanes,firstContext:O.firstContext},n.sibling=E.sibling,n.index=E.index,n.ref=E.ref,n.refCleanup=E.refCleanup,n}function En(E,O){E.flags&=65011714;var n=E.alternate;return n===null?(E.childLanes=0,E.lanes=O,E.child=null,E.subtreeFlags=0,E.memoizedProps=null,E.memoizedState=null,E.updateQueue=null,E.dependencies=null,E.stateNode=null):(E.childLanes=n.childLanes,E.lanes=n.lanes,E.child=n.child,E.subtreeFlags=0,E.deletions=null,E.memoizedProps=n.memoizedProps,E.memoizedState=n.memoizedState,E.updateQueue=n.updateQueue,E.type=n.type,O=n.dependencies,E.dependencies=O===null?null:{lanes:O.lanes,firstContext:O.firstContext}),E}function Qn(E,O,n,t,o,S){var d=0;if(t=E,typeof E=="function")MM(E)&&(d=1);else if(typeof E=="string")d=$S(E,n,FE.current)?26:E==="html"||E==="head"||E==="body"?27:5;else E:switch(E){case xN:return E=iT(31,n,O,o),E.elementType=xN,E.lanes=S,E;case zE:return qI(n.children,o,S,O);case wE:d=8,o|=24;break;case $E:return E=iT(12,n,O,o|2),E.elementType=$E,E.lanes=S,E;case PN:return E=iT(13,n,O,o),E.elementType=PN,E.lanes=S,E;case $N:return E=iT(19,n,O,o),E.elementType=$N,E.lanes=S,E;default:if(typeof E=="object"&&E!==null)switch(E.$$typeof){case xE:d=10;break E;case DE:d=9;break E;case gE:d=11;break E;case cE:d=14;break E;case pN:d=16,t=null;break E}d=29,n=Error(f(130,E===null?"null":typeof E,"")),t=null}return O=iT(d,n,O,o),O.elementType=E,O.type=t,O.lanes=S,O}function qI(E,O,n,t){return E=iT(7,E,t,O),E.lanes=n,E}function RM(E,O,n){return E=iT(6,E,null,O),E.lanes=n,E}function as(E){var O=iT(18,null,null,0);return O.stateNode=E,O}function le(E,O,n){return O=iT(4,E.children!==null?E.children:[],E.key,O),O.lanes=n,O.stateNode={containerInfo:E.containerInfo,pendingChildren:null,implementation:E.implementation},O}var Ds=new WeakMap;function yT(E,O){if(typeof E=="object"&&E!==null){var n=Ds.get(E);return n!==void 0?n:(O={value:E,source:O,stack:tI(O)},Ds.set(E,O),O)}return{value:E,source:O,stack:tI(O)}}var WI=[],QI=0,cI=null,IT=0,hN=[],Nn=0,On=null,UT=1,DT="";function FN(E,O){WI[QI++]=IT,WI[QI++]=cI,cI=E,IT=O}function eR(E,O,n){hN[Nn++]=UT,hN[Nn++]=DT,hN[Nn++]=On,On=E;var t=UT;E=DT;var o=32-nE(t)-1;t&=~(1<<o),n+=1;var S=32-nE(O)+o;if(30<S){var d=o-o%5;S=(t&(1<<d)-1).toString(32),t>>=d,o-=d,UT=1<<32-nE(O)+o|n<<o|t,DT=S+E}else UT=1<<S|n<<o|t,DT=E}function sM(E){E.return!==null&&(FN(E,1),eR(E,1,0))}function _M(E){for(;E===cI;)cI=WI[--QI],WI[QI]=null,IT=WI[--QI],WI[QI]=null;for(;E===On;)On=hN[--Nn],hN[Nn]=null,DT=hN[--Nn],hN[Nn]=null,UT=hN[--Nn],hN[Nn]=null}function IN(E,O){hN[Nn++]=UT,hN[Nn++]=DT,hN[Nn++]=On,UT=O.id,DT=O.overflow,On=E}var pO=null,nO=null,gN=!1,Dn=null,iN=!1,gt=Error(f(519));function hI(E){var O=Error(f(418,1<arguments.length&&arguments[1]!==void 0&&arguments[1]?"text":"HTML",""));throw re(yT(O,E)),gt}function MR(E){var O=E.stateNode,n=E.type,t=E.memoizedProps;switch(O[aO]=E,O[QO]=t,n){case"dialog":UN("cancel",O),UN("close",O);break;case"iframe":case"object":case"embed":UN("load",O);break;case"video":case"audio":for(n=0;n<xR.length;n++)UN(xR[n],O);break;case"source":UN("error",O);break;case"img":case"image":case"link":UN("error",O),UN("load",O);break;case"details":UN("toggle",O);break;case"input":UN("invalid",O),Te(O,t.value,t.defaultValue,t.checked,t.defaultChecked,t.type,t.name,!0);break;case"select":UN("invalid",O);break;case"textarea":UN("invalid",O),jM(O,t.value,t.defaultValue,t.children)}n=t.children,typeof n!="string"&&typeof n!="number"&&typeof n!="bigint"||O.textContent===""+n||t.suppressHydrationWarning===!0||R(O.textContent,n)?(t.popover!=null&&(UN("beforetoggle",O),UN("toggle",O)),t.onScroll!=null&&UN("scroll",O),t.onScrollEnd!=null&&UN("scrollend",O),t.onClick!=null&&(O.onclick=qT),O=!0):O=!1,O||hI(E,!0)}function Ls(E){for(pO=E.return;pO;)switch(pO.tag){case 5:case 31:case 13:iN=!1;return;case 27:case 3:iN=!0;return;default:pO=pO.return}}function LT(E){if(E!==pO)return!1;if(!gN)return Ls(E),gN=!0,!1;var O=E.tag,n;if((n=O!==3&&O!==27)&&((n=O===5)&&(n=E.type,n=!(n!=="form"&&n!=="button")||g(E.type,E.memoizedProps)),n=!n),n&&nO&&hI(E),Ls(E),O===13){if(E=E.memoizedState,E=E!==null?E.dehydrated:null,!E)throw Error(f(317));nO=lN(E)}else if(O===31){if(E=E.memoizedState,E=E!==null?E.dehydrated:null,!E)throw Error(f(317));nO=lN(E)}else O===27?(O=nO,aE(E.type)?(E=oN,oN=null,nO=E):nO=O):nO=pO?LO(E.stateNode.nextSibling):null;return!0}function Tn(){nO=pO=null,gN=!1}function RR(){var E=Dn;return E!==null&&(AT===null?AT=E:AT.push.apply(AT,E),Dn=null),E}function re(E){Dn===null?Dn=[E]:Dn.push(E)}var sR=EE(null),Ln=null,xT=null;function vT(E,O,n){yE(sR,O._currentValue),O._currentValue=n}function nn(E){E._currentValue=sR.current,z(sR)}function iM(E,O,n){for(;E!==null;){var t=E.alternate;if((E.childLanes&O)!==O?(E.childLanes|=O,t!==null&&(t.childLanes|=O)):t!==null&&(t.childLanes&O)!==O&&(t.childLanes|=O),E===n)break;E=E.return}}function Pe(E,O,n,t){var o=E.child;for(o!==null&&(o.return=E);o!==null;){var S=o.dependencies;if(S!==null){var d=o.child;S=S.firstContext;E:for(;S!==null;){var V=S;S=o;for(var X=0;X<O.length;X++)if(V.context===O[X]){S.lanes|=n,V=S.alternate,V!==null&&(V.lanes|=n),iM(S.return,n,E),t||(d=null);break E}S=V.next}}else if(o.tag===18){if(d=o.return,d===null)throw Error(f(341));d.lanes|=n,S=d.alternate,S!==null&&(S.lanes|=n),iM(d,n,E),d=null}else d=o.child;if(d!==null)d.return=o;else for(d=o;d!==null;){if(d===E){d=null;break}if(o=d.sibling,o!==null){o.return=d.return,d=o;break}d=d.return}o=d}}function dI(E,O,n,t){E=null;for(var o=O,S=!1;o!==null;){if(!S){if((o.flags&524288)!==0)S=!0;else if((o.flags&262144)!==0)break}if(o.tag===10){var d=o.alternate;if(d===null)throw Error(f(387));if(d=d.memoizedProps,d!==null){var V=o.type;ZO(o.pendingProps.value,d.value)||(E!==null?E.push(V):E=[V])}}else if(o===KN.current){if(d=o.alternate,d===null)throw Error(f(387));d.memoizedState.memoizedState!==o.memoizedState.memoizedState&&(E!==null?E.push(Si):E=[Si])}o=o.return}E!==null&&Pe(O,E,n,t),O.flags|=262144}function ae(E){for(E=E.firstContext;E!==null;){if(!ZO(E.context._currentValue,E.memoizedValue))return!0;E=E.next}return!1}function GI(E){Ln=E,xT=null,E=E.dependencies,E!==null&&(E.firstContext=null)}function tT(E){return _R(Ln,E)}function De(E,O){return Ln===null&&GI(E),_R(E,O)}function _R(E,O){var n=O._currentValue;if(O={context:O,memoizedValue:n,next:null},xT===null){if(E===null)throw Error(f(308));xT=O,E.dependencies={lanes:0,firstContext:O},E.flags|=524288}else xT=xT.next=O;return n}var oM=typeof AbortController<"u"?AbortController:function(){var E=[],O=this.signal={aborted:!1,addEventListener:function(n,t){E.push(t)}};this.abort=function(){O.aborted=!0,E.forEach(function(n){return n()})}},fn=G.unstable_scheduleCallback,D_=G.unstable_NormalPriority,KO={$$typeof:xE,Consumer:null,Provider:null,_currentValue:null,_currentValue2:null,_threadCount:0};function Le(){return{controller:new oM,data:new Map,refCount:0}}function yt(E){E.refCount--,E.refCount===0&&fn(D_,function(){E.controller.abort()})}var uI=null,iR=0,Jn=0,Ut=null;function ce(E,O){if(uI===null){var n=uI=[];iR=0,Jn=ei(),Ut={status:"pending",value:void 0,then:function(t){n.push(t)}}}return iR++,O.then(cs,cs),O}function cs(){if(--iR===0&&uI!==null){Ut!==null&&(Ut.status="fulfilled");var E=uI;uI=null,Jn=0,Ut=null;for(var O=0;O<E.length;O++)(0,E[O])()}}function hs(E,O){var n=[],t={status:"pending",value:null,reason:null,then:function(o){n.push(o)}};return E.then(function(){t.status="fulfilled",t.value=O;for(var o=0;o<n.length;o++)(0,n[o])(O)},function(o){for(t.status="rejected",t.reason=o,o=0;o<n.length;o++)(0,n[o])(void 0)}),t}var he=rE.S;rE.S=function(E,O){Ro=sT(),typeof O=="object"&&O!==null&&typeof O.then=="function"&&ce(E,O),he!==null&&he(E,O)};var JI=EE(null);function oR(){var E=JI.current;return E!==null?E:AO.pooledCache}function de(E,O){O===null?yE(JI,JI.current):yE(JI,O.pool)}function KT(){var E=oR();return E===null?null:{parent:KO._currentValue,pool:E}}var $I=Error(f(460)),YI=Error(f(474)),Ge=Error(f(542)),AM={then:function(){}};function xt(E){return E=E.status,E==="fulfilled"||E==="rejected"}function SM(E,O,n){switch(n=E[n],n===void 0?E.push(O):n!==O&&(O.then(qT,qT),O=n),O.status){case"fulfilled":return O.value;case"rejected":throw E=O.reason,_(E),E;default:if(typeof O.status=="string")O.then(qT,qT);else{if(E=AO,E!==null&&100<E.shellSuspendCounter)throw Error(f(482));E=O,E.status="pending",E.then(function(t){if(O.status==="pending"){var o=O;o.status="fulfilled",o.value=t}},function(t){if(O.status==="pending"){var o=O;o.status="rejected",o.reason=t}})}switch(O.status){case"fulfilled":return O.value;case"rejected":throw E=O.reason,_(E),E}throw Et=O,$I}}function JO(E){try{var O=E._init;return O(E._payload)}catch(n){throw n!==null&&typeof n=="object"&&typeof n.then=="function"?(Et=n,$I):n}}var Et=null;function a(){if(Et===null)throw Error(f(459));var E=Et;return Et=null,E}function _(E){if(E===$I||E===Ge)throw Error(f(483))}var r=null,L=0;function u(E){var O=L;return L+=1,r===null&&(r=[]),SM(r,E,O)}function m(E,O){O=O.props.ref,E.ref=O!==void 0?O:null}function b(E,O){throw O.$$typeof===CE?Error(f(525)):(E=Object.prototype.toString.call(O),Error(f(31,E==="[object Object]"?"object with keys {"+Object.keys(O).join(", ")+"}":E)))}function y(E){function O(TE,NE){if(E){var eE=TE.deletions;eE===null?(TE.deletions=[NE],TE.flags|=16):eE.push(NE)}}function n(TE,NE){if(!E)return null;for(;NE!==null;)O(TE,NE),NE=NE.sibling;return null}function t(TE){for(var NE=new Map;TE!==null;)TE.key!==null?NE.set(TE.key,TE):NE.set(TE.index,TE),TE=TE.sibling;return NE}function o(TE,NE){return TE=Wn(TE,NE),TE.index=0,TE.sibling=null,TE}function S(TE,NE,eE){return TE.index=eE,E?(eE=TE.alternate,eE!==null?(eE=eE.index,eE<NE?(TE.flags|=67108866,NE):eE):(TE.flags|=67108866,NE)):(TE.flags|=1048576,NE)}function d(TE){return E&&TE.alternate===null&&(TE.flags|=67108866),TE}function V(TE,NE,eE,hE){return NE===null||NE.tag!==6?(NE=RM(eE,TE.mode,hE),NE.return=TE,NE):(NE=o(NE,eE),NE.return=TE,NE)}function X(TE,NE,eE,hE){var AN=eE.type;return AN===zE?LE(TE,NE,eE.props.children,hE,eE.key):NE!==null&&(NE.elementType===AN||typeof AN=="object"&&AN!==null&&AN.$$typeof===pN&&JO(AN)===NE.type)?(NE=o(NE,eE.props),m(NE,eE),NE.return=TE,NE):(NE=Qn(eE.type,eE.key,eE.props,null,TE.mode,hE),m(NE,eE),NE.return=TE,NE)}function RE(TE,NE,eE,hE){return NE===null||NE.tag!==4||NE.stateNode.containerInfo!==eE.containerInfo||NE.stateNode.implementation!==eE.implementation?(NE=le(eE,TE.mode,hE),NE.return=TE,NE):(NE=o(NE,eE.children||[]),NE.return=TE,NE)}function LE(TE,NE,eE,hE,AN){return NE===null||NE.tag!==7?(NE=qI(eE,TE.mode,hE,AN),NE.return=TE,NE):(NE=o(NE,eE),NE.return=TE,NE)}function GE(TE,NE,eE){if(typeof NE=="string"&&NE!==""||typeof NE=="number"||typeof NE=="bigint")return NE=RM(""+NE,TE.mode,eE),NE.return=TE,NE;if(typeof NE=="object"&&NE!==null){switch(NE.$$typeof){case HE:return eE=Qn(NE.type,NE.key,NE.props,null,TE.mode,eE),m(eE,NE),eE.return=TE,eE;case fE:return NE=le(NE,TE.mode,eE),NE.return=TE,NE;case pN:return NE=JO(NE),GE(TE,NE,eE)}if(lT(NE)||vO(NE))return NE=qI(NE,TE.mode,eE,null),NE.return=TE,NE;if(typeof NE.then=="function")return GE(TE,u(NE),eE);if(NE.$$typeof===xE)return GE(TE,De(TE,NE),eE);b(TE,NE)}return null}function iE(TE,NE,eE,hE){var AN=NE!==null?NE.key:null;if(typeof eE=="string"&&eE!==""||typeof eE=="number"||typeof eE=="bigint")return AN!==null?null:V(TE,NE,""+eE,hE);if(typeof eE=="object"&&eE!==null){switch(eE.$$typeof){case HE:return eE.key===AN?X(TE,NE,eE,hE):null;case fE:return eE.key===AN?RE(TE,NE,eE,hE):null;case pN:return eE=JO(eE),iE(TE,NE,eE,hE)}if(lT(eE)||vO(eE))return AN!==null?null:LE(TE,NE,eE,hE,null);if(typeof eE.then=="function")return iE(TE,NE,u(eE),hE);if(eE.$$typeof===xE)return iE(TE,NE,De(TE,eE),hE);b(TE,eE)}return null}function SE(TE,NE,eE,hE,AN){if(typeof hE=="string"&&hE!==""||typeof hE=="number"||typeof hE=="bigint")return TE=TE.get(eE)||null,V(NE,TE,""+hE,AN);if(typeof hE=="object"&&hE!==null){switch(hE.$$typeof){case HE:return TE=TE.get(hE.key===null?eE:hE.key)||null,X(NE,TE,hE,AN);case fE:return TE=TE.get(hE.key===null?eE:hE.key)||null,RE(NE,TE,hE,AN);case pN:return hE=JO(hE),SE(TE,NE,eE,hE,AN)}if(lT(hE)||vO(hE))return TE=TE.get(eE)||null,LE(NE,TE,hE,AN,null);if(typeof hE.then=="function")return SE(TE,NE,eE,u(hE),AN);if(hE.$$typeof===xE)return SE(TE,NE,eE,De(NE,hE),AN);b(NE,hE)}return null}function ON(TE,NE,eE,hE){for(var AN=null,RO=null,eN=NE,mN=NE=0,ZN=null;eN!==null&&mN<eE.length;mN++){eN.index>mN?(ZN=eN,eN=null):ZN=eN.sibling;var sO=iE(TE,eN,eE[mN],hE);if(sO===null){eN===null&&(eN=ZN);break}E&&eN&&sO.alternate===null&&O(TE,eN),NE=S(sO,NE,mN),RO===null?AN=sO:RO.sibling=sO,RO=sO,eN=ZN}if(mN===eE.length)return n(TE,eN),gN&&FN(TE,mN),AN;if(eN===null){for(;mN<eE.length;mN++)eN=GE(TE,eE[mN],hE),eN!==null&&(NE=S(eN,NE,mN),RO===null?AN=eN:RO.sibling=eN,RO=eN);return gN&&FN(TE,mN),AN}for(eN=t(eN);mN<eE.length;mN++)ZN=SE(eN,TE,mN,eE[mN],hE),ZN!==null&&(E&&ZN.alternate!==null&&eN.delete(ZN.key===null?mN:ZN.key),NE=S(ZN,NE,mN),RO===null?AN=ZN:RO.sibling=ZN,RO=ZN);return E&&eN.forEach(function(kM){return O(TE,kM)}),gN&&FN(TE,mN),AN}function DN(TE,NE,eE,hE){if(eE==null)throw Error(f(151));for(var AN=null,RO=null,eN=NE,mN=NE=0,ZN=null,sO=eE.next();eN!==null&&!sO.done;mN++,sO=eE.next()){eN.index>mN?(ZN=eN,eN=null):ZN=eN.sibling;var kM=iE(TE,eN,sO.value,hE);if(kM===null){eN===null&&(eN=ZN);break}E&&eN&&kM.alternate===null&&O(TE,eN),NE=S(kM,NE,mN),RO===null?AN=kM:RO.sibling=kM,RO=kM,eN=ZN}if(sO.done)return n(TE,eN),gN&&FN(TE,mN),AN;if(eN===null){for(;!sO.done;mN++,sO=eE.next())sO=GE(TE,sO.value,hE),sO!==null&&(NE=S(sO,NE,mN),RO===null?AN=sO:RO.sibling=sO,RO=sO);return gN&&FN(TE,mN),AN}for(eN=t(eN);!sO.done;mN++,sO=eE.next())sO=SE(eN,TE,mN,sO.value,hE),sO!==null&&(E&&sO.alternate!==null&&eN.delete(sO.key===null?mN:sO.key),NE=S(sO,NE,mN),RO===null?AN=sO:RO.sibling=sO,RO=sO);return E&&eN.forEach(function(sl){return O(TE,sl)}),gN&&FN(TE,mN),AN}function hO(TE,NE,eE,hE){if(typeof eE=="object"&&eE!==null&&eE.type===zE&&eE.key===null&&(eE=eE.props.children),typeof eE=="object"&&eE!==null){switch(eE.$$typeof){case HE:E:{for(var AN=eE.key;NE!==null;){if(NE.key===AN){if(AN=eE.type,AN===zE){if(NE.tag===7){n(TE,NE.sibling),hE=o(NE,eE.props.children),hE.return=TE,TE=hE;break E}}else if(NE.elementType===AN||typeof AN=="object"&&AN!==null&&AN.$$typeof===pN&&JO(AN)===NE.type){n(TE,NE.sibling),hE=o(NE,eE.props),m(hE,eE),hE.return=TE,TE=hE;break E}n(TE,NE);break}else O(TE,NE);NE=NE.sibling}eE.type===zE?(hE=qI(eE.props.children,TE.mode,hE,eE.key),hE.return=TE,TE=hE):(hE=Qn(eE.type,eE.key,eE.props,null,TE.mode,hE),m(hE,eE),hE.return=TE,TE=hE)}return d(TE);case fE:E:{for(AN=eE.key;NE!==null;){if(NE.key===AN)if(NE.tag===4&&NE.stateNode.containerInfo===eE.containerInfo&&NE.stateNode.implementation===eE.implementation){n(TE,NE.sibling),hE=o(NE,eE.children||[]),hE.return=TE,TE=hE;break E}else{n(TE,NE);break}else O(TE,NE);NE=NE.sibling}hE=le(eE,TE.mode,hE),hE.return=TE,TE=hE}return d(TE);case pN:return eE=JO(eE),hO(TE,NE,eE,hE)}if(lT(eE))return ON(TE,NE,eE,hE);if(vO(eE)){if(AN=vO(eE),typeof AN!="function")throw Error(f(150));return eE=AN.call(eE),DN(TE,NE,eE,hE)}if(typeof eE.then=="function")return hO(TE,NE,u(eE),hE);if(eE.$$typeof===xE)return hO(TE,NE,De(TE,eE),hE);b(TE,eE)}return typeof eE=="string"&&eE!==""||typeof eE=="number"||typeof eE=="bigint"?(eE=""+eE,NE!==null&&NE.tag===6?(n(TE,NE.sibling),hE=o(NE,eE),hE.return=TE,TE=hE):(n(TE,NE),hE=RM(eE,TE.mode,hE),hE.return=TE,TE=hE),d(TE)):n(TE,NE)}return function(TE,NE,eE,hE){try{L=0;var AN=hO(TE,NE,eE,hE);return r=null,AN}catch(eN){if(eN===$I||eN===Ge)throw eN;var RO=iT(29,eN,null,TE.mode);return RO.lanes=hE,RO.return=TE,RO}}}var K=y(!0),w=y(!1),OE=!1;function tE(E){E.updateQueue={baseState:E.memoizedState,firstBaseUpdate:null,lastBaseUpdate:null,shared:{pending:null,lanes:0,hiddenCallbacks:null},callbacks:null}}function ME(E,O){E=E.updateQueue,O.updateQueue===E&&(O.updateQueue={baseState:E.baseState,firstBaseUpdate:E.firstBaseUpdate,lastBaseUpdate:E.lastBaseUpdate,shared:E.shared,callbacks:null})}function AE(E){return{lane:E,tag:0,payload:null,callback:null,next:null}}function bE(E,O,n){var t=E.updateQueue;if(t===null)return null;if(t=t.shared,(JN&2)!==0){var o=t.pending;return o===null?O.next=O:(O.next=o.next,o.next=O),t.pending=O,O=XI(E),Ps(E,null,n),O}return Vt(E,t,O,n),XI(E)}function VE(E,O,n){if(O=O.updateQueue,O!==null&&(O=O.shared,(n&4194048)!==0)){var t=O.lanes;t&=E.pendingLanes,n|=t,O.lanes=n,wN(E,n)}}function ZE(E,O){var n=E.updateQueue,t=E.alternate;if(t!==null&&(t=t.updateQueue,n===t)){var o=null,S=null;if(n=n.firstBaseUpdate,n!==null){do{var d={lane:n.lane,tag:n.tag,payload:n.payload,callback:null,next:null};S===null?o=S=d:S=S.next=d,n=n.next}while(n!==null);S===null?o=S=O:S=S.next=O}else o=S=O;n={baseState:t.baseState,firstBaseUpdate:o,lastBaseUpdate:S,shared:t.shared,callbacks:t.callbacks},E.updateQueue=n;return}E=n.lastBaseUpdate,E===null?n.firstBaseUpdate=O:E.next=O,n.lastBaseUpdate=O}var aN=!1;function LN(){if(aN){var E=Ut;if(E!==null)throw E}}function RN(E,O,n,t){aN=!1;var o=E.updateQueue;OE=!1;var S=o.firstBaseUpdate,d=o.lastBaseUpdate,V=o.shared.pending;if(V!==null){o.shared.pending=null;var X=V,RE=X.next;X.next=null,d===null?S=RE:d.next=RE,d=X;var LE=E.alternate;LE!==null&&(LE=LE.updateQueue,V=LE.lastBaseUpdate,V!==d&&(V===null?LE.firstBaseUpdate=RE:V.next=RE,LE.lastBaseUpdate=X))}if(S!==null){var GE=o.baseState;d=0,LE=RE=X=null,V=S;do{var iE=V.lane&-536870913,SE=iE!==V.lane;if(SE?(bN&iE)===iE:(t&iE)===iE){iE!==0&&iE===Jn&&(aN=!0),LE!==null&&(LE=LE.next={lane:0,tag:V.tag,payload:V.payload,callback:null,next:null});E:{var ON=E,DN=V;iE=O;var hO=n;switch(DN.tag){case 1:if(ON=DN.payload,typeof ON=="function"){GE=ON.call(hO,GE,iE);break E}GE=ON;break E;case 3:ON.flags=ON.flags&-65537|128;case 0:if(ON=DN.payload,iE=typeof ON=="function"?ON.call(hO,GE,iE):ON,iE==null)break E;GE=IE({},GE,iE);break E;case 2:OE=!0}}iE=V.callback,iE!==null&&(E.flags|=64,SE&&(E.flags|=8192),SE=o.callbacks,SE===null?o.callbacks=[iE]:SE.push(iE))}else SE={lane:iE,tag:V.tag,payload:V.payload,callback:V.callback,next:null},LE===null?(RE=LE=SE,X=GE):LE=LE.next=SE,d|=iE;if(V=V.next,V===null){if(V=o.shared.pending,V===null)break;SE=V,V=SE.next,SE.next=null,o.lastBaseUpdate=SE,o.shared.pending=null}}while(!0);LE===null&&(X=GE),o.baseState=X,o.firstBaseUpdate=RE,o.lastBaseUpdate=LE,S===null&&(o.shared.lanes=0),_n|=d,E.lanes=d,E.memoizedState=GE}}function qE(E,O){if(typeof E!="function")throw Error(f(191,E));E.call(O)}function uN(E,O){var n=E.callbacks;if(n!==null)for(E.callbacks=null,E=0;E<n.length;E++)qE(n[E],O)}var HN=EE(null),BN=EE(0);function CN(E,O){E=it,yE(BN,E),yE(HN,O),it=E|O.baseLanes}function iO(){yE(BN,it),yE(HN,HN.current)}function cT(){it=BN.current,z(HN),z(BN)}var oO=EE(null),rO=null;function YT(E){var O=E.alternate;yE(VO,VO.current&1),yE(oO,E),rO===null&&(O===null||HN.current!==null||O.memoizedState!==null)&&(rO=E)}function $n(E){yE(VO,VO.current),yE(oO,E),rO===null&&(rO=E)}function wT(E){E.tag===22?(yE(VO,VO.current),yE(oO,E),rO===null&&(rO=E)):$O()}function $O(){yE(VO,VO.current),yE(oO,oO.current)}function IO(E){z(oO),rO===E&&(rO=null),z(VO)}var VO=EE(0);function pn(E){for(var O=E;O!==null;){if(O.tag===13){var n=O.memoizedState;if(n!==null&&(n=n.dehydrated,n===null||WE(n)||eO(n)))return O}else if(O.tag===19&&(O.memoizedProps.revealOrder==="forwards"||O.memoizedProps.revealOrder==="backwards"||O.memoizedProps.revealOrder==="unstable_legacy-backwards"||O.memoizedProps.revealOrder==="together")){if((O.flags&128)!==0)return O}else if(O.child!==null){O.child.return=O,O=O.child;continue}if(O===E)break;for(;O.sibling===null;){if(O.return===null||O.return===E)return null;O=O.return}O.sibling.return=O.return,O=O.sibling}return null}var EI=0,dN=null,zN=null,gO=null,ue=!1,lM=!1,Ye=!1,cn=0,AR=0,He=null,eT=0;function yO(){throw Error(f(321))}function L_(E,O){if(O===null)return!1;for(var n=0;n<O.length&&n<E.length;n++)if(!ZO(E[n],O[n]))return!1;return!0}function ds(E,O,n,t,o,S){return EI=S,dN=O,O.memoizedState=null,O.updateQueue=null,O.lanes=0,rE.H=E===null||E.memoizedState===null?Ki:p_,Ye=!1,S=n(t,o),Ye=!1,lM&&(S=rM(O,n,t,o)),Gs(E),S}function Gs(E){rE.H=be;var O=zN!==null&&zN.next!==null;if(EI=0,gO=zN=dN=null,ue=!1,AR=0,He=null,O)throw Error(f(300));E===null||wO||(E=E.dependencies,E!==null&&ae(E)&&(wO=!0))}function rM(E,O,n,t){dN=E;var o=0;do{if(lM&&(He=null),AR=0,lM=!1,25<=o)throw Error(f(301));if(o+=1,gO=zN=null,E.updateQueue!=null){var S=E.updateQueue;S.lastEffect=null,S.events=null,S.stores=null,S.memoCache!=null&&(S.memoCache.index=0)}rE.H=ys,S=O(n,t)}while(lM);return S}function SR(){var E=rE.H,O=E.useState()[0];return O=typeof O.then=="function"?aM(O):O,E=E.useState()[0],(zN!==null?zN.memoizedState:null)!==E&&(dN.flags|=1024),O}function PM(){var E=cn!==0;return cn=0,E}function c_(E,O,n){O.updateQueue=E.updateQueue,O.flags&=-2053,E.lanes&=~n}function h_(E){if(ue){for(E=E.memoizedState;E!==null;){var O=E.queue;O!==null&&(O.pending=null),E=E.next}ue=!1}EI=0,gO=zN=dN=null,lM=!1,AR=cn=0,He=null}function HT(){var E={memoizedState:null,baseState:null,baseQueue:null,queue:null,next:null};return gO===null?dN.memoizedState=gO=E:gO=gO.next=E,gO}function UO(){if(zN===null){var E=dN.alternate;E=E!==null?E.memoizedState:null}else E=zN.next;var O=gO===null?dN.memoizedState:gO.next;if(O!==null)gO=O,zN=E;else{if(E===null)throw dN.alternate===null?Error(f(467)):Error(f(310));zN=E,E={memoizedState:zN.memoizedState,baseState:zN.baseState,baseQueue:zN.baseQueue,queue:zN.queue,next:null},gO===null?dN.memoizedState=gO=E:gO=gO.next=E}return gO}function lR(){return{lastEffect:null,events:null,stores:null,memoCache:null}}function aM(E){var O=AR;return AR+=1,He===null&&(He=[]),E=SM(He,E,O),O=dN,(gO===null?O.memoizedState:gO.next)===null&&(O=O.alternate,rE.H=O===null||O.memoizedState===null?Ki:p_),E}function rR(E){if(E!==null&&typeof E=="object"){if(typeof E.then=="function")return aM(E);if(E.$$typeof===xE)return tT(E)}throw Error(f(438,String(E)))}function d_(E){var O=null,n=dN.updateQueue;if(n!==null&&(O=n.memoCache),O==null){var t=dN.alternate;t!==null&&(t=t.updateQueue,t!==null&&(t=t.memoCache,t!=null&&(O={data:t.data.map(function(o){return o.slice()}),index:0})))}if(O==null&&(O={data:[],index:0}),n===null&&(n=lR(),dN.updateQueue=n),n.memoCache=O,n=O.data[O.index],n===void 0)for(n=O.data[O.index]=Array(E),t=0;t<E;t++)n[t]=mO;return O.index++,n}function Nt(E,O){return typeof O=="function"?O(E):O}function us(E){var O=UO();return Vn(O,zN,E)}function Vn(E,O,n){var t=E.queue;if(t===null)throw Error(f(311));t.lastRenderedReducer=n;var o=E.baseQueue,S=t.pending;if(S!==null){if(o!==null){var d=o.next;o.next=S.next,S.next=d}O.baseQueue=o=S,t.pending=null}if(S=E.baseState,o===null)E.memoizedState=S;else{O=o.next;var V=d=null,X=null,RE=O,LE=!1;do{var GE=RE.lane&-536870913;if(GE!==RE.lane?(bN&GE)===GE:(EI&GE)===GE){var iE=RE.revertLane;if(iE===0)X!==null&&(X=X.next={lane:0,revertLane:0,gesture:null,action:RE.action,hasEagerState:RE.hasEagerState,eagerState:RE.eagerState,next:null}),GE===Jn&&(LE=!0);else if((EI&iE)===iE){RE=RE.next,iE===Jn&&(LE=!0);continue}else GE={lane:0,revertLane:RE.revertLane,gesture:null,action:RE.action,hasEagerState:RE.hasEagerState,eagerState:RE.eagerState,next:null},X===null?(V=X=GE,d=S):X=X.next=GE,dN.lanes|=iE,_n|=iE;GE=RE.action,Ye&&n(S,GE),S=RE.hasEagerState?RE.eagerState:n(S,GE)}else iE={lane:GE,revertLane:RE.revertLane,gesture:RE.gesture,action:RE.action,hasEagerState:RE.hasEagerState,eagerState:RE.eagerState,next:null},X===null?(V=X=iE,d=S):X=X.next=iE,dN.lanes|=GE,_n|=GE;RE=RE.next}while(RE!==null&&RE!==O);if(X===null?d=S:X.next=V,!ZO(S,E.memoizedState)&&(wO=!0,LE&&(n=Ut,n!==null)))throw n;E.memoizedState=S,E.baseState=d,E.baseQueue=X,t.lastRenderedState=S}return o===null&&(t.lanes=0),[E.memoizedState,t.dispatch]}function Ys(E){var O=UO(),n=O.queue;if(n===null)throw Error(f(311));n.lastRenderedReducer=E;var t=n.dispatch,o=n.pending,S=O.memoizedState;if(o!==null){n.pending=null;var d=o=o.next;do S=E(S,d.action),d=d.next;while(d!==o);ZO(S,O.memoizedState)||(wO=!0),O.memoizedState=S,O.baseQueue===null&&(O.baseState=S),n.lastRenderedState=S}return[S,t]}function BO(E,O,n){var t=dN,o=UO(),S=gN;if(S){if(n===void 0)throw Error(f(407));n=n()}else n=O();var d=!ZO((zN||o).memoizedState,n);if(d&&(o.memoizedState=n,wO=!0),o=o.queue,ms(PR.bind(null,t,o,E),[E]),o.getSnapshot!==O||d||gO!==null&&gO.memoizedState.tag&1){if(t.flags|=2048,DM(9,{destroy:void 0},ui.bind(null,t,o,n,O),null),AO===null)throw Error(f(349));S||(EI&127)!==0||G_(t,O,n)}return n}function G_(E,O,n){E.flags|=16384,E={getSnapshot:O,value:n},O=dN.updateQueue,O===null?(O=lR(),dN.updateQueue=O,O.stores=[E]):(n=O.stores,n===null?O.stores=[E]:n.push(E))}function ui(E,O,n,t){O.value=n,O.getSnapshot=t,Yi(O)&&Hi(E)}function PR(E,O,n){return n(function(){Yi(O)&&Hi(E)})}function Yi(E){var O=E.getSnapshot;E=E.value;try{var n=O();return!ZO(E,n)}catch{return!0}}function Hi(E){var O=qn(E,2);O!==null&&Sn(O,E,2)}function u_(E){var O=HT();if(typeof E=="function"){var n=E;if(E=n(),Ye){UE(!0);try{n()}finally{UE(!1)}}}return O.memoizedState=O.baseState=E,O.queue={pending:null,lanes:0,dispatch:null,lastRenderedReducer:Nt,lastRenderedState:E},O}function Ce(E,O,n,t){return E.baseState=n,Vn(E,zN,typeof t=="function"?t:Nt)}function NA(E,O,n,t,o){if(HI(E))throw Error(f(485));if(E=O.action,E!==null){var S={payload:o,action:E,next:null,isTransition:!0,status:"pending",value:null,reason:null,listeners:[],then:function(d){S.listeners.push(d)}};rE.T!==null?n(!0):S.isTransition=!1,t(S),n=O.pending,n===null?(S.next=O.pending=S,Hs(O,S)):(S.next=n.next,O.pending=n.next=S)}}function Hs(E,O){var n=O.action,t=O.payload,o=E.state;if(O.isTransition){var S=rE.T,d={};rE.T=d;try{var V=n(o,t),X=rE.S;X!==null&&X(d,V),Y_(E,O,V)}catch(RE){Cs(E,O,RE)}finally{S!==null&&d.types!==null&&(S.types=d.types),rE.T=S}}else try{S=n(o,t),Y_(E,O,S)}catch(RE){Cs(E,O,RE)}}function Y_(E,O,n){n!==null&&typeof n=="object"&&typeof n.then=="function"?n.then(function(t){H_(E,O,t)},function(t){return Cs(E,O,t)}):H_(E,O,n)}function H_(E,O,n){O.status="fulfilled",O.value=n,Ci(O),E.state=n,O=E.pending,O!==null&&(n=O.next,n===O?E.pending=null:(n=n.next,O.next=n,Hs(E,n)))}function Cs(E,O,n){var t=E.pending;if(E.pending=null,t!==null){t=t.next;do O.status="rejected",O.reason=n,Ci(O),O=O.next;while(O!==t)}E.action=null}function Ci(E){E=E.listeners;for(var O=0;O<E.length;O++)(0,E[O])()}function XO(E,O){return O}function Bi(E,O){if(gN){var n=AO.formState;if(n!==null){E:{var t=dN;if(gN){if(nO){N:{for(var o=nO,S=iN;o.nodeType!==8;){if(!S){o=null;break N}if(o=LO(o.nextSibling),o===null){o=null;break N}}S=o.data,o=S==="F!"||S==="F"?o:null}if(o){nO=LO(o.nextSibling),t=o.data==="F!";break E}}hI(t)}t=!1}t&&(O=n[0])}}return n=HT(),n.memoizedState=n.baseState=O,t={pending:null,lanes:0,dispatch:null,lastRenderedReducer:XO,lastRenderedState:O},n.queue=t,n=xi.bind(null,dN,t),t.dispatch=n,t=u_(!1),S=gs.bind(null,dN,!1,t.queue),t=HT(),o={state:O,dispatch:null,action:E,pending:null},t.queue=o,n=NA.bind(null,dN,o,S,n),o.dispatch=n,t.memoizedState=E,[O,n,!1]}function bi(E){var O=UO();return C_(O,zN,E)}function C_(E,O,n){if(O=Vn(E,O,XO)[0],E=us(Nt)[0],typeof O=="object"&&O!==null&&typeof O.then=="function")try{var t=aM(O)}catch(d){throw d===$I?Ge:d}else t=O;O=UO();var o=O.queue,S=o.dispatch;return n!==O.memoizedState&&(dN.flags|=2048,DM(9,{destroy:void 0},Bs.bind(null,o,n),null)),[t,S,E]}function Bs(E,O){E.action=O}function Be(E){var O=UO(),n=zN;if(n!==null)return C_(O,n,E);UO(),O=O.memoizedState,n=UO();var t=n.queue.dispatch;return n.memoizedState=E,[O,t,!1]}function DM(E,O,n,t){return E={tag:E,create:n,deps:t,inst:O,next:null},O=dN.updateQueue,O===null&&(O=lR(),dN.updateQueue=O),n=O.lastEffect,n===null?O.lastEffect=E.next=E:(t=n.next,n.next=E,E.next=t,O.lastEffect=E),E}function DO(){return UO().memoizedState}function bs(E,O,n,t){var o=HT();dN.flags|=E,o.memoizedState=DM(1|O,{destroy:void 0},n,t===void 0?null:t)}function aR(E,O,n,t){var o=UO();t=t===void 0?null:t;var S=o.memoizedState.inst;zN!==null&&t!==null&&L_(t,zN.memoizedState.deps)?o.memoizedState=DM(O,S,n,t):(dN.flags|=E,o.memoizedState=DM(1|O,S,n,t))}function B_(E,O){bs(8390656,8,E,O)}function ms(E,O){aR(2048,8,E,O)}function MT(E){dN.flags|=4;var O=dN.updateQueue;if(O===null)O=lR(),dN.updateQueue=O,O.events=[E];else{var n=O.events;n===null?O.events=[E]:n.push(E)}}function mi(E){var O=UO().memoizedState;return MT({ref:O,nextImpl:E}),function(){if((JN&2)!==0)throw Error(f(440));return O.impl.apply(void 0,arguments)}}function LM(E,O){return aR(4,2,E,O)}function fs(E,O){return aR(4,4,E,O)}function GO(E,O){if(typeof O=="function"){E=E();var n=O(E);return function(){typeof n=="function"?n():O(null)}}if(O!=null)return E=E(),O.current=E,function(){O.current=null}}function fi(E,O,n){n=n!=null?n.concat([E]):null,aR(4,4,GO.bind(null,O,E),n)}function ps(){}function gn(E,O){var n=UO();O=O===void 0?null:O;var t=n.memoizedState;return O!==null&&L_(O,t[1])?t[0]:(n.memoizedState=[E,O],E)}function In(E,O){var n=UO();O=O===void 0?null:O;var t=n.memoizedState;if(O!==null&&L_(O,t[1]))return t[0];if(t=E(),Ye){UE(!0);try{E()}finally{UE(!1)}}return n.memoizedState=[t,O],t}function b_(E,O,n){return n===void 0||(EI&1073741824)!==0&&(bN&261930)===0?E.memoizedState=O:(E.memoizedState=n,E=_o(),dN.lanes|=E,_n|=E,n)}function pi(E,O,n,t){return ZO(n,O)?n:HN.current!==null?(E=b_(E,n,t),ZO(E,O)||(wO=!0),E):(EI&42)===0||(EI&1073741824)!==0&&(bN&261930)===0?(wO=!0,E.memoizedState=n):(E=_o(),dN.lanes|=E,_n|=E,O)}function m_(E,O,n,t,o){var S=pE.p;pE.p=S!==0&&8>S?S:8;var d=rE.T,V={};rE.T=V,gs(E,!1,O,n);try{var X=o(),RE=rE.S;if(RE!==null&&RE(V,X),X!==null&&typeof X=="object"&&typeof X.then=="function"){var LE=hs(X,t);hn(E,O,LE,An(E))}else hn(E,O,t,An(E))}catch(GE){hn(E,O,{then:function(){},status:"rejected",reason:GE},An())}finally{pE.p=S,d!==null&&V.types!==null&&(d.types=V.types),rE.T=d}}function OA(){}function Vs(E,O,n,t){if(E.tag!==5)throw Error(f(476));var o=Vi(E).queue;m_(E,o,O,MN,n===null?OA:function(){return gi(E),n(t)})}function Vi(E){var O=E.memoizedState;if(O!==null)return O;O={memoizedState:MN,baseState:MN,baseQueue:null,queue:{pending:null,lanes:0,dispatch:null,lastRenderedReducer:Nt,lastRenderedState:MN},next:null};var n={};return O.next={memoizedState:n,baseState:n,baseQueue:null,queue:{pending:null,lanes:0,dispatch:null,lastRenderedReducer:Nt,lastRenderedState:n},next:null},E.memoizedState=O,E=E.alternate,E!==null&&(E.memoizedState=O),O}function gi(E){var O=Vi(E);O.next===null&&(O=E.alternate.memoizedState),hn(E,O.next.queue,{},An())}function cM(){return tT(Si)}function yi(){return UO().memoizedState}function Ui(){return UO().memoizedState}function f_(E){for(var O=E.return;O!==null;){switch(O.tag){case 24:case 3:var n=An();E=AE(n);var t=bE(O,E,n);t!==null&&(Sn(t,O,n),VE(t,O,n)),O={cache:Le()},E.payload=O;return}O=O.return}}function TA(E,O,n){var t=An();n={lane:t,revertLane:0,gesture:null,action:n,hasEagerState:!1,eagerState:null,next:null},HI(E)?yn(O,n):(n=LI(E,O,n,t),n!==null&&(Sn(n,E,t),vi(n,O,t)))}function xi(E,O,n){var t=An();hn(E,O,n,t)}function hn(E,O,n,t){var o={lane:t,revertLane:0,gesture:null,action:n,hasEagerState:!1,eagerState:null,next:null};if(HI(E))yn(O,o);else{var S=E.alternate;if(E.lanes===0&&(S===null||S.lanes===0)&&(S=O.lastRenderedReducer,S!==null))try{var d=O.lastRenderedState,V=S(d,n);if(o.hasEagerState=!0,o.eagerState=V,ZO(V,d))return Vt(E,O,o,0),AO===null&&pt(),!1}catch{}if(n=LI(E,O,o,t),n!==null)return Sn(n,E,t),vi(n,O,t),!0}return!1}function gs(E,O,n,t){if(t={lane:2,revertLane:ei(),gesture:null,action:t,hasEagerState:!1,eagerState:null,next:null},HI(E)){if(O)throw Error(f(479))}else O=LI(E,n,t,2),O!==null&&Sn(O,E,2)}function HI(E){var O=E.alternate;return E===dN||O!==null&&O===dN}function yn(E,O){lM=ue=!0;var n=E.pending;n===null?O.next=O:(O.next=n.next,n.next=O),E.pending=O}function vi(E,O,n){if((n&4194048)!==0){var t=O.lanes;t&=E.pendingLanes,n|=t,O.lanes=n,wN(E,n)}}var be={readContext:tT,use:rR,useCallback:yO,useContext:yO,useEffect:yO,useImperativeHandle:yO,useLayoutEffect:yO,useInsertionEffect:yO,useMemo:yO,useReducer:yO,useRef:yO,useState:yO,useDebugValue:yO,useDeferredValue:yO,useTransition:yO,useSyncExternalStore:yO,useId:yO,useHostTransitionStatus:yO,useFormState:yO,useActionState:yO,useOptimistic:yO,useMemoCache:yO,useCacheRefresh:yO};be.useEffectEvent=yO;var Ki={readContext:tT,use:rR,useCallback:function(E,O){return HT().memoizedState=[E,O===void 0?null:O],E},useContext:tT,useEffect:B_,useImperativeHandle:function(E,O,n){n=n!=null?n.concat([E]):null,bs(4194308,4,GO.bind(null,O,E),n)},useLayoutEffect:function(E,O){return bs(4194308,4,E,O)},useInsertionEffect:function(E,O){bs(4,2,E,O)},useMemo:function(E,O){var n=HT();O=O===void 0?null:O;var t=E();if(Ye){UE(!0);try{E()}finally{UE(!1)}}return n.memoizedState=[t,O],t},useReducer:function(E,O,n){var t=HT();if(n!==void 0){var o=n(O);if(Ye){UE(!0);try{n(O)}finally{UE(!1)}}}else o=O;return t.memoizedState=t.baseState=o,E={pending:null,lanes:0,dispatch:null,lastRenderedReducer:E,lastRenderedState:o},t.queue=E,E=E.dispatch=TA.bind(null,dN,E),[t.memoizedState,E]},useRef:function(E){var O=HT();return E={current:E},O.memoizedState=E},useState:function(E){E=u_(E);var O=E.queue,n=xi.bind(null,dN,O);return O.dispatch=n,[E.memoizedState,n]},useDebugValue:ps,useDeferredValue:function(E,O){var n=HT();return b_(n,E,O)},useTransition:function(){var E=u_(!1);return E=m_.bind(null,dN,E.queue,!0,!1),HT().memoizedState=E,[!1,E]},useSyncExternalStore:function(E,O,n){var t=dN,o=HT();if(gN){if(n===void 0)throw Error(f(407));n=n()}else{if(n=O(),AO===null)throw Error(f(349));(bN&127)!==0||G_(t,O,n)}o.memoizedState=n;var S={value:n,getSnapshot:O};return o.queue=S,B_(PR.bind(null,t,S,E),[E]),t.flags|=2048,DM(9,{destroy:void 0},ui.bind(null,t,S,n,O),null),n},useId:function(){var E=HT(),O=AO.identifierPrefix;if(gN){var n=DT,t=UT;n=(t&~(1<<32-nE(t)-1)).toString(32)+n,O="_"+O+"R_"+n,n=cn++,0<n&&(O+="H"+n.toString(32)),O+="_"}else n=eT++,O="_"+O+"r_"+n.toString(32)+"_";return E.memoizedState=O},useHostTransitionStatus:cM,useFormState:Bi,useActionState:Bi,useOptimistic:function(E){var O=HT();O.memoizedState=O.baseState=E;var n={pending:null,lanes:0,dispatch:null,lastRenderedReducer:null,lastRenderedState:null};return O.queue=n,O=gs.bind(null,dN,!0,n),n.dispatch=O,[E,O]},useMemoCache:d_,useCacheRefresh:function(){return HT().memoizedState=f_.bind(null,dN)},useEffectEvent:function(E){var O=HT(),n={impl:E};return O.memoizedState=n,function(){if((JN&2)!==0)throw Error(f(440));return n.impl.apply(void 0,arguments)}}},p_={readContext:tT,use:rR,useCallback:gn,useContext:tT,useEffect:ms,useImperativeHandle:fi,useInsertionEffect:LM,useLayoutEffect:fs,useMemo:In,useReducer:us,useRef:DO,useState:function(){return us(Nt)},useDebugValue:ps,useDeferredValue:function(E,O){var n=UO();return pi(n,zN.memoizedState,E,O)},useTransition:function(){var E=us(Nt)[0],O=UO().memoizedState;return[typeof E=="boolean"?E:aM(E),O]},useSyncExternalStore:BO,useId:yi,useHostTransitionStatus:cM,useFormState:bi,useActionState:bi,useOptimistic:function(E,O){var n=UO();return Ce(n,zN,E,O)},useMemoCache:d_,useCacheRefresh:Ui};p_.useEffectEvent=mi;var ys={readContext:tT,use:rR,useCallback:gn,useContext:tT,useEffect:ms,useImperativeHandle:fi,useInsertionEffect:LM,useLayoutEffect:fs,useMemo:In,useReducer:Ys,useRef:DO,useState:function(){return Ys(Nt)},useDebugValue:ps,useDeferredValue:function(E,O){var n=UO();return zN===null?b_(n,E,O):pi(n,zN.memoizedState,E,O)},useTransition:function(){var E=Ys(Nt)[0],O=UO().memoizedState;return[typeof E=="boolean"?E:aM(E),O]},useSyncExternalStore:BO,useId:yi,useHostTransitionStatus:cM,useFormState:Be,useActionState:Be,useOptimistic:function(E,O){var n=UO();return zN!==null?Ce(n,zN,E,O):(n.baseState=E,[E,n.queue.dispatch])},useMemoCache:d_,useCacheRefresh:Ui};ys.useEffectEvent=mi;function Us(E,O,n,t){O=E.memoizedState,n=n(t,O),n=n==null?O:IE({},O,n),E.memoizedState=n,E.lanes===0&&(E.updateQueue.baseState=n)}var DR={enqueueSetState:function(E,O,n){E=E._reactInternals;var t=An(),o=AE(t);o.payload=O,n!=null&&(o.callback=n),O=bE(E,o,t),O!==null&&(Sn(O,E,t),VE(O,E,t))},enqueueReplaceState:function(E,O,n){E=E._reactInternals;var t=An(),o=AE(t);o.tag=1,o.payload=O,n!=null&&(o.callback=n),O=bE(E,o,t),O!==null&&(Sn(O,E,t),VE(O,E,t))},enqueueForceUpdate:function(E,O){E=E._reactInternals;var n=An(),t=AE(n);t.tag=2,O!=null&&(t.callback=O),O=bE(E,t,n),O!==null&&(Sn(O,E,n),VE(O,E,n))}};function wi(E,O,n,t,o,S,d){return E=E.stateNode,typeof E.shouldComponentUpdate=="function"?E.shouldComponentUpdate(t,S,d):O.prototype&&O.prototype.isPureReactComponent?!oe(n,t)||!oe(o,S):!0}function xs(E,O,n,t){E=O.state,typeof O.componentWillReceiveProps=="function"&&O.componentWillReceiveProps(n,t),typeof O.UNSAFE_componentWillReceiveProps=="function"&&O.UNSAFE_componentWillReceiveProps(n,t),O.state!==E&&DR.enqueueReplaceState(O,O.state,null)}function Ot(E,O){var n=O;if("ref"in O){n={};for(var t in O)t!=="ref"&&(n[t]=O[t])}if(E=E.defaultProps){n===O&&(n=IE({},n));for(var o in E)n[o]===void 0&&(n[o]=E[o])}return n}function ki(E){Se(E)}function V_(E){console.error(E)}function vt(E){Se(E)}function Kt(E,O){try{var n=E.onUncaughtError;n(O.value,{componentStack:O.stack})}catch(t){setTimeout(function(){throw t})}}function g_(E,O,n){try{var t=E.onCaughtError;t(n.value,{componentStack:n.stack,errorBoundary:O.tag===1?O.stateNode:null})}catch(o){setTimeout(function(){throw o})}}function y_(E,O,n){return n=AE(n),n.tag=3,n.payload={element:null},n.callback=function(){Kt(E,O)},n}function vs(E){return E=AE(E),E.tag=3,E}function Ks(E,O,n,t){var o=n.type.getDerivedStateFromError;if(typeof o=="function"){var S=t.value;E.payload=function(){return o(S)},E.callback=function(){g_(O,n,t)}}var d=n.stateNode;d!==null&&typeof d.componentDidCatch=="function"&&(E.callback=function(){g_(O,n,t),typeof o!="function"&&(Xt===null?Xt=new Set([this]):Xt.add(this));var V=t.stack;this.componentDidCatch(t.value,{componentStack:V!==null?V:""})})}function U_(E,O,n,t,o){if(n.flags|=32768,t!==null&&typeof t=="object"&&typeof t.then=="function"){if(O=n.alternate,O!==null&&dI(O,n,o,!0),n=oO.current,n!==null){switch(n.tag){case 31:case 13:return rO===null?$s():n.alternate===null&&zO===0&&(zO=3),n.flags&=-257,n.flags|=65536,n.lanes=o,t===AM?n.flags|=16384:(O=n.updateQueue,O===null?n.updateQueue=new Set([t]):O.add(t),n_(E,t,o)),!1;case 22:return n.flags|=65536,t===AM?n.flags|=16384:(O=n.updateQueue,O===null?(O={transitions:null,markerInstances:null,retryQueue:new Set([t])},n.updateQueue=O):(n=O.retryQueue,n===null?O.retryQueue=new Set([t]):n.add(t)),n_(E,t,o)),!1}throw Error(f(435,n.tag))}return n_(E,t,o),$s(),!1}if(gN)return O=oO.current,O!==null?((O.flags&65536)===0&&(O.flags|=256),O.flags|=65536,O.lanes=o,t!==gt&&(E=Error(f(422),{cause:t}),re(yT(E,n)))):(t!==gt&&(O=Error(f(423),{cause:t}),re(yT(O,n))),E=E.current.alternate,E.flags|=65536,o&=-o,E.lanes|=o,t=yT(t,n),o=y_(E.stateNode,t,o),ZE(E,o),zO!==4&&(zO=2)),!1;var S=Error(f(520),{cause:t});if(S=yT(S,n),ot===null?ot=[S]:ot.push(S),zO!==4&&(zO=2),O===null)return!0;t=yT(t,n),n=O;do{switch(n.tag){case 3:return n.flags|=65536,E=o&-o,n.lanes|=E,E=y_(n.stateNode,t,E),ZE(n,E),!1;case 1:if(O=n.type,S=n.stateNode,(n.flags&128)===0&&(typeof O.getDerivedStateFromError=="function"||S!==null&&typeof S.componentDidCatch=="function"&&(Xt===null||!Xt.has(S))))return n.flags|=65536,o&=-o,n.lanes|=o,o=vs(o),Ks(o,E,n,t),ZE(n,o),!1}n=n.return}while(n!==null);return!1}var ws=Error(f(461)),wO=!1;function PO(E,O,n,t){O.child=E===null?w(O,null,n,t):K(O,E.child,n,t)}function Tt(E,O,n,t,o){n=n.render;var S=O.ref;if("ref"in t){var d={};for(var V in t)V!=="ref"&&(d[V]=t[V])}else d=t;return GI(O),t=ds(E,O,n,d,S,o),V=PM(),E!==null&&!wO?(c_(E,O,o),tt(E,O,o)):(gN&&V&&sM(O),O.flags|=1,PO(E,O,t,o),O.child)}function x_(E,O,n,t,o){if(E===null){var S=n.type;return typeof S=="function"&&!MM(S)&&S.defaultProps===void 0&&n.compare===null?(O.tag=15,O.type=S,zi(E,O,S,t,o)):(E=Qn(n.type,null,t,O,O.mode,o),E.ref=O.ref,E.return=O,O.child=E)}if(S=E.child,!w_(E,o)){var d=S.memoizedProps;if(n=n.compare,n=n!==null?n:oe,n(d,t)&&E.ref===O.ref)return tt(E,O,o)}return O.flags|=1,E=Wn(S,t),E.ref=O.ref,E.return=O,O.child=E}function zi(E,O,n,t,o){if(E!==null){var S=E.memoizedProps;if(oe(S,t)&&E.ref===O.ref)if(wO=!1,O.pendingProps=t=S,w_(E,o))(E.flags&131072)!==0&&(wO=!0);else return O.lanes=E.lanes,tt(E,O,o)}return v_(E,O,n,t,o)}function Fi(E,O,n,t){var o=t.children,S=E!==null?E.memoizedState:null;if(E===null&&O.stateNode===null&&(O.stateNode={_visibility:1,_pendingMarkers:null,_retryCache:null,_transitions:null}),t.mode==="hidden"){if((O.flags&128)!==0){if(S=S!==null?S.baseLanes|n:n,E!==null){for(t=O.child=E.child,o=0;t!==null;)o=o|t.lanes|t.childLanes,t=t.sibling;t=o&~S}else t=0,O.child=null;return nt(E,O,S,n,t)}if((n&536870912)!==0)O.memoizedState={baseLanes:0,cachePool:null},E!==null&&de(O,S!==null?S.cachePool:null),S!==null?CN(O,S):iO(),wT(O);else return t=O.lanes=536870912,nt(E,O,S!==null?S.baseLanes|n:n,n,t)}else S!==null?(de(O,S.cachePool),CN(O,S),$O(),O.memoizedState=null):(E!==null&&de(O,null),iO(),$O());return PO(E,O,o,n),O.child}function wt(E,O){return E!==null&&E.tag===22||O.stateNode!==null||(O.stateNode={_visibility:1,_pendingMarkers:null,_retryCache:null,_transitions:null}),O.sibling}function nt(E,O,n,t,o){var S=oR();return S=S===null?null:{parent:KO._currentValue,pool:S},O.memoizedState={baseLanes:n,cachePool:S},E!==null&&de(O,null),iO(),wT(O),E!==null&&dI(E,O,t,!0),O.childLanes=o,null}function hM(E,O){return O=hR({mode:O.mode,children:O.children},E.mode),O.ref=E.ref,E.child=O,O.return=E,O}function yN(E,O,n){return K(O,E.child,null,n),E=hM(O,O.pendingProps),E.flags|=2,IO(O),O.memoizedState=null,E}function nA(E,O,n){var t=O.pendingProps,o=(O.flags&128)!==0;if(O.flags&=-129,E===null){if(gN){if(t.mode==="hidden")return E=hM(O,t),O.lanes=536870912,wt(null,E);if($n(O),(E=nO)?(E=JE(E,iN),E=E!==null&&E.data==="&"?E:null,E!==null&&(O.memoizedState={dehydrated:E,treeContext:On!==null?{id:UT,overflow:DT}:null,retryLane:536870912,hydrationErrors:null},n=as(E),n.return=O,O.child=n,pO=O,nO=null)):E=null,E===null)throw hI(O);return O.lanes=536870912,null}return hM(O,t)}var S=E.memoizedState;if(S!==null){var d=S.dehydrated;if($n(O),o)if(O.flags&256)O.flags&=-257,O=yN(E,O,n);else if(O.memoizedState!==null)O.child=E.child,O.flags|=128,O=null;else throw Error(f(558));else if(wO||dI(E,O,n,!1),o=(n&E.childLanes)!==0,wO||o){if(t=AO,t!==null&&(d=fO(t,n),d!==0&&d!==S.retryLane))throw S.retryLane=d,qn(E,d),Sn(t,E,d),ws;$s(),O=yN(E,O,n)}else E=S.treeContext,nO=LO(d.nextSibling),pO=O,gN=!0,Dn=null,iN=!1,E!==null&&IN(O,E),O=hM(O,t),O.flags|=4096;return O}return E=Wn(E.child,{mode:t.mode,children:t.children}),E.ref=O.ref,O.child=E,E.return=O,E}function dM(E,O){var n=O.ref;if(n===null)E!==null&&E.ref!==null&&(O.flags|=4194816);else{if(typeof n!="function"&&typeof n!="object")throw Error(f(284));(E===null||E.ref!==n)&&(O.flags|=4194816)}}function v_(E,O,n,t,o){return GI(O),n=ds(E,O,n,t,void 0,o),t=PM(),E!==null&&!wO?(c_(E,O,o),tt(E,O,o)):(gN&&t&&sM(O),O.flags|=1,PO(E,O,n,o),O.child)}function me(E,O,n,t,o,S){return GI(O),O.updateQueue=null,n=rM(O,t,n,o),Gs(E),t=PM(),E!==null&&!wO?(c_(E,O,S),tt(E,O,S)):(gN&&t&&sM(O),O.flags|=1,PO(E,O,n,S),O.child)}function ji(E,O,n,t,o){if(GI(O),O.stateNode===null){var S=$T,d=n.contextType;typeof d=="object"&&d!==null&&(S=tT(d)),S=new n(t,S),O.memoizedState=S.state!==null&&S.state!==void 0?S.state:null,S.updater=DR,O.stateNode=S,S._reactInternals=O,S=O.stateNode,S.props=t,S.state=O.memoizedState,S.refs={},tE(O),d=n.contextType,S.context=typeof d=="object"&&d!==null?tT(d):$T,S.state=O.memoizedState,d=n.getDerivedStateFromProps,typeof d=="function"&&(Us(O,n,d,t),S.state=O.memoizedState),typeof n.getDerivedStateFromProps=="function"||typeof S.getSnapshotBeforeUpdate=="function"||typeof S.UNSAFE_componentWillMount!="function"&&typeof S.componentWillMount!="function"||(d=S.state,typeof S.componentWillMount=="function"&&S.componentWillMount(),typeof S.UNSAFE_componentWillMount=="function"&&S.UNSAFE_componentWillMount(),d!==S.state&&DR.enqueueReplaceState(S,S.state,null),RN(O,t,S,o),LN(),S.state=O.memoizedState),typeof S.componentDidMount=="function"&&(O.flags|=4194308),t=!0}else if(E===null){S=O.stateNode;var V=O.memoizedProps,X=Ot(n,V);S.props=X;var RE=S.context,LE=n.contextType;d=$T,typeof LE=="object"&&LE!==null&&(d=tT(LE));var GE=n.getDerivedStateFromProps;LE=typeof GE=="function"||typeof S.getSnapshotBeforeUpdate=="function",V=O.pendingProps!==V,LE||typeof S.UNSAFE_componentWillReceiveProps!="function"&&typeof S.componentWillReceiveProps!="function"||(V||RE!==d)&&xs(O,S,t,d),OE=!1;var iE=O.memoizedState;S.state=iE,RN(O,t,S,o),LN(),RE=O.memoizedState,V||iE!==RE||OE?(typeof GE=="function"&&(Us(O,n,GE,t),RE=O.memoizedState),(X=OE||wi(O,n,X,t,iE,RE,d))?(LE||typeof S.UNSAFE_componentWillMount!="function"&&typeof S.componentWillMount!="function"||(typeof S.componentWillMount=="function"&&S.componentWillMount(),typeof S.UNSAFE_componentWillMount=="function"&&S.UNSAFE_componentWillMount()),typeof S.componentDidMount=="function"&&(O.flags|=4194308)):(typeof S.componentDidMount=="function"&&(O.flags|=4194308),O.memoizedProps=t,O.memoizedState=RE),S.props=t,S.state=RE,S.context=d,t=X):(typeof S.componentDidMount=="function"&&(O.flags|=4194308),t=!1)}else{S=O.stateNode,ME(E,O),d=O.memoizedProps,LE=Ot(n,d),S.props=LE,GE=O.pendingProps,iE=S.context,RE=n.contextType,X=$T,typeof RE=="object"&&RE!==null&&(X=tT(RE)),V=n.getDerivedStateFromProps,(RE=typeof V=="function"||typeof S.getSnapshotBeforeUpdate=="function")||typeof S.UNSAFE_componentWillReceiveProps!="function"&&typeof S.componentWillReceiveProps!="function"||(d!==GE||iE!==X)&&xs(O,S,t,X),OE=!1,iE=O.memoizedState,S.state=iE,RN(O,t,S,o),LN();var SE=O.memoizedState;d!==GE||iE!==SE||OE||E!==null&&E.dependencies!==null&&ae(E.dependencies)?(typeof V=="function"&&(Us(O,n,V,t),SE=O.memoizedState),(LE=OE||wi(O,n,LE,t,iE,SE,X)||E!==null&&E.dependencies!==null&&ae(E.dependencies))?(RE||typeof S.UNSAFE_componentWillUpdate!="function"&&typeof S.componentWillUpdate!="function"||(typeof S.componentWillUpdate=="function"&&S.componentWillUpdate(t,SE,X),typeof S.UNSAFE_componentWillUpdate=="function"&&S.UNSAFE_componentWillUpdate(t,SE,X)),typeof S.componentDidUpdate=="function"&&(O.flags|=4),typeof S.getSnapshotBeforeUpdate=="function"&&(O.flags|=1024)):(typeof S.componentDidUpdate!="function"||d===E.memoizedProps&&iE===E.memoizedState||(O.flags|=4),typeof S.getSnapshotBeforeUpdate!="function"||d===E.memoizedProps&&iE===E.memoizedState||(O.flags|=1024),O.memoizedProps=t,O.memoizedState=SE),S.props=t,S.state=SE,S.context=X,t=LE):(typeof S.componentDidUpdate!="function"||d===E.memoizedProps&&iE===E.memoizedState||(O.flags|=4),typeof S.getSnapshotBeforeUpdate!="function"||d===E.memoizedProps&&iE===E.memoizedState||(O.flags|=1024),t=!1)}return S=t,dM(E,O),t=(O.flags&128)!==0,S||t?(S=O.stateNode,n=t&&typeof n.getDerivedStateFromError!="function"?null:S.render(),O.flags|=1,E!==null&&t?(O.child=K(O,E.child,null,o),O.child=K(O,null,n,o)):PO(E,O,n,o),O.memoizedState=S.state,E=O.child):E=tt(E,O,o),E}function LR(E,O,n,t){return Tn(),O.flags|=256,PO(E,O,n,t),O.child}var Un={dehydrated:null,treeContext:null,retryLane:0,hydrationErrors:null};function cR(E){return{baseLanes:E,cachePool:KT()}}function CT(E,O,n){return E=E!==null?E.childLanes&~n:0,O&&(E|=on),E}function Zi(E,O,n){var t=O.pendingProps,o=!1,S=(O.flags&128)!==0,d;if((d=S)||(d=E!==null&&E.memoizedState===null?!1:(VO.current&2)!==0),d&&(o=!0,O.flags&=-129),d=(O.flags&32)!==0,O.flags&=-33,E===null){if(gN){if(o?YT(O):$O(),(E=nO)?(E=JE(E,iN),E=E!==null&&E.data!=="&"?E:null,E!==null&&(O.memoizedState={dehydrated:E,treeContext:On!==null?{id:UT,overflow:DT}:null,retryLane:536870912,hydrationErrors:null},n=as(E),n.return=O,O.child=n,pO=O,nO=null)):E=null,E===null)throw hI(O);return eO(E)?O.lanes=32:O.lanes=536870912,null}var V=t.children;return t=t.fallback,o?($O(),o=O.mode,V=hR({mode:"hidden",children:V},o),t=qI(t,o,n,null),V.return=O,t.return=O,V.sibling=t,O.child=V,t=O.child,t.memoizedState=cR(n),t.childLanes=CT(E,d,n),O.memoizedState=Un,wt(null,t)):(YT(O),ks(O,V))}var X=E.memoizedState;if(X!==null&&(V=X.dehydrated,V!==null)){if(S)O.flags&256?(YT(O),O.flags&=-257,O=GM(E,O,n)):O.memoizedState!==null?($O(),O.child=E.child,O.flags|=128,O=null):($O(),V=t.fallback,o=O.mode,t=hR({mode:"visible",children:t.children},o),V=qI(V,o,n,null),V.flags|=2,t.return=O,V.return=O,t.sibling=V,O.child=t,K(O,E.child,null,n),t=O.child,t.memoizedState=cR(n),t.childLanes=CT(E,d,n),O.memoizedState=Un,O=wt(null,t));else if(YT(O),eO(V)){if(d=V.nextSibling&&V.nextSibling.dataset,d)var RE=d.dgst;d=RE,t=Error(f(419)),t.stack="",t.digest=d,re({value:t,source:null,stack:null}),O=GM(E,O,n)}else if(wO||dI(E,O,n,!1),d=(n&E.childLanes)!==0,wO||d){if(d=AO,d!==null&&(t=fO(d,n),t!==0&&t!==X.retryLane))throw X.retryLane=t,qn(E,t),Sn(d,E,t),ws;WE(V)||$s(),O=GM(E,O,n)}else WE(V)?(O.flags|=192,O.child=E.child,O=null):(E=X.treeContext,nO=LO(V.nextSibling),pO=O,gN=!0,Dn=null,iN=!1,E!==null&&IN(O,E),O=ks(O,t.children),O.flags|=4096);return O}return o?($O(),V=t.fallback,o=O.mode,X=E.child,RE=X.sibling,t=Wn(X,{mode:"hidden",children:t.children}),t.subtreeFlags=X.subtreeFlags&65011712,RE!==null?V=Wn(RE,V):(V=qI(V,o,n,null),V.flags|=2),V.return=O,t.return=O,t.sibling=V,O.child=t,wt(null,t),t=O.child,V=E.child.memoizedState,V===null?V=cR(n):(o=V.cachePool,o!==null?(X=KO._currentValue,o=o.parent!==X?{parent:X,pool:X}:o):o=KT(),V={baseLanes:V.baseLanes|n,cachePool:o}),t.memoizedState=V,t.childLanes=CT(E,d,n),O.memoizedState=Un,wt(E.child,t)):(YT(O),n=E.child,E=n.sibling,n=Wn(n,{mode:"visible",children:t.children}),n.return=O,n.sibling=null,E!==null&&(d=O.deletions,d===null?(O.deletions=[E],O.flags|=16):d.push(E)),O.child=n,O.memoizedState=null,n)}function ks(E,O){return O=hR({mode:"visible",children:O},E.mode),O.return=E,E.child=O}function hR(E,O){return E=iT(22,E,null,O),E.lanes=0,E}function GM(E,O,n){return K(O,E.child,null,n),E=ks(O,O.pendingProps.children),E.flags|=2,O.memoizedState=null,E}function Xi(E,O,n){E.lanes|=O;var t=E.alternate;t!==null&&(t.lanes|=O),iM(E.return,O,n)}function K_(E,O,n,t,o,S){var d=E.memoizedState;d===null?E.memoizedState={isBackwards:O,rendering:null,renderingStartTime:0,last:t,tail:n,tailMode:o,treeForkCount:S}:(d.isBackwards=O,d.rendering=null,d.renderingStartTime=0,d.last=t,d.tail=n,d.tailMode=o,d.treeForkCount=S)}function It(E,O,n){var t=O.pendingProps,o=t.revealOrder,S=t.tail;t=t.children;var d=VO.current,V=(d&2)!==0;if(V?(d=d&1|2,O.flags|=128):d&=1,yE(VO,d),PO(E,O,t,n),t=gN?IT:0,!V&&E!==null&&(E.flags&128)!==0)E:for(E=O.child;E!==null;){if(E.tag===13)E.memoizedState!==null&&Xi(E,n,O);else if(E.tag===19)Xi(E,n,O);else if(E.child!==null){E.child.return=E,E=E.child;continue}if(E===O)break E;for(;E.sibling===null;){if(E.return===null||E.return===O)break E;E=E.return}E.sibling.return=E.return,E=E.sibling}switch(o){case"forwards":for(n=O.child,o=null;n!==null;)E=n.alternate,E!==null&&pn(E)===null&&(o=n),n=n.sibling;n=o,n===null?(o=O.child,O.child=null):(o=n.sibling,n.sibling=null),K_(O,!1,o,n,S,t);break;case"backwards":case"unstable_legacy-backwards":for(n=null,o=O.child,O.child=null;o!==null;){if(E=o.alternate,E!==null&&pn(E)===null){O.child=o;break}E=o.sibling,o.sibling=n,n=o,o=E}K_(O,!0,n,null,S,t);break;case"together":K_(O,!1,null,null,void 0,t);break;default:O.memoizedState=null}return O.child}function tt(E,O,n){if(E!==null&&(O.dependencies=E.dependencies),_n|=O.lanes,(n&O.childLanes)===0)if(E!==null){if(dI(E,O,n,!1),(n&O.childLanes)===0)return null}else return null;if(E!==null&&O.child!==E.child)throw Error(f(153));if(O.child!==null){for(E=O.child,n=Wn(E,E.pendingProps),O.child=n,n.return=O;E.sibling!==null;)E=E.sibling,n=n.sibling=Wn(E,E.pendingProps),n.return=O;n.sibling=null}return O.child}function w_(E,O){return(E.lanes&O)!==0?!0:(E=E.dependencies,!!(E!==null&&ae(E)))}function kt(E,O,n){switch(O.tag){case 3:YO(O,O.stateNode.containerInfo),vT(O,KO,E.memoizedState.cache),Tn();break;case 27:case 5:mT(O);break;case 4:YO(O,O.stateNode.containerInfo);break;case 10:vT(O,O.type,O.memoizedProps.value);break;case 31:if(O.memoizedState!==null)return O.flags|=128,$n(O),null;break;case 13:var t=O.memoizedState;if(t!==null)return t.dehydrated!==null?(YT(O),O.flags|=128,null):(n&O.child.childLanes)!==0?Zi(E,O,n):(YT(O),E=tt(E,O,n),E!==null?E.sibling:null);YT(O);break;case 19:var o=(E.flags&128)!==0;if(t=(n&O.childLanes)!==0,t||(dI(E,O,n,!1),t=(n&O.childLanes)!==0),o){if(t)return It(E,O,n);O.flags|=128}if(o=O.memoizedState,o!==null&&(o.rendering=null,o.tail=null,o.lastEffect=null),yE(VO,VO.current),t)break;return null;case 22:return O.lanes=0,Fi(E,O,n,O.pendingProps);case 24:vT(O,KO,E.memoizedState.cache)}return tt(E,O,n)}function dR(E,O,n){if(E!==null)if(E.memoizedProps!==O.pendingProps)wO=!0;else{if(!w_(E,n)&&(O.flags&128)===0)return wO=!1,kt(E,O,n);wO=(E.flags&131072)!==0}else wO=!1,gN&&(O.flags&1048576)!==0&&eR(O,IT,O.index);switch(O.lanes=0,O.tag){case 16:E:{var t=O.pendingProps;if(E=JO(O.elementType),O.type=E,typeof E=="function")MM(E)?(t=Ot(E,t),O.tag=1,O=ji(null,O,E,t,n)):(O.tag=0,O=v_(null,O,E,t,n));else{if(E!=null){var o=E.$$typeof;if(o===gE){O.tag=11,O=Tt(null,O,E,t,n);break E}else if(o===cE){O.tag=14,O=x_(null,O,E,t,n);break E}}throw O=EO(E)||E,Error(f(306,O,""))}}return O;case 0:return v_(E,O,O.type,O.pendingProps,n);case 1:return t=O.type,o=Ot(t,O.pendingProps),ji(E,O,t,o,n);case 3:E:{if(YO(O,O.stateNode.containerInfo),E===null)throw Error(f(387));t=O.pendingProps;var S=O.memoizedState;o=S.element,ME(E,O),RN(O,t,null,n);var d=O.memoizedState;if(t=d.cache,vT(O,KO,t),t!==S.cache&&Pe(O,[KO],n,!0),LN(),t=d.element,S.isDehydrated)if(S={element:t,isDehydrated:!1,cache:d.cache},O.updateQueue.baseState=S,O.memoizedState=S,O.flags&256){O=LR(E,O,t,n);break E}else if(t!==o){o=yT(Error(f(424)),O),re(o),O=LR(E,O,t,n);break E}else for(E=O.stateNode.containerInfo,E.nodeType===9?E=E.body:E=E.nodeName==="HTML"?E.ownerDocument.body:E,nO=LO(E.firstChild),pO=O,gN=!0,Dn=null,iN=!0,n=w(O,null,t,n),O.child=n;n;)n.flags=n.flags&-3|4096,n=n.sibling;else{if(Tn(),t===o){O=tt(E,O,n);break E}PO(E,O,t,n)}O=O.child}return O;case 26:return dM(E,O),E===null?(n=kA(O.type,null,O.pendingProps,null))?O.memoizedState=n:gN||(n=O.type,E=O.pendingProps,t=B(rN.current).createElement(n),t[aO]=O,t[QO]=E,l(t,n,E),dO(t),O.stateNode=t):O.memoizedState=kA(O.type,E.memoizedProps,O.pendingProps,E.memoizedState),null;case 27:return mT(O),E===null&&gN&&(t=O.stateNode=cN(O.type,O.pendingProps,rN.current),pO=O,iN=!0,o=nO,aE(O.type)?(oN=o,nO=LO(t.firstChild)):nO=o),PO(E,O,O.pendingProps.children,n),dM(E,O),E===null&&(O.flags|=4194304),O.child;case 5:return E===null&&gN&&((o=t=nO)&&(t=XE(t,O.type,O.pendingProps,iN),t!==null?(O.stateNode=t,pO=O,nO=LO(t.firstChild),iN=!1,o=!0):o=!1),o||hI(O)),mT(O),o=O.type,S=O.pendingProps,d=E!==null?E.memoizedProps:null,t=S.children,g(o,S)?t=null:d!==null&&g(o,d)&&(O.flags|=32),O.memoizedState!==null&&(o=ds(E,O,SR,null,null,n),Si._currentValue=o),dM(E,O),PO(E,O,t,n),O.child;case 6:return E===null&&gN&&((E=n=nO)&&(n=NN(n,O.pendingProps,iN),n!==null?(O.stateNode=n,pO=O,nO=null,E=!0):E=!1),E||hI(O)),null;case 13:return Zi(E,O,n);case 4:return YO(O,O.stateNode.containerInfo),t=O.pendingProps,E===null?O.child=K(O,null,t,n):PO(E,O,t,n),O.child;case 11:return Tt(E,O,O.type,O.pendingProps,n);case 7:return PO(E,O,O.pendingProps,n),O.child;case 8:return PO(E,O,O.pendingProps.children,n),O.child;case 12:return PO(E,O,O.pendingProps.children,n),O.child;case 10:return t=O.pendingProps,vT(O,O.type,t.value),PO(E,O,t.children,n),O.child;case 9:return o=O.type._context,t=O.pendingProps.children,GI(O),o=tT(o),t=t(o),O.flags|=1,PO(E,O,t,n),O.child;case 14:return x_(E,O,O.type,O.pendingProps,n);case 15:return zi(E,O,O.type,O.pendingProps,n);case 19:return It(E,O,n);case 31:return nA(E,O,n);case 22:return Fi(E,O,n,O.pendingProps);case 24:return GI(O),t=tT(KO),E===null?(o=oR(),o===null&&(o=AO,S=Le(),o.pooledCache=S,S.refCount++,S!==null&&(o.pooledCacheLanes|=n),o=S),O.memoizedState={parent:t,cache:o},tE(O),vT(O,KO,o)):((E.lanes&n)!==0&&(ME(E,O),RN(O,null,null,n),LN()),o=E.memoizedState,S=O.memoizedState,o.parent!==t?(o={parent:t,cache:t},O.memoizedState=o,O.lanes===0&&(O.memoizedState=O.updateQueue.baseState=o),vT(O,KO,t)):(t=S.cache,vT(O,KO,t),t!==o.cache&&Pe(O,[KO],n,!0))),PO(E,O,O.pendingProps.children,n),O.child;case 29:throw O.pendingProps}throw Error(f(156,O.tag))}function NI(E){E.flags|=4}function GR(E,O,n,t,o){if((O=(E.mode&32)!==0)&&(O=!1),O){if(E.flags|=16777216,(o&335544128)===o)if(E.stateNode.complete)E.flags|=8192;else if(Ao())E.flags|=8192;else throw Et=AM,YI}else E.flags&=-16777217}function qi(E,O){if(O.type!=="stylesheet"||(O.state.loading&4)!==0)E.flags&=-16777217;else if(E.flags|=16777216,!XA(O))if(Ao())E.flags|=8192;else throw Et=AM,YI}function uR(E,O){O!==null&&(E.flags|=4),E.flags&16384&&(O=E.tag!==22?nN():536870912,E.lanes|=O,dn|=O)}function uM(E,O){if(!gN)switch(E.tailMode){case"hidden":O=E.tail;for(var n=null;O!==null;)O.alternate!==null&&(n=O),O=O.sibling;n===null?E.tail=null:n.sibling=null;break;case"collapsed":n=E.tail;for(var t=null;n!==null;)n.alternate!==null&&(t=n),n=n.sibling;t===null?O||E.tail===null?E.tail=null:E.tail.sibling=null:t.sibling=null}}function uO(E){var O=E.alternate!==null&&E.alternate.child===E.child,n=0,t=0;if(O)for(var o=E.child;o!==null;)n|=o.lanes|o.childLanes,t|=o.subtreeFlags&65011712,t|=o.flags&65011712,o.return=E,o=o.sibling;else for(o=E.child;o!==null;)n|=o.lanes|o.childLanes,t|=o.subtreeFlags,t|=o.flags,o.return=E,o=o.sibling;return E.subtreeFlags|=t,E.childLanes=n,O}function Wi(E,O,n){var t=O.pendingProps;switch(_M(O),O.tag){case 16:case 15:case 0:case 11:case 7:case 8:case 12:case 9:case 14:return uO(O),null;case 1:return uO(O),null;case 3:return n=O.stateNode,t=null,E!==null&&(t=E.memoizedState.cache),O.memoizedState.cache!==t&&(O.flags|=2048),nn(KO),_O(),n.pendingContext&&(n.context=n.pendingContext,n.pendingContext=null),(E===null||E.child===null)&&(LT(O)?NI(O):E===null||E.memoizedState.isDehydrated&&(O.flags&256)===0||(O.flags|=1024,RR())),uO(O),null;case 26:var o=O.type,S=O.memoizedState;return E===null?(NI(O),S!==null?(uO(O),qi(O,S)):(uO(O),GR(O,o,null,t,n))):S?S!==E.memoizedState?(NI(O),uO(O),qi(O,S)):(uO(O),O.flags&=-16777217):(E=E.memoizedProps,E!==t&&NI(O),uO(O),GR(O,o,E,t,n)),null;case 27:if(HO(O),n=rN.current,o=O.type,E!==null&&O.stateNode!=null)E.memoizedProps!==t&&NI(O);else{if(!t){if(O.stateNode===null)throw Error(f(166));return uO(O),null}E=FE.current,LT(O)?MR(O):(E=cN(o,t,n),O.stateNode=E,NI(O))}return uO(O),null;case 5:if(HO(O),o=O.type,E!==null&&O.stateNode!=null)E.memoizedProps!==t&&NI(O);else{if(!t){if(O.stateNode===null)throw Error(f(166));return uO(O),null}if(S=FE.current,LT(O))MR(O);else{var d=B(rN.current);switch(S){case 1:S=d.createElementNS("http://www.w3.org/2000/svg",o);break;case 2:S=d.createElementNS("http://www.w3.org/1998/Math/MathML",o);break;default:switch(o){case"svg":S=d.createElementNS("http://www.w3.org/2000/svg",o);break;case"math":S=d.createElementNS("http://www.w3.org/1998/Math/MathML",o);break;case"script":S=d.createElement("div"),S.innerHTML="<script><\/script>",S=S.removeChild(S.firstChild);break;case"select":S=typeof t.is=="string"?d.createElement("select",{is:t.is}):d.createElement("select"),t.multiple?S.multiple=!0:t.size&&(S.size=t.size);break;default:S=typeof t.is=="string"?d.createElement(o,{is:t.is}):d.createElement(o)}}S[aO]=O,S[QO]=t;E:for(d=O.child;d!==null;){if(d.tag===5||d.tag===6)S.appendChild(d.stateNode);else if(d.tag!==4&&d.tag!==27&&d.child!==null){d.child.return=d,d=d.child;continue}if(d===O)break E;for(;d.sibling===null;){if(d.return===null||d.return===O)break E;d=d.return}d.sibling.return=d.return,d=d.sibling}O.stateNode=S;E:switch(l(S,o,t),o){case"button":case"input":case"select":case"textarea":t=!!t.autoFocus;break E;case"img":t=!0;break E;default:t=!1}t&&NI(O)}}return uO(O),GR(O,O.type,E===null?null:E.memoizedProps,O.pendingProps,n),null;case 6:if(E&&O.stateNode!=null)E.memoizedProps!==t&&NI(O);else{if(typeof t!="string"&&O.stateNode===null)throw Error(f(166));if(E=rN.current,LT(O)){if(E=O.stateNode,n=O.memoizedProps,t=null,o=pO,o!==null)switch(o.tag){case 27:case 5:t=o.memoizedProps}E[aO]=O,E=!!(E.nodeValue===n||t!==null&&t.suppressHydrationWarning===!0||R(E.nodeValue,n)),E||hI(O,!0)}else E=B(E).createTextNode(t),E[aO]=O,O.stateNode=E}return uO(O),null;case 31:if(n=O.memoizedState,E===null||E.memoizedState!==null){if(t=LT(O),n!==null){if(E===null){if(!t)throw Error(f(318));if(E=O.memoizedState,E=E!==null?E.dehydrated:null,!E)throw Error(f(557));E[aO]=O}else Tn(),(O.flags&128)===0&&(O.memoizedState=null),O.flags|=4;uO(O),E=!1}else n=RR(),E!==null&&E.memoizedState!==null&&(E.memoizedState.hydrationErrors=n),E=!0;if(!E)return O.flags&256?(IO(O),O):(IO(O),null);if((O.flags&128)!==0)throw Error(f(558))}return uO(O),null;case 13:if(t=O.memoizedState,E===null||E.memoizedState!==null&&E.memoizedState.dehydrated!==null){if(o=LT(O),t!==null&&t.dehydrated!==null){if(E===null){if(!o)throw Error(f(318));if(o=O.memoizedState,o=o!==null?o.dehydrated:null,!o)throw Error(f(317));o[aO]=O}else Tn(),(O.flags&128)===0&&(O.memoizedState=null),O.flags|=4;uO(O),o=!1}else o=RR(),E!==null&&E.memoizedState!==null&&(E.memoizedState.hydrationErrors=o),o=!0;if(!o)return O.flags&256?(IO(O),O):(IO(O),null)}return IO(O),(O.flags&128)!==0?(O.lanes=n,O):(n=t!==null,E=E!==null&&E.memoizedState!==null,n&&(t=O.child,o=null,t.alternate!==null&&t.alternate.memoizedState!==null&&t.alternate.memoizedState.cachePool!==null&&(o=t.alternate.memoizedState.cachePool.pool),S=null,t.memoizedState!==null&&t.memoizedState.cachePool!==null&&(S=t.memoizedState.cachePool.pool),S!==o&&(t.flags|=2048)),n!==E&&n&&(O.child.flags|=8192),uR(O,O.updateQueue),uO(O),null);case 4:return _O(),E===null&&_i(O.stateNode.containerInfo),uO(O),null;case 10:return nn(O.type),uO(O),null;case 19:if(z(VO),t=O.memoizedState,t===null)return uO(O),null;if(o=(O.flags&128)!==0,S=t.rendering,S===null)if(o)uM(t,!1);else{if(zO!==0||E!==null&&(E.flags&128)!==0)for(E=O.child;E!==null;){if(S=pn(E),S!==null){for(O.flags|=128,uM(t,!1),E=S.updateQueue,O.updateQueue=E,uR(O,E),O.subtreeFlags=0,E=n,n=O.child;n!==null;)En(n,E),n=n.sibling;return yE(VO,VO.current&1|2),gN&&FN(O,t.treeForkCount),O.child}E=E.sibling}t.tail!==null&&sT()>pR&&(O.flags|=128,o=!0,uM(t,!1),O.lanes=4194304)}else{if(!o)if(E=pn(S),E!==null){if(O.flags|=128,o=!0,E=E.updateQueue,O.updateQueue=E,uR(O,E),uM(t,!0),t.tail===null&&t.tailMode==="hidden"&&!S.alternate&&!gN)return uO(O),null}else 2*sT()-t.renderingStartTime>pR&&n!==536870912&&(O.flags|=128,o=!0,uM(t,!1),O.lanes=4194304);t.isBackwards?(S.sibling=O.child,O.child=S):(E=t.last,E!==null?E.sibling=S:O.child=S,t.last=S)}return t.tail!==null?(E=t.tail,t.rendering=E,t.tail=E.sibling,t.renderingStartTime=sT(),E.sibling=null,n=VO.current,yE(VO,o?n&1|2:n&1),gN&&FN(O,t.treeForkCount),E):(uO(O),null);case 22:case 23:return IO(O),cT(),t=O.memoizedState!==null,E!==null?E.memoizedState!==null!==t&&(O.flags|=8192):t&&(O.flags|=8192),t?(n&536870912)!==0&&(O.flags&128)===0&&(uO(O),O.subtreeFlags&6&&(O.flags|=8192)):uO(O),n=O.updateQueue,n!==null&&uR(O,n.retryQueue),n=null,E!==null&&E.memoizedState!==null&&E.memoizedState.cachePool!==null&&(n=E.memoizedState.cachePool.pool),t=null,O.memoizedState!==null&&O.memoizedState.cachePool!==null&&(t=O.memoizedState.cachePool.pool),t!==n&&(O.flags|=2048),E!==null&&z(JI),null;case 24:return n=null,E!==null&&(n=E.memoizedState.cache),O.memoizedState.cache!==n&&(O.flags|=2048),nn(KO),uO(O),null;case 25:return null;case 30:return null}throw Error(f(156,O.tag))}function YR(E,O){switch(_M(O),O.tag){case 1:return E=O.flags,E&65536?(O.flags=E&-65537|128,O):null;case 3:return nn(KO),_O(),E=O.flags,(E&65536)!==0&&(E&128)===0?(O.flags=E&-65537|128,O):null;case 26:case 27:case 5:return HO(O),null;case 31:if(O.memoizedState!==null){if(IO(O),O.alternate===null)throw Error(f(340));Tn()}return E=O.flags,E&65536?(O.flags=E&-65537|128,O):null;case 13:if(IO(O),E=O.memoizedState,E!==null&&E.dehydrated!==null){if(O.alternate===null)throw Error(f(340));Tn()}return E=O.flags,E&65536?(O.flags=E&-65537|128,O):null;case 19:return z(VO),null;case 4:return _O(),null;case 10:return nn(O.type),null;case 22:case 23:return IO(O),cT(),E!==null&&z(JI),E=O.flags,E&65536?(O.flags=E&-65537|128,O):null;case 24:return nn(KO),null;case 25:return null;default:return null}}function Qi(E,O){switch(_M(O),O.tag){case 3:nn(KO),_O();break;case 26:case 27:case 5:HO(O);break;case 4:_O();break;case 31:O.memoizedState!==null&&IO(O);break;case 13:IO(O);break;case 19:z(VO);break;case 10:nn(O.type);break;case 22:case 23:IO(O),cT(),E!==null&&z(JI);break;case 24:nn(KO)}}function HR(E,O){try{var n=O.updateQueue,t=n!==null?n.lastEffect:null;if(t!==null){var o=t.next;n=o;do{if((n.tag&E)===E){t=void 0;var S=n.create,d=n.inst;t=S(),d.destroy=t}n=n.next}while(n!==o)}}catch(V){tO(O,O.return,V)}}function zt(E,O,n){try{var t=O.updateQueue,o=t!==null?t.lastEffect:null;if(o!==null){var S=o.next;t=S;do{if((t.tag&E)===E){var d=t.inst,V=d.destroy;if(V!==void 0){d.destroy=void 0,o=O;var X=n,RE=V;try{RE()}catch(LE){tO(o,X,LE)}}}t=t.next}while(t!==S)}}catch(LE){tO(O,O.return,LE)}}function k_(E){var O=E.updateQueue;if(O!==null){var n=E.stateNode;try{uN(O,n)}catch(t){tO(E,E.return,t)}}}function zs(E,O,n){n.props=Ot(E.type,E.memoizedProps),n.state=E.memoizedState;try{n.componentWillUnmount()}catch(t){tO(E,O,t)}}function fe(E,O){try{var n=E.ref;if(n!==null){switch(E.tag){case 26:case 27:case 5:var t=E.stateNode;break;case 30:t=E.stateNode;break;default:t=E.stateNode}typeof n=="function"?E.refCleanup=n(t):n.current=t}}catch(o){tO(E,O,o)}}function tn(E,O){var n=E.ref,t=E.refCleanup;if(n!==null)if(typeof t=="function")try{t()}catch(o){tO(E,O,o)}finally{E.refCleanup=null,E=E.alternate,E!=null&&(E.refCleanup=null)}else if(typeof n=="function")try{n(null)}catch(o){tO(E,O,o)}else n.current=null}function z_(E){var O=E.type,n=E.memoizedProps,t=E.stateNode;try{E:switch(O){case"button":case"input":case"select":case"textarea":n.autoFocus&&t.focus();break E;case"img":n.src?t.src=n.src:n.srcSet&&(t.srcset=n.srcSet)}}catch(o){tO(E,E.return,o)}}function F_(E,O,n){try{var t=E.stateNode;D(t,E.type,n,O),t[QO]=O}catch(o){tO(E,E.return,o)}}function Ji(E){return E.tag===5||E.tag===3||E.tag===26||E.tag===27&&aE(E.type)||E.tag===4}function Fs(E){E:for(;;){for(;E.sibling===null;){if(E.return===null||Ji(E.return))return null;E=E.return}for(E.sibling.return=E.return,E=E.sibling;E.tag!==5&&E.tag!==6&&E.tag!==18;){if(E.tag===27&&aE(E.type)||E.flags&2||E.child===null||E.tag===4)continue E;E.child.return=E,E=E.child}if(!(E.flags&2))return E.stateNode}}function pe(E,O,n){var t=E.tag;if(t===5||t===6)E=E.stateNode,O?(n.nodeType===9?n.body:n.nodeName==="HTML"?n.ownerDocument.body:n).insertBefore(E,O):(O=n.nodeType===9?n.body:n.nodeName==="HTML"?n.ownerDocument.body:n,O.appendChild(E),n=n._reactRootContainer,n!=null||O.onclick!==null||(O.onclick=qT));else if(t!==4&&(t===27&&aE(E.type)&&(n=E.stateNode,O=null),E=E.child,E!==null))for(pe(E,O,n),E=E.sibling;E!==null;)pe(E,O,n),E=E.sibling}function CR(E,O,n){var t=E.tag;if(t===5||t===6)E=E.stateNode,O?n.insertBefore(E,O):n.appendChild(E);else if(t!==4&&(t===27&&aE(E.type)&&(n=E.stateNode),E=E.child,E!==null))for(CR(E,O,n),E=E.sibling;E!==null;)CR(E,O,n),E=E.sibling}function $i(E){var O=E.stateNode,n=E.memoizedProps;try{for(var t=E.type,o=O.attributes;o.length;)O.removeAttributeNode(o[0]);l(O,t,n),O[aO]=E,O[QO]=n}catch(S){tO(E,E.return,S)}}var et=!1,kO=!1,Mt=!1,js=typeof WeakSet=="function"?WeakSet:Set,oT=null;function IA(E,O){if(E=E.containerInfo,h=go,E=eM(E),Ae(E)){if("selectionStart"in E)var n={start:E.selectionStart,end:E.selectionEnd};else E:{n=(n=E.ownerDocument)&&n.defaultView||window;var t=n.getSelection&&n.getSelection();if(t&&t.rangeCount!==0){n=t.anchorNode;var o=t.anchorOffset,S=t.focusNode;t=t.focusOffset;try{n.nodeType,S.nodeType}catch{n=null;break E}var d=0,V=-1,X=-1,RE=0,LE=0,GE=E,iE=null;N:for(;;){for(var SE;GE!==n||o!==0&&GE.nodeType!==3||(V=d+o),GE!==S||t!==0&&GE.nodeType!==3||(X=d+t),GE.nodeType===3&&(d+=GE.nodeValue.length),(SE=GE.firstChild)!==null;)iE=GE,GE=SE;for(;;){if(GE===E)break N;if(iE===n&&++RE===o&&(V=d),iE===S&&++LE===t&&(X=d),(SE=GE.nextSibling)!==null)break;GE=iE,iE=GE.parentNode}GE=SE}n=V===-1||X===-1?null:{start:V,end:X}}else n=null}n=n||{start:0,end:0}}else n=null;for(H={focusedElem:E,selectionRange:n},go=!1,oT=O;oT!==null;)if(O=oT,E=O.child,(O.subtreeFlags&1028)!==0&&E!==null)E.return=O,oT=E;else for(;oT!==null;){switch(O=oT,S=O.alternate,E=O.flags,O.tag){case 0:if((E&4)!==0&&(E=O.updateQueue,E=E!==null?E.events:null,E!==null))for(n=0;n<E.length;n++)o=E[n],o.ref.impl=o.nextImpl;break;case 11:case 15:break;case 1:if((E&1024)!==0&&S!==null){E=void 0,n=O,o=S.memoizedProps,S=S.memoizedState,t=n.stateNode;try{var ON=Ot(n.type,o);E=t.getSnapshotBeforeUpdate(ON,S),t.__reactInternalSnapshotBeforeUpdate=E}catch(DN){tO(n,n.return,DN)}}break;case 3:if((E&1024)!==0){if(E=O.stateNode.containerInfo,n=E.nodeType,n===9)vE(E);else if(n===1)switch(E.nodeName){case"HEAD":case"HTML":case"BODY":vE(E);break;default:E.textContent=""}}break;case 5:case 26:case 27:case 6:case 4:case 17:break;default:if((E&1024)!==0)throw Error(f(163))}if(E=O.sibling,E!==null){E.return=O.return,oT=E;break}oT=O.return}}function Eo(E,O,n){var t=n.flags;switch(n.tag){case 0:case 11:case 15:st(E,n),t&4&&HR(5,n);break;case 1:if(st(E,n),t&4)if(E=n.stateNode,O===null)try{E.componentDidMount()}catch(d){tO(n,n.return,d)}else{var o=Ot(n.type,O.memoizedProps);O=O.memoizedState;try{E.componentDidUpdate(o,O,E.__reactInternalSnapshotBeforeUpdate)}catch(d){tO(n,n.return,d)}}t&64&&k_(n),t&512&&fe(n,n.return);break;case 3:if(st(E,n),t&64&&(E=n.updateQueue,E!==null)){if(O=null,n.child!==null)switch(n.child.tag){case 27:case 5:O=n.child.stateNode;break;case 1:O=n.child.stateNode}try{uN(E,O)}catch(d){tO(n,n.return,d)}}break;case 27:O===null&&t&4&&$i(n);case 26:case 5:st(E,n),O===null&&t&4&&z_(n),t&512&&fe(n,n.return);break;case 12:st(E,n);break;case 31:st(E,n),t&4&&To(E,n);break;case 13:st(E,n),t&4&&no(E,n),t&64&&(E=n.memoizedState,E!==null&&(E=E.dehydrated,E!==null&&(n=sA.bind(null,n),MO(E,n))));break;case 22:if(t=n.memoizedState!==null||et,!t){O=O!==null&&O.memoizedState!==null||kO,o=et;var S=kO;et=t,(kO=O)&&!S?OI(E,n,(n.subtreeFlags&8772)!==0):st(E,n),et=o,kO=S}break;case 30:break;default:st(E,n)}}function No(E){var O=E.alternate;O!==null&&(E.alternate=null,No(O)),E.child=null,E.deletions=null,E.sibling=null,E.tag===5&&(O=E.stateNode,O!==null&&lO(O)),E.stateNode=null,E.return=null,E.dependencies=null,E.memoizedProps=null,E.memoizedState=null,E.pendingProps=null,E.stateNode=null,E.updateQueue=null}var bO=null,en=!1;function Rt(E,O,n){for(n=n.child;n!==null;)Oo(E,O,n),n=n.sibling}function Oo(E,O,n){if(NT&&typeof NT.onCommitFiberUnmount=="function")try{NT.onCommitFiberUnmount(pT,n)}catch{}switch(n.tag){case 26:kO||tn(n,O),Rt(E,O,n),n.memoizedState?n.memoizedState.count--:n.stateNode&&(n=n.stateNode,n.parentNode.removeChild(n));break;case 27:kO||tn(n,O);var t=bO,o=en;aE(n.type)&&(bO=n.stateNode,en=!1),Rt(E,O,n),jN(n.stateNode),bO=t,en=o;break;case 5:kO||tn(n,O);case 6:if(t=bO,o=en,bO=null,Rt(E,O,n),bO=t,en=o,bO!==null)if(en)try{(bO.nodeType===9?bO.body:bO.nodeName==="HTML"?bO.ownerDocument.body:bO).removeChild(n.stateNode)}catch(S){tO(n,O,S)}else try{bO.removeChild(n.stateNode)}catch(S){tO(n,O,S)}break;case 18:bO!==null&&(en?(E=bO,lE(E.nodeType===9?E.body:E.nodeName==="HTML"?E.ownerDocument.body:E,n.stateNode),s_(E)):lE(bO,n.stateNode));break;case 4:t=bO,o=en,bO=n.stateNode.containerInfo,en=!0,Rt(E,O,n),bO=t,en=o;break;case 0:case 11:case 14:case 15:zt(2,n,O),kO||zt(4,n,O),Rt(E,O,n);break;case 1:kO||(tn(n,O),t=n.stateNode,typeof t.componentWillUnmount=="function"&&zs(n,O,t)),Rt(E,O,n);break;case 21:Rt(E,O,n);break;case 22:kO=(t=kO)||n.memoizedState!==null,Rt(E,O,n),kO=t;break;default:Rt(E,O,n)}}function To(E,O){if(O.memoizedState===null&&(E=O.alternate,E!==null&&(E=E.memoizedState,E!==null))){E=E.dehydrated;try{s_(E)}catch(n){tO(O,O.return,n)}}}function no(E,O){if(O.memoizedState===null&&(E=O.alternate,E!==null&&(E=E.memoizedState,E!==null&&(E=E.dehydrated,E!==null))))try{s_(E)}catch(n){tO(O,O.return,n)}}function tA(E){switch(E.tag){case 31:case 13:case 19:var O=E.stateNode;return O===null&&(O=E.stateNode=new js),O;case 22:return E=E.stateNode,O=E._retryCache,O===null&&(O=E._retryCache=new js),O;default:throw Error(f(435,E.tag))}}function BR(E,O){var n=tA(E);O.forEach(function(t){if(!n.has(t)){n.add(t);var o=ho.bind(null,E,t);t.then(o,o)}})}function Mn(E,O){var n=O.deletions;if(n!==null)for(var t=0;t<n.length;t++){var o=n[t],S=E,d=O,V=d;E:for(;V!==null;){switch(V.tag){case 27:if(aE(V.type)){bO=V.stateNode,en=!1;break E}break;case 5:bO=V.stateNode,en=!1;break E;case 3:case 4:bO=V.stateNode.containerInfo,en=!0;break E}V=V.return}if(bO===null)throw Error(f(160));Oo(S,d,o),bO=null,en=!1,S=o.alternate,S!==null&&(S.return=null),o.return=null}if(O.subtreeFlags&13886)for(O=O.child;O!==null;)Zs(O,E),O=O.sibling}var xn=null;function Zs(E,O){var n=E.alternate,t=E.flags;switch(E.tag){case 0:case 11:case 14:case 15:Mn(O,E),Rn(E),t&4&&(zt(3,E,E.return),HR(3,E),zt(5,E,E.return));break;case 1:Mn(O,E),Rn(E),t&512&&(kO||n===null||tn(n,n.return)),t&64&&et&&(E=E.updateQueue,E!==null&&(t=E.callbacks,t!==null&&(n=E.shared.hiddenCallbacks,E.shared.hiddenCallbacks=n===null?t:n.concat(t))));break;case 26:var o=xn;if(Mn(O,E),Rn(E),t&512&&(kO||n===null||tn(n,n.return)),t&4){var S=n!==null?n.memoizedState:null;if(t=E.memoizedState,n===null)if(t===null)if(E.stateNode===null){E:{t=E.type,n=E.memoizedProps,o=o.ownerDocument||o;N:switch(t){case"title":S=o.getElementsByTagName("title")[0],(!S||S[rn]||S[aO]||S.namespaceURI==="http://www.w3.org/2000/svg"||S.hasAttribute("itemprop"))&&(S=o.createElement(t),o.head.insertBefore(S,o.querySelector("head > title"))),l(S,t,n),S[aO]=E,dO(S),t=S;break E;case"link":var d=jA("link","href",o).get(t+(n.href||""));if(d){for(var V=0;V<d.length;V++)if(S=d[V],S.getAttribute("href")===(n.href==null||n.href===""?null:n.href)&&S.getAttribute("rel")===(n.rel==null?null:n.rel)&&S.getAttribute("title")===(n.title==null?null:n.title)&&S.getAttribute("crossorigin")===(n.crossOrigin==null?null:n.crossOrigin)){d.splice(V,1);break N}}S=o.createElement(t),l(S,t,n),o.head.appendChild(S);break;case"meta":if(d=jA("meta","content",o).get(t+(n.content||""))){for(V=0;V<d.length;V++)if(S=d[V],S.getAttribute("content")===(n.content==null?null:""+n.content)&&S.getAttribute("name")===(n.name==null?null:n.name)&&S.getAttribute("property")===(n.property==null?null:n.property)&&S.getAttribute("http-equiv")===(n.httpEquiv==null?null:n.httpEquiv)&&S.getAttribute("charset")===(n.charSet==null?null:n.charSet)){d.splice(V,1);break N}}S=o.createElement(t),l(S,t,n),o.head.appendChild(S);break;default:throw Error(f(468,t))}S[aO]=E,dO(S),t=S}E.stateNode=t}else ZA(o,E.type,E.stateNode);else E.stateNode=FA(o,t,E.memoizedProps);else S!==t?(S===null?n.stateNode!==null&&(n=n.stateNode,n.parentNode.removeChild(n)):S.count--,t===null?ZA(o,E.type,E.stateNode):FA(o,t,E.memoizedProps)):t===null&&E.stateNode!==null&&F_(E,E.memoizedProps,n.memoizedProps)}break;case 27:Mn(O,E),Rn(E),t&512&&(kO||n===null||tn(n,n.return)),n!==null&&t&4&&F_(E,E.memoizedProps,n.memoizedProps);break;case 5:if(Mn(O,E),Rn(E),t&512&&(kO||n===null||tn(n,n.return)),E.flags&32){o=E.stateNode;try{at(o,"")}catch(ON){tO(E,E.return,ON)}}t&4&&E.stateNode!=null&&(o=E.memoizedProps,F_(E,o,n!==null?n.memoizedProps:o)),t&1024&&(Mt=!0);break;case 6:if(Mn(O,E),Rn(E),t&4){if(E.stateNode===null)throw Error(f(162));t=E.memoizedProps,n=E.stateNode;try{n.nodeValue=t}catch(ON){tO(E,E.return,ON)}}break;case 3:if(mo=null,o=xn,xn=cO(O.containerInfo),Mn(O,E),xn=o,Rn(E),t&4&&n!==null&&n.memoizedState.isDehydrated)try{s_(O.containerInfo)}catch(ON){tO(E,E.return,ON)}Mt&&(Mt=!1,Io(E));break;case 4:t=xn,xn=cO(E.stateNode.containerInfo),Mn(O,E),Rn(E),xn=t;break;case 12:Mn(O,E),Rn(E);break;case 31:Mn(O,E),Rn(E),t&4&&(t=E.updateQueue,t!==null&&(E.updateQueue=null,BR(E,t)));break;case 13:Mn(O,E),Rn(E),E.child.flags&8192&&E.memoizedState!==null!=(n!==null&&n.memoizedState!==null)&&(Zt=sT()),t&4&&(t=E.updateQueue,t!==null&&(E.updateQueue=null,BR(E,t)));break;case 22:o=E.memoizedState!==null;var X=n!==null&&n.memoizedState!==null,RE=et,LE=kO;if(et=RE||o,kO=LE||X,Mn(O,E),kO=LE,et=RE,Rn(E),t&8192)E:for(O=E.stateNode,O._visibility=o?O._visibility&-2:O._visibility|1,o&&(n===null||X||et||kO||CI(E)),n=null,O=E;;){if(O.tag===5||O.tag===26){if(n===null){X=n=O;try{if(S=X.stateNode,o)d=S.style,typeof d.setProperty=="function"?d.setProperty("display","none","important"):d.display="none";else{V=X.stateNode;var GE=X.memoizedProps.style,iE=GE!=null&&GE.hasOwnProperty("display")?GE.display:null;V.style.display=iE==null||typeof iE=="boolean"?"":(""+iE).trim()}}catch(ON){tO(X,X.return,ON)}}}else if(O.tag===6){if(n===null){X=O;try{X.stateNode.nodeValue=o?"":X.memoizedProps}catch(ON){tO(X,X.return,ON)}}}else if(O.tag===18){if(n===null){X=O;try{var SE=X.stateNode;o?mE(SE,!0):mE(X.stateNode,!1)}catch(ON){tO(X,X.return,ON)}}}else if((O.tag!==22&&O.tag!==23||O.memoizedState===null||O===E)&&O.child!==null){O.child.return=O,O=O.child;continue}if(O===E)break E;for(;O.sibling===null;){if(O.return===null||O.return===E)break E;n===O&&(n=null),O=O.return}n===O&&(n=null),O.sibling.return=O.return,O=O.sibling}t&4&&(t=E.updateQueue,t!==null&&(n=t.retryQueue,n!==null&&(t.retryQueue=null,BR(E,n))));break;case 19:Mn(O,E),Rn(E),t&4&&(t=E.updateQueue,t!==null&&(E.updateQueue=null,BR(E,t)));break;case 30:break;case 21:break;default:Mn(O,E),Rn(E)}}function Rn(E){var O=E.flags;if(O&2){try{for(var n,t=E.return;t!==null;){if(Ji(t)){n=t;break}t=t.return}if(n==null)throw Error(f(160));switch(n.tag){case 27:var o=n.stateNode,S=Fs(E);CR(E,S,o);break;case 5:var d=n.stateNode;n.flags&32&&(at(d,""),n.flags&=-33);var V=Fs(E);CR(E,V,d);break;case 3:case 4:var X=n.stateNode.containerInfo,RE=Fs(E);pe(E,RE,X);break;default:throw Error(f(161))}}catch(LE){tO(E,E.return,LE)}E.flags&=-3}O&4096&&(E.flags&=-4097)}function Io(E){if(E.subtreeFlags&1024)for(E=E.child;E!==null;){var O=E;Io(O),O.tag===5&&O.flags&1024&&O.stateNode.reset(),E=E.sibling}}function st(E,O){if(O.subtreeFlags&8772)for(O=O.child;O!==null;)Eo(E,O.alternate,O),O=O.sibling}function CI(E){for(E=E.child;E!==null;){var O=E;switch(O.tag){case 0:case 11:case 14:case 15:zt(4,O,O.return),CI(O);break;case 1:tn(O,O.return);var n=O.stateNode;typeof n.componentWillUnmount=="function"&&zs(O,O.return,n),CI(O);break;case 27:jN(O.stateNode);case 26:case 5:tn(O,O.return),CI(O);break;case 22:O.memoizedState===null&&CI(O);break;case 30:CI(O);break;default:CI(O)}E=E.sibling}}function OI(E,O,n){for(n=n&&(O.subtreeFlags&8772)!==0,O=O.child;O!==null;){var t=O.alternate,o=E,S=O,d=S.flags;switch(S.tag){case 0:case 11:case 15:OI(o,S,n),HR(4,S);break;case 1:if(OI(o,S,n),t=S,o=t.stateNode,typeof o.componentDidMount=="function")try{o.componentDidMount()}catch(RE){tO(t,t.return,RE)}if(t=S,o=t.updateQueue,o!==null){var V=t.stateNode;try{var X=o.shared.hiddenCallbacks;if(X!==null)for(o.shared.hiddenCallbacks=null,o=0;o<X.length;o++)qE(X[o],V)}catch(RE){tO(t,t.return,RE)}}n&&d&64&&k_(S),fe(S,S.return);break;case 27:$i(S);case 26:case 5:OI(o,S,n),n&&t===null&&d&4&&z_(S),fe(S,S.return);break;case 12:OI(o,S,n);break;case 31:OI(o,S,n),n&&d&4&&To(o,S);break;case 13:OI(o,S,n),n&&d&4&&no(o,S);break;case 22:S.memoizedState===null&&OI(o,S,n),fe(S,S.return);break;case 30:break;default:OI(o,S,n)}O=O.sibling}}function Xs(E,O){var n=null;E!==null&&E.memoizedState!==null&&E.memoizedState.cachePool!==null&&(n=E.memoizedState.cachePool.pool),E=null,O.memoizedState!==null&&O.memoizedState.cachePool!==null&&(E=O.memoizedState.cachePool.pool),E!==n&&(E!=null&&E.refCount++,n!=null&&yt(n))}function j_(E,O){E=null,O.alternate!==null&&(E=O.alternate.memoizedState.cache),O=O.memoizedState.cache,O!==E&&(O.refCount++,E!=null&&yt(E))}function sn(E,O,n,t){if(O.subtreeFlags&10256)for(O=O.child;O!==null;)qs(E,O,n,t),O=O.sibling}function qs(E,O,n,t){var o=O.flags;switch(O.tag){case 0:case 11:case 15:sn(E,O,n,t),o&2048&&HR(9,O);break;case 1:sn(E,O,n,t);break;case 3:sn(E,O,n,t),o&2048&&(E=null,O.alternate!==null&&(E=O.alternate.memoizedState.cache),O=O.memoizedState.cache,O!==E&&(O.refCount++,E!=null&&yt(E)));break;case 12:if(o&2048){sn(E,O,n,t),E=O.stateNode;try{var S=O.memoizedProps,d=S.id,V=S.onPostCommit;typeof V=="function"&&V(d,O.alternate===null?"mount":"update",E.passiveEffectDuration,-0)}catch(X){tO(O,O.return,X)}}else sn(E,O,n,t);break;case 31:sn(E,O,n,t);break;case 13:sn(E,O,n,t);break;case 23:break;case 22:S=O.stateNode,d=O.alternate,O.memoizedState!==null?S._visibility&2?sn(E,O,n,t):bR(E,O):S._visibility&2?sn(E,O,n,t):(S._visibility|=2,Ve(E,O,n,t,(O.subtreeFlags&10256)!==0||!1)),o&2048&&Xs(d,O);break;case 24:sn(E,O,n,t),o&2048&&j_(O.alternate,O);break;default:sn(E,O,n,t)}}function Ve(E,O,n,t,o){for(o=o&&((O.subtreeFlags&10256)!==0||!1),O=O.child;O!==null;){var S=E,d=O,V=n,X=t,RE=d.flags;switch(d.tag){case 0:case 11:case 15:Ve(S,d,V,X,o),HR(8,d);break;case 23:break;case 22:var LE=d.stateNode;d.memoizedState!==null?LE._visibility&2?Ve(S,d,V,X,o):bR(S,d):(LE._visibility|=2,Ve(S,d,V,X,o)),o&&RE&2048&&Xs(d.alternate,d);break;case 24:Ve(S,d,V,X,o),o&&RE&2048&&j_(d.alternate,d);break;default:Ve(S,d,V,X,o)}O=O.sibling}}function bR(E,O){if(O.subtreeFlags&10256)for(O=O.child;O!==null;){var n=E,t=O,o=t.flags;switch(t.tag){case 22:bR(n,t),o&2048&&Xs(t.alternate,t);break;case 24:bR(n,t),o&2048&&j_(t.alternate,t);break;default:bR(n,t)}O=O.sibling}}var ge=8192;function YM(E,O,n){if(E.subtreeFlags&ge)for(E=E.child;E!==null;)to(E,O,n),E=E.sibling}function to(E,O,n){switch(E.tag){case 26:YM(E,O,n),E.flags&ge&&E.memoizedState!==null&&El(n,xn,E.memoizedState,E.memoizedProps);break;case 5:YM(E,O,n);break;case 3:case 4:var t=xn;xn=cO(E.stateNode.containerInfo),YM(E,O,n),xn=t;break;case 22:E.memoizedState===null&&(t=E.alternate,t!==null&&t.memoizedState!==null?(t=ge,ge=16777216,YM(E,O,n),ge=t):YM(E,O,n));break;default:YM(E,O,n)}}function Ws(E){var O=E.alternate;if(O!==null&&(E=O.child,E!==null)){O.child=null;do O=E.sibling,E.sibling=null,E=O;while(E!==null)}}function mR(E){var O=E.deletions;if((E.flags&16)!==0){if(O!==null)for(var n=0;n<O.length;n++){var t=O[n];oT=t,fR(t,E)}Ws(E)}if(E.subtreeFlags&10256)for(E=E.child;E!==null;)eo(E),E=E.sibling}function eo(E){switch(E.tag){case 0:case 11:case 15:mR(E),E.flags&2048&&zt(9,E,E.return);break;case 3:mR(E);break;case 12:mR(E);break;case 22:var O=E.stateNode;E.memoizedState!==null&&O._visibility&2&&(E.return===null||E.return.tag!==13)?(O._visibility&=-3,Qs(E)):mR(E);break;default:mR(E)}}function Qs(E){var O=E.deletions;if((E.flags&16)!==0){if(O!==null)for(var n=0;n<O.length;n++){var t=O[n];oT=t,fR(t,E)}Ws(E)}for(E=E.child;E!==null;){switch(O=E,O.tag){case 0:case 11:case 15:zt(8,O,O.return),Qs(O);break;case 22:n=O.stateNode,n._visibility&2&&(n._visibility&=-3,Qs(O));break;default:Qs(O)}E=E.sibling}}function fR(E,O){for(;oT!==null;){var n=oT;switch(n.tag){case 0:case 11:case 15:zt(8,n,O);break;case 23:case 22:if(n.memoizedState!==null&&n.memoizedState.cachePool!==null){var t=n.memoizedState.cachePool.pool;t!=null&&t.refCount++}break;case 24:yt(n.memoizedState.cache)}if(t=n.child,t!==null)t.return=n,oT=t;else E:for(n=E;oT!==null;){t=oT;var o=t.sibling,S=t.return;if(No(t),t===n){oT=null;break E}if(o!==null){o.return=S,oT=o;break E}oT=S}}}var Js={getCacheForType:function(E){var O=tT(KO),n=O.data.get(E);return n===void 0&&(n=E(),O.data.set(E,n)),n},cacheSignal:function(){return tT(KO).controller.signal}},Mo=typeof WeakMap=="function"?WeakMap:Map,JN=0,AO=null,fN=null,bN=0,OO=0,hT=null,Ft=!1,_t=!1,HM=!1,it=0,zO=0,_n=0,jt=0,CM=0,on=0,dn=0,ot=null,AT=null,Z_=!1,Zt=0,Ro=0,pR=1/0,ye=null,Xt=null,ET=0,qt=null,BM=null,At=0,X_=0,q_=null,so=null,Ue=0,W_=null;function An(){return(JN&2)!==0&&bN!==0?bN&-bN:rE.T!==null?ei():FT()}function _o(){if(on===0)if((bN&536870912)===0||gN){var E=jE;jE<<=1,(jE&3932160)===0&&(jE=262144),on=E}else on=536870912;return E=oO.current,E!==null&&(E.flags|=32),on}function Sn(E,O,n){(E===AO&&(OO===2||OO===9)||E.cancelPendingCommit!==null)&&(fM(E,0),Wt(E,bN,on,!1)),_N(E,n),((JN&2)===0||E!==AO)&&(E===AO&&((JN&2)===0&&(jt|=n),zO===4&&Wt(E,bN,on,!1)),TI(E))}function io(E,O,n){if((JN&6)!==0)throw Error(f(327));var t=!n&&(O&127)===0&&(O&E.expiredLanes)===0||TN(E,O),o=t?MA(E,O):$_(E,O,!0),S=t;do{if(o===0){_t&&!t&&Wt(E,O,0,!1);break}else{if(n=E.current.alternate,S&&!oo(n)){o=$_(E,O,!1),S=!1;continue}if(o===2){if(S=O,E.errorRecoveryDisabledLanes&S)var d=0;else d=E.pendingLanes&-536870913,d=d!==0?d:d&536870912?536870912:0;if(d!==0){O=d;E:{var V=E;o=ot;var X=V.current.memoizedState.isDehydrated;if(X&&(fM(V,d).flags|=256),d=$_(V,d,!1),d!==2){if(HM&&!X){V.errorRecoveryDisabledLanes|=S,jt|=S,o=4;break E}S=AT,AT=o,S!==null&&(AT===null?AT=S:AT.push.apply(AT,S))}o=d}if(S=!1,o!==2)continue}}if(o===1){fM(E,0),Wt(E,O,0,!0);break}E:{switch(t=E,S=o,S){case 0:case 1:throw Error(f(345));case 4:if((O&4194048)!==O)break;case 6:Wt(t,O,on,!Ft);break E;case 2:AT=null;break;case 3:case 5:break;default:throw Error(f(329))}if((O&62914560)===O&&(o=Zt+300-sT(),10<o)){if(Wt(t,O,on,!Ft),SN(t,0,!0)!==0)break E;At=O,t.timeoutHandle=Z(VR.bind(null,t,n,AT,ye,Z_,O,on,jt,dn,Ft,S,"Throttled",-0,0),o);break E}VR(t,n,AT,ye,Z_,O,on,jt,dn,Ft,S,null,-0,0)}}break}while(!0);TI(E)}function VR(E,O,n,t,o,S,d,V,X,RE,LE,GE,iE,SE){if(E.timeoutHandle=-1,GE=O.subtreeFlags,GE&8192||(GE&16785408)===16785408){GE={stylesheets:null,count:0,imgCount:0,imgBytes:0,suspenseyImages:[],waitingForImages:!0,waitingForViewTransition:!1,unsuspend:qT},to(O,S,GE);var ON=(S&62914560)===S?Zt-sT():(S&4194048)===S?Ro-sT():0;if(ON=Nl(GE,ON),ON!==null){At=S,E.cancelPendingCommit=ON(N_.bind(null,E,O,S,n,t,o,d,V,X,LE,GE,null,iE,SE)),Wt(E,S,d,!RE);return}}N_(E,O,S,n,t,o,d,V,X)}function oo(E){for(var O=E;;){var n=O.tag;if((n===0||n===11||n===15)&&O.flags&16384&&(n=O.updateQueue,n!==null&&(n=n.stores,n!==null)))for(var t=0;t<n.length;t++){var o=n[t],S=o.getSnapshot;o=o.value;try{if(!ZO(S(),o))return!1}catch{return!1}}if(n=O.child,O.subtreeFlags&16384&&n!==null)n.return=O,O=n;else{if(O===E)break;for(;O.sibling===null;){if(O.return===null||O.return===E)return!0;O=O.return}O.sibling.return=O.return,O=O.sibling}}return!0}function Wt(E,O,n,t){O&=~CM,O&=~jt,E.suspendedLanes|=O,E.pingedLanes&=~O,t&&(E.warmLanes|=O),t=E.expirationTimes;for(var o=O;0<o;){var S=31-nE(o),d=1<<S;t[S]=-1,o&=~d}n!==0&&GN(E,n,O)}function bM(){return(JN&6)===0?(yR(0),!1):!0}function mM(){if(fN!==null){if(OO===0)var E=fN.return;else E=fN,xT=Ln=null,h_(E),r=null,L=0,E=fN;for(;E!==null;)Qi(E.alternate,E),E=E.return;fN=null}}function fM(E,O){var n=E.timeoutHandle;n!==-1&&(E.timeoutHandle=-1,W(n)),n=E.cancelPendingCommit,n!==null&&(E.cancelPendingCommit=null,n()),At=0,mM(),AO=E,fN=n=Wn(E.current,null),bN=O,OO=0,hT=null,Ft=!1,_t=TN(E,O),HM=!1,dn=on=CM=jt=_n=zO=0,AT=ot=null,Z_=!1,(O&8)!==0&&(O|=O&32);var t=E.entangledLanes;if(t!==0)for(E=E.entanglements,t&=O;0<t;){var o=31-nE(t),S=1<<o;O|=E[o],t&=~S}return it=O,pt(),n}function Q_(E,O){dN=null,rE.H=be,O===$I||O===Ge?(O=a(),OO=3):O===YI?(O=a(),OO=4):OO=O===ws?8:O!==null&&typeof O=="object"&&typeof O.then=="function"?6:1,hT=O,fN===null&&(zO=1,Kt(E,yT(O,E.current)))}function Ao(){var E=oO.current;return E===null?!0:(bN&4194048)===bN?rO===null:(bN&62914560)===bN||(bN&536870912)!==0?E===rO:!1}function J_(){var E=rE.H;return rE.H=be,E===null?be:E}function So(){var E=rE.A;return rE.A=Js,E}function $s(){zO=4,Ft||(bN&4194048)!==bN&&oO.current!==null||(_t=!0),(_n&134217727)===0&&(jt&134217727)===0||AO===null||Wt(AO,bN,on,!1)}function $_(E,O,n){var t=JN;JN|=2;var o=J_(),S=So();(AO!==E||bN!==O)&&(ye=null,fM(E,O)),O=!1;var d=zO;E:do try{if(OO!==0&&fN!==null){var V=fN,X=hT;switch(OO){case 8:mM(),d=6;break E;case 3:case 2:case 9:case 6:oO.current===null&&(O=!0);var RE=OO;if(OO=0,hT=null,pM(E,V,X,RE),n&&_t){d=0;break E}break;default:RE=OO,OO=0,hT=null,pM(E,V,X,RE)}}eA(),d=zO;break}catch(LE){Q_(E,LE)}while(!0);return O&&E.shellSuspendCounter++,xT=Ln=null,JN=t,rE.H=o,rE.A=S,fN===null&&(AO=null,bN=0,pt()),d}function eA(){for(;fN!==null;)ro(fN)}function MA(E,O){var n=JN;JN|=2;var t=J_(),o=So();AO!==E||bN!==O?(ye=null,pR=sT()+500,fM(E,O)):_t=TN(E,O);E:do try{if(OO!==0&&fN!==null){O=fN;var S=hT;N:switch(OO){case 1:OO=0,hT=null,pM(E,O,S,1);break;case 2:case 9:if(xt(S)){OO=0,hT=null,Ei(O);break}O=function(){OO!==2&&OO!==9||AO!==E||(OO=7),TI(E)},S.then(O,O);break E;case 3:OO=7;break E;case 4:OO=5;break E;case 7:xt(S)?(OO=0,hT=null,Ei(O)):(OO=0,hT=null,pM(E,O,S,7));break;case 5:var d=null;switch(fN.tag){case 26:d=fN.memoizedState;case 5:case 27:var V=fN;if(d?XA(d):V.stateNode.complete){OO=0,hT=null;var X=V.sibling;if(X!==null)fN=X;else{var RE=V.return;RE!==null?(fN=RE,E_(RE)):fN=null}break N}}OO=0,hT=null,pM(E,O,S,5);break;case 6:OO=0,hT=null,pM(E,O,S,6);break;case 8:mM(),zO=6;break E;default:throw Error(f(462))}}lo();break}catch(LE){Q_(E,LE)}while(!0);return xT=Ln=null,rE.H=t,rE.A=o,JN=n,fN!==null?0:(AO=null,bN=0,pt(),zO)}function lo(){for(;fN!==null&&!we();)ro(fN)}function ro(E){var O=dR(E.alternate,E,it);E.memoizedProps=E.pendingProps,O===null?E_(E):fN=O}function Ei(E){var O=E,n=O.alternate;switch(O.tag){case 15:case 0:O=me(n,O,O.pendingProps,O.type,void 0,bN);break;case 11:O=me(n,O,O.pendingProps,O.type.render,O.ref,bN);break;case 5:h_(O);default:Qi(n,O),O=fN=En(O,it),O=dR(n,O,it)}E.memoizedProps=E.pendingProps,O===null?E_(E):fN=O}function pM(E,O,n,t){xT=Ln=null,h_(O),r=null,L=0;var o=O.return;try{if(U_(E,o,O,n,bN)){zO=1,Kt(E,yT(n,E.current)),fN=null;return}}catch(S){if(o!==null)throw fN=o,S;zO=1,Kt(E,yT(n,E.current)),fN=null;return}O.flags&32768?(gN||t===1?E=!0:_t||(bN&536870912)!==0?E=!1:(Ft=E=!0,(t===2||t===9||t===3||t===6)&&(t=oO.current,t!==null&&t.tag===13&&(t.flags|=16384))),Ni(O,E)):E_(O)}function E_(E){var O=E;do{if((O.flags&32768)!==0){Ni(O,Ft);return}E=O.return;var n=Wi(O.alternate,O,it);if(n!==null){fN=n;return}if(O=O.sibling,O!==null){fN=O;return}fN=O=E}while(O!==null);zO===0&&(zO=5)}function Ni(E,O){do{var n=YR(E.alternate,E);if(n!==null){n.flags&=32767,fN=n;return}if(n=E.return,n!==null&&(n.flags|=32768,n.subtreeFlags=0,n.deletions=null),!O&&(E=E.sibling,E!==null)){fN=E;return}fN=E=n}while(E!==null);zO=6,fN=null}function N_(E,O,n,t,o,S,d,V,X){E.cancelPendingCommit=null;do T_();while(ET!==0);if((JN&6)!==0)throw Error(f(327));if(O!==null){if(O===E.current)throw Error(f(177));if(S=O.lanes|O.childLanes,S|=ft,qN(E,n,S,d,V,X),E===AO&&(fN=AO=null,bN=0),BM=O,qt=E,At=n,X_=S,q_=o,so=t,(O.subtreeFlags&10256)!==0||(O.flags&10256)!==0?(E.callbackNode=null,E.callbackPriority=0,_A(fI,function(){return Oi(),null})):(E.callbackNode=null,E.callbackPriority=0),t=(O.flags&13878)!==0,(O.subtreeFlags&13878)!==0||t){t=rE.T,rE.T=null,o=pE.p,pE.p=2,d=JN,JN|=4;try{IA(E,O,n)}finally{JN=d,pE.p=o,rE.T=t}}ET=1,Po(),O_(),ao()}}function Po(){if(ET===1){ET=0;var E=qt,O=BM,n=(O.flags&13878)!==0;if((O.subtreeFlags&13878)!==0||n){n=rE.T,rE.T=null;var t=pE.p;pE.p=2;var o=JN;JN|=4;try{Zs(O,E);var S=H,d=eM(E.containerInfo),V=S.focusedElem,X=S.selectionRange;if(d!==V&&V&&V.ownerDocument&&As(V.ownerDocument.documentElement,V)){if(X!==null&&Ae(V)){var RE=X.start,LE=X.end;if(LE===void 0&&(LE=RE),"selectionStart"in V)V.selectionStart=RE,V.selectionEnd=Math.min(LE,V.value.length);else{var GE=V.ownerDocument||document,iE=GE&&GE.defaultView||window;if(iE.getSelection){var SE=iE.getSelection(),ON=V.textContent.length,DN=Math.min(X.start,ON),hO=X.end===void 0?DN:Math.min(X.end,ON);!SE.extend&&DN>hO&&(d=hO,hO=DN,DN=d);var TE=Ct(V,DN),NE=Ct(V,hO);if(TE&&NE&&(SE.rangeCount!==1||SE.anchorNode!==TE.node||SE.anchorOffset!==TE.offset||SE.focusNode!==NE.node||SE.focusOffset!==NE.offset)){var eE=GE.createRange();eE.setStart(TE.node,TE.offset),SE.removeAllRanges(),DN>hO?(SE.addRange(eE),SE.extend(NE.node,NE.offset)):(eE.setEnd(NE.node,NE.offset),SE.addRange(eE))}}}}for(GE=[],SE=V;SE=SE.parentNode;)SE.nodeType===1&&GE.push({element:SE,left:SE.scrollLeft,top:SE.scrollTop});for(typeof V.focus=="function"&&V.focus(),V=0;V<GE.length;V++){var hE=GE[V];hE.element.scrollLeft=hE.left,hE.element.scrollTop=hE.top}}go=!!h,H=h=null}finally{JN=o,pE.p=t,rE.T=n}}E.current=O,ET=2}}function O_(){if(ET===2){ET=0;var E=qt,O=BM,n=(O.flags&8772)!==0;if((O.subtreeFlags&8772)!==0||n){n=rE.T,rE.T=null;var t=pE.p;pE.p=2;var o=JN;JN|=4;try{Eo(E,O.alternate,O)}finally{JN=o,pE.p=t,rE.T=n}}ET=3}}function ao(){if(ET===4||ET===3){ET=0,zT();var E=qt,O=BM,n=At,t=so;(O.subtreeFlags&10256)!==0||(O.flags&10256)!==0?ET=5:(ET=0,BM=qt=null,Do(E,E.pendingLanes));var o=E.pendingLanes;if(o===0&&(Xt=null),TT(n),O=O.stateNode,NT&&typeof NT.onCommitFiberRoot=="function")try{NT.onCommitFiberRoot(pT,O,void 0,(O.current.flags&128)===128)}catch{}if(t!==null){O=rE.T,o=pE.p,pE.p=2,rE.T=null;try{for(var S=E.onRecoverableError,d=0;d<t.length;d++){var V=t[d];S(V.value,{componentStack:V.stack})}}finally{rE.T=O,pE.p=o}}(At&3)!==0&&T_(),TI(E),o=E.pendingLanes,(n&261930)!==0&&(o&42)!==0?E===W_?Ue++:(Ue=0,W_=E):Ue=0,yR(0)}}function Do(E,O){(E.pooledCacheLanes&=O)===0&&(O=E.pooledCache,O!=null&&(E.pooledCache=null,yt(O)))}function T_(){return Po(),O_(),ao(),Oi()}function Oi(){if(ET!==5)return!1;var E=qt,O=X_;X_=0;var n=TT(At),t=rE.T,o=pE.p;try{pE.p=32>n?32:n,rE.T=null,n=q_,q_=null;var S=qt,d=At;if(ET=0,BM=qt=null,At=0,(JN&6)!==0)throw Error(f(331));var V=JN;if(JN|=4,eo(S.current),qs(S,S.current,d,n),JN=V,yR(0,!1),NT&&typeof NT.onPostCommitFiberRoot=="function")try{NT.onPostCommitFiberRoot(pT,S)}catch{}return!0}finally{pE.p=o,rE.T=t,Do(E,O)}}function Lo(E,O,n){O=yT(n,O),O=y_(E.stateNode,O,2),E=bE(E,O,2),E!==null&&(_N(E,2),TI(E))}function tO(E,O,n){if(E.tag===3)Lo(E,E,n);else for(;O!==null;){if(O.tag===3){Lo(O,E,n);break}else if(O.tag===1){var t=O.stateNode;if(typeof O.type.getDerivedStateFromError=="function"||typeof t.componentDidCatch=="function"&&(Xt===null||!Xt.has(t))){E=yT(n,E),n=vs(2),t=bE(O,n,2),t!==null&&(Ks(n,t,O,E),_N(t,2),TI(t));break}}O=O.return}}function n_(E,O,n){var t=E.pingCache;if(t===null){t=E.pingCache=new Mo;var o=new Set;t.set(O,o)}else o=t.get(O),o===void 0&&(o=new Set,t.set(O,o));o.has(n)||(HM=!0,o.add(n),E=RA.bind(null,E,O,n),O.then(E,E))}function RA(E,O,n){var t=E.pingCache;t!==null&&t.delete(O),E.pingedLanes|=E.suspendedLanes&n,E.warmLanes&=~n,AO===E&&(bN&n)===n&&(zO===4||zO===3&&(bN&62914560)===bN&&300>sT()-Zt?(JN&2)===0&&fM(E,0):CM|=n,dn===bN&&(dn=0)),TI(E)}function co(E,O){O===0&&(O=nN()),E=qn(E,O),E!==null&&(_N(E,O),TI(E))}function sA(E){var O=E.memoizedState,n=0;O!==null&&(n=O.retryLane),co(E,n)}function ho(E,O){var n=0;switch(E.tag){case 31:case 13:var t=E.stateNode,o=E.memoizedState;o!==null&&(n=o.retryLane);break;case 19:t=E.stateNode;break;case 22:t=E.stateNode._retryCache;break;default:throw Error(f(314))}t!==null&&t.delete(O),co(E,n)}function _A(E,O){return fT(E,O)}var I_=null,VM=null,Ti=!1,gR=!1,t_=!1,Qt=0;function TI(E){E!==VM&&E.next===null&&(VM===null?I_=VM=E:VM=VM.next=E),gR=!0,Ti||(Ti=!0,ti())}function yR(E,O){if(!t_&&gR){t_=!0;do for(var n=!1,t=I_;t!==null;){if(E!==0){var o=t.pendingLanes;if(o===0)var S=0;else{var d=t.suspendedLanes,V=t.pingedLanes;S=(1<<31-nE(42|E)+1)-1,S&=o&~(d&~V),S=S&201326741?S&201326741|1:S?S|2:0}S!==0&&(n=!0,Yo(t,S))}else S=bN,S=SN(t,t===AO?S:0,t.cancelPendingCommit!==null||t.timeoutHandle!==-1),(S&3)===0||TN(t,S)||(n=!0,Yo(t,S));t=t.next}while(n);t_=!1}}function Go(){ni()}function ni(){gR=Ti=!1;var E=0;Qt!==0&&j()&&(E=Qt);for(var O=sT(),n=null,t=I_;t!==null;){var o=t.next,S=uo(t,O);S===0?(t.next=null,n===null?I_=o:n.next=o,o===null&&(VM=n)):(n=t,(E!==0||(S&3)!==0)&&(gR=!0)),t=o}ET!==0&&ET!==5||yR(E),Qt!==0&&(Qt=0)}function uo(E,O){for(var n=E.suspendedLanes,t=E.pingedLanes,o=E.expirationTimes,S=E.pendingLanes&-62914561;0<S;){var d=31-nE(S),V=1<<d,X=o[d];X===-1?((V&n)===0||(V&t)!==0)&&(o[d]=QE(V,O)):X<=O&&(E.expiredLanes|=V),S&=~V}if(O=AO,n=bN,n=SN(E,E===O?n:0,E.cancelPendingCommit!==null||E.timeoutHandle!==-1),t=E.callbackNode,n===0||E===O&&(OO===2||OO===9)||E.cancelPendingCommit!==null)return t!==null&&t!==null&&PT(t),E.callbackNode=null,E.callbackPriority=0;if((n&3)===0||TN(E,n)){if(O=n&-n,O===E.callbackPriority)return O;switch(t!==null&&PT(t),TT(n)){case 2:case 8:n=tN;break;case 32:n=fI;break;case 268435456:n=eI;break;default:n=fI}return t=Ii.bind(null,E),n=fT(n,t),E.callbackPriority=O,E.callbackNode=n,O}return t!==null&&t!==null&&PT(t),E.callbackPriority=2,E.callbackNode=null,2}function Ii(E,O){if(ET!==0&&ET!==5)return E.callbackNode=null,E.callbackPriority=0,null;var n=E.callbackNode;if(T_()&&E.callbackNode!==n)return null;var t=bN;return t=SN(E,E===AO?t:0,E.cancelPendingCommit!==null||E.timeoutHandle!==-1),t===0?null:(io(E,t,O),uo(E,sT()),E.callbackNode!=null&&E.callbackNode===n?Ii.bind(null,E):null)}function Yo(E,O){if(T_())return null;io(E,O,!0)}function ti(){$(function(){(JN&6)!==0?fT(Ne,Go):ni()})}function ei(){if(Qt===0){var E=Jn;E===0&&(E=kE,kE<<=1,(kE&261888)===0&&(kE=256)),Qt=E}return Qt}function Mi(E){return E==null||typeof E=="symbol"||typeof E=="boolean"?null:typeof E=="function"?E:ne(""+E)}function Ri(E,O){var n=O.ownerDocument.createElement("input");return n.name=O.name,n.value=O.value,E.id&&n.setAttribute("form",E.id),O.parentNode.insertBefore(n,O),E=new FormData(E),n.parentNode.removeChild(n),E}function iA(E,O,n,t,o){if(O==="submit"&&n&&n.stateNode===o){var S=Mi((o[QO]||null).action),d=t.submitter;d&&(O=(O=d[QO]||null)?Mi(O.formAction):d.getAttribute("formAction"),O!==null&&(S=O,d=null));var V=new KI("action","action",null,t,o);E.push({event:V,listeners:[{instance:null,listener:function(){if(t.defaultPrevented){if(Qt!==0){var X=d?Ri(o,d):new FormData(o);Vs(n,{pending:!0,data:X,method:o.method,action:S},null,X)}}else typeof S=="function"&&(V.preventDefault(),X=d?Ri(o,d):new FormData(o),Vs(n,{pending:!0,data:X,method:o.method,action:S},S,X))},currentTarget:o}]})}}for(var si=0;si<tR.length;si++){var UR=tR[si],oA=UR.toLowerCase(),AA=UR[0].toUpperCase()+UR.slice(1);QT(oA,"on"+AA)}QT(PI,"onAnimationEnd"),QT(aI,"onAnimationIteration"),QT(nR,"onAnimationStart"),QT("dblclick","onDoubleClick"),QT("focusin","onFocus"),QT("focusout","onBlur"),QT(ls,"onTransitionRun"),QT(IR,"onTransitionStart"),QT(rs,"onTransitionCancel"),QT(DI,"onTransitionEnd"),_I("onMouseEnter",["mouseout","mouseover"]),_I("onMouseLeave",["mouseout","mouseover"]),_I("onPointerEnter",["pointerout","pointerover"]),_I("onPointerLeave",["pointerout","pointerover"]),kn("onChange","change click focusin focusout input keydown keyup selectionchange".split(" ")),kn("onSelect","focusout contextmenu dragend focusin keydown keyup mousedown mouseup selectionchange".split(" ")),kn("onBeforeInput",["compositionend","keypress","textInput","paste"]),kn("onCompositionEnd","compositionend focusout keydown keypress keyup mousedown".split(" ")),kn("onCompositionStart","compositionstart focusout keydown keypress keyup mousedown".split(" ")),kn("onCompositionUpdate","compositionupdate focusout keydown keypress keyup mousedown".split(" "));var xR="abort canplay canplaythrough durationchange emptied encrypted ended error loadeddata loadedmetadata loadstart pause play playing progress ratechange resize seeked seeking stalled suspend timeupdate volumechange waiting".split(" "),SA=new Set("beforetoggle cancel close invalid load scroll scrollend toggle".split(" ").concat(xR));function Ho(E,O){O=(O&4)!==0;for(var n=0;n<E.length;n++){var t=E[n],o=t.event;t=t.listeners;E:{var S=void 0;if(O)for(var d=t.length-1;0<=d;d--){var V=t[d],X=V.instance,RE=V.currentTarget;if(V=V.listener,X!==S&&o.isPropagationStopped())break E;S=V,o.currentTarget=RE;try{S(o)}catch(LE){Se(LE)}o.currentTarget=null,S=X}else for(d=0;d<t.length;d++){if(V=t[d],X=V.instance,RE=V.currentTarget,V=V.listener,X!==S&&o.isPropagationStopped())break E;S=V,o.currentTarget=RE;try{S(o)}catch(LE){Se(LE)}o.currentTarget=null,S=X}}}}function UN(E,O){var n=O[QN];n===void 0&&(n=O[QN]=new Set);var t=E+"__bubble";n.has(t)||(Co(O,E,2,!1),n.add(t))}function gM(E,O,n){var t=0;O&&(t|=4),Co(n,E,t,O)}var e_="_reactListening"+Math.random().toString(36).slice(2);function _i(E){if(!E[e_]){E[e_]=!0,lt.forEach(function(n){n!=="selectionchange"&&(SA.has(n)||gM(n,!1,E),gM(n,!0,E))});var O=E.nodeType===9?E:E.ownerDocument;O===null||O[e_]||(O[e_]=!0,gM("selectionchange",!1,O))}}function Co(E,O,n,t){switch(NS(O)){case 2:var o=nl;break;case 8:o=Il;break;default:o=DA}n=o.bind(null,O,n,E),o=void 0,!Ie||O!=="touchstart"&&O!=="touchmove"&&O!=="wheel"||(o=!0),t?o!==void 0?E.addEventListener(O,n,{capture:!0,passive:o}):E.addEventListener(O,n,!0):o!==void 0?E.addEventListener(O,n,{passive:o}):E.addEventListener(O,n,!1)}function ii(E,O,n,t,o){var S=t;if((O&1)===0&&(O&2)===0&&t!==null)E:for(;;){if(t===null)return;var d=t.tag;if(d===3||d===4){var V=t.stateNode.containerInfo;if(V===o)break;if(d===4)for(d=t.return;d!==null;){var X=d.tag;if((X===3||X===4)&&d.stateNode.containerInfo===o)return;d=d.return}for(;V!==null;){if(d=ZT(V),d===null)return;if(X=d.tag,X===5||X===6||X===26||X===27){t=S=d;continue E}V=V.parentNode}}t=t.return}We(function(){var RE=S,LE=GT(n),GE=[];E:{var iE=mn.get(E);if(iE!==void 0){var SE=KI,ON=E;switch(E){case"keypress":if(Je(n)===0)break E;case"keydown":case"keyup":SE=Is;break;case"focusin":ON="focus",SE=EM;break;case"focusout":ON="blur",SE=EM;break;case"beforeblur":case"afterblur":SE=EM;break;case"click":if(n.button===2)break E;case"auxclick":case"dblclick":case"mousedown":case"mousemove":case"mouseup":case"mouseout":case"mouseover":case"contextmenu":SE=QM;break;case"drag":case"dragend":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"dragstart":case"drop":SE=Ns;break;case"touchcancel":case"touchend":case"touchmove":case"touchstart":SE=ts;break;case PI:case aI:case nR:SE=dt;break;case DI:SE=oI;break;case"scroll":case"scrollend":SE=jn;break;case"wheel":SE=Gt;break;case"copy":case"cut":case"paste":SE=te;break;case"gotpointercapture":case"lostpointercapture":case"pointercancel":case"pointerdown":case"pointermove":case"pointerout":case"pointerover":case"pointerup":SE=NM;break;case"toggle":case"beforetoggle":SE=Ms}var DN=(O&4)!==0,hO=!DN&&(E==="scroll"||E==="scrollend"),TE=DN?iE!==null?iE+"Capture":null:iE;DN=[];for(var NE=RE,eE;NE!==null;){var hE=NE;if(eE=hE.stateNode,hE=hE.tag,hE!==5&&hE!==26&&hE!==27||eE===null||TE===null||(hE=Fn(NE,TE),hE!=null&&DN.push(vR(NE,hE,eE))),hO)break;NE=NE.return}0<DN.length&&(iE=new SE(iE,ON,null,n,LE),GE.push({event:iE,listeners:DN}))}}if((O&7)===0){E:{if(iE=E==="mouseover"||E==="pointerover",SE=E==="mouseout"||E==="pointerout",iE&&n!==qe&&(ON=n.relatedTarget||n.fromElement)&&(ZT(ON)||ON[dT]))break E;if((SE||iE)&&(iE=LE.window===LE?LE:(iE=LE.ownerDocument)?iE.defaultView||iE.parentWindow:window,SE?(ON=n.relatedTarget||n.toElement,SE=RE,ON=ON?ZT(ON):null,ON!==null&&(hO=F(ON),DN=ON.tag,ON!==hO||DN!==5&&DN!==27&&DN!==6)&&(ON=null)):(SE=null,ON=RE),SE!==ON)){if(DN=QM,hE="onMouseLeave",TE="onMouseEnter",NE="mouse",(E==="pointerout"||E==="pointerover")&&(DN=NM,hE="onPointerLeave",TE="onPointerEnter",NE="pointer"),hO=SE==null?iE:RI(SE),eE=ON==null?iE:RI(ON),iE=new DN(hE,NE+"leave",SE,n,LE),iE.target=hO,iE.relatedTarget=eE,hE=null,ZT(LE)===RE&&(DN=new DN(TE,NE+"enter",ON,n,LE),DN.target=eE,DN.relatedTarget=hO,hE=DN),hO=hE,SE&&ON)N:{for(DN=N,TE=SE,NE=ON,eE=0,hE=TE;hE;hE=DN(hE))eE++;hE=0;for(var AN=NE;AN;AN=DN(AN))hE++;for(;0<eE-hE;)TE=DN(TE),eE--;for(;0<hE-eE;)NE=DN(NE),hE--;for(;eE--;){if(TE===NE||NE!==null&&TE===NE.alternate){DN=TE;break N}TE=DN(TE),NE=DN(NE)}DN=null}else DN=null;SE!==null&&T(GE,iE,SE,DN,!1),ON!==null&&hO!==null&&T(GE,hO,ON,DN,!0)}}E:{if(iE=RE?RI(RE):window,SE=iE.nodeName&&iE.nodeName.toLowerCase(),SE==="select"||SE==="input"&&iE.type==="file")var RO=nM;else if(se(iE))if(ER)RO=Xn;else{RO=ie;var eN=IM}else SE=iE.nodeName,!SE||SE.toLowerCase()!=="input"||iE.type!=="checkbox"&&iE.type!=="radio"?RE&&Ze(RE.elementType)&&(RO=nM):RO=tM;if(RO&&(RO=RO(E,RE))){jI(GE,RO,n,LE);break E}eN&&eN(E,iE,RE),E==="focusout"&&RE&&iE.type==="number"&&RE.memoizedProps.value!=null&&rt(iE,"number",iE.value)}switch(eN=RE?RI(RE):window,E){case"focusin":(se(eN)||eN.contentEditable==="true")&&(Bt=eN,NR=RE,lI=null);break;case"focusout":lI=NR=Bt=null;break;case"mousedown":bt=!0;break;case"contextmenu":case"mouseup":case"dragend":bt=!1,Ss(GE,n,LE);break;case"selectionchange":if(P_)break;case"keydown":case"keyup":Ss(GE,n,LE)}var mN;if(Re)E:{switch(E){case"compositionstart":var ZN="onCompositionStart";break E;case"compositionend":ZN="onCompositionEnd";break E;case"compositionupdate":ZN="onCompositionUpdate";break E}ZN=void 0}else ut?ss(E,n)&&(ZN="onCompositionEnd"):E==="keydown"&&n.keyCode===229&&(ZN="onCompositionStart");ZN&&($M&&n.locale!=="ko"&&(ut||ZN!=="onCompositionStart"?ZN==="onCompositionEnd"&&ut&&(mN=xI()):(Cn=LE,iI="value"in Cn?Cn.value:Cn.textContent,ut=!0)),eN=A(RE,ZN),0<eN.length&&(ZN=new Os(ZN,E,null,n,LE),GE.push({event:ZN,listeners:eN}),mN?ZN.data=mN:(mN=TM(n),mN!==null&&(ZN.data=mN)))),(mN=l_?_s(E,n):jO(E,n))&&(ZN=A(RE,"onBeforeInput"),0<ZN.length&&(eN=new Os("onBeforeInput","beforeinput",null,n,LE),GE.push({event:eN,listeners:ZN}),eN.data=mN)),iA(GE,E,RE,n,LE)}Ho(GE,O)})}function vR(E,O,n){return{instance:E,listener:O,currentTarget:n}}function A(E,O){for(var n=O+"Capture",t=[];E!==null;){var o=E,S=o.stateNode;if(o=o.tag,o!==5&&o!==26&&o!==27||S===null||(o=Fn(E,n),o!=null&&t.unshift(vR(E,o,S)),o=Fn(E,O),o!=null&&t.push(vR(E,o,S))),E.tag===3)return t;E=E.return}return[]}function N(E){if(E===null)return null;do E=E.return;while(E&&E.tag!==5&&E.tag!==27);return E||null}function T(E,O,n,t,o){for(var S=O._reactName,d=[];n!==null&&n!==t;){var V=n,X=V.alternate,RE=V.stateNode;if(V=V.tag,X!==null&&X===t)break;V!==5&&V!==26&&V!==27||RE===null||(X=RE,o?(RE=Fn(n,S),RE!=null&&d.unshift(vR(n,RE,X))):o||(RE=Fn(n,S),RE!=null&&d.push(vR(n,RE,X)))),n=n.return}d.length!==0&&E.push({event:O,listeners:d})}var I=/\r\n?/g,e=/\u0000|\uFFFD/g;function M(E){return(typeof E=="string"?E:""+E).replace(I,`
`).replace(e,"")}function R(E,O){return O=M(O),M(E)===O}function s(E,O,n,t,o,S){switch(n){case"children":typeof t=="string"?O==="body"||O==="textarea"&&t===""||at(E,t):(typeof t=="number"||typeof t=="bigint")&&O!=="body"&&at(E,""+t);break;case"className":ze(E,"class",t);break;case"tabIndex":ze(E,"tabindex",t);break;case"dir":case"role":case"viewBox":case"width":case"height":ze(E,n,t);break;case"style":yI(E,t,S);break;case"data":if(O!=="object"){ze(E,"data",t);break}case"src":case"href":if(t===""&&(O!=="a"||n!=="href")){E.removeAttribute(n);break}if(t==null||typeof t=="function"||typeof t=="symbol"||typeof t=="boolean"){E.removeAttribute(n);break}t=ne(""+t),E.setAttribute(n,t);break;case"action":case"formAction":if(typeof t=="function"){E.setAttribute(n,"javascript:throw new Error('A React form was unexpectedly submitted. If you called form.submit() manually, consider using form.requestSubmit() instead. If you\\'re trying to use event.stopPropagation() in a submit event handler, consider also calling event.preventDefault().')");break}else typeof S=="function"&&(n==="formAction"?(O!=="input"&&s(E,O,"name",o.name,o,null),s(E,O,"formEncType",o.formEncType,o,null),s(E,O,"formMethod",o.formMethod,o,null),s(E,O,"formTarget",o.formTarget,o,null)):(s(E,O,"encType",o.encType,o,null),s(E,O,"method",o.method,o,null),s(E,O,"target",o.target,o,null)));if(t==null||typeof t=="symbol"||typeof t=="boolean"){E.removeAttribute(n);break}t=ne(""+t),E.setAttribute(n,t);break;case"onClick":t!=null&&(E.onclick=qT);break;case"onScroll":t!=null&&UN("scroll",E);break;case"onScrollEnd":t!=null&&UN("scrollend",E);break;case"dangerouslySetInnerHTML":if(t!=null){if(typeof t!="object"||!("__html"in t))throw Error(f(61));if(n=t.__html,n!=null){if(o.children!=null)throw Error(f(60));E.innerHTML=n}}break;case"multiple":E.multiple=t&&typeof t!="function"&&typeof t!="symbol";break;case"muted":E.muted=t&&typeof t!="function"&&typeof t!="symbol";break;case"suppressContentEditableWarning":case"suppressHydrationWarning":case"defaultValue":case"defaultChecked":case"innerHTML":case"ref":break;case"autoFocus":break;case"xlinkHref":if(t==null||typeof t=="function"||typeof t=="boolean"||typeof t=="symbol"){E.removeAttribute("xlink:href");break}n=ne(""+t),E.setAttributeNS("http://www.w3.org/1999/xlink","xlink:href",n);break;case"contentEditable":case"spellCheck":case"draggable":case"value":case"autoReverse":case"externalResourcesRequired":case"focusable":case"preserveAlpha":t!=null&&typeof t!="function"&&typeof t!="symbol"?E.setAttribute(n,""+t):E.removeAttribute(n);break;case"inert":case"allowFullScreen":case"async":case"autoPlay":case"controls":case"default":case"defer":case"disabled":case"disablePictureInPicture":case"disableRemotePlayback":case"formNoValidate":case"hidden":case"loop":case"noModule":case"noValidate":case"open":case"playsInline":case"readOnly":case"required":case"reversed":case"scoped":case"seamless":case"itemScope":t&&typeof t!="function"&&typeof t!="symbol"?E.setAttribute(n,""):E.removeAttribute(n);break;case"capture":case"download":t===!0?E.setAttribute(n,""):t!==!1&&t!=null&&typeof t!="function"&&typeof t!="symbol"?E.setAttribute(n,t):E.removeAttribute(n);break;case"cols":case"rows":case"size":case"span":t!=null&&typeof t!="function"&&typeof t!="symbol"&&!isNaN(t)&&1<=t?E.setAttribute(n,t):E.removeAttribute(n);break;case"rowSpan":case"start":t==null||typeof t=="function"||typeof t=="symbol"||isNaN(t)?E.removeAttribute(n):E.setAttribute(n,t);break;case"popover":UN("beforetoggle",E),UN("toggle",E),ke(E,"popover",t);break;case"xlinkActuate":zn(E,"http://www.w3.org/1999/xlink","xlink:actuate",t);break;case"xlinkArcrole":zn(E,"http://www.w3.org/1999/xlink","xlink:arcrole",t);break;case"xlinkRole":zn(E,"http://www.w3.org/1999/xlink","xlink:role",t);break;case"xlinkShow":zn(E,"http://www.w3.org/1999/xlink","xlink:show",t);break;case"xlinkTitle":zn(E,"http://www.w3.org/1999/xlink","xlink:title",t);break;case"xlinkType":zn(E,"http://www.w3.org/1999/xlink","xlink:type",t);break;case"xmlBase":zn(E,"http://www.w3.org/XML/1998/namespace","xml:base",t);break;case"xmlLang":zn(E,"http://www.w3.org/XML/1998/namespace","xml:lang",t);break;case"xmlSpace":zn(E,"http://www.w3.org/XML/1998/namespace","xml:space",t);break;case"is":ke(E,"is",t);break;case"innerText":case"textContent":break;default:(!(2<n.length)||n[0]!=="o"&&n[0]!=="O"||n[1]!=="n"&&n[1]!=="N")&&(n=qM.get(n)||n,ke(E,n,t))}}function i(E,O,n,t,o,S){switch(n){case"style":yI(E,t,S);break;case"dangerouslySetInnerHTML":if(t!=null){if(typeof t!="object"||!("__html"in t))throw Error(f(61));if(n=t.__html,n!=null){if(o.children!=null)throw Error(f(60));E.innerHTML=n}}break;case"children":typeof t=="string"?at(E,t):(typeof t=="number"||typeof t=="bigint")&&at(E,""+t);break;case"onScroll":t!=null&&UN("scroll",E);break;case"onScrollEnd":t!=null&&UN("scrollend",E);break;case"onClick":t!=null&&(E.onclick=qT);break;case"suppressContentEditableWarning":case"suppressHydrationWarning":case"innerHTML":case"ref":break;case"innerText":case"textContent":break;default:if(!FR.hasOwnProperty(n))E:{if(n[0]==="o"&&n[1]==="n"&&(o=n.endsWith("Capture"),O=n.slice(2,o?n.length-7:void 0),S=E[QO]||null,S=S!=null?S[n]:null,typeof S=="function"&&E.removeEventListener(O,S,o),typeof t=="function")){typeof S!="function"&&S!==null&&(n in E?E[n]=null:E.hasAttribute(n)&&E.removeAttribute(n)),E.addEventListener(O,t,o);break E}n in E?E[n]=t:t===!0?E.setAttribute(n,""):ke(E,n,t)}}}function l(E,O,n){switch(O){case"div":case"span":case"svg":case"path":case"a":case"g":case"p":case"li":break;case"img":UN("error",E),UN("load",E);var t=!1,o=!1,S;for(S in n)if(n.hasOwnProperty(S)){var d=n[S];if(d!=null)switch(S){case"src":t=!0;break;case"srcSet":o=!0;break;case"children":case"dangerouslySetInnerHTML":throw Error(f(137,O));default:s(E,O,S,d,n,null)}}o&&s(E,O,"srcSet",n.srcSet,n,null),t&&s(E,O,"src",n.src,n,null);return;case"input":UN("invalid",E);var V=S=d=o=null,X=null,RE=null;for(t in n)if(n.hasOwnProperty(t)){var LE=n[t];if(LE!=null)switch(t){case"name":o=LE;break;case"type":d=LE;break;case"checked":X=LE;break;case"defaultChecked":RE=LE;break;case"value":S=LE;break;case"defaultValue":V=LE;break;case"children":case"dangerouslySetInnerHTML":if(LE!=null)throw Error(f(137,O));break;default:s(E,O,t,LE,n,null)}}Te(E,S,V,X,RE,d,o,!1);return;case"select":UN("invalid",E),t=d=S=null;for(o in n)if(n.hasOwnProperty(o)&&(V=n[o],V!=null))switch(o){case"value":S=V;break;case"defaultValue":d=V;break;case"multiple":t=V;default:s(E,O,o,V,n,null)}O=S,n=d,E.multiple=!!t,O!=null?Pt(E,!!t,O,!1):n!=null&&Pt(E,!!t,n,!0);return;case"textarea":UN("invalid",E),S=o=t=null;for(d in n)if(n.hasOwnProperty(d)&&(V=n[d],V!=null))switch(d){case"value":t=V;break;case"defaultValue":o=V;break;case"children":S=V;break;case"dangerouslySetInnerHTML":if(V!=null)throw Error(f(91));break;default:s(E,O,d,V,n,null)}jM(E,t,o,S);return;case"option":for(X in n)n.hasOwnProperty(X)&&(t=n[X],t!=null)&&(X==="selected"?E.selected=t&&typeof t!="function"&&typeof t!="symbol":s(E,O,X,t,n,null));return;case"dialog":UN("beforetoggle",E),UN("toggle",E),UN("cancel",E),UN("close",E);break;case"iframe":case"object":UN("load",E);break;case"video":case"audio":for(t=0;t<xR.length;t++)UN(xR[t],E);break;case"image":UN("error",E),UN("load",E);break;case"details":UN("toggle",E);break;case"embed":case"source":case"link":UN("error",E),UN("load",E);case"area":case"base":case"br":case"col":case"hr":case"keygen":case"meta":case"param":case"track":case"wbr":case"menuitem":for(RE in n)if(n.hasOwnProperty(RE)&&(t=n[RE],t!=null))switch(RE){case"children":case"dangerouslySetInnerHTML":throw Error(f(137,O));default:s(E,O,RE,t,n,null)}return;default:if(Ze(O)){for(LE in n)n.hasOwnProperty(LE)&&(t=n[LE],t!==void 0&&i(E,O,LE,t,n,void 0));return}}for(V in n)n.hasOwnProperty(V)&&(t=n[V],t!=null&&s(E,O,V,t,n,null))}function D(E,O,n,t){switch(O){case"div":case"span":case"svg":case"path":case"a":case"g":case"p":case"li":break;case"input":var o=null,S=null,d=null,V=null,X=null,RE=null,LE=null;for(SE in n){var GE=n[SE];if(n.hasOwnProperty(SE)&&GE!=null)switch(SE){case"checked":break;case"value":break;case"defaultValue":X=GE;default:t.hasOwnProperty(SE)||s(E,O,SE,null,t,GE)}}for(var iE in t){var SE=t[iE];if(GE=n[iE],t.hasOwnProperty(iE)&&(SE!=null||GE!=null))switch(iE){case"type":S=SE;break;case"name":o=SE;break;case"checked":RE=SE;break;case"defaultChecked":LE=SE;break;case"value":d=SE;break;case"defaultValue":V=SE;break;case"children":case"dangerouslySetInnerHTML":if(SE!=null)throw Error(f(137,O));break;default:SE!==GE&&s(E,O,iE,SE,t,GE)}}NO(E,d,V,X,RE,LE,S,o);return;case"select":SE=d=V=iE=null;for(S in n)if(X=n[S],n.hasOwnProperty(S)&&X!=null)switch(S){case"value":break;case"multiple":SE=X;default:t.hasOwnProperty(S)||s(E,O,S,null,t,X)}for(o in t)if(S=t[o],X=n[o],t.hasOwnProperty(o)&&(S!=null||X!=null))switch(o){case"value":iE=S;break;case"defaultValue":V=S;break;case"multiple":d=S;default:S!==X&&s(E,O,o,S,t,X)}O=V,n=d,t=SE,iE!=null?Pt(E,!!n,iE,!1):!!t!=!!n&&(O!=null?Pt(E,!!n,O,!0):Pt(E,!!n,n?[]:"",!1));return;case"textarea":SE=iE=null;for(V in n)if(o=n[V],n.hasOwnProperty(V)&&o!=null&&!t.hasOwnProperty(V))switch(V){case"value":break;case"children":break;default:s(E,O,V,null,t,o)}for(d in t)if(o=t[d],S=n[d],t.hasOwnProperty(d)&&(o!=null||S!=null))switch(d){case"value":iE=o;break;case"defaultValue":SE=o;break;case"children":break;case"dangerouslySetInnerHTML":if(o!=null)throw Error(f(91));break;default:o!==S&&s(E,O,d,o,t,S)}WR(E,iE,SE);return;case"option":for(var ON in n)iE=n[ON],n.hasOwnProperty(ON)&&iE!=null&&!t.hasOwnProperty(ON)&&(ON==="selected"?E.selected=!1:s(E,O,ON,null,t,iE));for(X in t)iE=t[X],SE=n[X],t.hasOwnProperty(X)&&iE!==SE&&(iE!=null||SE!=null)&&(X==="selected"?E.selected=iE&&typeof iE!="function"&&typeof iE!="symbol":s(E,O,X,iE,t,SE));return;case"img":case"link":case"area":case"base":case"br":case"col":case"embed":case"hr":case"keygen":case"meta":case"param":case"source":case"track":case"wbr":case"menuitem":for(var DN in n)iE=n[DN],n.hasOwnProperty(DN)&&iE!=null&&!t.hasOwnProperty(DN)&&s(E,O,DN,null,t,iE);for(RE in t)if(iE=t[RE],SE=n[RE],t.hasOwnProperty(RE)&&iE!==SE&&(iE!=null||SE!=null))switch(RE){case"children":case"dangerouslySetInnerHTML":if(iE!=null)throw Error(f(137,O));break;default:s(E,O,RE,iE,t,SE)}return;default:if(Ze(O)){for(var hO in n)iE=n[hO],n.hasOwnProperty(hO)&&iE!==void 0&&!t.hasOwnProperty(hO)&&i(E,O,hO,void 0,t,iE);for(LE in t)iE=t[LE],SE=n[LE],!t.hasOwnProperty(LE)||iE===SE||iE===void 0&&SE===void 0||i(E,O,LE,iE,t,SE);return}}for(var TE in n)iE=n[TE],n.hasOwnProperty(TE)&&iE!=null&&!t.hasOwnProperty(TE)&&s(E,O,TE,null,t,iE);for(GE in t)iE=t[GE],SE=n[GE],!t.hasOwnProperty(GE)||iE===SE||iE==null&&SE==null||s(E,O,GE,iE,t,SE)}function P(E){switch(E){case"css":case"script":case"font":case"img":case"image":case"input":case"link":return!0;default:return!1}}function c(){if(typeof performance.getEntriesByType=="function"){for(var E=0,O=0,n=performance.getEntriesByType("resource"),t=0;t<n.length;t++){var o=n[t],S=o.transferSize,d=o.initiatorType,V=o.duration;if(S&&V&&P(d)){for(d=0,V=o.responseEnd,t+=1;t<n.length;t++){var X=n[t],RE=X.startTime;if(RE>V)break;var LE=X.transferSize,GE=X.initiatorType;LE&&P(GE)&&(X=X.responseEnd,d+=LE*(X<V?1:(V-RE)/(X-RE)))}if(--t,O+=8*(S+d)/(o.duration/1e3),E++,10<E)break}}if(0<E)return O/E/1e6}return navigator.connection&&(E=navigator.connection.downlink,typeof E=="number")?E:5}var h=null,H=null;function B(E){return E.nodeType===9?E:E.ownerDocument}function Y(E){switch(E){case"http://www.w3.org/2000/svg":return 1;case"http://www.w3.org/1998/Math/MathML":return 2;default:return 0}}function C(E,O){if(E===0)switch(O){case"svg":return 1;case"math":return 2;default:return 0}return E===1&&O==="foreignObject"?0:E}function g(E,O){return E==="textarea"||E==="noscript"||typeof O.children=="string"||typeof O.children=="number"||typeof O.children=="bigint"||typeof O.dangerouslySetInnerHTML=="object"&&O.dangerouslySetInnerHTML!==null&&O.dangerouslySetInnerHTML.__html!=null}var x=null;function j(){var E=window.event;return E&&E.type==="popstate"?E===x?!1:(x=E,!0):(x=null,!1)}var Z=typeof setTimeout=="function"?setTimeout:void 0,W=typeof clearTimeout=="function"?clearTimeout:void 0,J=typeof Promise=="function"?Promise:void 0,$=typeof queueMicrotask=="function"?queueMicrotask:typeof J<"u"?function(E){return J.resolve(null).then(E).catch(PE)}:Z;function PE(E){setTimeout(function(){throw E})}function aE(E){return E==="head"}function lE(E,O){var n=O,t=0;do{var o=n.nextSibling;if(E.removeChild(n),o&&o.nodeType===8)if(n=o.data,n==="/$"||n==="/&"){if(t===0){E.removeChild(o),s_(O);return}t--}else if(n==="$"||n==="$?"||n==="$~"||n==="$!"||n==="&")t++;else if(n==="html")jN(E.ownerDocument.documentElement);else if(n==="head"){n=E.ownerDocument.head,jN(n);for(var S=n.firstChild;S;){var d=S.nextSibling,V=S.nodeName;S[rn]||V==="SCRIPT"||V==="STYLE"||V==="LINK"&&S.rel.toLowerCase()==="stylesheet"||n.removeChild(S),S=d}}else n==="body"&&jN(E.ownerDocument.body);n=o}while(n);s_(O)}function mE(E,O){var n=E;E=0;do{var t=n.nextSibling;if(n.nodeType===1?O?(n._stashedDisplay=n.style.display,n.style.display="none"):(n.style.display=n._stashedDisplay||"",n.getAttribute("style")===""&&n.removeAttribute("style")):n.nodeType===3&&(O?(n._stashedText=n.nodeValue,n.nodeValue=""):n.nodeValue=n._stashedText||""),t&&t.nodeType===8)if(n=t.data,n==="/$"){if(E===0)break;E--}else n!=="$"&&n!=="$?"&&n!=="$~"&&n!=="$!"||E++;n=t}while(n)}function vE(E){var O=E.firstChild;for(O&&O.nodeType===10&&(O=O.nextSibling);O;){var n=O;switch(O=O.nextSibling,n.nodeName){case"HTML":case"HEAD":case"BODY":vE(n),lO(n);continue;case"SCRIPT":case"STYLE":continue;case"LINK":if(n.rel.toLowerCase()==="stylesheet")continue}E.removeChild(n)}}function XE(E,O,n,t){for(;E.nodeType===1;){var o=n;if(E.nodeName.toLowerCase()!==O.toLowerCase()){if(!t&&(E.nodeName!=="INPUT"||E.type!=="hidden"))break}else if(t){if(!E[rn])switch(O){case"meta":if(!E.hasAttribute("itemprop"))break;return E;case"link":if(S=E.getAttribute("rel"),S==="stylesheet"&&E.hasAttribute("data-precedence"))break;if(S!==o.rel||E.getAttribute("href")!==(o.href==null||o.href===""?null:o.href)||E.getAttribute("crossorigin")!==(o.crossOrigin==null?null:o.crossOrigin)||E.getAttribute("title")!==(o.title==null?null:o.title))break;return E;case"style":if(E.hasAttribute("data-precedence"))break;return E;case"script":if(S=E.getAttribute("src"),(S!==(o.src==null?null:o.src)||E.getAttribute("type")!==(o.type==null?null:o.type)||E.getAttribute("crossorigin")!==(o.crossOrigin==null?null:o.crossOrigin))&&S&&E.hasAttribute("async")&&!E.hasAttribute("itemprop"))break;return E;default:return E}}else if(O==="input"&&E.type==="hidden"){var S=o.name==null?null:""+o.name;if(o.type==="hidden"&&E.getAttribute("name")===S)return E}else return E;if(E=LO(E.nextSibling),E===null)break}return null}function NN(E,O,n){if(O==="")return null;for(;E.nodeType!==3;)if((E.nodeType!==1||E.nodeName!=="INPUT"||E.type!=="hidden")&&!n||(E=LO(E.nextSibling),E===null))return null;return E}function JE(E,O){for(;E.nodeType!==8;)if((E.nodeType!==1||E.nodeName!=="INPUT"||E.type!=="hidden")&&!O||(E=LO(E.nextSibling),E===null))return null;return E}function WE(E){return E.data==="$?"||E.data==="$~"}function eO(E){return E.data==="$!"||E.data==="$?"&&E.ownerDocument.readyState!=="loading"}function MO(E,O){var n=E.ownerDocument;if(E.data==="$~")E._reactRetry=O;else if(E.data!=="$?"||n.readyState!=="loading")O();else{var t=function(){O(),n.removeEventListener("DOMContentLoaded",t)};n.addEventListener("DOMContentLoaded",t),E._reactRetry=t}}function LO(E){for(;E!=null;E=E.nextSibling){var O=E.nodeType;if(O===1||O===3)break;if(O===8){if(O=E.data,O==="$"||O==="$!"||O==="$?"||O==="$~"||O==="&"||O==="F!"||O==="F")break;if(O==="/$"||O==="/&")return null}}return E}var oN=null;function lN(E){E=E.nextSibling;for(var O=0;E;){if(E.nodeType===8){var n=E.data;if(n==="/$"||n==="/&"){if(O===0)return LO(E.nextSibling);O--}else n!=="$"&&n!=="$!"&&n!=="$?"&&n!=="$~"&&n!=="&"||O++}E=E.nextSibling}return null}function kN(E){E=E.previousSibling;for(var O=0;E;){if(E.nodeType===8){var n=E.data;if(n==="$"||n==="$!"||n==="$?"||n==="$~"||n==="&"){if(O===0)return E;O--}else n!=="/$"&&n!=="/&"||O++}E=E.previousSibling}return null}function cN(E,O,n){switch(O=B(n),E){case"html":if(E=O.documentElement,!E)throw Error(f(452));return E;case"head":if(E=O.head,!E)throw Error(f(453));return E;case"body":if(E=O.body,!E)throw Error(f(454));return E;default:throw Error(f(451))}}function jN(E){for(var O=E.attributes;O.length;)E.removeAttributeNode(O[0]);lO(E)}var XN=new Map,TO=new Set;function cO(E){return typeof E.getRootNode=="function"?E.getRootNode():E.nodeType===9?E:E.ownerDocument}var xO=pE.d;pE.d={f:kT,r:yM,D:St,C:Gn,L:xe,m:KR,X:UM,S:nI,M:Bo};function kT(){var E=xO.f(),O=bM();return E||O}function yM(E){var O=wn(E);O!==null&&O.tag===5&&O.type==="form"?gi(O):xO.r(E)}var BT=typeof document>"u"?null:document;function ST(E,O,n){var t=BT;if(t&&typeof O=="string"&&O){var o=XT(O);o='link[rel="'+E+'"][href="'+o+'"]',typeof n=="string"&&(o+='[crossorigin="'+n+'"]'),TO.has(o)||(TO.add(o),E={rel:E,crossOrigin:n,href:O},t.querySelector(o)===null&&(O=t.createElement("link"),l(O,"link",E),dO(O),t.head.appendChild(O)))}}function St(E){xO.D(E),ST("dns-prefetch",E,null)}function Gn(E,O){xO.C(E,O),ST("preconnect",E,O)}function xe(E,O,n){xO.L(E,O,n);var t=BT;if(t&&E&&O){var o='link[rel="preload"][as="'+XT(O)+'"]';O==="image"&&n&&n.imageSrcSet?(o+='[imagesrcset="'+XT(n.imageSrcSet)+'"]',typeof n.imageSizes=="string"&&(o+='[imagesizes="'+XT(n.imageSizes)+'"]')):o+='[href="'+XT(E)+'"]';var S=o;switch(O){case"style":S=M_(E);break;case"script":S=R_(E)}XN.has(S)||(E=IE({rel:"preload",href:O==="image"&&n&&n.imageSrcSet?void 0:E,as:O},n),XN.set(S,E),t.querySelector(o)!==null||O==="style"&&t.querySelector(oi(S))||O==="script"&&t.querySelector(Ai(S))||(O=t.createElement("link"),l(O,"link",E),dO(O),t.head.appendChild(O)))}}function KR(E,O){xO.m(E,O);var n=BT;if(n&&E){var t=O&&typeof O.as=="string"?O.as:"script",o='link[rel="modulepreload"][as="'+XT(t)+'"][href="'+XT(E)+'"]',S=o;switch(t){case"audioworklet":case"paintworklet":case"serviceworker":case"sharedworker":case"worker":case"script":S=R_(E)}if(!XN.has(S)&&(E=IE({rel:"modulepreload",href:E},O),XN.set(S,E),n.querySelector(o)===null)){switch(t){case"audioworklet":case"paintworklet":case"serviceworker":case"sharedworker":case"worker":case"script":if(n.querySelector(Ai(S)))return}t=n.createElement("link"),l(t,"link",E),dO(t),n.head.appendChild(t)}}}function nI(E,O,n){xO.S(E,O,n);var t=BT;if(t&&E){var o=sI(t).hoistableStyles,S=M_(E);O=O||"default";var d=o.get(S);if(!d){var V={loading:0,preload:null};if(d=t.querySelector(oi(S)))V.loading=5;else{E=IE({rel:"stylesheet",href:E,"data-precedence":O},n),(n=XN.get(S))&&lA(E,n);var X=d=t.createElement("link");dO(X),l(X,"link",E),X._p=new Promise(function(RE,LE){X.onload=RE,X.onerror=LE}),X.addEventListener("load",function(){V.loading|=1}),X.addEventListener("error",function(){V.loading|=2}),V.loading|=4,bo(d,O,t)}d={type:"stylesheet",instance:d,count:1,state:V},o.set(S,d)}}}function UM(E,O){xO.X(E,O);var n=BT;if(n&&E){var t=sI(n).hoistableScripts,o=R_(E),S=t.get(o);S||(S=n.querySelector(Ai(o)),S||(E=IE({src:E,async:!0},O),(O=XN.get(o))&&rA(E,O),S=n.createElement("script"),dO(S),l(S,"link",E),n.head.appendChild(S)),S={type:"script",instance:S,count:1,state:null},t.set(o,S))}}function Bo(E,O){xO.M(E,O);var n=BT;if(n&&E){var t=sI(n).hoistableScripts,o=R_(E),S=t.get(o);S||(S=n.querySelector(Ai(o)),S||(E=IE({src:E,async:!0,type:"module"},O),(O=XN.get(o))&&rA(E,O),S=n.createElement("script"),dO(S),l(S,"link",E),n.head.appendChild(S)),S={type:"script",instance:S,count:1,state:null},t.set(o,S))}}function kA(E,O,n,t){var o=(o=rN.current)?cO(o):null;if(!o)throw Error(f(446));switch(E){case"meta":case"title":return null;case"style":return typeof n.precedence=="string"&&typeof n.href=="string"?(O=M_(n.href),n=sI(o).hoistableStyles,t=n.get(O),t||(t={type:"style",instance:null,count:0,state:null},n.set(O,t)),t):{type:"void",instance:null,count:0,state:null};case"link":if(n.rel==="stylesheet"&&typeof n.href=="string"&&typeof n.precedence=="string"){E=M_(n.href);var S=sI(o).hoistableStyles,d=S.get(E);if(d||(o=o.ownerDocument||o,d={type:"stylesheet",instance:null,count:0,state:{loading:0,preload:null}},S.set(E,d),(S=o.querySelector(oi(E)))&&!S._p&&(d.instance=S,d.state.loading=5),XN.has(E)||(n={rel:"preload",as:"style",href:n.href,crossOrigin:n.crossOrigin,integrity:n.integrity,media:n.media,hrefLang:n.hrefLang,referrerPolicy:n.referrerPolicy},XN.set(E,n),S||JS(o,E,n,d.state))),O&&t===null)throw Error(f(528,""));return d}if(O&&t!==null)throw Error(f(529,""));return null;case"script":return O=n.async,n=n.src,typeof n=="string"&&O&&typeof O!="function"&&typeof O!="symbol"?(O=R_(n),n=sI(o).hoistableScripts,t=n.get(O),t||(t={type:"script",instance:null,count:0,state:null},n.set(O,t)),t):{type:"void",instance:null,count:0,state:null};default:throw Error(f(444,E))}}function M_(E){return'href="'+XT(E)+'"'}function oi(E){return'link[rel="stylesheet"]['+E+"]"}function zA(E){return IE({},E,{"data-precedence":E.precedence,precedence:null})}function JS(E,O,n,t){E.querySelector('link[rel="preload"][as="style"]['+O+"]")?t.loading=1:(O=E.createElement("link"),t.preload=O,O.addEventListener("load",function(){return t.loading|=1}),O.addEventListener("error",function(){return t.loading|=2}),l(O,"link",n),dO(O),E.head.appendChild(O))}function R_(E){return'[src="'+XT(E)+'"]'}function Ai(E){return"script[async]"+E}function FA(E,O,n){if(O.count++,O.instance===null)switch(O.type){case"style":var t=E.querySelector('style[data-href~="'+XT(n.href)+'"]');if(t)return O.instance=t,dO(t),t;var o=IE({},n,{"data-href":n.href,"data-precedence":n.precedence,href:null,precedence:null});return t=(E.ownerDocument||E).createElement("style"),dO(t),l(t,"style",o),bo(t,n.precedence,E),O.instance=t;case"stylesheet":o=M_(n.href);var S=E.querySelector(oi(o));if(S)return O.state.loading|=4,O.instance=S,dO(S),S;t=zA(n),(o=XN.get(o))&&lA(t,o),S=(E.ownerDocument||E).createElement("link"),dO(S);var d=S;return d._p=new Promise(function(V,X){d.onload=V,d.onerror=X}),l(S,"link",t),O.state.loading|=4,bo(S,n.precedence,E),O.instance=S;case"script":return S=R_(n.src),(o=E.querySelector(Ai(S)))?(O.instance=o,dO(o),o):(t=n,(o=XN.get(S))&&(t=IE({},n),rA(t,o)),E=E.ownerDocument||E,o=E.createElement("script"),dO(o),l(o,"link",t),E.head.appendChild(o),O.instance=o);case"void":return null;default:throw Error(f(443,O.type))}else O.type==="stylesheet"&&(O.state.loading&4)===0&&(t=O.instance,O.state.loading|=4,bo(t,n.precedence,E));return O.instance}function bo(E,O,n){for(var t=n.querySelectorAll('link[rel="stylesheet"][data-precedence],style[data-precedence]'),o=t.length?t[t.length-1]:null,S=o,d=0;d<t.length;d++){var V=t[d];if(V.dataset.precedence===O)S=V;else if(S!==o)break}S?S.parentNode.insertBefore(E,S.nextSibling):(O=n.nodeType===9?n.head:n,O.insertBefore(E,O.firstChild))}function lA(E,O){E.crossOrigin==null&&(E.crossOrigin=O.crossOrigin),E.referrerPolicy==null&&(E.referrerPolicy=O.referrerPolicy),E.title==null&&(E.title=O.title)}function rA(E,O){E.crossOrigin==null&&(E.crossOrigin=O.crossOrigin),E.referrerPolicy==null&&(E.referrerPolicy=O.referrerPolicy),E.integrity==null&&(E.integrity=O.integrity)}var mo=null;function jA(E,O,n){if(mo===null){var t=new Map,o=mo=new Map;o.set(n,t)}else o=mo,t=o.get(n),t||(t=new Map,o.set(n,t));if(t.has(E))return t;for(t.set(E,null),n=n.getElementsByTagName(E),o=0;o<n.length;o++){var S=n[o];if(!(S[rn]||S[aO]||E==="link"&&S.getAttribute("rel")==="stylesheet")&&S.namespaceURI!=="http://www.w3.org/2000/svg"){var d=S.getAttribute(O)||"";d=E+d;var V=t.get(d);V?V.push(S):t.set(d,[S])}}return t}function ZA(E,O,n){E=E.ownerDocument||E,E.head.insertBefore(n,O==="title"?E.querySelector("head > title"):null)}function $S(E,O,n){if(n===1||O.itemProp!=null)return!1;switch(E){case"meta":case"title":return!0;case"style":if(typeof O.precedence!="string"||typeof O.href!="string"||O.href==="")break;return!0;case"link":if(typeof O.rel!="string"||typeof O.href!="string"||O.href===""||O.onLoad||O.onError)break;return O.rel==="stylesheet"?(E=O.disabled,typeof O.precedence=="string"&&E==null):!0;case"script":if(O.async&&typeof O.async!="function"&&typeof O.async!="symbol"&&!O.onLoad&&!O.onError&&O.src&&typeof O.src=="string")return!0}return!1}function XA(E){return!(E.type==="stylesheet"&&(E.state.loading&3)===0)}function El(E,O,n,t){if(n.type==="stylesheet"&&(typeof t.media!="string"||matchMedia(t.media).matches!==!1)&&(n.state.loading&4)===0){if(n.instance===null){var o=M_(t.href),S=O.querySelector(oi(o));if(S){O=S._p,O!==null&&typeof O=="object"&&typeof O.then=="function"&&(E.count++,E=fo.bind(E),O.then(E,E)),n.state.loading|=4,n.instance=S,dO(S);return}S=O.ownerDocument||O,t=zA(t),(o=XN.get(o))&&lA(t,o),S=S.createElement("link"),dO(S);var d=S;d._p=new Promise(function(V,X){d.onload=V,d.onerror=X}),l(S,"link",t),n.instance=S}E.stylesheets===null&&(E.stylesheets=new Map),E.stylesheets.set(n,O),(O=n.state.preload)&&(n.state.loading&3)===0&&(E.count++,n=fo.bind(E),O.addEventListener("load",n),O.addEventListener("error",n))}}var PA=0;function Nl(E,O){return E.stylesheets&&E.count===0&&Vo(E,E.stylesheets),0<E.count||0<E.imgCount?function(n){var t=setTimeout(function(){if(E.stylesheets&&Vo(E,E.stylesheets),E.unsuspend){var S=E.unsuspend;E.unsuspend=null,S()}},6e4+O);0<E.imgBytes&&PA===0&&(PA=62500*c());var o=setTimeout(function(){if(E.waitingForImages=!1,E.count===0&&(E.stylesheets&&Vo(E,E.stylesheets),E.unsuspend)){var S=E.unsuspend;E.unsuspend=null,S()}},(E.imgBytes>PA?50:800)+O);return E.unsuspend=n,function(){E.unsuspend=null,clearTimeout(t),clearTimeout(o)}}:null}function fo(){if(this.count--,this.count===0&&(this.imgCount===0||!this.waitingForImages)){if(this.stylesheets)Vo(this,this.stylesheets);else if(this.unsuspend){var E=this.unsuspend;this.unsuspend=null,E()}}}var po=null;function Vo(E,O){E.stylesheets=null,E.unsuspend!==null&&(E.count++,po=new Map,O.forEach(Ol,E),po=null,fo.call(E))}function Ol(E,O){if(!(O.state.loading&4)){var n=po.get(E);if(n)var t=n.get(null);else{n=new Map,po.set(E,n);for(var o=E.querySelectorAll("link[data-precedence],style[data-precedence]"),S=0;S<o.length;S++){var d=o[S];(d.nodeName==="LINK"||d.getAttribute("media")!=="not all")&&(n.set(d.dataset.precedence,d),t=d)}t&&n.set(null,t)}o=O.instance,d=o.getAttribute("data-precedence"),S=n.get(d)||t,S===t&&n.set(null,o),n.set(d,o),this.count++,t=fo.bind(this),o.addEventListener("load",t),o.addEventListener("error",t),S?S.parentNode.insertBefore(o,S.nextSibling):(E=E.nodeType===9?E.head:E,E.insertBefore(o,E.firstChild)),O.state.loading|=4}}var Si={$$typeof:xE,Provider:null,Consumer:null,_currentValue:MN,_currentValue2:MN,_threadCount:0};function Tl(E,O,n,t,o,S,d,V,X){this.tag=1,this.containerInfo=E,this.pingCache=this.current=this.pendingChildren=null,this.timeoutHandle=-1,this.callbackNode=this.next=this.pendingContext=this.context=this.cancelPendingCommit=null,this.callbackPriority=0,this.expirationTimes=SO(-1),this.entangledLanes=this.shellSuspendCounter=this.errorRecoveryDisabledLanes=this.expiredLanes=this.warmLanes=this.pingedLanes=this.suspendedLanes=this.pendingLanes=0,this.entanglements=SO(0),this.hiddenUpdates=SO(null),this.identifierPrefix=t,this.onUncaughtError=o,this.onCaughtError=S,this.onRecoverableError=d,this.pooledCache=null,this.pooledCacheLanes=0,this.formState=X,this.incompleteTransitions=new Map}function qA(E,O,n,t,o,S,d,V,X,RE,LE,GE){return E=new Tl(E,O,n,d,X,RE,LE,GE,V),O=1,S===!0&&(O|=24),S=iT(3,null,null,O),E.current=S,S.stateNode=E,O=Le(),O.refCount++,E.pooledCache=O,O.refCount++,S.memoizedState={element:t,isDehydrated:n,cache:O},tE(S),E}function WA(E){return E?(E=$T,E):$T}function QA(E,O,n,t,o,S){o=WA(o),t.context===null?t.context=o:t.pendingContext=o,t=AE(O),t.payload={element:n},S=S===void 0?null:S,S!==null&&(t.callback=S),n=bE(E,t,O),n!==null&&(Sn(n,E,O),VE(n,E,O))}function JA(E,O){if(E=E.memoizedState,E!==null&&E.dehydrated!==null){var n=E.retryLane;E.retryLane=n!==0&&n<O?n:O}}function aA(E,O){JA(E,O),(E=E.alternate)&&JA(E,O)}function $A(E){if(E.tag===13||E.tag===31){var O=qn(E,67108864);O!==null&&Sn(O,E,67108864),aA(E,67108864)}}function ES(E){if(E.tag===13||E.tag===31){var O=An();O=OT(O);var n=qn(E,O);n!==null&&Sn(n,E,O),aA(E,O)}}var go=!0;function nl(E,O,n,t){var o=rE.T;rE.T=null;var S=pE.p;try{pE.p=2,DA(E,O,n,t)}finally{pE.p=S,rE.T=o}}function Il(E,O,n,t){var o=rE.T;rE.T=null;var S=pE.p;try{pE.p=8,DA(E,O,n,t)}finally{pE.p=S,rE.T=o}}function DA(E,O,n,t){if(go){var o=LA(t);if(o===null)ii(E,O,t,yo,n),OS(E,t);else if(el(o,E,O,n,t))t.stopPropagation();else if(OS(E,t),O&4&&-1<tl.indexOf(E)){for(;o!==null;){var S=wn(o);if(S!==null)switch(S.tag){case 3:if(S=S.stateNode,S.current.memoizedState.isDehydrated){var d=KE(S.pendingLanes);if(d!==0){var V=S;for(V.pendingLanes|=2,V.entangledLanes|=2;d;){var X=1<<31-nE(d);V.entanglements[1]|=X,d&=~X}TI(S),(JN&6)===0&&(pR=sT()+500,yR(0))}}break;case 31:case 13:V=qn(S,2),V!==null&&Sn(V,S,2),bM(),aA(S,2)}if(S=LA(t),S===null&&ii(E,O,t,yo,n),S===o)break;o=S}o!==null&&t.stopPropagation()}else ii(E,O,t,null,n)}}function LA(E){return E=GT(E),cA(E)}var yo=null;function cA(E){if(yo=null,E=ZT(E),E!==null){var O=F(E);if(O===null)E=null;else{var n=O.tag;if(n===13){if(E=Q(O),E!==null)return E;E=null}else if(n===31){if(E=sE(O),E!==null)return E;E=null}else if(n===3){if(O.stateNode.current.memoizedState.isDehydrated)return O.tag===3?O.stateNode.containerInfo:null;E=null}else O!==E&&(E=null)}}return yo=E,null}function NS(E){switch(E){case"beforetoggle":case"cancel":case"click":case"close":case"contextmenu":case"copy":case"cut":case"auxclick":case"dblclick":case"dragend":case"dragstart":case"drop":case"focusin":case"focusout":case"input":case"invalid":case"keydown":case"keypress":case"keyup":case"mousedown":case"mouseup":case"paste":case"pause":case"play":case"pointercancel":case"pointerdown":case"pointerup":case"ratechange":case"reset":case"resize":case"seeked":case"submit":case"toggle":case"touchcancel":case"touchend":case"touchstart":case"volumechange":case"change":case"selectionchange":case"textInput":case"compositionstart":case"compositionend":case"compositionupdate":case"beforeblur":case"afterblur":case"beforeinput":case"blur":case"fullscreenchange":case"focus":case"hashchange":case"popstate":case"select":case"selectstart":return 2;case"drag":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"mousemove":case"mouseout":case"mouseover":case"pointermove":case"pointerout":case"pointerover":case"scroll":case"touchmove":case"wheel":case"mouseenter":case"mouseleave":case"pointerenter":case"pointerleave":return 8;case"message":switch(Ee()){case Ne:return 2;case tN:return 8;case fI:case pI:return 32;case eI:return 268435456;default:return 32}default:return 32}}var hA=!1,xM=null,vM=null,KM=null,li=new Map,ri=new Map,wM=[],tl="mousedown mouseup touchcancel touchend touchstart auxclick dblclick pointercancel pointerdown pointerup dragend dragstart drop compositionend compositionstart keydown keypress keyup input textInput copy cut paste click change contextmenu reset".split(" ");function OS(E,O){switch(E){case"focusin":case"focusout":xM=null;break;case"dragenter":case"dragleave":vM=null;break;case"mouseover":case"mouseout":KM=null;break;case"pointerover":case"pointerout":li.delete(O.pointerId);break;case"gotpointercapture":case"lostpointercapture":ri.delete(O.pointerId)}}function Pi(E,O,n,t,o,S){return E===null||E.nativeEvent!==S?(E={blockedOn:O,domEventName:n,eventSystemFlags:t,nativeEvent:S,targetContainers:[o]},O!==null&&(O=wn(O),O!==null&&$A(O)),E):(E.eventSystemFlags|=t,O=E.targetContainers,o!==null&&O.indexOf(o)===-1&&O.push(o),E)}function el(E,O,n,t,o){switch(O){case"focusin":return xM=Pi(xM,E,O,n,t,o),!0;case"dragenter":return vM=Pi(vM,E,O,n,t,o),!0;case"mouseover":return KM=Pi(KM,E,O,n,t,o),!0;case"pointerover":var S=o.pointerId;return li.set(S,Pi(li.get(S)||null,E,O,n,t,o)),!0;case"gotpointercapture":return S=o.pointerId,ri.set(S,Pi(ri.get(S)||null,E,O,n,t,o)),!0}return!1}function TS(E){var O=ZT(E.target);if(O!==null){var n=F(O);if(n!==null){if(O=n.tag,O===13){if(O=Q(n),O!==null){E.blockedOn=O,Kn(E.priority,function(){ES(n)});return}}else if(O===31){if(O=sE(n),O!==null){E.blockedOn=O,Kn(E.priority,function(){ES(n)});return}}else if(O===3&&n.stateNode.current.memoizedState.isDehydrated){E.blockedOn=n.tag===3?n.stateNode.containerInfo:null;return}}}E.blockedOn=null}function Uo(E){if(E.blockedOn!==null)return!1;for(var O=E.targetContainers;0<O.length;){var n=LA(E.nativeEvent);if(n===null){n=E.nativeEvent;var t=new n.constructor(n.type,n);qe=t,n.target.dispatchEvent(t),qe=null}else return O=wn(n),O!==null&&$A(O),E.blockedOn=n,!1;O.shift()}return!0}function nS(E,O,n){Uo(E)&&n.delete(O)}function Ml(){hA=!1,xM!==null&&Uo(xM)&&(xM=null),vM!==null&&Uo(vM)&&(vM=null),KM!==null&&Uo(KM)&&(KM=null),li.forEach(nS),ri.forEach(nS)}function xo(E,O){E.blockedOn===O&&(E.blockedOn=null,hA||(hA=!0,G.unstable_scheduleCallback(G.unstable_NormalPriority,Ml)))}var vo=null;function IS(E){vo!==E&&(vo=E,G.unstable_scheduleCallback(G.unstable_NormalPriority,function(){vo===E&&(vo=null);for(var O=0;O<E.length;O+=3){var n=E[O],t=E[O+1],o=E[O+2];if(typeof t!="function"){if(cA(t||n)===null)continue;break}var S=wn(n);S!==null&&(E.splice(O,3),O-=3,Vs(S,{pending:!0,data:o,method:n.method,action:t},t,o))}}))}function s_(E){function O(X){return xo(X,E)}xM!==null&&xo(xM,E),vM!==null&&xo(vM,E),KM!==null&&xo(KM,E),li.forEach(O),ri.forEach(O);for(var n=0;n<wM.length;n++){var t=wM[n];t.blockedOn===E&&(t.blockedOn=null)}for(;0<wM.length&&(n=wM[0],n.blockedOn===null);)TS(n),n.blockedOn===null&&wM.shift();if(n=(E.ownerDocument||E).$$reactFormReplay,n!=null)for(t=0;t<n.length;t+=3){var o=n[t],S=n[t+1],d=o[QO]||null;if(typeof S=="function")d||IS(n);else if(d){var V=null;if(S&&S.hasAttribute("formAction")){if(o=S,d=S[QO]||null)V=d.formAction;else if(cA(o)!==null)continue}else V=d.action;typeof V=="function"?n[t+1]=V:(n.splice(t,3),t-=3),IS(n)}}}function tS(){function E(S){S.canIntercept&&S.info==="react-transition"&&S.intercept({handler:function(){return new Promise(function(d){return o=d})},focusReset:"manual",scroll:"manual"})}function O(){o!==null&&(o(),o=null),t||setTimeout(n,20)}function n(){if(!t&&!navigation.transition){var S=navigation.currentEntry;S&&S.url!=null&&navigation.navigate(S.url,{state:S.getState(),info:"react-transition",history:"replace"})}}if(typeof navigation=="object"){var t=!1,o=null;return navigation.addEventListener("navigate",E),navigation.addEventListener("navigatesuccess",O),navigation.addEventListener("navigateerror",O),setTimeout(n,100),function(){t=!0,navigation.removeEventListener("navigate",E),navigation.removeEventListener("navigatesuccess",O),navigation.removeEventListener("navigateerror",O),o!==null&&(o(),o=null)}}}function dA(E){this._internalRoot=E}Ko.prototype.render=dA.prototype.render=function(E){var O=this._internalRoot;if(O===null)throw Error(f(409));var n=O.current,t=An();QA(n,t,E,O,null,null)},Ko.prototype.unmount=dA.prototype.unmount=function(){var E=this._internalRoot;if(E!==null){this._internalRoot=null;var O=E.containerInfo;QA(E.current,2,null,E,null,null),bM(),O[dT]=null}};function Ko(E){this._internalRoot=E}Ko.prototype.unstable_scheduleHydration=function(E){if(E){var O=FT();E={blockedOn:null,target:E,priority:O};for(var n=0;n<wM.length&&O!==0&&O<wM[n].priority;n++);wM.splice(n,0,E),n===0&&TS(E)}};var eS=U.version;if(eS!=="19.2.4")throw Error(f(527,eS,"19.2.4"));pE.findDOMNode=function(E){var O=E._reactInternals;if(O===void 0)throw typeof E.render=="function"?Error(f(188)):(E=Object.keys(E).join(","),Error(f(268,E)));return E=k(O),E=E!==null?_E(E):null,E=E===null?null:E.stateNode,E};var Rl={bundleType:0,version:"19.2.4",rendererPackageName:"react-dom",currentDispatcherRef:rE,reconcilerVersion:"19.2.4"};if(typeof __REACT_DEVTOOLS_GLOBAL_HOOK__<"u"){var wo=__REACT_DEVTOOLS_GLOBAL_HOOK__;if(!wo.isDisabled&&wo.supportsFiber)try{pT=wo.inject(Rl),NT=wo}catch{}}return Di.createRoot=function(E,O){if(!v(E))throw Error(f(299));var n=!1,t="",o=ki,S=V_,d=vt;return O!=null&&(O.unstable_strictMode===!0&&(n=!0),O.identifierPrefix!==void 0&&(t=O.identifierPrefix),O.onUncaughtError!==void 0&&(o=O.onUncaughtError),O.onCaughtError!==void 0&&(S=O.onCaughtError),O.onRecoverableError!==void 0&&(d=O.onRecoverableError)),O=qA(E,1,!1,null,null,n,t,null,o,S,d,tS),E[dT]=O.current,_i(E),new dA(O)},Di.hydrateRoot=function(E,O,n){if(!v(E))throw Error(f(299));var t=!1,o="",S=ki,d=V_,V=vt,X=null;return n!=null&&(n.unstable_strictMode===!0&&(t=!0),n.identifierPrefix!==void 0&&(o=n.identifierPrefix),n.onUncaughtError!==void 0&&(S=n.onUncaughtError),n.onCaughtError!==void 0&&(d=n.onCaughtError),n.onRecoverableError!==void 0&&(V=n.onRecoverableError),n.formState!==void 0&&(X=n.formState)),O=qA(E,1,!0,O,n??null,t,o,X,S,d,V,tS),O.context=WA(null),n=O.current,t=An(),t=OT(t),o=AE(t),o.callback=null,bE(n,o,t),n=t,O.current.lanes=n,_N(O,n),TI(O),E[dT]=O.current,_i(E),new Ko(O)},Di.version="19.2.4",Di}var rS;function al(){if(rS)return YA.exports;rS=1;function G(){if(!(typeof __REACT_DEVTOOLS_GLOBAL_HOOK__>"u"||typeof __REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE!="function"))try{__REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE(G)}catch(U){console.error(U)}}return G(),YA.exports=Pl(),YA.exports}var Dl=al();var PS="popstate";function Ll(G={}){function U(f,v){let{pathname:F,search:Q,hash:sE}=f.location;return VA("",{pathname:F,search:Q,hash:sE},v.state&&v.state.usr||null,v.state&&v.state.key||"default")}function p(f,v){return typeof v=="string"?v:ci(v)}return hl(U,p,null,G)}function qO(G,U){if(G===!1||G===null||typeof G>"u")throw new Error(U)}function Jt(G,U){if(!G){typeof console<"u"&&console.warn(U);try{throw new Error(U)}catch{}}}function cl(){return Math.random().toString(36).substring(2,10)}function aS(G,U){return{usr:G.state,key:G.key,idx:U}}function VA(G,U,p=null,f){return{pathname:typeof G=="string"?G:G.pathname,search:"",hash:"",...typeof U=="string"?__(U):U,state:p,key:U&&U.key||f||cl()}}function ci({pathname:G="/",search:U="",hash:p=""}){return U&&U!=="?"&&(G+=U.charAt(0)==="?"?U:"?"+U),p&&p!=="#"&&(G+=p.charAt(0)==="#"?p:"#"+p),G}function __(G){let U={};if(G){let p=G.indexOf("#");p>=0&&(U.hash=G.substring(p),G=G.substring(0,p));let f=G.indexOf("?");f>=0&&(U.search=G.substring(f),G=G.substring(0,f)),G&&(U.pathname=G)}return U}function hl(G,U,p,f={}){let{window:v=document.defaultView,v5Compat:F=!1}=f,Q=v.history,sE="POP",q=null,k=_E();k==null&&(k=0,Q.replaceState({...Q.state,idx:k},""));function _E(){return(Q.state||{idx:null}).idx}function IE(){sE="POP";let wE=_E(),$E=wE==null?null:wE-k;k=wE,q&&q({action:sE,location:zE.location,delta:$E})}function CE(wE,$E){sE="PUSH";let DE=VA(zE.location,wE,$E);k=_E()+1;let xE=aS(DE,k),gE=zE.createHref(DE);try{Q.pushState(xE,"",gE)}catch(PN){if(PN instanceof DOMException&&PN.name==="DataCloneError")throw PN;v.location.assign(gE)}F&&q&&q({action:sE,location:zE.location,delta:1})}function HE(wE,$E){sE="REPLACE";let DE=VA(zE.location,wE,$E);k=_E();let xE=aS(DE,k),gE=zE.createHref(DE);Q.replaceState(xE,"",gE),F&&q&&q({action:sE,location:zE.location,delta:0})}function fE(wE){return dl(wE)}let zE={get action(){return sE},get location(){return G(v,Q)},listen(wE){if(q)throw new Error("A history only accepts one active listener");return v.addEventListener(PS,IE),q=wE,()=>{v.removeEventListener(PS,IE),q=null}},createHref(wE){return U(v,wE)},createURL:fE,encodeLocation(wE){let $E=fE(wE);return{pathname:$E.pathname,search:$E.search,hash:$E.hash}},push:CE,replace:HE,go(wE){return Q.go(wE)}};return zE}function dl(G,U=!1){let p="http://localhost";typeof window<"u"&&(p=window.location.origin!=="null"?window.location.origin:window.location.href),qO(p,"No window.location.(origin|href) available to create URL");let f=typeof G=="string"?G:ci(G);return f=f.replace(/ $/,"%20"),!U&&f.startsWith("//")&&(f=p+f),new URL(f,p)}function bS(G,U,p="/"){return Gl(G,U,p,!1)}function Gl(G,U,p,f){let v=typeof U=="string"?__(U):U,F=Ke(v.pathname||"/",p);if(F==null)return null;let Q=mS(G);ul(Q);let sE=null;for(let q=0;sE==null&&q<Q.length;++q){let k=yl(F);sE=Vl(Q[q],k,f)}return sE}function mS(G,U=[],p=[],f="",v=!1){let F=(Q,sE,q=v,k)=>{let _E={relativePath:k===void 0?Q.path||"":k,caseSensitive:Q.caseSensitive===!0,childrenIndex:sE,route:Q};if(_E.relativePath.startsWith("/")){if(!_E.relativePath.startsWith(f)&&q)return;qO(_E.relativePath.startsWith(f),`Absolute route path "${_E.relativePath}" nested under path "${f}" is not valid. An absolute child route path must start with the combined path of all its parent routes.`),_E.relativePath=_E.relativePath.slice(f.length)}let IE=ve([f,_E.relativePath]),CE=p.concat(_E);Q.children&&Q.children.length>0&&(qO(Q.index!==!0,`Index routes must not have child routes. Please remove all child routes from route path "${IE}".`),mS(Q.children,U,CE,IE,q)),!(Q.path==null&&!Q.index)&&U.push({path:IE,score:fl(IE,Q.index),routesMeta:CE})};return G.forEach((Q,sE)=>{if(Q.path===""||!Q.path?.includes("?"))F(Q,sE);else for(let q of fS(Q.path))F(Q,sE,!0,q)}),U}function fS(G){let U=G.split("/");if(U.length===0)return[];let[p,...f]=U,v=p.endsWith("?"),F=p.replace(/\?$/,"");if(f.length===0)return v?[F,""]:[F];let Q=fS(f.join("/")),sE=[];return sE.push(...Q.map(q=>q===""?F:[F,q].join("/"))),v&&sE.push(...Q),sE.map(q=>G.startsWith("/")&&q===""?"/":q)}function ul(G){G.sort((U,p)=>U.score!==p.score?p.score-U.score:pl(U.routesMeta.map(f=>f.childrenIndex),p.routesMeta.map(f=>f.childrenIndex)))}var Yl=/^:[\w-]+$/,Hl=3,Cl=2,Bl=1,bl=10,ml=-2,DS=G=>G==="*";function fl(G,U){let p=G.split("/"),f=p.length;return p.some(DS)&&(f+=ml),U&&(f+=Cl),p.filter(v=>!DS(v)).reduce((v,F)=>v+(Yl.test(F)?Hl:F===""?Bl:bl),f)}function pl(G,U){return G.length===U.length&&G.slice(0,-1).every((f,v)=>f===U[v])?G[G.length-1]-U[U.length-1]:0}function Vl(G,U,p=!1){let{routesMeta:f}=G,v={},F="/",Q=[];for(let sE=0;sE<f.length;++sE){let q=f[sE],k=sE===f.length-1,_E=F==="/"?U:U.slice(F.length)||"/",IE=Wo({path:q.relativePath,caseSensitive:q.caseSensitive,end:k},_E),CE=q.route;if(!IE&&k&&p&&!f[f.length-1].route.index&&(IE=Wo({path:q.relativePath,caseSensitive:q.caseSensitive,end:!1},_E)),!IE)return null;Object.assign(v,IE.params),Q.push({params:v,pathname:ve([F,IE.pathname]),pathnameBase:Kl(ve([F,IE.pathnameBase])),route:CE}),IE.pathnameBase!=="/"&&(F=ve([F,IE.pathnameBase]))}return Q}function Wo(G,U){typeof G=="string"&&(G={path:G,caseSensitive:!1,end:!0});let[p,f]=gl(G.path,G.caseSensitive,G.end),v=U.match(p);if(!v)return null;let F=v[0],Q=F.replace(/(.)\/+$/,"$1"),sE=v.slice(1);return{params:f.reduce((k,{paramName:_E,isOptional:IE},CE)=>{if(_E==="*"){let fE=sE[CE]||"";Q=F.slice(0,F.length-fE.length).replace(/(.)\/+$/,"$1")}const HE=sE[CE];return IE&&!HE?k[_E]=void 0:k[_E]=(HE||"").replace(/%2F/g,"/"),k},{}),pathname:F,pathnameBase:Q,pattern:G}}function gl(G,U=!1,p=!0){Jt(G==="*"||!G.endsWith("*")||G.endsWith("/*"),`Route path "${G}" will be treated as if it were "${G.replace(/\*$/,"/*")}" because the \`*\` character must always follow a \`/\` in the pattern. To get rid of this warning, please change the route path to "${G.replace(/\*$/,"/*")}".`);let f=[],v="^"+G.replace(/\/*\*?$/,"").replace(/^\/*/,"/").replace(/[\\.*+^${}|()[\]]/g,"\\$&").replace(/\/:([\w-]+)(\?)?/g,(Q,sE,q)=>(f.push({paramName:sE,isOptional:q!=null}),q?"/?([^\\/]+)?":"/([^\\/]+)")).replace(/\/([\w-]+)\?(\/|$)/g,"(/$1)?$2");return G.endsWith("*")?(f.push({paramName:"*"}),v+=G==="*"||G==="/*"?"(.*)$":"(?:\\/(.+)|\\/*)$"):p?v+="\\/*$":G!==""&&G!=="/"&&(v+="(?:(?=\\/|$))"),[new RegExp(v,U?void 0:"i"),f]}function yl(G){try{return G.split("/").map(U=>decodeURIComponent(U).replace(/\//g,"%2F")).join("/")}catch(U){return Jt(!1,`The URL path "${G}" could not be decoded because it is a malformed URL segment. This is probably due to a bad percent encoding (${U}).`),G}}function Ke(G,U){if(U==="/")return G;if(!G.toLowerCase().startsWith(U.toLowerCase()))return null;let p=U.endsWith("/")?U.length-1:U.length,f=G.charAt(p);return f&&f!=="/"?null:G.slice(p)||"/"}var Ul=/^(?:[a-z][a-z0-9+.-]*:|\/\/)/i;function xl(G,U="/"){let{pathname:p,search:f="",hash:v=""}=typeof G=="string"?__(G):G,F;return p?(p=p.replace(/\/\/+/g,"/"),p.startsWith("/")?F=LS(p.substring(1),"/"):F=LS(p,U)):F=U,{pathname:F,search:wl(f),hash:kl(v)}}function LS(G,U){let p=U.replace(/\/+$/,"").split("/");return G.split("/").forEach(v=>{v===".."?p.length>1&&p.pop():v!=="."&&p.push(v)}),p.length>1?p.join("/"):"/"}function bA(G,U,p,f){return`Cannot include a '${G}' character in a manually specified \`to.${U}\` field [${JSON.stringify(f)}].  Please separate it out to the \`to.${p}\` field. Alternatively you may provide the full path as a string in <Link to="..."> and the router will parse it for you.`}function vl(G){return G.filter((U,p)=>p===0||U.route.path&&U.route.path.length>0)}function pS(G){let U=vl(G);return U.map((p,f)=>f===U.length-1?p.pathname:p.pathnameBase)}function VS(G,U,p,f=!1){let v;typeof G=="string"?v=__(G):(v={...G},qO(!v.pathname||!v.pathname.includes("?"),bA("?","pathname","search",v)),qO(!v.pathname||!v.pathname.includes("#"),bA("#","pathname","hash",v)),qO(!v.search||!v.search.includes("#"),bA("#","search","hash",v)));let F=G===""||v.pathname==="",Q=F?"/":v.pathname,sE;if(Q==null)sE=p;else{let IE=U.length-1;if(!f&&Q.startsWith("..")){let CE=Q.split("/");for(;CE[0]==="..";)CE.shift(),IE-=1;v.pathname=CE.join("/")}sE=IE>=0?U[IE]:"/"}let q=xl(v,sE),k=Q&&Q!=="/"&&Q.endsWith("/"),_E=(F||Q===".")&&p.endsWith("/");return!q.pathname.endsWith("/")&&(k||_E)&&(q.pathname+="/"),q}var ve=G=>G.join("/").replace(/\/\/+/g,"/"),Kl=G=>G.replace(/\/+$/,"").replace(/^\/*/,"/"),wl=G=>!G||G==="?"?"":G.startsWith("?")?G:"?"+G,kl=G=>!G||G==="#"?"":G.startsWith("#")?G:"#"+G,zl=class{constructor(G,U,p,f=!1){this.status=G,this.statusText=U||"",this.internal=f,p instanceof Error?(this.data=p.toString(),this.error=p):this.data=p}};function Fl(G){return G!=null&&typeof G.status=="number"&&typeof G.statusText=="string"&&typeof G.internal=="boolean"&&"data"in G}function jl(G){return G.map(U=>U.route.path).filter(Boolean).join("/").replace(/\/\/*/g,"/")||"/"}var gS=typeof window<"u"&&typeof window.document<"u"&&typeof window.document.createElement<"u";function yS(G,U){let p=G;if(typeof p!="string"||!Ul.test(p))return{absoluteURL:void 0,isExternal:!1,to:p};let f=p,v=!1;if(gS)try{let F=new URL(window.location.href),Q=p.startsWith("//")?new URL(F.protocol+p):new URL(p),sE=Ke(Q.pathname,U);Q.origin===F.origin&&sE!=null?p=sE+Q.search+Q.hash:v=!0}catch{Jt(!1,`<Link to="${p}"> contains an invalid URL which will probably break when clicked - please update to a valid URL path.`)}return{absoluteURL:f,isExternal:v,to:p}}Object.getOwnPropertyNames(Object.prototype).sort().join("\0");var US=["POST","PUT","PATCH","DELETE"];new Set(US);var Zl=["GET",...US];new Set(Zl);var i_=dE.createContext(null);i_.displayName="DataRouter";var Jo=dE.createContext(null);Jo.displayName="DataRouterState";var Xl=dE.createContext(!1),xS=dE.createContext({isTransitioning:!1});xS.displayName="ViewTransition";var ql=dE.createContext(new Map);ql.displayName="Fetchers";var Wl=dE.createContext(null);Wl.displayName="Await";var BI=dE.createContext(null);BI.displayName="Navigation";var hi=dE.createContext(null);hi.displayName="Location";var $t=dE.createContext({outlet:null,matches:[],isDataRoute:!1});$t.displayName="Route";var UA=dE.createContext(null);UA.displayName="RouteError";var vS="REACT_ROUTER_ERROR",Ql="REDIRECT",Jl="ROUTE_ERROR_RESPONSE";function $l(G){if(G.startsWith(`${vS}:${Ql}:{`))try{let U=JSON.parse(G.slice(28));if(typeof U=="object"&&U&&typeof U.status=="number"&&typeof U.statusText=="string"&&typeof U.location=="string"&&typeof U.reloadDocument=="boolean"&&typeof U.replace=="boolean")return U}catch{}}function Er(G){if(G.startsWith(`${vS}:${Jl}:{`))try{let U=JSON.parse(G.slice(40));if(typeof U=="object"&&U&&typeof U.status=="number"&&typeof U.statusText=="string")return new zl(U.status,U.statusText,U.data)}catch{}}function Nr(G,{relative:U}={}){qO(di(),"useHref() may be used only in the context of a <Router> component.");let{basename:p,navigator:f}=dE.useContext(BI),{hash:v,pathname:F,search:Q}=Gi(G,{relative:U}),sE=F;return p!=="/"&&(sE=F==="/"?p:ve([p,F])),f.createHref({pathname:sE,search:Q,hash:v})}function di(){return dE.useContext(hi)!=null}function zR(){return qO(di(),"useLocation() may be used only in the context of a <Router> component."),dE.useContext(hi).location}var KS="You should call navigate() in a React.useEffect(), not when your component is first rendered.";function wS(G){dE.useContext(BI).static||dE.useLayoutEffect(G)}function Or(){let{isDataRoute:G}=dE.useContext($t);return G?lr():Tr()}function Tr(){qO(di(),"useNavigate() may be used only in the context of a <Router> component.");let G=dE.useContext(i_),{basename:U,navigator:p}=dE.useContext(BI),{matches:f}=dE.useContext($t),{pathname:v}=zR(),F=JSON.stringify(pS(f)),Q=dE.useRef(!1);return wS(()=>{Q.current=!0}),dE.useCallback((q,k={})=>{if(Jt(Q.current,KS),!Q.current)return;if(typeof q=="number"){p.go(q);return}let _E=VS(q,JSON.parse(F),v,k.relative==="path");G==null&&U!=="/"&&(_E.pathname=_E.pathname==="/"?U:ve([U,_E.pathname])),(k.replace?p.replace:p.push)(_E,k.state,k)},[U,p,F,v,G])}dE.createContext(null);function nr(){let{matches:G}=dE.useContext($t),U=G[G.length-1];return U?U.params:{}}function Gi(G,{relative:U}={}){let{matches:p}=dE.useContext($t),{pathname:f}=zR(),v=JSON.stringify(pS(p));return dE.useMemo(()=>VS(G,JSON.parse(v),f,U==="path"),[G,v,f,U])}function Ir(G,U){return kS(G,U)}function kS(G,U,p,f,v){qO(di(),"useRoutes() may be used only in the context of a <Router> component.");let{navigator:F}=dE.useContext(BI),{matches:Q}=dE.useContext($t),sE=Q[Q.length-1],q=sE?sE.params:{},k=sE?sE.pathname:"/",_E=sE?sE.pathnameBase:"/",IE=sE&&sE.route;{let DE=IE&&IE.path||"";FS(k,!IE||DE.endsWith("*")||DE.endsWith("*?"),`You rendered descendant <Routes> (or called \`useRoutes()\`) at "${k}" (under <Route path="${DE}">) but the parent route path has no trailing "*". This means if you navigate deeper, the parent won't match anymore and therefore the child routes will never render.

Please change the parent <Route path="${DE}"> to <Route path="${DE==="/"?"*":`${DE}/*`}">.`)}let CE=zR(),HE;if(U){let DE=typeof U=="string"?__(U):U;qO(_E==="/"||DE.pathname?.startsWith(_E),`When overriding the location using \`<Routes location>\` or \`useRoutes(routes, location)\`, the location pathname must begin with the portion of the URL pathname that was matched by all parent routes. The current pathname base is "${_E}" but pathname "${DE.pathname}" was given in the \`location\` prop.`),HE=DE}else HE=CE;let fE=HE.pathname||"/",zE=fE;if(_E!=="/"){let DE=_E.replace(/^\//,"").split("/");zE="/"+fE.replace(/^\//,"").split("/").slice(DE.length).join("/")}let wE=bS(G,{pathname:zE});Jt(IE||wE!=null,`No routes matched location "${HE.pathname}${HE.search}${HE.hash}" `),Jt(wE==null||wE[wE.length-1].route.element!==void 0||wE[wE.length-1].route.Component!==void 0||wE[wE.length-1].route.lazy!==void 0,`Matched leaf route at location "${HE.pathname}${HE.search}${HE.hash}" does not have an element or Component. This means it will render an <Outlet /> with a null value by default resulting in an "empty" page.`);let $E=sr(wE&&wE.map(DE=>Object.assign({},DE,{params:Object.assign({},q,DE.params),pathname:ve([_E,F.encodeLocation?F.encodeLocation(DE.pathname.replace(/\?/g,"%3F").replace(/#/g,"%23")).pathname:DE.pathname]),pathnameBase:DE.pathnameBase==="/"?_E:ve([_E,F.encodeLocation?F.encodeLocation(DE.pathnameBase.replace(/\?/g,"%3F").replace(/#/g,"%23")).pathname:DE.pathnameBase])})),Q,p,f,v);return U&&$E?dE.createElement(hi.Provider,{value:{location:{pathname:"/",search:"",hash:"",state:null,key:"default",...HE},navigationType:"POP"}},$E):$E}function tr(){let G=Sr(),U=Fl(G)?`${G.status} ${G.statusText}`:G instanceof Error?G.message:JSON.stringify(G),p=G instanceof Error?G.stack:null,f="rgba(200,200,200, 0.5)",v={padding:"0.5rem",backgroundColor:f},F={padding:"2px 4px",backgroundColor:f},Q=null;return console.error("Error handled by React Router default ErrorBoundary:",G),Q=dE.createElement(dE.Fragment,null,dE.createElement("p",null," Hey developer "),dE.createElement("p",null,"You can provide a way better UX than this when your app throws errors by providing your own ",dE.createElement("code",{style:F},"ErrorBoundary")," or"," ",dE.createElement("code",{style:F},"errorElement")," prop on your route.")),dE.createElement(dE.Fragment,null,dE.createElement("h2",null,"Unexpected Application Error!"),dE.createElement("h3",{style:{fontStyle:"italic"}},U),p?dE.createElement("pre",{style:v},p):null,Q)}var er=dE.createElement(tr,null),zS=class extends dE.Component{constructor(G){super(G),this.state={location:G.location,revalidation:G.revalidation,error:G.error}}static getDerivedStateFromError(G){return{error:G}}static getDerivedStateFromProps(G,U){return U.location!==G.location||U.revalidation!=="idle"&&G.revalidation==="idle"?{error:G.error,location:G.location,revalidation:G.revalidation}:{error:G.error!==void 0?G.error:U.error,location:U.location,revalidation:G.revalidation||U.revalidation}}componentDidCatch(G,U){this.props.onError?this.props.onError(G,U):console.error("React Router caught the following error during render",G)}render(){let G=this.state.error;if(this.context&&typeof G=="object"&&G&&"digest"in G&&typeof G.digest=="string"){const p=Er(G.digest);p&&(G=p)}let U=G!==void 0?dE.createElement($t.Provider,{value:this.props.routeContext},dE.createElement(UA.Provider,{value:G,children:this.props.component})):this.props.children;return this.context?dE.createElement(Mr,{error:G},U):U}};zS.contextType=Xl;var mA=new WeakMap;function Mr({children:G,error:U}){let{basename:p}=dE.useContext(BI);if(typeof U=="object"&&U&&"digest"in U&&typeof U.digest=="string"){let f=$l(U.digest);if(f){let v=mA.get(U);if(v)throw v;let F=yS(f.location,p);if(gS&&!mA.get(U))if(F.isExternal||f.reloadDocument)window.location.href=F.absoluteURL||F.to;else{const Q=Promise.resolve().then(()=>window.__reactRouterDataRouter.navigate(F.to,{replace:f.replace}));throw mA.set(U,Q),Q}return dE.createElement("meta",{httpEquiv:"refresh",content:`0;url=${F.absoluteURL||F.to}`})}}return G}function Rr({routeContext:G,match:U,children:p}){let f=dE.useContext(i_);return f&&f.static&&f.staticContext&&(U.route.errorElement||U.route.ErrorBoundary)&&(f.staticContext._deepestRenderedBoundaryId=U.route.id),dE.createElement($t.Provider,{value:G},p)}function sr(G,U=[],p=null,f=null,v=null){if(G==null){if(!p)return null;if(p.errors)G=p.matches;else if(U.length===0&&!p.initialized&&p.matches.length>0)G=p.matches;else return null}let F=G,Q=p?.errors;if(Q!=null){let _E=F.findIndex(IE=>IE.route.id&&Q?.[IE.route.id]!==void 0);qO(_E>=0,`Could not find a matching route for errors on route IDs: ${Object.keys(Q).join(",")}`),F=F.slice(0,Math.min(F.length,_E+1))}let sE=!1,q=-1;if(p)for(let _E=0;_E<F.length;_E++){let IE=F[_E];if((IE.route.HydrateFallback||IE.route.hydrateFallbackElement)&&(q=_E),IE.route.id){let{loaderData:CE,errors:HE}=p,fE=IE.route.loader&&!CE.hasOwnProperty(IE.route.id)&&(!HE||HE[IE.route.id]===void 0);if(IE.route.lazy||fE){sE=!0,q>=0?F=F.slice(0,q+1):F=[F[0]];break}}}let k=p&&f?(_E,IE)=>{f(_E,{location:p.location,params:p.matches?.[0]?.params??{},unstable_pattern:jl(p.matches),errorInfo:IE})}:void 0;return F.reduceRight((_E,IE,CE)=>{let HE,fE=!1,zE=null,wE=null;p&&(HE=Q&&IE.route.id?Q[IE.route.id]:void 0,zE=IE.route.errorElement||er,sE&&(q<0&&CE===0?(FS("route-fallback",!1,"No `HydrateFallback` element provided to render during initial hydration"),fE=!0,wE=null):q===CE&&(fE=!0,wE=IE.route.hydrateFallbackElement||null)));let $E=U.concat(F.slice(0,CE+1)),DE=()=>{let xE;return HE?xE=zE:fE?xE=wE:IE.route.Component?xE=dE.createElement(IE.route.Component,null):IE.route.element?xE=IE.route.element:xE=_E,dE.createElement(Rr,{match:IE,routeContext:{outlet:_E,matches:$E,isDataRoute:p!=null},children:xE})};return p&&(IE.route.ErrorBoundary||IE.route.errorElement||CE===0)?dE.createElement(zS,{location:p.location,revalidation:p.revalidation,component:zE,error:HE,children:DE(),routeContext:{outlet:null,matches:$E,isDataRoute:!0},onError:k}):DE()},null)}function xA(G){return`${G} must be used within a data router.  See https://reactrouter.com/en/main/routers/picking-a-router.`}function _r(G){let U=dE.useContext(i_);return qO(U,xA(G)),U}function ir(G){let U=dE.useContext(Jo);return qO(U,xA(G)),U}function or(G){let U=dE.useContext($t);return qO(U,xA(G)),U}function vA(G){let U=or(G),p=U.matches[U.matches.length-1];return qO(p.route.id,`${G} can only be used on routes that contain a unique "id"`),p.route.id}function Ar(){return vA("useRouteId")}function Sr(){let G=dE.useContext(UA),U=ir("useRouteError"),p=vA("useRouteError");return G!==void 0?G:U.errors?.[p]}function lr(){let{router:G}=_r("useNavigate"),U=vA("useNavigate"),p=dE.useRef(!1);return wS(()=>{p.current=!0}),dE.useCallback(async(v,F={})=>{Jt(p.current,KS),p.current&&(typeof v=="number"?await G.navigate(v):await G.navigate(v,{fromRouteId:U,...F}))},[G,U])}var cS={};function FS(G,U,p){!U&&!cS[G]&&(cS[G]=!0,Jt(!1,p))}dE.memo(rr);function rr({routes:G,future:U,state:p,onError:f}){return kS(G,void 0,p,f,U)}function gA(G){qO(!1,"A <Route> is only ever to be used as the child of <Routes> element, never rendered directly. Please wrap your <Route> in a <Routes>.")}function Pr({basename:G="/",children:U=null,location:p,navigationType:f="POP",navigator:v,static:F=!1,unstable_useTransitions:Q}){qO(!di(),"You cannot render a <Router> inside another <Router>. You should never have more than one in your app.");let sE=G.replace(/^\/*/,"/"),q=dE.useMemo(()=>({basename:sE,navigator:v,static:F,unstable_useTransitions:Q,future:{}}),[sE,v,F,Q]);typeof p=="string"&&(p=__(p));let{pathname:k="/",search:_E="",hash:IE="",state:CE=null,key:HE="default"}=p,fE=dE.useMemo(()=>{let zE=Ke(k,sE);return zE==null?null:{location:{pathname:zE,search:_E,hash:IE,state:CE,key:HE},navigationType:f}},[sE,k,_E,IE,CE,HE,f]);return Jt(fE!=null,`<Router basename="${sE}"> is not able to match the URL "${k}${_E}${IE}" because it does not start with the basename, so the <Router> won't render anything.`),fE==null?null:dE.createElement(BI.Provider,{value:q},dE.createElement(hi.Provider,{children:U,value:fE}))}function ar({children:G,location:U}){return Ir(yA(G),U)}function yA(G,U=[]){let p=[];return dE.Children.forEach(G,(f,v)=>{if(!dE.isValidElement(f))return;let F=[...U,v];if(f.type===dE.Fragment){p.push.apply(p,yA(f.props.children,F));return}qO(f.type===gA,`[${typeof f.type=="string"?f.type:f.type.name}] is not a <Route> component. All component children of <Routes> must be a <Route> or <React.Fragment>`),qO(!f.props.index||!f.props.children,"An index route cannot have child routes.");let Q={id:f.props.id||F.join("-"),caseSensitive:f.props.caseSensitive,element:f.props.element,Component:f.props.Component,index:f.props.index,path:f.props.path,middleware:f.props.middleware,loader:f.props.loader,action:f.props.action,hydrateFallbackElement:f.props.hydrateFallbackElement,HydrateFallback:f.props.HydrateFallback,errorElement:f.props.errorElement,ErrorBoundary:f.props.ErrorBoundary,hasErrorBoundary:f.props.hasErrorBoundary===!0||f.props.ErrorBoundary!=null||f.props.errorElement!=null,shouldRevalidate:f.props.shouldRevalidate,handle:f.props.handle,lazy:f.props.lazy};f.props.children&&(Q.children=yA(f.props.children,F)),p.push(Q)}),p}var zo="get",Fo="application/x-www-form-urlencoded";function $o(G){return typeof HTMLElement<"u"&&G instanceof HTMLElement}function Dr(G){return $o(G)&&G.tagName.toLowerCase()==="button"}function Lr(G){return $o(G)&&G.tagName.toLowerCase()==="form"}function cr(G){return $o(G)&&G.tagName.toLowerCase()==="input"}function hr(G){return!!(G.metaKey||G.altKey||G.ctrlKey||G.shiftKey)}function dr(G,U){return G.button===0&&(!U||U==="_self")&&!hr(G)}var ko=null;function Gr(){if(ko===null)try{new FormData(document.createElement("form"),0),ko=!1}catch{ko=!0}return ko}var ur=new Set(["application/x-www-form-urlencoded","multipart/form-data","text/plain"]);function fA(G){return G!=null&&!ur.has(G)?(Jt(!1,`"${G}" is not a valid \`encType\` for \`<Form>\`/\`<fetcher.Form>\` and will default to "${Fo}"`),null):G}function Yr(G,U){let p,f,v,F,Q;if(Lr(G)){let sE=G.getAttribute("action");f=sE?Ke(sE,U):null,p=G.getAttribute("method")||zo,v=fA(G.getAttribute("enctype"))||Fo,F=new FormData(G)}else if(Dr(G)||cr(G)&&(G.type==="submit"||G.type==="image")){let sE=G.form;if(sE==null)throw new Error('Cannot submit a <button> or <input type="submit"> without a <form>');let q=G.getAttribute("formaction")||sE.getAttribute("action");if(f=q?Ke(q,U):null,p=G.getAttribute("formmethod")||sE.getAttribute("method")||zo,v=fA(G.getAttribute("formenctype"))||fA(sE.getAttribute("enctype"))||Fo,F=new FormData(sE,G),!Gr()){let{name:k,type:_E,value:IE}=G;if(_E==="image"){let CE=k?`${k}.`:"";F.append(`${CE}x`,"0"),F.append(`${CE}y`,"0")}else k&&F.append(k,IE)}}else{if($o(G))throw new Error('Cannot submit element that is not <form>, <button>, or <input type="submit|image">');p=zo,f=null,v=Fo,Q=G}return F&&v==="text/plain"&&(Q=F,F=void 0),{action:f,method:p.toLowerCase(),encType:v,formData:F,body:Q}}Object.getOwnPropertyNames(Object.prototype).sort().join("\0");function KA(G,U){if(G===!1||G===null||typeof G>"u")throw new Error(U)}function Hr(G,U,p,f){let v=typeof G=="string"?new URL(G,typeof window>"u"?"server://singlefetch/":window.location.origin):G;return p?v.pathname.endsWith("/")?v.pathname=`${v.pathname}_.${f}`:v.pathname=`${v.pathname}.${f}`:v.pathname==="/"?v.pathname=`_root.${f}`:U&&Ke(v.pathname,U)==="/"?v.pathname=`${U.replace(/\/$/,"")}/_root.${f}`:v.pathname=`${v.pathname.replace(/\/$/,"")}.${f}`,v}async function Cr(G,U){if(G.id in U)return U[G.id];try{let p=await import(G.module);return U[G.id]=p,p}catch(p){return console.error(`Error loading route module \`${G.module}\`, reloading page...`),console.error(p),window.__reactRouterContext&&window.__reactRouterContext.isSpaMode,window.location.reload(),new Promise(()=>{})}}function Br(G){return G==null?!1:G.href==null?G.rel==="preload"&&typeof G.imageSrcSet=="string"&&typeof G.imageSizes=="string":typeof G.rel=="string"&&typeof G.href=="string"}async function br(G,U,p){let f=await Promise.all(G.map(async v=>{let F=U.routes[v.route.id];if(F){let Q=await Cr(F,p);return Q.links?Q.links():[]}return[]}));return Vr(f.flat(1).filter(Br).filter(v=>v.rel==="stylesheet"||v.rel==="preload").map(v=>v.rel==="stylesheet"?{...v,rel:"prefetch",as:"style"}:{...v,rel:"prefetch"}))}function hS(G,U,p,f,v,F){let Q=(q,k)=>p[k]?q.route.id!==p[k].route.id:!0,sE=(q,k)=>p[k].pathname!==q.pathname||p[k].route.path?.endsWith("*")&&p[k].params["*"]!==q.params["*"];return F==="assets"?U.filter((q,k)=>Q(q,k)||sE(q,k)):F==="data"?U.filter((q,k)=>{let _E=f.routes[q.route.id];if(!_E||!_E.hasLoader)return!1;if(Q(q,k)||sE(q,k))return!0;if(q.route.shouldRevalidate){let IE=q.route.shouldRevalidate({currentUrl:new URL(v.pathname+v.search+v.hash,window.origin),currentParams:p[0]?.params||{},nextUrl:new URL(G,window.origin),nextParams:q.params,defaultShouldRevalidate:!0});if(typeof IE=="boolean")return IE}return!0}):[]}function mr(G,U,{includeHydrateFallback:p}={}){return fr(G.map(f=>{let v=U.routes[f.route.id];if(!v)return[];let F=[v.module];return v.clientActionModule&&(F=F.concat(v.clientActionModule)),v.clientLoaderModule&&(F=F.concat(v.clientLoaderModule)),p&&v.hydrateFallbackModule&&(F=F.concat(v.hydrateFallbackModule)),v.imports&&(F=F.concat(v.imports)),F}).flat(1))}function fr(G){return[...new Set(G)]}function pr(G){let U={},p=Object.keys(G).sort();for(let f of p)U[f]=G[f];return U}function Vr(G,U){let p=new Set;return new Set(U),G.reduce((f,v)=>{let F=JSON.stringify(pr(v));return p.has(F)||(p.add(F),f.push({key:F,link:v})),f},[])}function jS(){let G=dE.useContext(i_);return KA(G,"You must render this element inside a <DataRouterContext.Provider> element"),G}function gr(){let G=dE.useContext(Jo);return KA(G,"You must render this element inside a <DataRouterStateContext.Provider> element"),G}var wA=dE.createContext(void 0);wA.displayName="FrameworkContext";function ZS(){let G=dE.useContext(wA);return KA(G,"You must render this element inside a <HydratedRouter> element"),G}function yr(G,U){let p=dE.useContext(wA),[f,v]=dE.useState(!1),[F,Q]=dE.useState(!1),{onFocus:sE,onBlur:q,onMouseEnter:k,onMouseLeave:_E,onTouchStart:IE}=U,CE=dE.useRef(null);dE.useEffect(()=>{if(G==="render"&&Q(!0),G==="viewport"){let zE=$E=>{$E.forEach(DE=>{Q(DE.isIntersecting)})},wE=new IntersectionObserver(zE,{threshold:.5});return CE.current&&wE.observe(CE.current),()=>{wE.disconnect()}}},[G]),dE.useEffect(()=>{if(f){let zE=setTimeout(()=>{Q(!0)},100);return()=>{clearTimeout(zE)}}},[f]);let HE=()=>{v(!0)},fE=()=>{v(!1),Q(!1)};return p?G!=="intent"?[F,CE,{}]:[F,CE,{onFocus:Li(sE,HE),onBlur:Li(q,fE),onMouseEnter:Li(k,HE),onMouseLeave:Li(_E,fE),onTouchStart:Li(IE,HE)}]:[!1,CE,{}]}function Li(G,U){return p=>{G&&G(p),p.defaultPrevented||U(p)}}function Ur({page:G,...U}){let{router:p}=jS(),f=dE.useMemo(()=>bS(p.routes,G,p.basename),[p.routes,G,p.basename]);return f?dE.createElement(vr,{page:G,matches:f,...U}):null}function xr(G){let{manifest:U,routeModules:p}=ZS(),[f,v]=dE.useState([]);return dE.useEffect(()=>{let F=!1;return br(G,U,p).then(Q=>{F||v(Q)}),()=>{F=!0}},[G,U,p]),f}function vr({page:G,matches:U,...p}){let f=zR(),{future:v,manifest:F,routeModules:Q}=ZS(),{basename:sE}=jS(),{loaderData:q,matches:k}=gr(),_E=dE.useMemo(()=>hS(G,U,k,F,f,"data"),[G,U,k,F,f]),IE=dE.useMemo(()=>hS(G,U,k,F,f,"assets"),[G,U,k,F,f]),CE=dE.useMemo(()=>{if(G===f.pathname+f.search+f.hash)return[];let zE=new Set,wE=!1;if(U.forEach(DE=>{let xE=F.routes[DE.route.id];!xE||!xE.hasLoader||(!_E.some(gE=>gE.route.id===DE.route.id)&&DE.route.id in q&&Q[DE.route.id]?.shouldRevalidate||xE.hasClientLoader?wE=!0:zE.add(DE.route.id))}),zE.size===0)return[];let $E=Hr(G,sE,v.unstable_trailingSlashAwareDataRequests,"data");return wE&&zE.size>0&&$E.searchParams.set("_routes",U.filter(DE=>zE.has(DE.route.id)).map(DE=>DE.route.id).join(",")),[$E.pathname+$E.search]},[sE,v.unstable_trailingSlashAwareDataRequests,q,f,F,_E,U,G,Q]),HE=dE.useMemo(()=>mr(IE,F),[IE,F]),fE=xr(IE);return dE.createElement(dE.Fragment,null,CE.map(zE=>dE.createElement("link",{key:zE,rel:"prefetch",as:"fetch",href:zE,...p})),HE.map(zE=>dE.createElement("link",{key:zE,rel:"modulepreload",href:zE,...p})),fE.map(({key:zE,link:wE})=>dE.createElement("link",{key:zE,nonce:p.nonce,...wE,crossOrigin:wE.crossOrigin??p.crossOrigin})))}function Kr(...G){return U=>{G.forEach(p=>{typeof p=="function"?p(U):p!=null&&(p.current=U)})}}var wr=typeof window<"u"&&typeof window.document<"u"&&typeof window.document.createElement<"u";try{wr&&(window.__reactRouterVersion="7.13.0")}catch{}function kr({basename:G,children:U,unstable_useTransitions:p,window:f}){let v=dE.useRef();v.current==null&&(v.current=Ll({window:f,v5Compat:!0}));let F=v.current,[Q,sE]=dE.useState({action:F.action,location:F.location}),q=dE.useCallback(k=>{p===!1?sE(k):dE.startTransition(()=>sE(k))},[p]);return dE.useLayoutEffect(()=>F.listen(q),[F,q]),dE.createElement(Pr,{basename:G,children:U,location:Q.location,navigationType:Q.action,navigator:F,unstable_useTransitions:p})}var XS=/^(?:[a-z][a-z0-9+.-]*:|\/\/)/i,EA=dE.forwardRef(function({onClick:U,discover:p="render",prefetch:f="none",relative:v,reloadDocument:F,replace:Q,state:sE,target:q,to:k,preventScrollReset:_E,viewTransition:IE,unstable_defaultShouldRevalidate:CE,...HE},fE){let{basename:zE,unstable_useTransitions:wE}=dE.useContext(BI),$E=typeof k=="string"&&XS.test(k),DE=yS(k,zE);k=DE.to;let xE=Nr(k,{relative:v}),[gE,PN,$N]=yr(f,HE),cE=Zr(k,{replace:Q,state:sE,target:q,preventScrollReset:_E,relative:v,viewTransition:IE,unstable_defaultShouldRevalidate:CE,unstable_useTransitions:wE});function pN(mO){U&&U(mO),mO.defaultPrevented||cE(mO)}let xN=dE.createElement("a",{...HE,...$N,href:DE.absoluteURL||xE,onClick:DE.isExternal||F?U:pN,ref:Kr(fE,PN),target:q,"data-discover":!$E&&p==="render"?"true":void 0});return gE&&!$E?dE.createElement(dE.Fragment,null,xN,dE.createElement(Ur,{page:xE})):xN});EA.displayName="Link";var zr=dE.forwardRef(function({"aria-current":U="page",caseSensitive:p=!1,className:f="",end:v=!1,style:F,to:Q,viewTransition:sE,children:q,...k},_E){let IE=Gi(Q,{relative:k.relative}),CE=zR(),HE=dE.useContext(Jo),{navigator:fE,basename:zE}=dE.useContext(BI),wE=HE!=null&&Jr(IE)&&sE===!0,$E=fE.encodeLocation?fE.encodeLocation(IE).pathname:IE.pathname,DE=CE.pathname,xE=HE&&HE.navigation&&HE.navigation.location?HE.navigation.location.pathname:null;p||(DE=DE.toLowerCase(),xE=xE?xE.toLowerCase():null,$E=$E.toLowerCase()),xE&&zE&&(xE=Ke(xE,zE)||xE);const gE=$E!=="/"&&$E.endsWith("/")?$E.length-1:$E.length;let PN=DE===$E||!v&&DE.startsWith($E)&&DE.charAt(gE)==="/",$N=xE!=null&&(xE===$E||!v&&xE.startsWith($E)&&xE.charAt($E.length)==="/"),cE={isActive:PN,isPending:$N,isTransitioning:wE},pN=PN?U:void 0,xN;typeof f=="function"?xN=f(cE):xN=[f,PN?"active":null,$N?"pending":null,wE?"transitioning":null].filter(Boolean).join(" ");let mO=typeof F=="function"?F(cE):F;return dE.createElement(EA,{...k,"aria-current":pN,className:xN,ref:_E,style:mO,to:Q,viewTransition:sE},typeof q=="function"?q(cE):q)});zr.displayName="NavLink";var Fr=dE.forwardRef(({discover:G="render",fetcherKey:U,navigate:p,reloadDocument:f,replace:v,state:F,method:Q=zo,action:sE,onSubmit:q,relative:k,preventScrollReset:_E,viewTransition:IE,unstable_defaultShouldRevalidate:CE,...HE},fE)=>{let{unstable_useTransitions:zE}=dE.useContext(BI),wE=Wr(),$E=Qr(sE,{relative:k}),DE=Q.toLowerCase()==="get"?"get":"post",xE=typeof sE=="string"&&XS.test(sE),gE=PN=>{if(q&&q(PN),PN.defaultPrevented)return;PN.preventDefault();let $N=PN.nativeEvent.submitter,cE=$N?.getAttribute("formmethod")||Q,pN=()=>wE($N||PN.currentTarget,{fetcherKey:U,method:cE,navigate:p,replace:v,state:F,relative:k,preventScrollReset:_E,viewTransition:IE,unstable_defaultShouldRevalidate:CE});zE&&p!==!1?dE.startTransition(()=>pN()):pN()};return dE.createElement("form",{ref:fE,method:DE,action:$E,onSubmit:f?q:gE,...HE,"data-discover":!xE&&G==="render"?"true":void 0})});Fr.displayName="Form";function jr(G){return`${G} must be used within a data router.  See https://reactrouter.com/en/main/routers/picking-a-router.`}function qS(G){let U=dE.useContext(i_);return qO(U,jr(G)),U}function Zr(G,{target:U,replace:p,state:f,preventScrollReset:v,relative:F,viewTransition:Q,unstable_defaultShouldRevalidate:sE,unstable_useTransitions:q}={}){let k=Or(),_E=zR(),IE=Gi(G,{relative:F});return dE.useCallback(CE=>{if(dr(CE,U)){CE.preventDefault();let HE=p!==void 0?p:ci(_E)===ci(IE),fE=()=>k(G,{replace:HE,state:f,preventScrollReset:v,relative:F,viewTransition:Q,unstable_defaultShouldRevalidate:sE});q?dE.startTransition(()=>fE()):fE()}},[_E,k,IE,p,f,U,G,v,F,Q,sE,q])}var Xr=0,qr=()=>`__${String(++Xr)}__`;function Wr(){let{router:G}=qS("useSubmit"),{basename:U}=dE.useContext(BI),p=Ar(),f=G.fetch,v=G.navigate;return dE.useCallback(async(F,Q={})=>{let{action:sE,method:q,encType:k,formData:_E,body:IE}=Yr(F,U);if(Q.navigate===!1){let CE=Q.fetcherKey||qr();await f(CE,p,Q.action||sE,{unstable_defaultShouldRevalidate:Q.unstable_defaultShouldRevalidate,preventScrollReset:Q.preventScrollReset,formData:_E,body:IE,formMethod:Q.method||q,formEncType:Q.encType||k,flushSync:Q.flushSync})}else await v(Q.action||sE,{unstable_defaultShouldRevalidate:Q.unstable_defaultShouldRevalidate,preventScrollReset:Q.preventScrollReset,formData:_E,body:IE,formMethod:Q.method||q,formEncType:Q.encType||k,replace:Q.replace,state:Q.state,fromRouteId:p,flushSync:Q.flushSync,viewTransition:Q.viewTransition})},[f,v,U,p])}function Qr(G,{relative:U}={}){let{basename:p}=dE.useContext(BI),f=dE.useContext($t);qO(f,"useFormAction must be used inside a RouteContext");let[v]=f.matches.slice(-1),F={...Gi(G||".",{relative:U})},Q=zR();if(G==null){F.search=Q.search;let sE=new URLSearchParams(F.search),q=sE.getAll("index");if(q.some(_E=>_E==="")){sE.delete("index"),q.filter(IE=>IE).forEach(IE=>sE.append("index",IE));let _E=sE.toString();F.search=_E?`?${_E}`:""}}return(!G||G===".")&&v.route.index&&(F.search=F.search?F.search.replace(/^\?/,"?index&"):"?index"),p!=="/"&&(F.pathname=F.pathname==="/"?p:ve([p,F.pathname])),ci(F)}function Jr(G,{relative:U}={}){let p=dE.useContext(xS);qO(p!=null,"`useViewTransitionState` must be used within `react-router-dom`'s `RouterProvider`.  Did you accidentally import `RouterProvider` from `react-router`?");let{basename:f}=qS("useViewTransitionState"),v=Gi(G,{relative:U});if(!p.isTransitioning)return!1;let F=Ke(p.currentLocation.pathname,f)||p.currentLocation.pathname,Q=Ke(p.nextLocation.pathname,f)||p.nextLocation.pathname;return Wo(v.pathname,Q)!=null||Wo(v.pathname,F)!=null}const WS=[{name:"Teresa Anderson",firstName:"Teresa",gender:"Female",dob:"2020-03-15",mrn:"C114759",description:`This patient is a White, non-Hispanic male born in 2012,
        enrolled in CBTN in 2014, and diagnosed with a low-grade glioma at
        approximately 18 months of age. Pathology was consistent with pilomyxoid
        astrocytoma/low-grade glioma, harboring a KIAA1549-BRAF fusion. The tumor
        involved the suprasellar/hypothalamic - pituitary region with ventricular
        extension and no evidence of metastatic disease. The clinical course
        included three documented progressions. Surgical management consisted of
        one partial resection followed by a later gross total resection. Systemic
        therapy began with carboplatin/vincristine and later included vinblastine
        and trametinib, including enrollment on a clinical trial. Comprehensive
        tumor and germline molecular profiling was performed.`,treatmentClass:["ALKYLATING","BRAF","CHEMOTHERAPY","MEK","MULTI_AGENT_CHEMOTHERAPY","RESECTION","TRAMETINIB","VINCA_ALKALOID","VINCRISTINE"],characteristics:[{label:"Histology",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"Pilomyxoid astrocytoma"})," ",oE.jsx("span",{className:"text-secondary"})]}),progressionEvidence:{progression:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},symptomsPresent:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},visionDecline:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})}}},{label:"Grade and behavior",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"Grade II benign"})," ",oE.jsx("span",{className:"text-secondary"})]}),progressionEvidence:{progression:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},symptomsPresent:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},visionDecline:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})}}},{label:"Age at diagnosis",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"2 years"})," ",oE.jsx("span",{className:"text-secondary"})]}),progressionEvidence:{progression:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},symptomsPresent:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},visionDecline:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})}}},{label:"Tumor location",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"Hypothalamic, diencephalic"})," ",oE.jsx("span",{className:"text-secondary"})]}),progressionEvidence:{progression:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},symptomsPresent:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},visionDecline:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})}}},{label:"Tumor mass effect",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"Hydrocephalus"})," ",oE.jsx("span",{className:"text-secondary"})]}),progressionEvidence:{progression:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},symptomsPresent:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},visionDecline:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})}}},{label:"Tumor surgery extent",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"Gross total resection"})," ",oE.jsx("span",{className:"text-secondary"})]}),progressionEvidence:{progression:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},symptomsPresent:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},visionDecline:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})}}},{label:"Molecular driver",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"7q34-KIAA1549-BRAF Fusion"})," ",oE.jsx("span",{className:"text-secondary"})]}),progressionEvidence:{progression:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},symptomsPresent:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})},visionDecline:{link:"",value:oE.jsx("span",{className:"opacity-25",children:"-"})}}}]},{name:"Nadine Esperanza",firstName:"Nadine",gender:"Female",dob:"2012-01-05",mrn:"C136530",description:`
        This patient is a Hispanic or Latino, Black or African American female
        born in 2012, enrolled in CBTN in 2014, and diagnosed with a low-grade
        glioma (pilocytic astrocytoma) at approximately 2.2 years of age. The
        tumor arose in the suprasellar/hypothalamic - pituitary region with
        leptomeningeal and CSF dissemination. She has experienced eight
        documented progressions without histologic transformation. Management
        has included two partial resections and multiple lines of systemic
        therapy, beginning with carboplatin/vincristine and followed by several
        chemotherapy and targeted regimens, including bevacizumab, trametinib,
        temozolomide, and combination therapies. Extensive tumor and germline
        molecular profiling has been performed.`,treatmentClass:["ALKYLATING","MEK","MTOR","CHEMOTHERAPY","MULTI_AGENT_CHEMOTHERAPY","RESECTION","TRAMETINIB","VINCA_ALKALOID","VINCRISTINE"],characteristics:[{label:"Histology",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"Pilocytic astrocytoma"})," "]}),link:oE.jsx("a",{href:"https://www.smartcumulus.org/pcx/views/53",target:"_blank",rel:"noopener noreferrer",className:"float-right text-decoration-none small opacity-75",children:"(N = 143)"}),progressionEvidence:{progression:{link:"https://www.smartcumulus.org/pcx/views/20",value:"52%"},symptomsPresent:{link:"https://www.smartcumulus.org/pcx/views/26",value:"72%"},visionDecline:{link:"https://www.smartcumulus.org/pcx/views/25",value:"32%"}}},{label:"Glioma Grade",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"WHO Grade I"})," "]}),link:oE.jsx("a",{href:"https://www.smartcumulus.org/pcx/views/12",target:"_blank",rel:"noopener noreferrer",className:"float-right text-decoration-none small opacity-75",children:"(N = 82)"}),progressionEvidence:{progression:{link:"https://www.smartcumulus.org/pcx/views/21",value:"67%"},symptomsPresent:{link:"https://www.smartcumulus.org/pcx/views/47",value:"89%"},visionDecline:{link:"https://www.smartcumulus.org/pcx/views/48",value:"23%"}}},{label:"Age at Diagnosis",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"2 years"})," "]}),link:oE.jsx("a",{href:"https://www.smartcumulus.org/pcx/views/61",target:"_blank",rel:"noopener noreferrer",className:"float-right text-decoration-none small opacity-75",children:"(N = 70)"}),progressionEvidence:{progression:{link:"https://www.smartcumulus.org/pcx/views/30",value:"61%"},symptomsPresent:{link:"https://www.smartcumulus.org/pcx/views/28",value:"83%"},visionDecline:{link:"https://www.smartcumulus.org/pcx/views/29",value:"49%"}}},{label:"Tumor Location",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"Hypothalamic"})," "]}),link:oE.jsx("a",{href:"https://www.smartcumulus.org/pcx/views/54",target:"_blank",rel:"noopener noreferrer",className:"float-right text-decoration-none small opacity-75",children:"(N = 65)"}),progressionEvidence:{progression:{link:"https://www.smartcumulus.org/pcx/views/31",value:"75%"},symptomsPresent:{link:"https://www.smartcumulus.org/pcx/views/33",value:"91%"},visionDecline:{link:"https://www.smartcumulus.org/pcx/views/32",value:"68%"}}},{label:"Tumor Mass Effect",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"Hydrocephalus"})," "]}),link:oE.jsx("a",{href:"https://www.smartcumulus.org/pcx/views/55",target:"_blank",rel:"noopener noreferrer",className:"float-right text-decoration-none small opacity-75",children:"(N = 225)"}),progressionEvidence:{progression:{link:"https://www.smartcumulus.org/pcx/views/34",value:"68%"},symptomsPresent:{link:"https://www.smartcumulus.org/pcx/views/36",value:"90%"},visionDecline:{link:"https://www.smartcumulus.org/pcx/views/35",value:"45%"}}},{label:"Tumor Surgery Extent",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"Partial resection"})," "]}),link:oE.jsx("a",{href:"https://www.smartcumulus.org/pcx/views/57",target:"_blank",rel:"noopener noreferrer",className:"float-right text-decoration-none small opacity-75",children:"(N = 77)"}),progressionEvidence:{progression:{link:"https://www.smartcumulus.org/pcx/views/37",value:"93%"},symptomsPresent:{link:"https://www.smartcumulus.org/pcx/views/46",value:"79%"},visionDecline:{link:"https://www.smartcumulus.org/pcx/views/38",value:"50%"}}},{label:"Molecular Driver",value:oE.jsxs(oE.Fragment,{children:[oE.jsx("b",{children:"BRAF-KIAA1549 fusion"})," "]}),link:oE.jsx("a",{href:"https://www.smartcumulus.org/pcx/views/58",target:"_blank",rel:"noopener noreferrer",className:"float-right text-decoration-none small opacity-75",children:"(N = 135)"}),progressionEvidence:{progression:{link:"https://www.smartcumulus.org/pcx/views/43",value:"73%"},symptomsPresent:{link:"https://www.smartcumulus.org/pcx/views/45",value:"81%"},visionDecline:{link:"https://www.smartcumulus.org/pcx/views/44",value:"31%"}}}]}],wR={cnt:{label:"Patient Count",description:"Number of unique patients"},progression:{label:"Treatment Response (evidence)",description:"Glioma disease progression status at least 30 days post-treatment."},progression_bin:{label:"Treatment Response",description:"Glioma disease progression or stable after 30 days post-treatment.",order:1},regrowth_pattern:{label:"Tumor Regrowth Pattern",description:"Glioma tumor regrowth observed"},symptom_burden:{label:"Glioma Symptom Burden",description:"Glioma symptom burden."},symptom_burden_bin:{label:"Glioma Symptom Burden",description:"Glioma symptom burden."},tx_class:{label:"Treatment Class",description:"Class of treatment (e.g. gross total resection, chemotherapy, BRAF, MEK, etc.)"},tx_modality:{label:"Treatment Modality",description:"Treatment modality (e.g. surgery, chemotherapy, etc)"},visual_status:{label:"Visual Acuity Progression",description:"Visual acuity (e.g. improving, declining, stable, etc)"},visual_status_bin:{label:"Visual Decline",description:"Visual status change (e.g. improving, declining, stable, etc)"},tx_specific:{label:"Specific Treatment",description:"The name of the specific treatment."},site:{label:"Healthcare Site",description:"Healthcare Site Name",enabled:!1},clinical_trial_status:{label:"Clinical Trial Eligibility",description:"Clinical Trial Eligibility"}};function $r(G,U={year:"numeric",month:"short",day:"numeric"}){return new Date(G).toLocaleDateString(void 0,{year:U.year,month:U.month,day:U.day})}function EP(G,U=","){const p=[];let f=0;const v=G.length;let F=[],Q="",sE=!1,q=!1;const k=()=>{let _E=q?Q:Q.trim();_E===""?F.push(null):F.push(_E),Q="",q=!1};for(;f<v;){const _E=G[f];sE?_E==='"'?f+1<v&&G[f+1]==='"'?(Q+='"',f+=1):sE=!1:Q+=_E:_E==='"'?Q===""?(sE=!0,q=!0):Q+=_E:_E===U?k():_E==="\r"?(f+1<v&&G[f+1]===`
`&&(f+=1),k(),p.push(F),F=[]):_E===`
`?(k(),p.push(F),F=[]):Q+=_E,f+=1}return sE&&(sE=!1),(Q!==""||q||F.length>0||G.endsWith(U))&&(k(),p.push(F)),p}function NP(G,U=","){const p=EP(G,U);if(p.length===0)return[];const v=p[0].map((Q,sE)=>{if(Q===null)return`column${sE+1}`;const q=String(Q).trim();return q===""?`column${sE+1}`:q}),F=[];for(let Q=1;Q<p.length;Q++){const sE=p[Q],q={};for(let k=0;k<v.length;k++){const _E=v[k],IE=k<sE.length?sE[k]:null;q[_E]=IE}F.push(q)}return F}function QS({patient:G}){return oE.jsxs("div",{className:"my-5",children:[oE.jsx("h4",{children:oE.jsx(EA,{to:`/${G.mrn}`,children:G.name})}),oE.jsxs("p",{className:"text-success",children:[oE.jsx("span",{className:"text-muted",children:"Gender: "}),G.gender,oE.jsx("span",{className:"text-muted",children:"DOB: "}),$r(G.dob),oE.jsx("span",{className:"text-muted",children:"MRN: "}),G.mrn]}),oE.jsx("p",{children:G.description})]})}function OP(){return oE.jsx("div",{id:"patient-list",children:WS.map((G,U)=>oE.jsx(QS,{patient:G},U))})}function TP(){return oE.jsxs("h1",{className:"d-flex flex-align-center",children:[oE.jsx("i",{className:"bi bi-boxes me-3 text-success"}),"PCX Cumulus Glioma Tumor Board"]})}var jo={exports:{}},nP=jo.exports,dS;function IP(){return dS||(dS=1,(function(G,U){(function(p,f){p._Highcharts=f(),G.exports=p._Highcharts})("u"<typeof window?nP:window,()=>(()=>{let p,f,v,F,Q,sE;var q,k,_E,IE,CE,HE,fE,zE,wE,$E,DE,xE,gE,PN,$N,cE,pN,xN,mO,WO,vO,bT,EO,lT,rE,pE,MN,VN,vN={};vN.d=(A,N)=>{for(var T in N)vN.o(N,T)&&!vN.o(A,T)&&Object.defineProperty(A,T,{enumerable:!0,get:N[T]})},vN.o=(A,N)=>Object.prototype.hasOwnProperty.call(A,N);var EE={};vN.d(EE,{default:()=>vR}),(q=DE||(DE={})).SVG_NS="http://www.w3.org/2000/svg",q.product="Highcharts",q.version="12.5.0",q.win="u">typeof window?window:{},q.doc=q.win.document,q.svg=!!q.doc?.createElementNS?.(q.SVG_NS,"svg")?.createSVGRect,q.pageLang=q.doc?.documentElement?.closest("[lang]")?.lang,q.userAgent=q.win.navigator?.userAgent||"",q.isChrome=q.win.chrome,q.isFirefox=q.userAgent.indexOf("Firefox")!==-1,q.isMS=/(edge|msie|trident)/i.test(q.userAgent)&&!q.win.opera,q.isSafari=!q.isChrome&&q.userAgent.indexOf("Safari")!==-1,q.isTouchDevice=/(Mobile|Android|Windows Phone)/.test(q.userAgent),q.isWebKit=q.userAgent.indexOf("AppleWebKit")!==-1,q.deg2rad=2*Math.PI/360,q.marginNames=["plotTop","marginRight","marginBottom","plotLeft"],q.noop=function(){},q.supportsPassiveEvents=(function(){let A=!1;if(!q.isMS){let N=Object.defineProperty({},"passive",{get:function(){A=!0}});q.win.addEventListener&&q.win.removeEventListener&&(q.win.addEventListener("testPassive",q.noop,N),q.win.removeEventListener("testPassive",q.noop,N))}return A})(),q.charts=[],q.composed=[],q.dateFormats={},q.seriesTypes={},q.symbolSizes={},q.chartCount=0;let z=DE,{charts:yE,doc:FE,win:sN}=z;function rN(A,N,T,I){let e=N?"Highcharts error":"Highcharts warning";A===32&&(A=`${e}: Deprecated member`);let M=bI(A),R=M?`${e} #${A}: www.highcharts.com/errors/${A}/`:A.toString();if(I!==void 0){let s="";M&&(R+="?"),zT(I,function(i,l){s+=`
 - ${l}: ${i}`,M&&(R+=encodeURI(l)+"="+encodeURI(i))}),R+=s}Ee(z,"displayError",{chart:T,code:A,message:R,params:I},function(){if(N)throw Error(R);sN.console&&rN.messages.indexOf(R)===-1&&console.warn(R)}),rN.messages.push(R)}function KN(A,N){return parseInt(A,N||10)}function YO(A){return typeof A=="string"}function _O(A){let N=Object.prototype.toString.call(A);return N==="[object Array]"||N==="[object Array Iterator]"}function mT(A,N){return!!A&&typeof A=="object"&&(!N||!_O(A))}function HO(A){return mT(A)&&typeof A.nodeType=="number"}function vn(A){let N=A?.constructor;return!!(mT(A,!0)&&!HO(A)&&N?.name&&N.name!=="Object")}function bI(A){return typeof A=="number"&&!isNaN(A)&&A<1/0&&A>-1/0}function RT(A){return A!=null}function mI(A,N,T){let I,e=YO(N)&&!RT(T),M=(R,s)=>{RT(R)?A.setAttribute(s,R):e?(I=A.getAttribute(s))||s!=="class"||(I=A.getAttribute(s+"Name")):A.removeAttribute(s)};return YO(N)?M(T,N):zT(N,M),I}function un(A){return _O(A)?A:[A]}function II(A,N){let T;for(T in A||(A={}),N)A[T]=N[T];return A}function tI(){let A=arguments,N=A.length;for(let T=0;T<N;T++){let I=A[T];if(I!=null)return I}}function rT(A,N){II(A.style,N)}function fT(A){return Math.pow(10,Math.floor(Math.log(A)/Math.LN10))}function PT(A,N){return A>1e14?A:parseFloat(A.toPrecision(N||14))}(rN||(rN={})).messages=[],Math.easeInOutSine=function(A){return-.5*(Math.cos(Math.PI*A)-1)};let we=Array.prototype.find?function(A,N){return A.find(N)}:function(A,N){let T,I=A.length;for(T=0;T<I;T++)if(N(A[T],T))return A[T]};function zT(A,N,T){for(let I in A)Object.hasOwnProperty.call(A,I)&&N.call(T||A[I],A[I],I,A)}function sT(A,N,T){function I(R,s){let i=A.removeEventListener;i&&i.call(A,R,s,!1)}function e(R){let s,i;A.nodeName&&(N?(s={})[N]=!0:s=R,zT(s,function(l,D){if(R[D])for(i=R[D].length;i--;)I(D,R[D][i].fn)}))}let M=typeof A=="function"&&A.prototype||A;if(Object.hasOwnProperty.call(M,"hcEvents")){let R=M.hcEvents;if(N){let s=R[N]||[];T?(R[N]=s.filter(function(i){return T!==i.fn}),I(N,T)):(e(R),R[N]=[])}else e(R),delete M.hcEvents}}function Ee(A,N,T,I){if(T=T||{},FE?.createEvent&&(A.dispatchEvent||A.fireEvent&&A!==z)){let e=FE.createEvent("Events");e.initEvent(N,!0,!0),T=II(e,T),A.dispatchEvent?A.dispatchEvent(T):A.fireEvent(N,T)}else if(A.hcEvents){T.target||II(T,{preventDefault:function(){T.defaultPrevented=!0},target:A,type:N});let e=[],M=A,R=!1;for(;M.hcEvents;)Object.hasOwnProperty.call(M,"hcEvents")&&M.hcEvents[N]&&(e.length&&(R=!0),e.unshift.apply(e,M.hcEvents[N])),M=Object.getPrototypeOf(M);R&&e.sort((s,i)=>s.order-i.order),e.forEach(s=>{s.fn.call(A,T)===!1&&T.preventDefault()})}I&&!T.defaultPrevented&&I.call(A,T)}let Ne=(v=Math.random().toString(36).substring(2,9)+"-",F=0,function(){return"highcharts-"+(p?"":v)+F++});sN.jQuery&&(sN.jQuery.fn.highcharts=function(){let A=[].slice.call(arguments);if(this[0])return A[0]?(new z[YO(A[0])?A.shift():"Chart"](this[0],A[0],A[1]),this):yE[mI(this[0],"data-highcharts-chart")]});let tN={addEvent:function(A,N,T,I={}){let e=typeof A=="function"&&A.prototype||A;Object.hasOwnProperty.call(e,"hcEvents")||(e.hcEvents={});let M=e.hcEvents;z.Point&&A instanceof z.Point&&A.series&&A.series.chart&&(A.series.chart.runTrackerClick=!0);let R=A.addEventListener;R&&R.call(A,N,T,!!z.supportsPassiveEvents&&{passive:I.passive===void 0?N.indexOf("touch")!==-1:I.passive,capture:!1}),M[N]||(M[N]=[]);let s={fn:T,order:typeof I.order=="number"?I.order:1/0};return M[N].push(s),M[N].sort((i,l)=>i.order-l.order),function(){sT(A,N,T)}},arrayMax:function(A){let N=A.length,T=A[0];for(;N--;)A[N]>T&&(T=A[N]);return T},arrayMin:function(A){let N=A.length,T=A[0];for(;N--;)A[N]<T&&(T=A[N]);return T},attr:mI,clamp:function(A,N,T){return A>N?A<T?A:T:N},clearTimeout:function(A){RT(A)&&clearTimeout(A)},correctFloat:PT,createElement:function(A,N,T,I,e){let M=FE.createElement(A);return N&&II(M,N),e&&rT(M,{padding:"0",border:"none",margin:"0"}),T&&rT(M,T),I&&I.appendChild(M),M},crisp:function(A,N=0,T){let I=N%2/2,e=T?-1:1;return(Math.round(A*e-I)+I)*e},css:rT,defined:RT,destroyObjectProperties:function(A,N,T){zT(A,function(I,e){I!==N&&I?.destroy&&I.destroy(),(I?.destroy||!T)&&delete A[e]})},diffObjects:function(A,N,T,I){let e={};return(function M(R,s,i,l){let D=T?s:R;zT(R,function(P,c){if(!l&&I&&I.indexOf(c)>-1&&s[c]){P=un(P),i[c]=[];for(let h=0;h<Math.max(P.length,s[c].length);h++)s[c][h]&&(P[h]===void 0?i[c][h]=s[c][h]:(i[c][h]={},M(P[h],s[c][h],i[c][h],l+1)))}else mT(P,!0)&&!P.nodeType?(i[c]=_O(P)?[]:{},M(P,s[c]||{},i[c],l+1),Object.keys(i[c]).length===0&&(c!=="colorAxis"||l!==0)&&delete i[c]):(R[c]!==s[c]||c in R&&!(c in s))&&c!=="__proto__"&&c!=="constructor"&&(i[c]=D[c])})})(A,N,e,0),e},discardElement:function(A){A?.parentElement?.removeChild(A)},erase:function(A,N){let T=A.length;for(;T--;)if(A[T]===N){A.splice(T,1);break}},error:rN,extend:II,extendClass:function(A,N){let T=function(){};return T.prototype=new A,II(T.prototype,N),T},find:we,fireEvent:Ee,getAlignFactor:(A="")=>({center:.5,right:1,middle:.5,bottom:1})[A]||0,getClosestDistance:function(A,N){let T,I,e,M=!N;return A.forEach(R=>{if(R.length>1)for(e=R.length-1;e>0;e--)(I=R[e]-R[e-1])<0&&!M?(N?.(),N=void 0):I&&(T===void 0||I<T)&&(T=I)}),T},getMagnitude:fT,getNestedProperty:function(A,N){let T=A.split(".");for(;T.length&&RT(N);){let I=T.shift();if(I===void 0||I==="__proto__")return;if(I==="this"){let M;return mT(N)&&(M=N["@this"]),M??N}let e=N[I.replace(/[\\'"]/g,"")];if(!RT(e)||typeof e=="function"||typeof e.nodeType=="number"||e===sN)return;N=e}return N},getStyle:function A(N,T,I){let e;if(T==="width"){let R=Math.min(N.offsetWidth,N.scrollWidth),s=N.getBoundingClientRect?.().width;return s<R&&s>=R-1&&(R=Math.floor(s)),Math.max(0,R-(A(N,"padding-left",!0)||0)-(A(N,"padding-right",!0)||0))}if(T==="height")return Math.max(0,Math.min(N.offsetHeight,N.scrollHeight)-(A(N,"padding-top",!0)||0)-(A(N,"padding-bottom",!0)||0));let M=sN.getComputedStyle(N,void 0);return M&&(e=M.getPropertyValue(T),tI(I,T!=="opacity")&&(e=KN(e))),e},insertItem:function(A,N){let T,I=A.options.index,e=N.length;for(T=A.options.isInternal?e:0;T<e+1;T++)if(!N[T]||bI(I)&&I<tI(N[T].options.index,N[T]._i)||N[T].options.isInternal){N.splice(T,0,A);break}return T},isArray:_O,isClass:vn,isDOMElement:HO,isFunction:function(A){return typeof A=="function"},isNumber:bI,isObject:mT,isString:YO,merge:function(A,...N){let T,I=[A,...N],e={},M=function(s,i){return typeof s!="object"&&(s={}),zT(i,function(l,D){D!=="__proto__"&&D!=="constructor"&&(!mT(l,!0)||vn(l)||HO(l)?s[D]=i[D]:s[D]=M(s[D]||{},l))}),s};A===!0&&(e=I[1],I=Array.prototype.slice.call(I,2));let R=I.length;for(T=0;T<R;T++)e=M(e,I[T]);return e},normalizeTickInterval:function(A,N,T,I,e){let M,R=A;T=tI(T,fT(A));let s=A/T;for(!N&&(N=e?[1,1.2,1.5,2,2.5,3,4,5,6,8,10]:[1,2,2.5,5,10],I===!1&&(T===1?N=N.filter(function(i){return i%1==0}):T<=.1&&(N=[1/T]))),M=0;M<N.length&&(R=N[M],(!e||!(R*T>=A))&&(e||!(s<=(N[M]+(N[M+1]||N[M]))/2)));M++);return PT(R*T,-Math.round(Math.log(.001)/Math.LN10))},objectEach:zT,offset:function(A){let N=FE.documentElement,T=A.parentElement||A.parentNode?A.getBoundingClientRect():{top:0,left:0,width:0,height:0};return{top:T.top+(sN.pageYOffset||N.scrollTop)-(N.clientTop||0),left:T.left+(sN.pageXOffset||N.scrollLeft)-(N.clientLeft||0),width:T.width,height:T.height}},pad:function(A,N,T){return Array((N||2)+1-String(A).replace("-","").length).join(T||"0")+A},pick:tI,pInt:KN,pushUnique:function(A,N){return 0>A.indexOf(N)&&!!A.push(N)},relativeLength:function(A,N,T){return/%$/.test(A)?N*parseFloat(A)/100+(T||0):parseFloat(A)},removeEvent:sT,replaceNested:function(A,...N){let T,I;do for(I of(T=A,N))A=A.replace(I[0],I[1]);while(A!==T);return A},splat:un,stableSort:function(A,N){let T,I,e=A.length;for(I=0;I<e;I++)A[I].safeI=I;for(A.sort(function(M,R){return(T=N(M,R))===0?M.safeI-R.safeI:T}),I=0;I<e;I++)delete A[I].safeI},syncTimeout:function(A,N,T){return N>0?setTimeout(A,N,T):(A.call(0,T),-1)},timeUnits:{millisecond:1,second:1e3,minute:6e4,hour:36e5,day:864e5,week:6048e5,month:24192e5,year:314496e5},ucfirst:function(A){return YO(A)?A.substring(0,1).toUpperCase()+A.substring(1):String(A)},uniqueKey:Ne,useSerialIds:function(A){return p=tI(A,p)},wrap:function(A,N,T){let I=A[N];A[N]=function(){let e=arguments,M=this;return T.apply(this,[function(){return I.apply(M,arguments.length?arguments:e)}].concat([].slice.call(arguments)))}}},{pageLang:fI,win:pI}=z,{defined:eI,error:VI,extend:Oe,isNumber:pT,isObject:NT,isString:UE,merge:nE,objectEach:uE,pad:YE,splat:EN,timeUnits:kE,ucfirst:jE}=tN,BE=z.isSafari&&pI.Intl&&!pI.Intl.DateTimeFormat.prototype.formatRange,KE=class{constructor(A,N){this.options={timezone:"UTC"},this.variableTimezone=!1,this.Date=pI.Date,this.update(A),this.lang=N}update(A={}){this.dTLCache={},this.options=A=nE(!0,this.options,A);let{timezoneOffset:N,useUTC:T,locale:I}=A;this.Date=A.Date||pI.Date||Date;let e=A.timezone;eI(T)&&(e=T?"UTC":void 0),N&&N%60==0&&(e="Etc/GMT"+(N>0?"+":"")+N/60),this.variableTimezone=e!=="UTC"&&e?.indexOf("Etc/GMT")!==0,this.timezone=e,this.lang&&I&&(this.lang.locale=I),["months","shortMonths","weekdays","shortWeekdays"].forEach(M=>{let R=/months/i.test(M),s=/short/.test(M),i={timeZone:"UTC"};i[R?"month":"weekday"]=s?"short":"long",this[M]=(R?[0,1,2,3,4,5,6,7,8,9,10,11]:[3,4,5,6,7,8,9]).map(l=>this.dateFormat(i,(R?31:1)*24*36e5*l))})}toParts(A){let[N,T,I,e,M,R,s]=this.dateTimeFormat({weekday:"narrow",day:"numeric",month:"numeric",year:"numeric",hour:"numeric",minute:"numeric",second:"numeric"},A,"es").split(/(?:, | |\/|:)/g);return[e,I-1,T,M,R,s,Math.floor(Number(A)||0)%1e3,"DLMXJVS".indexOf(N)].map(Number)}dateTimeFormat(A,N,T=this.options.locale||fI){let I=JSON.stringify(A)+T;UE(A)&&(A=this.str2dtf(A));let e=this.dTLCache[I];if(!e){A.timeZone??(A.timeZone=this.timezone);try{e=new Intl.DateTimeFormat(T,A)}catch(M){/Invalid time zone/i.test(M.message)?(VI(34),A.timeZone="UTC",e=new Intl.DateTimeFormat(T,A)):VI(M.message,!1)}}return this.dTLCache[I]=e,e?.format(N)||""}str2dtf(A,N={}){let T={L:{fractionalSecondDigits:3},S:{second:"2-digit"},M:{minute:"numeric"},H:{hour:"2-digit"},k:{hour:"numeric"},E:{weekday:"narrow"},a:{weekday:"short"},A:{weekday:"long"},d:{day:"2-digit"},e:{day:"numeric"},b:{month:"short"},B:{month:"long"},m:{month:"2-digit"},o:{month:"numeric"},y:{year:"2-digit"},Y:{year:"numeric"}};return Object.keys(T).forEach(I=>{A.indexOf(I)!==-1&&Oe(N,T[I])}),N}makeTime(A,N,T=1,I=0,e,M,R){let s=this.Date.UTC(A,N,T,I,e||0,M||0,R||0);if(this.timezone!=="UTC"){let i=this.getTimezoneOffset(s);if(s+=i,[2,3,8,9,10,11].indexOf(N)!==-1&&(I<5||I>20)){let l=this.getTimezoneOffset(s);i!==l?s+=l-i:i-36e5!==this.getTimezoneOffset(s-36e5)||BE||(s-=36e5)}}return s}parse(A){if(!UE(A))return A??void 0;let N=(A=A.replace(/\//g,"-").replace(/(GMT|UTC)/,"")).indexOf("Z")>-1||/([+-][0-9]{2}):?[0-9]{2}$/.test(A),T=/^[0-9]{4}-[0-9]{2}(-[0-9]{2}|)$/.test(A);N||T||(A+="Z");let I=Date.parse(A);if(pT(I))return I+(!N||T?this.getTimezoneOffset(I):0)}getTimezoneOffset(A){if(this.timezone!=="UTC"){let[N,T,I,e,M=0]=this.dateTimeFormat({timeZoneName:"shortOffset"},A,"en").split(/(GMT|:)/).map(Number),R=-(60*(I+M/60)*6e4);if(pT(R))return R}return 0}dateFormat(A,N,T){let I=this.lang;if(!eI(N)||isNaN(N))return I?.invalidDate||"";if(UE(A=A??"%Y-%m-%d %H:%M:%S")){let e,M=/%\[([a-zA-Z]+)\]/g;for(;e=M.exec(A);)A=A.replace(e[0],this.dateTimeFormat(e[1],N,I?.locale))}if(UE(A)&&A.indexOf("%")!==-1){let e=this,[M,R,s,i,l,D,P,c]=this.toParts(N),h=I?.weekdays||this.weekdays,H=I?.shortWeekdays||this.shortWeekdays,B=I?.months||this.months,Y=I?.shortMonths||this.shortMonths;uE(Oe({a:H?H[c]:h[c].substr(0,3),A:h[c],d:YE(s),e:YE(s,2," "),w:c,v:I?.weekFrom??"",b:Y[R],B:B[R],m:YE(R+1),o:R+1,y:M.toString().substr(2,2),Y:M,H:YE(i),k:i,I:YE(i%12||12),l:i%12||12,M:YE(l),p:i<12?"AM":"PM",P:i<12?"am":"pm",S:YE(D),L:YE(P,3)},z.dateFormats),function(C,g){if(UE(A))for(;A.indexOf("%"+g)!==-1;)A=A.replace("%"+g,typeof C=="function"?C.call(e,N):C)})}else if(NT(A)){let e=(this.getTimezoneOffset(N)||0)/36e5,M=this.timezone||"Etc/GMT"+(e>=0?"+":"")+e,{prefix:R="",suffix:s=""}=A;A=R+this.dateTimeFormat(Oe({timeZone:M},A),N)+s}return T?jE(A):A}resolveDTLFormat(A){return NT(A,!0)?NT(A,!0)&&A.main===void 0?{main:A}:A:{main:(A=EN(A))[0],from:A[1],to:A[2]}}getDateFormat(A,N,T,I){let e=this.dateFormat("%m-%d %H:%M:%S.%L",N),M="01-01 00:00:00.000",R={millisecond:15,second:12,minute:9,hour:6,day:3},s="millisecond",i=s;for(s in kE){if(A&&A===kE.week&&+this.dateFormat("%w",N)===T&&e.substr(6)===M.substr(6)){s="week";break}if(A&&kE[s]>A){s=i;break}if(R[s]&&e.substr(R[s])!==M.substr(R[s]))break;s!=="week"&&(i=s)}return this.resolveDTLFormat(I[s]).main}},{defined:SN,extend:TN,timeUnits:QE}=tN,nN=class extends KE{getTimeTicks(A,N,T,I){let e=this,M=[],R={},{count:s=1,unitRange:i}=A,[l,D,P,c,h,H]=e.toParts(N),B=(N||0)%1e3,Y;if(I??(I=1),SN(N)){if(B=i>=QE.second?0:s*Math.floor(B/s),i>=QE.second&&(H=i>=QE.minute?0:s*Math.floor(H/s)),i>=QE.minute&&(h=i>=QE.hour?0:s*Math.floor(h/s)),i>=QE.hour&&(c=i>=QE.day?0:s*Math.floor(c/s)),i>=QE.day&&(P=i>=QE.month?1:Math.max(1,s*Math.floor(P/s))),i>=QE.month&&(D=i>=QE.year?0:s*Math.floor(D/s)),i>=QE.year&&(l-=l%s),i===QE.week){s&&(N=e.makeTime(l,D,P,c,h,H,B));let x=this.dateTimeFormat({timeZone:this.timezone,weekday:"narrow"},N,"es"),j="DLMXJVS".indexOf(x);P+=-j+I+(j<I?-7:0)}N=e.makeTime(l,D,P,c,h,H,B),e.variableTimezone&&SN(T)&&(Y=T-N>4*QE.month||e.getTimezoneOffset(N)!==e.getTimezoneOffset(T));let C=N,g=1;for(;C<T;)M.push(C),i===QE.year?C=e.makeTime(l+g*s,0):i===QE.month?C=e.makeTime(l,D+g*s):Y&&(i===QE.day||i===QE.week)?C=e.makeTime(l,D,P+g*s*(i===QE.day?1:7)):Y&&i===QE.hour&&s>1?C=e.makeTime(l,D,P,c+g*s):C+=i*s,g++;M.push(C),i<=QE.hour&&M.length<1e4&&M.forEach(x=>{x%18e5==0&&e.dateFormat("%H%M%S%L",x)==="000000000"&&(R[x]="day")})}return M.info=TN(A,{higherRanks:R,totalRange:i*s}),M}},{isTouchDevice:SO}=z,{fireEvent:_N,merge:qN}=tN,GN={colors:["#2caffe","#544fc5","#00e272","#fe6a35","#6b8abc","#d568fb","#2ee0ca","#fa4b42","#feb56a","#91e8e1"],symbols:["circle","diamond","square","triangle","triangle-down"],lang:{weekFrom:"week from",chartTitle:"Chart title",locale:void 0,loading:"Loading...",months:void 0,seriesName:"Series {add index 1}",shortMonths:void 0,weekdays:void 0,numericSymbols:["k","M","G","T","P","E"],pieSliceName:"Slice",resetZoom:"Reset zoom",yAxisTitle:"Values",resetZoomTitle:"Reset zoom level 1:1"},global:{buttonTheme:{fill:"#f7f7f7",padding:8,r:2,stroke:"#cccccc","stroke-width":1,style:{color:"#333333",cursor:"pointer",fontSize:"0.8em",fontWeight:"normal"},states:{hover:{fill:"#e6e6e6"},select:{fill:"#e6e9ff",style:{color:"#000000",fontWeight:"bold"}},disabled:{style:{color:"#cccccc"}}}}},time:{Date:void 0,timezone:"UTC",timezoneOffset:0,useUTC:void 0},chart:{alignThresholds:!1,panning:{enabled:!1,type:"x"},styledMode:!1,borderRadius:0,colorCount:10,allowMutatingData:!0,ignoreHiddenSeries:!0,spacing:[10,10,15,10],resetZoomButton:{theme:{},position:{}},reflow:!0,type:"line",zooming:{singleTouch:!1,resetButton:{theme:{zIndex:6},position:{align:"right",x:-10,y:10}}},width:null,height:null,borderColor:"#334eff",backgroundColor:"#ffffff",plotBorderColor:"#cccccc"},title:{style:{color:"#333333",fontWeight:"bold"},text:"Chart title",margin:15,minScale:.67},subtitle:{style:{color:"#666666",fontSize:"0.8em"},text:""},caption:{margin:15,style:{color:"#666666",fontSize:"0.8em"},text:"",align:"left",verticalAlign:"bottom"},plotOptions:{},legend:{enabled:!0,align:"center",alignColumns:!0,className:"highcharts-no-tooltip",events:{},layout:"horizontal",itemMarginBottom:2,itemMarginTop:2,labelFormatter:function(){return this.name},borderColor:"#999999",borderRadius:0,navigation:{style:{fontSize:"0.8em"},activeColor:"#0022ff",inactiveColor:"#cccccc"},itemStyle:{color:"#333333",cursor:"pointer",fontSize:"0.8em",textDecoration:"none",textOverflow:"ellipsis"},itemHoverStyle:{color:"#000000"},itemHiddenStyle:{color:"#666666",textDecoration:"line-through"},shadow:!1,itemCheckboxStyle:{position:"absolute",width:"13px",height:"13px"},squareSymbol:!0,symbolPadding:5,verticalAlign:"bottom",x:0,y:0,title:{style:{color:"#333333",fontSize:"0.8em",fontWeight:"bold"}}},loading:{labelStyle:{fontWeight:"bold",position:"relative",top:"45%"},style:{position:"absolute",backgroundColor:"#ffffff",opacity:.5,textAlign:"center"}},tooltip:{enabled:!0,animation:{duration:300,easing:A=>Math.sqrt(1-Math.pow(A-1,2))},borderRadius:3,dateTimeLabelFormats:{millisecond:"%[AebHMSL]",second:"%[AebHMS]",minute:"%[AebHM]",hour:"%[AebHM]",day:"%[AebY]",week:"%v %[AebY]",month:"%[BY]",year:"%Y"},footerFormat:"",headerShape:"callout",hideDelay:500,padding:8,position:{x:0,y:3},shared:!1,snap:SO?25:10,headerFormat:'<span style="font-size: 0.8em">{ucfirst point.key}</span><br/>',pointFormat:'<span style="color:{point.color}"></span> {series.name}: <b>{point.y}</b><br/>',backgroundColor:"#ffffff",borderWidth:void 0,stickOnContact:!1,style:{color:"#333333",cursor:"default",fontSize:"0.8em"},useHTML:!1},credits:{enabled:!0,href:"https://www.highcharts.com?credits",position:{align:"right",x:-10,verticalAlign:"bottom",y:-5},style:{cursor:"pointer",color:"#999999",fontSize:"0.6em"},text:"Highcharts.com"}},wN=new nN(GN.time,GN.lang),fO={defaultOptions:GN,defaultTime:wN,getOptions:function(){return GN},setOptions:function(A){return _N(z,"setOptions",{options:A}),qN(!0,GN,A),A.time&&wN.update(GN.time),A.lang&&"locale"in A.lang&&wN.update({locale:A.lang.locale}),A.lang?.chartTitle&&(GN.title={...GN.title,text:A.lang.chartTitle}),GN}},{win:OT}=z,{isNumber:TT,isString:FT,merge:Kn,pInt:WN,defined:aO}=tN,QO=(A,N,T)=>`color-mix(in srgb,${A},${N} ${100*T}%)`,dT=A=>FT(A)&&!!A&&A!=="none";class QN{static parse(N){return N?new QN(N):QN.None}constructor(N){let T,I,e,M;this.rgba=[NaN,NaN,NaN,NaN],this.input=N;const R=z.Color;if(R&&R!==QN)return new R(N);if(typeof N=="object"&&N.stops!==void 0)this.stops=N.stops.map(s=>new QN(s[1]));else if(typeof N=="string")for(this.input=N=QN.names[N.toLowerCase()]||N,e=QN.parsers.length;e--&&!I;)(T=(M=QN.parsers[e]).regex.exec(N))&&(I=M.parse(T));I&&(this.rgba=I)}get(N){let T=this.input,I=this.rgba;if(this.output)return this.output;if(typeof T=="object"&&this.stops!==void 0){let e=Kn(T);return e.stops=[].slice.call(e.stops),this.stops.forEach((M,R)=>{e.stops[R]=[e.stops[R][0],M.get(N)]}),e}return I&&TT(I[0])?N!=="rgb"&&(N||I[3]!==1)?N==="a"?`${I[3]}`:"rgba("+I.join(",")+")":"rgb("+I[0]+","+I[1]+","+I[2]+")":T}brighten(N){let T=this.rgba;if(this.stops)this.stops.forEach(function(I){I.brighten(N)});else if(TT(N)&&N!==0)if(TT(T[0]))for(let I=0;I<3;I++)T[I]+=WN(255*N),T[I]<0&&(T[I]=0),T[I]>255&&(T[I]=255);else QN.useColorMix&&dT(this.input)&&(this.output=QO(this.input,N>0?"white":"black",Math.abs(N)));return this}setOpacity(N){return this.rgba[3]=N,this}tweenTo(N,T){let I=this.rgba,e=N.rgba;if(!TT(I[0])||!TT(e[0]))return QN.useColorMix&&dT(this.input)&&dT(N.input)&&T<.99?QO(this.input,N.input,T):N.input||"none";let M=e[3]!==1||I[3]!==1,R=(i,l)=>i+(I[l]-i)*(1-T),s=e.slice(0,3).map(R).map(Math.round);return M&&s.push(R(e[3],3)),(M?"rgba(":"rgb(")+s.join(",")+")"}}QN.names={white:"#ffffff",black:"#000000"},QN.parsers=[{regex:/rgba\(\s*(\d{1,3})\s*,\s*(\d{1,3})\s*,\s*(\d{1,3})\s*,\s*(\d?(?:\.\d+)?)\s*\)/,parse:function(A){return[WN(A[1]),WN(A[2]),WN(A[3]),parseFloat(A[4],10)]}},{regex:/rgb\(\s*(\d{1,3})\s*,\s*(\d{1,3})\s*,\s*(\d{1,3})\s*\)/,parse:function(A){return[WN(A[1]),WN(A[2]),WN(A[3]),1]}},{regex:/^#([a-f0-9])([a-f0-9])([a-f0-9])([a-f0-9])?$/i,parse:function(A){return[WN(A[1]+A[1],16),WN(A[2]+A[2],16),WN(A[3]+A[3],16),aO(A[4])?WN(A[4]+A[4],16)/255:1]}},{regex:/^#([a-f0-9]{2})([a-f0-9]{2})([a-f0-9]{2})([a-f0-9]{2})?$/i,parse:function(A){return[WN(A[1],16),WN(A[2],16),WN(A[3],16),aO(A[4])?WN(A[4],16)/255:1]}}],QN.useColorMix=OT.CSS?.supports("color","color-mix(in srgb,red,blue 9%)"),QN.None=new QN("");let{parse:MI}=QN,{win:VT}=z,{isNumber:jT,objectEach:rn}=tN;class lO{constructor(N,T,I){this.pos=NaN,this.options=T,this.elem=N,this.prop=I}dSetter(){let N=this.paths,T=N?.[0],I=N?.[1],e=this.now||0,M=[];if(e!==1&&T&&I)if(T.length===I.length&&e<1)for(let R=0;R<I.length;R++){let s=T[R],i=I[R],l=[];for(let D=0;D<i.length;D++){let P=s[D],c=i[D];jT(P)&&jT(c)&&(i[0]!=="A"||D!==4&&D!==5)?l[D]=P+e*(c-P):l[D]=c}M.push(l)}else M=I;else M=this.toD||[];this.elem.attr("d",M,void 0,!0)}update(){let N=this.elem,T=this.prop,I=this.now,e=this.options.step;this[T+"Setter"]?this[T+"Setter"]():N.attr?N.element&&N.attr(T,I,null,!0):N.style[T]=I+this.unit,e&&e.call(N,I,this)}run(N,T,I){let e=this,M=e.options,R=function(l){return!R.stopped&&e.step(l)},s=VT.requestAnimationFrame||function(l){setTimeout(l,13)},i=function(){for(let l=0;l<lO.timers.length;l++)lO.timers[l]()||lO.timers.splice(l--,1);lO.timers.length&&s(i)};N!==T||this.elem["forceAnimate:"+this.prop]?(this.startTime=+new Date,this.start=N,this.end=T,this.unit=I,this.now=this.start,this.pos=0,R.elem=this.elem,R.prop=this.prop,R()&&lO.timers.push(R)===1&&s(i)):(delete M.curAnim[this.prop],M.complete&&Object.keys(M.curAnim).length===0&&M.complete.call(this.elem))}step(N){let T,I,e=+new Date,M=this.options,R=this.elem,s=M.complete,i=M.duration,l=M.curAnim;return R.attr&&!R.element?T=!1:N||e>=i+this.startTime?(this.now=this.end,this.pos=1,this.update(),l[this.prop]=!0,I=!0,rn(l,function(D){D!==!0&&(I=!1)}),I&&s&&s.call(R),T=!1):(this.pos=M.easing((e-this.startTime)/i),this.now=this.start+(this.end-this.start)*this.pos,this.update(),T=!0),T}initPath(N,T,I){let e=N.startX,M=N.endX,R=I.slice(),s=N.isArea,i=s?2:1,l=T&&I.length>T.length&&I.hasStackedCliffs,D,P,c,h,H=T?.slice();if(!H||l)return[R,R];function B(C,g){for(;C.length<P;){let x=C[0],j=g[P-C.length];if(j&&x[0]==="M"&&(j[0]==="C"?C[0]=["C",x[1],x[2],x[1],x[2],x[1],x[2]]:C[0]=["L",x[1],x[2]]),C.unshift(x),s){let Z=C.pop();C.push(C[C.length-1],Z)}}}function Y(C){for(;C.length<P;){let g=C[Math.floor(C.length/i)-1].slice();if(g[0]==="C"&&(g[1]=g[5],g[2]=g[6]),s){let x=C[Math.floor(C.length/i)].slice();C.splice(C.length/2,0,g,x)}else C.push(g)}}if(e&&M&&M.length){for(c=0;c<e.length;c++)if(e[c]===M[0]){D=c;break}else if(e[0]===M[M.length-e.length+c]){D=c,h=!0;break}else if(e[e.length-1]===M[M.length-e.length+c]){D=e.length-c;break}D===void 0&&(H=[])}return H.length&&jT(D)&&(P=R.length+D*i,h?(B(H,R),Y(R)):(B(R,H),Y(H))),[H,R]}fillSetter(){lO.prototype.strokeSetter.apply(this,arguments)}strokeSetter(){this.elem.attr(this.prop,MI(this.start).tweenTo(MI(this.end),this.pos),void 0,!0)}}lO.timers=[];let{defined:ZT,getStyle:wn,isArray:RI,isNumber:sI,isObject:dO,merge:lt,objectEach:FR,pick:kn}=tN;function _I(A){return dO(A)?lt({duration:500,defer:0},A):{duration:500*!!A,defer:0}}function jR(A,N){let T=lO.timers.length;for(;T--;)lO.timers[T].elem!==A||N&&N!==lO.timers[T].prop||(lO.timers[T].stopped=!0)}let FO={animate:function(A,N,T){let I,e="",M,R,s;dO(T)||(s=arguments,T={duration:s[2],easing:s[3],complete:s[4]}),sI(T.duration)||(T.duration=400),T.easing=typeof T.easing=="function"?T.easing:Math[T.easing]||Math.easeInOutSine,T.curAnim=lt(N),FR(N,function(i,l){jR(A,l),R=new lO(A,T,l),M=void 0,l==="d"&&RI(N.d)?(R.paths=R.initPath(A,A.pathArray,N.d),R.toD=N.d,I=0,M=1):A.attr?I=A.attr(l):(I=parseFloat(wn(A,l))||0,l!=="opacity"&&(e="px")),M||(M=i),typeof M=="string"&&M.match("px")&&(M=M.replace(/px/g,"")),R.run(I,M,e)})},animObject:_I,getDeferredAnimation:function(A,N,T){let I=_I(N),e=T?[T]:A.series,M=0,R=0;return e.forEach(s=>{let i=_I(s.options.animation);M=dO(N)&&ZT(N.defer)?I.defer:Math.max(M,i.duration+i.defer),R=Math.min(I.duration,i.duration)}),A.renderer.forExport&&(M=0),{defer:Math.max(0,M-R),duration:Math.min(M,R)}},setAnimation:function(A,N){N.renderer.globalAnimation=kn(A,N.options.chart.animation,!0)},stop:jR},{SVG_NS:zM,win:FM}=z,{attr:ke,createElement:ze,css:zn,error:gT,isFunction:ZR,isString:XR,objectEach:Fe,splat:qR}=tN,{trustedTypes:gI}=FM,je=gI&&ZR(gI.createPolicy)&&gI.createPolicy("highcharts",{createHTML:A=>A}),XT=je?je.createHTML(""):"";class NO{static filterUserAttributes(N){return Fe(N,(T,I)=>{let e=!0;NO.allowedAttributes.indexOf(I)===-1&&(e=!1),["background","dynsrc","href","lowsrc","src"].indexOf(I)!==-1&&(e=XR(T)&&NO.allowedReferences.some(M=>T.indexOf(M)===0)),e||(gT(33,!1,void 0,{"Invalid attribute in config":`${I}`}),delete N[I]),XR(T)&&N[I]&&(N[I]=T.replace(/</g,"&lt;"))}),N}static parseStyle(N){return N.split(";").reduce((T,I)=>{let e=I.split(":").map(R=>R.trim()),M=e.shift();return M&&e.length&&(T[M.replace(/-([a-z])/g,R=>R[1].toUpperCase())]=e.join(":")),T},{})}static setElementHTML(N,T){N.innerHTML=NO.emptyHTML,T&&new NO(T).addToDOM(N)}constructor(N){this.nodes=typeof N=="string"?this.parseMarkup(N):N}addToDOM(N){return(function T(I,e){let M;return qR(I).forEach(function(R){let s,i=R.tagName,l=R.textContent?z.doc.createTextNode(R.textContent):void 0,D=NO.bypassHTMLFiltering;if(i)if(i==="#text")s=l;else if(NO.allowedTags.indexOf(i)!==-1||D){let P=i==="svg"?zM:e.namespaceURI||zM,c=z.doc.createElementNS(P,i),h=R.attributes||{};Fe(R,function(H,B){B!=="tagName"&&B!=="attributes"&&B!=="children"&&B!=="style"&&B!=="textContent"&&(h[B]=H)}),ke(c,D?h:NO.filterUserAttributes(h)),R.style&&zn(c,R.style),l&&c.appendChild(l),T(R.children||[],c),s=c}else gT(33,!1,void 0,{"Invalid tagName in config":i});s&&e.appendChild(s),M=s}),M})(this.nodes,N)}parseMarkup(N){let T,I=[];N=N.trim().replace(/ style=(["'])/g," data-style=$1");try{T=new DOMParser().parseFromString(je?je.createHTML(N):N,"text/html")}catch{}if(!T){let M=ze("div");M.innerHTML=N,T={body:M}}let e=(M,R)=>{let s=M.nodeName.toLowerCase(),i={tagName:s};s==="#text"&&(i.textContent=M.textContent||"");let l=M.attributes;if(l){let D={};[].forEach.call(l,P=>{P.name==="data-style"?i.style=NO.parseStyle(P.value):D[P.name]=P.value}),i.attributes=D}if(M.childNodes.length){let D=[];[].forEach.call(M.childNodes,P=>{e(P,D)}),D.length&&(i.children=D)}R.push(i)};return[].forEach.call(T.body.childNodes,M=>e(M,I)),I}}NO.allowedAttributes=["alt","aria-controls","aria-describedby","aria-expanded","aria-haspopup","aria-hidden","aria-label","aria-labelledby","aria-live","aria-pressed","aria-readonly","aria-roledescription","aria-selected","class","clip-path","color","colspan","cx","cy","d","disabled","dx","dy","fill","filterUnits","flood-color","flood-opacity","height","href","id","in","in2","markerHeight","markerWidth","offset","opacity","operator","orient","padding","paddingLeft","paddingRight","patternUnits","r","radius","refX","refY","result","role","rowspan","scope","slope","src","startOffset","stdDeviation","stroke-linecap","stroke-width","stroke","style","summary","tabindex","tableValues","target","text-align","text-anchor","textAnchor","textLength","title","type","valign","width","x","x1","x2","xlink:href","y","y1","y2","zIndex"],NO.allowedReferences=["https://","http://","mailto:","/","../","./","#"],NO.allowedTags=["#text","a","abbr","b","br","button","caption","circle","clipPath","code","dd","defs","div","dl","dt","em","feComponentTransfer","feComposite","feDropShadow","feFlood","feFuncA","feFuncB","feFuncG","feFuncR","feGaussianBlur","feMerge","feMergeNode","feMorphology","feOffset","filter","h1","h2","h3","h4","h5","h6","hr","i","img","li","linearGradient","marker","ol","p","path","pattern","pre","rect","small","span","stop","strong","style","sub","sup","svg","table","tbody","td","text","textPath","th","thead","title","tr","tspan","u","ul"],NO.emptyHTML=XT,NO.bypassHTMLFiltering=!1;let{defaultOptions:Te,defaultTime:rt}=fO,{pageLang:Pt}=z,{extend:WR,getNestedProperty:jM,isArray:at,isNumber:ZM,isObject:XM,isString:yI,pick:Ze,ucfirst:qM}=tN,Xe={add:(A,N)=>A+N,divide:(A,N)=>N!==0?A/N:"",eq:(A,N)=>A==N,each:function(A){let N=arguments[arguments.length-1];return!!at(A)&&A.map((T,I)=>qT(N.body,WR(XM(T)?T:{"@this":T},{"@index":I,"@first":I===0,"@last":I===A.length-1}))).join("")},ge:(A,N)=>A>=N,gt:(A,N)=>A>N,if:A=>!!A,le:(A,N)=>A<=N,lt:(A,N)=>A<N,multiply:(A,N)=>A*N,ne:(A,N)=>A!=N,subtract:(A,N)=>A-N,ucfirst:qM,unless:A=>!A},ne={};function qT(A="",N,T){let I=RegExp(`\\{([\\p{L}\\d:\\.,;\\-\\/<>\\[\\]%_@+"'= #\\(\\)]+)\\}`,"gu"),e=RegExp(`\\(([\\p{L}\\d:\\.,;\\-\\/<>\\[\\]%_@+"'= ]+)\\)`,"gu"),M=[],R=/f$/,s=/\.(\d)/,i=T?.options?.lang||Te.lang,l=T?.time||rt,D=T?.numberFormatter||qe.bind(T),P=(Y="")=>{let C;return Y==="true"||Y!=="false"&&((C=Number(Y)).toString()===Y?C:/^["'].+["']$/.test(Y)?Y.slice(1,-1):jM(Y,N))},c,h,H=0,B;for(;(c=I.exec(A))!==null;){let Y=c,C=e.exec(c[1]);C&&(c=C,B=!0),h?.isBlock||(h={ctx:N,expression:c[1],find:c[0],isBlock:c[1].charAt(0)==="#",start:c.index,startInner:c.index+c[0].length,length:c[0].length});let g=(h.isBlock?Y:c)[1].split(" ")[0].replace("#","");Xe[g]&&(h.isBlock&&g===h.fn&&H++,h.fn||(h.fn=g));let x=c[1]==="else";if(h.isBlock&&h.fn&&(c[1]===`/${h.fn}`||x))if(H)!x&&H--;else{let j=h.startInner,Z=A.substr(j,c.index-j);h.body===void 0?(h.body=Z,h.startInner=c.index+c[0].length):h.elseBody=Z,h.find+=Z+c[0],x||(M.push(h),h=void 0)}else h.isBlock||M.push(h);if(C&&!h?.isBlock)break}return M.forEach(Y=>{let C,g,{body:x,elseBody:j,expression:Z,fn:W}=Y;if(W){let J=[Y],$=[],PE=Z.length,aE=0,lE;for(g=0;g<=PE;g++){let mE=Z.charAt(g);lE||mE!=='"'&&mE!=="'"?lE===mE&&(lE=""):lE=mE,lE||mE!==" "&&g!==PE||($.push(Z.substr(aE,g-aE)),aE=g+1)}for(g=Xe[W].length;g--;)J.unshift(P($[g+1]));C=Xe[W].apply(N,J),Y.isBlock&&typeof C=="boolean"&&(C=qT(C?x:j,N,T))}else{let J=/^["'].+["']$/.test(Z)?[Z]:Z.split(":");if(C=P(J.shift()||""),J.length&&typeof C=="number"){let $=J.join(":");if(R.test($)){let PE=parseInt(($.match(s)||["","-1"])[1],10);C!==null&&(C=D(C,PE,i.decimalPoint,$.indexOf(",")>-1?i.thousandsSep:""))}else C=l.dateFormat($,C)}e.lastIndex=0,e.test(Y.find)&&yI(C)&&(C=`"${C}"`)}A=A.replace(Y.find,Ze(C,""))}),B?qT(A,N,T):A}function qe(A,N,T,I){N*=1;let e,M,[R,s]=(A=+A||0).toString().split("e").map(Number),i=this?.options?.lang||Te.lang,l=(A.toString().split(".")[1]||"").split("e")[0].length,D=N,P={};T??(T=i.decimalPoint),I??(I=i.thousandsSep),N===-1?N=Math.min(l,20):ZM(N)?N&&s<0&&((M=N+s)>=0?(R=+R.toExponential(M).split("e")[0],N=M):(R=Math.floor(R),A=N<20?+(R*Math.pow(10,s)).toFixed(N):0,s=0)):N=2,s&&(N??(N=2),A=R),ZM(N)&&N>=0&&(P.minimumFractionDigits=N,P.maximumFractionDigits=N),I===""&&(P.useGrouping=!1);let c=I||T,h=c?"en":this?.locale||i.locale||Pt,H=JSON.stringify(P)+h;return e=(ne[H]??(ne[H]=new Intl.NumberFormat(h,P))).format(A),c&&(e=e.replace(/([,\.])/g,"_$1").replace(/_\,/g,I??",").replace("_.",T??".")),(N||+e!=0)&&(!(s<0)||D)||(e="0"),s&&+e!=0&&(e+="e"+(s<0?"":"+")+s),e}let GT={dateFormat:function(A,N,T){return rt.dateFormat(A,N,T)},format:qT,helpers:Xe,numberFormat:qe};(k=xE||(xE={})).rendererTypes={},k.getRendererType=function(A=Q){return k.rendererTypes[A]||k.rendererTypes[Q]},k.registerRendererType=function(A,N,T){k.rendererTypes[A]=N,(!Q||T)&&(Q=A,z.Renderer=N)};let Yn=xE,{clamp:Dt,pick:QR,pushUnique:WM,stableSort:We}=tN;(gE||(gE={})).distribute=function A(N,T,I){let e=N,M=e.reducedLen||T,R=(x,j)=>x.target-j.target,s=[],i=N.length,l=[],D=s.push,P,c,h,H=!0,B,Y,C=0,g;for(P=i;P--;)C+=N[P].size;if(C>M){for(We(N,(x,j)=>(j.rank||0)-(x.rank||0)),h=(g=N[0].rank===N[N.length-1].rank)?i/2:-1,c=g?h:i-1;h&&C>M;)B=N[P=Math.floor(c)],WM(l,P)&&(C-=B.size),c+=h,g&&c>=N.length&&(h/=2,c=h);l.sort((x,j)=>j-x).forEach(x=>D.apply(s,N.splice(x,1)))}for(We(N,R),N=N.map(x=>({size:x.size,targets:[x.target],align:QR(x.align,.5)}));H;){for(P=N.length;P--;)B=N[P],Y=(Math.min.apply(0,B.targets)+Math.max.apply(0,B.targets))/2,B.pos=Dt(Y-B.size*B.align,0,T-B.size);for(P=N.length,H=!1;P--;)P>0&&N[P-1].pos+N[P-1].size>N[P].pos&&(N[P-1].size+=N[P].size,N[P-1].targets=N[P-1].targets.concat(N[P].targets),N[P-1].align=.5,N[P-1].pos+N[P-1].size>T&&(N[P-1].pos=T-N[P-1].size),N.splice(P,1),H=!0)}return D.apply(e,s),P=0,N.some(x=>{let j=0;return(x.targets||[]).some(()=>(e[P].pos=x.pos+j,I!==void 0&&Math.abs(e[P].pos-e[P].target)>I?(e.slice(0,P+1).forEach(Z=>delete Z.pos),e.reducedLen=(e.reducedLen||T)-.1*T,e.reducedLen>.1*T&&A(e,T,I),!0):(j+=e[P].size,P++,!1)))}),We(e,R),e};let Fn=gE,{animate:Hn,animObject:Ie,stop:UI}=FO,{deg2rad:Cn,doc:iI,svg:Qe,SVG_NS:xI,win:Je,isFirefox:$e}=z,{addEvent:JR,attr:nT,createElement:vI,crisp:KI,css:Lt,defined:jn,erase:$R,extend:ct,fireEvent:wI,getAlignFactor:ht,isArray:QM,isFunction:Es,isNumber:Ns,isObject:o_,isString:EM,merge:JM,objectEach:dt,pick:kI,pInt:te,pushUnique:A_,replaceNested:Os,syncTimeout:S_,uniqueKey:Ts}=tN;class CO{_defaultGetter(N){let T=kI(this[N+"Value"],this[N],this.element?this.element.getAttribute(N):null,0);return/^-?[\d\.]+$/.test(T)&&(T=parseFloat(T)),T}_defaultSetter(N,T,I){I.setAttribute(T,N)}add(N){let T,I=this.renderer,e=this.element;return N&&(this.parentGroup=N),this.textStr!==void 0&&this.element.nodeName==="text"&&I.buildText(this),this.added=!0,(!N||N.handleZ||this.zIndex)&&(T=this.zIndexSetter()),T||(N?N.element:I.box).appendChild(e),this.onAdd&&this.onAdd(),this}addClass(N,T){let I=T?"":this.attr("class")||"";return(N=(N||"").split(/ /g).reduce(function(e,M){return I.indexOf(M)===-1&&e.push(M),e},I?[I]:[]).join(" "))!==I&&this.attr("class",N),this}afterSetters(){this.doTransform&&(this.updateTransform(),this.doTransform=!1)}align(N,T,I,e=!0){let M=this.renderer,R=M.alignedObjects,s=!!N;N?(this.alignOptions=N,this.alignByTranslate=T,this.alignTo=I):(N=this.alignOptions||{},T=this.alignByTranslate,I=this.alignTo);let i=!I||EM(I)?I||"renderer":void 0;i&&(s&&A_(R,this),I=void 0);let l=kI(I,M[i],M),D=(l.x||0)+(N.x||0)+((l.width||0)-(N.width||0))*ht(N.align),P=(l.y||0)+(N.y||0)+((l.height||0)-(N.height||0))*ht(N.verticalAlign),c={};return N.align&&(c["text-align"]=N.align),c[T?"translateX":"x"]=Math.round(D),c[T?"translateY":"y"]=Math.round(P),e&&(this[this.placed?"animate":"attr"](c),this.placed=!0),this.alignAttr=c,this}alignSetter(N){let T={left:"start",center:"middle",right:"end"};T[N]&&(this.alignValue=N,this.element.setAttribute("text-anchor",T[N]))}animate(N,T,I){let e=Ie(kI(T,this.renderer.globalAnimation,!0)),M=e.defer;return iI.hidden&&(e.duration=0),e.duration!==0?(I&&(e.complete=I),S_(()=>{this.element&&Hn(this,N,e)},M)):(this.attr(N,void 0,I||e.complete),dt(N,function(R,s){e.step&&e.step.call(this,R,{prop:s,pos:1,elem:this})},this)),this}applyTextOutline(N){let T=this.element;N.indexOf("contrast")!==-1&&(N=N.replace(/contrast/g,this.renderer.getContrast(T.style.fill)));let I=N.indexOf(" "),e=N.substring(I+1),M=N.substring(0,I);if(M&&M!=="none"&&z.svg){this.fakeTS=!0,M=M.replace(/(^[\d\.]+)(.*?)$/g,function(D,P,c){return 2*Number(P)+c}),this.removeTextOutline();let R=iI.createElementNS(xI,"tspan");nT(R,{class:"highcharts-text-outline",fill:e,stroke:e,"stroke-width":M,"stroke-linejoin":"round"});let s=T.querySelector("textPath")||T;[].forEach.call(s.childNodes,D=>{let P=D.cloneNode(!0);P.removeAttribute&&["fill","stroke","stroke-width","stroke"].forEach(c=>P.removeAttribute(c)),R.appendChild(P)});let i=0;[].forEach.call(s.querySelectorAll("text tspan"),D=>{i+=Number(D.getAttribute("dy"))});let l=iI.createElementNS(xI,"tspan");l.textContent="",nT(l,{x:Number(T.getAttribute("x")),dy:-i}),R.appendChild(l),s.insertBefore(R,s.firstChild)}}attr(N,T,I,e){let{element:M}=this,R=CO.symbolCustomAttribs,s,i,l=this,D;return typeof N=="string"&&T!==void 0&&(s=N,(N={})[s]=T),typeof N=="string"?l=(this[N+"Getter"]||this._defaultGetter).call(this,N,M):(dt(N,function(P,c){D=!1,e||UI(this,c),this.symbolName&&R.indexOf(c)!==-1&&(i||(this.symbolAttr(N),i=!0),D=!0),this.rotation&&(c==="x"||c==="y")&&(this.doTransform=!0),D||(this[c+"Setter"]||this._defaultSetter).call(this,P,c,M)},this),this.afterSetters()),I&&I.call(this),l}clip(N){if(N&&!N.clipPath){let T=Ts()+"-",I=this.renderer.createElement("clipPath").attr({id:T}).add(this.renderer.defs);ct(N,{clipPath:I,id:T,count:0}),N.add(I)}return this.attr("clip-path",N?`url(${this.renderer.url}#${N.id})`:"none")}crisp(N,T){T=Math.round(T||N.strokeWidth||0);let I=N.x||this.x||0,e=N.y||this.y||0,M=(N.width||this.width||0)+I,R=(N.height||this.height||0)+e,s=KI(I,T),i=KI(e,T);return ct(N,{x:s,y:i,width:KI(M,T)-s,height:KI(R,T)-i}),jn(N.strokeWidth)&&(N.strokeWidth=T),N}complexColor(N,T,I){let e=this.renderer,M,R,s,i,l,D,P,c,h,H,B=[],Y;wI(this.renderer,"complexColor",{args:arguments},function(){if(N.radialGradient?R="radialGradient":N.linearGradient&&(R="linearGradient"),R){if(s=N[R],l=e.gradients,D=N.stops,h=I.radialReference,QM(s)&&(N[R]=s={x1:s[0],y1:s[1],x2:s[2],y2:s[3],gradientUnits:"userSpaceOnUse"}),R==="radialGradient"&&h&&!jn(s.gradientUnits)&&(i=s,s=JM(s,e.getRadialAttr(h,i),{gradientUnits:"userSpaceOnUse"})),dt(s,function(C,g){g!=="id"&&B.push(g,C)}),dt(D,function(C){B.push(C)}),l[B=B.join(",")])H=l[B].attr("id");else{s.id=H=Ts();let C=l[B]=e.createElement(R).attr(s).add(e.defs);C.radAttr=i,C.stops=[],D.forEach(function(g){g[1].indexOf("rgba")===0?(P=(M=QN.parse(g[1])).get("rgb"),c=M.get("a")):(P=g[1],c=1);let x=e.createElement("stop").attr({offset:g[0],"stop-color":P,"stop-opacity":c}).add(C);C.stops.push(x)})}Y="url("+e.url+"#"+H+")",I.setAttribute(T,Y),I.gradient=B,N.toString=function(){return Y}}})}css(N){let T=this.styles,I={},e=this.element,M,R=!T;if(T&&dt(N,function(s,i){T&&T[i]!==s&&(I[i]=s,R=!0)}),R){T&&(N=ct(T,I)),N.width===null||N.width==="auto"?delete this.textWidth:e.nodeName.toLowerCase()==="text"&&N.width&&(M=this.textWidth=te(N.width)),ct(this.styles,N),M&&!Qe&&this.renderer.forExport&&delete N.width;let s=$e&&N.fontSize||null;s&&(Ns(s)||/^\d+$/.test(s))&&(N.fontSize+="px");let i=JM(N);e.namespaceURI===this.SVG_NS&&(["textOutline","textOverflow","whiteSpace","width"].forEach(l=>i&&delete i[l]),i.color&&(i.fill=i.color,delete i.color)),Lt(e,i)}return this.added&&(this.element.nodeName==="text"&&this.renderer.buildText(this),N.textOutline&&this.applyTextOutline(N.textOutline)),this}dashstyleSetter(N){let T,I=this["stroke-width"];if(I==="inherit"&&(I=1),N){let e=(N=N.toLowerCase()).replace("shortdashdotdot","3,1,1,1,1,1,").replace("shortdashdot","3,1,1,1").replace("shortdot","1,1,").replace("shortdash","3,1,").replace("longdash","8,3,").replace(/dot/g,"1,3,").replace("dash","4,3,").replace(/,$/,"").split(",");for(T=e.length;T--;)e[T]=""+te(e[T])*kI(I,NaN);N=e.join(",").replace(/NaN/g,"none"),this.element.setAttribute("stroke-dasharray",N)}}destroy(){let N=this,{element:T={},renderer:I,stops:e}=N,M=T.ownerSVGElement,R=T.nodeName==="SPAN"&&N.parentGroup||void 0,s;if(T.onclick=T.onmouseout=T.onmouseover=T.onmousemove=T.point=null,UI(N),N.clipPath&&M){let i=N.clipPath;[].forEach.call(M.querySelectorAll("[clip-path],[CLIP-PATH]"),function(l){l.getAttribute("clip-path").indexOf(i.element.id)>-1&&l.removeAttribute("clip-path")}),N.clipPath=i.destroy()}if(e){for(let i of e)i.destroy();e.length=0}for(N.safeRemoveChild(T);R?.div&&R.div.childNodes.length===0;)s=R.parentGroup,N.safeRemoveChild(R.div),delete R.div,R=s;N.alignOptions&&$R(I.alignedObjects,N),dt(N,(i,l)=>{(N[l]?.parentGroup===N||["connector","foreignObject"].indexOf(l)!==-1)&&N[l]?.destroy?.(),delete N[l]})}dSetter(N,T,I){QM(N)&&(typeof N[0]=="string"&&(N=this.renderer.pathToSegments(N)),this.pathArray=N,N=N.reduce((e,M,R)=>M?.join?(R?e+" ":"")+M.join(" "):(M||"").toString(),"")),/(NaN| {2}|^$)/.test(N)&&(N="M 0 0"),this[T]!==N&&(I.setAttribute(T,N),this[T]=N)}fillSetter(N,T,I){typeof N=="string"?I.setAttribute(T,N):N&&this.complexColor(N,T,I)}hrefSetter(N,T,I){I.setAttributeNS("http://www.w3.org/1999/xlink",T,N)}getBBox(N,T){let I,e,M,{element:R,renderer:s,styles:i,textStr:l}=this,{cache:D,cacheKeys:P}=s,c=R.namespaceURI===this.SVG_NS,h=kI(T,this.rotation,0),H=s.styledMode?R&&CO.prototype.getStyle.call(R,"font-size"):i.fontSize,B=this.getBBoxCacheKey([s.rootFontSize,this.textWidth,this.alignValue,i.fontWeight,i.lineClamp,i.textOverflow,H,h]);if(B&&!N&&(I=D[B]),!I||I.polygon){if(c||s.forExport){try{M=this.fakeTS&&function(C){let g=R.querySelector(".highcharts-text-outline");g&&Lt(g,{display:C})},Es(M)&&M("none"),I=R.getBBox?ct({},R.getBBox()):{width:R.offsetWidth,height:R.offsetHeight,x:0,y:0},Es(M)&&M("")}catch{}(!I||I.width<0)&&(I={x:0,y:0,width:0,height:0})}else I=this.htmlGetBBox();e=I.height,c&&(I.height=e={"11px,17":14,"13px,20":16}[`${H||""},${Math.round(e)}`]||e),h&&(I=this.getRotatedBox(I,h));let Y={bBox:I};wI(this,"afterGetBBox",Y),I=Y.bBox}if(B&&(l===""||I.height>0)){for(;P.length>250;)delete D[P.shift()];D[B]||P.push(B),D[B]=I}return I}getBBoxCacheKey(N){if(jn(this.textStr)){let T=""+this.textStr;return T.indexOf("<")===-1&&(T=T.replace(/\d/g,"0")),[T,...N].join(",")}}getRotatedBox(N,T){let{x:I,y:e,width:M,height:R}=N,{alignValue:s,translateY:i,rotationOriginX:l=0,rotationOriginY:D=0}=this,P=ht(s),c=Number(this.element.getAttribute("y")||0)-(i?0:e),h=T*Cn,H=(T-90)*Cn,B=Math.cos(h),Y=Math.sin(h),C=M*B,g=M*Y,x=Math.cos(H),j=Math.sin(H),[[Z,W],[J,$]]=[l,D].map(oN=>[oN-oN*B,oN*Y]),PE=I+P*(M-C)+Z+$+c*x,aE=PE+C,lE=aE-R*x,mE=lE-C,vE=e+c-P*g-W+J+c*j,XE=vE+g,NN=XE-R*j,JE=NN-g,WE=Math.min(PE,aE,lE,mE),eO=Math.min(vE,XE,NN,JE),MO=Math.max(PE,aE,lE,mE)-WE,LO=Math.max(vE,XE,NN,JE)-eO;return{x:WE,y:eO,width:MO,height:LO,polygon:[[PE,vE],[aE,XE],[lE,NN],[mE,JE]]}}getStyle(N){return Je.getComputedStyle(this.element||this,"").getPropertyValue(N)}hasClass(N){return(""+this.attr("class")).split(" ").indexOf(N)!==-1}hide(){return this.attr({visibility:"hidden"})}htmlGetBBox(){return{height:0,width:0,x:0,y:0}}constructor(N,T){this.onEvents={},this.opacity=1,this.SVG_NS=xI,this.element=T==="span"||T==="body"?vI(T):iI.createElementNS(this.SVG_NS,T),this.renderer=N,this.styles={},wI(this,"afterInit")}on(N,T){let{onEvents:I}=this;return I[N]&&I[N](),I[N]=JR(this.element,N,T),this}opacitySetter(N,T,I){let e=Number(Number(N).toFixed(3));this.opacity=e,I.setAttribute(T,e)}reAlign(){this.alignOptions?.width&&this.alignOptions.align!=="left"&&(this.alignOptions.width=this.getBBox().width,this.placed=!1,this.align())}removeClass(N){return this.attr("class",(""+this.attr("class")).replace(EM(N)?RegExp(`(^| )${N}( |$)`):N," ").replace(/ +/g," ").trim())}removeTextOutline(){let N=this.element.querySelector("tspan.highcharts-text-outline");N&&this.safeRemoveChild(N)}safeRemoveChild(N){let T=N.parentNode;T&&T.removeChild(N)}setRadialReference(N){let T=this.element.gradient&&this.renderer.gradients[this.element.gradient]||void 0;return this.element.radialReference=N,T?.radAttr&&T.animate(this.renderer.getRadialAttr(N,T.radAttr)),this}shadow(N){let{renderer:T}=this,I=JM(this.parentGroup?.rotation===90?{offsetX:-1,offsetY:-1}:{},o_(N)?N:{}),e=T.shadowDefinition(I);return this.attr({filter:N?`url(${T.url}#${e})`:"none"})}show(N=!0){return this.attr({visibility:N?"inherit":"visible"})}"stroke-widthSetter"(N,T,I){this[T]=N,I.setAttribute(T,N)}strokeWidth(){if(!this.renderer.styledMode)return this["stroke-width"]||0;let N=this.getStyle("stroke-width"),T=0,I;return/px$/.test(N)?T=te(N):N!==""&&(nT(I=iI.createElementNS(xI,"rect"),{width:N,"stroke-width":0}),this.element.parentNode.appendChild(I),T=I.getBBox().width,I.parentNode.removeChild(I)),T}symbolAttr(N){let T=this;CO.symbolCustomAttribs.forEach(function(I){T[I]=kI(N[I],T[I])}),T.attr({d:T.renderer.symbols[T.symbolName](T.x,T.y,T.width,T.height,T)})}textSetter(N){N!==this.textStr&&(delete this.textPxLength,this.textStr=N,this.added&&this.renderer.buildText(this),this.reAlign())}titleSetter(N){let T=this.element,I=T.getElementsByTagName("title")[0]||iI.createElementNS(this.SVG_NS,"title");T.insertBefore?T.insertBefore(I,T.firstChild):T.appendChild(I),I.textContent=Os(kI(N,""),[/<[^>]*>/g,""]).replace(/&lt;/g,"<").replace(/&gt;/g,">")}toFront(){let N=this.element;return N.parentNode.appendChild(N),this}translate(N,T){return this.attr({translateX:N,translateY:T})}updateTransform(N="transform"){let{element:T,foreignObject:I,matrix:e,padding:M,rotation:R=0,rotationOriginX:s,rotationOriginY:i,scaleX:l,scaleY:D,text:P,translateX:c=0,translateY:h=0}=this,H=[`translate(${c},${h})`];jn(e)&&H.push("matrix("+e.join(",")+")"),R&&(H.push("rotate("+R+" "+(s??T.getAttribute("x")??this.x??0)+" "+(i??T.getAttribute("y")??this.y??0)+")"),P?.element.tagName!=="SPAN"||P?.foreignObject||P.attr({rotation:R,rotationOriginX:(s||0)-M,rotationOriginY:(i||0)-M})),(jn(l)||jn(D))&&H.push(`scale(${l??1} ${D??1})`),H.length&&!(P||this).textPath&&(I?.element||T).setAttribute(N,H.join(" "))}visibilitySetter(N,T,I){N==="inherit"?I.removeAttribute(T):this[T]!==N&&I.setAttribute(T,N),this[T]=N}xGetter(N){return this.element.nodeName==="circle"&&(N==="x"?N="cx":N==="y"&&(N="cy")),this._defaultGetter(N)}zIndexSetter(N,T){let I=this.renderer,e=this.parentGroup,M=(e||I).element||I.box,R=this.element,s=M===I.box,i,l,D,P=!1,c,h=this.added,H;if(jn(N)?(R.setAttribute("data-z-index",N),N*=1,this[T]===N&&(h=!1)):jn(this[T])&&R.removeAttribute("data-z-index"),this[T]=N,h){for((N=this.zIndex)&&e&&(e.handleZ=!0),H=(i=M.childNodes).length-1;H>=0&&!P;H--)c=!jn(D=(l=i[H]).getAttribute("data-z-index")),l!==R&&(N<0&&c&&!s&&!H?(M.insertBefore(R,i[H]),P=!0):(te(D)<=N||c&&(!jn(N)||N>=0))&&(M.insertBefore(R,i[H+1]),P=!0));P||(M.insertBefore(R,i[3*!!s]),P=!0)}return P}}CO.symbolCustomAttribs=["anchorX","anchorY","clockwise","end","height","innerR","r","start","width","x","y"],CO.prototype.strokeSetter=CO.prototype.fillSetter,CO.prototype.yGetter=CO.prototype.xGetter,CO.prototype.matrixSetter=CO.prototype.rotationOriginXSetter=CO.prototype.rotationOriginYSetter=CO.prototype.rotationSetter=CO.prototype.scaleXSetter=CO.prototype.scaleYSetter=CO.prototype.translateXSetter=CO.prototype.translateYSetter=CO.prototype.verticalAlignSetter=function(A,N){this[N]=A,this.doTransform=!0};let Pn=CO,{defined:Bn,extend:ns,getAlignFactor:Is,isNumber:ee,merge:NM,pick:Me,removeEvent:ts}=tN;class zI extends Pn{constructor(N,T,I,e,M,R,s,i,l,D){let P;super(N,"g"),this.paddingLeftSetter=this.paddingSetter,this.paddingRightSetter=this.paddingSetter,this.doUpdate=!1,this.textStr=T,this.x=I,this.y=e,this.anchorX=R,this.anchorY=s,this.baseline=l,this.className=D,this.addClass(D==="button"?"highcharts-no-tooltip":"highcharts-label"),D&&this.addClass("highcharts-"+D),this.text=N.text(void 0,0,0,i).attr({zIndex:1}),typeof M=="string"&&((P=/^url\((.*?)\)$/.test(M))||this.renderer.symbols[M])&&(this.symbolKey=M),this.bBox=zI.emptyBBox,this.padding=3,this.baselineOffset=0,this.needsBox=N.styledMode||P,this.deferredAttr={},this.alignFactor=0}alignSetter(N){let T=Is(N);this.textAlign=N,T!==this.alignFactor&&(this.alignFactor=T,this.bBox&&ee(this.xSetting)&&this.attr({x:this.xSetting}),this.updateTextPadding())}anchorXSetter(N,T){this.anchorX=N,this.boxAttr(T,Math.round(N)-this.getCrispAdjust()-this.xSetting)}anchorYSetter(N,T){this.anchorY=N,this.boxAttr(T,N-this.ySetting)}boxAttr(N,T){this.box?this.box.attr(N,T):this.deferredAttr[N]=T}css(N){if(N){let T={};N=NM(N),zI.textProps.forEach(I=>{N[I]!==void 0&&(T[I]=N[I],delete N[I])}),this.text.css(T),"fontSize"in T||"fontWeight"in T||"width"in T?this.updateTextPadding():"textOverflow"in T&&this.updateBoxSize()}return Pn.prototype.css.call(this,N)}destroy(){ts(this.element,"mouseenter"),ts(this.element,"mouseleave"),this.text&&this.text.destroy(),this.box&&(this.box=this.box.destroy()),Pn.prototype.destroy.call(this)}fillSetter(N,T){N&&(this.needsBox=!0),this.fill=N,this.boxAttr(T,N)}getBBox(N,T){(this.textStr&&this.bBox.width===0&&this.bBox.height===0||this.rotation)&&this.updateBoxSize();let{padding:I,height:e=0,translateX:M=0,translateY:R=0,width:s=0}=this,i=Me(this.paddingLeft,I),l=T??(this.rotation||0),D={width:s,height:e,x:M+this.bBox.x-i,y:R+this.bBox.y-I+this.baselineOffset};return l&&(D=this.getRotatedBox(D,l)),D}getCrispAdjust(){return(this.renderer.styledMode&&this.box?this.box.strokeWidth():this["stroke-width"]?parseInt(this["stroke-width"],10):0)%2/2}heightSetter(N){this.heightSetting=N,this.doUpdate=!0}afterSetters(){super.afterSetters(),this.doUpdate&&(this.updateBoxSize(),this.doUpdate=!1)}onAdd(){this.text.add(this),this.attr({text:Me(this.textStr,""),x:this.x||0,y:this.y||0}),this.box&&Bn(this.anchorX)&&this.attr({anchorX:this.anchorX,anchorY:this.anchorY})}paddingSetter(N,T){ee(N)?N!==this[T]&&(this[T]=N,this.updateTextPadding()):this[T]=void 0}rSetter(N,T){this.boxAttr(T,N)}strokeSetter(N,T){this.stroke=N,this.boxAttr(T,N)}"stroke-widthSetter"(N,T){N&&(this.needsBox=!0),this["stroke-width"]=N,this.boxAttr(T,N)}"text-alignSetter"(N){this.textAlign=this["text-align"]=N,this.updateTextPadding()}textSetter(N){N!==void 0&&this.text.attr({text:N}),this.updateTextPadding(),this.reAlign()}updateBoxSize(){let N,T=this.text,I={},e=this.padding,M=this.bBox=(!ee(this.widthSetting)||!ee(this.heightSetting)||this.textAlign)&&Bn(T.textStr)?T.getBBox(void 0,0):zI.emptyBBox;this.width=this.getPaddedWidth(),this.height=(this.heightSetting||M.height||0)+2*e;let R=this.renderer.fontMetrics(T);if(this.baselineOffset=e+Math.min((this.text.firstLineMetrics||R).b,M.height||1/0),this.heightSetting&&(this.baselineOffset+=(this.heightSetting-R.h)/2),this.needsBox&&!T.textPath){if(!this.box){let s=this.box=this.symbolKey?this.renderer.symbol(this.symbolKey):this.renderer.rect();s.addClass((this.className==="button"?"":"highcharts-label-box")+(this.className?" highcharts-"+this.className+"-box":"")),s.add(this)}I.x=N=this.getCrispAdjust(),I.y=(this.baseline?-this.baselineOffset:0)+N,I.width=Math.round(this.width),I.height=Math.round(this.height),this.box.attr(ns(I,this.deferredAttr)),this.deferredAttr={}}}updateTextPadding(){let N=this.text,T=N.styles.textAlign||this.textAlign;if(!N.textPath){this.updateBoxSize();let I=this.baseline?0:this.baselineOffset,e=(this.paddingLeft??this.padding)+Is(T)*(this.widthSetting??this.bBox.width);(e!==N.x||I!==N.y)&&(N.attr({align:T,x:e}),I!==void 0&&N.attr("y",I)),N.x=e,N.y=I}}widthSetter(N){this.widthSetting=ee(N)?N:void 0,this.doUpdate=!0}getPaddedWidth(){let N=this.padding,T=Me(this.paddingLeft,N),I=Me(this.paddingRight,N);return(this.widthSetting||this.bBox.width||0)+T+I}xSetter(N){this.x=N,this.alignFactor&&(N-=this.alignFactor*this.getPaddedWidth(),this["forceAnimate:x"]=!0),this.anchorX&&(this["forceAnimate:anchorX"]=!0),this.xSetting=Math.round(N),this.attr("translateX",this.xSetting)}ySetter(N){this.anchorY&&(this["forceAnimate:anchorY"]=!0),this.ySetting=this.y=Math.round(N),this.attr("translateY",this.ySetting)}}zI.emptyBBox={width:0,height:0,x:0,y:0},zI.textProps=["color","direction","fontFamily","fontSize","fontStyle","fontWeight","lineClamp","lineHeight","textAlign","textDecoration","textOutline","textOverflow","whiteSpace","width"];let{defined:oI,isNumber:OM,pick:Gt}=tN;function es(A,N,T,I,e){let M=[];if(e){let R=e.start||0,s=e.end||0,i=Gt(e.r,T),l=Gt(e.r,I||T),D=2e-4/(e.borderRadius?1:Math.max(i,1)),P=Math.abs(s-R-2*Math.PI)<D;P&&(R=Math.PI/2,s=2.5*Math.PI-D);let c=e.innerR,h=Gt(e.open,P),H=Math.cos(R),B=Math.sin(R),Y=Math.cos(s),C=Math.sin(s),g=Gt(e.longArc,s-R-Math.PI<D?0:1),x=["A",i,l,0,g,Gt(e.clockwise,1),A+i*Y,N+l*C];x.params={start:R,end:s,cx:A,cy:N},M.push(["M",A+i*H,N+l*B],x),oI(c)&&((x=["A",c,c,0,g,oI(e.clockwise)?1-e.clockwise:0,A+c*H,N+c*B]).params={start:s,end:R,cx:A,cy:N},M.push(h?["M",A+c*Y,N+c*C]:["L",A+c*Y,N+c*C],x)),h||M.push(["Z"])}return M}function Ms(A,N,T,I,e){return e?.r?FI(A,N,T,I,e):[["M",A,N],["L",A+T,N],["L",A+T,N+I],["L",A,N+I],["Z"]]}function FI(A,N,T,I,e){let M=e?.r||0;return[["M",A+M,N],["L",A+T-M,N],["A",M,M,0,0,1,A+T,N+M],["L",A+T,N+I-M],["A",M,M,0,0,1,A+T-M,N+I],["L",A+M,N+I],["A",M,M,0,0,1,A,N+I-M],["L",A,N+M],["A",M,M,0,0,1,A+M,N],["Z"]]}let Re={arc:es,callout:function(A,N,T,I,e){let M=Math.min(e?.r||0,T,I),R=M+6,s=e?.anchorX,i=e?.anchorY||0,l=FI(A,N,T,I,{r:M});if(!OM(s)||s<T&&s>0&&i<I&&i>0)return l;if(A+s>T-R)if(i>N+R&&i<N+I-R)l.splice(3,1,["L",A+T,i-6],["L",A+T+6,i],["L",A+T,i+6],["L",A+T,N+I-M]);else if(s<T){let D=i<N+R,P=D?N:N+I;l.splice(D?2:5,0,["L",s,i],["L",A+T-M,P])}else l.splice(3,1,["L",A+T,I/2],["L",s,i],["L",A+T,I/2],["L",A+T,N+I-M]);else if(A+s<R)if(i>N+R&&i<N+I-R)l.splice(7,1,["L",A,i+6],["L",A-6,i],["L",A,i-6],["L",A,N+M]);else if(s>0){let D=i<N+R,P=D?N:N+I;l.splice(D?1:6,0,["L",s,i],["L",A+M,P])}else l.splice(7,1,["L",A,I/2],["L",s,i],["L",A,I/2],["L",A,N+M]);else i>I&&s<T-R?l.splice(5,1,["L",s+6,N+I],["L",s,N+I+6],["L",s-6,N+I],["L",A+M,N+I]):i<0&&s>R&&l.splice(1,1,["L",s-6,N],["L",s,N-6],["L",s+6,N],["L",T-M,N]);return l},circle:function(A,N,T,I){return es(A+T/2,N+I/2,T/2,I/2,{start:.5*Math.PI,end:2.5*Math.PI,open:!1})},diamond:function(A,N,T,I){return[["M",A+T/2,N],["L",A+T,N+I/2],["L",A+T/2,N+I],["L",A,N+I/2],["Z"]]},rect:Ms,roundedRect:FI,square:Ms,triangle:function(A,N,T,I){return[["M",A+T/2,N],["L",A+T,N+I],["L",A,N+I],["Z"]]},"triangle-down":function(A,N,T,I){return[["M",A,N],["L",A+T,N],["L",A+T/2,N+I],["Z"]]}},{doc:an,SVG_NS:l_,win:$M}=z,{attr:Zn,extend:Rs,fireEvent:ss,isString:TM,objectEach:ut,pick:_s}=tN,jO=(A,N)=>A.substring(0,N)+"",is=class{constructor(A){const N=A.styles;this.renderer=A.renderer,this.svgElement=A,this.width=A.textWidth,this.textLineHeight=N?.lineHeight,this.textOutline=N?.textOutline,this.ellipsis=N?.textOverflow==="ellipsis",this.lineClamp=N?.lineClamp,this.noWrap=N?.whiteSpace==="nowrap"}buildSVG(){let A=this.svgElement,N=A.element,T=A.renderer,I=_s(A.textStr,"").toString(),e=I.indexOf("<")!==-1,M=N.childNodes,R=!A.added&&T.box,s=[I,this.ellipsis,this.noWrap,this.textLineHeight,this.textOutline,A.getStyle("font-size"),A.styles.lineClamp,this.width].join(",");if(s!==A.textCache){A.textCache=s,delete A.actualWidth;for(let i=M.length;i--;)N.removeChild(M[i]);if(e||this.ellipsis||this.width||A.textPath||I.indexOf(" ")!==-1&&(!this.noWrap||/<br.*?>/g.test(I))){if(I!==""){R&&R.appendChild(N);let i=new NO(I);this.modifyTree(i.nodes),i.addToDOM(N),this.modifyDOM(),this.ellipsis&&(N.textContent||"").indexOf("")!==-1&&A.attr("title",this.unescapeEntities(A.textStr||"",["&lt;","&gt;"])),R&&R.removeChild(N)}}else N.appendChild(an.createTextNode(this.unescapeEntities(I)));TM(this.textOutline)&&A.applyTextOutline&&A.applyTextOutline(this.textOutline)}}modifyDOM(){let A,N=this.svgElement,T=Zn(N.element,"x");for(N.firstLineMetrics=void 0;(A=N.element.firstChild)&&/^[\s\u200B]*$/.test(A.textContent||" ");)N.element.removeChild(A);[].forEach.call(N.element.querySelectorAll("tspan.highcharts-br"),(R,s)=>{R.nextSibling&&R.previousSibling&&(s===0&&R.previousSibling.nodeType===1&&(N.firstLineMetrics=N.renderer.fontMetrics(R.previousSibling)),Zn(R,{dy:this.getLineHeight(R.nextSibling),x:T}))});let I=this.width||0;if(!I)return;let e=(R,s)=>{let i=R.textContent||"",l=i.replace(/([^\^])-/g,"$1- ").split(" "),D=!this.noWrap&&(l.length>1||N.element.childNodes.length>1),P=this.getLineHeight(s),c=Math.max(0,I-.8*P),h=0,H=N.actualWidth;if(D){let B=[],Y=[];for(;s.firstChild&&s.firstChild!==R;)Y.push(s.firstChild),s.removeChild(s.firstChild);for(;l.length;)if(l.length&&!this.noWrap&&h>0&&(B.push(R.textContent||""),R.textContent=l.join(" ").replace(/- /g,"-")),this.truncate(R,void 0,l,h===0&&H||0,I,c,(C,g)=>l.slice(0,g).join(" ").replace(/- /g,"-")),H=N.actualWidth,h++,this.lineClamp&&h>=this.lineClamp){l.length&&(this.truncate(R,R.textContent||"",void 0,0,I,c,jO),R.textContent=R.textContent?.replace("","")+"");break}Y.forEach(C=>{s.insertBefore(C,R)}),B.forEach(C=>{s.insertBefore(an.createTextNode(C),R);let g=an.createElementNS(l_,"tspan");g.textContent="",Zn(g,{dy:P,x:T}),s.insertBefore(g,R)})}else this.ellipsis&&i&&this.truncate(R,i,void 0,0,I,c,jO)},M=R=>{[].slice.call(R.childNodes).forEach(s=>{s.nodeType===$M.Node.TEXT_NODE?e(s,R):(s.className.baseVal.indexOf("highcharts-br")!==-1&&(N.actualWidth=0),M(s))})};M(N.element)}getLineHeight(A){let N=A.nodeType===$M.Node.TEXT_NODE?A.parentElement:A;return this.textLineHeight?parseInt(this.textLineHeight.toString(),10):this.renderer.fontMetrics(N||this.svgElement.element).h}modifyTree(A){let N=(T,I)=>{let{attributes:e={},children:M,style:R={},tagName:s}=T,i=this.renderer.styledMode;if(s==="b"||s==="strong"?i?e.class="highcharts-strong":R.fontWeight="bold":(s==="i"||s==="em")&&(i?e.class="highcharts-emphasized":R.fontStyle="italic"),R?.color&&(R.fill=R.color),s==="br"){e.class="highcharts-br",T.textContent="";let l=A[I+1];l?.textContent&&(l.textContent=l.textContent.replace(/^ +/gm,""))}else s==="a"&&M&&M.some(l=>l.tagName==="#text")&&(T.children=[{children:M,tagName:"tspan"}]);s!=="#text"&&s!=="a"&&(T.tagName="tspan"),Rs(T,{attributes:e,style:R}),M&&M.filter(l=>l.tagName!=="#text").forEach(N)};A.forEach(N),ss(this.svgElement,"afterModifyTree",{nodes:A})}truncate(A,N,T,I,e,M,R){let s,i,l=this.svgElement,{rotation:D}=l,P=[],c=T&&!I?1:0,h=(N||T||"").length,H=h;T||(e=M);let B=function(Y,C){let g=C||Y,x=A.parentNode;if(x&&P[g]===void 0&&x.getSubStringLength)try{P[g]=I+x.getSubStringLength(0,T?g+1:g)}catch{}return P[g]};if(l.rotation=0,I+(i=B(A.textContent.length))>e){for(;c<=h;)H=Math.ceil((c+h)/2),T&&(s=R(T,H)),i=B(H,s&&s.length-1),c===h?c=h+1:i>e?h=H-1:c=H;h===0?A.textContent="":N&&h===N.length-1||(A.textContent=s||R(N||T,H)),this.ellipsis&&i>e&&this.truncate(A,A.textContent||"",void 0,0,e,M,jO)}T&&T.splice(0,H),l.actualWidth=i,l.rotation=D}unescapeEntities(A,N){return ut(this.renderer.escapes,function(T,I){N&&N.indexOf(T)!==-1||(A=A.toString().replace(RegExp(T,"g"),I))}),A}},{defaultOptions:se}=fO,{charts:jI,deg2rad:Yt,doc:aT,isFirefox:os,isMS:_e,isWebKit:nM,noop:ER,SVG_NS:WT,symbolSizes:bn,win:_T}=z,{addEvent:AI,attr:Ht,createElement:IM,crisp:ie,css:tM,defined:Xn,destroyObjectProperties:r_,extend:ZO,isArray:oe,isNumber:SI,isObject:Ct,isString:As,merge:eM,pick:Ae,pInt:P_,replaceNested:Bt,uniqueKey:NR}=tN;class lI{constructor(N,T,I,e,M,R,s){let i,l;this.x=0,this.y=0;const D=this.createElement("svg").attr({version:"1.1",class:"highcharts-root"}),P=D.element;s||D.css(this.getStyle(e||{})),N.appendChild(P),Ht(N,"dir","ltr"),N.innerHTML.indexOf("xmlns")===-1&&Ht(P,"xmlns",this.SVG_NS),this.box=P,this.boxWrapper=D,this.alignedObjects=[],this.url=this.getReferenceURL(),this.createElement("desc").add().element.appendChild(aT.createTextNode("Created with Highcharts 12.5.0")),this.defs=this.createElement("defs").add(),this.allowHTML=R,this.forExport=M,this.styledMode=s,this.gradients={},this.cache={},this.cacheKeys=[],this.imgCount=0,this.rootFontSize=D.getStyle("font-size"),this.setSize(T,I,!1),os&&N.getBoundingClientRect&&((i=function(){tM(N,{left:0,top:0}),l=N.getBoundingClientRect(),tM(N,{left:Math.ceil(l.left)-l.left+"px",top:Math.ceil(l.top)-l.top+"px"})})(),this.unSubPixelFix=AI(_T,"resize",i))}definition(N){return new NO([N]).addToDOM(this.defs.element)}getReferenceURL(){if((os||nM)&&aT.getElementsByTagName("base").length){if(!Xn(f)){let N=NR(),T=new NO([{tagName:"svg",attributes:{width:8,height:8},children:[{tagName:"defs",children:[{tagName:"clipPath",attributes:{id:N},children:[{tagName:"rect",attributes:{width:4,height:4}}]}]},{tagName:"rect",attributes:{id:"hitme",width:8,height:8,"clip-path":`url(#${N})`,fill:"rgba(0,0,0,0.001)"}}]}]).addToDOM(aT.body);tM(T,{position:"fixed",top:0,left:0,zIndex:9e5}),f=aT.elementFromPoint(6,6)?.id==="hitme",aT.body.removeChild(T)}if(f)return Bt(_T.location.href.split("#")[0],[/<[^>]*>/g,""],[/([\('\)])/g,"\\$1"],[/ /g,"%20"])}return""}getStyle(N){return this.style=ZO({fontFamily:'-apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol", sans-serif',fontSize:"1rem"},N),this.style}setStyle(N){this.boxWrapper.css(this.getStyle(N))}isHidden(){return!this.boxWrapper.getBBox().width}destroy(){let N=this.defs;return this.box=null,this.boxWrapper=this.boxWrapper.destroy(),r_(this.gradients||{}),this.gradients=null,this.defs=N.destroy(),this.unSubPixelFix&&this.unSubPixelFix(),this.alignedObjects=null,null}createElement(N){return new this.Element(this,N)}getRadialAttr(N,T){return{cx:N[0]-N[2]/2+(T.cx||0)*N[2],cy:N[1]-N[2]/2+(T.cy||0)*N[2],r:(T.r||0)*N[2]}}shadowDefinition(N){let T=[`highcharts-drop-shadow-${this.chartIndex}`,...Object.keys(N).map(e=>`${e}-${N[e]}`)].join("-").toLowerCase().replace(/[^a-z\d\-]/g,""),I=eM({color:"#000000",offsetX:1,offsetY:1,opacity:.15,width:5},N);return this.defs.element.querySelector(`#${T}`)||this.definition({tagName:"filter",attributes:{id:T,filterUnits:I.filterUnits},children:this.getShadowFilterContent(I)}),T}getShadowFilterContent(N){return[{tagName:"feDropShadow",attributes:{dx:N.offsetX,dy:N.offsetY,"flood-color":N.color,"flood-opacity":Math.min(5*N.opacity,1),stdDeviation:N.width/2}}]}buildText(N){new is(N).buildSVG()}getContrast(N){if(N==="transparent")return"#000000";let T=QN.parse(N).rgba,I=" clamp(0,calc(9e9*(0.5 - (0.2126*r + 0.7152*g + 0.0722*b))),1)";if(SI(T[0])||!QN.useColorMix){let e=T.map(R=>{let s=R/255;return s<=.04?s/12.92:Math.pow((s+.055)/1.055,2.4)}),M=.2126*e[0]+.7152*e[1]+.0722*e[2];return 1.05/(M+.05)>(M+.05)/.05?"#FFFFFF":"#000000"}return"color(from "+N+" srgb"+I+I+I+")"}button(N,T,I,e,M={},R,s,i,l,D){let P=this.label(N,T,I,l,void 0,void 0,D,void 0,"button"),c=this.styledMode,h=arguments,H=0;M=eM(se.global.buttonTheme,M),c&&(delete M.fill,delete M.stroke,delete M["stroke-width"]);let B=M.states||{},Y=M.style||{};delete M.states,delete M.style;let C=[NO.filterUserAttributes(M)],g=[Y];return c||["hover","select","disabled"].forEach((x,j)=>{C.push(eM(C[0],NO.filterUserAttributes(h[j+5]||B[x]||{}))),g.push(C[j+1].style),delete C[j+1].style}),AI(P.element,_e?"mouseover":"mouseenter",function(){H!==3&&P.setState(1)}),AI(P.element,_e?"mouseout":"mouseleave",function(){H!==3&&P.setState(H)}),P.setState=(x=0)=>{if(x!==1&&(P.state=H=x),P.removeClass(/highcharts-button-(normal|hover|pressed|disabled)/).addClass("highcharts-button-"+["normal","hover","pressed","disabled"][x]),!c){P.attr(C[x]);let j=g[x];Ct(j)&&P.css(j)}},P.attr(C[0]),!c&&(P.css(ZO({cursor:"default"},Y)),D&&P.text.css({pointerEvents:"none"})),P.on("touchstart",x=>x.stopPropagation()).on("click",function(x){H!==3&&e?.call(P,x)})}crispLine(N,T){let[I,e]=N;return Xn(I[1])&&I[1]===e[1]&&(I[1]=e[1]=ie(I[1],T)),Xn(I[2])&&I[2]===e[2]&&(I[2]=e[2]=ie(I[2],T)),N}path(N){let T=this.styledMode?{}:{fill:"none"};return oe(N)?T.d=N:Ct(N)&&ZO(T,N),this.createElement("path").attr(T)}circle(N,T,I){let e=Ct(N)?N:N===void 0?{}:{x:N,y:T,r:I},M=this.createElement("circle");return M.xSetter=M.ySetter=function(R,s,i){i.setAttribute("c"+s,R)},M.attr(e)}arc(N,T,I,e,M,R){let s;Ct(N)?(T=(s=N).y,I=s.r,e=s.innerR,M=s.start,R=s.end,N=s.x):s={innerR:e,start:M,end:R};let i=this.symbol("arc",N,T,I,I,s);return i.r=I,i}rect(N,T,I,e,M,R){let s=Ct(N)?N:N===void 0?{}:{x:N,y:T,r:M,width:Math.max(I||0,0),height:Math.max(e||0,0)},i=this.createElement("rect");return this.styledMode||(R!==void 0&&(s["stroke-width"]=R,ZO(s,i.crisp(s))),s.fill="none"),i.rSetter=function(l,D,P){i.r=l,Ht(P,{rx:l,ry:l})},i.rGetter=function(){return i.r||0},i.attr(s)}roundedRect(N){return this.symbol("roundedRect").attr(N)}setSize(N,T,I){this.width=N,this.height=T,this.boxWrapper.animate({width:N,height:T},{step:function(){this.attr({viewBox:"0 0 "+this.attr("width")+" "+this.attr("height")})},duration:Ae(I,!0)?void 0:0}),this.alignElements()}g(N){let T=this.createElement("g");return N?T.attr({class:"highcharts-"+N}):T}image(N,T,I,e,M,R){let s={preserveAspectRatio:"none"};SI(T)&&(s.x=T),SI(I)&&(s.y=I),SI(e)&&(s.width=e),SI(M)&&(s.height=M);let i=this.createElement("image").attr(s),l=function(D){i.attr({href:N}),R.call(i,D)};if(R){i.attr({href:"data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="});let D=new _T.Image;AI(D,"load",l),D.src=N,D.complete&&l({})}else i.attr({href:N});return i}symbol(N,T,I,e,M,R){let s,i,l,D,P=this,c=/^url\((.*?)\)$/,h=c.test(N),H=!h&&(this.symbols[N]?N:"circle"),B=H&&this.symbols[H];if(B)typeof T=="number"&&(i=B.call(this.symbols,T||0,I||0,e||0,M||0,R)),s=this.path(i),P.styledMode||s.attr("fill","none"),ZO(s,{symbolName:H||void 0,x:T,y:I,width:e,height:M}),R&&ZO(s,R);else if(h){l=N.match(c)[1];let Y=s=this.image(l);Y.imgwidth=Ae(R?.width,bn[l]?.width),Y.imgheight=Ae(R?.height,bn[l]?.height),D=C=>C.attr({width:C.width,height:C.height}),["width","height"].forEach(C=>{Y[`${C}Setter`]=function(g,x){this[x]=g;let{alignByTranslate:j,element:Z,width:W,height:J,imgwidth:$,imgheight:PE}=this,aE=x==="width"?$:PE,lE=1;R&&R.backgroundSize==="within"&&W&&J&&$&&PE?(lE=Math.min(W/$,J/PE),Ht(Z,{width:Math.round($*lE),height:Math.round(PE*lE)})):Z&&aE&&Z.setAttribute(x,aE),!j&&$&&PE&&this.translate(((W||0)-$*lE)/2,((J||0)-PE*lE)/2)}}),Xn(T)&&Y.attr({x:T,y:I}),Y.isImg=!0,Y.symbolUrl=N,Xn(Y.imgwidth)&&Xn(Y.imgheight)?D(Y):(Y.attr({width:0,height:0}),IM("img",{onload:function(){let C=jI[P.chartIndex];this.width===0&&(tM(this,{position:"absolute",top:"-999em"}),aT.body.appendChild(this)),bn[l]={width:this.width,height:this.height},Y.imgwidth=this.width,Y.imgheight=this.height,Y.element&&D(Y),this.parentNode&&this.parentNode.removeChild(this),P.imgCount--,P.imgCount||!C||C.hasLoaded||C.onload()},src:l}),this.imgCount++)}return s}clipRect(N,T,I,e){return this.rect(N,T,I,e,0)}text(N,T,I,e){let M={};if(e&&(this.allowHTML||!this.forExport))return this.html(N,T,I);M.x=Math.round(T||0),I&&(M.y=Math.round(I)),Xn(N)&&(M.text=N);let R=this.createElement("text").attr(M);return e&&(!this.forExport||this.allowHTML)||(R.xSetter=function(s,i,l){let D=l.getElementsByTagName("tspan"),P=l.getAttribute(i);for(let c=0,h;c<D.length;c++)(h=D[c]).getAttribute(i)===P&&h.setAttribute(i,s);l.setAttribute(i,s)}),R}fontMetrics(N){let T=SI(N)?N:P_(Pn.prototype.getStyle.call(N,"font-size")||0),I=T<24?T+3:Math.round(1.2*T),e=Math.round(.8*I);return{h:I,b:e,f:T}}rotCorr(N,T,I){let e=N;return T&&I&&(e=Math.max(e*Math.cos(T*Yt),4)),{x:-N/3*Math.sin(T*Yt),y:e}}pathToSegments(N){let T=[],I=[],e={A:8,C:7,H:2,L:3,M:3,Q:5,S:5,T:3,V:2};for(let M=0;M<N.length;M++)As(I[0])&&SI(N[M])&&I.length===e[I[0].toUpperCase()]&&N.splice(M,0,I[0].replace("M","L").replace("m","l")),typeof N[M]=="string"&&(I.length&&T.push(I.slice(0)),I.length=0),I.push(N[M]);return T.push(I.slice(0)),T}label(N,T,I,e,M,R,s,i,l){return new zI(this,N,T,I,e,M,R,s,i,l)}alignElements(){this.alignedObjects.forEach(N=>N.align())}}ZO(lI.prototype,{Element:Pn,SVG_NS:WT,escapes:{"&":"&amp;","<":"&lt;",">":"&gt;","'":"&#39;",'"':"&quot;"},symbols:Re,draw:ER}),Yn.registerRendererType("svg",lI,!0);let{composed:bt,isFirefox:Ss}=z,{attr:ZI,css:uT,createElement:OR,defined:TR,extend:rI,getAlignFactor:PI,isNumber:aI,pInt:nR,pushUnique:ls}=tN;function IR(A,N,T){let I=this.div?.style;Pn.prototype[`${N}Setter`].call(this,A,N,T),I&&(T.style[N]=I[N]=A)}let rs=(A,N)=>{if(!A.div){let T=ZI(A.element,"class"),I=A.css,e=OR("div",T?{className:T}:void 0,{position:"absolute",left:`${A.translateX||0}px`,top:`${A.translateY||0}px`,...A.styles,display:A.display,opacity:A.opacity,visibility:A.visibility},A.parentGroup?.div||N);A.classSetter=(M,R,s)=>{s.setAttribute("class",M),e.className=M},A.translateXSetter=A.translateYSetter=(M,R)=>{A[R]=M,e.style[R==="translateX"?"left":"top"]=`${M}px`,A.doTransform=!0},A.scaleXSetter=A.scaleYSetter=(M,R)=>{A[R]=M,A.doTransform=!0},A.opacitySetter=A.visibilitySetter=IR,A.css=M=>(I.call(A,M),M.cursor&&(e.style.cursor=M.cursor),M.pointerEvents&&(e.style.pointerEvents=M.pointerEvents),A),A.on=function(){return Pn.prototype.on.apply({element:e,onEvents:A.onEvents},arguments),A},A.div=e}return A.div};class DI extends Pn{static compose(N){ls(bt,this.compose)&&(N.prototype.html=function(T,I,e){return new DI(this,"span").attr({text:T,x:Math.round(I),y:Math.round(e)})})}constructor(N,T){super(N,T),DI.useForeignObject?this.foreignObject=N.createElement("foreignObject").attr({zIndex:2}):this.css({position:"absolute",...N.styledMode?{}:{fontFamily:N.style.fontFamily,fontSize:N.style.fontSize}}),this.element.style.whiteSpace="nowrap"}getSpanCorrection(N,T,I){this.xCorr=-N*I,this.yCorr=-T}css(N){let T,{element:I}=this,e=I.tagName==="SPAN"&&N&&"width"in N,M=e&&N.width;return e&&(delete N.width,this.textWidth=nR(M)||void 0,T=!0),N?.textOverflow==="ellipsis"&&(N.overflow="hidden",N.whiteSpace="nowrap"),N?.lineClamp&&(N.display="-webkit-box",N.WebkitLineClamp=N.lineClamp,N.WebkitBoxOrient="vertical",N.overflow="hidden"),aI(Number(N?.fontSize))&&(N.fontSize+="px"),rI(this.styles,N),uT(I,N),T&&this.updateTransform(),this}htmlGetBBox(){let{element:N}=this;return{x:N.offsetLeft,y:N.offsetTop,width:N.offsetWidth,height:N.offsetHeight}}updateTransform(){if(!this.added){this.alignOnAdd=!0;return}let{element:N,foreignObject:T,oldTextWidth:I,renderer:e,rotation:M,rotationOriginX:R,rotationOriginY:s,scaleX:i,scaleY:l,styles:{display:D="inline-block",whiteSpace:P},textAlign:c="left",textWidth:h,translateX:H=0,translateY:B=0,x:Y=0,y:C=0}=this,g=()=>this.textPxLength?this.textPxLength:(uT(N,{width:"",whiteSpace:P||"nowrap"}),N.offsetWidth);if(T||uT(N,{marginLeft:`${H}px`,marginTop:`${B}px`}),N.tagName==="SPAN"){let x,j=[M,c,N.innerHTML,h,this.textAlign].join(","),Z=-(this.parentGroup?.padding*1)||0;if(h!==I){let PE=g(),aE=h||0,lE=!e.styledMode&&N.style.textOverflow===""&&N.style.webkitLineClamp;(aE>I||PE>aE||lE)&&(/[\-\s\u00AD]/.test(N.textContent||N.innerText)||N.style.textOverflow==="ellipsis")&&(uT(N,{width:(M||i||PE>aE||lE)&&aI(h)?h+"px":"auto",display:D,whiteSpace:P||"normal"}),this.oldTextWidth=h)}T&&(uT(N,{display:"inline-block",verticalAlign:"top"}),T.attr({width:e.width,height:e.height})),j!==this.cTT&&(x=e.fontMetrics(N).b,TR(M)&&!T&&(M!==(this.oldRotation||0)||c!==this.oldAlign)&&uT(N,{transform:`rotate(${M}deg)`,transformOrigin:`${Z}% ${Z}px`}),this.getSpanCorrection(!TR(M)&&!this.textWidth&&this.textPxLength||N.offsetWidth,x,PI(c)));let{xCorr:W=0,yCorr:J=0}=this,$={left:`${Y+W}px`,top:`${C+J}px`,textAlign:c,transformOrigin:`${(R??Y)-W-Y-Z}px ${(s??C)-J-C-Z}px`};(i||l)&&($.transform=`scale(${i??1},${l??1})`),T?(super.updateTransform(),aI(Y)&&aI(C)?(T.attr({x:Y+W,y:C+J,width:N.offsetWidth+3,height:N.offsetHeight,"transform-origin":N.getAttribute("transform-origin")||"0 0"}),uT(N,{display:D,textAlign:c})):Ss&&T.attr({width:0,height:0})):uT(N,$),this.cTT=j,this.oldRotation=M,this.oldAlign=c}}add(N){let{foreignObject:T,renderer:I}=this,e=I.box.parentNode,M=[];if(T)T.add(N),super.add(I.createElement("body").attr({xmlns:"http://www.w3.org/1999/xhtml"}).css({background:"transparent",margin:"0 3px 0 0"}).add(T));else{let R;if(this.parentGroup=N,N&&!(R=N.div)){let s=N;for(;s;)M.push(s),s=s.parentGroup;for(let i of M.reverse())R=rs(i,e)}(R||e).appendChild(this.element)}return this.added=!0,this.alignOnAdd&&this.updateTransform(),this}textSetter(N){N!==this.textStr&&(delete this.bBox,delete this.oldTextWidth,NO.setElementHTML(this.element,N??""),this.textStr=N,this.doTransform=!0)}alignSetter(N){this.alignValue=this.textAlign=N,this.doTransform=!0}xSetter(N,T){this[T]=N,this.doTransform=!0}}let mn=DI.prototype;mn.visibilitySetter=mn.opacitySetter=IR,mn.ySetter=mn.rotationSetter=mn.rotationOriginXSetter=mn.rotationOriginYSetter=mn.xSetter,(_E=PN||(PN={})).xAxis={alignTicks:!0,allowDecimals:void 0,panningEnabled:!0,zIndex:2,zoomEnabled:!0,dateTimeLabelFormats:{millisecond:{main:"%[HMSL]",range:!1},second:{main:"%[HMS]",range:!1},minute:{main:"%[HM]",range:!1},hour:{main:"%[HM]",range:!1},day:{main:"%[eb]"},week:{main:"%[eb]"},month:{main:"%[bY]"},year:{main:"%Y"}},endOnTick:!1,gridLineDashStyle:"Solid",gridZIndex:1,labels:{autoRotationLimit:80,distance:15,enabled:!0,indentation:10,overflow:"justify",reserveSpace:void 0,rotation:void 0,staggerLines:0,step:0,useHTML:!1,zIndex:7,style:{color:"#333333",cursor:"default",fontSize:"0.8em",textOverflow:"ellipsis"}},maxPadding:.01,minorGridLineDashStyle:"Solid",minorTickLength:2,minorTickPosition:"outside",minorTicksPerMajor:5,minPadding:.01,offset:void 0,reversed:void 0,reversedStacks:!1,showEmpty:!0,showFirstLabel:!0,showLastLabel:!0,startOfWeek:1,startOnTick:!1,tickLength:10,tickmarkPlacement:"between",tickPixelInterval:100,tickPosition:"outside",title:{align:"middle",useHTML:!1,x:0,y:0,style:{color:"#666666",fontSize:"0.8em"}},visible:!0,minorGridLineColor:"#f2f2f2",minorGridLineWidth:1,minorTickColor:"#999999",lineColor:"#333333",lineWidth:1,gridLineColor:"#e6e6e6",gridLineWidth:void 0,tickColor:"#333333"},_E.yAxis={reversedStacks:!0,endOnTick:!0,maxPadding:.05,minPadding:.05,tickPixelInterval:72,showLastLabel:!0,labels:{x:void 0},startOnTick:!0,title:{},stackLabels:{animation:{},allowOverlap:!1,enabled:!1,crop:!0,overflow:"justify",formatter:function(){let{numberFormatter:A}=this.axis.chart;return A(this.total||0,-1)},style:{color:"#000000",fontSize:"0.7em",fontWeight:"bold",textOutline:"1px contrast"}},gridLineWidth:1,lineWidth:0};let tR=PN,{addEvent:QT,isFunction:Se,objectEach:JT,removeEvent:mt}=tN;($N||($N={})).registerEventOptions=function(A,N){A.eventOptions=A.eventOptions||{},JT(N.events,function(T,I){A.eventOptions[I]!==T&&(A.eventOptions[I]&&(mt(A,I,A.eventOptions[I]),delete A.eventOptions[I]),Se(T)&&(A.eventOptions[I]=T,QT(A,I,T,{order:0})))})};let ft=$N,{deg2rad:pt}=z,{clamp:Vt,correctFloat:LI,defined:qn,destroyObjectProperties:Ps,extend:XI,fireEvent:$T,getAlignFactor:a_,isNumber:iT,merge:MM,objectEach:Wn,pick:En}=tN,Qn=class{constructor(A,N,T,I,e){this.isNew=!0,this.isNewLabel=!0,this.axis=A,this.pos=N,this.type=T||"",this.parameters=e||{},this.tickmarkOffset=this.parameters.tickmarkOffset,this.options=this.parameters.options,$T(this,"init"),T||I||this.addLabel()}addLabel(){let A=this,N=A.axis,T=N.options,I=N.chart,e=N.categories,M=N.logarithmic,R=N.names,s=A.pos,i=En(A.options?.labels,T.labels),l=N.tickPositions,D=s===l[0],P=s===l[l.length-1],c=(!i.step||i.step===1)&&N.tickInterval===1,h=l.info,H=A.label,B,Y,C,g=this.parameters.category||(e?En(e[s],R[s],s):s);M&&iT(g)&&(g=LI(M.lin2log(g))),N.dateTime&&(h?B=(Y=I.time.resolveDTLFormat(T.dateTimeLabelFormats[!T.grid?.enabled&&h.higherRanks[s]||h.unitName])).main:iT(g)&&(B=N.dateTime.getXDateFormat(g,T.dateTimeLabelFormats||{}))),A.isFirst=D,A.isLast=P;let x={axis:N,chart:I,dateTimeLabelFormat:B,isFirst:D,isLast:P,pos:s,tick:A,tickPositionInfo:h,value:g};$T(this,"labelFormat",x);let j=J=>i.formatter?i.formatter.call(J,J):i.format?(J.text=N.defaultLabelFormatter.call(J),GT.format(i.format,J,I)):N.defaultLabelFormatter.call(J),Z=j.call(x,x),W=Y?.list;W?A.shortenLabel=function(){for(C=0;C<W.length;C++)if(XI(x,{dateTimeLabelFormat:W[C]}),H.attr({text:j.call(x,x)}),H.getBBox().width<N.getSlotWidth(A)-2*(i.padding||0))return;H.attr({text:""})}:A.shortenLabel=void 0,c&&N._addedPlotLB&&A.moveLabel(Z,i),qn(H)||A.movedLabel?H&&H.textStr!==Z&&!c&&(!H.textWidth||i.style.width||H.styles.width||H.css({width:null}),H.attr({text:Z}),H.textPxLength=H.getBBox().width):(A.label=H=A.createLabel(Z,i),A.rotation=0)}createLabel(A,N,T){let I=this.axis,{renderer:e,styledMode:M}=I.chart,R=N.style.whiteSpace,s=qn(A)&&N.enabled?e.text(A,T?.x,T?.y,N.useHTML).add(I.labelGroup):void 0;return s&&(M||s.css(MM(N.style)),s.textPxLength=s.getBBox().width,!M&&R&&s.css({whiteSpace:R})),s}destroy(){Ps(this,this.axis)}getPosition(A,N,T,I){let e=this.axis,M=e.chart,R=I&&M.oldChartHeight||M.chartHeight,s={x:A?LI(e.translate(N+T,void 0,void 0,I)+e.transB):e.left+e.offset+(e.opposite?(I&&M.oldChartWidth||M.chartWidth)-e.right-e.left:0),y:A?R-e.bottom+e.offset-(e.opposite?e.height:0):LI(R-e.translate(N+T,void 0,void 0,I)-e.transB)};return s.y=Vt(s.y,-1e9,1e9),$T(this,"afterGetPosition",{pos:s}),s}getLabelPosition(A,N,T,I,e,M,R,s){let i,l,D=this.axis,P=D.transA,c=D.isLinked&&D.linkedParent?D.linkedParent.reversed:D.reversed,h=D.staggerLines,H=D.tickRotCorr||{x:0,y:0},B=I||D.reserveSpaceDefault?0:-D.labelOffset*(D.labelAlign==="center"?.5:1),Y=e.distance,C={};return i=D.side===0?T.rotation?-Y:-T.getBBox().height:D.side===2?H.y+Y:Math.cos(T.rotation*pt)*(H.y-T.getBBox(!1,0).height/2),qn(e.y)&&(i=D.side===0&&D.horiz?e.y+i:e.y),A=A+En(e.x,[0,1,0,-1][D.side]*Y)+B+H.x-(M&&I?M*P*(c?-1:1):0),N=N+i-(M&&!I?M*P*(c?1:-1):0),h&&(l=R/(s||1)%h,D.opposite&&(l=h-l-1),N+=l*(D.labelOffset/h)),C.x=A,C.y=Math.round(N),$T(this,"afterGetLabelPosition",{pos:C,tickmarkOffset:M,index:R}),C}getLabelSize(){return this.label?this.label.getBBox()[this.axis.horiz?"height":"width"]:0}getMarkPath(A,N,T,I,e=!1,M){return M.crispLine([["M",A,N],["L",A+(e?0:-T),N+(e?T:0)]],I)}handleOverflow(A){let N=this.axis,T=N.options.labels,I=A.x,e=N.chart.chartWidth,M=N.chart.spacing,R=En(N.labelLeft,Math.min(N.pos,M[3])),s=En(N.labelRight,Math.max(N.isRadial?0:N.pos+N.len,e-M[1])),i=this.label,l=this.rotation,D=a_(N.labelAlign||i.attr("align")),P=i.getBBox().width,c=N.getSlotWidth(this),h=c,H=1,B;l||T.overflow!=="justify"?l<0&&I-D*P<R?B=Math.round(I/Math.cos(l*pt)-R):l>0&&I+D*P>s&&(B=Math.round((e-I)/Math.cos(l*pt))):(I-D*P<R?h=A.x+h*(1-D)-R:I+(1-D)*P>s&&(h=s-A.x+h*D,H=-1),(h=Math.min(c,h))<c&&N.labelAlign==="center"&&(A.x+=H*(c-h-D*(c-Math.min(P,h)))),(P>h||N.autoRotation&&i?.styles?.width)&&(B=h)),B&&i&&(this.shortenLabel?this.shortenLabel():i.css(XI({},{width:Math.floor(B)+"px",lineClamp:+!N.isRadial})))}moveLabel(A,N){let T=this,I=T.label,e=T.axis,M=!1,R;I&&I.textStr===A?(T.movedLabel=I,M=!0,delete T.label):Wn(e.ticks,function(s){M||s.isNew||s===T||!s.label||s.label.textStr!==A||(T.movedLabel=s.label,M=!0,s.labelPos=T.movedLabel.xy,delete s.label)}),!M&&(T.labelPos||I)&&(R=T.labelPos||I.xy,T.movedLabel=T.createLabel(A,N,R),T.movedLabel&&T.movedLabel.attr({opacity:0}))}render(A,N,T){let I=this.axis,e=I.horiz,M=this.pos,R=En(this.tickmarkOffset,I.tickmarkOffset),s=this.getPosition(e,M,R,N),i=s.x,l=s.y,D=I.pos,P=D+I.len,c=e?i:l,h=En(T,this.label?.newOpacity,1);!I.chart.polar&&(LI(c)<D||c>P)&&(T=0),T??(T=1),this.isActive=!0,this.renderGridLine(N,T),this.renderMark(s,T),this.renderLabel(s,N,h,A),this.isNew=!1,$T(this,"afterRender")}renderGridLine(A,N){let T=this.axis,I=T.options,e={},M=this.pos,R=this.type,s=En(this.tickmarkOffset,T.tickmarkOffset),i=T.chart.renderer,l=this.gridLine,D,P=I.gridLineWidth,c=I.gridLineColor,h=I.gridLineDashStyle;this.type==="minor"&&(P=I.minorGridLineWidth,c=I.minorGridLineColor,h=I.minorGridLineDashStyle),l||(T.chart.styledMode||(e.stroke=c,e["stroke-width"]=P||0,e.dashstyle=h),R||(e.zIndex=1),A&&(N=0),this.gridLine=l=i.path().attr(e).addClass("highcharts-"+(R?R+"-":"")+"grid-line").add(T.gridGroup)),l&&(D=T.getPlotLinePath({value:M+s,lineWidth:l.strokeWidth(),force:"pass",old:A,acrossPanes:!1}))&&l[A||this.isNew?"attr":"animate"]({d:D,opacity:N})}renderMark(A,N){let T=this.axis,I=T.options,e=T.chart.renderer,M=this.type,R=T.tickSize(M?M+"Tick":"tick"),s=A.x,i=A.y,l=En(I[M!=="minor"?"tickWidth":"minorTickWidth"],!M&&T.isXAxis?1:0),D=I[M!=="minor"?"tickColor":"minorTickColor"],P=this.mark,c=!P;R&&(T.opposite&&(R[0]=-R[0]),!P&&(this.mark=P=e.path().addClass("highcharts-"+(M?M+"-":"")+"tick").add(T.axisGroup),T.chart.styledMode||P.attr({stroke:D,"stroke-width":l})),P[c?"attr":"animate"]({d:this.getMarkPath(s,i,R[0],P.strokeWidth(),T.horiz,e),opacity:N}))}renderLabel(A,N,T,I){let e=this.axis,M=e.horiz,R=e.options,s=this.label,i=R.labels,l=i.step,D=En(this.tickmarkOffset,e.tickmarkOffset),P=A.x,c=A.y,h=!0;s&&iT(P)&&(s.xy=A=this.getLabelPosition(P,c,s,M,i,D,I,l),(!this.isFirst||this.isLast||R.showFirstLabel)&&(!this.isLast||this.isFirst||R.showLastLabel)?!M||i.step||i.rotation||N||T===0||this.handleOverflow(A):h=!1,l&&I%l&&(h=!1),h&&iT(A.y)?(A.opacity=T,s[this.isNewLabel?"attr":"animate"](A).show(!0),this.isNewLabel=!1):(s.hide(),this.isNewLabel=!0))}replaceMovedLabel(){let A=this.label,N=this.axis;A&&!this.isNew&&(A.animate({opacity:0},void 0,A.destroy),delete this.label),N.isDirty=!0,this.label=this.movedLabel,delete this.movedLabel}},{animObject:qI}=FO,{xAxis:RM,yAxis:as}=tR,{defaultOptions:le}=fO,{registerEventOptions:Ds}=ft,{deg2rad:yT}=z,{arrayMax:WI,arrayMin:QI,clamp:cI,correctFloat:IT,defined:hN,destroyObjectProperties:Nn,erase:On,error:UT,extend:DT,fireEvent:FN,getClosestDistance:eR,insertItem:sM,isArray:_M,isNumber:IN,isString:pO,merge:nO,normalizeTickInterval:gN,objectEach:Dn,pick:iN,relativeLength:gt,removeEvent:hI,splat:MR,syncTimeout:Ls}=tN,LT=(A,N)=>gN(N,void 0,void 0,iN(A.options.allowDecimals,N<.5||A.tickAmount!==void 0),!!A.tickAmount);DT(le,{xAxis:RM,yAxis:nO(RM,as)});class Tn{constructor(N,T,I){this.init(N,T,I)}init(N,T,I=this.coll){let e=I==="xAxis",M=this.isZAxis||(N.inverted?!e:e);this.chart=N,this.horiz=M,this.isXAxis=e,this.coll=I,FN(this,"init",{userOptions:T}),this.opposite=iN(T.opposite,this.opposite),this.side=iN(T.side,this.side,M?2*!this.opposite:this.opposite?1:3),this.setOptions(T);let R=this.options,s=R.labels;this.type??(this.type=R.type||"linear"),this.uniqueNames??(this.uniqueNames=R.uniqueNames??!0),FN(this,"afterSetType"),this.userOptions=T,this.minPixelPadding=0,this.reversed=iN(R.reversed,this.reversed),this.visible=R.visible,this.zoomEnabled=R.zoomEnabled,this.hasNames=this.type==="category"||R.categories===!0,this.categories=_M(R.categories)&&R.categories||(this.hasNames?[]:void 0),this.names||(this.names=[],this.names.keys={}),this.plotLinesAndBandsGroups={},this.positiveValuesOnly=!!this.logarithmic,this.isLinked=hN(R.linkedTo),this.ticks={},this.labelEdge=[],this.minorTicks={},this.plotLinesAndBands=[],this.alternateBands={},this.len??(this.len=0),this.minRange=this.userMinRange=R.minRange||R.maxZoom,this.range=R.range,this.offset=R.offset||0,this.max=void 0,this.min=void 0;let i=iN(R.crosshair,MR(N.options.tooltip.crosshairs)[+!e]);this.crosshair=i===!0?{}:i,N.axes.indexOf(this)===-1&&(e?N.axes.splice(N.xAxis.length,0,this):N.axes.push(this),sM(this,N[this.coll])),N.orderItems(this.coll),this.series=this.series||[],N.inverted&&!this.isZAxis&&e&&!hN(this.reversed)&&(this.reversed=!0),this.labelRotation=IN(s.rotation)?s.rotation:void 0,Ds(this,R),FN(this,"afterInit")}setOptions(N){let T=this.horiz?{labels:{autoRotation:[-45],padding:3},margin:15}:{labels:{padding:1},title:{rotation:90*this.side}};this.options=nO(T,this.coll==="yAxis"?{title:{text:this.chart.options.lang.yAxisTitle}}:{},le[this.coll],N),FN(this,"afterSetOptions",{userOptions:N})}defaultLabelFormatter(){let N=this.axis,{numberFormatter:T}=this.chart,I=IN(this.value)?this.value:NaN,e=N.chart.time,M=N.categories,R=this.dateTimeLabelFormat,s=le.lang,i=s.numericSymbols,l=s.numericSymbolMagnitude||1e3,D=N.logarithmic?Math.abs(I):N.tickInterval,P=i?.length,c,h;if(M)h=`${this.value}`;else if(R)h=e.dateFormat(R,I,!0);else if(P&&i&&D>=1e3)for(;P--&&h===void 0;)D>=(c=Math.pow(l,P+1))&&10*I%c==0&&i[P]!==null&&I!==0&&(h=T(I/c,-1)+i[P]);return h===void 0&&(h=Math.abs(I)>=1e4?T(I,-1):T(I,-1,void 0,"")),h}getSeriesExtremes(){let N,T=this;FN(this,"getSeriesExtremes",null,function(){T.hasVisibleSeries=!1,T.dataMin=T.dataMax=T.threshold=void 0,T.softThreshold=!T.isXAxis,T.series.forEach(I=>{if(I.reserveSpace()){let e=I.options,M,R=e.threshold,s,i;if(T.hasVisibleSeries=!0,T.positiveValuesOnly&&0>=(R||0)&&(R=void 0),T.isXAxis)(M=I.getColumn("x")).length&&(M=T.logarithmic?M.filter(l=>l>0):M,s=(N=I.getXExtremes(M)).min,i=N.max,IN(s)||s instanceof Date||(M=M.filter(IN),s=(N=I.getXExtremes(M)).min,i=N.max),M.length&&(T.dataMin=Math.min(iN(T.dataMin,s),s),T.dataMax=Math.max(iN(T.dataMax,i),i)));else{let l=I.applyExtremes();IN(l.dataMin)&&(s=l.dataMin,T.dataMin=Math.min(iN(T.dataMin,s),s)),IN(l.dataMax)&&(i=l.dataMax,T.dataMax=Math.max(iN(T.dataMax,i),i)),hN(R)&&(T.threshold=R),(!e.softThreshold||T.positiveValuesOnly)&&(T.softThreshold=!1)}}})}),FN(this,"afterGetSeriesExtremes")}translate(N,T,I,e,M,R){let s=this.linkedParent||this,i=e&&s.old?s.old.min:s.min;if(!IN(i))return NaN;let l=s.minPixelPadding,D=(s.isOrdinal||s.brokenAxis?.hasBreaks||s.logarithmic&&M)&&!!s.lin2val,P=1,c=0,h=e&&s.old?s.old.transA:s.transA,H=0;return h||(h=s.transA),I&&(P*=-1,c=s.len),s.reversed&&(P*=-1,c-=P*(s.sector||s.len)),T?(H=(N=N*P+c-l)/h+i,D&&(H=s.lin2val(H))):(D&&(N=s.val2lin(N)),H=P*(N-i)*h+c+P*l+(IN(R)?h*R:0),s.isRadial||(H=IT(H))),H}toPixels(N,T){return this.translate(this.chart?.time.parse(N)??NaN,!1,!this.horiz,void 0,!0)+(T?0:this.pos)}toValue(N,T){return this.translate(N-(T?0:this.pos),!0,!this.horiz,void 0,!0)}getPlotLinePath(N){let T=this,I=T.chart,e=T.left,M=T.top,R=N.old,s=N.value,i=N.lineWidth,l=R&&I.oldChartHeight||I.chartHeight,D=R&&I.oldChartWidth||I.chartWidth,P=T.transB,c=N.translatedValue,h=N.force,H,B,Y,C,g;function x(Z,W,J){return h!=="pass"&&(Z<W||Z>J)&&(h?Z=cI(Z,W,J):g=!0),Z}let j={value:s,lineWidth:i,old:R,force:h,acrossPanes:N.acrossPanes,translatedValue:c};return FN(this,"getPlotLinePath",j,function(Z){H=Y=(c=cI(c=iN(c,T.translate(s,void 0,void 0,R)),-1e9,1e9))+P,B=C=l-c-P,IN(c)?T.horiz?(B=M,C=l-T.bottom+(T.options.isInternal?0:I.scrollablePixelsY||0),H=Y=x(H,e,e+T.width)):(H=e,Y=D-T.right+(I.scrollablePixelsX||0),B=C=x(B,M,M+T.height)):(g=!0,h=!1),Z.path=g&&!h?void 0:I.renderer.crispLine([["M",H,B],["L",Y,C]],i||1)}),j.path}getLinearTickPositions(N,T,I){let e,M,R,s=IT(Math.floor(T/N)*N),i=IT(Math.ceil(I/N)*N),l=[];if(IT(s+N)===s&&(R=20),this.single)return[T];for(e=s;e<=i&&(l.push(e),(e=IT(e+N,R))!==M);)M=e;return l}getMinorTickInterval(){let{minorTicks:N,minorTickInterval:T}=this.options;return N===!0?iN(T,"auto"):N!==!1?T:void 0}getMinorTickPositions(){let N=this.options,T=this.tickPositions,I=this.minorTickInterval,e=this.pointRangePadding||0,M=(this.min||0)-e,R=(this.max||0)+e,s=this.brokenAxis?.hasBreaks?this.brokenAxis.unitLength:R-M,i=[],l;if(s&&s/I<this.len/3){let D=this.logarithmic;if(D)this.paddedTicks.forEach(function(P,c,h){c&&i.push.apply(i,D.getLogTickPositions(I,h[c-1],h[c],!0))});else if(this.dateTime&&this.getMinorTickInterval()==="auto")i=i.concat(this.getTimeTicks(this.dateTime.normalizeTimeTickInterval(I),M,R,N.startOfWeek));else for(l=M+(T[0]-M)%I;l<=R&&l!==i[0];l+=I)i.push(l)}return i.length!==0&&this.trimTicks(i),i}adjustForMinRange(){let N=this.options,T=this.logarithmic,I=this.chart.time,{max:e,min:M,minRange:R}=this,s,i,l,D;this.isXAxis&&R===void 0&&!T&&(R=hN(N.min)||hN(N.max)||hN(N.floor)||hN(N.ceiling)?null:Math.min(5*(eR(this.series.map(P=>{let c=P.getColumn("x");return P.xIncrement?c.slice(0,2):c}))||0),this.dataMax-this.dataMin)),IN(e)&&IN(M)&&IN(R)&&e-M<R&&(i=this.dataMax-this.dataMin>=R,s=(R-e+M)/2,l=[M-s,I.parse(N.min)??M-s],i&&(l[2]=T?T.log2lin(this.dataMin):this.dataMin),D=[(M=WI(l))+R,I.parse(N.max)??M+R],i&&(D[2]=T?T.log2lin(this.dataMax):this.dataMax),(e=QI(D))-M<R&&(l[0]=e-R,l[1]=I.parse(N.min)??e-R,M=WI(l))),this.minRange=R,this.min=M,this.max=e}getClosest(){let N,T;if(this.categories)T=1;else{let I=[];this.series.forEach(function(e){let M=e.closestPointRange,R=e.getColumn("x");R.length===1?I.push(R[0]):e.sorted&&hN(M)&&e.reserveSpace()&&(T=hN(T)?Math.min(T,M):M)}),I.length&&(I.sort((e,M)=>e-M),N=eR([I]))}return N&&T?Math.min(N,T):N||T}nameToX(N){let T=_M(this.options.categories),I=T?this.categories:this.names,e=N.options.x,M;return N.series.requireSorting=!1,hN(e)||(e=this.uniqueNames&&I?T?I.indexOf(N.name):iN(I.keys[N.name],-1):N.series.autoIncrement()),e===-1?!T&&I&&(M=I.length):IN(e)&&(M=e),M!==void 0?(this.names[M]=N.name,this.names.keys[N.name]=M):N.x&&(M=N.x),M}updateNames(){let N=this,T=this.names;T.length>0&&(Object.keys(T.keys).forEach(function(I){delete T.keys[I]}),T.length=0,this.minRange=this.userMinRange,(this.series||[]).forEach(I=>{I.xIncrement=null,(!I.points||I.isDirtyData)&&(N.max=Math.max(N.max||0,I.dataTable.rowCount-1),I.processData(),I.generatePoints());let e=I.getColumn("x").slice();I.data.forEach((M,R)=>{let s=e[R];M?.options&&M.name!==void 0&&(s=N.nameToX(M))!==void 0&&s!==M.x&&(e[R]=M.x=s)}),I.dataTable.setColumn("x",e)}))}setAxisTranslation(){let N=this,T=N.max-N.min,I=N.linkedParent,e=!!N.categories,M=N.isXAxis,R=N.axisPointRange||0,s,i=0,l=0,D,P=N.transA;(M||e||R)&&(s=N.getClosest(),I?(i=I.minPointOffset,l=I.pointRangePadding):N.series.forEach(function(c){let h=e?1:M?iN(c.options.pointRange,s,0):N.axisPointRange||0,H=c.options.pointPlacement;if(R=Math.max(R,h),!N.single||e){let B=c.is("xrange")?!M:M;i=Math.max(i,B&&pO(H)?0:h/2),l=Math.max(l,B&&H==="on"?0:h)}}),D=N.ordinal?.slope&&s?N.ordinal.slope/s:1,N.minPointOffset=i*=D,N.pointRangePadding=l*=D,N.pointRange=Math.min(R,N.single&&e?1:T),M&&(N.closestPointRange=s)),N.translationSlope=N.transA=P=N.staticScale||N.len/(T+l||1),N.transB=N.horiz?N.left:N.bottom,N.minPixelPadding=P*i,FN(this,"afterSetAxisTranslation")}minFromRange(){let{max:N,min:T}=this;return IN(N)&&IN(T)&&N-T||void 0}setTickInterval(N){let{categories:T,chart:I,dataMax:e,dataMin:M,dateTime:R,isXAxis:s,logarithmic:i,options:l,softThreshold:D}=this,P=I.time,c=IN(this.threshold)?this.threshold:void 0,h=this.minRange||0,{ceiling:H,floor:B,linkedTo:Y,softMax:C,softMin:g}=l,x=IN(Y)&&I[this.coll]?.[Y],j=l.tickPixelInterval,Z=l.maxPadding,W=l.minPadding,J=0,$,PE=IN(l.tickInterval)&&l.tickInterval>=0?l.tickInterval:void 0,aE,lE,mE,vE;if(R||T||x||this.getTickAmount(),mE=iN(this.userMin,P.parse(l.min)),vE=iN(this.userMax,P.parse(l.max)),x?(this.linkedParent=x,$=x.getExtremes(),this.min=iN($.min,$.dataMin),this.max=iN($.max,$.dataMax),this.type!==x.type&&UT(11,!0,I)):(D&&hN(c)&&IN(e)&&IN(M)&&(M>=c?(aE=c,W=0):e<=c&&(lE=c,Z=0)),this.min=iN(mE,aE,M),this.max=iN(vE,lE,e)),IN(this.max)&&IN(this.min)&&(i&&(this.positiveValuesOnly&&!N&&0>=Math.min(this.min,iN(M,this.min))&&UT(10,!0,I),this.min=IT(i.log2lin(this.min),16),this.max=IT(i.log2lin(this.max),16)),this.range&&IN(M)&&(this.userMin=this.min=mE=Math.max(M,this.minFromRange()||0),this.userMax=vE=this.max,this.range=void 0)),FN(this,"foundExtremes"),this.adjustForMinRange(),IN(this.min)&&IN(this.max)){if(!IN(this.userMin)&&IN(g)&&g<this.min&&(this.min=mE=g),!IN(this.userMax)&&IN(C)&&C>this.max&&(this.max=vE=C),T||this.axisPointRange||this.stacking?.usePercentage||x||(J=this.max-this.min)&&(!hN(mE)&&W&&(this.min-=J*W),!hN(vE)&&Z&&(this.max+=J*Z)),!IN(this.userMin)&&IN(B)&&(this.min=Math.max(this.min,B)),!IN(this.userMax)&&IN(H)&&(this.max=Math.min(this.max,H)),D&&IN(M)&&IN(e)){let NN=c||0;!hN(mE)&&this.min<NN&&M>=NN?this.min=l.minRange?Math.min(NN,this.max-h):NN:!hN(vE)&&this.max>NN&&e<=NN&&(this.max=l.minRange?Math.max(NN,this.min+h):NN)}!I.polar&&this.min>this.max&&(hN(l.min)?this.max=this.min:hN(l.max)&&(this.min=this.max)),J=this.max-this.min}if(this.min!==this.max&&IN(this.min)&&IN(this.max)?x&&!PE&&j===x.options.tickPixelInterval?this.tickInterval=PE=x.tickInterval:this.tickInterval=iN(PE,this.tickAmount?J/Math.max(this.tickAmount-1,1):void 0,T?1:J*j/Math.max(this.len,j)):this.tickInterval=1,s&&!N){let NN=this.min!==this.old?.min||this.max!==this.old?.max;this.series.forEach(function(JE){JE.forceCrop=JE.forceCropping?.(),JE.processData(NN)}),FN(this,"postProcessData",{hasExtremesChanged:NN})}this.setAxisTranslation(),FN(this,"initialAxisTranslation"),this.pointRange&&!PE&&(this.tickInterval=Math.max(this.pointRange,this.tickInterval));let XE=iN(l.minTickInterval,R&&!this.series.some(NN=>!NN.sorted)?this.closestPointRange:0);!PE&&XE&&this.tickInterval<XE&&(this.tickInterval=XE),R||i||PE||(this.tickInterval=LT(this,this.tickInterval)),this.tickAmount||(this.tickInterval=this.unsquish()),this.setTickPositions()}setTickPositions(){let N=this.options,T=N.tickPositions,I=N.tickPositioner,e=this.getMinorTickInterval(),M=!this.isPanning,R=M&&N.startOnTick,s=M&&N.endOnTick,i=[],l;if(this.tickmarkOffset=this.categories&&N.tickmarkPlacement==="between"&&this.tickInterval===1?.5:0,this.single=this.min===this.max&&hN(this.min)&&!this.tickAmount&&(this.min%1==0||N.allowDecimals!==!1),T)i=T.slice();else if(IN(this.min)&&IN(this.max)){if(!this.ordinal?.positions&&(this.max-this.min)/this.tickInterval>Math.max(2*this.len,200))i=[this.min,this.max],UT(19,!1,this.chart);else if(this.dateTime)i=this.getTimeTicks(this.dateTime.normalizeTimeTickInterval(this.tickInterval,N.units),this.min,this.max,N.startOfWeek,this.ordinal?.positions,this.closestPointRange,!0);else if(this.logarithmic)i=this.logarithmic.getLogTickPositions(this.tickInterval,this.min,this.max);else{let D=this.tickInterval,P=D;for(;P<=2*D&&(i=this.getLinearTickPositions(this.tickInterval,this.min,this.max),this.tickAmount&&i.length>this.tickAmount);)this.tickInterval=LT(this,P*=1.1)}i.length>this.len&&(i=[i[0],i[i.length-1]])[0]===i[1]&&(i.length=1),I&&(this.tickPositions=i,(l=I.apply(this,[this.min,this.max]))&&(i=l))}this.tickPositions=i,this.minorTickInterval=e==="auto"&&this.tickInterval?this.tickInterval/N.minorTicksPerMajor:e,this.paddedTicks=i.slice(0),this.trimTicks(i,R,s),!this.isLinked&&IN(this.min)&&IN(this.max)&&(this.single&&i.length<2&&!this.categories&&!this.series.some(D=>D.is("heatmap")&&D.options.pointPlacement==="between")&&(this.min-=.5,this.max+=.5),T||l||this.adjustTickAmount()),FN(this,"afterSetTickPositions")}trimTicks(N,T,I){let e=N[0],M=N[N.length-1],R=!this.isOrdinal&&this.minPointOffset||0;if(FN(this,"trimTicks"),!this.isLinked||!this.grid){if(T&&e!==-1/0)this.min=e;else for(;this.min-R>N[0];)N.shift();if(I)this.max=M;else for(;this.max+R<N[N.length-1];)N.pop();N.length===0&&hN(e)&&!this.options.tickPositions&&N.push((M+e)/2)}}alignToOthers(){let N,T=this,I=T.chart,e=[this],M=T.options,R=I.options.chart,s=this.coll==="yAxis"&&R.alignThresholds,i=[];if(T.thresholdAlignment=void 0,(R.alignTicks!==!1&&M.alignTicks||s)&&M.startOnTick!==!1&&M.endOnTick!==!1&&!T.logarithmic){let l=P=>{let{horiz:c,options:h}=P;return[c?h.left:h.top,h.width,h.height,h.pane].join(",")},D=l(this);I[this.coll].forEach(function(P){let{series:c}=P;c.length&&c.some(h=>h.visible)&&P!==T&&l(P)===D&&(N=!0,e.push(P))})}if(N&&s){e.forEach(D=>{let P=D.getThresholdAlignment(T);IN(P)&&i.push(P)});let l=i.length>1?i.reduce((D,P)=>D+=P,0)/i.length:void 0;e.forEach(D=>{D.thresholdAlignment=l})}return N}getThresholdAlignment(N){if((!IN(this.dataMin)||this!==N&&this.series.some(T=>T.isDirty||T.isDirtyData||T.xAxis?.isDirty))&&this.getSeriesExtremes(),IN(this.threshold)){let T=cI((this.threshold-(this.dataMin||0))/((this.dataMax||0)-(this.dataMin||0)),0,1);return this.options.reversed&&(T=1-T),T}}getTickAmount(){let N=this.options,T=N.tickPixelInterval,I=N.tickAmount;hN(N.tickInterval)||I||!(this.len<T)||this.isRadial||this.logarithmic||!N.startOnTick||!N.endOnTick||(I=2),!I&&this.alignToOthers()&&(I=Math.ceil(this.len/T)+1),I<4&&(this.finalTickAmt=I,I=5),this.tickAmount=I}adjustTickAmount(){let N=this,{finalTickAmt:T,max:I,min:e,options:M,tickPositions:R,tickAmount:s,thresholdAlignment:i}=N,l=R?.length,D=iN(N.threshold,N.softThreshold?0:null),P,c,h=N.tickInterval,H,B=()=>R.push(IT(R[R.length-1]+h)),Y=()=>R.unshift(IT(R[0]-h));if(IN(i)&&(H=i===0?0:i===1?s-1:Math.round(cI(i*(s-1),1,s-2)),M.reversed&&(H=s-1-H)),N.hasData()&&IN(e)&&IN(I)){let C=()=>{N.transA*=(l-1)/(s-1),N.min=M.startOnTick?R[0]:Math.min(e,R[0]),N.max=M.endOnTick?R[R.length-1]:Math.max(I,R[R.length-1])};if(IN(H)&&IN(N.threshold)){for(;R[H]!==D||R.length!==s||R[0]>e||R[R.length-1]<I;){for(R.length=0,R.push(N.threshold);R.length<s;)R[H]===void 0||R[H]>N.threshold?Y():B();if(h>8*N.tickInterval)break;h*=2}C()}else if(l<s){for(;R.length<s;)R.length%2||e===D?B():Y();C()}if(hN(T)){for(c=P=R.length;c--;)(T===3&&c%2==1||T<=2&&c>0&&c<P-1)&&R.splice(c,1);N.finalTickAmt=void 0}}}setScale(){let{coll:N,stacking:T}=this,I=!1,e=!1;this.series.forEach(R=>{I=I||R.isDirtyData||R.isDirty,e=e||R.xAxis?.isDirty||!1}),this.setAxisSize();let M=this.len!==this.old?.len;M||I||e||this.isLinked||this.forceRedraw||this.userMin!==this.old?.userMin||this.userMax!==this.old?.userMax||this.alignToOthers()?(T&&N==="yAxis"&&T.buildStacks(),this.forceRedraw=!1,this.userMinRange||(this.minRange=void 0),this.getSeriesExtremes(),this.setTickInterval(),T&&N==="xAxis"&&T.buildStacks(),this.isDirty||(this.isDirty=M||this.min!==this.old?.min||this.max!==this.old?.max)):T&&T.cleanStacks(),I&&delete this.allExtremes,FN(this,"afterSetScale")}setExtremes(N,T,I=!0,e,M){let R=this.chart;this.series.forEach(s=>{delete s.kdTree}),N=R.time.parse(N),T=R.time.parse(T),FN(this,"setExtremes",M=DT(M,{min:N,max:T}),s=>{this.userMin=s.min,this.userMax=s.max,this.eventArgs=s,I&&R.redraw(e)})}setAxisSize(){let N=this.chart,T=this.options,I=T.offsets||[0,0,0,0],e=this.horiz,M=this.width=Math.round(gt(iN(T.width,N.plotWidth-I[3]+I[1]),N.plotWidth)),R=this.height=Math.round(gt(iN(T.height,N.plotHeight-I[0]+I[2]),N.plotHeight)),s=this.top=Math.round(gt(iN(T.top,N.plotTop+I[0]),N.plotHeight,N.plotTop)),i=this.left=Math.round(gt(iN(T.left,N.plotLeft+I[3]),N.plotWidth,N.plotLeft));this.bottom=N.chartHeight-R-s,this.right=N.chartWidth-M-i,this.len=Math.max(e?M:R,0),this.pos=e?i:s}getExtremes(){let N=this.logarithmic;return{min:N?IT(N.lin2log(this.min)):this.min,max:N?IT(N.lin2log(this.max)):this.max,dataMin:this.dataMin,dataMax:this.dataMax,userMin:this.userMin,userMax:this.userMax}}getThreshold(N){let T=this.logarithmic,I=T?T.lin2log(this.min):this.min,e=T?T.lin2log(this.max):this.max;return N===null||N===-1/0?N=I:N===1/0?N=e:I>N?N=I:e<N&&(N=e),this.translate(N,0,1,0,1)}autoLabelAlign(N){let T=((N-90*this.side)%360+360)%360,I={align:"center"};return FN(this,"autoLabelAlign",I,function(e){T>15&&T<165?e.align="right":T>195&&T<345&&(e.align="left")}),I.align}tickSize(N){let T=this.options,I=iN(T[N==="tick"?"tickWidth":"minorTickWidth"],N==="tick"&&this.isXAxis&&!this.categories?1:0),e=T[N==="tick"?"tickLength":"minorTickLength"],M;I&&e&&(T[N+"Position"]==="inside"&&(e=-e),M=[e,I]);let R={tickSize:M};return FN(this,"afterTickSize",R),R.tickSize}labelMetrics(){let N=this.chart.renderer,T=this.ticks,I=T[Object.keys(T)[0]]||{};return this.chart.renderer.fontMetrics(I.label||I.movedLabel||N.box)}unsquish(){let N=this.options.labels,T=N.padding||0,I=this.horiz,e=this.tickInterval,M=this.len/((+!!this.categories+this.max-this.min)/e),R=N.rotation,s=IT(.8*this.labelMetrics().h),i=Math.max(this.max-this.min,0),l=function(H){let B=(H+2*T)/(M||1);return(B=B>1?Math.ceil(B):1)*e>i&&H!==1/0&&M!==1/0&&i&&(B=Math.ceil(i/e)),IT(B*e)},D=e,P,c=Number.MAX_VALUE,h;if(I){if(!N.staggerLines&&(IN(R)?h=[R]:M<N.autoRotationLimit&&(h=N.autoRotation)),h){let H,B;for(let Y of h)(Y===R||Y&&Y>=-90&&Y<=90)&&(B=(H=l(Math.abs(s/Math.sin(yT*Y))))+Math.abs(Y/360))<c&&(c=B,P=Y,D=H)}}else D=l(.75*s);return this.autoRotation=h,this.labelRotation=iN(P,IN(R)?R:0),N.step?e:D}getSlotWidth(N){let T=this.chart,I=this.horiz,e=this.options.labels,M=Math.max(this.tickPositions.length-!this.categories,1),R=T.margin[3];if(N&&IN(N.slotWidth))return N.slotWidth;if(I&&e.step<2&&!this.isRadial)return e.rotation?0:(this.staggerLines||1)*this.len/M;if(!I){let s=e.style.width;if(s!==void 0)return parseInt(String(s),10);if(!this.opposite&&R)return R-T.spacing[3]}return .33*T.chartWidth}renderUnsquish(){let N=this.chart,T=N.renderer,I=this.tickPositions,e=this.ticks,M=this.options.labels,R=M.style,s=this.horiz,i=this.getSlotWidth(),l=Math.max(1,Math.round(i-(s?2*(M.padding||0):M.distance||0))),D={},P=this.labelMetrics(),c=R.lineClamp,h,H=c??(Math.floor(this.len/(I.length*P.h))||1),B=0;pO(M.rotation)||(D.rotation=M.rotation||0),I.forEach(function(Y){let C=e[Y];C.movedLabel&&C.replaceMovedLabel();let g=C.label?.textPxLength||0;g>B&&(B=g)}),this.maxLabelLength=B,this.autoRotation?B>l&&B>P.h?D.rotation=this.labelRotation:this.labelRotation=0:i&&(h=l),D.rotation&&(h=B>.5*N.chartHeight?.33*N.chartHeight:B,c||(H=1)),this.labelAlign=M.align||this.autoLabelAlign(this.labelRotation||0),this.labelAlign&&(D.align=this.labelAlign),I.forEach(function(Y){let C=e[Y],g=C?.label,x=R.width,j={};g&&(g.attr(D),C.shortenLabel?C.shortenLabel():h&&!x&&R.whiteSpace!=="nowrap"&&(h<(g.textPxLength||0)||g.element.tagName==="SPAN")?g.css(DT(j,{width:`${h}px`,lineClamp:H})):!g.styles.width||j.width||x||g.css({width:"auto"}),C.rotation=D.rotation)},this),this.tickRotCorr=T.rotCorr(P.b,this.labelRotation||0,this.side!==0)}hasData(){return this.series.some(function(N){return N.hasData()})||this.options.showEmpty&&hN(this.min)&&hN(this.max)}addTitle(N){let T,I=this.chart.renderer,e=this.horiz,M=this.opposite,R=this.options.title,s=this.chart.styledMode;this.axisTitle||((T=R.textAlign)||(T=(e?{low:"left",middle:"center",high:"right"}:{low:M?"right":"left",middle:"center",high:M?"left":"right"})[R.align]),this.axisTitle=I.text(R.text||"",0,0,R.useHTML).attr({zIndex:7,rotation:R.rotation||0,align:T}).addClass("highcharts-axis-title"),s||this.axisTitle.css(nO(R.style)),this.axisTitle.add(this.axisGroup),this.axisTitle.isNew=!0),s||R.style.width||this.isRadial||this.axisTitle.css({width:this.len+"px"}),this.axisTitle[N?"show":"hide"](N)}generateTick(N){let T=this.ticks;T[N]?T[N].addLabel():T[N]=new Qn(this,N)}createGroups(){let{axisParent:N,chart:T,coll:I,options:e}=this,M=T.renderer,R=(s,i,l)=>M.g(s).attr({zIndex:l}).addClass(`highcharts-${I.toLowerCase()}${i} `+(this.isRadial?`highcharts-radial-axis${i} `:"")+(e.className||"")).add(N);this.axisGroup||(this.gridGroup=R("grid","-grid",e.gridZIndex),this.axisGroup=R("axis","",e.zIndex),this.labelGroup=R("axis-labels","-labels",e.labels.zIndex))}getOffset(){let N=this,{chart:T,horiz:I,options:e,side:M,ticks:R,tickPositions:s,coll:i}=N,l=T.inverted&&!N.isZAxis?[1,0,3,2][M]:M,D=N.hasData(),P=e.title,c=e.labels,h=IN(e.crossing),H=T.axisOffset,B=T.clipOffset,Y=[-1,1,1,-1][M],C,g=0,x,j=0,Z=0,W,J;if(N.showAxis=C=D||e.showEmpty,N.staggerLines=N.horiz&&c.staggerLines||void 0,N.createGroups(),D||N.isLinked?(s.forEach(function($){N.generateTick($)}),N.renderUnsquish(),N.reserveSpaceDefault=M===0||M===2||{1:"left",3:"right"}[M]===N.labelAlign,iN(c.reserveSpace,!h&&null,N.labelAlign==="center"||null,N.reserveSpaceDefault)&&s.forEach(function($){Z=Math.max(R[$].getLabelSize(),Z)}),N.staggerLines&&(Z*=N.staggerLines),N.labelOffset=Z*(N.opposite?-1:1)):Dn(R,function($,PE){$.destroy(),delete R[PE]}),P?.text&&P.enabled!==!1&&(N.addTitle(C),C&&!h&&P.reserveSpace!==!1&&(N.titleOffset=g=N.axisTitle.getBBox()[I?"height":"width"],j=hN(x=P.offset)?0:iN(P.margin,I?5:10))),N.renderLine(),N.offset=Y*iN(e.offset,H[M]?H[M]+(e.margin||0):0),N.tickRotCorr=N.tickRotCorr||{x:0,y:0},J=M===0?-N.labelMetrics().h:M===2?N.tickRotCorr.y:0,W=Math.abs(Z)+j,Z&&(W-=J,W+=Y*(I?iN(c.y,N.tickRotCorr.y+Y*c.distance):iN(c.x,Y*c.distance))),N.axisTitleMargin=iN(x,W),N.getMaxLabelDimensions&&(N.maxLabelDimensions=N.getMaxLabelDimensions(R,s)),i!=="colorAxis"&&B){let $=this.tickSize("tick");H[M]=Math.max(H[M],(N.axisTitleMargin||0)+g+Y*N.offset,W,s?.length&&$?$[0]+Y*N.offset:0);let PE=!N.axisLine||e.offset?0:N.axisLine.strokeWidth()/2;B[l]=Math.max(B[l],PE)}FN(this,"afterGetOffset")}getLinePath(N){let T=this.chart,I=this.opposite,e=this.offset,M=this.horiz,R=this.left+(I?this.width:0)+e,s=T.chartHeight-this.bottom-(I?this.height:0)+e;return I&&(N*=-1),T.renderer.crispLine([["M",M?this.left:R,M?s:this.top],["L",M?T.chartWidth-this.right:R,M?s:T.chartHeight-this.bottom]],N)}renderLine(){!this.axisLine&&(this.axisLine=this.chart.renderer.path().addClass("highcharts-axis-line").add(this.axisGroup),this.chart.styledMode||this.axisLine.attr({stroke:this.options.lineColor,"stroke-width":this.options.lineWidth,zIndex:7}))}getTitlePosition(N){let T=this.horiz,I=this.left,e=this.top,M=this.len,R=this.options.title,s=T?I:e,i=this.opposite,l=this.offset,D=R.x,P=R.y,c=this.chart.renderer.fontMetrics(N),h=N?Math.max(N.getBBox(!1,0).height-c.h-1,0):0,H={low:s+(T?0:M),middle:s+M/2,high:s+(T?M:0)}[R.align],B=(T?e+this.height:I)+(T?1:-1)*(i?-1:1)*(this.axisTitleMargin||0)+[-h,h,c.f,-h][this.side],Y={x:T?H+D:B+(i?this.width:0)+l+D,y:T?B+P-(i?this.height:0)+l:H+P};return FN(this,"afterGetTitlePosition",{titlePosition:Y}),Y}renderMinorTick(N,T){let I=this.minorTicks;I[N]||(I[N]=new Qn(this,N,"minor")),T&&I[N].isNew&&I[N].render(null,!0),I[N].render(null,!1,1)}renderTick(N,T,I){let e=this.isLinked,M=this.ticks;(!e||N>=this.min&&N<=this.max||this.grid?.isColumn)&&(M[N]||(M[N]=new Qn(this,N)),I&&M[N].isNew&&M[N].render(T,!0,-1),M[N].render(T))}render(){let N,T,I=this,e=I.chart,M=I.logarithmic,R=e.renderer,s=I.options,i=I.isLinked,l=I.tickPositions,D=I.axisTitle,P=I.ticks,c=I.minorTicks,h=I.alternateBands,H=s.stackLabels,B=s.alternateGridColor,Y=s.crossing,C=I.tickmarkOffset,g=I.axisLine,x=I.showAxis,j=qI(R.globalAnimation);if(I.labelEdge.length=0,I.overlap=!1,[P,c,h].forEach(function(Z){Dn(Z,function(W){W.isActive=!1})}),IN(Y)){let Z=this.isXAxis?e.yAxis[0]:e.xAxis[0],W=[1,-1,-1,1][this.side];if(Z){let J=Z.toPixels(Y,!0);I.horiz&&(J=Z.len-J),I.offset=W*J}}if(I.hasData()||i){let Z=I.chart.hasRendered&&I.old&&IN(I.old.min);I.minorTickInterval&&!I.categories&&I.getMinorTickPositions().forEach(function(W){I.renderMinorTick(W,Z)}),l.length&&(l.forEach(function(W,J){I.renderTick(W,J,Z)}),C&&(I.min===0||I.single)&&(P[-1]||(P[-1]=new Qn(I,-1,null,!0)),P[-1].render(-1))),B&&l.forEach(function(W,J){T=l[J+1]!==void 0?l[J+1]+C:I.max-C,J%2==0&&W<I.max&&T<=I.max+(e.polar?-C:C)&&(h[W]||(h[W]=new z.PlotLineOrBand(I,{})),N=W+C,h[W].options={from:M?M.lin2log(N):N,to:M?M.lin2log(T):T,color:B,className:"highcharts-alternate-grid"},h[W].render(),h[W].isActive=!0)}),I._addedPlotLB||(I._addedPlotLB=!0,(s.plotLines||[]).concat(s.plotBands||[]).forEach(function(W){I.addPlotBandOrLine(W)}))}[P,c,h].forEach(function(Z){let W=[],J=j.duration;Dn(Z,function($,PE){$.isActive||($.render(PE,!1,0),$.isActive=!1,W.push(PE))}),Ls(function(){let $=W.length;for(;$--;)Z[W[$]]&&!Z[W[$]].isActive&&(Z[W[$]].destroy(),delete Z[W[$]])},Z!==h&&e.hasRendered&&J?J:0)}),g&&(g[g.isPlaced?"animate":"attr"]({d:this.getLinePath(g.strokeWidth())}),g.isPlaced=!0,g[x?"show":"hide"](x)),D&&x&&(D[D.isNew?"attr":"animate"](I.getTitlePosition(D)),D.isNew=!1),H?.enabled&&I.stacking&&I.stacking.renderStackTotals(),I.old={len:I.len,max:I.max,min:I.min,transA:I.transA,userMax:I.userMax,userMin:I.userMin},I.isDirty=!1,FN(this,"afterRender")}redraw(){this.visible&&(this.render(),this.plotLinesAndBands.forEach(function(N){N.render()})),this.series.forEach(function(N){N.isDirty=!0})}getKeepProps(){return this.keepProps||Tn.keepProps}destroy(N){let T=this,I=T.plotLinesAndBands,e=this.eventOptions;if(FN(this,"destroy",{keepEvents:N}),N||hI(T),[T.ticks,T.minorTicks,T.alternateBands].forEach(function(M){Nn(M)}),I){let M=I.length;for(;M--;)I[M].destroy()}for(let M in["axisLine","axisTitle","axisGroup","gridGroup","labelGroup","cross","scrollbar"].forEach(function(R){T[R]&&(T[R]=T[R].destroy())}),T.plotLinesAndBandsGroups)T.plotLinesAndBandsGroups[M]=T.plotLinesAndBandsGroups[M].destroy();Dn(T,function(M,R){T.getKeepProps().indexOf(R)===-1&&delete T[R]}),this.eventOptions=e}drawCrosshair(N,T){let I=this.crosshair,e=I?.snap??!0,M=this.chart,R,s,i,l=this.cross,D;if(FN(this,"drawCrosshair",{e:N,point:T}),N||(N=this.cross?.e),I&&(hN(T)||!e)!==!1){if(e?hN(T)&&(s=iN(this.coll!=="colorAxis"?T.crosshairPos:null,this.isXAxis?T.plotX:this.len-T.plotY)):s=N&&(this.horiz?N.chartX-this.pos:this.len-N.chartY+this.pos),hN(s)&&(D={value:T&&(this.isXAxis?T.x:iN(T.stackY,T.y)),translatedValue:s},M.polar&&DT(D,{isCrosshair:!0,chartX:N?.chartX,chartY:N?.chartY,point:T}),R=this.getPlotLinePath(D)||null),!hN(R))return void this.hideCrosshair();i=this.categories&&!this.isRadial,l||(this.cross=l=M.renderer.path().addClass("highcharts-crosshair highcharts-crosshair-"+(i?"category ":"thin ")+(I.className||"")).attr({zIndex:iN(I.zIndex,2)}).add(),!M.styledMode&&(l.attr({stroke:I.color||(i?QN.parse("#ccd3ff").setOpacity(.25).get():"#cccccc"),"stroke-width":iN(I.width,1)}).css({"pointer-events":"none"}),I.dashStyle&&l.attr({dashstyle:I.dashStyle}))),l.show().attr({d:R}),i&&!I.width&&l.attr({"stroke-width":this.transA}),this.cross.e=N}else this.hideCrosshair();FN(this,"afterDrawCrosshair",{e:N,point:T})}hideCrosshair(){this.cross&&this.cross.hide(),FN(this,"afterHideCrosshair")}update(N,T){let I=this.chart;N=nO(this.userOptions,N),this.destroy(!0),this.init(I,N),I.isDirtyBox=!0,iN(T,!0)&&I.redraw()}remove(N){let T=this.chart,I=this.coll,e=this.series,M=e.length;for(;M--;)e[M]&&e[M].remove(!1);On(T.axes,this),On(T[I]||[],this),T.orderItems(I),this.destroy(),T.isDirtyBox=!0,iN(N,!0)&&T.redraw()}setTitle(N,T){this.update({title:N},T)}setCategories(N,T){this.update({categories:N},T)}}Tn.keepProps=["coll","extKey","hcEvents","len","names","series","userMax","userMin"];let{addEvent:RR,getMagnitude:re,normalizeTickInterval:sR,timeUnits:Ln}=tN;(function(A){function N(){return this.chart.time.getTimeTicks.apply(this.chart.time,arguments)}function T(){if(this.type!=="datetime"){this.dateTime=void 0;return}this.dateTime||(this.dateTime=new I(this))}A.compose=function(e){return e.keepProps.includes("dateTime")||(e.keepProps.push("dateTime"),e.prototype.getTimeTicks=N,RR(e,"afterSetType",T)),e};class I{constructor(M){this.axis=M}normalizeTimeTickInterval(M,R){let s=R||[["millisecond",[1,2,5,10,20,25,50,100,200,500]],["second",[1,2,5,10,15,30]],["minute",[1,2,5,10,15,30]],["hour",[1,2,3,4,6,8,12]],["day",[1,2]],["week",[1,2]],["month",[1,2,3,4,6]],["year",null]],i=s[s.length-1],l=Ln[i[0]],D=i[1],P;for(P=0;P<s.length&&(l=Ln[(i=s[P])[0]],D=i[1],!s[P+1]||!(M<=(l*D[D.length-1]+Ln[s[P+1][0]])/2));P++);l===Ln.year&&M<5*l&&(D=[1,2,5]);let c=sR(M/l,D,i[0]==="year"?Math.max(re(M/l),1):1);return{unitRange:l,count:c,unitName:i[0]}}getXDateFormat(M,R){let{axis:s}=this,i=s.chart.time;return s.closestPointRange?i.getDateFormat(s.closestPointRange,M,s.options.startOfWeek,R)||i.resolveDTLFormat(R.year).main:i.resolveDTLFormat(R.day).main}}A.Additions=I})(cE||(cE={}));let xT=cE,{addEvent:vT,normalizeTickInterval:nn,pick:iM}=tN;(function(A){function N(){this.type!=="logarithmic"?this.logarithmic=void 0:this.logarithmic??(this.logarithmic=new I(this))}function T(){let e=this.logarithmic;e&&(this.lin2val=function(M){return e.lin2log(M)},this.val2lin=function(M){return e.log2lin(M)})}A.compose=function(e){return e.keepProps.includes("logarithmic")||(e.keepProps.push("logarithmic"),vT(e,"afterSetType",N),vT(e,"afterInit",T)),e};class I{constructor(M){this.axis=M}getLogTickPositions(M,R,s,i){let l=this.axis,D=l.len,P=l.options,c=[];if(i||(this.minorAutoInterval=void 0),M>=.5)M=Math.round(M),c=l.getLinearTickPositions(M,R,s);else if(M>=.08){let h,H,B,Y,C,g,x,j=Math.floor(R);for(h=M>.3?[1,2,4]:M>.15?[1,2,4,6,8]:[1,2,3,4,5,6,7,8,9],H=j;H<s+1&&!x;H++)for(B=0,Y=h.length;B<Y&&!x;B++)(C=this.log2lin(this.lin2log(H)*h[B]))>R&&(!i||g<=s)&&g!==void 0&&c.push(g),g>s&&(x=!0),g=C}else{let h=this.lin2log(R),H=this.lin2log(s),B=i?l.getMinorTickInterval():P.tickInterval,Y=P.tickPixelInterval/(i?5:1),C=i?D/l.tickPositions.length:D;M=nn(M=iM(B==="auto"?null:B,this.minorAutoInterval,(H-h)*Y/(C||1))),c=l.getLinearTickPositions(M,h,H).map(this.log2lin),i||(this.minorAutoInterval=M/5)}return i||(l.tickInterval=M),c}lin2log(M){return Math.pow(10,M)}log2lin(M){return Math.log(M)/Math.LN10}}A.Additions=I})(pN||(pN={}));let Pe=pN,{erase:dI,extend:ae,isNumber:GI}=tN;(function(A){let N;function T(l){return this.addPlotBandOrLine(l,"plotBands")}function I(l,D){let P=this.userOptions,c=new N(this,l);if(this.visible&&(c=c.render()),c){if(this._addedPlotLB||(this._addedPlotLB=!0,(P.plotLines||[]).concat(P.plotBands||[]).forEach(h=>{this.addPlotBandOrLine(h)})),D){let h=P[D]||[];h.push(l),P[D]=h}this.plotLinesAndBands.push(c)}return c}function e(l){return this.addPlotBandOrLine(l,"plotLines")}function M(l,D,P){P=P||this.options;let c=this.getPlotLinePath({value:D,force:!0,acrossPanes:P.acrossPanes}),h=[],H=this.horiz,B=!GI(this.min)||!GI(this.max)||l<this.min&&D<this.min||l>this.max&&D>this.max,Y=this.getPlotLinePath({value:l,force:!0,acrossPanes:P.acrossPanes}),C,g=1,x;if(Y&&c)for(B&&(x=Y.toString()===c.toString(),g=0),C=0;C<Y.length;C+=2){let j=Y[C],Z=Y[C+1],W=c[C],J=c[C+1];(j[0]==="M"||j[0]==="L")&&(Z[0]==="M"||Z[0]==="L")&&(W[0]==="M"||W[0]==="L")&&(J[0]==="M"||J[0]==="L")&&(H&&W[1]===j[1]?(W[1]+=g,J[1]+=g):H||W[2]!==j[2]||(W[2]+=g,J[2]+=g),h.push(["M",j[1],j[2]],["L",Z[1],Z[2]],["L",J[1],J[2]],["L",W[1],W[2]],["Z"])),h.isFlat=x}return h}function R(l){this.removePlotBandOrLine(l)}function s(l){let D=this.plotLinesAndBands,P=this.options,c=this.userOptions;if(D){let h=D.length;for(;h--;)D[h].id===l&&D[h].destroy();[P.plotLines||[],c.plotLines||[],P.plotBands||[],c.plotBands||[]].forEach(function(H){for(h=H.length;h--;)H[h]?.id===l&&dI(H,H[h])})}}function i(l){this.removePlotBandOrLine(l)}A.compose=function(l,D){let P=D.prototype;return P.addPlotBand||(N=l,ae(P,{addPlotBand:T,addPlotLine:e,addPlotBandOrLine:I,getPlotBandPath:M,removePlotBand:R,removePlotLine:i,removePlotBandOrLine:s})),D}})(xN||(xN={}));let tT=xN,{addEvent:De,arrayMax:_R,arrayMin:oM,defined:fn,destroyObjectProperties:D_,erase:KO,fireEvent:Le,merge:yt,objectEach:uI,pick:iR}=tN;class Jn{static compose(N,T){return De(N,"afterInit",function(){this.labelCollectors.push(()=>{let I=[];for(let e of this.axes)for(let{label:M,options:R}of e.plotLinesAndBands)M&&!R?.label?.allowOverlap&&I.push(M);return I})}),tT.compose(Jn,T)}constructor(N,T){this.axis=N,this.options=T,this.id=T.id}render(){Le(this,"render");let{axis:N,options:T}=this,{horiz:I,logarithmic:e}=N,{color:M,events:R,zIndex:s=0}=T,{renderer:i,time:l}=N.chart,D={},P=l.parse(T.to),c=l.parse(T.from),h=l.parse(T.value),H=T.borderWidth,B=T.label,{label:Y,svgElem:C}=this,g=[],x,j=fn(c)&&fn(P),Z=fn(h),W=!C,J={class:"highcharts-plot-"+(j?"band ":"line ")+(T.className||"")},$=j?"bands":"lines";if(!N.chart.styledMode&&(Z?(J.stroke=M||"#999999",J["stroke-width"]=iR(T.width,1),T.dashStyle&&(J.dashstyle=T.dashStyle)):j&&(J.fill=M||"#e6e9ff",H&&(J.stroke=T.borderColor,J["stroke-width"]=H))),D.zIndex=s,$+="-"+s,(x=N.plotLinesAndBandsGroups[$])||(N.plotLinesAndBandsGroups[$]=x=i.g("plot-"+$).attr(D).add()),C||(this.svgElem=C=i.path().attr(J).add(x)),fn(h))g=N.getPlotLinePath({value:e?.log2lin(h)??h,lineWidth:C.strokeWidth(),acrossPanes:T.acrossPanes});else{if(!(fn(c)&&fn(P)))return;g=N.getPlotBandPath(e?.log2lin(c)??c,e?.log2lin(P)??P,T)}return!this.eventsAdded&&R&&(uI(R,(PE,aE)=>{C?.on(aE,lE=>{R[aE].apply(this,[lE])})}),this.eventsAdded=!0),(W||!C.d)&&g?.length?C.attr({d:g}):C&&(g?(C.show(),C.animate({d:g})):C.d&&(C.hide(),Y&&(this.label=Y=Y.destroy()))),B&&(fn(B.text)||fn(B.formatter))&&g?.length&&N.width>0&&N.height>0&&!g.isFlat?(B=yt({align:I&&j?"center":void 0,x:I?!j&&4:10,verticalAlign:!I&&j?"middle":void 0,y:I?j?16:10:j?6:-4,rotation:I&&!j?90:0,...j?{inside:!0}:{}},B),this.renderLabel(B,g,j,s)):Y&&Y.hide(),this}renderLabel(N,T,I,e){let M=this.axis,R=M.chart.renderer,s=N.inside,i=this.label;i||(this.label=i=R.text(this.getLabelText(N),0,0,N.useHTML).attr({align:N.textAlign||N.align,rotation:N.rotation,class:"highcharts-plot-"+(I?"band":"line")+"-label "+(N.className||""),zIndex:e}),M.chart.styledMode||i.css(yt({color:M.chart.options.title?.style?.color,fontSize:"0.8em",textOverflow:I&&!s?"":"ellipsis"},N.style)),i.add());let l=T.xBounds||[T[0][1],T[1][1],I?T[2][1]:T[0][1]],D=T.yBounds||[T[0][2],T[1][2],I?T[2][2]:T[0][2]],P=oM(l),c=oM(D),h=_R(l)-P;i.align(N,!1,{x:P,y:c,width:h,height:_R(D)-c}),i.alignAttr.y-=R.fontMetrics(i).b,(!i.alignValue||i.alignValue==="left"||fn(s))&&i.css({width:(N.style?.width||(I&&s?h:i.rotation===90?M.height-(i.alignAttr.y-M.top):(N.clip?M.width:M.chart.chartWidth)-(i.alignAttr.x-M.left)))+"px"}),i.show(!0)}getLabelText(N){return fn(N.formatter)?N.formatter.call(this):N.text}destroy(){KO(this.axis.plotLinesAndBands,this),delete this.axis,D_(this)}}let{animObject:Ut}=FO,{format:ce}=GT,{composed:cs,dateFormats:hs,doc:he,isSafari:JI}=z,{distribute:oR}=Fn,{addEvent:de,clamp:KT,css:$I,clearTimeout:YI,discardElement:Ge,extend:AM,fireEvent:xt,getAlignFactor:SM,isArray:JO,isNumber:Et,isObject:a,isString:_,merge:r,pick:L,pushUnique:u,splat:m,syncTimeout:b}=tN;class y{constructor(N,T,I){this.allowShared=!0,this.crosshairs=[],this.distance=0,this.isHidden=!0,this.isSticky=!1,this.options={},this.outside=!1,this.chart=N,this.init(N,T),this.pointer=I}bodyFormatter(N){return N.map(T=>{let I=T.series.tooltipOptions,e=T.formatPrefix||"point";return(I[e+"Formatter"]||T.tooltipFormatter).call(T,I[e+"Format"]||"")})}cleanSplit(N){this.chart.series.forEach(function(T){let I=T?.tt;I&&(!I.isActive||N?T.tt=I.destroy():I.isActive=!1)})}defaultFormatter(N){let T,I=this.points||m(this);return(T=(T=[N.headerFooterFormatter(I[0])]).concat(N.bodyFormatter(I))).push(N.headerFooterFormatter(I[0],!0)),T}destroy(){this.label&&(this.label=this.label.destroy()),this.split&&(this.cleanSplit(!0),this.tt&&(this.tt=this.tt.destroy())),this.renderer&&(this.renderer=this.renderer.destroy(),Ge(this.container)),YI(this.hideTimer)}getAnchor(N,T){let I,{chart:e,pointer:M}=this,R=e.inverted,s=e.plotTop,i=e.plotLeft;if(N=m(N),N[0].series?.yAxis&&!N[0].series.yAxis.options.reversedStacks&&(N=N.slice().reverse()),this.followPointer&&T)T.chartX===void 0&&(T=M.normalize(T)),I=[T.chartX-i,T.chartY-s];else if(N[0].tooltipPos)I=N[0].tooltipPos;else{let D=0,P=0;N.forEach(function(c){let h=c.pos(!0);h&&(D+=h[0],P+=h[1])}),D/=N.length,P/=N.length,this.shared&&N.length>1&&T&&(R?D=T.chartX:P=T.chartY),I=[D-i,P-s]}let l={point:N[0],ret:I};return xt(this,"getAnchor",l),l.ret.map(Math.round)}getClassName(N,T,I){let e=this.options,M=N.series,R=M.options;return[e.className,"highcharts-label",I&&"highcharts-tooltip-header",T?"highcharts-tooltip-box":"highcharts-tooltip",!I&&"highcharts-color-"+L(N.colorIndex,M.colorIndex),R?.className].filter(_).join(" ")}getLabel({anchorX:N,anchorY:T}={anchorX:0,anchorY:0}){let I=this,e=this.chart.styledMode,M=this.options,R=this.split&&this.allowShared,s=this.container,i=this.chart.renderer;if(this.label){let l=!this.label.hasClass("highcharts-label");(!R&&l||R&&!l)&&this.destroy()}if(!this.label){if(this.outside){let l=this.chart,D=l.options.chart.style,P=Yn.getRendererType();this.container=s=z.doc.createElement("div"),s.className="highcharts-tooltip-container "+(l.renderTo.className.match(/(highcharts[a-zA-Z0-9-]+)\s?/gm)||""),$I(s,{position:"absolute",top:"1px",pointerEvents:"none",zIndex:Math.max(this.options.style.zIndex||0,(D?.zIndex||0)+3)}),this.renderer=i=new P(s,0,0,D,void 0,void 0,i.styledMode)}if(R?this.label=i.g("tooltip"):(this.label=i.label("",N,T,M.shape||"callout",void 0,void 0,M.useHTML,void 0,"tooltip").attr({padding:M.padding,r:M.borderRadius}),e||this.label.attr({fill:M.backgroundColor,"stroke-width":M.borderWidth||0}).css(M.style).css({pointerEvents:M.style.pointerEvents||(this.shouldStickOnContact()?"auto":"none")})),I.outside){let l=this.label;[l.xSetter,l.ySetter].forEach((D,P)=>{l[P?"ySetter":"xSetter"]=c=>{D.call(l,I.distance),l[P?"y":"x"]=c,s&&(s.style[P?"top":"left"]=`${c}px`)}})}this.label.attr({zIndex:8}).shadow(M.shadow??!M.fixed).add()}return s&&!s.parentElement&&z.doc.body.appendChild(s),this.label}getPlayingField(){let{body:N,documentElement:T}=he,{chart:I,distance:e,outside:M}=this;return{width:M?Math.max(N.scrollWidth,T.scrollWidth,N.offsetWidth,T.offsetWidth,T.clientWidth)-2*e-2:I.chartWidth,height:M?Math.max(N.scrollHeight,T.scrollHeight,N.offsetHeight,T.offsetHeight,T.clientHeight):I.chartHeight}}getPosition(N,T,I){let{distance:e,chart:M,outside:R,pointer:s}=this,{inverted:i,plotLeft:l,plotTop:D,polar:P}=M,{plotX:c=0,plotY:h=0}=I,H={},B=i&&I.h||0,{height:Y,width:C}=this.getPlayingField(),g=s.getChartPosition(),x=vE=>{let XE=vE==="x";return[vE,XE?C:Y,XE?N:T].concat(R?[XE?N*g.scaleX:T*g.scaleY,XE?g.left-e+(c+l)*g.scaleX:g.top-e+(h+D)*g.scaleY,0,XE?C:Y]:[XE?N:T,XE?c+l:h+D,XE?l:D,XE?l+M.plotWidth:D+M.plotHeight])},j=x("y"),Z=x("x"),W,J=!!I.negative;!P&&M.hoverSeries?.yAxis?.reversed&&(J=!J);let $=!this.followPointer&&L(I.ttBelow,!P&&!i===J),PE=function(vE,XE,NN,JE,WE,eO,MO){let LO=R?vE==="y"?e*g.scaleY:e*g.scaleX:e,oN=(NN-JE)/2,lN=JE<WE-e,kN=WE+e+JE<XE,cN=WE-LO-NN+oN,jN=WE+LO-oN;if($&&kN)H[vE]=jN;else if(!$&&lN)H[vE]=cN;else if(lN)H[vE]=Math.min(MO-JE,cN-B<0?cN:cN-B);else{if(!kN)return H[vE]=0,!1;H[vE]=Math.max(eO,jN+B+NN>XE?jN:jN+B)}},aE=function(vE,XE,NN,JE,WE){if(WE<e||WE>XE-e)return!1;WE<NN/2?H[vE]=1:WE>XE-JE/2?H[vE]=XE-JE-2:H[vE]=WE-NN/2},lE=function(vE){[j,Z]=[Z,j],W=vE},mE=()=>{PE.apply(0,j)!==!1?aE.apply(0,Z)!==!1||W||(lE(!0),mE()):W?H.x=H.y=0:(lE(!0),mE())};return(i&&!P||this.len>1)&&lE(),mE(),H}getFixedPosition(N,T,I){let e=I.series,{chart:M,options:R,split:s}=this,i=R.position,l=i.relativeTo,D=R.shared||e?.yAxis?.isRadial&&(l==="pane"||!l)?"plotBox":l,P=D==="chart"?M.renderer:M[D]||M.getClipBox(e,!0);return{x:P.x+(P.width-N)*SM(i.align)+i.x,y:P.y+(P.height-T)*SM(i.verticalAlign)+(!s&&i.y||0)}}hide(N){let T=this;YI(this.hideTimer),N=L(N,this.options.hideDelay),this.isHidden||(this.hideTimer=b(function(){let I=T.getLabel();T.getLabel().animate({opacity:0},{duration:N&&150,complete:()=>{I.hide(),T.container&&T.container.remove()}}),T.isHidden=!0},N))}init(N,T){this.chart=N,this.options=T,this.crosshairs=[],this.isHidden=!0,this.split=T.split&&!N.inverted&&!N.polar,this.shared=T.shared||this.split,this.outside=L(T.outside,!!(N.scrollablePixelsX||N.scrollablePixelsY))}shouldStickOnContact(N){return!!(!this.followPointer&&this.options.stickOnContact&&(!N||this.pointer.inClass(N.target,"highcharts-tooltip")))}move(N,T,I,e){let{followPointer:M,options:R}=this,s=Ut(!M&&!this.isHidden&&!R.fixed&&R.animation),i=M||(this.len||0)>1,l={x:N,y:T};i?l.anchorX=l.anchorY=NaN:(l.anchorX=I,l.anchorY=e),s.step=()=>this.drawTracker(),this.getLabel().animate(l,s)}refresh(N,T){let{chart:I,options:e,pointer:M,shared:R}=this,s=m(N),i=s[0],l=e.format,D=e.formatter||this.defaultFormatter,P=I.styledMode,c=this.allowShared;if(!e.enabled||!i.series)return;YI(this.hideTimer),this.allowShared=!(!JO(N)&&N.series&&N.series.noSharedTooltip),c=c&&!this.allowShared,this.followPointer=!this.split&&i.series.tooltipOptions.followPointer;let h=this.getAnchor(N,T),H=h[0],B=h[1];R&&this.allowShared&&(M.applyInactiveState(s),s.forEach(g=>g.setState("hover")),i.points=s),this.len=s.length;let Y=_(l)?ce(l,i,I):D.call(i,this);i.points=void 0;let C=i.series;if(this.distance=L(C.tooltipOptions.distance,16),Y===!1)this.hide();else{if(this.split&&this.allowShared)this.renderSplit(Y,s);else{let g=H,x=B;if(T&&M.isDirectTouch&&(g=T.chartX-I.plotLeft,x=T.chartY-I.plotTop),!(I.polar||C.options.clip===!1||s.some(j=>M.isDirectTouch||j.series.shouldShowTooltip(g,x))))return void this.hide();{let j=this.getLabel(c&&this.tt||{});(!e.style.width||P)&&j.css({width:(this.outside?this.getPlayingField():I.spacingBox).width+"px"}),j.attr({class:this.getClassName(i),text:Y&&Y.join?Y.join(""):Y}),this.outside&&j.attr({x:KT(j.x||0,0,this.getPlayingField().width-(j.width||0)-1)}),P||j.attr({stroke:e.borderColor||i.color||C.color||"#666666"}),this.updatePosition({plotX:H,plotY:B,negative:i.negative,ttBelow:i.ttBelow,series:C,h:h[2]||0})}}this.isHidden&&this.label&&this.label.attr({opacity:1}).show(),this.isHidden=!1}xt(this,"refresh")}renderSplit(N,T){let I=this,{chart:e,chart:{chartWidth:M,chartHeight:R,plotHeight:s,plotLeft:i,plotTop:l,scrollablePixelsY:D=0,scrollablePixelsX:P,styledMode:c},distance:h,options:H,options:{fixed:B,position:Y,positioner:C},pointer:g}=I,{scrollLeft:x=0,scrollTop:j=0}=e.scrollablePlotArea?.scrollingContainer||{},Z=I.outside&&typeof P!="number"?he.documentElement.getBoundingClientRect():{left:x,right:x+M},W=I.getLabel(),J=this.renderer||e.renderer,$=!!e.xAxis[0]?.opposite,{left:PE,top:aE}=g.getChartPosition(),lE=C||B,mE=l+j,vE=0,XE=s-D,NN=function(oN,lN,kN,cN=[0,0],jN=!0){let XN,TO;if(kN.isHeader)TO=$?0:XE,XN=KT(cN[0]-oN/2,Z.left,Z.right-oN-(I.outside?PE:0));else if(B&&kN){let cO=I.getFixedPosition(oN,lN,kN);XN=cO.x,TO=cO.y-mE}else TO=cN[1]-mE,XN=KT(XN=jN?cN[0]-oN-h:cN[0]+h,jN?XN:Z.left,Z.right);return{x:XN,y:TO}};_(N)&&(N=[!1,N]);let JE=N.slice(0,T.length+1).reduce(function(oN,lN,kN){if(lN!==!1&&lN!==""){let cN=T[kN-1]||{isHeader:!0,plotX:T[0].plotX,plotY:s,series:{}},jN=cN.isHeader,XN=jN?I:cN.series,TO=XN.tt=(function(BT,ST,St){let Gn=BT,{isHeader:xe,series:KR}=ST,nI=KR.tooltipOptions||H;if(!Gn){let UM={padding:nI.padding,r:nI.borderRadius};c||(UM.fill=nI.backgroundColor,UM["stroke-width"]=nI.borderWidth??(B&&!xe?0:1)),Gn=J.label("",0,0,nI[xe?"headerShape":"shape"]||(B&&!xe?"rect":"callout"),void 0,void 0,nI.useHTML).addClass(I.getClassName(ST,!0,xe)).attr(UM).add(W)}return Gn.isActive=!0,Gn.attr({text:St}),c||Gn.css(nI.style).attr({stroke:nI.borderColor||ST.color||KR.color||"#333333"}),Gn})(XN.tt,cN,lN.toString()),cO=TO.getBBox(),xO=cO.width+TO.strokeWidth();jN&&(vE=cO.height,XE+=vE,$&&(mE-=vE));let{anchorX:kT,anchorY:yM}=(function(BT){let ST,St,{isHeader:Gn,plotX:xe=0,plotY:KR=0,series:nI}=BT;if(Gn)ST=Math.max(i+xe,i),St=l+s/2;else{let{xAxis:UM,yAxis:Bo}=nI;ST=UM.pos+KT(xe,-h,UM.len+h),nI.shouldShowTooltip(0,Bo.pos-l+KR,{ignoreX:!0})&&(St=Bo.pos+KR)}return{anchorX:ST=KT(ST,Z.left-h,Z.right+h),anchorY:St}})(cN);if(typeof yM=="number"){let BT=cO.height+1,ST=(C||NN).call(I,xO,BT,cN,[kT,yM]);oN.push({align:lE?0:void 0,anchorX:kT,anchorY:yM,boxWidth:xO,point:cN,rank:L(ST.rank,+!!jN),size:BT,target:ST.y,tt:TO,x:ST.x})}else TO.isActive=!1}return oN},[]);!lE&&JE.some(oN=>{let{outside:lN}=I,kN=(lN?PE:0)+oN.anchorX;return kN<Z.left&&kN+oN.boxWidth<Z.right||kN<PE-Z.left+oN.boxWidth&&Z.right-kN>kN})&&(JE=JE.map(oN=>{let{x:lN,y:kN}=NN.call(this,oN.boxWidth,oN.size,oN.point,[oN.anchorX,oN.anchorY],!1);return AM(oN,{target:kN,x:lN})})),I.cleanSplit(),oR(JE,XE);let WE={left:PE,right:PE};JE.forEach(function(oN){let{x:lN,boxWidth:kN,isHeader:cN}=oN;!cN&&(I.outside&&PE+lN<WE.left&&(WE.left=PE+lN),!cN&&I.outside&&WE.left+kN>WE.right&&(WE.right=PE+lN))}),JE.forEach(function(oN){let{x:lN,anchorX:kN,anchorY:cN,pos:jN,point:{isHeader:XN}}=oN,TO={visibility:jN===void 0?"hidden":"inherit",x:lN,y:(jN||0)+mE+(B&&Y.y||0),anchorX:kN,anchorY:cN};if(I.outside&&lN<kN){let cO=PE-WE.left;cO>0&&(XN||(TO.x=lN+cO,TO.anchorX=kN+cO),XN&&(TO.x=(WE.right-WE.left)/2,TO.anchorX=kN+cO))}oN.tt.attr(TO)});let{container:eO,outside:MO,renderer:LO}=I;if(MO&&eO&&LO){let{width:oN,height:lN,x:kN,y:cN}=W.getBBox();LO.setSize(oN+kN,lN+cN,!1),eO.style.left=WE.left+"px",eO.style.top=aE+"px"}JI&&W.attr({opacity:W.opacity===1?.999:1})}drawTracker(){let N=this;if(!this.shouldStickOnContact()){N.tracker&&(N.tracker=N.tracker.destroy());return}let T=N.chart,I=N.label,e=N.shared?T.hoverPoints:T.hoverPoint;if(!I||!e)return;let M={x:0,y:0,width:0,height:0},R=this.getAnchor(e),s=I.getBBox();R[0]+=T.plotLeft-(I.translateX||0),R[1]+=T.plotTop-(I.translateY||0),M.x=Math.min(0,R[0]),M.y=Math.min(0,R[1]),M.width=R[0]<0?Math.max(Math.abs(R[0]),s.width-R[0]):Math.max(Math.abs(R[0]),s.width),M.height=R[1]<0?Math.max(Math.abs(R[1]),s.height-Math.abs(R[1])):Math.max(Math.abs(R[1]),s.height),N.tracker?N.tracker.attr(M):(N.tracker=I.renderer.rect(M).addClass("highcharts-tracker").add(I),de(N.tracker.element,"mouseenter",()=>{YI(N.hideTimer)}),T.styledMode||N.tracker.attr({fill:"rgba(0,0,0,0)"}))}styledModeFormat(N){return N.replace('style="font-size: 0.8em"','class="highcharts-header"').replace(/style="color:{(point|series)\.color}"/g,'class="highcharts-color-{$1.colorIndex} {series.options.className} {point.options.className}"')}headerFooterFormatter(N,T){let I=N.series,e=I.tooltipOptions,M=I.xAxis,R=M?.dateTime,s={isFooter:T,point:N},i=e.xDateFormat||"",l=e[T?"footerFormat":"headerFormat"];return xt(this,"headerFormatter",s,function(D){if(R&&!i&&Et(N.key)&&(i=R.getXDateFormat(N.key,e.dateTimeLabelFormats)),R&&i){if(a(i)){let P=i;hs[0]=c=>I.chart.time.dateFormat(P,c),i="%0"}(N.tooltipDateKeys||["key"]).forEach(P=>{l=l.replace(RegExp("point\\."+P+"([ \\)}])"),`(point.${P}:${i})$1`)})}I.chart.styledMode&&(l=this.styledModeFormat(l)),D.text=ce(l,N,this.chart)}),s.text||""}update(N){this.destroy(),this.init(this.chart,r(!0,this.options,N))}updatePosition(N){let{chart:T,container:I,distance:e,options:M,pointer:R,renderer:s}=this,{height:i=0,width:l=0}=this.getLabel(),{fixed:D,positioner:P}=M,{left:c,top:h,scaleX:H,scaleY:B}=R.getChartPosition(),Y=(P||D&&this.getFixedPosition||this.getPosition).call(this,l,i,N),C=z.doc,g=(N.plotX||0)+T.plotLeft,x=(N.plotY||0)+T.plotTop,j;if(s&&I){if(P||D){let{scrollLeft:Z=0,scrollTop:W=0}=T.scrollablePlotArea?.scrollingContainer||{};Y.x+=Z+c-e,Y.y+=W+h-e}j=(M.borderWidth||0)+2*e+2,s.setSize(KT(l+j,0,C.documentElement.clientWidth)-1,i+j,!1),(H!==1||B!==1)&&($I(I,{transform:`scale(${H}, ${B})`}),g*=H,x*=B),g+=c-Y.x,x+=h-Y.y}this.move(Math.round(Y.x),Math.round(Y.y||0),g,x)}}(IE=y||(y={})).compose=function(A){u(cs,"Core.Tooltip")&&de(A,"afterInit",function(){let N=this.chart;N.options.tooltip&&(N.tooltip=new IE(N,N.options.tooltip,this))})};let K=y,{animObject:w}=FO,{defaultOptions:OE}=fO,{format:tE}=GT,{addEvent:ME,crisp:AE,erase:bE,extend:VE,fireEvent:ZE,getNestedProperty:aN,isArray:LN,isFunction:RN,isNumber:qE,isObject:uN,merge:HN,pick:BN,syncTimeout:CN,removeEvent:iO,uniqueKey:cT}=tN;class oO{constructor(N,T,I){this.formatPrefix="point",this.visible=!0,this.point=this,this.series=N,this.applyOptions(T,I),this.id??(this.id=cT()),this.resolveColor(),this.dataLabelOnNull??(this.dataLabelOnNull=N.options.nullInteraction),N.chart.pointCount++,this.category=N.xAxis?.categories?.[this.x]??this.x,this.key=this.name??this.category,ZE(this,"afterInit")}animateBeforeDestroy(){let N=this,T={x:N.startXPos,opacity:0},I=N.getGraphicalProps();I.singular.forEach(function(e){N[e]=N[e].animate(e==="dataLabel"?{x:N[e].startXPos,y:N[e].startYPos,opacity:0}:T)}),I.plural.forEach(function(e){N[e].forEach(function(M){M.element&&M.animate(VE({x:N.startXPos},M.startYPos?{x:M.startXPos,y:M.startYPos}:{}))})})}applyOptions(N,T){let I=this.series,e=I.options.pointValKey||I.pointValKey;return VE(this,N=oO.prototype.optionsToObject.call(this,N)),this.options=this.options?VE(this.options,N):N,N.group&&delete this.group,N.dataLabels&&delete this.dataLabels,e&&(this.y=oO.prototype.getNestedProperty.call(this,e)),this.selected&&(this.state="select"),"name"in this&&T===void 0&&I.xAxis&&I.xAxis.hasNames&&(this.x=I.xAxis.nameToX(this)),this.x===void 0&&I?this.x=T??I.autoIncrement():qE(N.x)&&I.options.relativeXValue?this.x=I.autoIncrement(N.x):typeof this.x=="string"&&(T??(T=I.chart.time.parse(this.x)),qE(T)&&(this.x=T)),this.isNull=this.isValid&&!this.isValid(),this.formatPrefix=this.isNull?"null":"point",this}destroy(){if(!this.destroyed){let N=this,T=N.series,I=T.chart,e=T.options.dataSorting,M=I.hoverPoints,R=w(N.series.chart.renderer.globalAnimation),s=()=>{for(let i in(N.graphic||N.graphics||N.dataLabel||N.dataLabels)&&(iO(N),N.destroyElements()),N)delete N[i]};N.legendItem&&I.legend.destroyItem(N),M&&(N.setState(),bE(M,N),M.length||(I.hoverPoints=null)),N===I.hoverPoint&&N.onMouseOut(),e?.enabled?(this.animateBeforeDestroy(),CN(s,R.duration)):s(),I.pointCount--}this.destroyed=!0}destroyElements(N){let T=this,I=T.getGraphicalProps(N);I.singular.forEach(function(e){T[e]=T[e].destroy()}),I.plural.forEach(function(e){T[e].forEach(function(M){M?.element&&M.destroy()}),delete T[e]})}firePointEvent(N,T,I){let e=this,M=this.series.options;e.manageEvent(N),N==="click"&&M.allowPointSelect&&(I=function(R){!e.destroyed&&e.select&&e.select(null,R.ctrlKey||R.metaKey||R.shiftKey)}),ZE(e,N,T,I)}getClassName(){return"highcharts-point"+(this.selected?" highcharts-point-select":"")+(this.negative?" highcharts-negative":"")+(this.isNull?" highcharts-null-point":"")+(this.colorIndex!==void 0?" highcharts-color-"+this.colorIndex:"")+(this.options.className?" "+this.options.className:"")+(this.zone?.className?" "+this.zone.className.replace("highcharts-negative",""):"")}getGraphicalProps(N){let T,I,e=this,M=[],R={singular:[],plural:[]};for((N=N||{graphic:1,dataLabel:1}).graphic&&M.push("graphic","connector"),N.dataLabel&&M.push("dataLabel","dataLabelPath","dataLabelUpper"),I=M.length;I--;)e[T=M[I]]&&R.singular.push(T);return["graphic","dataLabel"].forEach(function(s){let i=s+"s";N[s]&&e[i]&&R.plural.push(i)}),R}getNestedProperty(N){if(N)return N.indexOf("custom.")===0?aN(N,this.options):this[N]}getZone(){let N=this.series,T=N.zones,I=N.zoneAxis||"y",e,M=0;for(e=T[0];this[I]>=e.value;)e=T[++M];return this.nonZonedColor||(this.nonZonedColor=this.color),e?.color&&!this.options.color?this.color=e.color:this.color=this.nonZonedColor,e}hasNewShapeType(){return(this.graphic&&(this.graphic.symbolName||this.graphic.element.nodeName))!==this.shapeType}isValid(){return(qE(this.x)||this.x instanceof Date)&&qE(this.y)}optionsToObject(N){let T=this.series,I=T.options.keys,e=I||T.pointArrayMap||["y"],M=e.length,R={},s,i=0,l=0;if(qE(N)||N===null)R[e[0]]=N;else if(LN(N))for(!I&&N.length>M&&((s=typeof N[0])=="string"?T.xAxis?.dateTime?R.x=T.chart.time.parse(N[0]):R.name=N[0]:s==="number"&&(R.x=N[0]),i++);l<M;)I&&N[i]===void 0||(e[l].indexOf(".")>0?oO.prototype.setNestedProperty(R,N[i],e[l]):R[e[l]]=N[i]),i++,l++;else typeof N=="object"&&(R=N,N.dataLabels&&(T.hasDataLabels=()=>!0),N.marker&&(T._hasPointMarkers=!0));return R}pos(N,T=this.plotY){if(!this.destroyed){let{plotX:I,series:e}=this,{chart:M,xAxis:R,yAxis:s}=e,i=0,l=0;if(qE(I)&&qE(T))return N&&(i=R?R.pos:M.plotLeft,l=s?s.pos:M.plotTop),M.inverted&&R&&s?[s.len-T+l,R.len-I+i]:[I+i,T+l]}}resolveColor(){let N=this.series,T=N.chart.options.chart,I=N.chart.styledMode,e,M,R=T.colorCount,s;delete this.nonZonedColor,N.options.colorByPoint?(I||(e=(M=N.options.colors||N.chart.options.colors)[N.colorCounter],R=M.length),s=N.colorCounter,N.colorCounter++,N.colorCounter===R&&(N.colorCounter=0)):(I||(e=N.color),s=N.colorIndex),this.colorIndex=BN(this.options.colorIndex,s),this.color=BN(this.options.color,e)}setNestedProperty(N,T,I){return I.split(".").reduce(function(e,M,R,s){let i=s.length-1===R;return e[M]=i?T:uN(e[M],!0)?e[M]:{},e[M]},N),N}shouldDraw(){return!this.isNull}tooltipFormatter(N){let{chart:T,pointArrayMap:I=["y"],tooltipOptions:e}=this.series,{valueDecimals:M="",valuePrefix:R="",valueSuffix:s=""}=e;return T.styledMode&&(N=T.tooltip?.styledModeFormat(N)||N),I.forEach(i=>{i="{point."+i,(R||s)&&(N=N.replace(RegExp(i+"}","g"),R+i+"}"+s)),N=N.replace(RegExp(i+"}","g"),i+":,."+M+"f}")}),tE(N,this,T)}update(N,T,I,e){let M,R=this,s=R.series,i=R.graphic,l=s.chart,D=s.options;function P(){R.applyOptions(N);let c=i&&R.hasMockGraphic,h=R.y===null?!c:c;i&&h&&(R.graphic=i.destroy(),delete R.hasMockGraphic),uN(N,!0)&&(i?.element&&N&&N.marker&&N.marker.symbol!==void 0&&(R.graphic=i.destroy()),N?.dataLabels&&R.dataLabel&&(R.dataLabel=R.dataLabel.destroy())),M=R.index;let H={};for(let B of s.dataColumnKeys())H[B]=R[B];s.dataTable.setRow(H,M),D.data[M]=uN(D.data[M],!0)||uN(N,!0)?R.options:BN(N,D.data[M]),s.isDirty=s.isDirtyData=!0,!s.fixedBox&&s.hasCartesianSeries&&(l.isDirtyBox=!0),D.legendType==="point"&&(l.isDirtyLegend=!0),T&&l.redraw(I)}T=BN(T,!0),e===!1?P():R.firePointEvent("update",{options:N},P)}remove(N,T){this.series.removePoint(this.series.data.indexOf(this),N,T)}select(N,T){let I=this,e=I.series,M=e.chart;N=BN(N,!I.selected),this.selectedStaging=N,I.firePointEvent(N?"select":"unselect",{accumulate:T},function(){I.selected=I.options.selected=N,e.options.data[e.data.indexOf(I)]=I.options,I.setState(N&&"select"),T||M.getSelectedPoints().forEach(function(R){let s=R.series;R.selected&&R!==I&&(R.selected=R.options.selected=!1,s.options.data[s.data.indexOf(R)]=R.options,R.setState(M.hoverPoints&&s.options.inactiveOtherPoints?"inactive":""),R.firePointEvent("unselect"))})}),delete this.selectedStaging}onMouseOver(N){let{inverted:T,pointer:I}=this.series.chart;I&&(N=N?I.normalize(N):I.getChartCoordinatesFromPoint(this,T),I.runPointActions(N,this))}onMouseOut(){let N=this.series.chart;this.firePointEvent("mouseOut"),this.series.options.inactiveOtherPoints||(N.hoverPoints||[]).forEach(function(T){T.setState()}),N.hoverPoints=N.hoverPoint=null}manageEvent(N){let T=HN(this.series.options.point,this.options),I=T.events?.[N];RN(I)&&(!this.hcEvents?.[N]||this.hcEvents?.[N]?.map(e=>e.fn).indexOf(I)===-1)?(this.importedUserEvent?.(),this.importedUserEvent=ME(this,N,I),this.hcEvents&&(this.hcEvents[N].userEvent=!0)):this.importedUserEvent&&!I&&this.hcEvents?.[N]&&this.hcEvents?.[N].userEvent&&(iO(this,N),delete this.hcEvents[N],Object.keys(this.hcEvents)||delete this.importedUserEvent)}setState(N,T){let I=this.series,e=this.state,M=I.options.states[N||"normal"]||{},R=OE.plotOptions[I.type].marker&&I.options.marker,s=R&&R.enabled===!1,i=R?.states?.[N||"normal"]||{},l=i.enabled===!1,D=this.marker||{},P=I.chart,c=R&&I.markerAttribs,h=I.halo,H,B,Y,C=I.stateMarkerGraphic,g;if((N=N||"")===this.state&&!T||this.selected&&N!=="select"||M.enabled===!1||N&&(l||s&&i.enabled===!1)||N&&D.states&&D.states[N]&&D.states[N].enabled===!1)return;if(this.state=N,c&&(H=I.markerAttribs(this,N)),this.graphic&&!this.hasMockGraphic){if(e&&this.graphic.removeClass("highcharts-point-"+e),N&&this.graphic.addClass("highcharts-point-"+N),!P.styledMode){B=I.pointAttribs(this,N),Y=BN(P.options.chart.animation,M.animation);let W=B.opacity;I.options.inactiveOtherPoints&&qE(W)&&(this.dataLabels||[]).forEach(function(J){J&&!J.hasClass("highcharts-data-label-hidden")&&(J.animate({opacity:W},Y),J.connector&&J.connector.animate({opacity:W},Y))}),this.graphic.animate(B,Y)}H&&this.graphic.animate(H,BN(P.options.chart.animation,i.animation,R.animation)),C&&C.hide()}else N&&i&&(g=D.symbol||I.symbol,C&&C.currentSymbol!==g&&(C=C.destroy()),H&&(C?C[T?"animate":"attr"]({x:H.x,y:H.y}):g&&(I.stateMarkerGraphic=C=P.renderer.symbol(g,H.x,H.y,H.width,H.height,HN(R,i)).add(I.markerGroup),C.currentSymbol=g)),!P.styledMode&&C&&this.state!=="inactive"&&C.attr(I.pointAttribs(this,N))),C&&(C[N&&this.isInside?"show":"hide"](),C.element.point=this,C.addClass(this.getClassName(),!0));let x=M.halo,j=this.graphic||C,Z=j?.visibility||"inherit";x?.size&&j&&Z!=="hidden"&&!this.isCluster?(h||(I.halo=h=P.renderer.path().add(j.parentGroup)),h.show()[T?"animate":"attr"]({d:this.haloPath(x.size)}),h.attr({class:"highcharts-halo highcharts-color-"+BN(this.colorIndex,I.colorIndex)+(this.className?" "+this.className:""),visibility:Z,zIndex:-1}),h.point=this,P.styledMode||h.attr(VE({fill:this.color||I.color,"fill-opacity":x.opacity},NO.filterUserAttributes(x.attributes||{})))):h?.point?.haloPath&&!h.point.destroyed&&h.animate({d:h.point.haloPath(0)},null,h.hide),ZE(this,"afterSetState",{state:N})}haloPath(N){let T=this.pos();return T?this.series.chart.renderer.symbols.circle(AE(T[0],1)-N,T[1]-N,2*N,2*N):[]}}let rO=oO,{parse:YT}=QN,{charts:$n,composed:wT,isTouchDevice:$O}=z,{addEvent:IO,attr:VO,css:pn,extend:EI,find:dN,fireEvent:zN,isNumber:gO,isObject:ue,objectEach:lM,offset:Ye,pick:cn,pushUnique:AR,splat:He}=tN;class eT{applyInactiveState(N=[]){let T=[];for(let I of(N.forEach(e=>{let M=e.series;T.push(M),M.linkedParent&&T.push(M.linkedParent),M.linkedSeries&&T.push.apply(T,M.linkedSeries),M.navigatorSeries&&T.push(M.navigatorSeries),M.boosted&&M.markerGroup&&T.push.apply(T,this.chart.series.filter(R=>R.markerGroup===M.markerGroup))}),this.chart.series)){let e=I.options;e.states?.inactive?.enabled!==!1&&(T.indexOf(I)===-1?I.setState("inactive",!0):e.inactiveOtherPoints&&I.setAllPointsToState("inactive"))}}destroy(){let N=this;this.eventsToUnbind.forEach(T=>T()),this.eventsToUnbind=[],!z.chartCount&&(eT.unbindDocumentMouseUp.forEach(T=>T.unbind()),eT.unbindDocumentMouseUp.length=0,eT.unbindDocumentTouchEnd&&(eT.unbindDocumentTouchEnd=eT.unbindDocumentTouchEnd())),lM(N,function(T,I){N[I]=void 0})}getSelectionMarkerAttrs(N,T){let I={args:{chartX:N,chartY:T},attrs:{},shapeType:"rect"};return zN(this,"getSelectionMarkerAttrs",I,e=>{let M,{chart:R,zoomHor:s,zoomVert:i}=this,{mouseDownX:l=0,mouseDownY:D=0}=R,P=e.attrs;P.x=R.plotLeft,P.y=R.plotTop,P.width=s?1:R.plotWidth,P.height=i?1:R.plotHeight,s&&(P.width=Math.max(1,Math.abs(M=N-l)),P.x=(M>0?0:M)+l),i&&(P.height=Math.max(1,Math.abs(M=T-D)),P.y=(M>0?0:M)+D)}),I}drag(N){let{chart:T}=this,{mouseDownX:I=0,mouseDownY:e=0}=T,{panning:M,panKey:R,selectionMarkerFill:s}=T.options.chart,i=T.plotLeft,l=T.plotTop,D=T.plotWidth,P=T.plotHeight,c=ue(M)?M.enabled:M,h=R&&N[`${R}Key`],H=N.chartX,B=N.chartY,Y,C=this.selectionMarker;if((!C||!C.touch)&&(H<i?H=i:H>i+D&&(H=i+D),B<l?B=l:B>l+P&&(B=l+P),this.hasDragged=Math.sqrt(Math.pow(I-H,2)+Math.pow(e-B,2)),this.hasDragged>10)){Y=T.isInsidePlot(I-i,e-l,{visiblePlotOnly:!0});let{shapeType:g,attrs:x}=this.getSelectionMarkerAttrs(H,B);this.hasZoom&&Y&&!h&&!C&&(this.selectionMarker=C=T.renderer[g](),C.attr({class:"highcharts-selection-marker",zIndex:7}).add(),T.styledMode||C.attr({fill:s||YT("#334eff").setOpacity(.25).get()})),C&&C.attr(x),Y&&!C&&c&&T.pan(N,M)}}dragStart(N){let T=this.chart;T.mouseIsDown=N.type,T.cancelClick=!1,T.mouseDownX=N.chartX,T.mouseDownY=N.chartY}getSelectionBox(N){let T={args:{marker:N},result:N.getBBox()};return zN(this,"getSelectionBox",T),T.result}drop(N){let T,{chart:I,selectionMarker:e}=this;for(let M of I.axes)M.isPanning&&(M.isPanning=!1,(M.options.startOnTick||M.options.endOnTick||M.series.some(R=>R.boosted))&&(M.forceRedraw=!0,M.setExtremes(M.userMin,M.userMax,!1),T=!0));if(T&&I.redraw(),e&&N){if(this.hasDragged){let M=this.getSelectionBox(e);I.transform({axes:I.axes.filter(R=>R.zoomEnabled&&(R.coll==="xAxis"&&this.zoomX||R.coll==="yAxis"&&this.zoomY)),selection:{originalEvent:N,xAxis:[],yAxis:[],...M},from:M})}gO(I.index)&&(this.selectionMarker=e.destroy())}I&&gO(I.index)&&(pn(I.container,{cursor:I._cursor}),I.cancelClick=this.hasDragged>10,I.mouseIsDown=!1,this.hasDragged=0,this.pinchDown=[],this.hasPinchMoved=!1)}findNearestKDPoint(N,T,I){let e;return N.forEach(function(M){var R;let s,i,l,D=!(M.noSharedTooltip&&T)&&0>M.options.findNearestPointBy.indexOf("y"),P=M.searchPoint(I,D);ue(P,!0)&&P.series&&(!ue(e,!0)||(s=(R=e).distX-P.distX,i=R.dist-P.dist,l=P.series.group?.zIndex-R.series.group?.zIndex,(s!==0&&T?s:i!==0?i:l!==0?l:R.series.index>P.series.index?-1:1)>0))&&(e=P)}),e}getChartCoordinatesFromPoint(N,T){let{xAxis:I,yAxis:e}=N.series,M=N.shapeArgs;if(I&&e){let R=N.clientX??N.plotX??0,s=N.plotY||0;return N.isNode&&M&&gO(M.x)&&gO(M.y)&&(R=M.x,s=M.y),T?{chartX:e.len+e.pos-s,chartY:I.len+I.pos-R}:{chartX:R+I.pos,chartY:s+e.pos}}if(M?.x&&M.y)return{chartX:M.x,chartY:M.y}}getChartPosition(){if(this.chartPosition)return this.chartPosition;let{container:N}=this.chart,T=Ye(N);this.chartPosition={left:T.left,top:T.top,scaleX:1,scaleY:1};let{offsetHeight:I,offsetWidth:e}=N;return e>2&&I>2&&(this.chartPosition.scaleX=T.width/e,this.chartPosition.scaleY=T.height/I),this.chartPosition}getCoordinates(N){let T={xAxis:[],yAxis:[]};for(let I of this.chart.axes)T[I.isXAxis?"xAxis":"yAxis"].push({axis:I,value:I.toValue(N[I.horiz?"chartX":"chartY"])});return T}getHoverData(N,T,I,e,M,R){let s=[],i=function(h){return h.visible&&!(!M&&h.directTouch)&&cn(h.options.enableMouseTracking,!0)},l=T,D,P={chartX:R?R.chartX:void 0,chartY:R?R.chartY:void 0,shared:M};zN(this,"beforeGetHoverData",P),D=l&&!l.stickyTracking?[l]:I.filter(h=>h.stickyTracking&&(P.filter||i)(h));let c=e&&N||!R?N:this.findNearestKDPoint(D,M,R);return l=c?.series,c&&(M&&!l.noSharedTooltip?(D=I.filter(function(h){return P.filter?P.filter(h):i(h)&&!h.noSharedTooltip})).forEach(function(h){let H=h.options?.nullInteraction,B=dN(h.points,function(Y){return Y.x===c.x&&(!Y.isNull||!!H)});ue(B)&&(h.boosted&&h.boost&&(B=h.boost.getPoint(B)),s.push(B))}):s.push(c)),zN(this,"afterGetHoverData",P={hoverPoint:c}),{hoverPoint:P.hoverPoint,hoverSeries:l,hoverPoints:s}}getPointFromEvent(N){let T=N.target,I;for(;T&&!I;)I=T.point,T=T.parentNode;return I}onTrackerMouseOut(N){let T=this.chart,I=N.relatedTarget,e=T.hoverSeries;this.isDirectTouch=!1,!e||!I||e.stickyTracking||this.inClass(I,"highcharts-tooltip")||this.inClass(I,"highcharts-series-"+e.index)&&this.inClass(I,"highcharts-tracker")||e.onMouseOut()}inClass(N,T){let I=N,e;for(;I;){if(e=VO(I,"class")){if(e.indexOf(T)!==-1)return!0;if(e.indexOf("highcharts-container")!==-1)return!1}I=I.parentElement}}constructor(N,T){this.hasDragged=0,this.pointerCaptureEventsToUnbind=[],this.eventsToUnbind=[],this.options=T,this.chart=N,this.runChartClick=!!T.chart.events?.click,this.pinchDown=[],this.setDOMEvents(),zN(this,"afterInit")}normalize(N,T){let I=N.touches,e=I?I.length?I.item(0):cn(I.changedTouches,N.changedTouches)[0]:N;T||(T=this.getChartPosition());let M=e.pageX-T.left,R=e.pageY-T.top;return EI(N,{chartX:Math.round(M/=T.scaleX),chartY:Math.round(R/=T.scaleY)})}onContainerClick(N){let T=this.chart,I=T.hoverPoint,e=this.normalize(N),M=T.plotLeft,R=T.plotTop;!T.cancelClick&&(I&&this.inClass(e.target,"highcharts-tracker")?(zN(I.series,"click",EI(e,{point:I})),T.hoverPoint&&I.firePointEvent("click",e)):(EI(e,this.getCoordinates(e)),T.isInsidePlot(e.chartX-M,e.chartY-R,{visiblePlotOnly:!0})&&zN(T,"click",e)))}onContainerMouseDown(N){let T=(1&(N.buttons||N.button))==1;N=this.normalize(N),z.isFirefox&&N.button!==0&&this.onContainerMouseMove(N),(N.button===void 0||T)&&(this.zoomOption(N),T&&N.preventDefault?.(),this.dragStart(N))}onContainerMouseLeave(N){let{pointer:T}=$n[cn(eT.hoverChartIndex,-1)]||{};N=this.normalize(N),this.onContainerMouseMove(N),T&&!this.inClass(N.relatedTarget,"highcharts-tooltip")&&(T.reset(),T.chartPosition=void 0)}onContainerMouseEnter(){delete this.chartPosition}onContainerMouseMove(N){let T=this.chart,I=T.tooltip,e=this.normalize(N);this.setHoverChartIndex(N),(T.mouseIsDown==="mousedown"||this.touchSelect(e))&&this.drag(e),!T.exporting?.openMenu&&(this.inClass(e.target,"highcharts-tracker")||T.isInsidePlot(e.chartX-T.plotLeft,e.chartY-T.plotTop,{visiblePlotOnly:!0}))&&!I?.shouldStickOnContact(e)&&(this.inClass(e.target,"highcharts-no-tooltip")?this.reset(!1,0):this.runPointActions(e))}onDocumentTouchEnd(N){this.onDocumentMouseUp(N)}onContainerTouchMove(N){this.touchSelect(N)?this.onContainerMouseMove(N):this.touch(N)}onContainerTouchStart(N){this.touchSelect(N)?this.onContainerMouseDown(N):(this.zoomOption(N),this.touch(N,!0))}onDocumentMouseMove(N){let T=this.chart,I=T.tooltip,e=this.chartPosition,M=this.normalize(N,e);!e||T.isInsidePlot(M.chartX-T.plotLeft,M.chartY-T.plotTop,{visiblePlotOnly:!0})||I?.shouldStickOnContact(M)||M.target!==T.container.ownerDocument&&this.inClass(M.target,"highcharts-tracker")||this.reset()}onDocumentMouseUp(N){N?.touches&&this.hasPinchMoved&&N?.preventDefault?.(),$n[cn(eT.hoverChartIndex,-1)]?.pointer?.drop(N)}pinch(N){let T=this,{chart:I,hasZoom:e,lastTouches:M}=T,R=[].map.call(N.touches||[],P=>T.normalize(P)),s=R.length,i=s===1&&(T.inClass(N.target,"highcharts-tracker")&&I.runTrackerClick||T.runChartClick),l=I.tooltip,D=s===1&&cn(l?.options.followTouchMove,!0);s>1?T.initiated=!0:D&&(T.initiated=!1),e&&T.initiated&&!i&&N.cancelable!==!1&&N.preventDefault(),N.type==="touchstart"?(T.pinchDown=R,T.res=!0,I.mouseDownX=N.chartX):D?this.runPointActions(T.normalize(N)):M&&(zN(I,"touchpan",{originalEvent:N,touches:R},()=>{let P=c=>{let h=c[0],H=c[1]||h;return{x:h.chartX,y:h.chartY,width:H.chartX-h.chartX,height:H.chartY-h.chartY}};I.transform({axes:I.axes.filter(c=>c.zoomEnabled&&(this.zoomHor&&c.horiz||this.zoomVert&&!c.horiz)),to:P(R),from:P(M),trigger:N.type})}),T.res&&(T.res=!1,this.reset(!1,0))),T.lastTouches=R}reset(N,T){let I=this.chart,e=I.hoverSeries,M=I.hoverPoint,R=I.hoverPoints,s=I.tooltip,i=s?.shared?R:M;N&&i&&He(i).forEach(function(l){l.series.isCartesian&&l.plotX===void 0&&(N=!1)}),N?s&&i&&He(i).length&&(s.refresh(i),s.shared&&R?R.forEach(function(l){l.setState(l.state,!0),l.series.isCartesian&&(l.series.xAxis.crosshair&&l.series.xAxis.drawCrosshair(null,l),l.series.yAxis.crosshair&&l.series.yAxis.drawCrosshair(null,l))}):M&&(M.setState(M.state,!0),I.axes.forEach(function(l){l.crosshair&&M.series[l.coll]===l&&l.drawCrosshair(null,M)}))):(M&&M.onMouseOut(),R&&R.forEach(function(l){l.setState()}),e&&e.onMouseOut(),s&&s.hide(T),this.unDocMouseMove&&(this.unDocMouseMove=this.unDocMouseMove()),I.axes.forEach(function(l){l.hideCrosshair()}),I.hoverPoints=I.hoverPoint=void 0)}runPointActions(N,T,I){let e=this.chart,M=e.series,R=e.tooltip?.options.enabled?e.tooltip:void 0,s=!!R&&R.shared,i=T||e.hoverPoint,l=i?.series||e.hoverSeries,D=(!N||N.type!=="touchmove")&&(!!T||l?.directTouch&&this.isDirectTouch),P=this.getHoverData(i,l,M,D,s,N);i=P.hoverPoint,l=P.hoverSeries;let c=P.hoverPoints,h=l?.tooltipOptions.followPointer&&!l.tooltipOptions.split,H=s&&l&&!l.noSharedTooltip;if(i&&(I||i!==e.hoverPoint||R?.isHidden)){if((e.hoverPoints||[]).forEach(function(B){c.indexOf(B)===-1&&B.setState()}),e.hoverSeries!==l&&l.onMouseOver(),this.applyInactiveState(c),(c||[]).forEach(function(B){B.setState("hover")}),e.hoverPoint&&e.hoverPoint.firePointEvent("mouseOut"),!i.series)return;e.hoverPoints=c,e.hoverPoint=i,i.firePointEvent("mouseOver",void 0,()=>{R&&i&&R.refresh(H?c:i,N)})}else if(h&&R&&!R.isHidden){let B=R.getAnchor([{}],N);e.isInsidePlot(B[0],B[1],{visiblePlotOnly:!0})&&R.updatePosition({plotX:B[0],plotY:B[1]})}this.unDocMouseMove||(this.unDocMouseMove=IO(e.container.ownerDocument,"mousemove",B=>$n[eT.hoverChartIndex??-1]?.pointer?.onDocumentMouseMove(B)),this.eventsToUnbind.push(this.unDocMouseMove)),e.axes.forEach(function(B){let Y,C=B.crosshair?.snap??!0;C&&((Y=e.hoverPoint)&&Y.series[B.coll]===B||(Y=dN(c,g=>g.series?.[B.coll]===B))),Y||!C?B.drawCrosshair(N,Y):B.hideCrosshair()})}setDOMEvents(){let N=this.chart.container,T=N.ownerDocument,I=M=>M.parentElement||M.getRootNode()?.host?.parentElement;N.onmousedown=this.onContainerMouseDown.bind(this),N.onmousemove=this.onContainerMouseMove.bind(this),N.onclick=this.onContainerClick.bind(this),this.eventsToUnbind.push(IO(N,"mouseenter",this.onContainerMouseEnter.bind(this)),IO(N,"mouseleave",this.onContainerMouseLeave.bind(this))),eT.unbindDocumentMouseUp.some(M=>M.doc===T)||eT.unbindDocumentMouseUp.push({doc:T,unbind:IO(T,"mouseup",this.onDocumentMouseUp.bind(this))});let e=I(this.chart.renderTo);for(;e&&e.tagName!=="BODY";)this.eventsToUnbind.push(IO(e,"scroll",()=>{delete this.chartPosition})),e=I(e);this.eventsToUnbind.push(IO(N,"touchstart",this.onContainerTouchStart.bind(this),{passive:!1}),IO(N,"touchmove",this.onContainerTouchMove.bind(this),{passive:!1})),eT.unbindDocumentTouchEnd||(eT.unbindDocumentTouchEnd=IO(T,"touchend",this.onDocumentTouchEnd.bind(this),{passive:!1})),this.setPointerCapture(),IO(this.chart,"redraw",this.setPointerCapture.bind(this))}setPointerCapture(){if(!$O)return;let N=this.pointerCaptureEventsToUnbind,T=this.chart,I=T.container,e=cn(T.options.tooltip?.followTouchMove,!0)&&T.series.some(M=>M.options.findNearestPointBy.indexOf("y")>-1);!this.hasPointerCapture&&e?(N.push(IO(I,"pointerdown",M=>{M.target?.hasPointerCapture(M.pointerId)&&M.target?.releasePointerCapture(M.pointerId)}),IO(I,"pointermove",M=>{T.pointer?.getPointFromEvent(M)?.onMouseOver(M)})),T.styledMode||pn(I,{"touch-action":"none"}),I.className+=" highcharts-no-touch-action",this.hasPointerCapture=!0):this.hasPointerCapture&&!e&&(N.forEach(M=>M()),N.length=0,T.styledMode||pn(I,{"touch-action":cn(T.options.chart.style?.["touch-action"],"manipulation")}),I.className=I.className.replace(" highcharts-no-touch-action",""),this.hasPointerCapture=!1)}setHoverChartIndex(N){let T=this.chart,I=z.charts[cn(eT.hoverChartIndex,-1)];if(I&&I!==T){let e={relatedTarget:T.container};N&&!N?.relatedTarget&&Object.assign({},N,e),I.pointer?.onContainerMouseLeave(N||e)}I?.mouseIsDown||(eT.hoverChartIndex=T.index)}touch(N,T){let I,{chart:e,pinchDown:M=[]}=this;this.setHoverChartIndex(),(N=this.normalize(N)).touches.length===1?e.isInsidePlot(N.chartX-e.plotLeft,N.chartY-e.plotTop,{visiblePlotOnly:!0})&&!e.exporting?.openMenu?(T&&this.runPointActions(N),N.type==="touchmove"&&(this.hasPinchMoved=I=!!M[0]&&Math.pow(M[0].chartX-N.chartX,2)+Math.pow(M[0].chartY-N.chartY,2)>=16),cn(I,!0)&&this.pinch(N)):T&&this.reset():N.touches.length===2&&this.pinch(N)}touchSelect(N){return!!(this.chart.zooming.singleTouch&&N.touches&&N.touches.length===1)}zoomOption(N){let T=this.chart,I=T.inverted,e=T.zooming.type||"",M,R;/touch/.test(N.type)&&(e=cn(T.zooming.pinchType,e)),this.zoomX=M=/x/.test(e),this.zoomY=R=/y/.test(e),this.zoomHor=M&&!I||R&&I,this.zoomVert=R&&!I||M&&I,this.hasZoom=M||R}}eT.unbindDocumentMouseUp=[],(CE=eT||(eT={})).compose=function(A){AR(wT,"Core.Pointer")&&IO(A,"beforeRender",function(){this.pointer=new CE(this,this.options)})};let yO=eT;(HE=mO||(mO={})).setLength=function(A,N,T){return Array.isArray(A)?(A.length=N,A):A[T?"subarray":"slice"](0,N)},HE.splice=function(A,N,T,I,e=[]){if(Array.isArray(A))return Array.isArray(e)||(e=Array.from(e)),{removed:A.splice(N,T,...e),array:A};let M=Object.getPrototypeOf(A).constructor,R=A[I?"subarray":"slice"](N,N+T),s=new M(A.length-T+e.length);return s.set(A.subarray(0,N),0),s.set(e,N),s.set(A.subarray(N+T),N+e.length),{removed:R,array:s}},HE.convertToNumber=function(A,N){switch(typeof A){case"boolean":return+!!A;case"number":return isNaN(A)&&!N?null:A;default:return isNaN(A=parseFloat(`${A??""}`))&&!N?null:A}};let{setLength:L_,splice:ds}=mO,{fireEvent:Gs,objectEach:rM,uniqueKey:SR}=tN,PM=class{constructor(A={}){this.autoId=!A.id,this.columns={},this.id=A.id||SR(),this.rowCount=0,this.versionTag=SR();let N=0;rM(A.columns||{},(T,I)=>{this.columns[I]=T.slice(),N=Math.max(N,T.length)}),this.applyRowCount(N)}applyRowCount(A){this.rowCount=A,rM(this.columns,(N,T)=>{N.length!==A&&(this.columns[T]=L_(N,A))})}deleteRows(A,N=1){if(N>0&&A<this.rowCount){let T=0;rM(this.columns,(I,e)=>{this.columns[e]=ds(I,A,N).array,T=I.length}),this.rowCount=T}Gs(this,"afterDeleteRows",{rowIndex:A,rowCount:N}),this.versionTag=SR()}getColumn(A,N){return this.columns[A]}getColumns(A,N){return(A||Object.keys(this.columns)).reduce((T,I)=>(T[I]=this.columns[I],T),{})}getRow(A,N){return(N||Object.keys(this.columns)).map(T=>this.columns[T]?.[A])}setColumn(A,N=[],T=0,I){this.setColumns({[A]:N},T,I)}setColumns(A,N,T){let I=this.rowCount;rM(A,(e,M)=>{this.columns[M]=e.slice(),I=e.length}),this.applyRowCount(I),T?.silent||(Gs(this,"afterSetColumns"),this.versionTag=SR())}setRow(A,N=this.rowCount,T,I){let{columns:e}=this,M=T?this.rowCount+1:N+1,R=Object.keys(A);if(I?.addColumns!==!1)for(let s=0,i=R.length;s<i;s++){let l=R[s];e[l]||(e[l]=[])}rM(e,(s,i)=>{s||I?.addColumns===!1||(s=Array(M)),s&&(T?s=ds(s,N,0,!0,[A[i]??null]).array:s[N]=A[i]??null,e[i]=s)}),M>this.rowCount&&this.applyRowCount(M),I?.silent||(Gs(this,"afterSetRows"),this.versionTag=SR())}getModified(){return this.modified||this}},{extend:c_,merge:h_,pick:HT}=tN;var UO=WO||(WO={});function lR(A,N,T){let I=this.legendItem=this.legendItem||{},{chart:e,options:M}=this,{baseline:R=0,symbolWidth:s,symbolHeight:i}=A,l=this.symbol||"circle",D=i/2,P=e.renderer,c=I.group,h=R-Math.round((A.fontMetrics?.b||i)*(T?.4:.3)),H={},B,Y=M.marker,C=0;if(e.styledMode||(H["stroke-width"]=Math.min(M.lineWidth||0,24),M.dashStyle?H.dashstyle=M.dashStyle:M.linecap!=="square"&&(H["stroke-linecap"]="round")),I.line=P.path().addClass("highcharts-graph").attr(H).add(c),T&&(I.area=P.path().addClass("highcharts-area").add(c)),H["stroke-linecap"]&&(C=Math.min(I.line.strokeWidth(),s)/2),s){let g=[["M",C,h],["L",s-C,h]];I.line.attr({d:g}),I.area?.attr({d:[...g,["L",s-C,R],["L",C,R]]})}if(Y&&Y.enabled!==!1&&s){let g=Math.min(HT(Y.radius,D),D);l.indexOf("url")===0&&(Y=h_(Y,{width:i,height:i}),g=0),I.symbol=B=P.symbol(l,s/2-g,h-g,2*g,2*g,c_({context:"legend"},Y)).addClass("highcharts-point").add(c),B.isMarker=!0}}UO.areaMarker=function(A,N){lR.call(this,A,N,!0)},UO.lineMarker=lR,UO.rectangle=function(A,N){let T=N.legendItem||{},I=A.options,e=A.symbolHeight,M=I.squareSymbol,R=M?e:A.symbolWidth;T.symbol=this.chart.renderer.rect(M?(A.symbolWidth-e)/2:0,A.baseline-e+1,R,e,HT(A.options.symbolRadius,e/2)).addClass("highcharts-point").attr({zIndex:3}).add(T.group)};let aM=WO,{defaultOptions:rR}=fO,{extend:d_,extendClass:Nt,merge:us}=tN;var Vn=vO||(vO={});function Ys(A,N){let T=rR.plotOptions||{},I=N.defaultOptions,e=N.prototype;return e.type=A,e.pointClass||(e.pointClass=rO),!Vn.seriesTypes[A]&&(I&&(T[A]=I),Vn.seriesTypes[A]=N,!0)}Vn.seriesTypes=z.seriesTypes,Vn.registerSeriesType=Ys,Vn.seriesType=function(A,N,T,I,e){let M=rR.plotOptions||{};if(N=N||"",M[A]=us(M[N],T),delete Vn.seriesTypes[A],Ys(A,Nt(Vn.seriesTypes[N]||z.Series,I)),Vn.seriesTypes[A].prototype.type=A,e){class R extends rO{}d_(R.prototype,e),Vn.seriesTypes[A].prototype.pointClass=R}return Vn.seriesTypes[A]};let BO=vO,{animObject:G_,setAnimation:ui}=FO,{defaultOptions:PR}=fO,{registerEventOptions:Yi}=ft,{svg:Hi,win:u_}=z,{seriesTypes:Ce}=BO,{format:NA}=GT,{arrayMax:Hs,arrayMin:Y_,clamp:H_,correctFloat:Cs,crisp:Ci,defined:XO,destroyObjectProperties:Bi,diffObjects:bi,erase:C_,error:Bs,extend:Be,find:DM,fireEvent:DO,getClosestDistance:bs,getNestedProperty:aR,insertItem:B_,isArray:ms,isNumber:MT,isString:mi,merge:LM,objectEach:fs,pick:GO,removeEvent:fi,syncTimeout:ps}=tN;class gn{constructor(){this.zoneAxis="y"}init(N,T){let I;DO(this,"init",{options:T}),this.dataTable??(this.dataTable=new PM);let e=N.series;this.eventsToUnbind=[],this.chart=N,this.options=this.setOptions(T);let M=this.options,R=M.visible!==!1;this.linkedSeries=[],this.bindAxes(),Be(this,{name:M.name,state:"",visible:R,selected:M.selected===!0}),Yi(this,M),(M.events?.click||M.point?.events?.click||M.allowPointSelect)&&(N.runTrackerClick=!0),this.getColor(),this.getSymbol(),this.isCartesian&&(N.hasCartesianSeries=!0),e.length&&(I=e[e.length-1]),this._i=GO(I?._i,-1)+1,this.opacity=this.options.opacity,N.orderItems("series",B_(this,e)),M.dataSorting?.enabled?this.setDataSortingOptions():this.points||this.data||this.setData(M.data,!1),DO(this,"afterInit")}is(N){return Ce[N]&&this instanceof Ce[N]}bindAxes(){let N,T=this,I=T.options,e=T.chart;DO(this,"bindAxes",null,function(){(T.axisTypes||[]).forEach(function(M){(e[M]||[]).forEach(function(R){N=R.options,(GO(I[M],0)===R.index||I[M]!==void 0&&I[M]===N.id)&&(B_(T,R.series),T[M]=R,R.isDirty=!0)}),T[M]||T.optionalAxis===M||Bs(18,!0,e)})}),DO(this,"afterBindAxes")}hasData(){return this.visible&&this.dataMax!==void 0&&this.dataMin!==void 0||this.visible&&this.dataTable.rowCount>0}hasMarkerChanged(N,T){let I=N.marker,e=T.marker||{};return I&&(e.enabled&&!I.enabled||e.symbol!==I.symbol||e.height!==I.height||e.width!==I.width)}autoIncrement(N){let T,I=this.options,{pointIntervalUnit:e,relativeXValue:M}=this.options,R=this.chart.time,s=this.xIncrement??R.parse(I.pointStart)??0;if(this.pointInterval=T=GO(this.pointInterval,I.pointInterval,1),M&&MT(N)&&(T*=N),e){let i=R.toParts(s);e==="day"?i[2]+=T:e==="month"?i[1]+=T:e==="year"&&(i[0]+=T),T=R.makeTime.apply(R,i)-s}return M&&MT(N)?s+T:(this.xIncrement=s+T,s)}setDataSortingOptions(){let N=this.options;Be(this,{requireSorting:!1,sorted:!1,enabledDataSorting:!0,allowDG:!1}),XO(N.pointRange)||(N.pointRange=1)}setOptions(N){let T,I=this.chart,e=I.options.plotOptions,M=I.userOptions||{},R=LM(N),s=I.styledMode,i={plotOptions:e,userOptions:R};DO(this,"setOptions",i);let l=i.plotOptions[this.type],D=M.plotOptions||{},P=D.series||{},c=PR.plotOptions[this.type]||{},h=D[this.type]||{};l.dataLabels=this.mergeArrays(c.dataLabels,l.dataLabels),this.userOptions=i.userOptions;let H=LM(l,e.series,h,R);this.tooltipOptions=LM(PR.tooltip,PR.plotOptions.series?.tooltip,c?.tooltip,I.userOptions.tooltip,D.series?.tooltip,h.tooltip,R.tooltip),this.stickyTracking=GO(R.stickyTracking,h.stickyTracking,P.stickyTracking,!!this.tooltipOptions.shared&&!this.noSharedTooltip||H.stickyTracking),l.marker===null&&delete H.marker,this.zoneAxis=H.zoneAxis||"y";let B=this.zones=(H.zones||[]).map(Y=>({...Y}));return(H.negativeColor||H.negativeFillColor)&&!H.zones&&(T={value:H[this.zoneAxis+"Threshold"]||H.threshold||0,className:"highcharts-negative"},s||(T.color=H.negativeColor,T.fillColor=H.negativeFillColor),B.push(T)),B.length&&XO(B[B.length-1].value)&&B.push(s?{}:{color:this.color,fillColor:this.fillColor}),DO(this,"afterSetOptions",{options:H}),H}getName(){return this.options.name??NA(this.chart.options.lang.seriesName,this,this.chart)}getCyclic(N,T,I){let e,M,R=this.chart,s=`${N}Index`,i=`${N}Counter`,l=I?.length||R.options.chart.colorCount;!T&&(XO(M=GO(N==="color"?this.options.colorIndex:void 0,this[s]))?e=M:(R.series.length||(R[i]=0),e=R[i]%l,R[i]+=1),I&&(T=I[e])),e!==void 0&&(this[s]=e),this[N]=T}getColor(){this.chart.styledMode?this.getCyclic("color"):this.options.colorByPoint?this.color="#cccccc":this.getCyclic("color",this.options.color||PR.plotOptions[this.type].color,this.chart.options.colors)}getPointsCollection(){return(this.hasGroupedData?this.points:this.data)||[]}getSymbol(){let N=this.options.marker;this.getCyclic("symbol",N.symbol,this.chart.options.symbols)}getColumn(N,T){return(T?this.dataTable.getModified():this.dataTable).getColumn(N,!0)||[]}findPointIndex(N,T){let I,e,M,{id:R,x:s}=N,i=this.points,l=this.options.dataSorting,D=this.cropStart||0;if(R){let P=this.chart.get(R);P instanceof rO&&(I=P)}else if(this.linkedParent||this.enabledDataSorting||this.options.relativeXValue){let P=c=>!c.touched&&c.index===N.index;if(l?.matchByName?P=c=>!c.touched&&c.name===N.name:this.options.relativeXValue&&(P=c=>!c.touched&&c.options.x===N.x),!(I=DM(i,P)))return}return I&&(M=I?.index)!==void 0&&(e=!0),M===void 0&&MT(s)&&(M=this.getColumn("x").indexOf(s,T)),M!==-1&&M!==void 0&&this.cropped&&(M=M>=D?M-D:M),!e&&MT(M)&&i[M]?.touched&&(M=void 0),M}updateData(N,T){let{options:I,requireSorting:e}=this,M=I.dataSorting,R=this.points,s=[],i=N.length===R.length,l=this.xIncrement,D,P,c,h,H=!0;if(this.xIncrement=null,N.forEach((Y,C)=>{let g,x=XO(Y)&&this.pointClass.prototype.optionsToObject.call({series:this},Y)||{},{id:j,x:Z}=x;j||MT(Z)?((g=this.findPointIndex(x,h))===-1||g===void 0?s.push(Y):R[g]&&Y!==I.data?.[g]?(R[g].update(Y,!1,void 0,!1),R[g].touched=!0,e&&(h=g+1)):R[g]&&(R[g].touched=!0),(!i||C!==g||M?.enabled||this.hasDerivedData)&&(D=!0)):s.push(Y)},this),D)for(P=R.length;P--;)(c=R[P])&&!c.touched&&c.remove?.(!1,T);else i&&!M?.enabled?(N.forEach((Y,C)=>{Y===R[C].y||R[C].destroyed||R[C].update(Y,!1,void 0,!1)}),s.length=0):H=!1;if(R.forEach(Y=>{Y&&(Y.touched=!1)}),!H)return!1;s.forEach(Y=>{this.addPoint(Y,!1,void 0,void 0,!1)},this);let B=this.getColumn("x");return l!==null&&this.xIncrement===null&&B.length&&(this.xIncrement=Hs(B),this.autoIncrement()),!0}dataColumnKeys(){return["x",...this.pointArrayMap||["y"]]}setData(N,T=!0,I,e){let M=this.points,R=M?.length||0,s=this.options,i=this.chart,l=s.dataSorting,D=this.xAxis,P=s.turboThreshold,c=this.dataTable,h=this.dataColumnKeys(),H=this.pointValKey||"y",B=(this.pointArrayMap||[]).length,Y=s.keys,C,g,x=0,j=1,Z;i.options.chart.allowMutatingData||(s.data&&delete this.options.data,this.userOptions.data&&delete this.userOptions.data,Z=LM(!0,N));let W=(N=Z||N||[]).length;if(l?.enabled&&(N=this.sortData(N)),i.options.chart.allowMutatingData&&e!==!1&&W&&R&&!this.cropped&&!this.hasGroupedData&&this.visible&&!this.boosted&&(g=this.updateData(N,I)),!g){this.xIncrement=null,this.colorCounter=0;let J=P&&!s.relativeXValue&&W>P;if(J){let $=this.getFirstValidPoint(N),PE=this.getFirstValidPoint(N,W-1,-1),aE=lE=>!!(ms(lE)&&(Y||MT(lE[0])));if(MT($)&&MT(PE)){let lE=[],mE=[];for(let vE of N)lE.push(this.autoIncrement()),mE.push(vE);c.setColumns({x:lE,[H]:mE})}else if(aE($)&&aE(PE))if(B){let lE=+($.length===B),mE=Array(h.length).fill(0).map(()=>[]);for(let vE of N){lE&&mE[0].push(this.autoIncrement());for(let XE=lE;XE<=B;XE++)mE[XE]?.push(vE[XE-lE])}c.setColumns(h.reduce((vE,XE,NN)=>(vE[XE]=mE[NN],vE),{}))}else{Y&&(x=Y.indexOf("x"),j=Y.indexOf("y"),x=x>=0?x:0,j=j>=0?j:1),$.length===1&&(j=0);let lE=[],mE=[];if(x===j)for(let vE of N)lE.push(this.autoIncrement()),mE.push(vE[j]);else for(let vE of N)lE.push(vE[x]),mE.push(vE[j]);c.setColumns({x:lE,[H]:mE})}else J=!1}if(!J){let $=h.reduce((PE,aE)=>(PE[aE]=[],PE),{});for(C=0;C<W;C++){let PE=this.pointClass.prototype.applyOptions.apply({series:this},[N[C]]);for(let aE of h)$[aE][C]=PE[aE]}c.setColumns($)}for(mi(this.getColumn("y")[0])&&Bs(14,!0,i),this.data=[],this.options.data=this.userOptions.data=N,C=R;C--;)M[C]?.destroy();D&&(D.minRange=D.userMinRange),this.isDirty=i.isDirtyBox=!0,this.isDirtyData=!!M,I=!1}s.legendType==="point"&&(this.processData(),this.generatePoints()),T&&i.redraw(I)}sortData(N){let T=this,I=T.options.dataSorting.sortKey||"y",e=function(M,R){return XO(R)&&M.pointClass.prototype.optionsToObject.call({series:M},R)||{}};return N.forEach(function(M,R){N[R]=e(T,M),N[R].index=R},this),N.concat().sort((M,R)=>{let s=aR(I,M),i=aR(I,R);return i<s?-1:+(i>s)}).forEach(function(M,R){M.x=R},this),T.linkedSeries&&T.linkedSeries.forEach(function(M){let R=M.options,s=R.data;!R.dataSorting?.enabled&&s&&(s.forEach(function(i,l){s[l]=e(M,i),N[l]&&(s[l].x=N[l].x,s[l].index=l)}),M.setData(s,!1))}),N}getProcessedData(N){let T=this,{dataTable:I,isCartesian:e,options:M,xAxis:R}=T,s=M.cropThreshold,i=N||T.getExtremesFromAll,l=R?.logarithmic,D=I.rowCount,P,c,h=0,H,B,Y,C=T.getColumn("x"),g=I,x=!1;return R&&(B=(H=R.getExtremes()).min,Y=H.max,x=!!(R.categories&&!R.names.length),e&&T.sorted&&!i&&(!s||D>s||T.forceCrop)&&(C[D-1]<B||C[0]>Y?g=new PM:T.getColumn(T.pointValKey||"y").length&&(C[0]<B||C[D-1]>Y)&&(g=(P=this.cropData(I,B,Y)).modified,h=P.start,c=!0))),C=g.getColumn("x")||[],{modified:g,cropped:c,cropStart:h,closestPointRange:bs([l?C.map(l.log2lin):C],()=>T.requireSorting&&!x&&Bs(15,!1,T.chart))}}processData(N){let T=this.xAxis,I=this.dataTable;if(this.isCartesian&&!this.isDirty&&!T.isDirty&&!this.yAxis.isDirty&&!N)return!1;let e=this.getProcessedData();I.modified=e.modified,this.cropped=e.cropped,this.cropStart=e.cropStart,this.closestPointRange=this.basePointRange=e.closestPointRange,DO(this,"afterProcessData")}cropData(N,T,I){let e=N.getColumn("x",!0)||[],M=e.length,R={},s,i,l=0,D=M;for(s=0;s<M;s++)if(e[s]>=T){l=Math.max(0,s-1);break}for(i=s;i<M;i++)if(e[i]>I){D=i+1;break}for(let P of this.dataColumnKeys()){let c=N.getColumn(P,!0);c&&(R[P]=c.slice(l,D))}return{modified:new PM({columns:R}),start:l,end:D}}generatePoints(){let N=this.options,T=this.processedData||N.data,I=this.dataTable.getModified(),e=this.getColumn("x",!0),M=this.pointClass,R=I.rowCount,s=this.cropStart||0,i=this.hasGroupedData,l=N.keys,D=[],P=N.dataGrouping?.groupAll?s:0,c=this.pointArrayMap||["y"],h=this.dataColumnKeys(),H,B,Y,C,g=this.data,x;if(!g&&!i){let j=[];j.length=T?.length||0,g=this.data=j}for(l&&i&&(this.options.keys=!1),C=0;C<R;C++)B=s+C,i?((Y=new M(this,I.getRow(C,h)||[])).dataGroup=this.groupMap?.[P+C],Y.dataGroup?.options&&(Y.options=Y.dataGroup.options,Be(Y,Y.dataGroup.options),delete Y.dataLabels,Y.key=Y.name??Y.category)):(Y=g[B],x=T?T[B]:I.getRow(C,c),Y||x===void 0?Y&&(Y.category=this.xAxis?.categories?.[Y.x]??Y.x,Y.key=Y.name??Y.category):g[B]=Y=new M(this,x,e[C])),Y&&(Y.index=i?P+C:B,D[C]=Y);if(this.options.keys=l,g&&(R!==(H=g.length)||i))for(C=0;C<H;C++)C!==s||i||(C+=R),g[C]&&(g[C].destroyElements(),g[C].plotX=void 0);this.data=g,this.points=D,DO(this,"afterGeneratePoints")}getXExtremes(N){return{min:Y_(N),max:Hs(N)}}getExtremes(N,T){let{xAxis:I,yAxis:e}=this,M=T||this.getExtremesFromAll||this.options.getExtremesFromAll,R=M&&this.cropped?this.dataTable:this.dataTable.getModified(),s=R.rowCount,i=N||this.stackedYData,l=i?[i]:(this.keysAffectYAxis||this.pointArrayMap||["y"])?.map(Z=>R.getColumn(Z,!0)||[])||[],D=this.getColumn("x",!0),P=[],c=this.requireSorting&&!this.is("column")?1:0,h=!!e&&e.positiveValuesOnly,H=M||this.cropped||!I,B,Y,C,g=0,x=0;for(I&&(g=(B=I.getExtremes()).min,x=B.max),C=0;C<s;C++)if(Y=D[C],H||(D[C+c]||Y)>=g&&(D[C-c]||Y)<=x)for(let Z of l){let W=Z[C];MT(W)&&(W>0||!h)&&P.push(W)}let j={activeYData:P,dataMin:Y_(P),dataMax:Hs(P)};return DO(this,"afterGetExtremes",{dataExtremes:j}),j}applyExtremes(){let N=this.getExtremes();return this.dataMin=N.dataMin,this.dataMax=N.dataMax,N}getFirstValidPoint(N,T=0,I=1){let e=N.length,M=T;for(;M>=0&&M<e;){if(XO(N[M]))return N[M];M+=I}}translate(){this.generatePoints();let N=this.options,T=N.stacking,I=this.xAxis,e=this.enabledDataSorting,M=this.yAxis,R=this.points,s=R.length,i=this.pointPlacementToXValue(),l=!!i,D=N.threshold,P=N.startFromThreshold?D:0,c=N?.nullInteraction&&M.len,h,H,B,Y,C=Number.MAX_VALUE;function g(x){return H_(x,-1e9,1e9)}for(h=0;h<s;h++){let x,j=R[h],Z=j.x,W,J,$=j.y,PE=j.low,aE=T&&M.stacking?.stacks[(this.negStacks&&$<(P?0:D)?"-":"")+this.stackKey];j.plotX=MT(H=I.translate(Z,!1,!1,!1,!0,i))?Cs(g(H)):void 0,T&&this.visible&&aE&&aE[Z]&&(Y=this.getStackIndicator(Y,Z,this.index),!j.isNull&&Y.key&&(J=(W=aE[Z]).points[Y.key]),W&&ms(J)&&(PE=J[0],$=J[1],PE===P&&Y.key===aE[Z].base&&(PE=GO(MT(D)?D:M.min)),M.positiveValuesOnly&&XO(PE)&&PE<=0&&(PE=void 0),j.total=j.stackTotal=GO(W.total),j.percentage=XO(j.y)&&W.total?j.y/W.total*100:void 0,j.stackY=$,this.irregularWidths||W.setOffset(this.pointXOffset||0,this.barW||0,void 0,void 0,void 0,this.xAxis))),j.yBottom=XO(PE)?g(M.translate(PE,!1,!0,!1,!0)):void 0,this.dataModify&&($=this.dataModify.modifyValue($,h)),MT($)&&j.plotX!==void 0?x=MT(x=M.translate($,!1,!0,!1,!0))?g(x):void 0:!MT($)&&c&&(x=c),j.plotY=x,j.isInside=this.isPointInside(j),j.clientX=l?Cs(I.translate(Z,!1,!1,!1,!0,i)):H,j.negative=(j.y||0)<(D||0),j.isNull||j.visible===!1||(B!==void 0&&(C=Math.min(C,Math.abs(H-B))),B=H),j.zone=this.zones.length?j.getZone():void 0,!j.graphic&&this.group&&e&&(j.isNew=!0)}this.closestPointRangePx=C,DO(this,"afterTranslate")}getValidPoints(N,T,I){let e=this.chart;return(N||this.points||[]).filter(function(M){let{plotX:R,plotY:s}=M;return(!!I||!M.isNull&&!!MT(s))&&(!T||!!e.isInsidePlot(R,s,{inverted:e.inverted}))&&M.visible!==!1})}getSharedClipKey(){return this.sharedClipKey=(this.options.xAxis||0)+","+(this.options.yAxis||0),this.sharedClipKey}setClip(){let{chart:N,group:T,markerGroup:I}=this,e=N.sharedClips,M=N.renderer,R=N.getClipBox(this),s=this.getSharedClipKey(),i=e[s];DO(this,"setClip",{clipBox:R}),i?i.animate(R):e[s]=i=M.clipRect(R),T&&T.clip(this.options.clip===!1?void 0:i),I&&I.clip()}animate(N){let{chart:T,group:I,markerGroup:e}=this,M=T.inverted,R=G_(this.options.animation),s=[this.getSharedClipKey(),R.duration,R.easing,R.defer].join(","),i=T.sharedClips[s],l=T.sharedClips[s+"m"];if(N&&I){let D=T.getClipBox(this);if(i)i.attr("height",D.height);else{D.width=0,M&&(D.x=T.plotHeight),i=T.renderer.clipRect(D),T.sharedClips[s]=i;let P={x:-99,y:-99,width:M?T.plotWidth+199:99,height:M?99:T.plotHeight+199};l=T.renderer.clipRect(P),T.sharedClips[s+"m"]=l}I.clip(i),e?.clip(l)}else if(i&&!i.hasClass("highcharts-animating")){let D=T.getClipBox(this),P=R.step;(e?.element.childNodes.length||T.series.length>1)&&(R.step=function(c,h){P&&P.apply(h,arguments),h.prop==="width"&&l?.element&&l.attr(M?"height":"width",c+99)}),i.addClass("highcharts-animating").animate(D,R)}}afterAnimate(){this.setClip(),fs(this.chart.sharedClips,(N,T,I)=>{N&&!this.chart.container.querySelector(`[clip-path="url(#${N.id})"]`)&&(N.destroy(),delete I[T])}),this.finishedAnimating=!0,DO(this,"afterAnimate")}drawPoints(N=this.points){let T,I,e,M,R,s,i,l=this.chart,D=l.styledMode,{colorAxis:P,options:c}=this,h=c.marker,H=c.nullInteraction,B=this[this.specialGroup||"markerGroup"],Y=this.xAxis,C=GO(h.enabled,!Y||!!Y.isRadial||null,this.closestPointRangePx>=h.enabledThreshold*h.radius);if(h.enabled!==!1||this._hasPointMarkers)for(T=0;T<N.length;T++){M=(e=(I=N[T]).graphic)?"animate":"attr",R=I.marker||{},s=!!I.marker;let g=I.isNull;if((C&&!XO(R.enabled)||R.enabled)&&(!g||H)&&I.visible!==!1){let x=GO(R.symbol,this.symbol,"rect");i=this.markerAttribs(I,I.selected&&"select"),this.enabledDataSorting&&(I.startXPos=Y.reversed?-(i.width||0):Y.width);let j=I.isInside!==!1;if(!e&&j&&((i.width||0)>0||I.hasImage)&&(I.graphic=e=l.renderer.symbol(x,i.x,i.y,i.width,i.height,s?R:h).add(B),this.enabledDataSorting&&l.hasRendered&&(e.attr({x:I.startXPos}),M="animate")),e&&M==="animate"&&e[j?"show":"hide"](j).animate(i),e){let Z=this.pointAttribs(I,D||!I.selected?void 0:"select");D?P&&e.css({fill:Z.fill}):e[M](Z)}e&&e.addClass(I.getClassName(),!0)}else e&&(I.graphic=e.destroy())}}markerAttribs(N,T){let I=this.options,e=I.marker,M=N.marker||{},R=M.symbol||e.symbol,s={},i,l,D=GO(M.radius,e?.radius);T&&(i=e.states[T],l=M.states&&M.states[T],D=GO(l?.radius,i?.radius,D&&D+(i?.radiusPlus||0))),N.hasImage=R&&R.indexOf("url")===0,N.hasImage&&(D=0);let P=N.pos();return MT(D)&&P&&(I.crisp&&(P[0]=Ci(P[0],N.hasImage?0:R==="rect"?e?.lineWidth||0:1)),s.x=P[0]-D,s.y=P[1]-D),D&&(s.width=s.height=2*D),s}pointAttribs(N,T){let I=this.options,e=I.marker,M=N?.options,R=M?.marker||{},s=M?.color,i=N?.color,l=N?.zone?.color,D,P,c=this.color,h,H,B=GO(R.lineWidth,e.lineWidth),Y=N?.isNull&&I.nullInteraction?0:1;return c=s||l||i||c,h=R.fillColor||e.fillColor||c,H=R.lineColor||e.lineColor||c,T=T||"normal",D=e.states[T]||{},B=GO((P=R.states&&R.states[T]||{}).lineWidth,D.lineWidth,B+GO(P.lineWidthPlus,D.lineWidthPlus,0)),h=P.fillColor||D.fillColor||h,H=P.lineColor||D.lineColor||H,{stroke:H,"stroke-width":B,fill:h,opacity:Y=GO(P.opacity,D.opacity,Y)}}destroy(N){let T,I,e=this,M=e.chart,R=/AppleWebKit\/533/.test(u_.navigator.userAgent),s=e.data||[];for(DO(e,"destroy",{keepEventsForUpdate:N}),this.removeEvents(N),(e.axisTypes||[]).forEach(function(i){I=e[i],I?.series&&(C_(I.series,e),I.isDirty=I.forceRedraw=!0)}),e.legendItem&&e.chart.legend.destroyItem(e),T=s.length;T--;)s[T]?.destroy?.();for(let i of e.zones)Bi(i,void 0,!0);tN.clearTimeout(e.animationTimeout),fs(e,function(i,l){i instanceof Pn&&!i.survive&&i[R&&l==="group"?"hide":"destroy"]()}),M.hoverSeries===e&&(M.hoverSeries=void 0),C_(M.series,e),M.orderItems("series"),fs(e,function(i,l){N&&l==="hcEvents"||delete e[l]})}applyZones(){let{area:N,chart:T,graph:I,zones:e,points:M,xAxis:R,yAxis:s,zoneAxis:i}=this,{inverted:l,renderer:D}=T,P=this[`${i}Axis`],{isXAxis:c,len:h=0,minPointOffset:H=0}=P||{},B=(I?.strokeWidth()||0)/2+1,Y=(C,g=0,x=0)=>{l&&(x=h-x);let{translated:j=0,lineClip:Z}=C,W=x-j;Z?.push(["L",g,Math.abs(W)<B?x-B*(W<=0?-1:1):j])};if(e.length&&(I||N)&&P&&MT(P.min)){let C=P.getExtremes().max+H,g=Z=>{Z.forEach((W,J)=>{(W[0]==="M"||W[0]==="L")&&(Z[J]=[W[0],c?h-W[1]:W[1],c?W[2]:h-W[2]])})};if(e.forEach(Z=>{Z.lineClip=[],Z.translated=H_(P.toPixels(GO(Z.value,C),!0)||0,0,h)}),I&&!this.showLine&&I.hide(),N&&N.hide(),i==="y"&&M.length<R.len)for(let Z of M){let{plotX:W,plotY:J,zone:$}=Z,PE=$&&e[e.indexOf($)-1];$&&Y($,W,J),PE&&Y(PE,W,J)}let x=[],j=P.toPixels(P.getExtremes().min-H,!0);e.forEach(Z=>{let W=Z.lineClip||[],J=Math.round(Z.translated||0);R.reversed&&W.reverse();let{clip:$,simpleClip:PE}=Z,aE=0,lE=0,mE=R.len,vE=s.len;c?(aE=J,mE=j):(lE=J,vE=j);let XE=[["M",aE,lE],["L",mE,lE],["L",mE,vE],["L",aE,vE],["Z"]],NN=[XE[0],...W,XE[1],XE[2],...x,XE[3],XE[4]];x=W.reverse(),j=J,l&&(g(NN),N&&g(XE)),$?($.animate({d:NN}),PE?.animate({d:XE})):($=Z.clip=D.path(NN),N&&(PE=Z.simpleClip=D.path(XE))),I&&Z.graph?.clip($),N&&Z.area?.clip(PE)})}else this.visible&&(I&&I.show(),N&&N.show())}plotGroup(N,T,I,e,M){let R=this[N],s=!R,i={visibility:I,zIndex:e||.1};return XO(this.opacity)&&!this.chart.styledMode&&this.state!=="inactive"&&(i.opacity=this.opacity),R||(this[N]=R=this.chart.renderer.g().add(M)),R.addClass("highcharts-"+T+" highcharts-series-"+this.index+" highcharts-"+this.type+"-series "+(XO(this.colorIndex)?"highcharts-color-"+this.colorIndex+" ":"")+(this.options.className||"")+(R.hasClass("highcharts-tracker")?" highcharts-tracker":""),!0),R.attr(i)[s?"attr":"animate"](this.getPlotBox(T)),R}getPlotBox(N){let T=this.xAxis,I=this.yAxis,e=this.chart,M=e.inverted&&!e.polar&&T&&this.invertible&&N==="series";e.inverted&&(T=I,I=this.xAxis);let R={scale:1,translateX:T?T.left:e.plotLeft,translateY:I?I.top:e.plotTop,name:N};DO(this,"getPlotBox",R);let{scale:s,translateX:i,translateY:l}=R;return{translateX:i,translateY:l,rotation:90*!!M,rotationOriginX:M?s*(T.len-I.len)/2:0,rotationOriginY:M?s*(T.len+I.len)/2:0,scaleX:M?-s:s,scaleY:s}}removeEvents(N){let{eventsToUnbind:T}=this;N||fi(this),T.length&&(T.forEach(I=>{I()}),T.length=0)}render(){let N=this,{chart:T,options:I,hasRendered:e}=N,M=G_(I.animation),R=N.visible?"inherit":"hidden",s=I.zIndex,i=T.seriesGroup,l=N.finishedAnimating?0:M.duration;DO(this,"render"),N.plotGroup("group","series",R,s,i),N.markerGroup=N.plotGroup("markerGroup","markers",R,s,i),I.clip!==!1&&N.setClip(),l&&N.animate?.(!0),N.drawGraph&&(N.drawGraph(),N.applyZones()),N.visible&&N.drawPoints(),N.drawDataLabels?.(),N.redrawPoints?.(),I.enableMouseTracking&&N.drawTracker?.(),l&&N.animate?.(),e||(l&&M.defer&&(l+=M.defer),N.animationTimeout=ps(()=>{N.afterAnimate()},l||0)),N.isDirty=!1,N.hasRendered=!0,DO(N,"afterRender")}redraw(){let N=this.isDirty||this.isDirtyData;this.translate(),this.render(),N&&delete this.kdTree}reserveSpace(){return this.visible||!this.chart.options.chart.ignoreHiddenSeries}searchPoint(N,T){let{xAxis:I,yAxis:e}=this,M=this.chart.inverted;return this.searchKDTree({clientX:M?I.len-N.chartY+I.pos:N.chartX-I.pos,plotY:M?e.len-N.chartX+e.pos:N.chartY-e.pos},T,N)}buildKDTree(N){this.buildingKdTree=!0;let T=this,I=T.options,e=I.findNearestPointBy.indexOf("y")>-1?2:1;delete T.kdTree,ps(function(){T.kdTree=(function M(R,s,i){let l,D,P=R?.length;if(P)return l=T.kdAxisArray[s%i],R.sort((c,h)=>(c[l]||0)-(h[l]||0)),{point:R[D=Math.floor(P/2)],left:M(R.slice(0,D),s+1,i),right:M(R.slice(D+1),s+1,i)}})(T.getValidPoints(void 0,!T.directTouch,I?.nullInteraction),e,e),T.buildingKdTree=!1},I.kdNow||N?.type==="touchstart"?0:1)}searchKDTree(N,T,I,e,M){let R=this,[s,i]=this.kdAxisArray,l=T?"distX":"dist",D=(R.options.findNearestPointBy||"").indexOf("y")>-1?2:1,P=!!R.isBubble,c=e||((H,B,Y)=>{let C=H[Y]||0,g=B[Y]||0;return[C===g&&H.index>B.index||C<g?H:B,!1]}),h=M||((H,B)=>H<B);if(this.kdTree||this.buildingKdTree||this.buildKDTree(I),this.kdTree)return(function H(B,Y,C,g){let x,j,Z,W,J,$,PE,aE=Y.point,lE=R.kdAxisArray[C%g],mE=aE,vE=!1;x=B[s],j=aE[s],Z=XO(x)&&XO(j)?x-j:null,W=B[i],J=aE[i],$=XO(W)&&XO(J)?W-J:0,PE=P&&aE.marker?.radius||0,aE.dist=Math.sqrt((Z&&Z*Z||0)+$*$)-PE,aE.distX=XO(Z)?Math.abs(Z)-PE:Number.MAX_VALUE;let XE=(B[lE]||0)-(aE[lE]||0)+(P&&aE.marker?.radius||0),NN=XE<0?"left":"right",JE=XE<0?"right":"left";return Y[NN]&&([mE,vE]=c(aE,H(B,Y[NN],C+1,g),l)),Y[JE]&&h(Math.sqrt(XE*XE),mE[l],vE)&&(mE=c(mE,H(B,Y[JE],C+1,g),l)[0]),mE})(N,this.kdTree,D,D)}pointPlacementToXValue(){let{options:N,xAxis:T}=this,I=N.pointPlacement;return I==="between"&&(I=T.reversed?-.5:.5),MT(I)?I*(N.pointRange||T.pointRange):0}isPointInside(N){let{chart:T,xAxis:I,yAxis:e}=this,{plotX:M=-1,plotY:R=-1}=N;return R>=0&&R<=(e?e.len:T.plotHeight)&&M>=0&&M<=(I?I.len:T.plotWidth)}drawTracker(){let N=this,T=N.options,I=T.trackByArea,e=[].concat((I?N.areaPath:N.graphPath)||[]),M=N.chart,R=M.pointer,s=M.renderer,i=M.options.tooltip?.snap||0,l=()=>{T.enableMouseTracking&&M.hoverSeries!==N&&N.onMouseOver()},D="rgba(192,192,192,"+(Hi?1e-4:.002)+")",P=N.tracker;P?P.attr({d:e}):N.graph&&(N.tracker=P=s.path(e).attr({visibility:N.visible?"inherit":"hidden",zIndex:2}).addClass(I?"highcharts-tracker-area":"highcharts-tracker-line").add(N.group),M.styledMode||P.attr({"stroke-linecap":"round","stroke-linejoin":"round",stroke:D,fill:I?D:"none","stroke-width":N.graph.strokeWidth()+(I?0:2*i)}),[N.tracker,N.markerGroup,...N.dataLabelsGroups||[]].forEach(c=>{c&&(c.addClass("highcharts-tracker").on("mouseover",l).on("mouseout",h=>{R?.onTrackerMouseOut(h)}),T.cursor&&!M.styledMode&&c.css({cursor:T.cursor}),c.on("touchstart",l))})),DO(this,"afterDrawTracker")}addPoint(N,T,I,e,M){let R,s,i=this.options,{chart:l,data:D,dataTable:P,xAxis:c}=this,h=c?.hasNames&&c.names,H=i.data,B=this.getColumn("x");T=GO(T,!0);let Y={series:this};this.pointClass.prototype.applyOptions.apply(Y,[N]);let C=Y.x;if(s=B.length,this.requireSorting&&C<B[s-1])for(R=!0;s&&B[s-1]>C;)s--;P.setRow(Y,s,!0,{addColumns:!1}),h&&Y.name&&(h[C]=Y.name),H?.splice(s,0,N),(R||this.processedData)&&(this.data.splice(s,0,null),this.processData()),i.legendType==="point"&&this.generatePoints(),I&&(D[0]&&D[0].remove?D[0].remove(!1):([D,H].filter(XO).forEach(g=>{g.shift()}),P.deleteRows(0))),M!==!1&&DO(this,"addPoint",{point:Y}),this.isDirty=!0,this.isDirtyData=!0,T&&l.redraw(e)}removePoint(N,T,I){let e=this,{chart:M,data:R,points:s,dataTable:i}=e,l=R[N],D=function(){[s?.length===R.length?s:void 0,R,e.options.data].filter(XO).forEach(P=>{P.splice(N,1)}),i.deleteRows(N),l?.destroy(),e.isDirty=!0,e.isDirtyData=!0,T&&M.redraw()};ui(I,M),T=GO(T,!0),l?l.firePointEvent("remove",null,D):D()}remove(N,T,I,e){let M=this,R=M.chart;function s(){M.destroy(e),R.isDirtyLegend=R.isDirtyBox=!0,R.linkSeries(e),GO(N,!0)&&R.redraw(T)}I!==!1?DO(M,"remove",null,s):s()}update(N,T){DO(this,"update",{options:N=bi(N,this.userOptions)});let I=this,e=I.chart,M=I.userOptions,R=I.initialType||I.type,s=e.options.plotOptions,i=Ce[R].prototype,l=I.finishedAnimating&&{animation:!1},D={},P,c,h=gn.keepProps.slice(),H=N.type||M.type||e.options.chart.type,B=!(this.hasDerivedData||H&&H!==this.type||N.keys!==void 0||N.pointStart!==void 0||N.pointInterval!==void 0||N.relativeXValue!==void 0||N.joinBy||N.mapData||["dataGrouping","pointStart","pointInterval","pointIntervalUnit","keys"].some(C=>I.hasOptionChanged(C)));H=H||R,B?(h.push.apply(h,gn.keepPropsForPoints),N.visible!==!1&&h.push("area","graph"),I.parallelArrays.forEach(function(C){h.push(C+"Data")}),N.data&&(N.dataSorting&&Be(I.options.dataSorting,N.dataSorting),this.setData(N.data,!1))):this.dataTable.modified=this.dataTable,N.dataLabels&&M.dataLabels&&(N.dataLabels=this.mergeArrays(M.dataLabels,N.dataLabels)),N=LM(M,{index:M.index===void 0?I.index:M.index,pointStart:s?.series?.pointStart??M.pointStart??I.getColumn("x")[0]},!B&&{data:I.options.data},N,l),B&&N.data&&(N.data=I.options.data),(h=["dataLabelsGroup","dataLabelsGroups","dataLabelsParentGroups","group","markerGroup","transformGroup"].concat(h)).forEach(function(C){h[C]=I[C],delete I[C]});let Y=!1;if(Ce[H]){if(Y=H!==I.type,I.remove(!1,!1,!1,!0),Y)if(e.propFromSeries(),Object.setPrototypeOf)Object.setPrototypeOf(I,Ce[H].prototype);else{let C=Object.hasOwnProperty.call(I,"hcEvents")&&I.hcEvents;for(c in i)I[c]=void 0;Be(I,Ce[H].prototype),C?I.hcEvents=C:delete I.hcEvents}}else Bs(17,!0,e,{missingModuleFor:H});if(h.forEach(function(C){I[C]=h[C]}),I.init(e,N),B&&this.points)for(let C of((P=I.options).visible===!1?(D.graphic=1,D.dataLabel=1):(this.hasMarkerChanged(P,M)&&(D.graphic=1),I.hasDataLabels?.()||(D.dataLabel=1)),this.points))C?.series&&(C.resolveColor(),Object.keys(D).length&&C.destroyElements(D),P.showInLegend===!1&&C.legendItem&&e.legend.destroyItem(C));I.initialType=R,e.linkSeries(),e.setSortedData(),Y&&I.linkedSeries.length&&(I.isDirtyData=!0),DO(this,"afterUpdate"),GO(T,!0)&&e.redraw(!!B&&void 0)}setName(N){this.name=this.options.name=this.userOptions.name=N,this.chart.isDirtyLegend=!0}hasOptionChanged(N){let T=this.chart,I=this.options[N],e=T.options.plotOptions,M=this.userOptions[N],R=GO(e?.[this.type]?.[N],e?.series?.[N]);return M&&!XO(R)?I!==M:I!==GO(R,I)}onMouseOver(){let N=this.chart,T=N.hoverSeries;N.pointer?.setHoverChartIndex(),T&&T!==this&&T.onMouseOut(),this.options.events.mouseOver&&DO(this,"mouseOver"),this.setState("hover"),N.hoverSeries=this}onMouseOut(){let N=this.options,T=this.chart,I=T.tooltip,e=T.hoverPoint;T.hoverSeries=null,e&&e.onMouseOut(),this&&N.events.mouseOut&&DO(this,"mouseOut"),I&&!this.stickyTracking&&(!I.shared||this.noSharedTooltip)&&I.hide(),T.series.forEach(function(M){M.setState("",!0)})}setState(N,T){let I=this,{graph:e,options:M}=I,{inactiveOtherPoints:R,states:s}=M,i=GO(s?.[N||"normal"]?.animation,I.chart.options.chart.animation),{lineWidth:l,opacity:D}=M;if(N=N||"",I.state!==N&&([I.group,I.markerGroup,...I.dataLabelsGroups||[]].forEach(function(P){P&&(I.state&&P.removeClass("highcharts-series-"+I.state),N&&P.addClass("highcharts-series-"+N))}),I.state=N,!I.chart.styledMode)){if(s[N]?.enabled===!1)return;if(N&&(l=s[N].lineWidth||l+(s[N].lineWidthPlus||0),D=GO(s[N].opacity,D)),e&&!e.dashstyle&&MT(l))for(let P of[e,...this.zones.map(c=>c.graph)])P?.animate({"stroke-width":l},i);R||[I.group,I.markerGroup,...I.dataLabelsGroups||[],I.labelBySeries].forEach(function(P){P?.animate({opacity:D},i)})}T&&R&&I.points&&I.setAllPointsToState(N||void 0)}setAllPointsToState(N){this.points.forEach(function(T){T.setState&&T.setState(N)})}setVisible(N,T){let I=this,e=I.chart,M=e.options.chart.ignoreHiddenSeries,R=I.visible;I.visible=N=I.options.visible=I.userOptions.visible=N===void 0?!R:N;let s=N?"show":"hide";["group","markerGroup","tracker","tt"].forEach(i=>{I[i]?.[s]()}),I.dataLabelsGroups?.forEach(i=>{i?.[s]()}),(e.hoverSeries===I||e.hoverPoint?.series===I)&&I.onMouseOut(),I.legendItem&&e.legend.colorizeItem(I,N),I.isDirty=!0,I.options.stacking&&e.series.forEach(i=>{i.options.stacking&&i.visible&&(i.isDirty=!0)}),I.linkedSeries.forEach(i=>{i.setVisible(N,!1)}),M&&(e.isDirtyBox=!0),DO(I,s),T!==!1&&e.redraw()}show(){this.setVisible(!0)}hide(){this.setVisible(!1)}select(N){this.selected=N=this.options.selected=N===void 0?!this.selected:N,this.checkbox&&(this.checkbox.checked=N),DO(this,N?"select":"unselect")}shouldShowTooltip(N,T,I={}){return I.series=this,I.visiblePlotOnly=!0,this.chart.isInsidePlot(N,T,I)}drawLegendSymbol(N,T){aM[this.options.legendSymbol||"rectangle"]?.call(this,N,T)}}gn.defaultOptions={lineWidth:2,allowPointSelect:!1,crisp:!0,showCheckbox:!1,animation:{duration:1e3},enableMouseTracking:!0,events:{},marker:{enabledThreshold:2,lineColor:"#ffffff",lineWidth:0,radius:4,states:{normal:{animation:!0},hover:{animation:{duration:150},enabled:!0,radiusPlus:2,lineWidthPlus:1},select:{fillColor:"#cccccc",lineColor:"#000000",lineWidth:2}}},point:{events:{}},dataLabels:{animation:{},align:"center",borderWidth:0,defer:!0,formatter:function(){let{numberFormatter:A}=this.series.chart;return typeof this.y!="number"?"":A(this.y,-1)},padding:5,style:{fontSize:"0.7em",fontWeight:"bold",color:"contrast",textOutline:"1px contrast"},verticalAlign:"bottom",x:0,y:0},cropThreshold:300,opacity:1,pointRange:0,softThreshold:!0,states:{normal:{animation:!0},hover:{animation:{duration:150},lineWidthPlus:1,marker:{},halo:{size:10,opacity:.25}},select:{animation:{duration:0}},inactive:{animation:{duration:150},opacity:.2}},stickyTracking:!0,turboThreshold:1e3,findNearestPointBy:"x"},gn.types=BO.seriesTypes,gn.registerType=BO.registerSeriesType,gn.keepProps=["colorIndex","eventOptions","navigatorSeries","symbolIndex","baseSeries"],gn.keepPropsForPoints=["data","isDirtyData","isDirtyCanvas","points","dataTable","processedData","xIncrement","cropped","_hasPointMarkers","hasDataLabels","nodes","layout","level","mapMap","mapData","minY","maxY","minX","maxX","transformGroups"],Be(gn.prototype,{axisTypes:["xAxis","yAxis"],coll:"series",colorCounter:0,directTouch:!1,invertible:!0,isCartesian:!0,kdAxisArray:["clientX","plotY"],parallelArrays:["x","y"],pointClass:rO,requireSorting:!0,sorted:!0}),BO.series=gn;let In=gn,{animObject:b_,setAnimation:pi}=FO,{registerEventOptions:m_}=ft,{composed:OA,marginNames:Vs}=z,{distribute:Vi}=Fn,{format:gi}=GT,{addEvent:cM,createElement:yi,css:Ui,defined:f_,discardElement:TA,find:xi,fireEvent:hn,isNumber:gs,merge:HI,pick:yn,pushUnique:vi,relativeLength:be,stableSort:Ki,syncTimeout:p_}=tN;class ys{constructor(N,T){this.allItems=[],this.initialItemY=0,this.itemHeight=0,this.itemMarginBottom=0,this.itemMarginTop=0,this.itemX=0,this.itemY=0,this.lastItemY=0,this.lastLineHeight=0,this.legendHeight=0,this.legendWidth=0,this.maxItemWidth=0,this.maxLegendWidth=0,this.offsetWidth=0,this.padding=0,this.pages=[],this.symbolHeight=0,this.symbolWidth=0,this.titleHeight=0,this.totalItemWidth=0,this.widthOption=0,this.chart=N,this.setOptions(T),T.enabled&&(this.render(),m_(this,T),cM(this.chart,"endResize",function(){this.legend.positionCheckboxes()})),cM(this.chart,"render",()=>{this.options.enabled&&this.proximate&&(this.proximatePositions(),this.positionItems())})}setOptions(N){let T=yn(N.padding,8);this.options=N,this.chart.styledMode||(this.itemStyle=N.itemStyle,this.itemHiddenStyle=HI(this.itemStyle,N.itemHiddenStyle)),this.itemMarginTop=N.itemMarginTop,this.itemMarginBottom=N.itemMarginBottom,this.padding=T,this.initialItemY=T-5,this.symbolWidth=yn(N.symbolWidth,16),this.pages=[],this.proximate=N.layout==="proximate"&&!this.chart.inverted,this.baseline=void 0}update(N,T){let I=this.chart;this.setOptions(HI(!0,this.options,N)),"events"in this.options&&m_(this,this.options),this.destroy(),I.isDirtyLegend=I.isDirtyBox=!0,yn(T,!0)&&I.redraw(),hn(this,"afterUpdate",{redraw:T})}colorizeItem(N,T){let I=N.color,{area:e,group:M,label:R,line:s,symbol:i}=N.legendItem||{};if((N instanceof In||N instanceof rO)&&(N.color=N.options?.legendSymbolColor||I),M?.[T?"removeClass":"addClass"]("highcharts-legend-item-hidden"),!this.chart.styledMode){let{itemHiddenStyle:l={}}=this,D=l.color,{fillColor:P,fillOpacity:c,lineColor:h,marker:H}=N.options,B=Y=>(!T&&(Y.fill&&(Y.fill=D),Y.stroke&&(Y.stroke=D)),Y);R?.css(HI(T?this.itemStyle:l)),s?.attr(B({stroke:h||N.color})),i&&i.attr(B(H&&i.isMarker?N.pointAttribs():{fill:N.color})),e?.attr(B({fill:P||N.color,"fill-opacity":P?1:c??.75}))}N.color=I,hn(this,"afterColorizeItem",{item:N,visible:T})}positionItems(){this.allItems.forEach(this.positionItem,this),this.chart.isResizing||this.positionCheckboxes()}positionItem(N){let{group:T,x:I=0,y:e=0}=N.legendItem||{},M=this.options,R=M.symbolPadding,s=!M.rtl,i=N.checkbox;if(T?.element){let l={translateX:s?I:this.legendWidth-I-2*R-4,translateY:e},D=()=>{hn(this,"afterPositionItem",{item:N})};T[f_(T.translateY)?"animate":"attr"](l,void 0,D)}i&&(i.x=I,i.y=e)}destroyItem(N){let T=N.legendItem||{};for(let I of["group","label","line","symbol"])T[I]&&(T[I]=T[I].destroy());N.checkbox=TA(N.checkbox),N.legendItem=void 0}destroy(){for(let N of this.getAllItems())this.destroyItem(N);for(let N of["clipRect","up","down","pager","nav","box","title","group"])this[N]&&(this[N]=this[N].destroy());this.display=null}positionCheckboxes(){let N,T=this.group?.alignAttr,I=this.clipHeight||this.legendHeight,e=this.titleHeight;T&&(N=T.translateY,this.allItems.forEach(function(M){let R,s=M.checkbox;s&&(R=N+e+s.y+(this.scrollOffset||0)+3,Ui(s,{left:T.translateX+M.checkboxOffset+s.x-20+"px",top:R+"px",display:this.proximate||R>N-6&&R<N+I-6?"":"none"}))},this))}renderTitle(){let N=this.options,T=this.padding,I=N.title,e,M=0;I.text&&(this.title||(this.title=this.chart.renderer.label(I.text,T-3,T-4,void 0,void 0,void 0,N.useHTML,void 0,"legend-title").attr({zIndex:1}),this.chart.styledMode||this.title.css(I.style),this.title.add(this.group)),I.width||this.title.css({width:this.maxLegendWidth+"px"}),M=(e=this.title.getBBox()).height,this.offsetWidth=e.width,this.contentGroup.attr({translateY:M})),this.titleHeight=M}setText(N){let T=this.options;N.legendItem.label.attr({text:T.labelFormat?gi(T.labelFormat,N,this.chart):T.labelFormatter.call(N)})}renderItem(N){let T=N.legendItem=N.legendItem||{},I=this.chart,e=I.renderer,M=this.options,R=M.layout==="horizontal",s=this.symbolWidth,i=M.symbolPadding||0,l=this.itemStyle,D=this.itemHiddenStyle,P=R?yn(M.itemDistance,20):0,c=!M.rtl,h=!N.series,H=!h&&N.series.drawLegendSymbol?N.series:N,B=H.options,Y=!!this.createCheckboxForItem&&B&&B.showCheckbox,C=M.useHTML,g=N.options.className,x=T.label,j=s+i+P+20*!!Y;!x&&(T.group=e.g("legend-item").addClass("highcharts-"+H.type+"-series highcharts-color-"+N.colorIndex+(g?" "+g:"")+(h?" highcharts-series-"+N.index:"")).attr({zIndex:1}).add(this.scrollGroup),T.label=x=e.text("",c?s+i:-i,this.baseline||0,C),I.styledMode||x.css(HI(N.visible?l:D)),x.attr({align:c?"left":"right",zIndex:2}).add(T.group),!this.baseline&&(this.fontMetrics=e.fontMetrics(x),this.baseline=this.fontMetrics.f+3+this.itemMarginTop,x.attr("y",this.baseline),this.symbolHeight=yn(M.symbolHeight,this.fontMetrics.f),M.squareSymbol&&(this.symbolWidth=yn(M.symbolWidth,Math.max(this.symbolHeight,16)),j=this.symbolWidth+i+P+20*!!Y,c&&x.attr("x",this.symbolWidth+i))),H.drawLegendSymbol(this,N),this.setItemEvents&&this.setItemEvents(N,x,C)),Y&&!N.checkbox&&this.createCheckboxForItem&&this.createCheckboxForItem(N),this.colorizeItem(N,N.visible),(I.styledMode||!l.width)&&x.css({width:Math.min(M.itemWidth||this.widthOption||I.spacingBox.width,M.maxWidth?be(M.maxWidth,I.chartWidth):1/0)-j+"px"}),this.setText(N);let Z=x.getBBox(),W=this.fontMetrics?.h||0;N.itemWidth=N.checkboxOffset=M.itemWidth||T.labelWidth||Z.width+j,this.maxItemWidth=Math.max(this.maxItemWidth,N.itemWidth),this.totalItemWidth+=N.itemWidth,this.itemHeight=N.itemHeight=Math.round(T.labelHeight||(Z.height>1.5*W?Z.height:W))}layoutItem(N){let T=this.options,I=this.padding,e=T.layout==="horizontal",M=N.itemHeight,R=this.itemMarginBottom,s=this.itemMarginTop,i=e?yn(T.itemDistance,20):0,l=this.maxLegendWidth,D=T.alignColumns&&this.totalItemWidth>l?this.maxItemWidth:N.itemWidth,P=N.legendItem||{};e&&this.itemX-I+D>l&&(this.itemX=I,this.lastLineHeight&&(this.itemY+=s+this.lastLineHeight+R),this.lastLineHeight=0),this.lastItemY=s+this.itemY+R,this.lastLineHeight=Math.max(M,this.lastLineHeight),P.x=this.itemX,P.y=this.itemY,e?this.itemX+=D:(this.itemY+=s+M+R,this.lastLineHeight=M),this.offsetWidth=this.widthOption||Math.max((e?this.itemX-I-(N.checkbox?0:i):D)+I,this.offsetWidth)}getAllItems(){let N=[];return this.chart.series.forEach(function(T){let I=T?.options;T&&yn(I.showInLegend,!f_(I.linkedTo)&&void 0,!0)&&(N=N.concat(T.legendItem?.labels||(I.legendType==="point"?T.data:T)))}),hn(this,"afterGetAllItems",{allItems:N}),N}getAlignment(){let N=this.options;return this.proximate?N.align.charAt(0)+"tv":N.floating?"":N.align.charAt(0)+N.verticalAlign.charAt(0)+N.layout.charAt(0)}adjustMargins(N,T){let I=this.chart,e=this.options,M=this.getAlignment();M&&[/(lth|ct|rth)/,/(rtv|rm|rbv)/,/(rbh|cb|lbh)/,/(lbv|lm|ltv)/].forEach((R,s)=>{R.test(M)&&!f_(N[s])&&(I[Vs[s]]=Math.max(I[Vs[s]],I.legend[(s+1)%2?"legendHeight":"legendWidth"]+[1,-1,-1,1][s]*e[s%2?"x":"y"]+(e.margin??12)+T[s]+(I.titleOffset[s]||0)))})}proximatePositions(){let N,T=this.chart,I=[],e=this.options.align==="left";for(let M of(this.allItems.forEach(function(R){let s,i,l=e,D,P;R.yAxis&&(R.xAxis.options.reversed&&(l=!l),R.points&&(s=xi(l?R.points:R.points.slice(0).reverse(),function(c){return gs(c.plotY)})),i=this.itemMarginTop+R.legendItem.label.getBBox().height+this.itemMarginBottom,P=R.yAxis.top-T.plotTop,D=R.visible?(s?s.plotY:R.yAxis.height)+(P-.3*i):P+R.yAxis.height,I.push({target:D,size:i,item:R}))},this),Vi(I,T.plotHeight)))N=M.item.legendItem||{},gs(M.pos)&&(N.y=T.plotTop-T.spacing[0]+M.pos)}render(){let N=this.chart,T=N.spacingBox.width,I=N.renderer,e=this.options,M=this.padding,R=this.getAllItems(),s,i,l,D=this.group,P,c=this.box;this.itemX=M,this.itemY=this.initialItemY,this.offsetWidth=0,this.lastItemY=0,this.widthOption=be(e.width,T-M),P=T-2*M-e.x,["rm","lm"].indexOf(this.getAlignment().substring(0,2))>-1&&(P/=2),this.maxLegendWidth=this.widthOption||P,D||(this.group=D=I.g("legend").addClass(e.className||"").attr({zIndex:7}).add(),this.contentGroup=I.g().attr({zIndex:1}).add(D),this.scrollGroup=I.g().add(this.contentGroup)),this.renderTitle(),Ki(R,(h,H)=>(h.options?.legendIndex||0)-(H.options?.legendIndex||0)),e.reversed&&R.reverse(),this.allItems=R,this.display=s=!!R.length,this.lastLineHeight=0,this.maxItemWidth=0,this.totalItemWidth=0,this.itemHeight=0,R.forEach(this.renderItem,this),R.forEach(this.layoutItem,this),i=(e.maxWidth?Math.min(this.widthOption||this.offsetWidth,P,be(e.maxWidth,N.chartWidth)||1/0):this.widthOption||this.offsetWidth)+M,l=this.lastItemY+this.lastLineHeight+this.titleHeight,l=this.handleOverflow(l)+M,c||(this.box=c=I.rect().addClass("highcharts-legend-box").attr({r:e.borderRadius}).add(D)),N.styledMode||c.attr({stroke:e.borderColor,"stroke-width":e.borderWidth||0,fill:e.backgroundColor||"none"}).shadow(e.shadow),i>0&&l>0&&c[c.placed?"animate":"attr"](c.crisp.call({},{x:0,y:0,width:i,height:l},c.strokeWidth())),D[s?"show":"hide"](),N.styledMode&&D.getStyle("display")==="none"&&(i=l=0),this.legendWidth=i,this.legendHeight=l,s&&this.align(),this.proximate||this.positionItems(),hn(this,"afterRender")}align(N=this.chart.spacingBox){let T=this.chart,I=this.options,e=N.y;/(lth|ct|rth)/.test(this.getAlignment())&&T.titleOffset[0]>0?e+=T.titleOffset[0]:/(lbh|cb|rbh)/.test(this.getAlignment())&&T.titleOffset[2]>0&&(e-=T.titleOffset[2]),e!==N.y&&(N=HI(N,{y:e})),T.hasRendered||(this.group.placed=!1),this.group.align(HI(I,{width:this.legendWidth,height:this.legendHeight,verticalAlign:this.proximate?"top":I.verticalAlign}),!0,N)}handleOverflow(N){let T=this,I=this.chart,e=I.renderer,M=this.options,R=M.y,s=M.verticalAlign==="top",i=this.padding,l=M.maxHeight,D=M.navigation,P=yn(D.animation,!0),c=D.arrowSize||12,h=this.pages,H=this.allItems,B=function($){typeof $=="number"?J.attr({height:$}):J&&(T.clipRect=J.destroy(),T.contentGroup.clip()),T.contentGroup.div&&(T.contentGroup.div.style.clip=$?"rect("+i+"px,9999px,"+(i+$)+"px,0)":"auto")},Y=function($){return T[$]=e.circle(0,0,1.3*c).translate(c/2,c/2).add(W),I.styledMode||T[$].attr("fill","rgba(0,0,0,0.0001)"),T[$]},C,g,x,j,Z=I.spacingBox.height+(s?-R:R)-i,W=this.nav,J=this.clipRect;return M.layout!=="horizontal"||M.verticalAlign==="middle"||M.floating||(Z/=2),l&&(Z=Math.min(Z,l)),h.length=0,N&&Z>0&&N>Z&&D.enabled!==!1?(this.clipHeight=C=Math.max(Z-20-this.titleHeight-i,0),this.currentPage=yn(this.currentPage,1),this.fullHeight=N,H.forEach(($,PE)=>{let aE=(x=$.legendItem||{}).y||0,lE=Math.round(x.label.getBBox().height),mE=h.length;(!mE||aE-h[mE-1]>C&&(g||aE)!==h[mE-1])&&(h.push(g||aE),mE++),x.pageIx=mE-1,g&&j&&(j.pageIx=mE-1),PE===H.length-1&&aE+lE-h[mE-1]>C&&aE>h[mE-1]&&(h.push(aE),x.pageIx=mE),aE!==g&&(g=aE),j=x}),J||(J=T.clipRect=e.clipRect(0,i-2,9999,0),T.contentGroup.clip(J)),B(C),W||(this.nav=W=e.g().attr({zIndex:1}).add(this.group),this.up=e.symbol("triangle",0,0,c,c).add(W),Y("upTracker").on("click",function(){T.scroll(-1,P)}),this.pager=e.text("",15,10).addClass("highcharts-legend-navigation"),!I.styledMode&&D.style&&this.pager.css(D.style),this.pager.add(W),this.down=e.symbol("triangle-down",0,0,c,c).add(W),Y("downTracker").on("click",function(){T.scroll(1,P)})),T.scroll(0),N=Z):W&&(B(),this.nav=W.destroy(),this.scrollGroup.attr({translateY:1}),this.clipHeight=0),N}scroll(N,T){let I=this.chart,e=this.pages,M=e.length,R=this.clipHeight,s=this.options.navigation,i=this.pager,l=this.padding,D=this.currentPage+N;D>M&&(D=M),D>0&&(T!==void 0&&pi(T,I),this.nav.attr({translateX:l,translateY:R+this.padding+7+this.titleHeight,visibility:"inherit"}),[this.up,this.upTracker].forEach(function(P){P.attr({class:D===1?"highcharts-legend-nav-inactive":"highcharts-legend-nav-active"})}),i.attr({text:D+"/"+M}),[this.down,this.downTracker].forEach(function(P){P.attr({x:18+this.pager.getBBox().width,class:D===M?"highcharts-legend-nav-inactive":"highcharts-legend-nav-active"})},this),I.styledMode||(this.up.attr({fill:D===1?s.inactiveColor:s.activeColor}),this.upTracker.css({cursor:D===1?"default":"pointer"}),this.down.attr({fill:D===M?s.inactiveColor:s.activeColor}),this.downTracker.css({cursor:D===M?"default":"pointer"})),this.scrollOffset=-e[D-1]+this.initialItemY,this.scrollGroup.animate({translateY:this.scrollOffset}),this.currentPage=D,this.positionCheckboxes(),p_(()=>{hn(this,"afterScroll",{currentPage:D})},b_(yn(T,I.renderer.globalAnimation,!0)).duration))}setItemEvents(N,T,I){let e=this,M=N.legendItem||{},R=e.chart.renderer.boxWrapper,s=N instanceof rO,i=N instanceof In,l="highcharts-legend-"+(s?"point":"series")+"-active",D=e.chart.styledMode,P=I?[T,M.symbol]:[M.group],c=h=>{e.allItems.forEach(H=>{N!==H&&[H].concat(H.linkedSeries||[]).forEach(B=>{B.setState(h,!s)})})};for(let h of P)h&&h.on("mouseover",function(){N.visible&&c("inactive"),N.setState("hover"),N.visible&&R.addClass(l),D||T.css(e.options.itemHoverStyle)}).on("mouseout",function(){e.chart.styledMode||T.css(HI(N.visible?e.itemStyle:e.itemHiddenStyle)),c(""),R.removeClass(l),N.setState()}).on("click",function(H){let B=function(){N.setVisible&&N.setVisible(),c(N.visible?"inactive":"")};R.removeClass(l),hn(e,"itemClick",{browserEvent:H,legendItem:N},B),s?N.firePointEvent("legendItemClick",{browserEvent:H}):i&&hn(N,"legendItemClick",{browserEvent:H})})}createCheckboxForItem(N){N.checkbox=yi("input",{type:"checkbox",className:"highcharts-legend-checkbox",checked:N.selected,defaultChecked:N.selected},this.options.itemCheckboxStyle,this.chart.container),cM(N.checkbox,"click",function(T){let I=T.target;hn(N.series||N,"checkboxClick",{checked:I.checked,item:N},function(){N.select()})})}}(fE=ys||(ys={})).compose=function(A){vi(OA,"Core.Legend")&&cM(A,"beforeMargins",function(){this.legend=new fE(this,this.options.legend)})};let Us=ys,{animate:DR,animObject:wi,setAnimation:xs}=FO,{defaultOptions:Ot}=fO,{numberFormat:ki}=GT,{registerEventOptions:V_}=ft,{charts:vt,doc:Kt,marginNames:g_,svg:y_,win:vs}=z,{seriesTypes:Ks}=BO,{addEvent:U_,attr:ws,createElement:wO,css:PO,defined:Tt,diffObjects:x_,discardElement:zi,erase:Fi,error:wt,extend:nt,find:hM,fireEvent:yN,getAlignFactor:nA,getStyle:dM,isArray:v_,isNumber:me,isObject:ji,isString:LR,merge:Un,objectEach:cR,pick:CT,pInt:Zi,relativeLength:ks,removeEvent:hR,splat:GM,syncTimeout:Xi,uniqueKey:K_}=tN;class It{static chart(N,T,I){return new It(N,T,I)}constructor(N,T,I){this.sharedClips={};const e=[...arguments];(LR(N)||N.nodeName)&&(this.renderTo=e.shift()),this.init(e[0],e[1])}setZoomOptions(){let N=this.options.chart,T=N.zooming;this.zooming={...T,type:CT(N.zoomType,T.type),key:CT(N.zoomKey,T.key),pinchType:CT(N.pinchType,T.pinchType),singleTouch:CT(N.zoomBySingleTouch,T.singleTouch,!1),resetButton:Un(T.resetButton,N.resetZoomButton)}}init(N,T){yN(this,"init",{args:arguments},function(){let I=Un(Ot,N),e=I.chart,M=this.renderTo||e.renderTo;this.userOptions=nt({},N),(this.renderTo=LR(M)?Kt.getElementById(M):M)||wt(13,!0,this),this.margin=[],this.spacing=[],this.labelCollectors=[],this.callback=T,this.isResizing=0,this.options=I,this.axes=[],this.series=[],this.locale=I.lang.locale??this.renderTo.closest("[lang]")?.lang,this.time=new nN(nt(I.time||{},{locale:this.locale}),I.lang),I.time=this.time.options,this.numberFormatter=(e.numberFormatter||ki).bind(this),this.styledMode=e.styledMode,this.hasCartesianSeries=e.showAxes,this.index=vt.length,vt.push(this),z.chartCount++,V_(this,e),this.xAxis=[],this.yAxis=[],this.pointCount=this.colorCounter=this.symbolCounter=0,this.setZoomOptions(),yN(this,"afterInit"),this.firstRender()})}initSeries(N){let T=this.options.chart,I=N.type||T.type,e=Ks[I];e||wt(17,!0,this,{missingModuleFor:I});let M=new e;return typeof M.init=="function"&&M.init(this,N),M}setSortedData(){this.getSeriesOrderByLinks().forEach(function(N){N.points||N.data||!N.enabledDataSorting||N.setData(N.options.data,!1)})}getSeriesOrderByLinks(){return this.series.concat().sort(function(N,T){return N.linkedSeries.length||T.linkedSeries.length?T.linkedSeries.length-N.linkedSeries.length:0})}orderItems(N,T=0){let I=this[N],e=this.options[N]=GM(this.options[N]).slice(),M=this.userOptions[N]=this.userOptions[N]?GM(this.userOptions[N]).slice():[];if(this.hasRendered&&(e.splice(T),M.splice(T)),I)for(let R=T,s=I.length;R<s;++R){let i=I[R];i&&(i.index=R,i instanceof In&&(i.name=i.getName()),i.options.isInternal||(e[R]=i.options,M[R]=i.userOptions))}}getClipBox(N,T){let I=this.inverted,{xAxis:e,yAxis:M}=N||{},{x:R,y:s,width:i,height:l}=Un(this.clipBox);return N&&(e&&e.len!==this.plotSizeX&&(i=e.len),M&&M.len!==this.plotSizeY&&(l=M.len),I&&!N.invertible&&([i,l]=[l,i])),T&&(R+=(I?M:e)?.pos??this.plotLeft,s+=(I?e:M)?.pos??this.plotTop),{x:R,y:s,width:i,height:l}}isInsidePlot(N,T,I={}){let{inverted:e,plotBox:M,plotLeft:R,plotTop:s,scrollablePlotBox:i}=this,{scrollLeft:l=0,scrollTop:D=0}=I.visiblePlotOnly&&this.scrollablePlotArea?.scrollingContainer||{},P=I.series,c=I.visiblePlotOnly&&i||M,h=I.inverted?T:N,H=I.inverted?N:T,B={x:h,y:H,isInsidePlot:!0,options:I};if(!I.ignoreX){let Y=P&&(e&&!this.polar?P.yAxis:P.xAxis)||{pos:R,len:1/0},C=I.paneCoordinates?Y.pos+h:R+h;C>=Math.max(l+R,Y.pos)&&C<=Math.min(l+R+c.width,Y.pos+Y.len)||(B.isInsidePlot=!1)}if(!I.ignoreY&&B.isInsidePlot){let Y=!e&&I.axis&&!I.axis.isXAxis&&I.axis||P&&(e?P.xAxis:P.yAxis)||{pos:s,len:1/0},C=I.paneCoordinates?Y.pos+H:s+H;C>=Math.max(D+s,Y.pos)&&C<=Math.min(D+s+c.height,Y.pos+Y.len)||(B.isInsidePlot=!1)}return yN(this,"afterIsInsidePlot",B),B.isInsidePlot}redraw(N){yN(this,"beforeRedraw");let T=this.hasCartesianSeries?this.axes:this.colorAxis||[],I=this.series,e=this.pointer,M=this.legend,R=this.userOptions.legend,s=this.renderer,i=s.isHidden(),l=[],D,P,c,h=this.isDirtyBox,H=this.isDirtyLegend,B;for(s.rootFontSize=s.boxWrapper.getStyle("font-size"),this.setResponsive&&this.setResponsive(!1),xs(!!this.hasRendered&&N,this),i&&this.temporaryDisplay(),this.layOutTitles(!1),c=I.length;c--;)if(((B=I[c]).options.stacking||B.options.centerInCategory)&&(P=!0,B.isDirty)){D=!0;break}if(D)for(c=I.length;c--;)(B=I[c]).options.stacking&&(B.isDirty=!0);I.forEach(function(Y){Y.isDirty&&(Y.options.legendType==="point"?(typeof Y.updateTotals=="function"&&Y.updateTotals(),H=!0):R&&(R.labelFormatter||R.labelFormat)&&(H=!0)),Y.isDirtyData&&yN(Y,"updatedData")}),H&&M&&M.options.enabled&&(M.render(),this.isDirtyLegend=!1),P&&this.getStacks(),T.forEach(function(Y){Y.updateNames(),Y.setScale()}),this.getMargins(),T.forEach(function(Y){Y.isDirty&&(h=!0)}),T.forEach(function(Y){let C=Y.min+","+Y.max;Y.extKey!==C&&(Y.extKey=C,l.push(function(){yN(Y,"afterSetExtremes",nt(Y.eventArgs,Y.getExtremes())),delete Y.eventArgs})),(h||P)&&Y.redraw()}),h&&this.drawChartBox(),yN(this,"predraw"),I.forEach(function(Y){(h||Y.isDirty)&&Y.visible&&Y.redraw(),Y.isDirtyData=!1}),e&&e.reset(!0),s.draw(),yN(this,"redraw"),yN(this,"render"),i&&this.temporaryDisplay(!0),l.forEach(function(Y){Y.call()})}get(N){let T=this.series;function I(M){return M.id===N||M.options&&M.options.id===N}let e=hM(this.axes,I)||hM(this.series,I);for(let M=0;!e&&M<T.length;M++)e=hM(T[M].points||[],I);return e}createAxes(){let N=this.userOptions;for(let T of(yN(this,"createAxes"),["xAxis","yAxis"]))for(let I of N[T]=GM(N[T]||{}))new Tn(this,I,T);yN(this,"afterCreateAxes")}getSelectedPoints(){return this.series.reduce((N,T)=>(T.getPointsCollection().forEach(I=>{CT(I.selectedStaging,I.selected)&&N.push(I)}),N),[])}getSelectedSeries(){return this.series.filter(N=>N.selected)}setTitle(N,T,I){this.applyDescription("title",N),this.applyDescription("subtitle",T),this.applyDescription("caption",void 0),this.layOutTitles(I)}applyDescription(N,T){let I=this,e=this.options[N]=Un(this.options[N],T),M=this[N];M&&T&&(this[N]=M=M.destroy()),e&&!M&&((M=this.renderer.text(e.text,0,0,e.useHTML).attr({align:e.align,class:"highcharts-"+N,zIndex:e.zIndex||4}).css({textOverflow:"ellipsis",whiteSpace:"nowrap"}).add()).update=function(R,s){I.applyDescription(N,R),I.layOutTitles(s)},this.styledMode||M.css(nt(N==="title"?{fontSize:this.options.isStock?"1em":"1.2em"}:{},e.style)),M.textPxLength=M.getBBox().width,M.css({whiteSpace:e.style?.whiteSpace}),this[N]=M)}layOutTitles(N=!0){let T=[0,0,0],{options:I,renderer:e,spacingBox:M}=this;["title","subtitle","caption"].forEach(s=>{let i=this[s],l=this.options[s],D=Un(M),P=i?.textPxLength||0;if(i&&l){yN(this,"layOutTitle",{alignTo:D,key:s,textPxLength:P});let c=e.fontMetrics(i),h=c.b,H=c.h,B=l.verticalAlign||"top",Y=B==="top",C=Y&&l.minScale||1,g=s==="title"?Y?-3:0:Y?T[0]+2:0,x=Math.min(D.width/P,1),j=Math.max(C,x),Z=Un({y:B==="bottom"?h:g+h},{align:s==="title"?x<C?"left":"center":this.title?.alignValue},l),W=(l.width||(x>C?this.chartWidth:D.width)/j)+"px";i.alignValue!==Z.align&&(i.placed=!1);let J=Math.round(i.css({width:W}).getBBox(l.useHTML).height);if(Z.height=J,i.align(Z,!1,D).attr({align:Z.align,scaleX:j,scaleY:j,"transform-origin":`${D.x+P*j*nA(Z.align)} ${H}`}),!l.floating){let $=J*(J<1.2*H?1:j);B==="top"?T[0]=Math.ceil(T[0]+$):B==="bottom"&&(T[2]=Math.ceil(T[2]+$))}}},this),T[0]&&(I.title?.verticalAlign||"top")==="top"&&(T[0]+=I.title?.margin||0),T[2]&&I.caption?.verticalAlign==="bottom"&&(T[2]+=I.caption?.margin||0);let R=!this.titleOffset||this.titleOffset.join(",")!==T.join(",");this.titleOffset=T,yN(this,"afterLayOutTitles"),!this.isDirtyBox&&R&&(this.isDirtyBox=this.isDirtyLegend=R,this.hasRendered&&N&&this.isDirtyBox&&this.redraw())}getContainerBox(){let N=[].map.call(this.renderTo.children,I=>{if(I!==this.container){let e=I.style.display;return I.style.display="none",[I,e]}}),T={width:dM(this.renderTo,"width",!0)||0,height:dM(this.renderTo,"height",!0)||0};return N.filter(Boolean).forEach(([I,e])=>{I.style.display=e}),T}getChartSize(){let N=this.options.chart,T=N.width,I=N.height,e=this.getContainerBox(),M=e.height<=1||!this.renderTo.parentElement?.style.height&&this.renderTo.style.height==="100%";this.chartWidth=Math.max(0,T||e.width||600),this.chartHeight=Math.max(0,ks(I,this.chartWidth)||(M?400:e.height)),this.containerBox=e}temporaryDisplay(N){let T=this.renderTo,I;if(N)for(;T?.style;)T.hcOrigStyle&&(PO(T,T.hcOrigStyle),delete T.hcOrigStyle),T.hcOrigDetached&&(Kt.body.removeChild(T),T.hcOrigDetached=!1),T=T.parentNode;else for(;T?.style&&(Kt.body.contains(T)||T.parentNode||(T.hcOrigDetached=!0,Kt.body.appendChild(T)),(dM(T,"display",!1)==="none"||T.hcOricDetached)&&(T.hcOrigStyle={display:T.style.display,height:T.style.height,overflow:T.style.overflow},I={display:"block",overflow:"hidden"},T!==this.renderTo&&(I.height=0),PO(T,I),T.offsetWidth||T.style.setProperty("display","block","important")),(T=T.parentNode)!==Kt.body););}setClassName(N){this.container.className="highcharts-container "+(N||"")}getContainer(){let N,T=this.options,I=T.chart,e="data-highcharts-chart",M=K_(),R=this.renderTo,s=Zi(ws(R,e));me(s)&&vt[s]&&vt[s].hasRendered&&vt[s].destroy(),ws(R,e,this.index),R.innerHTML=NO.emptyHTML,I.skipClone||R.offsetWidth||this.temporaryDisplay(),this.getChartSize();let i=this.chartHeight,l=this.chartWidth;PO(R,{overflow:"hidden"}),this.styledMode||(N=nt({position:"relative",overflow:"hidden",width:l+"px",height:i+"px",textAlign:"left",lineHeight:"normal",zIndex:0,"-webkit-tap-highlight-color":"rgba(0,0,0,0)",userSelect:"none","touch-action":"manipulation",outline:"none",padding:"0px"},I.style||{}));let D=wO("div",{id:M},N,R);this.container=D,this.getChartSize(),l!==this.chartWidth&&(l=this.chartWidth,this.styledMode||PO(D,{width:CT(I.style?.width,l+"px")})),this.containerBox=this.getContainerBox(),this._cursor=D.style.cursor;let P=I.renderer||!y_?Yn.getRendererType(I.renderer):lI;if(this.renderer=new P(D,l,i,void 0,I.forExport,T.exporting?.allowHTML,this.styledMode),xs(void 0,this),this.setClassName(I.className),this.styledMode)for(let c in T.defs)this.renderer.definition(T.defs[c]);else this.renderer.setStyle(I.style);this.renderer.chartIndex=this.index,yN(this,"afterGetContainer")}getMargins(N){let{spacing:T,margin:I,titleOffset:e}=this;this.resetMargins(),e[0]&&!Tt(I[0])&&(this.plotTop=Math.max(this.plotTop,e[0]+T[0])),e[2]&&!Tt(I[2])&&(this.marginBottom=Math.max(this.marginBottom,e[2]+T[2])),this.legend?.display&&this.legend.adjustMargins(I,T),yN(this,"getMargins"),N||this.getAxisMargins()}getAxisMargins(){let N=this,T=N.axisOffset=[0,0,0,0],I=N.colorAxis,e=N.margin,M=R=>{R.forEach(s=>{s.visible&&s.getOffset()})};N.hasCartesianSeries?M(N.axes):I?.length&&M(I),g_.forEach((R,s)=>{Tt(e[s])||(N[R]+=T[s])}),N.setChartSize()}getOptions(){return x_(this.userOptions,Ot)}reflow(N){let T=this,I=T.containerBox,e=T.getContainerBox();delete T.pointer?.chartPosition,!T.exporting?.isPrinting&&!T.isResizing&&I&&e.width&&((e.width!==I.width||e.height!==I.height)&&(tN.clearTimeout(T.reflowTimeout),T.reflowTimeout=Xi(function(){T.container&&T.setSize(void 0,void 0,!1)},100*!!N)),T.containerBox=e)}setReflow(){let N=this,T=I=>{N.options?.chart.reflow&&N.hasLoaded&&N.reflow(I)};if(typeof ResizeObserver=="function")new ResizeObserver(T).observe(N.renderTo);else{let I=U_(vs,"resize",T);U_(this,"destroy",I)}}setSize(N,T,I){let e=this,M=e.renderer;e.isResizing+=1,xs(I,e);let R=M.globalAnimation;e.oldChartHeight=e.chartHeight,e.oldChartWidth=e.chartWidth,N!==void 0&&(e.options.chart.width=N),T!==void 0&&(e.options.chart.height=T),e.getChartSize();let{chartWidth:s,chartHeight:i,scrollablePixelsX:l=0,scrollablePixelsY:D=0}=e;(e.isDirtyBox||s!==e.oldChartWidth||i!==e.oldChartHeight)&&(e.styledMode||(R?DR:PO)(e.container,{width:`${s+l}px`,height:`${i+D}px`},R),e.setChartSize(!0),M.setSize(s,i,R),e.axes.forEach(function(P){P.isDirty=!0,P.setScale()}),e.isDirtyLegend=!0,e.isDirtyBox=!0,e.layOutTitles(),e.getMargins(),e.redraw(R),e.oldChartHeight=void 0,yN(e,"resize"),setTimeout(()=>{e&&yN(e,"endResize")},wi(R).duration)),e.isResizing-=1}setChartSize(N){let T,I,e,M,{chartHeight:R,chartWidth:s,inverted:i,spacing:l,renderer:D}=this,P=this.clipOffset,c=Math[i?"floor":"round"];this.plotLeft=T=Math.round(this.plotLeft),this.plotTop=I=Math.round(this.plotTop),this.plotWidth=e=Math.max(0,Math.round(s-T-(this.marginRight??0))),this.plotHeight=M=Math.max(0,Math.round(R-I-(this.marginBottom??0))),this.plotSizeX=i?M:e,this.plotSizeY=i?e:M,this.spacingBox=D.spacingBox={x:l[3],y:l[0],width:s-l[3]-l[1],height:R-l[0]-l[2]},this.plotBox=D.plotBox={x:T,y:I,width:e,height:M},P&&(this.clipBox={x:c(P[3]),y:c(P[0]),width:c(this.plotSizeX-P[1]-P[3]),height:c(this.plotSizeY-P[0]-P[2])}),N||(this.axes.forEach(function(h){h.setAxisSize(),h.setAxisTranslation()}),D.alignElements()),yN(this,"afterSetChartSize",{skipAxes:N})}resetMargins(){yN(this,"resetMargins");let N=this,T=N.options.chart,I=T.plotBorderWidth||0,e=Math.round(I)/2;["margin","spacing"].forEach(M=>{let R=T[M],s=ji(R)?R:[R,R,R,R];["Top","Right","Bottom","Left"].forEach((i,l)=>{N[M][l]=T[`${M}${i}`]??s[l]})}),g_.forEach((M,R)=>{N[M]=N.margin[R]??N.spacing[R]}),N.axisOffset=[0,0,0,0],N.clipOffset=[e,e,e,e],N.plotBorderWidth=I}drawChartBox(){let N=this.options.chart,T=this.renderer,I=this.chartWidth,e=this.chartHeight,M=this.styledMode,R=this.plotBGImage,s=N.backgroundColor,i=N.plotBackgroundColor,l=N.plotBackgroundImage,D=this.plotLeft,P=this.plotTop,c=this.plotWidth,h=this.plotHeight,H=this.plotBox,B=this.clipRect,Y=this.clipBox,C=this.chartBackground,g=this.plotBackground,x=this.plotBorder,j,Z,W,J="animate";C||(this.chartBackground=C=T.rect().addClass("highcharts-background").add(),J="attr"),M?j=Z=C.strokeWidth():(Z=(j=N.borderWidth||0)+8*!!N.shadow,W={fill:s||"none"},(j||C["stroke-width"])&&(W.stroke=N.borderColor,W["stroke-width"]=j),C.attr(W).shadow(N.shadow)),C[J]({x:Z/2,y:Z/2,width:I-Z-j%2,height:e-Z-j%2,r:N.borderRadius}),J="animate",g||(J="attr",this.plotBackground=g=T.rect().addClass("highcharts-plot-background").add()),g[J](H),!M&&(g.attr({fill:i||"none"}).shadow(N.plotShadow),l&&(R?(l!==R.attr("href")&&R.attr("href",l),R.animate(H)):this.plotBGImage=T.image(l,D,P,c,h).add())),B?B.animate({width:Y.width,height:Y.height}):this.clipRect=T.clipRect(Y),J="animate",x||(J="attr",this.plotBorder=x=T.rect().addClass("highcharts-plot-border").attr({zIndex:1}).add()),M||x.attr({stroke:N.plotBorderColor,"stroke-width":N.plotBorderWidth||0,fill:"none"}),x[J](x.crisp(H,-x.strokeWidth())),this.isDirtyBox=!1,yN(this,"afterDrawChartBox")}propFromSeries(){let N,T,I,e=this,M=e.options.chart,R=e.options.series;["inverted","angular","polar"].forEach(function(s){for(T=Ks[M.type],I=M[s]||T&&T.prototype[s],N=R?.length;!I&&N--;)(T=Ks[R[N].type])&&T.prototype[s]&&(I=!0);e[s]=I})}linkSeries(N){let T=this,I=T.series;I.forEach(function(e){e.linkedSeries.length=0}),I.forEach(function(e){let{linkedTo:M}=e.options,R=LR(M)&&(M===":previous"?I[e.index-1]:T.get(M));R&&R.linkedParent!==e&&(R.linkedSeries.push(e),e.linkedParent=R,R.enabledDataSorting&&e.setDataSortingOptions(),e.visible=e.options.visible??R.options.visible??e.visible)}),yN(this,"afterLinkSeries",{isUpdating:N})}renderSeries(){this.series.forEach(function(N){N.translate(),N.render()})}render(){let N=this.axes,T=this.colorAxis,I=this.renderer,e=this.options.chart.axisLayoutRuns||2,M=D=>{D.forEach(P=>{P.visible&&P.render()})},R=0,s=!0,i,l=0;for(let D of(this.setTitle(),yN(this,"beforeMargins"),this.getStacks?.(),this.getMargins(!0),this.setChartSize(),N)){let{options:P}=D,{labels:c}=P;if(this.hasCartesianSeries&&D.horiz&&D.visible&&c.enabled&&D.series.length&&D.coll!=="colorAxis"&&!this.polar){R=P.tickLength,D.createGroups();let h=new Qn(D,0,"",!0),H=h.createLabel("x",c);if(h.destroy(),H&&CT(c.reserveSpace,!me(P.crossing))&&(R=H.getBBox().height+c.distance+Math.max(P.offset||0,0)),R){H?.destroy();break}}}for(this.plotHeight=Math.max(this.plotHeight-R,0);(s||i||e>1)&&l<e;){let D=this.plotWidth,P=this.plotHeight;for(let c of N)l===0?c.setScale():(c.horiz&&s||!c.horiz&&i)&&c.setTickInterval(!0);l===0?this.getAxisMargins():this.getMargins(),s=D/this.plotWidth>(l?1:1.1),i=P/this.plotHeight>(l?1:1.05),l++}this.drawChartBox(),this.hasCartesianSeries?M(N):T?.length&&M(T),this.seriesGroup||(this.seriesGroup=I.g("series-group").attr({zIndex:3}).shadow(this.options.chart.seriesGroupShadow).add()),this.renderSeries(),this.addCredits(),this.setResponsive&&this.setResponsive(),this.hasRendered=!0}addCredits(N){let T=this,I=Un(!0,this.options.credits,N);I.enabled&&!this.credits&&(this.credits=this.renderer.text(I.text+(this.mapCredits||""),0,0).addClass("highcharts-credits").on("click",function(){I.href&&(vs.location.href=I.href)}).attr({align:I.position.align,zIndex:8}),T.styledMode||this.credits.css(I.style),this.credits.add().align(I.position),this.credits.update=function(e){T.credits=T.credits.destroy(),T.addCredits(e)})}destroy(){let N,T=this,I=T.axes,e=T.series,M=T.container,R=M?.parentNode;for(yN(T,"destroy"),T.renderer.forExport?Fi(vt,T):vt[T.index]=void 0,z.chartCount--,T.renderTo.removeAttribute("data-highcharts-chart"),hR(T),N=I.length;N--;)I[N]=I[N].destroy();for(this.scroller?.destroy?.(),N=e.length;N--;)e[N]=e[N].destroy();["title","subtitle","chartBackground","plotBackground","plotBGImage","plotBorder","seriesGroup","clipRect","credits","pointer","rangeSelector","legend","resetZoomButton","tooltip","renderer"].forEach(s=>{T[s]=T[s]?.destroy?.()}),M&&(M.innerHTML=NO.emptyHTML,hR(M),R&&zi(M)),cR(T,function(s,i){delete T[i]})}firstRender(){let N=this,T=N.options;N.getContainer(),N.resetMargins(),N.setChartSize(),N.propFromSeries(),N.createAxes();let I=v_(T.series)?T.series:[];T.series=[],I.forEach(function(e){N.initSeries(e)}),N.linkSeries(),N.setSortedData(),yN(N,"beforeRender"),N.render(),N.pointer?.getChartPosition(),N.renderer.imgCount||N.hasLoaded||N.onload(),N.temporaryDisplay(!0)}onload(){this.callbacks.concat([this.callback]).forEach(function(N){N&&this.index!==void 0&&N.apply(this,[this])},this),yN(this,"load"),yN(this,"render"),Tt(this.index)&&this.setReflow(),this.warnIfA11yModuleNotLoaded(),this.warnIfCSSNotLoaded(),this.hasLoaded=!0}warnIfA11yModuleNotLoaded(){let{options:N,title:T}=this;N&&!this.accessibility&&(this.renderer.boxWrapper.attr({role:"img","aria-label":(T?.element.textContent||"").replace(/</g,"&lt;")}),N.accessibility&&N.accessibility.enabled===!1||wt('Highcharts warning: Consider including the "accessibility.js" module to make your chart more usable for people with disabilities. Set the "accessibility.enabled" option to false to remove this warning. See https://www.highcharts.com/docs/accessibility/accessibility-module.',!1,this))}warnIfCSSNotLoaded(){this.styledMode&&vs.getComputedStyle(this.container).zIndex!=="0"&&wt(35,!1,this)}addSeries(N,T,I){let e,M=this;return N&&(T=CT(T,!0),yN(M,"addSeries",{options:N},function(){e=M.initSeries(N),M.isDirtyLegend=!0,M.linkSeries(),e.enabledDataSorting&&e.setData(N.data,!1),yN(M,"afterAddSeries",{series:e}),T&&M.redraw(I)})),e}addAxis(N,T,I,e){return this.createAxis(T?"xAxis":"yAxis",{axis:N,redraw:I,animation:e})}addColorAxis(N,T,I){return this.createAxis("colorAxis",{axis:N,redraw:T,animation:I})}createAxis(N,T){let I=new Tn(this,T.axis,N);return CT(T.redraw,!0)&&this.redraw(T.animation),I}showLoading(N){let T=this,I=T.options,e=I.loading,M=function(){R&&PO(R,{left:T.plotLeft+"px",top:T.plotTop+"px",width:T.plotWidth+"px",height:T.plotHeight+"px"})},R=T.loadingDiv,s=T.loadingSpan;R||(T.loadingDiv=R=wO("div",{className:"highcharts-loading highcharts-loading-hidden"},null,T.container)),s||(T.loadingSpan=s=wO("span",{className:"highcharts-loading-inner"},null,R),U_(T,"redraw",M)),R.className="highcharts-loading",NO.setElementHTML(s,CT(N,I.lang.loading,"")),!T.styledMode&&(PO(R,nt(e.style,{zIndex:10})),PO(s,e.labelStyle),T.loadingShown||(PO(R,{opacity:0,display:""}),DR(R,{opacity:e.style.opacity||.5},{duration:e.showDuration||0}))),T.loadingShown=!0,M()}hideLoading(){let N=this.options,T=this.loadingDiv;T&&(T.className="highcharts-loading highcharts-loading-hidden",this.styledMode||DR(T,{opacity:0},{duration:N.loading.hideDuration||100,complete:function(){PO(T,{display:"none"})}})),this.loadingShown=!1}update(N,T,I,e){let M,R,s,i=this,l={credits:"addCredits",title:"setTitle",subtitle:"setSubtitle",caption:"setCaption"},D=N.isResponsiveOptions,P=[];yN(i,"update",{options:N}),D||i.setResponsive(!1,!0),N=x_(N,i.options),i.userOptions=Un(i.userOptions,N);let c=N.chart;c&&(Un(!0,i.options.chart,c),this.setZoomOptions(),"className"in c&&i.setClassName(c.className),("inverted"in c||"polar"in c||"type"in c)&&(i.propFromSeries(),M=!0),"alignTicks"in c&&(M=!0),"events"in c&&V_(this,c),cR(c,function(B,Y){i.propsRequireUpdateSeries.indexOf("chart."+Y)!==-1&&(R=!0),i.propsRequireDirtyBox.indexOf(Y)!==-1&&(i.isDirtyBox=!0),i.propsRequireReflow.indexOf(Y)!==-1&&(i.isDirtyBox=!0,D||(s=!0))}),!i.styledMode&&c.style&&i.renderer.setStyle(i.options.chart.style||{})),!i.styledMode&&N.colors&&(this.options.colors=N.colors),cR(N,function(B,Y){i[Y]&&typeof i[Y].update=="function"?i[Y].update(B,!1):typeof i[l[Y]]=="function"?i[l[Y]](B):Y!=="colors"&&i.collectionsWithUpdate.indexOf(Y)===-1&&Un(!0,i.options[Y],N[Y]),Y!=="chart"&&i.propsRequireUpdateSeries.indexOf(Y)!==-1&&(R=!0)}),this.collectionsWithUpdate.forEach(function(B){N[B]&&(GM(N[B]).forEach(function(Y,C){let g,x=Tt(Y.id);x&&(g=i.get(Y.id)),!g&&i[B]&&(g=i[B][CT(Y.index,C)])&&(x&&Tt(g.options.id)||g.options.isInternal)&&(g=void 0),g&&g.coll===B&&(g.update(Y,!1),I&&(g.touched=!0)),!g&&I&&i.collectionsWithInit[B]&&(i.collectionsWithInit[B][0].apply(i,[Y].concat(i.collectionsWithInit[B][1]||[]).concat([!1])).touched=!0)}),I&&i[B].forEach(function(Y){Y.touched||Y.options.isInternal?delete Y.touched:P.push(Y)}))}),P.forEach(function(B){B.chart&&B.remove&&B.remove(!1)}),M&&i.axes.forEach(function(B){B.update({},!1)}),R&&i.getSeriesOrderByLinks().forEach(function(B){B.chart&&B.update({},!1)},this);let h=c?.width,H=c&&(LR(c.height)?ks(c.height,h||i.chartWidth):c.height);s||me(h)&&h!==i.chartWidth||me(H)&&H!==i.chartHeight?i.setSize(h,H,e):CT(T,!0)&&i.redraw(e),yN(i,"afterUpdate",{options:N,redraw:T,animation:e})}setSubtitle(N,T){this.applyDescription("subtitle",N),this.layOutTitles(T)}setCaption(N,T){this.applyDescription("caption",N),this.layOutTitles(T)}showResetZoom(){let N=this,T=Ot.lang,I=N.zooming.resetButton,e=I.theme,M=I.relativeTo==="chart"||I.relativeTo==="spacingBox"?null:"plotBox";function R(){N.zoomOut()}yN(this,"beforeShowResetZoom",null,function(){N.resetZoomButton=N.renderer.button(T.resetZoom,null,null,R,e).attr({align:I.position.align,title:T.resetZoomTitle}).addClass("highcharts-reset-zoom").add().align(I.position,!1,M)}),yN(this,"afterShowResetZoom")}zoomOut(){yN(this,"selection",{resetSelection:!0},()=>this.transform({reset:!0,trigger:"zoom"}))}pan(N,T){let I=this,e=typeof T=="object"?T:{enabled:T,type:"x"},M=e.type,R=M&&I[{x:"xAxis",xy:"axes",y:"yAxis"}[M]].filter(i=>i.options.panningEnabled&&!i.options.isInternal),s=I.options.chart;s?.panning&&(s.panning=e),yN(this,"pan",{originalEvent:N},()=>{I.transform({axes:R,event:N,to:{x:N.chartX-(I.mouseDownX||0),y:N.chartY-(I.mouseDownY||0)},trigger:"pan"}),PO(I.container,{cursor:"move"})})}transform(N){let{axes:T=this.axes,event:I,from:e={},reset:M,selection:R,to:s={},trigger:i,allowResetButton:l=!0}=N,{inverted:D,time:P}=this;this.hoverPoints?.forEach(B=>B.setState()),yN(this,"transform",N);let c=N.hasZoomed||!1,h,H;for(let B of T){let{horiz:Y,len:C,minPointOffset:g=0,options:x,reversed:j}=B,Z=Y?"width":"height",W=Y?"x":"y",J=CT(s[Z],B.len),$=CT(e[Z],B.len),PE=10>Math.abs(J)?1:J/$,aE=(e[W]||0)+$/2-B.pos,lE=aE-((s[W]??B.pos)+J/2-B.pos)/PE,mE=j&&!D||!j&&D?-1:1;if(!M&&(aE<0||aE>B.len))continue;let vE=B.chart.polar||B.isOrdinal?0:g*mE||0,XE=B.toValue(lE,!0),NN=B.toValue(lE+C/PE,!0),JE=XE+vE,WE=NN-vE,eO=B.allExtremes;if(R&&R[B.coll].push({axis:B,min:Math.min(XE,NN),max:Math.max(XE,NN)}),JE>WE&&([JE,WE]=[WE,JE]),PE===1&&!M&&B.coll==="yAxis"&&!eO){for(let St of B.series){let Gn=St.getExtremes(St.getProcessedData(!0).modified.getColumn(St.pointValKey||"y")||[],!0);eO??(eO={dataMin:Number.MAX_VALUE,dataMax:-Number.MAX_VALUE}),me(Gn.dataMin)&&me(Gn.dataMax)&&(eO.dataMin=Math.min(Gn.dataMin,eO.dataMin),eO.dataMax=Math.max(Gn.dataMax,eO.dataMax))}B.allExtremes=eO}let{dataMin:MO,dataMax:LO,min:oN,max:lN}=nt(B.getExtremes(),eO||{}),kN=P.parse(x.min),cN=P.parse(x.max),jN=MO??kN,XN=LO??cN,TO=WE-JE,cO=B.categories?0:Math.min(TO,XN-jN),xO=jN-cO*(Tt(kN)?0:x.minPadding),kT=XN+cO*(Tt(cN)?0:x.maxPadding),yM=B.allowZoomOutside||PE===1||i!=="zoom"&&PE>1,BT=Math.min(kN??xO,xO,yM?oN:xO),ST=Math.max(cN??kT,kT,yM?lN:kT);(!B.isOrdinal||PE!==1||M)&&(JE<BT&&(JE=BT,PE>=1&&(WE=JE+TO)),WE>ST&&(WE=ST,PE>=1&&(JE=WE-TO)),(M||B.series.length&&(JE!==oN||WE!==lN)&&JE>=BT&&WE<=ST)&&(R?R[B.coll].push({axis:B,min:JE,max:WE}):(B.isPanning=i!=="zoom",B.isPanning&&i!=="mousewheel"&&(H=!0),B.setExtremes(M?void 0:JE,M?void 0:WE,!1,!1,{move:lE,trigger:i,scale:PE}),!M&&(JE>BT||WE<ST)&&(h=l)),c=!0),this.hasCartesianSeries||M||(h=l),I&&(this[Y?"mouseDownX":"mouseDownY"]=I[Y?"chartX":"chartY"]))}return c&&(R?yN(this,"selection",R,()=>{delete N.selection,N.trigger="zoom",this.transform(N)}):(!h||H||this.resetZoomButton?!h&&this.resetZoomButton&&(this.resetZoomButton=this.resetZoomButton.destroy()):this.showResetZoom(),this.redraw(i==="zoom"&&(this.options.chart.animation??this.pointCount<100)))),c}}nt(It.prototype,{callbacks:[],collectionsWithInit:{xAxis:[It.prototype.addAxis,[!0]],yAxis:[It.prototype.addAxis,[!1]],series:[It.prototype.addSeries]},collectionsWithUpdate:["xAxis","yAxis","series"],propsRequireDirtyBox:["backgroundColor","borderColor","borderWidth","borderRadius","plotBackgroundColor","plotBackgroundImage","plotBorderColor","plotBorderWidth","plotShadow","shadow"],propsRequireReflow:["margin","marginTop","marginRight","marginBottom","marginLeft","spacing","spacingTop","spacingRight","spacingBottom","spacingLeft"],propsRequireUpdateSeries:["chart.inverted","chart.polar","chart.ignoreHiddenSeries","chart.type","colors","plotOptions","time","tooltip"]});let{stop:tt}=FO,{composed:w_}=z,{addEvent:kt,createElement:dR,css:NI,defined:GR,erase:qi,merge:uR,pushUnique:uM}=tN;function uO(){let A=this.scrollablePlotArea;(this.scrollablePixelsX||this.scrollablePixelsY)&&!A&&(this.scrollablePlotArea=A=new YR(this)),A?.applyFixed()}function Wi(){this.chart.scrollablePlotArea&&(this.chart.scrollablePlotArea.isDirty=!0)}class YR{static compose(N,T,I){uM(w_,this.compose)&&(kt(N,"afterInit",Wi),kt(T,"afterSetChartSize",e=>this.afterSetSize(e.target,e)),kt(T,"render",uO),kt(I,"show",Wi))}static afterSetSize(N,T){let I,e,M,{minWidth:R,minHeight:s}=N.options.chart.scrollablePlotArea||{},{clipBox:i,plotBox:l,inverted:D,renderer:P}=N;if(!P.forExport)if(R?(N.scrollablePixelsX=I=Math.max(0,R-N.chartWidth),I&&(N.scrollablePlotBox=uR(N.plotBox),l.width=N.plotWidth+=I,i[D?"height":"width"]+=I,M=!0)):s&&(N.scrollablePixelsY=e=Math.max(0,s-N.chartHeight),GR(e)&&(N.scrollablePlotBox=uR(N.plotBox),l.height=N.plotHeight+=e,i[D?"width":"height"]+=e,M=!1)),GR(M)){if(!T.skipAxes)for(let c of N.axes)(c.horiz===M||N.hasParallelCoordinates&&c.coll==="yAxis")&&(c.setAxisSize(),c.setAxisTranslation())}else delete N.scrollablePlotBox}constructor(N){let T;const I=N.options.chart,e=Yn.getRendererType(),M=I.scrollablePlotArea||{},R=this.moveFixedElements.bind(this),s={WebkitOverflowScrolling:"touch",overflowX:"hidden",overflowY:"hidden"};N.scrollablePixelsX&&(s.overflowX="auto"),N.scrollablePixelsY&&(s.overflowY="auto"),this.chart=N;const i=this.parentDiv=dR("div",{className:"highcharts-scrolling-parent"},{position:"relative"},N.renderTo),l=this.scrollingContainer=dR("div",{className:"highcharts-scrolling"},s,i),D=this.innerContainer=dR("div",{className:"highcharts-inner-container"},void 0,l),P=this.fixedDiv=dR("div",{className:"highcharts-fixed"},{position:"absolute",overflow:"hidden",pointerEvents:"none",zIndex:(I.style?.zIndex||0)+2,top:0},void 0,!0),c=this.fixedRenderer=new e(P,N.chartWidth,N.chartHeight,I.style);this.mask=c.path().attr({fill:I.backgroundColor||"#fff","fill-opacity":M.opacity??.85,zIndex:-1}).addClass("highcharts-scrollable-mask").add(),l.parentNode.insertBefore(P,l),NI(N.renderTo,{overflow:"visible"}),kt(N,"afterShowResetZoom",R),kt(N,"afterApplyDrilldown",R),kt(N,"afterLayOutTitles",R),kt(l,"scroll",()=>{let{pointer:h,hoverPoint:H}=N;h&&(delete h.chartPosition,H&&(T=H),h.runPointActions(void 0,T,!0))}),D.appendChild(N.container)}applyFixed(){let{chart:N,fixedRenderer:T,isDirty:I,scrollingContainer:e}=this,{axisOffset:M,chartWidth:R,chartHeight:s,container:i,plotHeight:l,plotLeft:D,plotTop:P,plotWidth:c,scrollablePixelsX:h=0,scrollablePixelsY:H=0}=N,{scrollPositionX:B=0,scrollPositionY:Y=0}=N.options.chart.scrollablePlotArea||{},C=R+h,g=s+H;T.setSize(R,s),(I??!0)&&(this.isDirty=!1,this.moveFixedElements()),tt(N.container),NI(i,{width:`${C}px`,height:`${g}px`}),N.renderer.boxWrapper.attr({width:C,height:g,viewBox:["0 0",C,g].join(" ")}),N.chartBackground?.attr({width:C,height:g}),NI(e,{width:`${R}px`,height:`${s}px`}),GR(I)||(e.scrollLeft=h*B,e.scrollTop=H*Y);let x=P-M[0]-1,j=D-M[3]-1,Z=P+l+M[2]+1,W=D+c+M[1]+1,J=D+c-h,$=P+l-H,PE=[["M",0,0]];h?PE=[["M",0,x],["L",D-1,x],["L",D-1,Z],["L",0,Z],["Z"],["M",J,x],["L",R,x],["L",R,Z],["L",J,Z],["Z"]]:H&&(PE=[["M",j,0],["L",j,P-1],["L",W,P-1],["L",W,0],["Z"],["M",j,$],["L",j,s],["L",W,s],["L",W,$],["Z"]]),N.redrawTrigger!=="adjustHeight"&&this.mask.attr({d:PE})}moveFixedElements(){let N,{container:T,inverted:I,scrollablePixelsX:e,scrollablePixelsY:M}=this.chart,R=this.fixedRenderer,s=YR.fixedSelectors;if(e&&!I?N=".highcharts-yaxis":e&&I||M&&!I?N=".highcharts-xaxis":M&&I&&(N=".highcharts-yaxis"),N&&!(this.chart.hasParallelCoordinates&&N===".highcharts-yaxis"))for(let i of[`${N}:not(.highcharts-radial-axis)`,`${N}-labels:not(.highcharts-radial-axis-labels)`])uM(s,i);else for(let i of[".highcharts-xaxis",".highcharts-yaxis"])for(let l of[`${i}:not(.highcharts-radial-axis)`,`${i}-labels:not(.highcharts-radial-axis-labels)`])qi(s,l);for(let i of s)[].forEach.call(T.querySelectorAll(i),l=>{(l.namespaceURI===R.SVG_NS?R.box:R.box.parentNode).appendChild(l),l.style.pointerEvents="auto"})}}YR.fixedSelectors=[".highcharts-breadcrumbs-group",".highcharts-contextbutton",".highcharts-caption",".highcharts-credits",".highcharts-drillup-button",".highcharts-legend",".highcharts-legend-checkbox",".highcharts-navigator-series",".highcharts-navigator-xaxis",".highcharts-navigator-yaxis",".highcharts-navigator",".highcharts-range-selector-group",".highcharts-reset-zoom",".highcharts-scrollbar",".highcharts-subtitle",".highcharts-title"];let{format:Qi}=GT,{series:HR}=BO,{destroyObjectProperties:zt,fireEvent:k_,getAlignFactor:zs,isNumber:fe,pick:tn}=tN,z_=class{constructor(A,N,T,I,e){const M=A.chart.inverted,R=A.reversed;this.axis=A;const s=this.isNegative=!!T!=!!R;this.options=N=N||{},this.x=I,this.total=null,this.cumulative=null,this.points={},this.hasValidPoints=!1,this.stack=e,this.leftCliff=0,this.rightCliff=0,this.alignOptions={align:N.align||(M?s?"left":"right":"center"),verticalAlign:N.verticalAlign||(M?"middle":s?"bottom":"top"),y:N.y,x:N.x},this.textAlign=N.textAlign||(M?s?"right":"left":"center")}destroy(){zt(this,this.axis)}render(A){let N=this.axis.chart,T=this.options,I=T.format,e=I?Qi(I,this,N):T.formatter.call(this);if(this.label)this.label.attr({text:e,visibility:"hidden"});else{this.label=N.renderer.label(e,null,void 0,T.shape,void 0,void 0,T.useHTML,!1,"stack-labels");let M={r:T.borderRadius||0,text:e,padding:tn(T.padding,5),visibility:"hidden"};N.styledMode||(M.fill=T.backgroundColor,M.stroke=T.borderColor,M["stroke-width"]=T.borderWidth,this.label.css(T.style||{})),this.label.attr(M),this.label.added||this.label.add(A)}this.label.labelrank=N.plotSizeY,k_(this,"afterRender")}setOffset(A,N,T,I,e,M){let{alignOptions:R,axis:s,label:i,options:l,textAlign:D}=this,P=s.chart,c=this.getStackBox({xOffset:A,width:N,boxBottom:T,boxTop:I,defaultX:e,xAxis:M}),{verticalAlign:h}=R;if(i&&c){let H=i.getBBox(void 0,0),B=i.padding,Y=tn(l.overflow,"justify")==="justify",C;R.x=l.x||0,R.y=l.y||0;let{x:g,y:x}=this.adjustStackPosition({labelBox:H,verticalAlign:h,textAlign:D});c.x-=g,c.y-=x,i.align(R,!1,c),(C=P.isInsidePlot(i.alignAttr.x+R.x+g,i.alignAttr.y+R.y+x))||(Y=!1),Y&&HR.prototype.justifyDataLabel.call(s,i,R,i.alignAttr,H,c),i.attr({x:i.alignAttr.x,y:i.alignAttr.y,rotation:l.rotation,rotationOriginX:H.width*zs(l.textAlign||"center"),rotationOriginY:H.height/2}),tn(!Y&&l.crop,!0)&&(C=fe(i.x)&&fe(i.y)&&P.isInsidePlot(i.x-B+(i.width||0),i.y)&&P.isInsidePlot(i.x+B,i.y)),i[C?"show":"hide"]()}k_(this,"afterSetOffset",{xOffset:A,width:N})}adjustStackPosition({labelBox:A,verticalAlign:N,textAlign:T}){return{x:A.width/2+A.width/2*(2*zs(T)-1),y:A.height/2*2*(1-zs(N))}}getStackBox(A){let N=this.axis,T=N.chart,{boxTop:I,defaultX:e,xOffset:M,width:R,boxBottom:s}=A,i=N.stacking.usePercentage?100:tn(I,this.total,0),l=N.toPixels(i),D=A.xAxis||T.xAxis[0],P=tn(e,D.translate(this.x))+M,c=Math.abs(l-N.toPixels(s||fe(N.min)&&N.logarithmic&&N.logarithmic.lin2log(N.min)||0)),h=T.inverted,H=this.isNegative;return h?{x:(H?l:l-c)-T.plotLeft,y:D.height-P-R+D.top-T.plotTop,width:c,height:R}:{x:P+D.transB-T.plotLeft,y:(H?l-c:l)-T.plotTop,width:R,height:c}}},{getDeferredAnimation:F_}=FO,{series:{prototype:Ji}}=BO,{addEvent:Fs,correctFloat:pe,defined:CR,destroyObjectProperties:$i,fireEvent:et,isNumber:kO,objectEach:Mt,pick:js}=tN;function oT(){let A=this.inverted;this.axes.forEach(N=>{N.stacking?.stacks&&N.hasVisibleSeries&&(N.stacking.oldStacks=N.stacking.stacks)}),this.series.forEach(N=>{let T=N.xAxis?.options||{};N.options.stacking&&N.reserveSpace()&&(N.stackKey=[N.type,js(N.options.stack,""),A?T.top:T.left,A?T.height:T.width].join(","))})}function IA(){let A=this.stacking;if(A){let N=A.stacks;Mt(N,(T,I)=>{$i(T),delete N[I]}),A.stackTotalGroup?.destroy()}}function Eo(){this.stacking||(this.stacking=new To(this))}function No(A,N,T,I){return!CR(A)||A.x!==N||I&&A.stackKey!==I?A={x:N,index:0,key:I,stackKey:I}:A.index++,A.key=[T,N,A.index].join(","),A}function bO(){let A,N=this,T=N.yAxis,I=N.stackKey||"",e=T.stacking.stacks,M=N.getColumn("x",!0),R=N.options.stacking,s=N[R+"Stacker"];s&&[I,"-"+I].forEach(i=>{let l=M.length,D,P,c;for(;l--;)D=M[l],A=N.getStackIndicator(A,D,N.index,i),P=e[i]?.[D],(c=P?.points[A.key||""])&&s.call(N,c,P,l)})}function en(A,N,T){let I=N.total?100/N.total:0;A[0]=pe(A[0]*I),A[1]=pe(A[1]*I),this.stackedYData[T]=A[1]}function Rt(A){(this.is("column")||this.is("columnrange"))&&(this.options.centerInCategory&&this.chart.series.length>1?Ji.setStackedPoints.call(this,A,"group"):A.stacking.resetStacks())}function Oo(A,N){let T,I,e,M,R,s,i,l=N||this.options.stacking;if(!l||!this.reserveSpace()||({group:"xAxis"}[l]||"yAxis")!==A.coll)return;let D=this.getColumn("x",!0),P=this.getColumn(this.pointValKey||"y",!0),c=[],h=P.length,H=this.options,B=H.threshold||0,Y=H.startFromThreshold?B:0,C=H.stack,g=N?`${this.type},${l}`:this.stackKey||"",x="-"+g,j=this.negStacks,Z=A.stacking,W=Z.stacks,J=Z.oldStacks;for(Z.stacksTouched+=1,i=0;i<h;i++){let $=D[i]||0,PE=P[i],aE=kO(PE)&&PE||0;s=(T=this.getStackIndicator(T,$,this.index)).key||"",W[R=(I=j&&aE<(Y?0:B))?x:g]||(W[R]={}),W[R][$]||(J[R]?.[$]?(W[R][$]=J[R][$],W[R][$].total=null):W[R][$]=new z_(A,A.options.stackLabels,!!I,$,C)),e=W[R][$],PE!==null?(e.points[s]=e.points[this.index]=[js(e.cumulative,Y)],CR(e.cumulative)||(e.base=s),e.touched=Z.stacksTouched,T.index>0&&this.singleStacks===!1&&(e.points[s][0]=e.points[this.index+","+$+",0"][0])):(delete e.points[s],delete e.points[this.index]);let lE=e.total||0;l==="percent"?(M=I?g:x,lE=j&&W[M]?.[$]?(M=W[M][$]).total=Math.max(M.total||0,lE)+Math.abs(aE):pe(lE+Math.abs(aE))):l==="group"?kO(PE)&&lE++:lE=pe(lE+aE),l==="group"?e.cumulative=(lE||1)-1:e.cumulative=pe(js(e.cumulative,Y)+aE),e.total=lE,PE!==null&&(e.points[s].push(e.cumulative),c[i]=e.cumulative,e.hasValidPoints=!0)}l==="percent"&&(Z.usePercentage=!0),l!=="group"&&(this.stackedYData=c),Z.oldStacks={}}class To{constructor(N){this.oldStacks={},this.stacks={},this.stacksTouched=0,this.axis=N}buildStacks(){let N,T,I=this.axis,e=I.series,M=I.coll==="xAxis",R=I.options.reversedStacks,s=e.length;for(this.resetStacks(),this.usePercentage=!1,T=s;T--;)N=e[R?T:s-T-1],M&&N.setGroupedPoints(I),N.setStackedPoints(I);if(!M)for(T=0;T<s;T++)e[T].modifyStacks();et(I,"afterBuildStacks")}cleanStacks(){this.oldStacks&&(this.stacks=this.oldStacks,Mt(this.stacks,N=>{Mt(N,T=>{T.cumulative=T.total})}))}resetStacks(){Mt(this.stacks,N=>{Mt(N,(T,I)=>{kO(T.touched)&&T.touched<this.stacksTouched?(T.destroy(),delete N[I]):(T.total=null,T.cumulative=null)})})}renderStackTotals(){let N=this.axis,T=N.chart,I=T.renderer,e=this.stacks,M=F_(T,N.options.stackLabels?.animation||!1),R=this.stackTotalGroup=this.stackTotalGroup||I.g("stack-labels").attr({zIndex:6,opacity:0}).add();R.translate(T.plotLeft,T.plotTop),Mt(e,s=>{Mt(s,i=>{i.render(R)})}),R.animate({opacity:1},M)}}(bT||(bT={})).compose=function(A,N,T){let I=N.prototype,e=T.prototype;I.getStacks||(Fs(A,"init",Eo),Fs(A,"destroy",IA),I.getStacks=oT,e.getStackIndicator=No,e.modifyStacks=bO,e.percentStacker=en,e.setGroupedPoints=Rt,e.setStackedPoints=Oo)};let no=bT,{defined:tA,merge:BR,isObject:Mn}=tN;class xn extends In{drawGraph(){let N=this.options,T=(this.gappedPath||this.getGraphPath).call(this),I=this.chart.styledMode;[this,...this.zones].forEach((e,M)=>{let R,s=e.graph,i=s?"animate":"attr",l=e.dashStyle||N.dashStyle;s?(s.endX=this.preventGraphAnimation?null:T.xMap,s.animate({d:T})):T.length&&(e.graph=s=this.chart.renderer.path(T).addClass("highcharts-graph"+(M?` highcharts-zone-graph-${M-1} `:" ")+(M&&e.className||"")).attr({zIndex:1}).add(this.group)),s&&!I&&(R={stroke:!M&&N.lineColor||e.color||this.color||"#cccccc","stroke-width":N.lineWidth||0,fill:this.fillGraph&&this.color||"none"},l?R.dashstyle=l:N.linecap!=="square"&&(R["stroke-linecap"]=R["stroke-linejoin"]="round"),s[i](R).shadow(N.shadow&&BR({filterUnits:"userSpaceOnUse"},Mn(N.shadow)?N.shadow:{}))),s&&(s.startX=T.xMap,s.isArea=T.isArea)})}getGraphPath(N,T,I){let e=this,M=e.options,R=[],s=[],i,l=M.step,D=(N=N||e.points).reversed;return D&&N.reverse(),(l={right:1,center:2}[l]||l&&3)&&D&&(l=4-l),(N=this.getValidPoints(N,!1,M.nullInteraction||!(M.connectNulls&&!T&&!I))).forEach(function(P,c){let h,H=P.plotX,B=P.plotY,Y=N[c-1],C=P.isNull||typeof B!="number";(P.leftCliff||Y?.rightCliff)&&!I&&(i=!0),C&&!tA(T)&&c>0?i=!M.connectNulls:C&&!T?i=!0:(c===0||i?h=[["M",P.plotX,P.plotY]]:e.getPointSpline?h=[e.getPointSpline(N,P,c)]:l?(h=l===1?[["L",Y.plotX,B]]:l===2?[["L",(Y.plotX+H)/2,Y.plotY],["L",(Y.plotX+H)/2,B]]:[["L",H,Y.plotY]]).push(["L",H,B]):h=[["L",H,B]],s.push(P.x),l&&(s.push(P.x),l===2&&s.push(P.x)),R.push.apply(R,h),i=!1)}),R.xMap=s,e.graphPath=R,R}}xn.defaultOptions=BR(In.defaultOptions,{legendSymbol:"lineMarker"}),BO.registerSeriesType("line",xn);let{seriesTypes:{line:Zs}}=BO,{extend:Rn,merge:Io,objectEach:st,pick:CI}=tN;class OI extends Zs{drawGraph(){this.areaPath=[],super.drawGraph.apply(this);let{areaPath:N,options:T}=this;[this,...this.zones].forEach((I,e)=>{let M={},R=I.fillColor||T.fillColor,s=I.area,i=s?"animate":"attr";s?(s.endX=this.preventGraphAnimation?null:N.xMap,s.animate({d:N})):(M.zIndex=0,(s=I.area=this.chart.renderer.path(N).addClass("highcharts-area"+(e?` highcharts-zone-area-${e-1} `:" ")+(e&&I.className||"")).add(this.group)).isArea=!0),this.chart.styledMode||(M.fill=R||I.color||this.color,M["fill-opacity"]=R?1:T.fillOpacity??.75,s.css({pointerEvents:this.stickyTracking?"none":"auto"})),s[i](M),s.startX=N.xMap,s.shiftUnit=T.step?2:1})}getGraphPath(N){let T,I,e,M=Zs.prototype.getGraphPath,R=this.options,s=R.stacking,i=this.yAxis,l=[],D=[],P=this.index,c=i.stacking.stacks[this.stackKey],h=R.threshold,H=Math.round(i.getThreshold(R.threshold)),B=CI(R.connectNulls,s==="percent"),Y=function(W,J,$){let PE=N[W],aE=s&&c[PE.x].points[P],lE=PE[$+"Null"]||0,mE=PE[$+"Cliff"]||0,vE,XE,NN=!0;mE||lE?(vE=(lE?aE[0]:aE[1])+mE,XE=aE[0]+mE,NN=!!lE):!s&&N[J]&&N[J].isNull&&(vE=XE=h),vE!==void 0&&(D.push({plotX:T,plotY:vE===null?H:i.getThreshold(vE),isNull:NN,isCliff:!0}),l.push({plotX:T,plotY:XE===null?H:i.getThreshold(XE),doCurve:!1}))};N=N||this.points,s&&(N=this.getStackPoints(N));for(let W=0,J=N.length;W<J;++W)s||(N[W].leftCliff=N[W].rightCliff=N[W].leftNull=N[W].rightNull=void 0),I=N[W].isNull,T=CI(N[W].rectPlotX,N[W].plotX),e=s?CI(N[W].yBottom,H):H,(!I||B)&&(B||Y(W,W-1,"left"),I&&!s&&B||(D.push(N[W]),l.push({x:W,plotX:T,plotY:e})),B||Y(W,W+1,"right"));let C=M.call(this,D,!0,!0);l.reversed=!0;let g=M.call(this,l,!0,!0),x=g[0];x&&x[0]==="M"&&(g[0]=["L",x[1],x[2]]);let j=C.concat(g);j.length&&j.push(["Z"]);let Z=M.call(this,D,!1,B);return this.chart.series.length>1&&s&&D.some(W=>W.isCliff)&&(j.hasStackedCliffs=Z.hasStackedCliffs=!0),j.xMap=C.xMap,this.areaPath=j,Z}getStackPoints(N){let T=this,I=[],e=[],M=this.xAxis,R=this.yAxis,s=R.stacking.stacks[this.stackKey],i={},l=R.series,D=l.length,P=R.options.reversedStacks?1:-1,c=l.indexOf(T);if(N=N||this.points,this.options.stacking){for(let H=0;H<N.length;H++)N[H].leftNull=N[H].rightNull=void 0,i[N[H].x]=N[H];st(s,function(H,B){H.total!==null&&e.push(B)}),e.sort(function(H,B){return H-B});let h=l.map(H=>H.visible);e.forEach(function(H,B){let Y=0,C,g;if(i[H]&&!i[H].isNull)I.push(i[H]),[-1,1].forEach(function(x){let j=x===1?"rightNull":"leftNull",Z=s[e[B+x]],W=0;if(Z){let J=c;for(;J>=0&&J<D;){let $=l[J].index;!(C=Z.points[$])&&($===T.index?i[H][j]=!0:h[J]&&(g=s[H].points[$])&&(W-=g[1]-g[0])),J+=P}}i[H][x===1?"rightCliff":"leftCliff"]=W});else{let x=c;for(;x>=0&&x<D;){let j=l[x].index;if(C=s[H].points[j]){Y=C[1];break}x+=P}Y=CI(Y,0),Y=R.translate(Y,0,1,0,1),I.push({isNull:!0,plotX:M.translate(H,0,0,0,1),x:H,plotY:Y,yBottom:Y})}})}return I}}OI.defaultOptions=Io(Zs.defaultOptions,{threshold:0,legendSymbol:"areaMarker"}),Rn(OI.prototype,{singleStacks:!1}),BO.registerSeriesType("area",OI);let{line:Xs}=BO.seriesTypes,{merge:j_,pick:sn}=tN;class qs extends Xs{getPointSpline(N,T,I){let e,M,R,s,i=T.plotX||0,l=T.plotY||0,D=N[I-1],P=N[I+1];function c(H){return H&&!H.isNull&&H.doCurve!==!1&&!T.isCliff}if(c(D)&&c(P)){let H=D.plotX||0,B=D.plotY||0,Y=P.plotX||0,C=P.plotY||0,g=0;e=(1.5*i+H)/2.5,M=(1.5*l+B)/2.5,R=(1.5*i+Y)/2.5,s=(1.5*l+C)/2.5,R!==e&&(g=(s-M)*(R-i)/(R-e)+l-s),M+=g,s+=g,M>B&&M>l?(M=Math.max(B,l),s=2*l-M):M<B&&M<l&&(M=Math.min(B,l),s=2*l-M),s>C&&s>l?(s=Math.max(C,l),M=2*l-s):s<C&&s<l&&(s=Math.min(C,l),M=2*l-s),T.rightContX=R,T.rightContY=s,T.controlPoints={low:[e,M],high:[R,s]}}let h=["C",sn(D.rightContX,D.plotX,0),sn(D.rightContY,D.plotY,0),sn(e,i,0),sn(M,l,0),i,l];return D.rightContX=D.rightContY=void 0,h}}qs.defaultOptions=j_(Xs.defaultOptions),BO.registerSeriesType("spline",qs);let Ve=qs,{area:bR,area:{prototype:ge}}=BO.seriesTypes,{extend:YM,merge:to}=tN;class Ws extends Ve{}Ws.defaultOptions=to(Ve.defaultOptions,bR.defaultOptions),YM(Ws.prototype,{getGraphPath:ge.getGraphPath,getStackPoints:ge.getStackPoints,drawGraph:ge.drawGraph}),BO.registerSeriesType("areaspline",Ws);let{animObject:mR}=FO,{parse:eo}=QN,{noop:Qs}=z,{clamp:fR,crisp:Js,defined:Mo,extend:JN,fireEvent:AO,isArray:fN,isNumber:bN,merge:OO,pick:hT,objectEach:Ft}=tN;class _t extends In{animate(N){let T,I,e=this,M=this.yAxis,R=M.pos,s=M.reversed,i=e.options,{clipOffset:l,inverted:D}=this.chart,P={},c=D?"translateX":"translateY";N&&l?(P.scaleY=.001,I=fR(M.toPixels(i.threshold||0),R,R+M.len),D?P.translateX=(I+=s?-Math.floor(l[0]):Math.ceil(l[2]))-M.len:P.translateY=I+=s?Math.ceil(l[0]):-Math.floor(l[2]),e.clipBox&&e.setClip(),e.group.attr(P)):(T=Number(e.group.attr(c)),e.group.animate({scaleY:1},JN(mR(e.options.animation),{step:function(h,H){e.group&&(P[c]=T+H.pos*(R-T),e.group.attr(P))}})))}init(N,T){super.init.apply(this,arguments);let I=this;(N=I.chart).hasRendered&&N.series.forEach(function(e){e.type===I.type&&(e.isDirty=!0)})}getColumnMetrics(){let N=this,T=N.options,I=N.xAxis,e=N.yAxis,M=I.options.reversedStacks,R=I.reversed&&!M||!I.reversed&&M,s={},i,l=0;T.grouping===!1?l=1:N.chart.series.forEach(function(B){let Y,C=B.yAxis,g=B.options;B.type===N.type&&B.reserveSpace()&&e.len===C.len&&e.pos===C.pos&&(g.stacking&&g.stacking!=="group"?(s[i=B.stackKey]===void 0&&(s[i]=l++),Y=s[i]):g.grouping!==!1&&(Y=l++),B.columnIndex=Y)});let D=Math.min(Math.abs(I.transA)*(!I.brokenAxis?.hasBreaks&&I.ordinal?.slope||T.pointRange||I.closestPointRange||I.tickInterval||1),I.len),P=D*T.groupPadding,c=(D-2*P)/(l||1),h=Math.min(T.maxPointWidth||I.len,hT(T.pointWidth,c*(1-2*T.pointPadding))),H=(N.columnIndex||0)+ +!!R;return N.columnMetrics={width:h,offset:(c-h)/2+(P+H*c-D/2)*(R?-1:1),paddedWidth:c,columnCount:l},N.columnMetrics}crispCol(N,T,I,e){let M=this.borderWidth,R=this.chart.inverted;return e=Js(T+e,M,R)-(T=Js(T,M,R)),this.options.crisp&&(I=Js(N+I,M)-(N=Js(N,M))),{x:N,y:T,width:I,height:e}}adjustForMissingColumns(N,T,I,e){if(!I.isNull&&e.columnCount>1){let M=this.xAxis.series.filter(l=>l.visible).map(l=>l.index),R=0,s=0;Ft(this.xAxis.stacking?.stacks,l=>{let D=typeof I.x=="number"?l[I.x.toString()]?.points:void 0,P=D?.[this.index],c={};if(D&&fN(P)){let h=this.index,H=Object.keys(D).filter(B=>!B.match(",")&&D[B]&&D[B].length>1).map(parseFloat).filter(B=>M.indexOf(B)!==-1).filter(B=>{let Y=this.chart.series[B].options,C=Y.stacking&&Y.stack;if(Mo(C)){if(bN(c[C]))return h===B&&(h=c[C]),!1;c[C]=B}return!0}).sort((B,Y)=>Y-B);R=H.indexOf(h),s=H.length}}),R=this.xAxis.reversed?s-1-R:R;let i=(s-1)*e.paddedWidth+T;N=(I.plotX||0)+i/2-T-R*e.paddedWidth}return N}translate(){let N=this,T=N.chart,I=N.options,e=N.dense=N.closestPointRange*N.xAxis.transA<2,M=N.borderWidth=hT(I.borderWidth,+!e),R=N.xAxis,s=N.yAxis,i=I.threshold,l=hT(I.minPointLength,5),D=N.getColumnMetrics(),P=D.width,c=N.pointXOffset=D.offset,h=N.dataMin,H=N.dataMax,B=N.translatedThreshold=s.getThreshold(i),Y=N.barW=Math.max(P,1+2*M);I.pointPadding&&I.crisp&&(Y=Math.ceil(Y)),In.prototype.translate.apply(N),N.points.forEach(function(C){let g=hT(C.yBottom,B),x=999+Math.abs(g),j=C.plotX||0,Z=fR(C.plotY,-x,s.len+x),W,J=Math.min(Z,g),$=Math.max(Z,g)-J,PE=P,aE=j+c,lE=Y;l&&Math.abs($)<l&&($=l,W=!s.reversed&&!C.negative||s.reversed&&C.negative,bN(i)&&bN(H)&&C.y===i&&H<=i&&(s.min||0)<i&&(h!==H||(s.max||0)<=i)&&(W=!W,C.negative=!C.negative),J=Math.abs(J-B)>l?g-l:B-(W?l:0)),Mo(C.options.pointWidth)&&(aE-=Math.round(((PE=lE=Math.ceil(C.options.pointWidth))-P)/2)),I.centerInCategory&&(aE=N.adjustForMissingColumns(aE,PE,C,D)),C.barX=aE,C.pointWidth=PE,C.tooltipPos=T.inverted?[fR(s.len+s.pos-T.plotLeft-Z,s.pos-T.plotLeft,s.len+s.pos-T.plotLeft),R.len+R.pos-T.plotTop-aE-lE/2,$]:[R.left-T.plotLeft+aE+lE/2,fR(Z+s.pos-T.plotTop,s.pos-T.plotTop,s.len+s.pos-T.plotTop),$],C.shapeType=N.pointClass.prototype.shapeType||"roundedRect",C.shapeArgs=N.crispCol(aE,J,lE,C.isNull?0:$)}),AO(this,"afterColumnTranslate")}drawGraph(){this.group[this.dense?"addClass":"removeClass"]("highcharts-dense-data")}pointAttribs(N,T){let I=this.options,e=this.pointAttrToOptions||{},M=e.stroke||"borderColor",R=e["stroke-width"]||"borderWidth",s,i,l,D=N&&N.color||this.color,P=N&&N[M]||I[M]||D,c=N&&N.options.dashStyle||I.dashStyle,h=N&&N[R]||I[R]||this[R]||0,H=N?.isNull&&I.nullInteraction?0:N?.opacity??I.opacity??1;N&&this.zones.length&&(i=N.getZone(),D=N.options.color||i&&(i.color||N.nonZonedColor)||this.color,i&&(P=i.borderColor||P,c=i.dashStyle||c,h=i.borderWidth||h)),T&&N&&(l=(s=OO(I.states[T],N.options.states?.[T]||{})).brightness,D=s.color||l!==void 0&&eo(D).brighten(s.brightness).get()||D,P=s[M]||P,h=s[R]||h,c=s.dashStyle||c,H=hT(s.opacity,H));let B={fill:D,stroke:P,"stroke-width":h,opacity:H};return c&&(B.dashstyle=c),B}drawPoints(N=this.points){let T,I=this,e=this.chart,M=I.options,R=M.nullInteraction,s=e.renderer,i=M.animationLimit||250;N.forEach(function(l){let D=l.plotY,P=l.graphic,c=!!P,h=P&&e.pointCount<i?"animate":"attr";bN(D)&&(l.y!==null||R)?(T=l.shapeArgs,P&&l.hasNewShapeType()&&(P=P.destroy()),I.enabledDataSorting&&(l.startXPos=I.xAxis.reversed?-(T&&T.width||0):I.xAxis.width),!P&&(l.graphic=P=s[l.shapeType](T).add(l.group||I.group),P&&I.enabledDataSorting&&e.hasRendered&&e.pointCount<i&&(P.attr({x:l.startXPos}),c=!0,h="animate")),P&&c&&P[h](OO(T)),e.styledMode||P[h](I.pointAttribs(l,l.selected&&"select")).shadow(l.allowShadow!==!1&&M.shadow),P&&(P.addClass(l.getClassName(),!0),P.attr({visibility:l.visible?"inherit":"hidden"}))):P&&(l.graphic=P.destroy())})}drawTracker(N=this.points){let T,I=this,e=I.chart,M=e.pointer,R=function(s){M?.normalize(s);let i=M?.getPointFromEvent(s);M&&i&&I.options.enableMouseTracking&&(e.isInsidePlot(s.chartX-e.plotLeft,s.chartY-e.plotTop,{visiblePlotOnly:!0})||M?.inClass(s.target,"highcharts-data-label"))&&(M.isDirectTouch=!0,i.onMouseOver(s))};N.forEach(function(s){T=fN(s.dataLabels)?s.dataLabels:s.dataLabel?[s.dataLabel]:[],s.graphic&&(s.graphic.element.point=s),T.forEach(function(i){(i.div||i.element).point=s})}),I._hasTracking||(I.trackerGroups?.reduce((s,i)=>(i==="dataLabelsGroup"?s.push(...I.dataLabelsGroups||[]):s.push(I[i]),s),[]).forEach(s=>{s&&(s.addClass("highcharts-tracker").on("mouseover",R).on("mouseout",function(i){M?.onTrackerMouseOut(i)}).on("touchstart",R),!e.styledMode&&I.options.cursor&&s.css({cursor:I.options.cursor}))}),I._hasTracking=!0),AO(this,"afterDrawTracker")}remove(){let N=this,T=N.chart;T.hasRendered&&T.series.forEach(function(I){I.type===N.type&&(I.isDirty=!0)}),In.prototype.remove.apply(N,arguments)}}_t.defaultOptions=OO(In.defaultOptions,{borderRadius:3,centerInCategory:!1,groupPadding:.2,marker:null,pointPadding:.1,minPointLength:0,cropThreshold:50,pointRange:null,states:{hover:{halo:!1,brightness:.1},select:{color:"#cccccc",borderColor:"#000000"}},dataLabels:{align:void 0,verticalAlign:void 0,y:void 0},startFromThreshold:!0,stickyTracking:!1,tooltip:{distance:6},threshold:0,borderColor:"#ffffff"}),JN(_t.prototype,{directTouch:!0,getSymbol:Qs,negStacks:!0,trackerGroups:["group","dataLabelsGroup"]}),BO.registerSeriesType("column",_t);let HM=_t,{getDeferredAnimation:it}=FO,{format:zO}=GT,{defined:_n,extend:jt,fireEvent:CM,getAlignFactor:on,isArray:dn,isString:ot,merge:AT,objectEach:Z_,pick:Zt,pInt:Ro,splat:pR}=tN;(function(A){function N(){return i(this).some(D=>D?.enabled)}function T(D,P,c,h,H){let{chart:B,enabledDataSorting:Y}=this,C=this.isCartesian&&B.inverted,g=D.plotX,x=D.plotY,j=c.rotation||0,Z=_n(g)&&_n(x)&&B.isInsidePlot(g,Math.round(x),{inverted:C,paneCoordinates:!0,series:this}),W=j===0&&Zt(c.overflow,Y?"none":"justify")==="justify",J=this.visible&&D.visible!==!1&&_n(g)&&(D.series.forceDL||Y&&!W||Z||Zt(c.inside,!!this.options.stacking)&&h&&B.isInsidePlot(g,C?h.x+1:h.y+h.height-1,{inverted:C,paneCoordinates:!0,series:this})),$=D.pos();if(J&&$){var PE;let aE=P.getBBox(),lE=P.getBBox(void 0,0);if(h=jt({x:$[0],y:Math.round($[1]),width:0,height:0},h||{}),c.alignTo==="plotEdges"&&this.isCartesian&&(h[C?"x":"y"]=0,h[C?"width":"height"]=this.yAxis?.len||0),jt(c,{width:aE.width,height:aE.height}),PE=h,Y&&this.xAxis&&!W&&this.setDataLabelStartPos(D,P,H,Z,PE),P.align(AT(c,{width:lE.width,height:lE.height}),!1,h,!1),P.alignAttr.x+=on(c.align)*(lE.width-aE.width),P.alignAttr.y+=on(c.verticalAlign)*(lE.height-aE.height),P[P.placed?"animate":"attr"]({"text-align":P.alignAttr["text-align"]||"center",x:P.alignAttr.x+(aE.width-lE.width)/2,y:P.alignAttr.y+(aE.height-lE.height)/2,rotationOriginX:(P.width||0)/2,rotationOriginY:(P.height||0)/2}),W&&h.height>=0)this.justifyDataLabel(P,c,P.alignAttr,aE,h,H);else if(Zt(c.crop,!0)){let{x:mE,y:vE}=P.alignAttr;J=B.isInsidePlot(mE,vE,{paneCoordinates:!0,series:this})&&B.isInsidePlot(mE+aE.width-1,vE+aE.height-1,{paneCoordinates:!0,series:this})}c.shape&&!j&&P[H?"attr":"animate"]({anchorX:$[0],anchorY:$[1]})}H&&Y&&(P.placed=!1),J||Y&&!W?(P.show(),P.placed=!0):(P.hide(),P.placed=!1)}function I(D,P){CM(this,"initDataLabelsGroup",{index:D,zIndex:P?.zIndex??6}),this.dataLabelsGroup=this.dataLabelsGroups?.[D];let c=this.plotGroup("dataLabelsGroup","data-labels",this.hasRendered?"inherit":"hidden",P?.zIndex??6,this.dataLabelsParentGroups?.[D]);return this.dataLabelsGroups||(this.dataLabelsGroups=[]),this.dataLabelsGroups[D]=c,this.dataLabelsGroup=this.dataLabelsGroups[0],c}function e(D,P,c){let h=!!this.hasRendered,H=this.initDataLabelsGroup(D,c).attr({opacity:+h});return!h&&H&&(this.visible&&H.show(),this.options.animation?H.animate({opacity:1},P):H.attr({opacity:1})),H}function M(D){let P;D=D||this.points;let c=this,h=c.chart,H=c.options,B=h.renderer,{backgroundColor:Y,plotBackgroundColor:C}=h.options.chart,g=B.getContrast(ot(C)&&C||ot(Y)&&Y||"#000000"),x=i(c),{animation:j,defer:Z}=x[0],W=Z?it(h,j,c):{defer:0,duration:0};CM(this,"drawDataLabels"),c.hasDataLabels?.()&&D.forEach(J=>{let $=J.dataLabels||[],PE=J.color||c.color;pR(s(x,J.dlOptions||J.options?.dataLabels)).forEach((lE,mE)=>{P=this.initDataLabels(mE,W,lE);let vE=lE.enabled&&(J.visible||J.dataLabelOnHidden)&&(!J.isNull||J.dataLabelOnNull)&&(function(jN,XN){let TO=XN.filter;if(TO){let cO=TO.operator,xO=jN[TO.property],kT=TO.value;return cO===">"&&xO>kT||cO==="<"&&xO<kT||cO===">="&&xO>=kT||cO==="<="&&xO<=kT||cO==="=="&&xO==kT||cO==="==="&&xO===kT||cO==="!="&&xO!=kT||cO==="!=="&&xO!==kT||!1}return!0})(J,lE),{backgroundColor:XE,borderColor:NN,distance:JE,style:WE={}}=lE,eO,MO,LO,oN={},lN=$[mE],kN=!lN,cN;vE&&(MO=_n(eO=Zt(lE[J.formatPrefix+"Format"],lE.format))?zO(eO,J,h):(lE[J.formatPrefix+"Formatter"]||lE.formatter).call(J,lE),LO=lE.rotation,!h.styledMode&&(WE.color=Zt(lE.color,WE.color,ot(c.color)?c.color:void 0,"#000000"),WE.color==="contrast"?(XE!=="none"&&(cN=XE),J.contrastColor=B.getContrast(cN!=="auto"&&ot(cN)&&cN||(ot(PE)?PE:"")),WE.color=cN||!_n(JE)&&lE.inside||0>Ro(JE||0)||H.stacking?J.contrastColor:g):delete J.contrastColor,H.cursor&&(WE.cursor=H.cursor)),oN={r:lE.borderRadius||0,rotation:LO,padding:lE.padding,zIndex:1},h.styledMode||(oN.fill=XE==="auto"?J.color:XE,oN.stroke=NN==="auto"?J.color:NN,oN["stroke-width"]=lE.borderWidth),Z_(oN,(jN,XN)=>{jN===void 0&&delete oN[XN]})),!lN||vE&&_n(MO)&&!!(lN.div||lN.text?.foreignObject)==!!lE.useHTML&&(lN.rotation&&lE.rotation||lN.rotation===lE.rotation)||(lN=void 0,kN=!0),vE&&_n(MO)&&MO!==""&&(lN?oN.text=MO:(lN=B.label(MO,0,0,lE.shape,void 0,void 0,lE.useHTML,void 0,"data-label")).addClass(" highcharts-data-label-color-"+J.colorIndex+" "+(lE.className||"")+(lE.useHTML?" highcharts-tracker":"")),lN&&(lN.options=lE,lN.attr(oN),h.styledMode?WE.width&&lN.css({width:WE.width,textOverflow:WE.textOverflow,whiteSpace:WE.whiteSpace}):lN.css(WE).shadow(lE.shadow),CM(lN,"beforeAddingDataLabel",{labelOptions:lE,point:J}),lN.added||lN.add(P),c.alignDataLabel(J,lN,lE,void 0,kN),lN.isActive=!0,$[mE]&&$[mE]!==lN&&$[mE].destroy(),$[mE]=lN))});let aE=$.length;for(;aE--;)$[aE]?.isActive?$[aE].isActive=!1:($[aE]?.destroy(),$.splice(aE,1));J.dataLabel=$[0],J.dataLabels=$}),CM(this,"afterDrawDataLabels")}function R(D,P,c,h,H,B){let Y=this.chart,C=P.align,g=P.verticalAlign,x=D.box?0:D.padding||0,j=Y.inverted?this.yAxis:this.xAxis,Z=j?j.left-Y.plotLeft:0,W=Y.inverted?this.xAxis:this.yAxis,J=W?W.top-Y.plotTop:0,{x:$=0,y:PE=0}=P,aE,lE;return(aE=(c.x||0)+x+Z)<0&&(C==="right"&&$>=0?(P.align="left",P.inside=!0):$-=aE,lE=!0),(aE=(c.x||0)+h.width-x+Z)>Y.plotWidth&&(C==="left"&&$<=0?(P.align="right",P.inside=!0):$+=Y.plotWidth-aE,lE=!0),(aE=c.y+x+J)<0&&(g==="bottom"&&PE>=0?(P.verticalAlign="top",P.inside=!0):PE-=aE,lE=!0),(aE=(c.y||0)+h.height-x+J)>Y.plotHeight&&(g==="top"&&PE<=0?(P.verticalAlign="bottom",P.inside=!0):PE+=Y.plotHeight-aE,lE=!0),lE&&(P.x=$,P.y=PE,D.placed=!B,D.align(P,void 0,H)),lE}function s(D,P){let c=[],h;if(dn(D)&&!dn(P))c=D.map(function(H){return AT(H,P)});else if(dn(P)&&!dn(D))c=P.map(function(H){return AT(D,H)});else if(dn(D)||dn(P)){if(dn(D)&&dn(P))for(h=Math.max(D.length,P.length);h--;)c[h]=AT(D[h],P[h])}else c=AT(D,P);return c}function i(D){let P=D.chart.options.plotOptions;return pR(s(s(P?.series?.dataLabels,P?.[D.type]?.dataLabels),D.options.dataLabels))}function l(D,P,c,h,H){let B=this.chart,Y=B.inverted,C=this.xAxis,g=C.reversed,x=((Y?P.height:P.width)||0)/2,j=D.pointWidth,Z=j?j/2:0;P.startXPos=Y?H.x:g?-x-Z:C.width-x+Z,P.startYPos=Y?g?this.yAxis.height-x+Z:-x-Z:H.y,h?P.visibility==="hidden"&&(P.show(),P.attr({opacity:0}).animate({opacity:1})):P.attr({opacity:1}).animate({opacity:0},void 0,P.hide),B.hasRendered&&(c&&P.attr({x:P.startXPos,y:P.startYPos}),P.placed=!0)}A.compose=function(D){let P=D.prototype;P.initDataLabels||(P.initDataLabels=e,P.initDataLabelsGroup=I,P.alignDataLabel=T,P.drawDataLabels=M,P.justifyDataLabel=R,P.mergeArrays=s,P.setDataLabelStartPos=l,P.hasDataLabels=N)}})(EO||(EO={}));let ye=EO,{composed:Xt}=z,{series:ET}=BO,{merge:qt,pushUnique:BM}=tN;function At(A,N,T,I,e){let{chart:M,options:R}=this,s=M.inverted,i=this.xAxis?.len||M.plotSizeX||0,l=this.yAxis?.len||M.plotSizeY||0,D=A.dlBox||A.shapeArgs,P=A.below??(A.plotY||0)>(this.translatedThreshold??l),c=T.inside??!!R.stacking;if(D){if(I=qt(D),T.overflow!=="allow"||T.crop!==!1||R.clip!==!1){I.y<0&&(I.height+=I.y,I.y=0);let h=I.y+I.height-l;h>0&&h<I.height-1&&(I.height-=h)}s&&(I={x:l-I.y-I.height,y:i-I.x-I.width,width:I.height,height:I.width}),c||(s?(I.x+=P?0:I.width,I.width=0):(I.y+=P?I.height:0,I.height=0))}T.align??(T.align=!s||c?"center":P?"right":"left"),T.verticalAlign??(T.verticalAlign=s||c?"middle":P?"top":"bottom"),ET.prototype.alignDataLabel.call(this,A,N,T,I,e),T.inside&&A.contrastColor&&N.css({color:A.contrastColor})}(lT||(lT={})).compose=function(A){ye.compose(ET),BM(Xt,"ColumnDataLabel")&&(A.prototype.alignDataLabel=At)};let X_=lT,{extend:q_,merge:so}=tN;class Ue extends HM{}Ue.defaultOptions=so(HM.defaultOptions,{}),q_(Ue.prototype,{inverted:!0}),BO.registerSeriesType("bar",Ue);let{column:W_,line:An}=BO.seriesTypes,{addEvent:_o,extend:Sn,merge:io}=tN;class VR extends An{applyJitter(){let N=this,T=this.options.jitter,I=this.points.length;T&&this.points.forEach(function(e,M){["x","y"].forEach(function(R,s){if(T[R]&&!e.isNull){let i=`plot${R.toUpperCase()}`,l=N[`${R}Axis`],D=T[R]*l.transA;if(l&&!l.logarithmic){let P,c=Math.max(0,(e[i]||0)-D),h=Math.min(l.len,(e[i]||0)+D);e[i]=c+(h-c)*((P=1e4*Math.sin(M+s*I))-Math.floor(P)),R==="x"&&(e.clientX=e.plotX)}}})})}drawGraph(){this.options.lineWidth?super.drawGraph():this.graph&&(this.graph=this.graph.destroy())}}VR.defaultOptions=io(An.defaultOptions,{lineWidth:0,findNearestPointBy:"xy",jitter:{x:0,y:0},marker:{enabled:!0},tooltip:{headerFormat:'<span style="color:{point.color}"></span> <span style="font-size: 0.8em"> {series.name}</span><br/>',pointFormat:"x: <b>{point.x}</b><br/>y: <b>{point.y}</b><br/>"}}),Sn(VR.prototype,{drawTracker:W_.prototype.drawTracker,sorted:!1,requireSorting:!1,noSharedTooltip:!0,trackerGroups:["group","markerGroup","dataLabelsGroup"]}),_o(VR,"afterTranslate",function(){this.applyJitter()}),BO.registerSeriesType("scatter",VR);let{deg2rad:oo}=z,{fireEvent:Wt,isNumber:bM,pick:mM,relativeLength:fM}=tN;(zE=rE||(rE={})).getCenter=function(){let A=this.options,N=this.chart,T=2*(A.slicedOffset||0),I=N.plotWidth-2*T,e=N.plotHeight-2*T,M=A.center,R=Math.min(I,e),s=A.thickness,i,l=A.size,D=A.innerSize||0,P,c;typeof l=="string"&&(l=parseFloat(l)),typeof D=="string"&&(D=parseFloat(D));let h=[mM(M?.[0],"50%"),mM(M?.[1],"50%"),mM(l&&l<0?void 0:A.size,"100%"),mM(D&&D<0?void 0:A.innerSize||0,"0%")];for(!N.angular||this instanceof In||(h[3]=0),P=0;P<4;++P)c=h[P],i=P<2||P===2&&/%$/.test(c),h[P]=fM(c,[I,e,R,h[2]][P])+(i?T:0);return h[3]>h[2]&&(h[3]=h[2]),bM(s)&&2*s<h[2]&&s>0&&(h[3]=h[2]-2*s),Wt(this,"afterGetCenter",{positions:h}),h},zE.getStartAndEndRadians=function(A,N){let T=bM(A)?A:0,I=bM(N)&&N>T&&N-T<360?N:T+360;return{start:oo*(T+-90),end:oo*(I+-90)}};let Q_=rE,{setAnimation:Ao}=FO,{addEvent:J_,defined:So,extend:$s,isNumber:$_,pick:eA,relativeLength:MA}=tN;class lo extends rO{getConnectorPath(N){let T=N.dataLabelPosition,I=N.options||{},e=I.connectorShape,M=this.connectorShapes[e]||e;return T&&M.call(this,{...T.computed,alignment:T.alignment},T.connectorPosition,I)||[]}getTranslate(){return this.sliced&&this.slicedTranslation||{translateX:0,translateY:0}}haloPath(N){let T=this.shapeArgs;return this.sliced||!this.visible?[]:this.series.chart.renderer.symbols.arc(T.x,T.y,T.r+N,T.r+N,{innerR:T.r-1,start:T.start,end:T.end,borderRadius:T.borderRadius})}constructor(N,T,I){super(N,T,I),this.half=0,this.name??(this.name=N.chart.options.lang.pieSliceName);const e=M=>{this.slice(M.type==="select")};J_(this,"select",e),J_(this,"unselect",e)}isValid(){return $_(this.y)&&this.y>=0}setVisible(N,T=!0){N!==this.visible&&this.update({visible:N??!this.visible},T,void 0,!1)}slice(N,T,I){let e=this.series;Ao(I,e.chart),T=eA(T,!0),this.sliced=this.options.sliced=N=So(N)?N:!this.sliced,e.options.data[e.data.indexOf(this)]=this.options,this.graphic&&this.graphic.animate(this.getTranslate())}}$s(lo.prototype,{connectorShapes:{fixedOffset:function(A,N,T){let I=N.breakAt,e=N.touchingSliceAt,M=T.softConnector?["C",A.x+(A.alignment==="left"?-5:5),A.y,2*I.x-e.x,2*I.y-e.y,I.x,I.y]:["L",I.x,I.y];return[["M",A.x,A.y],M,["L",e.x,e.y]]},straight:function(A,N){let T=N.touchingSliceAt;return[["M",A.x,A.y],["L",T.x,T.y]]},crookedLine:function(A,N,T){let{angle:I=this.angle||0,breakAt:e,touchingSliceAt:M}=N,{series:R}=this,[s,i,l]=R.center,D=l/2,{plotLeft:P,plotWidth:c}=R.chart,h=A.alignment==="left",{x:H,y:B}=A,Y=e.x;if(T.crookDistance){let g=MA(T.crookDistance,1);Y=h?s+D+(c+P-s-D)*(1-g):P+(s-D)*g}else Y=s+(i-B)*Math.tan(I-Math.PI/2);let C=[["M",H,B]];return(h?Y<=H&&Y>=e.x:Y>=H&&Y<=e.x)&&C.push(["L",Y,B]),C.push(["L",e.x,e.y],["L",M.x,M.y]),C}}});let{getStartAndEndRadians:ro}=Q_,{noop:Ei}=z,{clamp:pM,extend:E_,fireEvent:Ni,merge:N_,pick:Po}=tN;class O_ extends In{animate(N){let T=this,I=T.points,e=T.startAngleRad;N||I.forEach(function(M){let R=M.graphic,s=M.shapeArgs;R&&s&&(R.attr({r:Po(M.startR,T.center&&T.center[3]/2),start:e,end:e}),R.animate({r:s.r,start:s.start,end:s.end},T.options.animation))})}drawEmpty(){let N,T,I=this.startAngleRad,e=this.endAngleRad,M=this.options;this.total===0&&this.center?(N=this.center[0],T=this.center[1],this.graph||(this.graph=this.chart.renderer.arc(N,T,this.center[1]/2,0,I,e).addClass("highcharts-empty-series").add(this.group)),this.graph.attr({d:Re.arc(N,T,this.center[2]/2,0,{start:I,end:e,innerR:this.center[3]/2})}),this.chart.styledMode||this.graph.attr({"stroke-width":M.borderWidth,fill:M.fillColor||"none",stroke:M.color||"#cccccc"})):this.graph&&(this.graph=this.graph.destroy())}drawPoints(){let N=this.chart.renderer;this.points.forEach(function(T){T.graphic&&T.hasNewShapeType()&&(T.graphic=T.graphic.destroy()),T.graphic||(T.graphic=N[T.shapeType](T.shapeArgs).add(T.series.group),T.delayedRendering=!0)})}generatePoints(){super.generatePoints(),this.updateTotals()}getX(N,T,I,e){let M=this.center,R=this.radii?this.radii[I.index]||0:M[2]/2,s=e.dataLabelPosition,i=s?.distance||0,l=Math.asin(pM((N-M[1])/(R+i),-1,1));return M[0]+Math.cos(l)*(R+i)*(T?-1:1)+(i>0?(T?-1:1)*(e.padding||0):0)}hasData(){return this.points.some(N=>N.visible)}redrawPoints(){let N,T,I,e,M=this,R=M.chart;this.drawEmpty(),M.group&&!R.styledMode&&M.group.shadow(M.options.shadow),M.points.forEach(function(s){let i={};T=s.graphic,!s.isNull&&T?(e=s.shapeArgs,N=s.getTranslate(),R.styledMode||(I=M.pointAttribs(s,s.selected&&"select")),s.delayedRendering?(T.setRadialReference(M.center).attr(e).attr(N),R.styledMode||T.attr(I).attr({"stroke-linejoin":"round"}),s.delayedRendering=!1):(T.setRadialReference(M.center),R.styledMode||N_(!0,i,I),N_(!0,i,e,N),T.animate(i)),T.attr({visibility:s.visible?"inherit":"hidden"}),T.addClass(s.getClassName(),!0)):T&&(s.graphic=T.destroy())})}sortByAngle(N,T){N.sort(function(I,e){return I.angle!==void 0&&(e.angle-I.angle)*T})}translate(N){Ni(this,"translate"),this.generatePoints();let T=this.options,I=T.slicedOffset,e=ro(T.startAngle,T.endAngle),M=this.startAngleRad=e.start,R=(this.endAngleRad=e.end)-M,s=this.points,i=T.ignoreHiddenPoint,l=s.length,D,P,c,h,H,B,Y,C=0;for(N||(this.center=N=this.getCenter()),B=0;B<l;B++){Y=s[B],D=M+C*R,Y.isValid()&&(!i||Y.visible)&&(C+=Y.percentage/100),P=M+C*R;let g={x:N[0],y:N[1],r:N[2]/2,innerR:N[3]/2,start:Math.round(1e3*D)/1e3,end:Math.round(1e3*P)/1e3};Y.shapeType="arc",Y.shapeArgs=g,(c=(P+D)/2)>1.5*Math.PI?c-=2*Math.PI:c<-Math.PI/2&&(c+=2*Math.PI),Y.slicedTranslation={translateX:Math.round(Math.cos(c)*I),translateY:Math.round(Math.sin(c)*I)},h=Math.cos(c)*N[2]/2,H=Math.sin(c)*N[2]/2,Y.tooltipPos=[N[0]+.7*h,N[1]+.7*H],Y.half=+(c<-Math.PI/2||c>Math.PI/2),Y.angle=c}Ni(this,"afterTranslate")}updateTotals(){let N=this.points,T=N.length,I=this.options.ignoreHiddenPoint,e,M,R=0;for(e=0;e<T;e++)(M=N[e]).isValid()&&(!I||M.visible)&&(R+=M.y);for(e=0,this.total=R;e<T;e++)(M=N[e]).percentage=R>0&&(M.visible||!I)?M.y/R*100:0,M.total=R}}O_.defaultOptions=N_(In.defaultOptions,{borderRadius:3,center:[null,null],clip:!1,colorByPoint:!0,dataLabels:{connectorPadding:5,connectorShape:"crookedLine",crookDistance:void 0,distance:30,enabled:!0,formatter:function(){return this.isNull?void 0:this.name},softConnector:!0,x:0},fillColor:void 0,ignoreHiddenPoint:!0,inactiveOtherPoints:!0,legendType:"point",marker:null,size:null,showInLegend:!1,slicedOffset:10,stickyTracking:!1,tooltip:{followPointer:!0},borderColor:"#ffffff",borderWidth:1,lineWidth:void 0,states:{hover:{brightness:.1}}}),E_(O_.prototype,{axisTypes:[],directTouch:!0,drawGraph:void 0,drawTracker:HM.prototype.drawTracker,getCenter:Q_.getCenter,getSymbol:Ei,invertible:!1,isCartesian:!1,noSharedTooltip:!0,pointAttribs:HM.prototype.pointAttribs,pointClass:lo,requireSorting:!1,searchPoint:Ei,trackerGroups:["group","dataLabelsGroup"]}),BO.registerSeriesType("pie",O_);let{composed:ao,noop:Do}=z,{distribute:T_}=Fn,{series:Oi}=BO,{arrayMax:Lo,clamp:tO,defined:n_,isNumber:RA,pick:co,pushUnique:sA,relativeLength:ho}=tN;(function(A){let N={radialDistributionY:function(R,s){return(s.dataLabelPosition?.top||0)+R.distributeBox.pos},radialDistributionX:function(R,s,i,l,D){let P=D.dataLabelPosition;return R.getX(i<(P?.top||0)+2||i>(P?.bottom||0)-2?l:i,s.half,s,D)},justify:function(R,s,i,l){return l[0]+(R.half?-1:1)*(i+(s.dataLabelPosition?.distance||0))},alignToPlotEdges:function(R,s,i,l){let D=R.getBBox().width;return s?D+l:i-D-l},alignToConnectors:function(R,s,i,l){let D=0,P;return R.forEach(function(c){(P=c.dataLabel.getBBox().width)>D&&(D=P)}),s?D+l:i-D-l}};function T(R,s){let i=Math.PI/2,{start:l=0,end:D=0}=R.shapeArgs||{},P=R.angle||0;s>0&&l<i&&D>i&&P>i/2&&P<1.5*i&&(P=P<=i?Math.max(i/2,(l+i)/2):Math.min(1.5*i,(i+D)/2));let{center:c,options:h}=this,H=c[2]/2,B=Math.cos(P),Y=Math.sin(P),C=c[0]+B*H,g=c[1]+Y*H,x=Math.min((h.slicedOffset||0)+(h.borderWidth||0),s/5);return{natural:{x:C+B*s,y:g+Y*s},computed:{},alignment:s<0?"center":R.half?"right":"left",connectorPosition:{angle:P,breakAt:{x:C+B*x,y:g+Y*x},touchingSliceAt:{x:C,y:g}},distance:s}}function I(){let R=this,s=R.points,i=R.chart,l=i.plotWidth,D=i.plotHeight,P=i.plotLeft,c=Math.round(i.chartWidth/3),h=R.center,H=h[2]/2,B=h[1],Y=[[],[]],C=[0,0,0,0],g=R.dataLabelPositioners,x,j,Z,W=0;R.visible&&R.hasDataLabels?.()&&(s.forEach(J=>{(J.dataLabels||[]).forEach($=>{$.shortened&&($.attr({width:"auto"}).css({width:"auto",textOverflow:"clip"}),$.shortened=!1)})}),Oi.prototype.drawDataLabels.apply(R),s.forEach(J=>{(J.dataLabels||[]).forEach(($,PE)=>{let aE=h[2]/2,lE=$.options,mE=ho(lE?.distance||0,aE);PE===0&&Y[J.half].push(J),!n_(lE?.style?.width)&&$.getBBox().width>c&&($.css({width:Math.round(.7*c)+"px"}),$.shortened=!0),$.dataLabelPosition=this.getDataLabelPosition(J,mE),W=Math.max(W,mE)})}),Y.forEach((J,$)=>{let PE=J.length,aE=[],lE,mE,vE=0,XE;PE&&(R.sortByAngle(J,$-.5),W>0&&(lE=Math.max(0,B-H-W),mE=Math.min(B+H+W,i.plotHeight),J.forEach(NN=>{(NN.dataLabels||[]).forEach(JE=>{let WE=JE.dataLabelPosition;WE&&WE.distance>0&&(WE.top=Math.max(0,B-H-WE.distance),WE.bottom=Math.min(B+H+WE.distance,i.plotHeight),vE=JE.getBBox().height||21,JE.lineHeight=i.renderer.fontMetrics(JE.text||JE).h+2*JE.padding,NN.distributeBox={target:(JE.dataLabelPosition?.natural.y||0)-WE.top+JE.lineHeight/2,size:vE,rank:NN.y},aE.push(NN.distributeBox))})}),T_(aE,XE=mE+vE-lE,XE/5)),J.forEach(NN=>{(NN.dataLabels||[]).forEach(JE=>{let WE=JE.options||{},eO=NN.distributeBox,MO=JE.dataLabelPosition,LO=MO?.natural.y||0,oN=WE.connectorPadding||0,lN=JE.lineHeight||21,kN=(lN-JE.getBBox().height)/2,cN=0,jN=LO,XN="inherit";if(MO){if(aE&&n_(eO)&&MO.distance>0&&(eO.pos===void 0?XN="hidden":(Z=eO.size,jN=g.radialDistributionY(NN,JE))),WE.justify)cN=g.justify(NN,JE,H,h);else switch(WE.alignTo){case"connectors":cN=g.alignToConnectors(J,$,l,P);break;case"plotEdges":cN=g.alignToPlotEdges(JE,$,l,P);break;default:cN=g.radialDistributionX(R,NN,jN-kN,LO,JE)}if(MO.attribs={visibility:XN,align:MO.alignment},MO.posAttribs={x:cN+(WE.x||0)+({left:oN,right:-oN}[MO.alignment]||0),y:jN+(WE.y||0)-lN/2},MO.computed.x=cN,MO.computed.y=jN-kN,co(WE.crop,!0)){let TO;cN-(j=JE.getBBox().width)<oN&&$===1?(TO=Math.round(j-cN+oN),C[3]=Math.max(TO,C[3])):cN+j>l-oN&&$===0&&(TO=Math.round(cN+j-l+oN),C[1]=Math.max(TO,C[1])),jN-Z/2<0?C[0]=Math.max(Math.round(-jN+Z/2),C[0]):jN+Z/2>D&&(C[2]=Math.max(Math.round(jN+Z/2-D),C[2])),MO.sideOverflow=TO}}})}))}),(Lo(C)===0||this.verifyDataLabelOverflow(C))&&(this.placeDataLabels(),this.points.forEach(J=>{J.dataLabels?.forEach(($,PE)=>{let{connectorColor:aE,connectorWidth:lE=1}=$.options||{},mE=$.dataLabelPosition;if(RA(lE)){let vE;x=$.connector,mE&&mE.distance>0?(vE=!x,x||($.connector=x=i.renderer.path().addClass("highcharts-data-label-connector  highcharts-color-"+J.colorIndex+(J.className?" "+J.className:"")).add(R.dataLabelsGroups?.[PE])),i.styledMode||x.attr({"stroke-width":lE,stroke:aE||J.color||"#666666"}),x[vE?"attr":"animate"]({d:J.getConnectorPath($)}),x.attr({visibility:mE.attribs?.visibility})):x&&($.connector=x.destroy())}})})))}function e(){this.points.forEach(R=>{(R.dataLabels||[]).forEach(s=>{let i=s.dataLabelPosition;i?(i.sideOverflow&&(s.css({width:Math.max(s.getBBox().width-i.sideOverflow,0)+"px",textOverflow:s.options?.style?.textOverflow||"ellipsis"}),s.shortened=!0),s.attr(i.attribs),s[s.moved?"animate":"attr"](i.posAttribs),s.moved=!0):s&&s.attr({y:-9999})}),delete R.distributeBox},this)}function M(R){let s=this.center,i=this.options,l=i.center,D=i.minSize||80,P=D,c=i.size!==null;return!c&&(l[0]!==null?P=Math.max(s[2]-Math.max(R[1],R[3]),D):(P=Math.max(s[2]-R[1]-R[3],D),s[0]+=(R[3]-R[1])/2),l[1]!==null?P=tO(P,D,s[2]-Math.max(R[0],R[2])):(P=tO(P,D,s[2]-R[0]-R[2]),s[1]+=(R[0]-R[2])/2),P<s[2]?(s[2]=P,s[3]=Math.min(i.thickness?Math.max(0,P-2*i.thickness):Math.max(0,ho(i.innerSize||0,P)),P),this.translate(s),this.drawDataLabels&&this.drawDataLabels()):c=!0),c}A.compose=function(R){if(ye.compose(Oi),sA(ao,"PieDataLabel")){let s=R.prototype;s.dataLabelPositioners=N,s.alignDataLabel=Do,s.drawDataLabels=I,s.getDataLabelPosition=T,s.placeDataLabels=e,s.verifyDataLabelOverflow=M}}})(pE||(pE={}));let _A=pE;(wE=MN||(MN={})).getCenterOfPoints=function(A){let N=A.reduce((T,I)=>(T.x+=I.x,T.y+=I.y,T),{x:0,y:0});return{x:N.x/A.length,y:N.y/A.length}},wE.getDistanceBetweenPoints=function(A,N){return Math.sqrt(Math.pow(N.x-A.x,2)+Math.pow(N.y-A.y,2))},wE.getAngleBetweenPoints=function(A,N){return Math.atan2(N.x-A.x,N.y-A.y)},wE.pointInPolygon=function({x:A,y:N},T){let I=T.length,e,M,R=!1;for(e=0,M=I-1;e<I;M=e++){let[s,i]=T[e],[l,D]=T[M];i>N!=D>N&&A<(l-s)*(N-i)/(D-i)+s&&(R=!R)}return R};let{pointInPolygon:I_}=MN,{addEvent:VM,getAlignFactor:Ti,fireEvent:gR,objectEach:t_,pick:Qt}=tN;function TI(A,N){let T,I=!1;return A&&(T=A.newOpacity,A.oldOpacity!==T&&(A.hasClass("highcharts-data-label")?(A[T?"removeClass":"addClass"]("highcharts-data-label-hidden"),I=!0,A[A.isOld?"animate":"attr"]({opacity:T},void 0,function(){N.styledMode||A.css({pointerEvents:T?"auto":"none"})}),gR(N,"afterHideOverlappingLabel")):A.attr({opacity:T})),A.isOld=!0),I}let{defaultOptions:yR}=fO,{noop:Go}=z,{addEvent:ni,extend:uo,isObject:Ii,merge:Yo,relativeLength:ti}=tN,ei={radius:0,scope:"stack",where:void 0},Mi=Go,Ri=Go;function iA(A,N,T,I,e={}){let M=Mi(A,N,T,I,e),{brStart:R=!0,brEnd:s=!0,innerR:i=0,r:l=T,start:D=0,end:P=0}=e;if(e.open||!e.borderRadius)return M;let c=P-D,h=Math.sin(c/2),H=Math.max(Math.min(ti(e.borderRadius||0,l-i),(l-i)/2,l*h/(1+h)),0),B=Math.min(H,c/Math.PI*2*i),Y=M.length-1;for(;Y--;)(R||Y!==0&&Y!==3)&&(s||Y!==1&&Y!==2)&&(function(C,g,x){let j,Z,W,J=C[g],$=C[g+1];if($[0]==="Z"&&($=C[0]),(J[0]==="M"||J[0]==="L")&&$[0]==="A"?(j=J,Z=$,W=!0):J[0]==="A"&&($[0]==="M"||$[0]==="L")&&(j=$,Z=J),j&&Z&&Z.params){let PE=Z[1],aE=Z[5],lE=Z.params,{start:mE,end:vE,cx:XE,cy:NN}=lE,JE=aE?PE-x:PE+x,WE=JE?Math.asin(x/JE):0,eO=aE?WE:-WE,MO=Math.cos(WE)*JE;W?(lE.start=mE+eO,j[1]=XE+MO*Math.cos(mE),j[2]=NN+MO*Math.sin(mE),C.splice(g+1,0,["A",x,x,0,0,1,XE+PE*Math.cos(lE.start),NN+PE*Math.sin(lE.start)])):(lE.end=vE-eO,Z[6]=XE+PE*Math.cos(lE.end),Z[7]=NN+PE*Math.sin(lE.end),C.splice(g+1,0,["A",x,x,0,0,1,XE+MO*Math.cos(vE),NN+MO*Math.sin(vE)])),Z[4]=Math.abs(lE.end-lE.start)<Math.PI?0:1}})(M,Y,Y>1?B:H);return M}function si(){if(this.options.borderRadius&&!(this.chart.is3d&&this.chart.is3d())){let{options:A,yAxis:N}=this,T=A.stacking==="percent",I=yR.plotOptions?.[this.type]?.borderRadius,e=UR(A.borderRadius,Ii(I)?I:{}),M=N.options.reversed;for(let R of this.points){let{shapeArgs:s}=R;if(R.shapeType==="roundedRect"&&s){let{width:i=0,height:l=0,y:D=0}=s,P=D,c=l;if(e.scope==="stack"&&R.stackTotal){let Y=N.translate(T?100:R.stackTotal,!1,!0,!1,!0),C=N.translate(A.threshold||0,!1,!0,!1,!0),g=this.crispCol(0,Math.min(Y,C),0,Math.abs(Y-C));P=g.y,c=g.height}let h=(R.negative?-1:1)*(M?-1:1)==-1,H=e.where;!H&&this.is("waterfall")&&Math.abs((R.yBottom||0)-(this.translatedThreshold||0))>this.borderWidth&&(H="all"),H||(H="end");let B=Math.min(ti(e.radius,i),i/2,H==="all"?l/2:1/0)||0;H==="end"&&(h&&(P-=B),c+=B),uo(s,{brBoxHeight:c,brBoxY:P,r:B})}}}}function UR(A,N){return Ii(A)||(A={radius:A||0}),Yo(ei,N,A)}function oA(){let A=UR(this.options.borderRadius);for(let N of this.points){let T=N.shapeArgs;T&&(T.borderRadius=ti(A.radius,(T.r||0)-(T.innerR||0)))}}function AA(A,N,T,I,e={}){let M=Ri(A,N,T,I,e),{r:R=0,brBoxHeight:s=I,brBoxY:i=N}=e,l=N-i,D=i+s-(N+I),P=l-R>-.1?0:R,c=D-R>-.1?0:R,h=Math.max(P&&l,0),H=Math.max(c&&D,0),B=[A+P,N],Y=[A+T-P,N],C=[A+T,N+P],g=[A+T,N+I-c],x=[A+T-c,N+I],j=[A+c,N+I],Z=[A,N+I-c],W=[A,N+P],J=($,PE)=>Math.sqrt(Math.pow($,2)-Math.pow(PE,2));if(h){let $=J(P,P-h);B[0]-=$,Y[0]+=$,C[1]=W[1]=N+P-h}if(I<P-h){let $=J(P,P-h-I);C[0]=g[0]=A+T-P+$,x[0]=Math.min(C[0],x[0]),j[0]=Math.max(g[0],j[0]),Z[0]=W[0]=A+P-$,C[1]=W[1]=N+I}if(H){let $=J(c,c-H);x[0]+=$,j[0]-=$,g[1]=Z[1]=N+I-c+H}if(I<c-H){let $=J(c,c-H-I);C[0]=g[0]=A+T-c+$,Y[0]=Math.min(C[0],Y[0]),B[0]=Math.max(g[0],B[0]),Z[0]=W[0]=A+c-$,g[1]=Z[1]=N}return M.length=0,M.push(["M",...B],["L",...Y],["A",P,P,0,0,1,...C],["L",...g],["A",c,c,0,0,1,...x],["L",...j],["A",c,c,0,0,1,...Z],["L",...W],["A",P,P,0,0,1,...B],["Z"]),M}let{diffObjects:xR,extend:SA,find:Ho,merge:UN,pick:gM,uniqueKey:e_}=tN;function _i(A,N){let T=A.condition;(T.callback||function(){return this.chartWidth<=gM(T.maxWidth,Number.MAX_VALUE)&&this.chartHeight<=gM(T.maxHeight,Number.MAX_VALUE)&&this.chartWidth>=gM(T.minWidth,0)&&this.chartHeight>=gM(T.minHeight,0)}).call(this)&&N.push(A._id)}function Co(A,N){let T=this.options.responsive,I=this.currentResponsive,e=[],M;!N&&T&&T.rules&&T.rules.forEach(i=>{i._id===void 0&&(i._id=e_()),this.matchResponsiveRule(i,e)},this);let R=UN(...e.map(i=>Ho(T?.rules||[],l=>l._id===i)).map(i=>i?.chartOptions));R.isResponsiveOptions=!0,e=e.toString()||void 0;let s=I?.ruleIds;e!==s&&(I&&(this.currentResponsive=void 0,this.updatingResponsive=!0,this.update(I.undoOptions,A,!0),this.updatingResponsive=!1),e?((M=xR(R,this.options,!0,this.collectionsWithUpdate)).isResponsiveOptions=!0,this.currentResponsive={ruleIds:e,mergedOptions:R,undoOptions:M},this.updatingResponsive||this.update(R,A,!0)):this.currentResponsive=void 0)}(VN||(VN={})).compose=function(A){let N=A.prototype;return N.matchResponsiveRule||SA(N,{matchResponsiveRule:_i,setResponsive:Co}),A};let ii=VN;z.AST=NO,z.Axis=Tn,z.Chart=It,z.Color=QN,z.DataLabel=ye,z.DataTableCore=PM,z.Fx=lO,z.HTMLElement=DI,z.Legend=Us,z.LegendSymbol=aM,z.PlotLineOrBand=Jn,z.Point=rO,z.Pointer=yO,z.RendererRegistry=Yn,z.Series=In,z.SeriesRegistry=BO,z.StackItem=z_,z.SVGElement=Pn,z.SVGRenderer=lI,z.Templating=GT,z.Tick=Qn,z.Time=nN,z.Tooltip=K,z.animate=FO.animate,z.animObject=FO.animObject,z.chart=It.chart,z.color=QN.parse,z.dateFormat=GT.dateFormat,z.defaultOptions=fO.defaultOptions,z.distribute=Fn.distribute,z.format=GT.format,z.getDeferredAnimation=FO.getDeferredAnimation,z.getOptions=fO.getOptions,z.numberFormat=GT.numberFormat,z.seriesType=BO.seriesType,z.setAnimation=FO.setAnimation,z.setOptions=fO.setOptions,z.stop=FO.stop,z.time=fO.defaultTime,z.timers=lO.timers,{compose:function(A,N,T){let I=A.types.pie;if(!N.symbolCustomAttribs.includes("borderRadius")){let e=T.prototype.symbols;ni(A,"afterColumnTranslate",si,{order:9}),ni(I,"afterTranslate",oA),N.symbolCustomAttribs.push("borderRadius","brBoxHeight","brBoxY","brEnd","brStart"),Mi=e.arc,Ri=e.roundedRect,e.arc=iA,e.roundedRect=AA}},optionsToObject:UR}.compose(z.Series,z.SVGElement,z.SVGRenderer),X_.compose(z.Series.types.column),ye.compose(z.Series),xT.compose(z.Axis),DI.compose(z.SVGRenderer),Us.compose(z.Chart),Pe.compose(z.Axis),(sE=($E=z.Chart).prototype).hideOverlappingLabels||(sE.hideOverlappingLabels=function(A){let N=A.length,T=(D,P)=>!(P.x>=D.x+D.width||P.x+P.width<=D.x||P.y>=D.y+D.height||P.y+P.height<=D.y),I=(D,P)=>{for(let c of D)if(I_({x:c[0],y:c[1]},P))return!0;return!1},e,M,R,s,i,l=!1;for(let D=0;D<N;D++)(e=A[D])&&(e.oldOpacity=e.opacity,e.newOpacity=1,e.absoluteBox=(function(P){if(P&&(!P.alignAttr||P.placed)){let c=P.box?0:P.padding||0,h=P.alignAttr||{x:P.attr("x"),y:P.attr("y")},{height:H,polygon:B,width:Y}=P.getBBox(),C=Ti(P.alignValue)*Y;return P.width=Y,P.height=H,{x:h.x+(P.parentGroup?.translateX||0)+c-C,y:h.y+(P.parentGroup?.translateY||0)+c,width:Y-2*c,height:H-2*c,polygon:B}}})(e));A.sort((D,P)=>(P?.labelrank||0)-(D?.labelrank||0));for(let D=0;D<N;++D){s=(M=A[D])&&M.absoluteBox;let P=s?.polygon;for(let c=D+1;c<N;++c){i=(R=A[c])&&R.absoluteBox;let h=!1;if(s&&i&&M!==R&&M?.newOpacity!==0&&R?.newOpacity!==0&&M?.visibility!=="hidden"&&R?.visibility!=="hidden"){let H=i.polygon;if(P&&H&&P!==H?I(P,H)&&(h=!0):T(s,i)&&(h=!0),h){let B=M?.labelrank<R?.labelrank?M:R,Y=B?.text;B&&(B.newOpacity=0),Y?.element.querySelector("textPath")&&Y.hide()}}}}for(let D of A)D&&TI(D,this)&&(l=!0);l&&gR(this,"afterHideAllOverlappingLabels")},VM($E,"render",function(){let A=this,N=[];for(let T of A.labelCollectors||[])N=N.concat(T());for(let T of A.yAxis||[])T.stacking&&T.options.stackLabels&&!T.options.stackLabels.allowOverlap&&t_(T.stacking.stacks,I=>{t_(I,e=>{e.label&&N.push(e.label)})});for(let T of A.series||[])if(T.visible&&T.hasDataLabels?.()){let I=e=>{for(let M of e)M.visible&&(M.dataLabels||[]).forEach(R=>{let s=R.options||{};R.labelrank=Qt(s.labelrank,M.labelrank,M.shapeArgs?.height),s.allowOverlap??Number(s.distance)>0?(R.oldOpacity=R.opacity,R.newOpacity=1,TI(R,A)):N.push(R)})};I(T.nodes||[]),I(T.points)}this.hideOverlappingLabels(N)})),_A.compose(z.Series.types.pie),Jn.compose(z.Chart,z.Axis),yO.compose(z.Chart),ii.compose(z.Chart),YR.compose(z.Axis,z.Chart,z.Series),no.compose(z.Axis,z.Chart,z.Series),K.compose(z.Pointer),tN.extend(z,tN);let vR=z;return EE.default})())})(jo)),jo.exports}var tP=IP();const eP=BS(tP);var Zo={exports:{}},MP=Zo.exports,GS;function RP(){return GS||(GS=1,(function(G,U){(function(p,f){G.exports=f(Qo())})(typeof self<"u"?self:MP,function(p){return(function(f){function v(Q){if(F[Q])return F[Q].exports;var sE=F[Q]={i:Q,l:!1,exports:{}};return f[Q].call(sE.exports,sE,sE.exports,v),sE.l=!0,sE.exports}var F={};return v.m=f,v.c=F,v.d=function(Q,sE,q){v.o(Q,sE)||Object.defineProperty(Q,sE,{configurable:!1,enumerable:!0,get:q})},v.n=function(Q){var sE=Q&&Q.__esModule?function(){return Q.default}:function(){return Q};return v.d(sE,"a",sE),sE},v.o=function(Q,sE){return Object.prototype.hasOwnProperty.call(Q,sE)},v.p="",v(v.s=0)})([function(f,v,F){function Q(){return Q=Object.assign?Object.assign.bind():function(DE){for(var xE=1;xE<arguments.length;xE++){var gE=arguments[xE];for(var PN in gE)Object.prototype.hasOwnProperty.call(gE,PN)&&(DE[PN]=gE[PN])}return DE},Q.apply(this,arguments)}function sE(DE){return IE(DE)||_E(DE)||k(DE)||q()}function q(){throw new TypeError(`Invalid attempt to spread non-iterable instance.
In order to be iterable, non-array objects must have a [Symbol.iterator]() method.`)}function k(DE,xE){if(DE){if(typeof DE=="string")return CE(DE,xE);var gE=Object.prototype.toString.call(DE).slice(8,-1);return gE==="Object"&&DE.constructor&&(gE=DE.constructor.name),gE==="Map"||gE==="Set"?Array.from(DE):gE==="Arguments"||/^(?:Ui|I)nt(?:8|16|32)(?:Clamped)?Array$/.test(gE)?CE(DE,xE):void 0}}function _E(DE){if(typeof Symbol<"u"&&DE[Symbol.iterator]!=null||DE["@@iterator"]!=null)return Array.from(DE)}function IE(DE){if(Array.isArray(DE))return CE(DE)}function CE(DE,xE){(xE==null||xE>DE.length)&&(xE=DE.length);for(var gE=0,PN=new Array(xE);gE<xE;gE++)PN[gE]=DE[gE];return PN}function HE(DE){"@babel/helpers - typeof";return(HE=typeof Symbol=="function"&&typeof Symbol.iterator=="symbol"?function(xE){return typeof xE}:function(xE){return xE&&typeof Symbol=="function"&&xE.constructor===Symbol&&xE!==Symbol.prototype?"symbol":typeof xE})(DE)}Object.defineProperty(v,"__esModule",{value:!0}),F.d(v,"HighchartsReact",function(){return $E});var fE=F(1),zE=F.n(fE),wE=typeof window<"u"?fE.useLayoutEffect:fE.useEffect,$E=Object(fE.memo)(Object(fE.forwardRef)(function(DE,xE){var gE=Object(fE.useRef)(),PN=Object(fE.useRef)(),$N=Object(fE.useRef)(DE.constructorType),cE=Object(fE.useRef)(DE.highcharts);return wE(function(){function pN(){var mO=DE.highcharts||(typeof window>"u"?"undefined":HE(window))==="object"&&window.Highcharts,WO=DE.constructorType||"chart";mO?mO[WO]?DE.options?PN.current=mO[WO](gE.current,DE.options,DE.callback):console.warn('The "options" property was not passed.'):console.warn('The "constructorType" property is incorrect or some required module is not imported.'):console.warn('The "highcharts" property was not passed.')}if(PN.current){if(DE.allowChartUpdate!==!1)if(DE.constructorType!==$N.current||DE.highcharts!==cE.current)$N.current=DE.constructorType,cE.current=DE.highcharts,pN();else if(!DE.immutable&&PN.current){var xN;(xN=PN.current).update.apply(xN,[DE.options].concat(sE(DE.updateArgs||[!0,!0])))}else pN()}else pN()},[DE.options,DE.allowChartUpdate,DE.updateArgs,DE.containerProps,DE.highcharts,DE.constructorType]),wE(function(){return function(){PN.current&&(PN.current.destroy(),PN.current=null)}},[]),Object(fE.useImperativeHandle)(xE,function(){return{get chart(){return PN.current},container:gE}},[]),zE.a.createElement("div",Q({},DE.containerProps,{ref:gE}))}));v.default=$E},function(f,v){f.exports=p}])})})(Zo)),Zo.exports}var sP=RP();const _P=BS(sP),iP=`cnt,clinical_trial_status,progression_bin,symptom_burden_bin,tx_class,tx_modality,tx_specific,visual_status_bin,site
207,,,,,,,,
207,,,,,,,,boston_childrens
196,NOT_MENTIONED,,,,,,,
196,NOT_MENTIONED,,,,,,,boston_childrens
185,,,,,,,NOT_MENTIONED,
185,,,,,,,NOT_MENTIONED,boston_childrens
182,,,SYMPTOM_PRESENT,,,,,
182,,,SYMPTOM_PRESENT,,,,,boston_childrens
176,NOT_MENTIONED,,,,,,NOT_MENTIONED,
176,NOT_MENTIONED,,,,,,NOT_MENTIONED,boston_childrens
172,NOT_MENTIONED,,SYMPTOM_PRESENT,,,,,
172,NOT_MENTIONED,,SYMPTOM_PRESENT,,,,,boston_childrens
157,,,SYMPTOM_PRESENT,,,,NOT_MENTIONED,
157,,,SYMPTOM_PRESENT,,,,NOT_MENTIONED,boston_childrens
149,NOT_MENTIONED,,SYMPTOM_PRESENT,,,,NOT_MENTIONED,
149,,PROGRESSION,,,,,,
149,NOT_MENTIONED,,SYMPTOM_PRESENT,,,,NOT_MENTIONED,boston_childrens
149,,PROGRESSION,,,,,,boston_childrens
145,,,NOT_MENTIONED,,,,,
145,,,NOT_MENTIONED,,,,,boston_childrens
140,NOT_MENTIONED,PROGRESSION,,,,,,
140,NOT_MENTIONED,PROGRESSION,,,,,,boston_childrens
137,,PROGRESSION,,,,,NOT_MENTIONED,
137,,PROGRESSION,,,,,NOT_MENTIONED,boston_childrens
136,,PROGRESSION,SYMPTOM_PRESENT,,,,,
136,,,NOT_MENTIONED,,,,NOT_MENTIONED,
136,,PROGRESSION,SYMPTOM_PRESENT,,,,,boston_childrens
136,,,NOT_MENTIONED,,,,NOT_MENTIONED,boston_childrens
134,NOT_MENTIONED,,NOT_MENTIONED,,,,,
134,NOT_MENTIONED,,NOT_MENTIONED,,,,,boston_childrens
130,NOT_MENTIONED,PROGRESSION,,,,,NOT_MENTIONED,
130,NOT_MENTIONED,PROGRESSION,,,,,NOT_MENTIONED,boston_childrens
128,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,,,
128,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,,,boston_childrens
124,NOT_MENTIONED,,NOT_MENTIONED,,,,NOT_MENTIONED,
124,NOT_MENTIONED,,NOT_MENTIONED,,,,NOT_MENTIONED,boston_childrens
121,,PROGRESSION,SYMPTOM_PRESENT,,,,NOT_MENTIONED,
121,,,,,,NOT_MENTIONED,,
121,,PROGRESSION,SYMPTOM_PRESENT,,,,NOT_MENTIONED,boston_childrens
121,,,,,,NOT_MENTIONED,,boston_childrens
119,,,,,CHEMOTHERAPY,,,
119,,,,,CHEMOTHERAPY,,,boston_childrens
116,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,,NOT_MENTIONED,
116,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,,NOT_MENTIONED,boston_childrens
115,NOT_MENTIONED,,,,,NOT_MENTIONED,,
115,,,,CHEMOTHERAPY,CHEMOTHERAPY,,,
115,,,,CHEMOTHERAPY,,,,
115,,,,,,NOT_MENTIONED,NOT_MENTIONED,
115,NOT_MENTIONED,,,,,NOT_MENTIONED,,boston_childrens
115,,,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
115,,,,CHEMOTHERAPY,,,,boston_childrens
115,,,,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
111,NOT_MENTIONED,,,,CHEMOTHERAPY,,,
111,,,,,CHEMOTHERAPY,,NOT_MENTIONED,
111,NOT_MENTIONED,,,,CHEMOTHERAPY,,,boston_childrens
111,,,,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
110,NOT_MENTIONED,,,,,NOT_MENTIONED,NOT_MENTIONED,
110,NOT_MENTIONED,,,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
108,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,,,
108,NOT_MENTIONED,,,CHEMOTHERAPY,,,,
108,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
108,NOT_MENTIONED,,,CHEMOTHERAPY,,,,boston_childrens
107,,,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
107,,,,CHEMOTHERAPY,,,NOT_MENTIONED,
107,,,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
107,,,,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
105,NOT_MENTIONED,,,,CHEMOTHERAPY,,NOT_MENTIONED,
105,,,,OBSERVATION,OBSERVATION,OBSERVATION,,
105,,,,OBSERVATION,OBSERVATION,,,
105,,,,OBSERVATION,,OBSERVATION,,
105,,,,OBSERVATION,,,,
105,,,,,OBSERVATION,OBSERVATION,,
105,,,,,OBSERVATION,,,
105,,,,,,OBSERVATION,,
105,NOT_MENTIONED,,,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
105,,,,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
105,,,,OBSERVATION,OBSERVATION,,,boston_childrens
105,,,,OBSERVATION,,OBSERVATION,,boston_childrens
105,,,,OBSERVATION,,,,boston_childrens
105,,,,,OBSERVATION,OBSERVATION,,boston_childrens
105,,,,,OBSERVATION,,,boston_childrens
105,,,,,,OBSERVATION,,boston_childrens
104,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,
104,,,SYMPTOM_PRESENT,,,NOT_MENTIONED,,
104,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,boston_childrens
104,,,SYMPTOM_PRESENT,,,NOT_MENTIONED,,boston_childrens
102,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
102,NOT_MENTIONED,,,CHEMOTHERAPY,,,NOT_MENTIONED,
102,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
102,NOT_MENTIONED,,,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
101,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,
101,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,
101,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
101,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,boston_childrens
99,NOT_MENTIONED,,SYMPTOM_PRESENT,,,NOT_MENTIONED,,
99,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,OBSERVATION,,
99,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,,,
99,NOT_MENTIONED,,,OBSERVATION,,OBSERVATION,,
99,NOT_MENTIONED,,,OBSERVATION,,,,
99,NOT_MENTIONED,,,,OBSERVATION,OBSERVATION,,
99,NOT_MENTIONED,,,,OBSERVATION,,,
99,NOT_MENTIONED,,,,,OBSERVATION,,
99,,PROGRESSION,NOT_MENTIONED,,,,,
99,NOT_MENTIONED,,SYMPTOM_PRESENT,,,NOT_MENTIONED,,boston_childrens
99,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
99,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,,,boston_childrens
99,NOT_MENTIONED,,,OBSERVATION,,OBSERVATION,,boston_childrens
99,NOT_MENTIONED,,,OBSERVATION,,,,boston_childrens
99,NOT_MENTIONED,,,,OBSERVATION,OBSERVATION,,boston_childrens
99,NOT_MENTIONED,,,,OBSERVATION,,,boston_childrens
99,NOT_MENTIONED,,,,,OBSERVATION,,boston_childrens
99,,PROGRESSION,NOT_MENTIONED,,,,,boston_childrens
96,,PROGRESSION,NOT_MENTIONED,,,,NOT_MENTIONED,
96,,PROGRESSION,NOT_MENTIONED,,,,NOT_MENTIONED,boston_childrens
95,,PROGRESSION,,,CHEMOTHERAPY,,,
95,,PROGRESSION,,,,NOT_MENTIONED,,
95,,,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,
95,,PROGRESSION,,,CHEMOTHERAPY,,,boston_childrens
95,,PROGRESSION,,,,NOT_MENTIONED,,boston_childrens
95,,,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
94,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,
94,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,boston_childrens
93,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,
93,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
92,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,,,
92,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,
92,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,
92,,,,,,,DECLINING,
92,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,,,boston_childrens
92,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
92,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,boston_childrens
92,,,,,,,DECLINING,boston_childrens
91,AVAILABLE_AND_ELIGIBLE,,,,,,,
91,NOT_MENTIONED,,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,
91,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,,
91,,PROGRESSION,,CHEMOTHERAPY,,,,
91,AVAILABLE_AND_ELIGIBLE,,,,,,,boston_childrens
91,NOT_MENTIONED,,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
91,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
91,,PROGRESSION,,CHEMOTHERAPY,,,,boston_childrens
90,NOT_MENTIONED,PROGRESSION,,,,NOT_MENTIONED,,
90,,PROGRESSION,,,,NOT_MENTIONED,NOT_MENTIONED,
90,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
90,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,
90,,,,VINCA ALKALOID,CHEMOTHERAPY,,,
90,,,,VINCA ALKALOID,,,,
90,NOT_MENTIONED,PROGRESSION,,,,NOT_MENTIONED,,boston_childrens
90,,PROGRESSION,,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
90,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
90,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
90,,,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
90,,,,VINCA ALKALOID,,,,boston_childrens
88,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,,NOT_MENTIONED,
88,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,,,
88,,,,,CHEMOTHERAPY,NOT_MENTIONED,,
88,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,,NOT_MENTIONED,boston_childrens
88,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,,,boston_childrens
88,,,,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
87,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,,,
87,NOT_MENTIONED,,,VINCA ALKALOID,,,,
87,,PROGRESSION,,,CHEMOTHERAPY,,NOT_MENTIONED,
87,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
87,NOT_MENTIONED,,,VINCA ALKALOID,,,,boston_childrens
87,,PROGRESSION,,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
86,NOT_MENTIONED,PROGRESSION,,,,NOT_MENTIONED,NOT_MENTIONED,
86,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,
86,NOT_MENTIONED,PROGRESSION,,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
86,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
85,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,,
85,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,,,
85,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,
85,,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,,
85,,PROGRESSION,,,,,DECLINING,
85,,,SYMPTOM_PRESENT,,,,DECLINING,
85,,,,,CHEMOTHERAPY,OTHER,,
85,,,,,,OTHER,,
85,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
85,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,,,boston_childrens
85,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,boston_childrens
85,,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,,boston_childrens
85,,PROGRESSION,,,,,DECLINING,boston_childrens
85,,,SYMPTOM_PRESENT,,,,DECLINING,boston_childrens
85,,,,,CHEMOTHERAPY,OTHER,,boston_childrens
85,,,,,,OTHER,,boston_childrens
84,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
84,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,
84,,,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
84,,,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
84,,,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
84,,,,OBSERVATION,,,NOT_MENTIONED,
84,,,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
84,,,,VINCA ALKALOID,,,NOT_MENTIONED,
84,,,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
84,,,,,OBSERVATION,,NOT_MENTIONED,
84,,,,,,OBSERVATION,NOT_MENTIONED,
84,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
84,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
84,,,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
84,,,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
84,,,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
84,,,,OBSERVATION,,,NOT_MENTIONED,boston_childrens
84,,,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
84,,,,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
84,,,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
84,,,,,OBSERVATION,,NOT_MENTIONED,boston_childrens
84,,,,,,OBSERVATION,NOT_MENTIONED,boston_childrens
83,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
83,,PROGRESSION,,CHEMOTHERAPY,,,NOT_MENTIONED,
83,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,
83,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,
83,,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,
83,,,SYMPTOM_PRESENT,OBSERVATION,,,,
83,,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,
83,,,SYMPTOM_PRESENT,,OBSERVATION,,,
83,,,SYMPTOM_PRESENT,,,OBSERVATION,,
83,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
83,,PROGRESSION,,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
83,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
83,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,boston_childrens
83,,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,boston_childrens
83,,,SYMPTOM_PRESENT,OBSERVATION,,,,boston_childrens
83,,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,boston_childrens
83,,,SYMPTOM_PRESENT,,OBSERVATION,,,boston_childrens
83,,,SYMPTOM_PRESENT,,,OBSERVATION,,boston_childrens
82,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,,NOT_MENTIONED,
82,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
82,NOT_MENTIONED,,,VINCA ALKALOID,,,NOT_MENTIONED,
82,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,
82,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,
82,,PROGRESSION,SYMPTOM_PRESENT,,,,DECLINING,
82,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
82,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
82,NOT_MENTIONED,,,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
82,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
82,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,boston_childrens
82,,PROGRESSION,SYMPTOM_PRESENT,,,,DECLINING,boston_childrens
81,NOT_MENTIONED,,,,CHEMOTHERAPY,NOT_MENTIONED,,
81,,,,PLATINUM,CHEMOTHERAPY,,,
81,,,,PLATINUM,,,,
81,,,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
81,NOT_MENTIONED,,,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
81,,,,PLATINUM,CHEMOTHERAPY,,,boston_childrens
81,,,,PLATINUM,,,,boston_childrens
81,,,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
80,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,,
80,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,,boston_childrens
79,AVAILABLE_AND_ELIGIBLE,,,,,,NOT_MENTIONED,
79,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
79,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,,NOT_MENTIONED,
79,,,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
79,,,,,,OTHER,NOT_MENTIONED,
79,AVAILABLE_AND_ELIGIBLE,,,,,,NOT_MENTIONED,boston_childrens
79,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
79,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
79,,,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
79,,,,,,OTHER,NOT_MENTIONED,boston_childrens
78,NOT_MENTIONED,,,,CHEMOTHERAPY,OTHER,,
78,NOT_MENTIONED,,,,,OTHER,,
78,NOT_MENTIONED,,,,,,DECLINING,
78,,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,
78,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,
78,,,SYMPTOM_PRESENT,VINCA ALKALOID,,,,
78,NOT_MENTIONED,,,,CHEMOTHERAPY,OTHER,,boston_childrens
78,NOT_MENTIONED,,,,,OTHER,,boston_childrens
78,NOT_MENTIONED,,,,,,DECLINING,boston_childrens
78,,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
78,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
78,,,SYMPTOM_PRESENT,VINCA ALKALOID,,,,boston_childrens
77,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,
77,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,
77,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,
77,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,,,
77,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,
77,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,,,
77,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OBSERVATION,,
77,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
77,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
77,NOT_MENTIONED,,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
77,NOT_MENTIONED,,,OBSERVATION,,,NOT_MENTIONED,
77,NOT_MENTIONED,,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
77,NOT_MENTIONED,,,,OBSERVATION,,NOT_MENTIONED,
77,NOT_MENTIONED,,,,,OBSERVATION,NOT_MENTIONED,
77,,,NOT_MENTIONED,,CHEMOTHERAPY,,,
77,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
77,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,boston_childrens
77,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,boston_childrens
77,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,,,boston_childrens
77,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,boston_childrens
77,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,,,boston_childrens
77,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OBSERVATION,,boston_childrens
77,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
77,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
77,NOT_MENTIONED,,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
77,NOT_MENTIONED,,,OBSERVATION,,,NOT_MENTIONED,boston_childrens
77,NOT_MENTIONED,,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
77,NOT_MENTIONED,,,,OBSERVATION,,NOT_MENTIONED,boston_childrens
77,NOT_MENTIONED,,,,,OBSERVATION,NOT_MENTIONED,boston_childrens
77,,,NOT_MENTIONED,,CHEMOTHERAPY,,,boston_childrens
76,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,,,
76,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,
76,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,,,
76,NOT_MENTIONED,,,PLATINUM,,,,
76,NOT_MENTIONED,,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
76,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,
76,,,,,TARGETED_THERAPY,,,
76,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,,,boston_childrens
76,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,boston_childrens
76,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,,,boston_childrens
76,NOT_MENTIONED,,,PLATINUM,,,,boston_childrens
76,NOT_MENTIONED,,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
76,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
76,,,,,TARGETED_THERAPY,,,boston_childrens
75,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,,,
75,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,
75,,,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,
75,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,,,boston_childrens
75,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
75,,,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
74,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,
74,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,
74,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,
74,NOT_MENTIONED,,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
74,NOT_MENTIONED,,,,,OTHER,NOT_MENTIONED,
74,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,
74,,,NOT_MENTIONED,CHEMOTHERAPY,,,,
74,,,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
74,,,,PLATINUM,,,NOT_MENTIONED,
74,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
74,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,boston_childrens
74,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
74,NOT_MENTIONED,,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
74,NOT_MENTIONED,,,,,OTHER,NOT_MENTIONED,boston_childrens
74,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
74,,,NOT_MENTIONED,CHEMOTHERAPY,,,,boston_childrens
74,,,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
74,,,,PLATINUM,,,NOT_MENTIONED,boston_childrens
73,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,
73,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,,,
73,,PROGRESSION,,,TARGETED_THERAPY,,,
73,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,
73,,,SYMPTOM_PRESENT,,,OTHER,,
73,,,,,TARGETED_THERAPY,cumulus__none,,
73,,,,,,cumulus__none,,
73,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
73,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,,,boston_childrens
73,,PROGRESSION,,,TARGETED_THERAPY,,,boston_childrens
73,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,boston_childrens
73,,,SYMPTOM_PRESENT,,,OTHER,,boston_childrens
73,,,,,TARGETED_THERAPY,cumulus__none,,boston_childrens
73,,,,,,cumulus__none,,boston_childrens
72,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
72,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,
72,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
72,,,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,
72,,,NOT_MENTIONED,,,NOT_MENTIONED,,
72,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
72,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
72,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
72,,,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
72,,,NOT_MENTIONED,,,NOT_MENTIONED,,boston_childrens
71,NOT_MENTIONED,PROGRESSION,,,,,DECLINING,
71,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
71,NOT_MENTIONED,,,PLATINUM,,,NOT_MENTIONED,
71,,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,,
71,,PROGRESSION,,,,cumulus__none,,
71,,,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,
71,NOT_MENTIONED,PROGRESSION,,,,,DECLINING,boston_childrens
71,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
71,NOT_MENTIONED,,,PLATINUM,,,NOT_MENTIONED,boston_childrens
71,,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,,boston_childrens
71,,PROGRESSION,,,,cumulus__none,,boston_childrens
71,,,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
70,NOT_MENTIONED,,SYMPTOM_PRESENT,,,,DECLINING,
70,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,
70,,,SYMPTOM_PRESENT,PLATINUM,,,,
70,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
70,,,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,
70,NOT_MENTIONED,,SYMPTOM_PRESENT,,,,DECLINING,boston_childrens
70,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,boston_childrens
70,,,SYMPTOM_PRESENT,PLATINUM,,,,boston_childrens
70,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
70,,,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
69,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,
69,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,
69,,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,,
69,,PROGRESSION,,OBSERVATION,OBSERVATION,,,
69,,PROGRESSION,,OBSERVATION,,OBSERVATION,,
69,,PROGRESSION,,OBSERVATION,,,,
69,,PROGRESSION,,,OBSERVATION,OBSERVATION,,
69,,PROGRESSION,,,OBSERVATION,,,
69,,PROGRESSION,,,,OBSERVATION,,
69,,,,,TARGETED_THERAPY,,NOT_MENTIONED,
69,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
69,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
69,,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
69,,PROGRESSION,,OBSERVATION,OBSERVATION,,,boston_childrens
69,,PROGRESSION,,OBSERVATION,,OBSERVATION,,boston_childrens
69,,PROGRESSION,,OBSERVATION,,,,boston_childrens
69,,PROGRESSION,,,OBSERVATION,OBSERVATION,,boston_childrens
69,,PROGRESSION,,,OBSERVATION,,,boston_childrens
69,,PROGRESSION,,,,OBSERVATION,,boston_childrens
69,,,,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
68,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,,
68,,PROGRESSION,,VINCA ALKALOID,,,,
68,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,
68,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
68,,PROGRESSION,,VINCA ALKALOID,,,,boston_childrens
68,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,boston_childrens
67,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
67,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,
67,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,,DECLINING,
67,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
67,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,
67,,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,,
67,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
67,,,,ALKYLATING,CHEMOTHERAPY,,,
67,,,,ALKYLATING,,,,
67,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
67,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
67,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,,DECLINING,boston_childrens
67,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
67,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
67,,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
67,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
67,,,,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
67,,,,ALKYLATING,,,,boston_childrens
66,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,,
66,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,,
66,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,,,
66,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,,,
66,,PROGRESSION,,,CHEMOTHERAPY,OTHER,,
66,,PROGRESSION,,,TARGETED_THERAPY,,NOT_MENTIONED,
66,,PROGRESSION,,,,OTHER,,
66,,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
66,,,,CHEMOTHERAPY,,OTHER,,
66,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,,boston_childrens
66,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
66,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,,,boston_childrens
66,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,,,boston_childrens
66,,PROGRESSION,,,CHEMOTHERAPY,OTHER,,boston_childrens
66,,PROGRESSION,,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
66,,PROGRESSION,,,,OTHER,,boston_childrens
66,,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
66,,,,CHEMOTHERAPY,,OTHER,,boston_childrens
65,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,,
65,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,,,
65,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,OBSERVATION,,
65,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,,,
65,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,OBSERVATION,,
65,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,,,
65,NOT_MENTIONED,PROGRESSION,,,,OBSERVATION,,
65,NOT_MENTIONED,,NOT_MENTIONED,,,NOT_MENTIONED,,
65,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,
65,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OTHER,,
65,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,
65,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,
65,,,NOT_MENTIONED,VINCA ALKALOID,,,,
65,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
65,,,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,
65,,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
65,,,,VINCA ALKALOID,,NOT_MENTIONED,,
65,,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
65,,,,,SURGERY,,,
65,,,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
65,,,,,,CARBOPLATIN_VINCRISTINE,,
65,,,,,,cumulus__none,NOT_MENTIONED,
65,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
65,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,,,boston_childrens
65,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,OBSERVATION,,boston_childrens
65,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,,,boston_childrens
65,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,OBSERVATION,,boston_childrens
65,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,,,boston_childrens
65,NOT_MENTIONED,PROGRESSION,,,,OBSERVATION,,boston_childrens
65,NOT_MENTIONED,,NOT_MENTIONED,,,NOT_MENTIONED,,boston_childrens
65,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,boston_childrens
65,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OTHER,,boston_childrens
65,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,boston_childrens
65,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
65,,,NOT_MENTIONED,VINCA ALKALOID,,,,boston_childrens
65,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
65,,,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,boston_childrens
65,,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
65,,,,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
65,,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
65,,,,,SURGERY,,,boston_childrens
65,,,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
65,,,,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
65,,,,,,cumulus__none,NOT_MENTIONED,boston_childrens
64,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,,NOT_MENTIONED,
64,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,
64,NOT_MENTIONED,,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,
64,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,
64,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,,,
64,NOT_MENTIONED,,,,SURGERY,,,
64,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,
64,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,
64,,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,
64,,,NOT_MENTIONED,OBSERVATION,,,,
64,,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,
64,,,NOT_MENTIONED,,OBSERVATION,,,
64,,,NOT_MENTIONED,,,OBSERVATION,,
64,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,
64,,,SYMPTOM_PRESENT,,,cumulus__none,,
64,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,,NOT_MENTIONED,boston_childrens
64,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
64,NOT_MENTIONED,,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
64,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,boston_childrens
64,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,,,boston_childrens
64,NOT_MENTIONED,,,,SURGERY,,,boston_childrens
64,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
64,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,boston_childrens
64,,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,boston_childrens
64,,,NOT_MENTIONED,OBSERVATION,,,,boston_childrens
64,,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,boston_childrens
64,,,NOT_MENTIONED,,OBSERVATION,,,boston_childrens
64,,,NOT_MENTIONED,,,OBSERVATION,,boston_childrens
64,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,boston_childrens
64,,,SYMPTOM_PRESENT,,,cumulus__none,,boston_childrens
63,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,
63,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,,,
63,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
63,NOT_MENTIONED,,,,TARGETED_THERAPY,,,
63,,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
63,,PROGRESSION,,,,cumulus__none,NOT_MENTIONED,
63,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
63,,,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,
63,,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
63,,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
63,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
63,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,,,boston_childrens
63,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
63,NOT_MENTIONED,,,,TARGETED_THERAPY,,,boston_childrens
63,,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
63,,PROGRESSION,,,,cumulus__none,NOT_MENTIONED,boston_childrens
63,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
63,,,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
63,,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
63,,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
62,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
62,NOT_MENTIONED,,,CHEMOTHERAPY,,OTHER,,
62,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
62,NOT_MENTIONED,,,VINCA ALKALOID,,NOT_MENTIONED,,
62,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,
62,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,,
62,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,
62,,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,,
62,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
62,,PROGRESSION,,VINCA ALKALOID,,,NOT_MENTIONED,
62,,,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
62,,,,ALKYLATING,,,NOT_MENTIONED,
62,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
62,NOT_MENTIONED,,,CHEMOTHERAPY,,OTHER,,boston_childrens
62,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
62,NOT_MENTIONED,,,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
62,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
62,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,,boston_childrens
62,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,boston_childrens
62,,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,,boston_childrens
62,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
62,,PROGRESSION,,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
62,,,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
62,,,,ALKYLATING,,,NOT_MENTIONED,boston_childrens
61,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
61,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,,NOT_MENTIONED,
61,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,,
61,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
61,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,
61,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,,,
61,NOT_MENTIONED,,,ALKYLATING,,,,
61,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
61,NOT_MENTIONED,,,,SURGERY,,NOT_MENTIONED,
61,NOT_MENTIONED,,,,TARGETED_THERAPY,cumulus__none,,
61,NOT_MENTIONED,,,,,CARBOPLATIN_VINCRISTINE,,
61,NOT_MENTIONED,,,,,cumulus__none,,
61,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,,
61,,PROGRESSION,,PLATINUM,,,,
61,,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
61,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
61,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
61,,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
61,,,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,
61,,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
61,,,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,
61,,,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,
61,,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
61,,,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
61,,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
61,,,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
61,,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
61,,,,,SURGERY,,NOT_MENTIONED,
61,,,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
61,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
61,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
61,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
61,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
61,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
61,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
61,NOT_MENTIONED,,,ALKYLATING,,,,boston_childrens
61,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
61,NOT_MENTIONED,,,,SURGERY,,NOT_MENTIONED,boston_childrens
61,NOT_MENTIONED,,,,TARGETED_THERAPY,cumulus__none,,boston_childrens
61,NOT_MENTIONED,,,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
61,NOT_MENTIONED,,,,,cumulus__none,,boston_childrens
61,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,,boston_childrens
61,,PROGRESSION,,PLATINUM,,,,boston_childrens
61,,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
61,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
61,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
61,,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
61,,,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,boston_childrens
61,,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
61,,,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,boston_childrens
61,,,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,boston_childrens
61,,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
61,,,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
61,,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
61,,,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
61,,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
61,,,,,SURGERY,,NOT_MENTIONED,boston_childrens
61,,,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
60,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,,NOT_MENTIONED,
60,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,,,
60,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,OTHER,,
60,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,,,
60,NOT_MENTIONED,PROGRESSION,,,,OTHER,,
60,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
60,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,
60,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,
60,,PROGRESSION,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
60,,PROGRESSION,,,,OTHER,NOT_MENTIONED,
60,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
60,,,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,
60,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
60,,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,
60,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,,NOT_MENTIONED,boston_childrens
60,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,,,boston_childrens
60,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,OTHER,,boston_childrens
60,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,,,boston_childrens
60,NOT_MENTIONED,PROGRESSION,,,,OTHER,,boston_childrens
60,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
60,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,boston_childrens
60,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
60,,PROGRESSION,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
60,,PROGRESSION,,,,OTHER,NOT_MENTIONED,boston_childrens
60,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
60,,,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,boston_childrens
60,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
60,,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
59,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,,
59,NOT_MENTIONED,PROGRESSION,,,,cumulus__none,,
59,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,
59,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,,,
59,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
59,NOT_MENTIONED,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
59,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
59,NOT_MENTIONED,,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
59,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,
59,,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,,
59,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
59,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
59,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,
59,,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
59,,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
59,,,,,SURGERY,NOT_MENTIONED,,
59,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,,boston_childrens
59,NOT_MENTIONED,PROGRESSION,,,,cumulus__none,,boston_childrens
59,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
59,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,,,boston_childrens
59,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
59,NOT_MENTIONED,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
59,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
59,NOT_MENTIONED,,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
59,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,boston_childrens
59,,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,,boston_childrens
59,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
59,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
59,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
59,,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
59,,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
59,,,,,SURGERY,NOT_MENTIONED,,boston_childrens
58,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,,,
58,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,,,
58,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,
58,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,,
58,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,
58,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,
58,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,
58,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,,,
58,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,
58,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,,,
58,NOT_MENTIONED,,NOT_MENTIONED,,,OBSERVATION,,
58,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
58,NOT_MENTIONED,,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
58,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
58,NOT_MENTIONED,,,,SURGERY,NOT_MENTIONED,,
58,NOT_MENTIONED,,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
58,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,,
58,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,
58,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,
58,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,
58,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,,
58,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,
58,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,,
58,,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,,
58,,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
58,,PROGRESSION,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
58,,PROGRESSION,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
58,,PROGRESSION,,OBSERVATION,,,NOT_MENTIONED,
58,,PROGRESSION,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
58,,PROGRESSION,,,OBSERVATION,,NOT_MENTIONED,
58,,PROGRESSION,,,SURGERY,,,
58,,PROGRESSION,,,,OBSERVATION,NOT_MENTIONED,
58,,STABLE,,,,,,
58,,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
58,,,,ALKYLATING,,NOT_MENTIONED,,
58,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
58,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,,,boston_childrens
58,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
58,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,,boston_childrens
58,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
58,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,boston_childrens
58,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,boston_childrens
58,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,,,boston_childrens
58,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,boston_childrens
58,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,,,boston_childrens
58,NOT_MENTIONED,,NOT_MENTIONED,,,OBSERVATION,,boston_childrens
58,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
58,NOT_MENTIONED,,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
58,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
58,NOT_MENTIONED,,,,SURGERY,NOT_MENTIONED,,boston_childrens
58,NOT_MENTIONED,,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
58,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,,boston_childrens
58,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
58,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,boston_childrens
58,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,boston_childrens
58,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,,boston_childrens
58,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,boston_childrens
58,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,,boston_childrens
58,,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,,boston_childrens
58,,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
58,,PROGRESSION,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
58,,PROGRESSION,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
58,,PROGRESSION,,OBSERVATION,,,NOT_MENTIONED,boston_childrens
58,,PROGRESSION,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
58,,PROGRESSION,,,OBSERVATION,,NOT_MENTIONED,boston_childrens
58,,PROGRESSION,,,SURGERY,,,boston_childrens
58,,PROGRESSION,,,,OBSERVATION,NOT_MENTIONED,boston_childrens
58,,STABLE,,,,,,boston_childrens
58,,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
58,,,,ALKYLATING,,NOT_MENTIONED,,boston_childrens
57,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,,
57,NOT_MENTIONED,PROGRESSION,,PLATINUM,,,,
57,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
57,NOT_MENTIONED,PROGRESSION,,,SURGERY,,,
57,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
57,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,
57,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
57,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,
57,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
57,NOT_MENTIONED,,,ALKYLATING,,,NOT_MENTIONED,
57,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,
57,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,,boston_childrens
57,NOT_MENTIONED,PROGRESSION,,PLATINUM,,,,boston_childrens
57,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
57,NOT_MENTIONED,PROGRESSION,,,SURGERY,,,boston_childrens
57,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
57,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
57,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
57,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,boston_childrens
57,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
57,NOT_MENTIONED,,,ALKYLATING,,,NOT_MENTIONED,boston_childrens
57,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
56,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
56,NOT_MENTIONED,PROGRESSION,,,,OTHER,NOT_MENTIONED,
56,NOT_MENTIONED,STABLE,,,,,,
56,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,
56,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
56,NOT_MENTIONED,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
56,NOT_MENTIONED,,,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
56,NOT_MENTIONED,,,,TARGETED_THERAPY,,NOT_MENTIONED,
56,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,
56,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,
56,,,NOT_MENTIONED,PLATINUM,,,,
56,,,SYMPTOM_PRESENT,,SURGERY,,,
56,,,,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
56,,,,,,,IMPROVING,
56,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
56,NOT_MENTIONED,PROGRESSION,,,,OTHER,NOT_MENTIONED,boston_childrens
56,NOT_MENTIONED,STABLE,,,,,,boston_childrens
56,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,boston_childrens
56,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
56,NOT_MENTIONED,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
56,NOT_MENTIONED,,,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
56,NOT_MENTIONED,,,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
56,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
56,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,boston_childrens
56,,,NOT_MENTIONED,PLATINUM,,,,boston_childrens
56,,,SYMPTOM_PRESENT,,SURGERY,,,boston_childrens
56,,,,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
56,,,,,,,IMPROVING,boston_childrens
55,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
55,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,,,
55,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,
55,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,
55,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,,
55,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,
55,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,,
55,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
55,,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,,
55,,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,
55,,,NOT_MENTIONED,,,OTHER,,
55,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
55,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,
55,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
55,,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
55,,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
55,,,,CHEMOTHERAPY,,NOT_MENTIONED,,
55,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
55,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,,,boston_childrens
55,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
55,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
55,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,,boston_childrens
55,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,boston_childrens
55,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,,boston_childrens
55,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
55,,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
55,,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,boston_childrens
55,,,NOT_MENTIONED,,,OTHER,,boston_childrens
55,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
55,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,boston_childrens
55,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
55,,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
55,,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
55,,,,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
54,NOT_MENTIONED,PROGRESSION,,,SURGERY,,NOT_MENTIONED,
54,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
54,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
54,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
54,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
54,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
54,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,
54,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
54,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,
54,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,
54,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
54,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,
54,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
54,,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
54,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
54,,PROGRESSION,,PLATINUM,,,NOT_MENTIONED,
54,,PROGRESSION,,,SURGERY,NOT_MENTIONED,,
54,,PROGRESSION,,,SURGERY,,NOT_MENTIONED,
54,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
54,,,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,
54,,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,
54,,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
54,,,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,
54,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,
54,,,SYMPTOM_PRESENT,ALKYLATING,,,,
54,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
54,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
54,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
54,,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,
54,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
54,,,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,
54,,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
54,,,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
54,,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
54,,,,PLATINUM,,NOT_MENTIONED,,
54,,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
54,,,,VINCA ALKALOID,,OTHER,,
54,NOT_MENTIONED,PROGRESSION,,,SURGERY,,NOT_MENTIONED,boston_childrens
54,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
54,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
54,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
54,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
54,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
54,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,boston_childrens
54,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
54,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,boston_childrens
54,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,boston_childrens
54,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
54,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
54,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
54,,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
54,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
54,,PROGRESSION,,PLATINUM,,,NOT_MENTIONED,boston_childrens
54,,PROGRESSION,,,SURGERY,NOT_MENTIONED,,boston_childrens
54,,PROGRESSION,,,SURGERY,,NOT_MENTIONED,boston_childrens
54,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
54,,,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,boston_childrens
54,,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
54,,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
54,,,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,boston_childrens
54,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
54,,,SYMPTOM_PRESENT,ALKYLATING,,,,boston_childrens
54,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
54,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
54,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
54,,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
54,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
54,,,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,boston_childrens
54,,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
54,,,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
54,,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
54,,,,PLATINUM,,NOT_MENTIONED,,boston_childrens
54,,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
54,,,,VINCA ALKALOID,,OTHER,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,,
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,,
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,,
53,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
53,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
53,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
53,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,,NOT_MENTIONED,
53,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
53,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,,NOT_MENTIONED,
53,NOT_MENTIONED,PROGRESSION,,,SURGERY,NOT_MENTIONED,,
53,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,,NOT_MENTIONED,
53,NOT_MENTIONED,PROGRESSION,,,,OBSERVATION,NOT_MENTIONED,
53,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,
53,NOT_MENTIONED,,SYMPTOM_PRESENT,,,cumulus__none,,
53,NOT_MENTIONED,,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
53,NOT_MENTIONED,,,,,cumulus__none,NOT_MENTIONED,
53,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
53,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,
53,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
53,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
53,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
53,,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
53,,,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,
53,,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
53,,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
53,,,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,
53,,,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,
53,,,,ALKYLATING,CHEMOTHERAPY,OTHER,,
53,,,,ALKYLATING,,OTHER,,
53,,,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
53,,,,CHEMOTHERAPY,,,DECLINING,
53,,,,,CHEMOTHERAPY,,DECLINING,
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
53,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
53,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
53,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,,NOT_MENTIONED,boston_childrens
53,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
53,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,,NOT_MENTIONED,boston_childrens
53,NOT_MENTIONED,PROGRESSION,,,SURGERY,NOT_MENTIONED,,boston_childrens
53,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
53,NOT_MENTIONED,PROGRESSION,,,,OBSERVATION,NOT_MENTIONED,boston_childrens
53,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,boston_childrens
53,NOT_MENTIONED,,SYMPTOM_PRESENT,,,cumulus__none,,boston_childrens
53,NOT_MENTIONED,,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
53,NOT_MENTIONED,,,,,cumulus__none,NOT_MENTIONED,boston_childrens
53,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
53,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
53,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
53,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
53,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
53,,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
53,,,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,boston_childrens
53,,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
53,,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
53,,,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,boston_childrens
53,,,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,boston_childrens
53,,,,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
53,,,,ALKYLATING,,OTHER,,boston_childrens
53,,,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
53,,,,CHEMOTHERAPY,,,DECLINING,boston_childrens
53,,,,,CHEMOTHERAPY,,DECLINING,boston_childrens
52,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,,,
52,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,,NOT_MENTIONED,
52,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
52,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,
52,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
52,NOT_MENTIONED,PROGRESSION,,PLATINUM,,,NOT_MENTIONED,
52,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
52,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,,
52,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
52,NOT_MENTIONED,,,ALKYLATING,,NOT_MENTIONED,,
52,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
52,NOT_MENTIONED,,,VINCA ALKALOID,,OTHER,,
52,,PROGRESSION,NOT_MENTIONED,,,NOT_MENTIONED,,
52,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
52,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
52,,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,
52,,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,
52,,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
52,,,NOT_MENTIONED,,TARGETED_THERAPY,,,
52,,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,
52,,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
52,,,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
52,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,,,boston_childrens
52,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
52,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
52,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
52,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
52,NOT_MENTIONED,PROGRESSION,,PLATINUM,,,NOT_MENTIONED,boston_childrens
52,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
52,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
52,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
52,NOT_MENTIONED,,,ALKYLATING,,NOT_MENTIONED,,boston_childrens
52,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
52,NOT_MENTIONED,,,VINCA ALKALOID,,OTHER,,boston_childrens
52,,PROGRESSION,NOT_MENTIONED,,,NOT_MENTIONED,,boston_childrens
52,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
52,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
52,,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,boston_childrens
52,,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,boston_childrens
52,,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
52,,,NOT_MENTIONED,,TARGETED_THERAPY,,,boston_childrens
52,,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
52,,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
52,,,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
51,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,NOT_MENTIONED,
51,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,
51,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,
51,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,,
51,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,,
51,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
51,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
51,NOT_MENTIONED,PROGRESSION,,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
51,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
51,NOT_MENTIONED,PROGRESSION,,,,cumulus__none,NOT_MENTIONED,
51,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
51,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
51,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
51,NOT_MENTIONED,,,PLATINUM,,NOT_MENTIONED,,
51,,PROGRESSION,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,
51,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
51,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
51,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
51,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,,
51,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,
51,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,,
51,,PROGRESSION,,ALKYLATING,,,,
51,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
51,,PROGRESSION,,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
51,,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
51,,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,
51,,,NOT_MENTIONED,,,cumulus__none,,
51,,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
51,,,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
51,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,NOT_MENTIONED,boston_childrens
51,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,boston_childrens
51,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,boston_childrens
51,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,,boston_childrens
51,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,,boston_childrens
51,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
51,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
51,NOT_MENTIONED,PROGRESSION,,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
51,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
51,NOT_MENTIONED,PROGRESSION,,,,cumulus__none,NOT_MENTIONED,boston_childrens
51,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
51,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
51,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
51,NOT_MENTIONED,,,PLATINUM,,NOT_MENTIONED,,boston_childrens
51,,PROGRESSION,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
51,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
51,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
51,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
51,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,,boston_childrens
51,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
51,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
51,,PROGRESSION,,ALKYLATING,,,,boston_childrens
51,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
51,,PROGRESSION,,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
51,,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
51,,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,boston_childrens
51,,,NOT_MENTIONED,,,cumulus__none,,boston_childrens
51,,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
51,,,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
50,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,,,
50,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,,
50,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,
50,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,,,
50,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
50,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
50,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
50,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,
50,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
50,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,
50,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,,NOT_MENTIONED,
50,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
50,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
50,,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
50,,PROGRESSION,,CHEMOTHERAPY,,OTHER,,
50,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
50,,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
50,,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
50,,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
50,,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,,
50,,,SYMPTOM_PRESENT,,SURGERY,,NOT_MENTIONED,
50,,,,BRAF,TARGETED_THERAPY,,,
50,,,,BRAF,,,,
50,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,,,boston_childrens
50,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,,boston_childrens
50,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,boston_childrens
50,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,,,boston_childrens
50,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
50,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
50,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
50,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,boston_childrens
50,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
50,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
50,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,,NOT_MENTIONED,boston_childrens
50,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
50,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
50,,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
50,,PROGRESSION,,CHEMOTHERAPY,,OTHER,,boston_childrens
50,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
50,,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
50,,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
50,,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
50,,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,,boston_childrens
50,,,SYMPTOM_PRESENT,,SURGERY,,NOT_MENTIONED,boston_childrens
50,,,,BRAF,TARGETED_THERAPY,,,boston_childrens
50,,,,BRAF,,,,boston_childrens
49,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
49,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,,NOT_MENTIONED,
49,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,
49,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,,
49,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
49,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
49,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
49,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,,
49,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
49,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,OTHER,,
49,NOT_MENTIONED,,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
49,NOT_MENTIONED,,,ALKYLATING,,OTHER,,
49,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
49,NOT_MENTIONED,,,CHEMOTHERAPY,,NOT_MENTIONED,,
49,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
49,NOT_MENTIONED,,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
49,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,
49,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,,
49,,PROGRESSION,NOT_MENTIONED,,,cumulus__none,,
49,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
49,,PROGRESSION,,CHEMOTHERAPY,,,DECLINING,
49,,PROGRESSION,,,CHEMOTHERAPY,,DECLINING,
49,,,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,
49,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
49,,,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,
49,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
49,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,
49,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
49,,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
49,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,
49,,,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
49,,,,ALKYLATING,,OTHER,NOT_MENTIONED,
49,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
49,,,,PLATINUM,,CARBOPLATIN,,
49,,,,,CHEMOTHERAPY,CARBOPLATIN,,
49,,,,,,CARBOPLATIN,,
49,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
49,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
49,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,boston_childrens
49,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,,boston_childrens
49,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
49,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
49,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
49,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,,boston_childrens
49,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
49,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
49,NOT_MENTIONED,,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
49,NOT_MENTIONED,,,ALKYLATING,,OTHER,,boston_childrens
49,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
49,NOT_MENTIONED,,,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
49,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
49,NOT_MENTIONED,,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
49,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,boston_childrens
49,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,,boston_childrens
49,,PROGRESSION,NOT_MENTIONED,,,cumulus__none,,boston_childrens
49,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
49,,PROGRESSION,,CHEMOTHERAPY,,,DECLINING,boston_childrens
49,,PROGRESSION,,,CHEMOTHERAPY,,DECLINING,boston_childrens
49,,,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
49,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
49,,,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,boston_childrens
49,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
49,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,boston_childrens
49,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
49,,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
49,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,boston_childrens
49,,,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
49,,,,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
49,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
49,,,,PLATINUM,,CARBOPLATIN,,boston_childrens
49,,,,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
49,,,,,,CARBOPLATIN,,boston_childrens
48,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,,
48,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,,,
48,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,,
48,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
48,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
48,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
48,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
48,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
48,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,
48,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,
48,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
48,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,
48,NOT_MENTIONED,,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,
48,NOT_MENTIONED,,NOT_MENTIONED,,,OTHER,,
48,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,
48,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,,,
48,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
48,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN,,
48,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN,,
48,NOT_MENTIONED,,,,,CARBOPLATIN,,
48,,PROGRESSION,,BRAF,TARGETED_THERAPY,,,
48,,PROGRESSION,,BRAF,,,,
48,,STABLE,,,,,NOT_MENTIONED,
48,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
48,,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
48,,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
48,,,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,
48,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
48,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
48,,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
48,,,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
48,,,,,,NOT_MENTIONED,DECLINING,
48,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
48,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,,,boston_childrens
48,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,,boston_childrens
48,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
48,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
48,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
48,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
48,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
48,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,boston_childrens
48,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,boston_childrens
48,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
48,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,boston_childrens
48,NOT_MENTIONED,,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,boston_childrens
48,NOT_MENTIONED,,NOT_MENTIONED,,,OTHER,,boston_childrens
48,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
48,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,,,boston_childrens
48,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
48,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN,,boston_childrens
48,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
48,NOT_MENTIONED,,,,,CARBOPLATIN,,boston_childrens
48,,PROGRESSION,,BRAF,TARGETED_THERAPY,,,boston_childrens
48,,PROGRESSION,,BRAF,,,,boston_childrens
48,,STABLE,,,,,NOT_MENTIONED,boston_childrens
48,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
48,,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
48,,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
48,,,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,boston_childrens
48,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
48,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
48,,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
48,,,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
48,,,,,,NOT_MENTIONED,DECLINING,boston_childrens
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,
47,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
47,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,OTHER,,
47,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
47,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,
47,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
47,NOT_MENTIONED,,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,
47,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
47,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
47,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,
47,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
47,NOT_MENTIONED,,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
47,NOT_MENTIONED,,,,,,IMPROVING,
47,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
47,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,
47,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,
47,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,,
47,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
47,,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,
47,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
47,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
47,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
47,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,OTHER,,boston_childrens
47,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
47,NOT_MENTIONED,,,,,,IMPROVING,boston_childrens
47,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
47,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,boston_childrens
47,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,boston_childrens
47,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,,boston_childrens
47,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
47,,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
47,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
47,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
46,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,,NOT_MENTIONED,
46,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,
46,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,
46,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,NOT_MENTIONED,,
46,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,,
46,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,
46,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,,
46,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,,,
46,NOT_MENTIONED,STABLE,,,,,NOT_MENTIONED,
46,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,
46,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
46,NOT_MENTIONED,,,ALKYLATING,,OTHER,NOT_MENTIONED,
46,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
46,NOT_MENTIONED,,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
46,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,
46,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,,
46,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
46,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,
46,,PROGRESSION,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
46,,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,
46,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
46,,PROGRESSION,,ALKYLATING,,,NOT_MENTIONED,
46,,STABLE,NOT_MENTIONED,,,,,
46,,STABLE,SYMPTOM_PRESENT,,,,,
46,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
46,,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,
46,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
46,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,
46,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,
46,,,SYMPTOM_PRESENT,,,CARBOPLATIN,,
46,,,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
46,,,,BRAF,,,NOT_MENTIONED,
46,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,,NOT_MENTIONED,boston_childrens
46,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,boston_childrens
46,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
46,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,NOT_MENTIONED,,boston_childrens
46,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,,boston_childrens
46,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
46,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
46,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,,,boston_childrens
46,NOT_MENTIONED,STABLE,,,,,NOT_MENTIONED,boston_childrens
46,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
46,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
46,NOT_MENTIONED,,,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
46,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
46,NOT_MENTIONED,,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
46,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,,boston_childrens
46,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
46,,PROGRESSION,,ALKYLATING,,,NOT_MENTIONED,boston_childrens
46,,STABLE,NOT_MENTIONED,,,,,boston_childrens
46,,STABLE,SYMPTOM_PRESENT,,,,,boston_childrens
46,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
46,,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,boston_childrens
46,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
46,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,boston_childrens
46,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
46,,,SYMPTOM_PRESENT,,,CARBOPLATIN,,boston_childrens
46,,,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
46,,,,BRAF,,,NOT_MENTIONED,boston_childrens
45,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,,,
45,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,
45,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,,
45,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,
45,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,NOT_MENTIONED,
45,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
45,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
45,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
45,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
45,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,,,
45,NOT_MENTIONED,,,BRAF,,,,
45,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,NOT_MENTIONED,
45,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
45,,PROGRESSION,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
45,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
45,,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,,
45,,PROGRESSION,,,,NOT_MENTIONED,DECLINING,
45,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
45,,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
45,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
45,,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,
45,,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
45,,,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,
45,,,,MEK,TARGETED_THERAPY,,,
45,,,,MEK,,,,
45,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,,,boston_childrens
45,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
45,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,,boston_childrens
45,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
45,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,NOT_MENTIONED,boston_childrens
45,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
45,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
45,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
45,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
45,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,,,boston_childrens
45,NOT_MENTIONED,,,BRAF,,,,boston_childrens
45,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,NOT_MENTIONED,boston_childrens
45,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
45,,PROGRESSION,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
45,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
45,,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
45,,PROGRESSION,,,,NOT_MENTIONED,DECLINING,boston_childrens
45,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
45,,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
45,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
45,,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,boston_childrens
45,,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
45,,,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,boston_childrens
45,,,,MEK,TARGETED_THERAPY,,,boston_childrens
45,,,,MEK,,,,boston_childrens
44,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,
44,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,
44,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,,,
44,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,,,
44,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
44,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,
44,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
44,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,
44,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,
44,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN,,
44,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
44,NOT_MENTIONED,,,CHEMOTHERAPY,,,DECLINING,
44,NOT_MENTIONED,,,,CHEMOTHERAPY,,DECLINING,
44,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
44,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,
44,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,
44,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,,
44,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
44,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,
44,,PROGRESSION,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
44,,PROGRESSION,,BRAF,,,NOT_MENTIONED,
44,,PROGRESSION,,MEK,TARGETED_THERAPY,,,
44,,PROGRESSION,,MEK,,,,
44,,,,MEK,TARGETED_THERAPY,cumulus__none,,
44,,,,MEK,,cumulus__none,,
44,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
44,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,boston_childrens
44,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,,,boston_childrens
44,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,,,boston_childrens
44,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
44,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,boston_childrens
44,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
44,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,boston_childrens
44,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
44,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN,,boston_childrens
44,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
44,NOT_MENTIONED,,,CHEMOTHERAPY,,,DECLINING,boston_childrens
44,NOT_MENTIONED,,,,CHEMOTHERAPY,,DECLINING,boston_childrens
44,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
44,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
44,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
44,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,,boston_childrens
44,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
44,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,boston_childrens
44,,PROGRESSION,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
44,,PROGRESSION,,BRAF,,,NOT_MENTIONED,boston_childrens
44,,PROGRESSION,,MEK,TARGETED_THERAPY,,,boston_childrens
44,,PROGRESSION,,MEK,,,,boston_childrens
44,,,,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
44,,,,MEK,,cumulus__none,,boston_childrens
43,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,,,
43,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,,,
43,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,,,
43,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,cumulus__none,,
43,AVAILABLE_AND_ELIGIBLE,,,,,cumulus__none,,
43,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
43,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
43,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,,,
43,NOT_MENTIONED,PROGRESSION,,BRAF,,,,
43,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
43,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
43,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
43,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,,
43,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
43,NOT_MENTIONED,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,
43,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
43,NOT_MENTIONED,,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,
43,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
43,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
43,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
43,NOT_MENTIONED,,,,,CARBOPLATIN,NOT_MENTIONED,
43,,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,
43,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
43,,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,,
43,,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,,
43,,PROGRESSION,,MEK,,cumulus__none,,
43,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
43,,PROGRESSION,,PLATINUM,,CARBOPLATIN,,
43,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,,
43,,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,DECLINING,
43,,PROGRESSION,,,TARGETED_THERAPY,,DECLINING,
43,,PROGRESSION,,,,CARBOPLATIN,,
43,,PROGRESSION,,,,cumulus__none,DECLINING,
43,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,
43,,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,
43,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,
43,,,SYMPTOM_PRESENT,BRAF,,,,
43,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
43,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
43,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
43,,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,
43,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
43,,,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
43,,,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
43,,,,,TARGETED_THERAPY,cumulus__none,DECLINING,
43,,,,,TARGETED_THERAPY,,DECLINING,
43,,,,,,CARBOPLATIN,NOT_MENTIONED,
43,,,,,,cumulus__none,DECLINING,
43,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,,,boston_childrens
43,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
43,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,,,boston_childrens
43,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,cumulus__none,,boston_childrens
43,AVAILABLE_AND_ELIGIBLE,,,,,cumulus__none,,boston_childrens
43,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,,,boston_childrens
43,NOT_MENTIONED,PROGRESSION,,BRAF,,,,boston_childrens
43,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
43,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
43,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
43,NOT_MENTIONED,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
43,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
43,NOT_MENTIONED,,,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
43,,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,boston_childrens
43,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
43,,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
43,,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
43,,PROGRESSION,,MEK,,cumulus__none,,boston_childrens
43,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
43,,PROGRESSION,,PLATINUM,,CARBOPLATIN,,boston_childrens
43,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
43,,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
43,,PROGRESSION,,,TARGETED_THERAPY,,DECLINING,boston_childrens
43,,PROGRESSION,,,,CARBOPLATIN,,boston_childrens
43,,PROGRESSION,,,,cumulus__none,DECLINING,boston_childrens
43,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
43,,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,boston_childrens
43,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,boston_childrens
43,,,SYMPTOM_PRESENT,BRAF,,,,boston_childrens
43,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
43,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
43,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
43,,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,boston_childrens
43,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
43,,,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
43,,,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
43,,,,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
43,,,,,TARGETED_THERAPY,,DECLINING,boston_childrens
43,,,,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
43,,,,,,cumulus__none,DECLINING,boston_childrens
42,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,,NOT_MENTIONED,
42,AVAILABLE_NOT_ELIGIBLE,,,,,,,
42,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
42,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
42,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,
42,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
42,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,,NOT_MENTIONED,
42,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
42,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN,,
42,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,,
42,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN,,
42,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,,,
42,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
42,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,
42,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,
42,NOT_MENTIONED,,NOT_MENTIONED,,,cumulus__none,,
42,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
42,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,
42,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
42,,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,
42,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
42,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
42,,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,,
42,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
42,,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
42,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,
42,,,SYMPTOM_PRESENT,MEK,,,,
42,,,SYMPTOM_PRESENT,,,,IMPROVING,
42,,,,BRAF,TARGETED_THERAPY,cumulus__none,,
42,,,,BRAF,,cumulus__none,,
42,,,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
42,,,,VINCA ALKALOID,,,DECLINING,
42,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
42,AVAILABLE_NOT_ELIGIBLE,,,,,,,boston_childrens
42,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
42,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
42,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,boston_childrens
42,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
42,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,,NOT_MENTIONED,boston_childrens
42,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
42,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN,,boston_childrens
42,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
42,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN,,boston_childrens
42,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,,,boston_childrens
42,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
42,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
42,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,boston_childrens
42,NOT_MENTIONED,,NOT_MENTIONED,,,cumulus__none,,boston_childrens
42,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
42,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
42,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
42,,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
42,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
42,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
42,,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,,boston_childrens
42,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
42,,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
42,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,boston_childrens
42,,,SYMPTOM_PRESENT,MEK,,,,boston_childrens
42,,,SYMPTOM_PRESENT,,,,IMPROVING,boston_childrens
42,,,,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
42,,,,BRAF,,cumulus__none,,boston_childrens
42,,,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
42,,,,VINCA ALKALOID,,,DECLINING,boston_childrens
41,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,,
41,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,cumulus__none,,
41,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,OTHER,,
41,AVAILABLE_AND_ELIGIBLE,,,,,NOT_MENTIONED,,
41,AVAILABLE_AND_ELIGIBLE,,,,,OTHER,,
41,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,
41,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,,
41,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,,
41,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
41,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
41,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
41,NOT_MENTIONED,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
41,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
41,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,
41,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
41,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,
41,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
41,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,
41,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
41,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
41,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,
41,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,,
41,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,
41,,PROGRESSION,SYMPTOM_PRESENT,MEK,,,,
41,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,
41,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,
41,,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,
41,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
41,,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
41,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
41,,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,
41,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,
41,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,
41,,,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,
41,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,,boston_childrens
41,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,cumulus__none,,boston_childrens
41,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,OTHER,,boston_childrens
41,AVAILABLE_AND_ELIGIBLE,,,,,NOT_MENTIONED,,boston_childrens
41,AVAILABLE_AND_ELIGIBLE,,,,,OTHER,,boston_childrens
41,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
41,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,,boston_childrens
41,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,,boston_childrens
41,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
41,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
41,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
41,NOT_MENTIONED,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
41,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
41,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,boston_childrens
41,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
41,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,boston_childrens
41,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
41,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,boston_childrens
41,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
41,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
41,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,boston_childrens
41,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,,boston_childrens
41,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,boston_childrens
41,,PROGRESSION,SYMPTOM_PRESENT,MEK,,,,boston_childrens
41,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
41,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,boston_childrens
41,,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,boston_childrens
41,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
41,,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
41,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
41,,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,boston_childrens
41,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
41,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,boston_childrens
41,,,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,boston_childrens
40,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,,,
40,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,,,
40,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,
40,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,cumulus__none,,
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,
40,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
40,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,,DECLINING,
40,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
40,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
40,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,,DECLINING,
40,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
40,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
40,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,
40,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
40,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,
40,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,
40,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
40,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,
40,,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
40,,PROGRESSION,NOT_MENTIONED,,,OTHER,,
40,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
40,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,
40,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
40,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,
40,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,
40,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,,
40,,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,,
40,,PROGRESSION,,BRAF,,cumulus__none,,
40,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
40,,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
40,,STABLE,NOT_MENTIONED,,,,NOT_MENTIONED,
40,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
40,,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,
40,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,
40,,,SYMPTOM_PRESENT,MEK,,cumulus__none,,
40,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
40,,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
40,,,,CRANIOTOMY,SURGERY,,,
40,,,,CRANIOTOMY,,,,
40,,,,NOT MENTIONED,,NOT_MENTIONED,,
40,,,,NOT MENTIONED,,,,
40,,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
40,,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
40,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,,,boston_childrens
40,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,,,boston_childrens
40,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,boston_childrens
40,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,cumulus__none,,boston_childrens
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
40,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,,DECLINING,boston_childrens
40,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,,DECLINING,boston_childrens
40,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
40,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
40,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,boston_childrens
40,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,boston_childrens
40,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
40,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,boston_childrens
40,,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
40,,PROGRESSION,NOT_MENTIONED,,,OTHER,,boston_childrens
40,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
40,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,boston_childrens
40,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
40,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
40,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
40,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,,boston_childrens
40,,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
40,,PROGRESSION,,BRAF,,cumulus__none,,boston_childrens
40,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
40,,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
40,,STABLE,NOT_MENTIONED,,,,NOT_MENTIONED,boston_childrens
40,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
40,,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,boston_childrens
40,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
40,,,SYMPTOM_PRESENT,MEK,,cumulus__none,,boston_childrens
40,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
40,,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
40,,,,CRANIOTOMY,SURGERY,,,boston_childrens
40,,,,CRANIOTOMY,,,,boston_childrens
40,,,,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
40,,,,NOT MENTIONED,,,,boston_childrens
40,,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
40,,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
39,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,
39,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
39,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,,NOT_MENTIONED,
39,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
39,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,
39,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
39,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,
39,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
39,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,,
39,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
39,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
39,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,
39,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,
39,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,
39,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,,,
39,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
39,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
39,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,cumulus__none,,
39,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
39,NOT_MENTIONED,,,BRAF,,cumulus__none,,
39,NOT_MENTIONED,,,BRAF,,,NOT_MENTIONED,
39,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,,,
39,NOT_MENTIONED,,,CRANIOTOMY,,,,
39,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
39,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,,,
39,NOT_MENTIONED,,,NOT MENTIONED,,NOT_MENTIONED,,
39,NOT_MENTIONED,,,NOT MENTIONED,,,,
39,NOT_MENTIONED,,,,,NOT_MENTIONED,DECLINING,
39,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
39,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
39,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,
39,,PROGRESSION,NOT_MENTIONED,PLATINUM,,,,
39,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
39,,PROGRESSION,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,
39,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
39,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,
39,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
39,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,
39,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,
39,,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,,
39,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,,
39,,PROGRESSION,,ALKYLATING,,OTHER,,
39,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
39,,PROGRESSION,,VINCA ALKALOID,,,DECLINING,
39,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,
39,,,NOT_MENTIONED,ALKYLATING,,,,
39,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
39,,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
39,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
39,,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
39,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
39,,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,
39,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
39,,,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,
39,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
39,,,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,
39,,,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
39,,,,BRAF,,cumulus__none,NOT_MENTIONED,
39,,,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
39,,,,MEK,,,NOT_MENTIONED,
39,,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
39,,,,NOT MENTIONED,SURGERY,,,
39,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,boston_childrens
39,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
39,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
39,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
39,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
39,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
39,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,boston_childrens
39,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
39,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
39,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
39,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
39,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
39,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,boston_childrens
39,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,boston_childrens
39,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,,,boston_childrens
39,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
39,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
39,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
39,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
39,NOT_MENTIONED,,,BRAF,,cumulus__none,,boston_childrens
39,NOT_MENTIONED,,,BRAF,,,NOT_MENTIONED,boston_childrens
39,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,,,boston_childrens
39,NOT_MENTIONED,,,CRANIOTOMY,,,,boston_childrens
39,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
39,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,,,boston_childrens
39,NOT_MENTIONED,,,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
39,NOT_MENTIONED,,,NOT MENTIONED,,,,boston_childrens
39,NOT_MENTIONED,,,,,NOT_MENTIONED,DECLINING,boston_childrens
39,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
39,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
39,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,boston_childrens
39,,PROGRESSION,NOT_MENTIONED,PLATINUM,,,,boston_childrens
39,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
39,,PROGRESSION,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,boston_childrens
39,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
39,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,boston_childrens
39,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
39,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
39,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
39,,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,,boston_childrens
39,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
39,,PROGRESSION,,ALKYLATING,,OTHER,,boston_childrens
39,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
39,,PROGRESSION,,VINCA ALKALOID,,,DECLINING,boston_childrens
39,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
39,,,NOT_MENTIONED,ALKYLATING,,,,boston_childrens
39,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
39,,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
39,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
39,,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
39,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
39,,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
39,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
39,,,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,boston_childrens
39,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
39,,,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,boston_childrens
39,,,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
39,,,,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
39,,,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
39,,,,MEK,,,NOT_MENTIONED,boston_childrens
39,,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
39,,,,NOT MENTIONED,SURGERY,,,boston_childrens
38,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,
38,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
38,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,NOT_MENTIONED,,
38,AVAILABLE_AND_ELIGIBLE,,,,,CARBOPLATIN_VINCRISTINE,,
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,,
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,,
38,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
38,NOT_MENTIONED,,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,
38,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
38,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
38,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
38,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
38,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
38,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
38,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
38,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN,NOT_MENTIONED,
38,,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,
38,,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,
38,,PROGRESSION,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,
38,,PROGRESSION,NOT_MENTIONED,OBSERVATION,,,,
38,,PROGRESSION,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,
38,,PROGRESSION,NOT_MENTIONED,,OBSERVATION,,,
38,,PROGRESSION,NOT_MENTIONED,,,OBSERVATION,,
38,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
38,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
38,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
38,,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
38,,PROGRESSION,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
38,,PROGRESSION,,MEK,,,NOT_MENTIONED,
38,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,
38,,,NOT_MENTIONED,BRAF,,,,
38,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
38,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
38,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
38,,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
38,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
38,,,SYMPTOM_PRESENT,,,CARBOPLATIN,NOT_MENTIONED,
38,,,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
38,,,,MEK,,cumulus__none,NOT_MENTIONED,
38,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
38,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
38,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
38,AVAILABLE_AND_ELIGIBLE,,,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,,boston_childrens
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,boston_childrens
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,boston_childrens
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,boston_childrens
38,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,,boston_childrens
38,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
38,NOT_MENTIONED,,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,boston_childrens
38,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
38,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
38,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
38,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
38,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
38,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
38,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
38,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
38,,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
38,,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,boston_childrens
38,,PROGRESSION,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,boston_childrens
38,,PROGRESSION,NOT_MENTIONED,OBSERVATION,,,,boston_childrens
38,,PROGRESSION,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,boston_childrens
38,,PROGRESSION,NOT_MENTIONED,,OBSERVATION,,,boston_childrens
38,,PROGRESSION,NOT_MENTIONED,,,OBSERVATION,,boston_childrens
38,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
38,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
38,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
38,,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
38,,PROGRESSION,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
38,,PROGRESSION,,MEK,,,NOT_MENTIONED,boston_childrens
38,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,boston_childrens
38,,,NOT_MENTIONED,BRAF,,,,boston_childrens
38,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
38,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
38,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
38,,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
38,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
38,,,SYMPTOM_PRESENT,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
38,,,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
38,,,,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
37,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,
37,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,
37,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,
37,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
37,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
37,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,,
37,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,,,
37,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,
37,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,
37,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,,
37,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
37,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,,
37,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,,
37,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
37,NOT_MENTIONED,PROGRESSION,,BRAF,,cumulus__none,,
37,NOT_MENTIONED,PROGRESSION,,BRAF,,,NOT_MENTIONED,
37,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
37,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
37,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
37,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
37,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
37,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN,NOT_MENTIONED,
37,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,,,
37,NOT_MENTIONED,,,MEK,,,,
37,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
37,NOT_MENTIONED,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
37,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
37,,PROGRESSION,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,
37,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,
37,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
37,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,
37,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
37,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,
37,,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
37,,PROGRESSION,,BRAF,,cumulus__none,NOT_MENTIONED,
37,,PROGRESSION,,CRANIOTOMY,SURGERY,,,
37,,PROGRESSION,,CRANIOTOMY,,,,
37,,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
37,,PROGRESSION,,MEK,,cumulus__none,NOT_MENTIONED,
37,,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,,
37,,PROGRESSION,,NOT MENTIONED,,,,
37,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
37,,PROGRESSION,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
37,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
37,,PROGRESSION,,VINCA ALKALOID,,OTHER,,
37,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
37,,PROGRESSION,,,,CARBOPLATIN,NOT_MENTIONED,
37,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
37,,,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,
37,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
37,,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,
37,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,
37,,,SYMPTOM_PRESENT,BRAF,,cumulus__none,,
37,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
37,,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
37,,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,,
37,,,,CRANIOTOMY,,NOT_MENTIONED,,
37,,,,PLATINUM,CHEMOTHERAPY,,DECLINING,
37,,,,PLATINUM,,,DECLINING,
37,,,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
37,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
37,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,boston_childrens
37,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,boston_childrens
37,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
37,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
37,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,,boston_childrens
37,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,,,boston_childrens
37,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
37,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,boston_childrens
37,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,BRAF,,cumulus__none,,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,BRAF,,,NOT_MENTIONED,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
37,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
37,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,,,boston_childrens
37,NOT_MENTIONED,,,MEK,,,,boston_childrens
37,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
37,NOT_MENTIONED,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
37,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
37,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
37,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,boston_childrens
37,,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,,CRANIOTOMY,SURGERY,,,boston_childrens
37,,PROGRESSION,,CRANIOTOMY,,,,boston_childrens
37,,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
37,,PROGRESSION,,NOT MENTIONED,,,,boston_childrens
37,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
37,,PROGRESSION,,VINCA ALKALOID,,OTHER,,boston_childrens
37,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
37,,PROGRESSION,,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
37,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
37,,,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,boston_childrens
37,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
37,,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,boston_childrens
37,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
37,,,SYMPTOM_PRESENT,BRAF,,cumulus__none,,boston_childrens
37,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
37,,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
37,,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,,boston_childrens
37,,,,CRANIOTOMY,,NOT_MENTIONED,,boston_childrens
37,,,,PLATINUM,CHEMOTHERAPY,,DECLINING,boston_childrens
37,,,,PLATINUM,,,DECLINING,boston_childrens
37,,,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
36,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,
36,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,,,
36,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,,,
36,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
36,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,,NOT_MENTIONED,
36,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,,NOT_MENTIONED,
36,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
36,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,
36,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
36,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,
36,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,,,
36,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,,,
36,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,,,
36,NOT_MENTIONED,PROGRESSION,,MEK,,,,
36,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
36,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,,,
36,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,,
36,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,,,
36,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
36,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,OTHER,,
36,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,,DECLINING,
36,NOT_MENTIONED,PROGRESSION,,,,NOT_MENTIONED,DECLINING,
36,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,,NOT_MENTIONED,
36,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
36,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,
36,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
36,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,
36,NOT_MENTIONED,,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,
36,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,,
36,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
36,NOT_MENTIONED,,,CRANIOTOMY,,NOT_MENTIONED,,
36,NOT_MENTIONED,,,CRANIOTOMY,,,NOT_MENTIONED,
36,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,cumulus__none,,
36,NOT_MENTIONED,,,MEK,,cumulus__none,,
36,NOT_MENTIONED,,,,TARGETED_THERAPY,,DECLINING,
36,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,
36,,PROGRESSION,NOT_MENTIONED,BRAF,,,,
36,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
36,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
36,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,
36,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
36,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
36,,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
36,,PROGRESSION,,NOT MENTIONED,SURGERY,,,
36,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
36,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,,
36,,PROGRESSION,,OTHER TARGETED,,cumulus__none,,
36,,PROGRESSION,,OTHER TARGETED,,,,
36,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
36,,PROGRESSION,,PLATINUM,,NOT_MENTIONED,,
36,,STABLE,SYMPTOM_PRESENT,,,,NOT_MENTIONED,
36,,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,,
36,,STABLE,,OBSERVATION,OBSERVATION,,,
36,,STABLE,,OBSERVATION,,OBSERVATION,,
36,,STABLE,,OBSERVATION,,,,
36,,STABLE,,,OBSERVATION,OBSERVATION,,
36,,STABLE,,,OBSERVATION,,,
36,,STABLE,,,,OBSERVATION,,
36,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
36,,,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,
36,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
36,,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,,
36,,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,,
36,,,NOT_MENTIONED,,,CARBOPLATIN,,
36,,,,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
36,,,,CRANIOTOMY,,,NOT_MENTIONED,
36,,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
36,,,,OTHER TARGETED,TARGETED_THERAPY,,,
36,,,,OTHER TARGETED,,cumulus__none,,
36,,,,OTHER TARGETED,,,,
36,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,boston_childrens
36,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,,,boston_childrens
36,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,,,boston_childrens
36,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
36,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
36,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
36,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
36,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,boston_childrens
36,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,MEK,,,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,OTHER,,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,,DECLINING,boston_childrens
36,NOT_MENTIONED,PROGRESSION,,,,NOT_MENTIONED,DECLINING,boston_childrens
36,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,,NOT_MENTIONED,boston_childrens
36,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
36,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,boston_childrens
36,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
36,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
36,NOT_MENTIONED,,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,boston_childrens
36,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,,boston_childrens
36,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
36,NOT_MENTIONED,,,CRANIOTOMY,,NOT_MENTIONED,,boston_childrens
36,NOT_MENTIONED,,,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
36,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
36,NOT_MENTIONED,,,MEK,,cumulus__none,,boston_childrens
36,NOT_MENTIONED,,,,TARGETED_THERAPY,,DECLINING,boston_childrens
36,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,boston_childrens
36,,PROGRESSION,NOT_MENTIONED,BRAF,,,,boston_childrens
36,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
36,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
36,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,boston_childrens
36,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
36,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
36,,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
36,,PROGRESSION,,NOT MENTIONED,SURGERY,,,boston_childrens
36,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
36,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
36,,PROGRESSION,,OTHER TARGETED,,cumulus__none,,boston_childrens
36,,PROGRESSION,,OTHER TARGETED,,,,boston_childrens
36,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
36,,PROGRESSION,,PLATINUM,,NOT_MENTIONED,,boston_childrens
36,,STABLE,SYMPTOM_PRESENT,,,,NOT_MENTIONED,boston_childrens
36,,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
36,,STABLE,,OBSERVATION,OBSERVATION,,,boston_childrens
36,,STABLE,,OBSERVATION,,OBSERVATION,,boston_childrens
36,,STABLE,,OBSERVATION,,,,boston_childrens
36,,STABLE,,,OBSERVATION,OBSERVATION,,boston_childrens
36,,STABLE,,,OBSERVATION,,,boston_childrens
36,,STABLE,,,,OBSERVATION,,boston_childrens
36,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
36,,,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,boston_childrens
36,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
36,,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,,boston_childrens
36,,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
36,,,NOT_MENTIONED,,,CARBOPLATIN,,boston_childrens
36,,,,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
36,,,,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
36,,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
36,,,,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
36,,,,OTHER TARGETED,,cumulus__none,,boston_childrens
36,,,,OTHER TARGETED,,,,boston_childrens
35,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,,NOT_MENTIONED,
35,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
35,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,
35,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,
35,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,cumulus__none,,
35,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
35,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
35,AVAILABLE_AND_ELIGIBLE,,,,,OTHER,NOT_MENTIONED,
35,AVAILABLE_AND_ELIGIBLE,,,,,cumulus__none,NOT_MENTIONED,
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,,,,
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,OBSERVATION,,,
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,OBSERVATION,,
35,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
35,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
35,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,
35,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
35,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,,
35,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,OTHER,,
35,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,,
35,NOT_MENTIONED,PROGRESSION,,MEK,,cumulus__none,,
35,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,DECLINING,
35,NOT_MENTIONED,PROGRESSION,,,,cumulus__none,DECLINING,
35,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,
35,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,,,
35,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
35,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,
35,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
35,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
35,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
35,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
35,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
35,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
35,NOT_MENTIONED,,,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
35,NOT_MENTIONED,,,NOT MENTIONED,,,NOT_MENTIONED,
35,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
35,NOT_MENTIONED,,,VINCA ALKALOID,,,DECLINING,
35,NOT_MENTIONED,,,,SURGERY,SUBTOTAL,,
35,NOT_MENTIONED,,,,TARGETED_THERAPY,cumulus__none,DECLINING,
35,NOT_MENTIONED,,,,,SUBTOTAL,,
35,NOT_MENTIONED,,,,,cumulus__none,DECLINING,
35,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,
35,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,,
35,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
35,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
35,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
35,,PROGRESSION,,ALKYLATING,,OTHER,NOT_MENTIONED,
35,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,DECLINING,
35,,PROGRESSION,,PLATINUM,,,DECLINING,
35,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
35,,,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,
35,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
35,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
35,,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
35,,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
35,,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
35,,,NOT_MENTIONED,,,CARBOPLATIN,NOT_MENTIONED,
35,,,NOT_MENTIONED,,,,IMPROVING,
35,,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
35,,,,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
35,,,,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
35,,,,NOT MENTIONED,,,NOT_MENTIONED,
35,,,,PLATINUM,CHEMOTHERAPY,OTHER,,
35,,,,PLATINUM,,OTHER,,
35,,,,,CHEMOTHERAPY,OTHER,DECLINING,
35,,,,,SURGERY,SUBTOTAL,,
35,,,,,,OTHER,DECLINING,
35,,,,,,SUBTOTAL,,
35,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,,NOT_MENTIONED,boston_childrens
35,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
35,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
35,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,boston_childrens
35,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,cumulus__none,,boston_childrens
35,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
35,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
35,AVAILABLE_AND_ELIGIBLE,,,,,OTHER,NOT_MENTIONED,boston_childrens
35,AVAILABLE_AND_ELIGIBLE,,,,,cumulus__none,NOT_MENTIONED,boston_childrens
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,,,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,OBSERVATION,,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,OBSERVATION,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
35,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
35,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,OTHER,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,,MEK,,cumulus__none,,boston_childrens
35,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
35,NOT_MENTIONED,PROGRESSION,,,,cumulus__none,DECLINING,boston_childrens
35,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
35,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,,,boston_childrens
35,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
35,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,boston_childrens
35,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
35,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
35,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
35,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
35,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
35,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
35,NOT_MENTIONED,,,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
35,NOT_MENTIONED,,,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
35,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
35,NOT_MENTIONED,,,VINCA ALKALOID,,,DECLINING,boston_childrens
35,NOT_MENTIONED,,,,SURGERY,SUBTOTAL,,boston_childrens
35,NOT_MENTIONED,,,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
35,NOT_MENTIONED,,,,,SUBTOTAL,,boston_childrens
35,NOT_MENTIONED,,,,,cumulus__none,DECLINING,boston_childrens
35,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
35,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,,boston_childrens
35,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
35,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
35,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
35,,PROGRESSION,,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
35,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,DECLINING,boston_childrens
35,,PROGRESSION,,PLATINUM,,,DECLINING,boston_childrens
35,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
35,,,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,boston_childrens
35,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
35,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
35,,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
35,,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
35,,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
35,,,NOT_MENTIONED,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
35,,,NOT_MENTIONED,,,,IMPROVING,boston_childrens
35,,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
35,,,,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
35,,,,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
35,,,,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
35,,,,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
35,,,,PLATINUM,,OTHER,,boston_childrens
35,,,,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
35,,,,,SURGERY,SUBTOTAL,,boston_childrens
35,,,,,,OTHER,DECLINING,boston_childrens
35,,,,,,SUBTOTAL,,boston_childrens
34,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,
34,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,,
34,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,OTHER,,
34,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,,NOT_MENTIONED,
34,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,OTHER,,
34,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,
34,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,,,
34,AVAILABLE_AND_ELIGIBLE,,,,,NOT_MENTIONED,NOT_MENTIONED,
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,,,
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,OTHER,,
34,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
34,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,
34,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,
34,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,
34,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
34,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
34,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
34,NOT_MENTIONED,PROGRESSION,,PLATINUM,,NOT_MENTIONED,,
34,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,,
34,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,,,
34,NOT_MENTIONED,STABLE,,OBSERVATION,,OBSERVATION,,
34,NOT_MENTIONED,STABLE,,OBSERVATION,,,,
34,NOT_MENTIONED,STABLE,,,OBSERVATION,OBSERVATION,,
34,NOT_MENTIONED,STABLE,,,OBSERVATION,,,
34,NOT_MENTIONED,STABLE,,,,OBSERVATION,,
34,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
34,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
34,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
34,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
34,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,
34,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,cumulus__none,,
34,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,
34,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,,,
34,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,
34,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
34,NOT_MENTIONED,,,BRAF,,cumulus__none,NOT_MENTIONED,
34,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,OTHER,,
34,NOT_MENTIONED,,,PLATINUM,,OTHER,,
34,NOT_MENTIONED,,,SUBTOTAL,SURGERY,SUBTOTAL,,
34,NOT_MENTIONED,,,SUBTOTAL,SURGERY,,,
34,NOT_MENTIONED,,,SUBTOTAL,,SUBTOTAL,,
34,NOT_MENTIONED,,,SUBTOTAL,,,,
34,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
34,,PROGRESSION,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,
34,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
34,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,
34,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,
34,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,,
34,,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,,
34,,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,,
34,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
34,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
34,,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
34,,PROGRESSION,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
34,,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
34,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,,
34,,,SYMPTOM_PRESENT,CRANIOTOMY,,,,
34,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
34,,,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,
34,,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,,
34,,,SYMPTOM_PRESENT,NOT MENTIONED,,,,
34,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
34,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,
34,,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,
34,,,SYMPTOM_PRESENT,OTHER TARGETED,,,,
34,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,DECLINING,
34,,,SYMPTOM_PRESENT,PLATINUM,,,DECLINING,
34,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
34,,,,SUBTOTAL,SURGERY,SUBTOTAL,,
34,,,,SUBTOTAL,SURGERY,,,
34,,,,SUBTOTAL,,SUBTOTAL,,
34,,,,SUBTOTAL,,,,
34,,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
34,,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
34,,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
34,,,,VINCA ALKALOID,,VINBLASTINE,,
34,,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
34,,,,,CHEMOTHERAPY,VINBLASTINE,,
34,,,,,,CARBOPLATIN_VINCRISTINE,DECLINING,
34,,,,,,VINBLASTINE,,
34,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,boston_childrens
34,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,,boston_childrens
34,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,OTHER,,boston_childrens
34,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
34,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,OTHER,,boston_childrens
34,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
34,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,,,boston_childrens
34,AVAILABLE_AND_ELIGIBLE,,,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,boston_childrens
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,,,boston_childrens
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,boston_childrens
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
34,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,OTHER,,boston_childrens
34,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,boston_childrens
34,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,boston_childrens
34,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
34,NOT_MENTIONED,PROGRESSION,,PLATINUM,,NOT_MENTIONED,,boston_childrens
34,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
34,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,,,boston_childrens
34,NOT_MENTIONED,STABLE,,OBSERVATION,,OBSERVATION,,boston_childrens
34,NOT_MENTIONED,STABLE,,OBSERVATION,,,,boston_childrens
34,NOT_MENTIONED,STABLE,,,OBSERVATION,OBSERVATION,,boston_childrens
34,NOT_MENTIONED,STABLE,,,OBSERVATION,,,boston_childrens
34,NOT_MENTIONED,STABLE,,,,OBSERVATION,,boston_childrens
34,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
34,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,cumulus__none,,boston_childrens
34,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,boston_childrens
34,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,,,boston_childrens
34,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,boston_childrens
34,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,,,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
34,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
34,NOT_MENTIONED,,,PLATINUM,,OTHER,,boston_childrens
34,NOT_MENTIONED,,,SUBTOTAL,SURGERY,SUBTOTAL,,boston_childrens
34,NOT_MENTIONED,,,SUBTOTAL,SURGERY,,,boston_childrens
34,NOT_MENTIONED,,,SUBTOTAL,,SUBTOTAL,,boston_childrens
34,NOT_MENTIONED,,,SUBTOTAL,,,,boston_childrens
34,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
34,,PROGRESSION,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,boston_childrens
34,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
34,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
34,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,boston_childrens
34,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,,boston_childrens
34,,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,,boston_childrens
34,,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,,boston_childrens
34,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
34,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
34,,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
34,,PROGRESSION,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
34,,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
34,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,,boston_childrens
34,,,SYMPTOM_PRESENT,CRANIOTOMY,,,,boston_childrens
34,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
34,,,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,boston_childrens
34,,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
34,,,SYMPTOM_PRESENT,NOT MENTIONED,,,,boston_childrens
34,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
34,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
34,,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,boston_childrens
34,,,SYMPTOM_PRESENT,OTHER TARGETED,,,,boston_childrens
34,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,DECLINING,boston_childrens
34,,,SYMPTOM_PRESENT,PLATINUM,,,DECLINING,boston_childrens
34,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
34,,,,SUBTOTAL,SURGERY,SUBTOTAL,,boston_childrens
34,,,,SUBTOTAL,SURGERY,,,boston_childrens
34,,,,SUBTOTAL,,SUBTOTAL,,boston_childrens
34,,,,SUBTOTAL,,,,boston_childrens
34,,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
34,,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
34,,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
34,,,,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
34,,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
34,,,,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
34,,,,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
34,,,,,,VINBLASTINE,,boston_childrens
33,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,,
33,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,,,
33,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
33,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,cumulus__none,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
33,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
33,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,,,
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,
33,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,,
33,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,,
33,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
33,NOT_MENTIONED,PROGRESSION,,,SURGERY,SUBTOTAL,,
33,NOT_MENTIONED,PROGRESSION,,,,SUBTOTAL,,
33,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,,NOT_MENTIONED,
33,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
33,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,
33,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,
33,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,,,
33,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
33,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,,
33,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,,
33,NOT_MENTIONED,,NOT_MENTIONED,,,CARBOPLATIN,,
33,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
33,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,
33,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,,
33,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,,,
33,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
33,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,,
33,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,,
33,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,,,
33,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,
33,NOT_MENTIONED,,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,
33,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
33,NOT_MENTIONED,,,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,
33,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
33,NOT_MENTIONED,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
33,NOT_MENTIONED,,,,SURGERY,SUBTOTAL,NOT_MENTIONED,
33,NOT_MENTIONED,,,,,SUBTOTAL,NOT_MENTIONED,
33,,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
33,,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
33,,PROGRESSION,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
33,,PROGRESSION,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,
33,,PROGRESSION,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
33,,PROGRESSION,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,
33,,PROGRESSION,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,
33,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,
33,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,
33,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,,
33,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,,
33,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
33,,PROGRESSION,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,
33,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,DECLINING,
33,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,DECLINING,
33,,PROGRESSION,,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
33,,PROGRESSION,,CRANIOTOMY,,,NOT_MENTIONED,
33,,PROGRESSION,,,SURGERY,SUBTOTAL,,
33,,PROGRESSION,,,,SUBTOTAL,,
33,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
33,,,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
33,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
33,,,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,
33,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
33,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,,
33,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,
33,,,SYMPTOM_PRESENT,,,OTHER,DECLINING,
33,,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
33,,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
33,,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
33,,,,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,
33,,,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
33,,,,OBSERVATION,OBSERVATION,,IMPROVING,
33,,,,OBSERVATION,,OBSERVATION,IMPROVING,
33,,,,OBSERVATION,,,IMPROVING,
33,,,,TOPOISOMERASE,CHEMOTHERAPY,,,
33,,,,TOPOISOMERASE,,,,
33,,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
33,,,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
33,,,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
33,,,,,OBSERVATION,OBSERVATION,IMPROVING,
33,,,,,OBSERVATION,,IMPROVING,
33,,,,,SURGERY,SUBTOTAL,NOT_MENTIONED,
33,,,,,,OBSERVATION,IMPROVING,
33,,,,,,SUBTOTAL,NOT_MENTIONED,
33,,,,,,VINBLASTINE,NOT_MENTIONED,
33,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
33,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,,,boston_childrens
33,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
33,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,cumulus__none,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
33,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
33,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,boston_childrens
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,,,boston_childrens
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
33,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,boston_childrens
33,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,,boston_childrens
33,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,,boston_childrens
33,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,PROGRESSION,,,SURGERY,SUBTOTAL,,boston_childrens
33,NOT_MENTIONED,PROGRESSION,,,,SUBTOTAL,,boston_childrens
33,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,boston_childrens
33,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,,,boston_childrens
33,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
33,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,,boston_childrens
33,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
33,NOT_MENTIONED,,NOT_MENTIONED,,,CARBOPLATIN,,boston_childrens
33,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,,boston_childrens
33,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,,,boston_childrens
33,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
33,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,,boston_childrens
33,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
33,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,,,boston_childrens
33,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
33,NOT_MENTIONED,,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,boston_childrens
33,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,,,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,,,,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
33,NOT_MENTIONED,,,,,SUBTOTAL,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
33,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,boston_childrens
33,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,,boston_childrens
33,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,,boston_childrens
33,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,DECLINING,boston_childrens
33,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,DECLINING,boston_childrens
33,,PROGRESSION,,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
33,,PROGRESSION,,,SURGERY,SUBTOTAL,,boston_childrens
33,,PROGRESSION,,,,SUBTOTAL,,boston_childrens
33,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
33,,,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
33,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
33,,,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
33,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
33,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,,boston_childrens
33,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
33,,,SYMPTOM_PRESENT,,,OTHER,DECLINING,boston_childrens
33,,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
33,,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
33,,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
33,,,,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
33,,,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
33,,,,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
33,,,,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
33,,,,OBSERVATION,,,IMPROVING,boston_childrens
33,,,,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
33,,,,TOPOISOMERASE,,,,boston_childrens
33,,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
33,,,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
33,,,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
33,,,,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
33,,,,,OBSERVATION,,IMPROVING,boston_childrens
33,,,,,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
33,,,,,,OBSERVATION,IMPROVING,boston_childrens
33,,,,,,SUBTOTAL,NOT_MENTIONED,boston_childrens
33,,,,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
32,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,NOT_MENTIONED,,
32,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,
32,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,NOT_MENTIONED,,
32,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,OTHER,,
32,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
32,AVAILABLE_AND_ELIGIBLE,,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,,
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,,
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,,
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,OTHER,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,,BRAF,,cumulus__none,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,,NOT_MENTIONED,
32,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,SURGERY,SUBTOTAL,,
32,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,SURGERY,,,
32,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,,SUBTOTAL,,
32,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,,,,
32,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
32,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,,DECLINING,
32,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
32,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,
32,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,
32,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,cumulus__none,,
32,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
32,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,
32,NOT_MENTIONED,,SYMPTOM_PRESENT,,,,IMPROVING,
32,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,,,
32,NOT_MENTIONED,,,TOPOISOMERASE,,,,
32,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
32,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
32,NOT_MENTIONED,,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
32,NOT_MENTIONED,,,VINCA ALKALOID,,VINBLASTINE,,
32,NOT_MENTIONED,,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
32,NOT_MENTIONED,,,,CHEMOTHERAPY,VINBLASTINE,,
32,NOT_MENTIONED,,,,,VINBLASTINE,NOT_MENTIONED,
32,NOT_MENTIONED,,,,,VINBLASTINE,,
32,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
32,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
32,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,,
32,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,,
32,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
32,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
32,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
32,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,
32,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
32,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
32,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
32,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,
32,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
32,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
32,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,NOT_MENTIONED,
32,,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
32,,PROGRESSION,,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
32,,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
32,,PROGRESSION,,NOT MENTIONED,,,NOT_MENTIONED,
32,,PROGRESSION,,SUBTOTAL,SURGERY,SUBTOTAL,,
32,,PROGRESSION,,SUBTOTAL,SURGERY,,,
32,,PROGRESSION,,SUBTOTAL,,SUBTOTAL,,
32,,PROGRESSION,,SUBTOTAL,,,,
32,,PROGRESSION,,,CHEMOTHERAPY,OTHER,DECLINING,
32,,PROGRESSION,,,,OTHER,DECLINING,
32,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,
32,,,NOT_MENTIONED,BRAF,,cumulus__none,,
32,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,
32,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,
32,,,NOT_MENTIONED,MEK,,cumulus__none,,
32,,,NOT_MENTIONED,MEK,,,,
32,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,,
32,,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,,
32,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
32,,,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,
32,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
32,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
32,,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
32,,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,
32,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,
32,,,SYMPTOM_PRESENT,,,VINBLASTINE,,
32,,,,MTOR,TARGETED_THERAPY,,,
32,,,,MTOR,,,,
32,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,NOT_MENTIONED,,boston_childrens
32,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,boston_childrens
32,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,NOT_MENTIONED,,boston_childrens
32,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,OTHER,,boston_childrens
32,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
32,AVAILABLE_AND_ELIGIBLE,,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,,boston_childrens
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,,boston_childrens
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,,boston_childrens
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,SURGERY,SUBTOTAL,,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,SURGERY,,,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,,SUBTOTAL,,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,,,,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
32,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,,DECLINING,boston_childrens
32,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
32,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,boston_childrens
32,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
32,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,cumulus__none,,boston_childrens
32,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
32,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,boston_childrens
32,NOT_MENTIONED,,SYMPTOM_PRESENT,,,,IMPROVING,boston_childrens
32,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
32,NOT_MENTIONED,,,TOPOISOMERASE,,,,boston_childrens
32,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
32,NOT_MENTIONED,,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,,,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
32,NOT_MENTIONED,,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,,,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
32,NOT_MENTIONED,,,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
32,NOT_MENTIONED,,,,,VINBLASTINE,,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
32,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
32,,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
32,,PROGRESSION,,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
32,,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
32,,PROGRESSION,,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
32,,PROGRESSION,,SUBTOTAL,SURGERY,SUBTOTAL,,boston_childrens
32,,PROGRESSION,,SUBTOTAL,SURGERY,,,boston_childrens
32,,PROGRESSION,,SUBTOTAL,,SUBTOTAL,,boston_childrens
32,,PROGRESSION,,SUBTOTAL,,,,boston_childrens
32,,PROGRESSION,,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
32,,PROGRESSION,,,,OTHER,DECLINING,boston_childrens
32,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
32,,,NOT_MENTIONED,BRAF,,cumulus__none,,boston_childrens
32,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
32,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,boston_childrens
32,,,NOT_MENTIONED,MEK,,cumulus__none,,boston_childrens
32,,,NOT_MENTIONED,MEK,,,,boston_childrens
32,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,,boston_childrens
32,,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,,boston_childrens
32,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
32,,,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
32,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
32,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
32,,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
32,,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
32,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
32,,,SYMPTOM_PRESENT,,,VINBLASTINE,,boston_childrens
32,,,,MTOR,TARGETED_THERAPY,,,boston_childrens
32,,,,MTOR,,,,boston_childrens
31,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,
31,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
31,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
31,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
31,AVAILABLE_NOT_ELIGIBLE,,,,,,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,,,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,,
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,,
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,,
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,,
31,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
31,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,,
31,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,cumulus__none,,
31,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,,,
31,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
31,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
31,NOT_MENTIONED,PROGRESSION,,,SURGERY,SUBTOTAL,NOT_MENTIONED,
31,NOT_MENTIONED,PROGRESSION,,,,SUBTOTAL,NOT_MENTIONED,
31,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
31,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
31,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
31,NOT_MENTIONED,,NOT_MENTIONED,,,CARBOPLATIN,NOT_MENTIONED,
31,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,,
31,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,,
31,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
31,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
31,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
31,NOT_MENTIONED,,,MEK,,,NOT_MENTIONED,
31,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
31,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,,,
31,NOT_MENTIONED,,,OTHER TARGETED,,cumulus__none,,
31,NOT_MENTIONED,,,OTHER TARGETED,,,,
31,NOT_MENTIONED,,,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,
31,NOT_MENTIONED,,,SUBTOTAL,SURGERY,,NOT_MENTIONED,
31,NOT_MENTIONED,,,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,
31,NOT_MENTIONED,,,SUBTOTAL,,,NOT_MENTIONED,
31,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
31,NOT_MENTIONED,,,,,CARBOPLATIN_VINCRISTINE,DECLINING,
31,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,
31,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,
31,,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,,
31,,PROGRESSION,NOT_MENTIONED,MEK,,,,
31,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
31,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,
31,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,,
31,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,,
31,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
31,,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,
31,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
31,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,,
31,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,
31,,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,DECLINING,
31,,PROGRESSION,,MTOR,TARGETED_THERAPY,,,
31,,PROGRESSION,,MTOR,,,,
31,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
31,,PROGRESSION,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
31,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
31,,PROGRESSION,,,SURGERY,SUBTOTAL,NOT_MENTIONED,
31,,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,DECLINING,
31,,PROGRESSION,,,,SUBTOTAL,NOT_MENTIONED,
31,,STABLE,,,,,IMPROVING,
31,,,,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,
31,,,,SUBTOTAL,SURGERY,,NOT_MENTIONED,
31,,,,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,
31,,,,SUBTOTAL,,,NOT_MENTIONED,
31,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
31,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
31,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
31,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
31,AVAILABLE_NOT_ELIGIBLE,,,,,,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,cumulus__none,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
31,NOT_MENTIONED,PROGRESSION,,,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,PROGRESSION,,,,SUBTOTAL,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,NOT_MENTIONED,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,,boston_childrens
31,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,,boston_childrens
31,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,,MEK,,,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
31,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
31,NOT_MENTIONED,,,OTHER TARGETED,,cumulus__none,,boston_childrens
31,NOT_MENTIONED,,,OTHER TARGETED,,,,boston_childrens
31,NOT_MENTIONED,,,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,,SUBTOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,,SUBTOTAL,,,NOT_MENTIONED,boston_childrens
31,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
31,NOT_MENTIONED,,,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
31,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
31,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,boston_childrens
31,,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,,boston_childrens
31,,PROGRESSION,NOT_MENTIONED,MEK,,,,boston_childrens
31,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
31,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
31,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,,boston_childrens
31,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,,boston_childrens
31,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
31,,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
31,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
31,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,,boston_childrens
31,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
31,,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,DECLINING,boston_childrens
31,,PROGRESSION,,MTOR,TARGETED_THERAPY,,,boston_childrens
31,,PROGRESSION,,MTOR,,,,boston_childrens
31,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
31,,PROGRESSION,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
31,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
31,,PROGRESSION,,,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
31,,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
31,,PROGRESSION,,,,SUBTOTAL,NOT_MENTIONED,boston_childrens
31,,STABLE,,,,,IMPROVING,boston_childrens
31,,,,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
31,,,,SUBTOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
31,,,,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,boston_childrens
31,,,,SUBTOTAL,,,NOT_MENTIONED,boston_childrens
30,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
30,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
30,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
30,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,,
30,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,,DECLINING,
30,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,,,
30,AVAILABLE_AND_ELIGIBLE,,,BRAF,,,,
30,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
30,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,OTHER,,
30,AVAILABLE_AND_ELIGIBLE,,,,,,DECLINING,
30,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,,NOT_MENTIONED,
30,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,,
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,,
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,
30,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
30,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,
30,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
30,NOT_MENTIONED,PROGRESSION,,MEK,,,NOT_MENTIONED,
30,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
30,NOT_MENTIONED,PROGRESSION,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
30,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
30,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,
30,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
30,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,
30,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
30,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
30,NOT_MENTIONED,,NOT_MENTIONED,,,,IMPROVING,
30,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
30,NOT_MENTIONED,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
30,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
30,NOT_MENTIONED,,,MEK,,cumulus__none,NOT_MENTIONED,
30,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
30,NOT_MENTIONED,,,PLATINUM,,OTHER,NOT_MENTIONED,
30,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,
30,,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,,
30,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
30,,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,,
30,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
30,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,
30,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,,
30,,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN,,
30,,PROGRESSION,,BRAF,TARGETED_THERAPY,,DECLINING,
30,,PROGRESSION,,BRAF,,,DECLINING,
30,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
30,,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
30,,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
30,,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,
30,,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,,
30,,PROGRESSION,,MTOR,,cumulus__none,,
30,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
30,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
30,,PROGRESSION,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
30,,PROGRESSION,,OTHER TARGETED,,,NOT_MENTIONED,
30,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
30,,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,,
30,,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,,
30,,PROGRESSION,,,,VINBLASTINE,,
30,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,
30,,,NOT_MENTIONED,ALKYLATING,,OTHER,,
30,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
30,,,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,
30,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
30,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
30,,,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,
30,,,NOT_MENTIONED,MEK,,,NOT_MENTIONED,
30,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
30,,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
30,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
30,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
30,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,
30,,,SYMPTOM_PRESENT,MTOR,,,,
30,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
30,,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
30,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
30,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
30,,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,DECLINING,
30,,,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,
30,,,,BRAF,TARGETED_THERAPY,,DECLINING,
30,,,,BRAF,,,DECLINING,
30,,,,MTOR,TARGETED_THERAPY,cumulus__none,,
30,,,,MTOR,,cumulus__none,,
30,,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
30,,,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
30,,,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
30,,,,OTHER TARGETED,,,NOT_MENTIONED,
30,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
30,,,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
30,,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
30,,,,PLATINUM,,OTHER,NOT_MENTIONED,
30,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
30,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
30,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
30,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
30,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,,DECLINING,boston_childrens
30,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,,,boston_childrens
30,AVAILABLE_AND_ELIGIBLE,,,BRAF,,,,boston_childrens
30,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
30,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,OTHER,,boston_childrens
30,AVAILABLE_AND_ELIGIBLE,,,,,,DECLINING,boston_childrens
30,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,,boston_childrens
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,,boston_childrens
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,boston_childrens
30,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,boston_childrens
30,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,PROGRESSION,,MEK,,,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,PROGRESSION,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
30,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,boston_childrens
30,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,,NOT_MENTIONED,,,,IMPROVING,boston_childrens
30,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
30,NOT_MENTIONED,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
30,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,,,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
30,NOT_MENTIONED,,,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
30,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
30,,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,,boston_childrens
30,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
30,,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,,boston_childrens
30,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
30,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
30,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
30,,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN,,boston_childrens
30,,PROGRESSION,,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
30,,PROGRESSION,,BRAF,,,DECLINING,boston_childrens
30,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
30,,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
30,,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
30,,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
30,,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
30,,PROGRESSION,,MTOR,,cumulus__none,,boston_childrens
30,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
30,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
30,,PROGRESSION,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
30,,PROGRESSION,,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
30,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
30,,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
30,,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
30,,PROGRESSION,,,,VINBLASTINE,,boston_childrens
30,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
30,,,NOT_MENTIONED,ALKYLATING,,OTHER,,boston_childrens
30,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
30,,,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
30,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
30,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
30,,,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
30,,,NOT_MENTIONED,MEK,,,NOT_MENTIONED,boston_childrens
30,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
30,,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
30,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
30,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
30,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,boston_childrens
30,,,SYMPTOM_PRESENT,MTOR,,,,boston_childrens
30,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
30,,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
30,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
30,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
30,,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
30,,,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
30,,,,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
30,,,,BRAF,,,DECLINING,boston_childrens
30,,,,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
30,,,,MTOR,,cumulus__none,,boston_childrens
30,,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
30,,,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
30,,,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
30,,,,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
30,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
30,,,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
30,,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
30,,,,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,DECLINING,
29,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,,
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,,DECLINING,
29,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,,,
29,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,,,
29,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,cumulus__none,,
29,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,,,
29,AVAILABLE_AND_ELIGIBLE,,,MEK,,cumulus__none,,
29,AVAILABLE_AND_ELIGIBLE,,,MEK,,,,
29,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
29,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,,NOT_MENTIONED,
29,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
29,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,NOT_MENTIONED,,
29,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,,
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
29,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
29,NOT_MENTIONED,PROGRESSION,,MEK,,cumulus__none,NOT_MENTIONED,
29,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,
29,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,SURGERY,,NOT_MENTIONED,
29,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,
29,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,,,NOT_MENTIONED,
29,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,
29,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,cumulus__none,,
29,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,,NOT_MENTIONED,
29,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,,,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,,,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,,SUBTOTAL,,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,,VINBLASTINE,,
29,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,,,
29,NOT_MENTIONED,,,OTHER SURGERY,,,,
29,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,,DECLINING,
29,NOT_MENTIONED,,,PLATINUM,,,DECLINING,
29,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
29,NOT_MENTIONED,,,TOPOISOMERASE,,,NOT_MENTIONED,
29,NOT_MENTIONED,,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
29,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
29,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
29,,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,
29,,PROGRESSION,NOT_MENTIONED,MEK,,,NOT_MENTIONED,
29,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
29,,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
29,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
29,,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN,NOT_MENTIONED,
29,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
29,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,
29,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,
29,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,DECLINING,
29,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
29,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
29,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,
29,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,,
29,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
29,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
29,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
29,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,DECLINING,
29,,PROGRESSION,,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,
29,,PROGRESSION,,SUBTOTAL,SURGERY,,NOT_MENTIONED,
29,,PROGRESSION,,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,
29,,PROGRESSION,,SUBTOTAL,,,NOT_MENTIONED,
29,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,,
29,,PROGRESSION,,TOPOISOMERASE,,,,
29,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
29,,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
29,,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
29,,PROGRESSION,,,,VINBLASTINE,NOT_MENTIONED,
29,,,NOT_MENTIONED,,SURGERY,,NOT_MENTIONED,
29,,,NOT_MENTIONED,,SURGERY,,,
29,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,
29,,,SYMPTOM_PRESENT,BRAF,,,DECLINING,
29,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,
29,,,SYMPTOM_PRESENT,TOPOISOMERASE,,,,
29,,,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,,
29,,,SYMPTOM_PRESENT,,,SUBTOTAL,,
29,,,,ANTIMETABOLITE,CHEMOTHERAPY,,,
29,,,,ANTIMETABOLITE,,,,
29,,,,BIOPSY,SURGERY,,,
29,,,,BIOPSY,,,,
29,,,,OTHER SURGERY,SURGERY,,,
29,,,,OTHER SURGERY,,,,
29,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
29,,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
29,,,,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
29,,,,TOPOISOMERASE,,,NOT_MENTIONED,
29,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,DECLINING,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,,DECLINING,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,,MEK,,cumulus__none,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,,MEK,,,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,,NOT_MENTIONED,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
29,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
29,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,boston_childrens
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,boston_childrens
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,,boston_childrens
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
29,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
29,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,PROGRESSION,,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,PROGRESSION,,SUBTOTAL,,,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
29,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,cumulus__none,,boston_childrens
29,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,,,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,,,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,,SUBTOTAL,,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,,SYMPTOM_PRESENT,,,VINBLASTINE,,boston_childrens
29,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,,,boston_childrens
29,NOT_MENTIONED,,,OTHER SURGERY,,,,boston_childrens
29,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,,DECLINING,boston_childrens
29,NOT_MENTIONED,,,PLATINUM,,,DECLINING,boston_childrens
29,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,,,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
29,NOT_MENTIONED,,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
29,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,NOT_MENTIONED,MEK,,,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,DECLINING,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
29,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
29,,PROGRESSION,,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,,SUBTOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,,SUBTOTAL,,,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
29,,PROGRESSION,,TOPOISOMERASE,,,,boston_childrens
29,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
29,,PROGRESSION,,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
29,,,NOT_MENTIONED,,SURGERY,,NOT_MENTIONED,boston_childrens
29,,,NOT_MENTIONED,,SURGERY,,,boston_childrens
29,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
29,,,SYMPTOM_PRESENT,BRAF,,,DECLINING,boston_childrens
29,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
29,,,SYMPTOM_PRESENT,TOPOISOMERASE,,,,boston_childrens
29,,,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,,boston_childrens
29,,,SYMPTOM_PRESENT,,,SUBTOTAL,,boston_childrens
29,,,,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
29,,,,ANTIMETABOLITE,,,,boston_childrens
29,,,,BIOPSY,SURGERY,,,boston_childrens
29,,,,BIOPSY,,,,boston_childrens
29,,,,OTHER SURGERY,SURGERY,,,boston_childrens
29,,,,OTHER SURGERY,,,,boston_childrens
29,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
29,,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
29,,,,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
29,,,,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,,,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,,,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,,,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,cumulus__none,,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,,,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,OTHER,NOT_MENTIONED,
28,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,,,
28,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,
28,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,,,
28,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
28,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,,
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,SUBTOTAL,,
28,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,,,
28,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,,,
28,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,,
28,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,,,
28,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
28,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
28,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
28,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,,
28,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
28,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
28,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,,
28,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,DECLINING,
28,NOT_MENTIONED,PROGRESSION,,,,VINBLASTINE,NOT_MENTIONED,
28,NOT_MENTIONED,PROGRESSION,,,,VINBLASTINE,,
28,NOT_MENTIONED,STABLE,,,,,IMPROVING,
28,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
28,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,,NOT_MENTIONED,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,,
28,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,,,,
28,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,,,
28,NOT_MENTIONED,,,ANTIMETABOLITE,,,,
28,NOT_MENTIONED,,,BIOPSY,SURGERY,,,
28,NOT_MENTIONED,,,BIOPSY,,,,
28,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,,,
28,NOT_MENTIONED,,,MTOR,,,,
28,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
28,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,,IMPROVING,
28,NOT_MENTIONED,,,OBSERVATION,,OBSERVATION,IMPROVING,
28,NOT_MENTIONED,,,OBSERVATION,,,IMPROVING,
28,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,,
28,NOT_MENTIONED,,,OTHER SURGERY,,NOT_MENTIONED,,
28,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
28,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
28,NOT_MENTIONED,,,,OBSERVATION,OBSERVATION,IMPROVING,
28,NOT_MENTIONED,,,,OBSERVATION,,IMPROVING,
28,NOT_MENTIONED,,,,,OBSERVATION,IMPROVING,
28,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
28,,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,
28,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
28,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,
28,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
28,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
28,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,
28,,PROGRESSION,SYMPTOM_PRESENT,MEK,,,DECLINING,
28,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,
28,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,,
28,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
28,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
28,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
28,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,
28,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
28,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,
28,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,
28,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,,
28,,PROGRESSION,SYMPTOM_PRESENT,,,SUBTOTAL,,
28,,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,,
28,,PROGRESSION,,MEK,TARGETED_THERAPY,,DECLINING,
28,,PROGRESSION,,MEK,,,DECLINING,
28,,PROGRESSION,,OTHER SURGERY,SURGERY,,,
28,,PROGRESSION,,OTHER SURGERY,,,,
28,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
28,,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
28,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
28,,,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,
28,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
28,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
28,,,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
28,,,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,,
28,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
28,,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,CRANIOTOMY,,,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,
28,,,SYMPTOM_PRESENT,MEK,,,DECLINING,
28,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,
28,,,SYMPTOM_PRESENT,MTOR,,cumulus__none,,
28,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,NOT MENTIONED,,,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,
28,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
28,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
28,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,,
28,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,,
28,,,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,,
28,,,SYMPTOM_PRESENT,SUBTOTAL,,,,
28,,,,MEK,TARGETED_THERAPY,,DECLINING,
28,,,,MEK,,,DECLINING,
28,,,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
28,,,,MTOR,,,NOT_MENTIONED,
28,,,,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,
28,,,,OBSERVATION,OBSERVATION,,DECLINING,
28,,,,OBSERVATION,,OBSERVATION,DECLINING,
28,,,,OBSERVATION,,,DECLINING,
28,,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,,
28,,,,OTHER SURGERY,,NOT_MENTIONED,,
28,,,,,OBSERVATION,OBSERVATION,DECLINING,
28,,,,,OBSERVATION,,DECLINING,
28,,,,,,OBSERVATION,DECLINING,
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,,,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,,,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,,,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,cumulus__none,,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,,,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,OTHER,NOT_MENTIONED,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,,,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,boston_childrens
28,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,SUBTOTAL,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,PROGRESSION,,,,VINBLASTINE,,boston_childrens
28,NOT_MENTIONED,STABLE,,,,,IMPROVING,boston_childrens
28,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,,boston_childrens
28,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,,,,boston_childrens
28,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
28,NOT_MENTIONED,,,ANTIMETABOLITE,,,,boston_childrens
28,NOT_MENTIONED,,,BIOPSY,SURGERY,,,boston_childrens
28,NOT_MENTIONED,,,BIOPSY,,,,boston_childrens
28,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,,,boston_childrens
28,NOT_MENTIONED,,,MTOR,,,,boston_childrens
28,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
28,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
28,NOT_MENTIONED,,,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
28,NOT_MENTIONED,,,OBSERVATION,,,IMPROVING,boston_childrens
28,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,,boston_childrens
28,NOT_MENTIONED,,,OTHER SURGERY,,NOT_MENTIONED,,boston_childrens
28,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
28,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
28,NOT_MENTIONED,,,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
28,NOT_MENTIONED,,,,OBSERVATION,,IMPROVING,boston_childrens
28,NOT_MENTIONED,,,,,OBSERVATION,IMPROVING,boston_childrens
28,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
28,,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
28,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
28,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,boston_childrens
28,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,MEK,,,DECLINING,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,,,SUBTOTAL,,boston_childrens
28,,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,,boston_childrens
28,,PROGRESSION,,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
28,,PROGRESSION,,MEK,,,DECLINING,boston_childrens
28,,PROGRESSION,,OTHER SURGERY,SURGERY,,,boston_childrens
28,,PROGRESSION,,OTHER SURGERY,,,,boston_childrens
28,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
28,,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
28,,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
28,,,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
28,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
28,,,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,,,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
28,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
28,,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
28,,,SYMPTOM_PRESENT,MEK,,,DECLINING,boston_childrens
28,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
28,,,SYMPTOM_PRESENT,MTOR,,cumulus__none,,boston_childrens
28,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
28,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
28,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
28,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,,boston_childrens
28,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,,boston_childrens
28,,,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,,boston_childrens
28,,,SYMPTOM_PRESENT,SUBTOTAL,,,,boston_childrens
28,,,,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
28,,,,MEK,,,DECLINING,boston_childrens
28,,,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
28,,,,MTOR,,,NOT_MENTIONED,boston_childrens
28,,,,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
28,,,,OBSERVATION,OBSERVATION,,DECLINING,boston_childrens
28,,,,OBSERVATION,,OBSERVATION,DECLINING,boston_childrens
28,,,,OBSERVATION,,,DECLINING,boston_childrens
28,,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,,boston_childrens
28,,,,OTHER SURGERY,,NOT_MENTIONED,,boston_childrens
28,,,,,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
28,,,,,OBSERVATION,,DECLINING,boston_childrens
28,,,,,,OBSERVATION,DECLINING,boston_childrens
27,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,
27,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,,
27,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,,
27,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,,,
27,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,
27,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,,,
27,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,,
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,,
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,,
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN,,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,NOT_MENTIONED,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,,,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
27,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
27,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
27,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,,,
27,NOT_MENTIONED,PROGRESSION,,MTOR,,,,
27,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,,
27,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,,
27,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,DECLINING,
27,NOT_MENTIONED,PROGRESSION,,PLATINUM,,,DECLINING,
27,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
27,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
27,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,
27,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,OTHER,,
27,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
27,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
27,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,,
27,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,,,
27,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
27,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,DECLINING,
27,NOT_MENTIONED,,,BIOPSY,SURGERY,,NOT_MENTIONED,
27,NOT_MENTIONED,,,BIOPSY,,,NOT_MENTIONED,
27,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
27,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
27,NOT_MENTIONED,,,,CHEMOTHERAPY,OTHER,DECLINING,
27,NOT_MENTIONED,,,,,OTHER,DECLINING,
27,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
27,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,NOT_MENTIONED,
27,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
27,,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,
27,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,,
27,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,,
27,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,,
27,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,,,
27,,PROGRESSION,,BIOPSY,SURGERY,,,
27,,PROGRESSION,,BIOPSY,,,,
27,,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
27,,PROGRESSION,,MEK,,cumulus__none,DECLINING,
27,,PROGRESSION,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
27,,PROGRESSION,,MTOR,,,NOT_MENTIONED,
27,,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,,
27,,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,,
27,,,NOT_MENTIONED,,,,DECLINING,
27,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,
27,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,
27,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
27,,,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,
27,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,,
27,,,SYMPTOM_PRESENT,OTHER SURGERY,,,,
27,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
27,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
27,,,,ALKYLATING,CHEMOTHERAPY,,DECLINING,
27,,,,ALKYLATING,,,DECLINING,
27,,,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
27,,,,ANTIMETABOLITE,,,NOT_MENTIONED,
27,,,,BIOPSY,SURGERY,,NOT_MENTIONED,
27,,,,BIOPSY,,,NOT_MENTIONED,
27,,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
27,,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
27,,,,CHEMOTHERAPY,,BEVACIZUMAB,,
27,,,,CHEMOTHERAPY,,OTHER,DECLINING,
27,,,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
27,,,,MEK,,cumulus__none,DECLINING,
27,,,,,CHEMOTHERAPY,BEVACIZUMAB,,
27,,,,,,BEVACIZUMAB,,
27,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
27,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,,boston_childrens
27,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,,boston_childrens
27,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,,,boston_childrens
27,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
27,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,,,boston_childrens
27,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
27,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
27,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,,MTOR,,,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,,boston_childrens
27,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,DECLINING,boston_childrens
27,NOT_MENTIONED,PROGRESSION,,PLATINUM,,,DECLINING,boston_childrens
27,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
27,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,OTHER,,boston_childrens
27,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
27,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
27,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,,boston_childrens
27,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,,,boston_childrens
27,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
27,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
27,NOT_MENTIONED,,,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,,,BIOPSY,,,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
27,NOT_MENTIONED,,,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
27,NOT_MENTIONED,,,,,OTHER,DECLINING,boston_childrens
27,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
27,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
27,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
27,,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,boston_childrens
27,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,,boston_childrens
27,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,,boston_childrens
27,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,,boston_childrens
27,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,,,boston_childrens
27,,PROGRESSION,,BIOPSY,SURGERY,,,boston_childrens
27,,PROGRESSION,,BIOPSY,,,,boston_childrens
27,,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
27,,PROGRESSION,,MEK,,cumulus__none,DECLINING,boston_childrens
27,,PROGRESSION,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
27,,PROGRESSION,,MTOR,,,NOT_MENTIONED,boston_childrens
27,,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,,boston_childrens
27,,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,,boston_childrens
27,,,NOT_MENTIONED,,,,DECLINING,boston_childrens
27,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
27,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,boston_childrens
27,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
27,,,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,boston_childrens
27,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,,boston_childrens
27,,,SYMPTOM_PRESENT,OTHER SURGERY,,,,boston_childrens
27,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
27,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
27,,,,ALKYLATING,CHEMOTHERAPY,,DECLINING,boston_childrens
27,,,,ALKYLATING,,,DECLINING,boston_childrens
27,,,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
27,,,,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
27,,,,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
27,,,,BIOPSY,,,NOT_MENTIONED,boston_childrens
27,,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
27,,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
27,,,,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
27,,,,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
27,,,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
27,,,,MEK,,cumulus__none,DECLINING,boston_childrens
27,,,,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
27,,,,,,BEVACIZUMAB,,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,
26,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,,
26,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
26,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,,NOT_MENTIONED,
26,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,
26,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,
26,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,,,
26,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,cumulus__none,,
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,
26,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,cumulus__none,,
26,AVAILABLE_AND_ELIGIBLE,,,BRAF,,cumulus__none,,
26,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
26,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,OTHER,,
26,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,NOT_MENTIONED,
26,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,NOT_MENTIONED,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,DECLINING,
26,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,,,
26,NOT_MENTIONED,PROGRESSION,,BIOPSY,,,,
26,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,,DECLINING,
26,NOT_MENTIONED,PROGRESSION,,BRAF,,,DECLINING,
26,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,,
26,NOT_MENTIONED,PROGRESSION,,MTOR,,cumulus__none,,
26,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
26,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
26,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,
26,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,
26,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,
26,NOT_MENTIONED,,NOT_MENTIONED,MEK,,cumulus__none,,
26,NOT_MENTIONED,,NOT_MENTIONED,MEK,,,,
26,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
26,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
26,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
26,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,,,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,DECLINING,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,,DECLINING,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,,,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,NOT_MENTIONED,
26,NOT_MENTIONED,,SYMPTOM_PRESENT,,,SUBTOTAL,NOT_MENTIONED,
26,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
26,NOT_MENTIONED,,,ANTIMETABOLITE,,,NOT_MENTIONED,
26,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,,DECLINING,
26,NOT_MENTIONED,,,BRAF,,,DECLINING,
26,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,cumulus__none,,
26,NOT_MENTIONED,,,MTOR,,cumulus__none,,
26,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,,NOT_MENTIONED,
26,NOT_MENTIONED,,,OTHER SURGERY,,,NOT_MENTIONED,
26,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,
26,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,,,
26,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
26,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
26,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
26,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,
26,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,,
26,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,,
26,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
26,,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,
26,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
26,,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,,
26,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
26,,PROGRESSION,,PLATINUM,,CARBOPLATIN,DECLINING,
26,,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,,
26,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
26,,PROGRESSION,,,,BEVACIZUMAB,,
26,,PROGRESSION,,,,CARBOPLATIN,DECLINING,
26,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,
26,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,
26,,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,
26,,STABLE,NOT_MENTIONED,OBSERVATION,,,,
26,,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,
26,,STABLE,NOT_MENTIONED,,OBSERVATION,,,
26,,STABLE,NOT_MENTIONED,,,OBSERVATION,,
26,,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
26,,STABLE,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
26,,STABLE,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
26,,STABLE,,OBSERVATION,,,NOT_MENTIONED,
26,,STABLE,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
26,,STABLE,,,OBSERVATION,,NOT_MENTIONED,
26,,STABLE,,,,NOT_MENTIONED,,
26,,STABLE,,,,OBSERVATION,NOT_MENTIONED,
26,,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,
26,,,NOT_MENTIONED,MTOR,,,,
26,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
26,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
26,,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
26,,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,,
26,,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
26,,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,,
26,,,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
26,,,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,,
26,,,NOT_MENTIONED,,,VINBLASTINE,NOT_MENTIONED,
26,,,NOT_MENTIONED,,,VINBLASTINE,,
26,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
26,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,,
26,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
26,,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,
26,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
26,,,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,
26,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,,
26,,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,,
26,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,,
26,,,SYMPTOM_PRESENT,PLATINUM,,OTHER,,
26,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,,
26,,,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,NOT_MENTIONED,
26,,,SYMPTOM_PRESENT,,,BEVACIZUMAB,,
26,,,SYMPTOM_PRESENT,,,SUBTOTAL,NOT_MENTIONED,
26,,,,OTHER SURGERY,SURGERY,,NOT_MENTIONED,
26,,,,OTHER SURGERY,,,NOT_MENTIONED,
26,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
26,,,,PLATINUM,,CARBOPLATIN,DECLINING,
26,,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
26,,,,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,
26,,,,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
26,,,,,,CARBOPLATIN,DECLINING,
26,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,,,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,cumulus__none,,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,,BRAF,,cumulus__none,,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
26,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,OTHER,,boston_childrens
26,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,NOT_MENTIONED,boston_childrens
26,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
26,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
26,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,,,boston_childrens
26,NOT_MENTIONED,PROGRESSION,,BIOPSY,,,,boston_childrens
26,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
26,NOT_MENTIONED,PROGRESSION,,BRAF,,,DECLINING,boston_childrens
26,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
26,NOT_MENTIONED,PROGRESSION,,MTOR,,cumulus__none,,boston_childrens
26,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
26,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
26,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,boston_childrens
26,NOT_MENTIONED,,NOT_MENTIONED,MEK,,cumulus__none,,boston_childrens
26,NOT_MENTIONED,,NOT_MENTIONED,MEK,,,,boston_childrens
26,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
26,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
26,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,,,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,DECLINING,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,,DECLINING,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,,,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,SYMPTOM_PRESENT,,,SUBTOTAL,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
26,NOT_MENTIONED,,,BRAF,,,DECLINING,boston_childrens
26,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
26,NOT_MENTIONED,,,MTOR,,cumulus__none,,boston_childrens
26,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,,NOT_MENTIONED,boston_childrens
26,NOT_MENTIONED,,,OTHER SURGERY,,,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
26,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,,,boston_childrens
26,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
26,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
26,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
26,,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
26,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
26,,PROGRESSION,,PLATINUM,,CARBOPLATIN,DECLINING,boston_childrens
26,,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
26,,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
26,,PROGRESSION,,,,BEVACIZUMAB,,boston_childrens
26,,PROGRESSION,,,,CARBOPLATIN,DECLINING,boston_childrens
26,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
26,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,boston_childrens
26,,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,boston_childrens
26,,STABLE,NOT_MENTIONED,OBSERVATION,,,,boston_childrens
26,,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,boston_childrens
26,,STABLE,NOT_MENTIONED,,OBSERVATION,,,boston_childrens
26,,STABLE,NOT_MENTIONED,,,OBSERVATION,,boston_childrens
26,,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
26,,STABLE,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
26,,STABLE,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
26,,STABLE,,OBSERVATION,,,NOT_MENTIONED,boston_childrens
26,,STABLE,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
26,,STABLE,,,OBSERVATION,,NOT_MENTIONED,boston_childrens
26,,STABLE,,,,NOT_MENTIONED,,boston_childrens
26,,STABLE,,,,OBSERVATION,NOT_MENTIONED,boston_childrens
26,,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,boston_childrens
26,,,NOT_MENTIONED,MTOR,,,,boston_childrens
26,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
26,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
26,,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
26,,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
26,,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
26,,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
26,,,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,,,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,,boston_childrens
26,,,NOT_MENTIONED,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
26,,,NOT_MENTIONED,,,VINBLASTINE,,boston_childrens
26,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
26,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
26,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
26,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
26,,,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,boston_childrens
26,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,,boston_childrens
26,,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,,boston_childrens
26,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
26,,,SYMPTOM_PRESENT,PLATINUM,,OTHER,,boston_childrens
26,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
26,,,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
26,,,SYMPTOM_PRESENT,,,BEVACIZUMAB,,boston_childrens
26,,,SYMPTOM_PRESENT,,,SUBTOTAL,NOT_MENTIONED,boston_childrens
26,,,,OTHER SURGERY,SURGERY,,NOT_MENTIONED,boston_childrens
26,,,,OTHER SURGERY,,,NOT_MENTIONED,boston_childrens
26,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
26,,,,PLATINUM,,CARBOPLATIN,DECLINING,boston_childrens
26,,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
26,,,,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,boston_childrens
26,,,,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
26,,,,,,CARBOPLATIN,DECLINING,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
25,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,
25,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,NOT_MENTIONED,NOT_MENTIONED,
25,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
25,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,
25,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
25,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
25,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,NOT_MENTIONED,,
25,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,,NOT_MENTIONED,
25,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
25,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,NOT_MENTIONED,,
25,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
25,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,CARBOPLATIN,,
25,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,CARBOPLATIN,,
25,AVAILABLE_AND_ELIGIBLE,,,,,CARBOPLATIN,,
25,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,
25,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,
25,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,,
25,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,,,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,DECLINING,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,DECLINING,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,DECLINING,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,SUBTOTAL,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,,
25,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,,BIOPSY,,,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
25,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,,NOT_MENTIONED,
25,NOT_MENTIONED,STABLE,,,,NOT_MENTIONED,,
25,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
25,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,
25,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,
25,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,
25,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,
25,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,,DECLINING,
25,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
25,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,,
25,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
25,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,OTHER,,
25,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,
25,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OTHER,DECLINING,
25,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
25,NOT_MENTIONED,,,CHEMOTHERAPY,,BEVACIZUMAB,,
25,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
25,NOT_MENTIONED,,,MTOR,,,NOT_MENTIONED,
25,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
25,NOT_MENTIONED,,,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,
25,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
25,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
25,NOT_MENTIONED,,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
25,NOT_MENTIONED,,,OTHER TARGETED,,,NOT_MENTIONED,
25,NOT_MENTIONED,,,,CHEMOTHERAPY,BEVACIZUMAB,,
25,NOT_MENTIONED,,,,,BEVACIZUMAB,,
25,,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,
25,,PROGRESSION,NOT_MENTIONED,MTOR,,,,
25,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
25,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
25,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
25,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,,
25,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
25,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,
25,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,,
25,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,,
25,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,
25,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,,
25,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,,
25,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,NOT_MENTIONED,
25,,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,,
25,,PROGRESSION,SYMPTOM_PRESENT,,,SUBTOTAL,NOT_MENTIONED,
25,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,DECLINING,
25,,PROGRESSION,,ALKYLATING,,,DECLINING,
25,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,,
25,,PROGRESSION,,ANTIMETABOLITE,,,,
25,,PROGRESSION,,BIOPSY,SURGERY,,NOT_MENTIONED,
25,,PROGRESSION,,BIOPSY,,,NOT_MENTIONED,
25,,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,
25,,PROGRESSION,,BRAF,,cumulus__none,DECLINING,
25,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
25,,PROGRESSION,,CHEMOTHERAPY,,OTHER,DECLINING,
25,,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
25,,PROGRESSION,,MTOR,,cumulus__none,NOT_MENTIONED,
25,,PROGRESSION,,OTHER SURGERY,SURGERY,,NOT_MENTIONED,
25,,PROGRESSION,,OTHER SURGERY,,,NOT_MENTIONED,
25,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
25,,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
25,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
25,,PROGRESSION,,TOPOISOMERASE,,,NOT_MENTIONED,
25,,PROGRESSION,,,,,IMPROVING,
25,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,
25,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,
25,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,
25,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,,
25,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,
25,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,,
25,,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,,
25,,STABLE,,,,NOT_MENTIONED,NOT_MENTIONED,
25,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
25,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,NOT_MENTIONED,
25,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
25,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,
25,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
25,,,SYMPTOM_PRESENT,TOPOISOMERASE,,,NOT_MENTIONED,
25,,,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,
25,,,,BRAF,,cumulus__none,DECLINING,
25,,,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
25,,,,MTOR,,cumulus__none,NOT_MENTIONED,
25,,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
25,,,,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,
25,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,NOT_MENTIONED,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,NOT_MENTIONED,,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,,NOT_MENTIONED,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,CARBOPLATIN,,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
25,AVAILABLE_AND_ELIGIBLE,,,,,CARBOPLATIN,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,DECLINING,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,DECLINING,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,DECLINING,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,SUBTOTAL,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,,boston_childrens
25,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,,BIOPSY,,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,STABLE,,,,NOT_MENTIONED,,boston_childrens
25,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
25,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,boston_childrens
25,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
25,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,,DECLINING,boston_childrens
25,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
25,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,OTHER,,boston_childrens
25,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
25,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OTHER,DECLINING,boston_childrens
25,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
25,NOT_MENTIONED,,,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
25,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,,MTOR,,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
25,NOT_MENTIONED,,,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
25,NOT_MENTIONED,,,,,BEVACIZUMAB,,boston_childrens
25,,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,boston_childrens
25,,PROGRESSION,NOT_MENTIONED,MTOR,,,,boston_childrens
25,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,,boston_childrens
25,,PROGRESSION,SYMPTOM_PRESENT,,,SUBTOTAL,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,DECLINING,boston_childrens
25,,PROGRESSION,,ALKYLATING,,,DECLINING,boston_childrens
25,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
25,,PROGRESSION,,ANTIMETABOLITE,,,,boston_childrens
25,,PROGRESSION,,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,,BIOPSY,,,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
25,,PROGRESSION,,BRAF,,cumulus__none,DECLINING,boston_childrens
25,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
25,,PROGRESSION,,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
25,,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,,OTHER SURGERY,SURGERY,,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,,OTHER SURGERY,,,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
25,,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
25,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
25,,PROGRESSION,,,,,IMPROVING,boston_childrens
25,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
25,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,boston_childrens
25,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,boston_childrens
25,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,,boston_childrens
25,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,boston_childrens
25,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,,boston_childrens
25,,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,,boston_childrens
25,,STABLE,,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
25,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
25,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
25,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
25,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
25,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
25,,,SYMPTOM_PRESENT,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
25,,,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
25,,,,BRAF,,cumulus__none,DECLINING,boston_childrens
25,,,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
25,,,,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
25,,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
25,,,,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,cumulus__none,,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,cumulus__none,,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,OTHER,,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,
24,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,,,,
24,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,,,BRAF,,,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,,,MEK,,cumulus__none,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,,,MEK,,,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
24,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,,,
24,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,
24,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,,
24,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
24,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,,
24,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,,,
24,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
24,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,,
24,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,,MTOR,,,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,
24,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,,
24,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,OTHER,DECLINING,
24,NOT_MENTIONED,PROGRESSION,,,,BEVACIZUMAB,,
24,NOT_MENTIONED,PROGRESSION,,,,OTHER,DECLINING,
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,,
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,,
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,,
24,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
24,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
24,NOT_MENTIONED,STABLE,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
24,NOT_MENTIONED,STABLE,,OBSERVATION,,,NOT_MENTIONED,
24,NOT_MENTIONED,STABLE,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
24,NOT_MENTIONED,STABLE,,,OBSERVATION,,NOT_MENTIONED,
24,NOT_MENTIONED,STABLE,,,,NOT_MENTIONED,NOT_MENTIONED,
24,NOT_MENTIONED,STABLE,,,,OBSERVATION,NOT_MENTIONED,
24,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
24,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,cumulus__none,,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,NOT_MENTIONED,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,,NOT_MENTIONED,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,NOT_MENTIONED,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,,,NOT_MENTIONED,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,,
24,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BEVACIZUMAB,,
24,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
24,NOT_MENTIONED,,,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
24,NOT_MENTIONED,,,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
24,NOT_MENTIONED,,,,,BEVACIZUMAB,NOT_MENTIONED,
24,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
24,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,
24,,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,
24,,PROGRESSION,NOT_MENTIONED,MTOR,,cumulus__none,,
24,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
24,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
24,,PROGRESSION,NOT_MENTIONED,,SURGERY,,NOT_MENTIONED,
24,,PROGRESSION,NOT_MENTIONED,,SURGERY,,,
24,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,,
24,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,,
24,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,
24,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,DECLINING,
24,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
24,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,
24,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
24,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,
24,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
24,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,DECLINING,
24,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
24,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,DECLINING,
24,,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,,
24,,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,,
24,,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,
24,,PROGRESSION,,OBSERVATION,OBSERVATION,,DECLINING,
24,,PROGRESSION,,OBSERVATION,,OBSERVATION,DECLINING,
24,,PROGRESSION,,OBSERVATION,,,DECLINING,
24,,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
24,,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,
24,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
24,,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
24,,PROGRESSION,,,OBSERVATION,OBSERVATION,DECLINING,
24,,PROGRESSION,,,OBSERVATION,,DECLINING,
24,,PROGRESSION,,,SURGERY,BIOPSY_ONLY,,
24,,PROGRESSION,,,,BIOPSY_ONLY,,
24,,PROGRESSION,,,,OBSERVATION,DECLINING,
24,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
24,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,,
24,,STABLE,,CHEMOTHERAPY,,,NOT_MENTIONED,
24,,STABLE,,CHEMOTHERAPY,,,,
24,,STABLE,,,CHEMOTHERAPY,,NOT_MENTIONED,
24,,STABLE,,,CHEMOTHERAPY,,,
24,,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,
24,,,NOT_MENTIONED,MTOR,,cumulus__none,,
24,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,DECLINING,
24,,,SYMPTOM_PRESENT,ALKYLATING,,,DECLINING,
24,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,,
24,,,SYMPTOM_PRESENT,BIOPSY,,,,
24,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,
24,,,SYMPTOM_PRESENT,BRAF,,cumulus__none,DECLINING,
24,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
24,,,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,
24,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,
24,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,DECLINING,
24,,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,DECLINING,
24,,,SYMPTOM_PRESENT,OBSERVATION,,,DECLINING,
24,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,NOT_MENTIONED,
24,,,SYMPTOM_PRESENT,OTHER SURGERY,,,NOT_MENTIONED,
24,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
24,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,DECLINING,
24,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,
24,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,NOT_MENTIONED,
24,,,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,
24,,,SYMPTOM_PRESENT,SUBTOTAL,,,NOT_MENTIONED,
24,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
24,,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,
24,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
24,,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,DECLINING,
24,,,SYMPTOM_PRESENT,,OBSERVATION,,DECLINING,
24,,,SYMPTOM_PRESENT,,,CARBOPLATIN,DECLINING,
24,,,SYMPTOM_PRESENT,,,OBSERVATION,DECLINING,
24,,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
24,,,,ALKYLATING,,NOT_MENTIONED,DECLINING,
24,,,,BIOPSY,SURGERY,BIOPSY_ONLY,,
24,,,,BIOPSY,,BIOPSY_ONLY,,
24,,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
24,,,,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
24,,,,MAPK,TARGETED_THERAPY,,,
24,,,,MAPK,,,,
24,,,,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
24,,,,,SURGERY,BIOPSY_ONLY,,
24,,,,,,BEVACIZUMAB,NOT_MENTIONED,
24,,,,,,BIOPSY_ONLY,,
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,cumulus__none,,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,cumulus__none,,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,OTHER,,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,,,,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,,BRAF,,,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,,MEK,,,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
24,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,MTOR,,,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,,,BEVACIZUMAB,,boston_childrens
24,NOT_MENTIONED,PROGRESSION,,,,OTHER,DECLINING,boston_childrens
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,boston_childrens
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,boston_childrens
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,,boston_childrens
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,boston_childrens
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,,boston_childrens
24,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,,boston_childrens
24,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,STABLE,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,STABLE,,OBSERVATION,,,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,STABLE,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,STABLE,,,OBSERVATION,,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,STABLE,,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,STABLE,,,,OBSERVATION,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,cumulus__none,,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,SUBTOTAL,,,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
24,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BEVACIZUMAB,,boston_childrens
24,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
24,NOT_MENTIONED,,,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
24,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
24,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,boston_childrens
24,,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
24,,PROGRESSION,NOT_MENTIONED,MTOR,,cumulus__none,,boston_childrens
24,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
24,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
24,,PROGRESSION,NOT_MENTIONED,,SURGERY,,NOT_MENTIONED,boston_childrens
24,,PROGRESSION,NOT_MENTIONED,,SURGERY,,,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,DECLINING,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,DECLINING,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
24,,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,DECLINING,boston_childrens
24,,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
24,,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,,boston_childrens
24,,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
24,,PROGRESSION,,OBSERVATION,OBSERVATION,,DECLINING,boston_childrens
24,,PROGRESSION,,OBSERVATION,,OBSERVATION,DECLINING,boston_childrens
24,,PROGRESSION,,OBSERVATION,,,DECLINING,boston_childrens
24,,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
24,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
24,,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
24,,PROGRESSION,,,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
24,,PROGRESSION,,,OBSERVATION,,DECLINING,boston_childrens
24,,PROGRESSION,,,SURGERY,BIOPSY_ONLY,,boston_childrens
24,,PROGRESSION,,,,BIOPSY_ONLY,,boston_childrens
24,,PROGRESSION,,,,OBSERVATION,DECLINING,boston_childrens
24,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
24,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
24,,STABLE,,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
24,,STABLE,,CHEMOTHERAPY,,,,boston_childrens
24,,STABLE,,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
24,,STABLE,,,CHEMOTHERAPY,,,boston_childrens
24,,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
24,,,NOT_MENTIONED,MTOR,,cumulus__none,,boston_childrens
24,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,ALKYLATING,,,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,,boston_childrens
24,,,SYMPTOM_PRESENT,BIOPSY,,,,boston_childrens
24,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,BRAF,,cumulus__none,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
24,,,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
24,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,OBSERVATION,,,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,NOT_MENTIONED,boston_childrens
24,,,SYMPTOM_PRESENT,OTHER SURGERY,,,NOT_MENTIONED,boston_childrens
24,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
24,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
24,,,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,boston_childrens
24,,,SYMPTOM_PRESENT,SUBTOTAL,,,NOT_MENTIONED,boston_childrens
24,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,,OBSERVATION,,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,,,CARBOPLATIN,DECLINING,boston_childrens
24,,,SYMPTOM_PRESENT,,,OBSERVATION,DECLINING,boston_childrens
24,,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
24,,,,ALKYLATING,,NOT_MENTIONED,DECLINING,boston_childrens
24,,,,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
24,,,,BIOPSY,,BIOPSY_ONLY,,boston_childrens
24,,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
24,,,,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
24,,,,MAPK,TARGETED_THERAPY,,,boston_childrens
24,,,,MAPK,,,,boston_childrens
24,,,,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
24,,,,,SURGERY,BIOPSY_ONLY,,boston_childrens
24,,,,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
24,,,,,,BIOPSY_ONLY,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,,,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,cumulus__none,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,cumulus__none,,
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,,,
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,OTHER,,
23,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,OTHER,,
23,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
23,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,
23,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,,,
23,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,,
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,DECLINING,
23,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,,
23,NOT_MENTIONED,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,,
23,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
23,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
23,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,,,SURGERY,BIOPSY_ONLY,,
23,NOT_MENTIONED,PROGRESSION,,,,BEVACIZUMAB,NOT_MENTIONED,
23,NOT_MENTIONED,PROGRESSION,,,,BIOPSY_ONLY,,
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,,,
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,,,
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,OBSERVATION,,
23,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
23,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,,
23,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,,NOT_MENTIONED,
23,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,,,
23,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,,NOT_MENTIONED,
23,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,,,
23,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
23,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
23,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
23,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,,
23,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
23,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
23,NOT_MENTIONED,,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,
23,NOT_MENTIONED,,NOT_MENTIONED,MEK,,,NOT_MENTIONED,
23,NOT_MENTIONED,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,
23,NOT_MENTIONED,,NOT_MENTIONED,MTOR,,,,
23,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
23,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,,
23,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,,
23,NOT_MENTIONED,,NOT_MENTIONED,,,VINBLASTINE,,
23,NOT_MENTIONED,,NOT_MENTIONED,,,,DECLINING,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,,,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
23,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BEVACIZUMAB,NOT_MENTIONED,
23,NOT_MENTIONED,,,BIOPSY,SURGERY,BIOPSY_ONLY,,
23,NOT_MENTIONED,,,BIOPSY,,BIOPSY_ONLY,,
23,NOT_MENTIONED,,,DEBULKING,SURGERY,,,
23,NOT_MENTIONED,,,DEBULKING,,,,
23,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,
23,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,,DECLINING,
23,NOT_MENTIONED,,,OBSERVATION,,OBSERVATION,DECLINING,
23,NOT_MENTIONED,,,OBSERVATION,,,DECLINING,
23,NOT_MENTIONED,,,,OBSERVATION,OBSERVATION,DECLINING,
23,NOT_MENTIONED,,,,OBSERVATION,,DECLINING,
23,NOT_MENTIONED,,,,SURGERY,BIOPSY_ONLY,,
23,NOT_MENTIONED,,,,,BIOPSY_ONLY,,
23,NOT_MENTIONED,,,,,OBSERVATION,DECLINING,
23,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
23,,PROGRESSION,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,
23,,PROGRESSION,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
23,,PROGRESSION,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,,
23,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,DECLINING,
23,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,DECLINING,
23,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,
23,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,
23,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,NOT_MENTIONED,
23,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,NOT_MENTIONED,
23,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
23,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
23,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,
23,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,NOT_MENTIONED,
23,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,
23,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,,NOT_MENTIONED,
23,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
23,,PROGRESSION,,ANTIMETABOLITE,,,NOT_MENTIONED,
23,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
23,,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
23,,PROGRESSION,,MAPK,TARGETED_THERAPY,,,
23,,PROGRESSION,,MAPK,,,,
23,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,
23,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,
23,,PROGRESSION,,OTHER TARGETED,,cumulus__none,DECLINING,
23,,PROGRESSION,,OTHER TARGETED,,,DECLINING,
23,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
23,,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,
23,,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
23,,PROGRESSION,,,,BEVACIZUMAB,NOT_MENTIONED,
23,,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
23,,,NOT_MENTIONED,MTOR,,,NOT_MENTIONED,
23,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
23,,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
23,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
23,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
23,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
23,,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,
23,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
23,,,SYMPTOM_PRESENT,,,BEVACIZUMAB,NOT_MENTIONED,
23,,,,DEBULKING,SURGERY,,,
23,,,,DEBULKING,,,,
23,,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,
23,,,,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,
23,,,,OTHER TARGETED,,cumulus__none,DECLINING,
23,,,,OTHER TARGETED,,,DECLINING,
23,,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
23,,,,PLATINUM,,NOT_MENTIONED,DECLINING,
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,cumulus__none,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,OTHER,,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
23,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,DECLINING,boston_childrens
23,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,,,SURGERY,BIOPSY_ONLY,,boston_childrens
23,NOT_MENTIONED,PROGRESSION,,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,PROGRESSION,,,,BIOPSY_ONLY,,boston_childrens
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,boston_childrens
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,boston_childrens
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,,,boston_childrens
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,boston_childrens
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,,,boston_childrens
23,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,OBSERVATION,,boston_childrens
23,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
23,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,,,boston_childrens
23,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,,,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,MEK,,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,MTOR,,,,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,,,VINBLASTINE,,boston_childrens
23,NOT_MENTIONED,,NOT_MENTIONED,,,,DECLINING,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,,,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,NOT_MENTIONED,,,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
23,NOT_MENTIONED,,,BIOPSY,,BIOPSY_ONLY,,boston_childrens
23,NOT_MENTIONED,,,DEBULKING,SURGERY,,,boston_childrens
23,NOT_MENTIONED,,,DEBULKING,,,,boston_childrens
23,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
23,NOT_MENTIONED,,,OBSERVATION,OBSERVATION,,DECLINING,boston_childrens
23,NOT_MENTIONED,,,OBSERVATION,,OBSERVATION,DECLINING,boston_childrens
23,NOT_MENTIONED,,,OBSERVATION,,,DECLINING,boston_childrens
23,NOT_MENTIONED,,,,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
23,NOT_MENTIONED,,,,OBSERVATION,,DECLINING,boston_childrens
23,NOT_MENTIONED,,,,SURGERY,BIOPSY_ONLY,,boston_childrens
23,NOT_MENTIONED,,,,,BIOPSY_ONLY,,boston_childrens
23,NOT_MENTIONED,,,,,OBSERVATION,DECLINING,boston_childrens
23,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
23,,PROGRESSION,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,boston_childrens
23,,PROGRESSION,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,NOT_MENTIONED,,SURGERY,NOT_MENTIONED,,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,DECLINING,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,DECLINING,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,,MAPK,TARGETED_THERAPY,,,boston_childrens
23,,PROGRESSION,,MAPK,,,,boston_childrens
23,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
23,,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,boston_childrens
23,,PROGRESSION,,OTHER TARGETED,,cumulus__none,DECLINING,boston_childrens
23,,PROGRESSION,,OTHER TARGETED,,,DECLINING,boston_childrens
23,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
23,,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,boston_childrens
23,,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,,PROGRESSION,,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
23,,,NOT_MENTIONED,MTOR,,,NOT_MENTIONED,boston_childrens
23,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
23,,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
23,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
23,,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
23,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,,,SYMPTOM_PRESENT,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
23,,,,DEBULKING,SURGERY,,,boston_childrens
23,,,,DEBULKING,,,,boston_childrens
23,,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
23,,,,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,boston_childrens
23,,,,OTHER TARGETED,,cumulus__none,DECLINING,boston_childrens
23,,,,OTHER TARGETED,,,DECLINING,boston_childrens
23,,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
23,,,,PLATINUM,,NOT_MENTIONED,DECLINING,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
22,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,
22,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
22,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,,NOT_MENTIONED,
22,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
22,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
22,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,
22,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,
22,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
22,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,
22,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
22,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,
22,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
22,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,,,,
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,
22,NOT_MENTIONED,PROGRESSION,,BRAF,,cumulus__none,DECLINING,
22,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,,,
22,NOT_MENTIONED,PROGRESSION,,DEBULKING,,,,
22,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,,MTOR,,cumulus__none,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
22,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN,DECLINING,
22,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
22,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
22,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN,DECLINING,
22,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
22,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
22,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
22,NOT_MENTIONED,,NOT_MENTIONED,,,VINBLASTINE,NOT_MENTIONED,
22,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
22,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
22,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
22,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,
22,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,
22,NOT_MENTIONED,,,ANTIMETABOLITE,,OTHER,,
22,NOT_MENTIONED,,,BIOPSY,SURGERY,NOT_MENTIONED,,
22,NOT_MENTIONED,,,BIOPSY,,NOT_MENTIONED,,
22,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,
22,NOT_MENTIONED,,,BRAF,,cumulus__none,DECLINING,
22,NOT_MENTIONED,,,DEBULKING,SURGERY,,NOT_MENTIONED,
22,NOT_MENTIONED,,,DEBULKING,,,NOT_MENTIONED,
22,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,,,
22,NOT_MENTIONED,,,MAPK,,,,
22,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
22,NOT_MENTIONED,,,MTOR,,cumulus__none,NOT_MENTIONED,
22,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
22,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN,DECLINING,
22,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
22,NOT_MENTIONED,,,,,CARBOPLATIN,DECLINING,
22,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
22,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,
22,,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
22,,PROGRESSION,NOT_MENTIONED,MTOR,,,NOT_MENTIONED,
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,,
22,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
22,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,,
22,,PROGRESSION,NOT_MENTIONED,,,VINBLASTINE,NOT_MENTIONED,
22,,PROGRESSION,NOT_MENTIONED,,,VINBLASTINE,,
22,,PROGRESSION,NOT_MENTIONED,,,,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
22,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
22,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
22,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
22,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
22,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,NOT_MENTIONED,
22,,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,DECLINING,
22,,PROGRESSION,SYMPTOM_PRESENT,,,,IMPROVING,
22,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
22,,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,DECLINING,
22,,PROGRESSION,,DEBULKING,SURGERY,,,
22,,PROGRESSION,,DEBULKING,,,,
22,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
22,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,,
22,,STABLE,,VINCA ALKALOID,,,NOT_MENTIONED,
22,,STABLE,,VINCA ALKALOID,,,,
22,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
22,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,,
22,,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
22,,,NOT_MENTIONED,PLATINUM,,OTHER,,
22,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,
22,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,
22,,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,DECLINING,
22,,,SYMPTOM_PRESENT,OTHER TARGETED,,,DECLINING,
22,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
22,,,SYMPTOM_PRESENT,PLATINUM,,OTHER,NOT_MENTIONED,
22,,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
22,,,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,
22,,,,ANTIMETABOLITE,,NOT_MENTIONED,,
22,,,,ANTIMETABOLITE,,OTHER,,
22,,,,BIOPSY,SURGERY,NOT_MENTIONED,,
22,,,,BIOPSY,,NOT_MENTIONED,,
22,,,,DEBULKING,SURGERY,,NOT_MENTIONED,
22,,,,DEBULKING,,,NOT_MENTIONED,
22,,,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
22,,,,MAPK,,,NOT_MENTIONED,
22,,,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,
22,,,,TOPOISOMERASE,,OTHER,,
22,,,,TRAMETINIB,TARGETED_THERAPY,,,
22,,,,TRAMETINIB,,,,
22,,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
22,,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,
22,,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,
22,,,,VINCA ALKALOID,,OTHER,DECLINING,
22,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,,NOT_MENTIONED,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
22,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,boston_childrens
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,,,,boston_childrens
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
22,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,BRAF,,cumulus__none,DECLINING,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,,,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,DEBULKING,,,,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN,DECLINING,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
22,NOT_MENTIONED,PROGRESSION,,,,CARBOPLATIN,DECLINING,boston_childrens
22,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,NOT_MENTIONED,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,boston_childrens
22,NOT_MENTIONED,,,ANTIMETABOLITE,,OTHER,,boston_childrens
22,NOT_MENTIONED,,,BIOPSY,SURGERY,NOT_MENTIONED,,boston_childrens
22,NOT_MENTIONED,,,BIOPSY,,NOT_MENTIONED,,boston_childrens
22,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
22,NOT_MENTIONED,,,BRAF,,cumulus__none,DECLINING,boston_childrens
22,NOT_MENTIONED,,,DEBULKING,SURGERY,,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,,DEBULKING,,,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,,,boston_childrens
22,NOT_MENTIONED,,,MAPK,,,,boston_childrens
22,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
22,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
22,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN,DECLINING,boston_childrens
22,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
22,NOT_MENTIONED,,,,,CARBOPLATIN,DECLINING,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,MTOR,,,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,,,VINBLASTINE,,boston_childrens
22,,PROGRESSION,NOT_MENTIONED,,,,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,DECLINING,boston_childrens
22,,PROGRESSION,SYMPTOM_PRESENT,,,,IMPROVING,boston_childrens
22,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
22,,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,DECLINING,boston_childrens
22,,PROGRESSION,,DEBULKING,SURGERY,,,boston_childrens
22,,PROGRESSION,,DEBULKING,,,,boston_childrens
22,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
22,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
22,,STABLE,,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
22,,STABLE,,VINCA ALKALOID,,,,boston_childrens
22,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
22,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
22,,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
22,,,NOT_MENTIONED,PLATINUM,,OTHER,,boston_childrens
22,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
22,,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,boston_childrens
22,,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,DECLINING,boston_childrens
22,,,SYMPTOM_PRESENT,OTHER TARGETED,,,DECLINING,boston_childrens
22,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
22,,,SYMPTOM_PRESENT,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
22,,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
22,,,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,boston_childrens
22,,,,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
22,,,,ANTIMETABOLITE,,OTHER,,boston_childrens
22,,,,BIOPSY,SURGERY,NOT_MENTIONED,,boston_childrens
22,,,,BIOPSY,,NOT_MENTIONED,,boston_childrens
22,,,,DEBULKING,SURGERY,,NOT_MENTIONED,boston_childrens
22,,,,DEBULKING,,,NOT_MENTIONED,boston_childrens
22,,,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
22,,,,MAPK,,,NOT_MENTIONED,boston_childrens
22,,,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,boston_childrens
22,,,,TOPOISOMERASE,,OTHER,,boston_childrens
22,,,,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
22,,,,TRAMETINIB,,,,boston_childrens
22,,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
22,,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
22,,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
22,,,,VINCA ALKALOID,,OTHER,DECLINING,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,,
21,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
21,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,,
21,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,,cumulus__none,,
21,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,,,,
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,cumulus__none,,
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,,,
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,,,
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,
21,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,
21,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,,,
21,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,
21,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,,cumulus__none,,
21,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
21,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
21,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
21,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
21,AVAILABLE_AND_ELIGIBLE,,,BRAF,,cumulus__none,NOT_MENTIONED,
21,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
21,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,TARGETED_THERAPY,,,
21,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,,cumulus__none,,
21,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,,,,
21,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
21,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,NOT_MENTIONED,,
21,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,,,
21,AVAILABLE_NOT_ELIGIBLE,,,,TARGETED_THERAPY,,,
21,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,DECLINING,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,,DECLINING,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
21,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,,DEBULKING,,,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,,,
21,NOT_MENTIONED,PROGRESSION,,MAPK,,,,
21,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,,DECLINING,
21,NOT_MENTIONED,PROGRESSION,,MEK,,,DECLINING,
21,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,OTHER,,
21,NOT_MENTIONED,PROGRESSION,,PLATINUM,,OTHER,,
21,NOT_MENTIONED,PROGRESSION,,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
21,NOT_MENTIONED,PROGRESSION,,,,BIOPSY_ONLY,NOT_MENTIONED,
21,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
21,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,,
21,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,,NOT_MENTIONED,
21,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,,,
21,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
21,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
21,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,
21,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,cumulus__none,DECLINING,
21,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,,
21,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,,,
21,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,
21,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,,DECLINING,
21,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
21,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,
21,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
21,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,OTHER,NOT_MENTIONED,
21,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,,DECLINING,
21,NOT_MENTIONED,,,ALKYLATING,,,DECLINING,
21,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
21,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
21,NOT_MENTIONED,,,ANTIMETABOLITE,,NOT_MENTIONED,,
21,NOT_MENTIONED,,,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,
21,NOT_MENTIONED,,,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
21,NOT_MENTIONED,,,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
21,NOT_MENTIONED,,,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
21,NOT_MENTIONED,,,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,
21,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,,DECLINING,
21,NOT_MENTIONED,,,MEK,,,DECLINING,
21,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,
21,NOT_MENTIONED,,,TOPOISOMERASE,,OTHER,,
21,NOT_MENTIONED,,,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
21,NOT_MENTIONED,,,,SURGERY,GROSS_TOTAL,,
21,NOT_MENTIONED,,,,,BIOPSY_ONLY,NOT_MENTIONED,
21,NOT_MENTIONED,,,,,GROSS_TOTAL,,
21,,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
21,,PROGRESSION,NOT_MENTIONED,MTOR,,cumulus__none,NOT_MENTIONED,
21,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
21,,PROGRESSION,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
21,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
21,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,NOT_MENTIONED,
21,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,,
21,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,,
21,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,,
21,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,,
21,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
21,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,NOT_MENTIONED,
21,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,,
21,,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,,
21,,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
21,,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
21,,PROGRESSION,,DEBULKING,SURGERY,,NOT_MENTIONED,
21,,PROGRESSION,,DEBULKING,,,NOT_MENTIONED,
21,,PROGRESSION,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
21,,PROGRESSION,,MAPK,,,NOT_MENTIONED,
21,,PROGRESSION,,MTOR,TARGETED_THERAPY,,DECLINING,
21,,PROGRESSION,,MTOR,,,DECLINING,
21,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
21,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,OTHER,,
21,,PROGRESSION,,PLATINUM,,NOT_MENTIONED,DECLINING,
21,,PROGRESSION,,PLATINUM,,OTHER,,
21,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,,
21,,PROGRESSION,,TRAMETINIB,,,,
21,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
21,,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,
21,,PROGRESSION,,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
21,,PROGRESSION,,,,BIOPSY_ONLY,NOT_MENTIONED,
21,,STABLE,NOT_MENTIONED,,,,IMPROVING,
21,,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
21,,STABLE,,OBSERVATION,OBSERVATION,,IMPROVING,
21,,STABLE,,OBSERVATION,,OBSERVATION,IMPROVING,
21,,STABLE,,OBSERVATION,,,IMPROVING,
21,,STABLE,,,CHEMOTHERAPY,NOT_MENTIONED,,
21,,STABLE,,,OBSERVATION,OBSERVATION,IMPROVING,
21,,STABLE,,,OBSERVATION,,IMPROVING,
21,,STABLE,,,,OBSERVATION,IMPROVING,
21,,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
21,,,NOT_MENTIONED,MTOR,,cumulus__none,NOT_MENTIONED,
21,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
21,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,IMPROVING,
21,,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,IMPROVING,
21,,,NOT_MENTIONED,OBSERVATION,,,IMPROVING,
21,,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,IMPROVING,
21,,,NOT_MENTIONED,,OBSERVATION,,IMPROVING,
21,,,NOT_MENTIONED,,,OBSERVATION,IMPROVING,
21,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
21,,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,DECLINING,
21,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,,
21,,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,,
21,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,,
21,,,SYMPTOM_PRESENT,DEBULKING,,,,
21,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,
21,,,SYMPTOM_PRESENT,MAPK,,,,
21,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
21,,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,DECLINING,
21,,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,,
21,,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,,
21,,,,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,
21,,,,ALKYLATING,,OTHER,DECLINING,
21,,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
21,,,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
21,,,,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,
21,,,,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,
21,,,,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
21,,,,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
21,,,,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
21,,,,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,
21,,,,MTOR,TARGETED_THERAPY,,DECLINING,
21,,,,MTOR,,,DECLINING,
21,,,,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
21,,,,,SURGERY,GROSS_TOTAL,,
21,,,,,,BIOPSY_ONLY,NOT_MENTIONED,
21,,,,,,GROSS_TOTAL,,
21,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,,cumulus__none,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,cumulus__none,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,,cumulus__none,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,,cumulus__none,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,,,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
21,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,NOT_MENTIONED,,boston_childrens
21,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,,,boston_childrens
21,AVAILABLE_NOT_ELIGIBLE,,,,TARGETED_THERAPY,,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,DECLINING,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,,DECLINING,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,DEBULKING,,,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,MAPK,,,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,MEK,,,DECLINING,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,PLATINUM,,OTHER,,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,PROGRESSION,,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
21,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,,,boston_childrens
21,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
21,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
21,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
21,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,cumulus__none,DECLINING,boston_childrens
21,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,,boston_childrens
21,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,,,boston_childrens
21,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
21,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,,DECLINING,boston_childrens
21,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,,DECLINING,boston_childrens
21,NOT_MENTIONED,,,ALKYLATING,,,DECLINING,boston_childrens
21,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
21,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
21,NOT_MENTIONED,,,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
21,NOT_MENTIONED,,,MEK,,,DECLINING,boston_childrens
21,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,boston_childrens
21,NOT_MENTIONED,,,TOPOISOMERASE,,OTHER,,boston_childrens
21,NOT_MENTIONED,,,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,,,SURGERY,GROSS_TOTAL,,boston_childrens
21,NOT_MENTIONED,,,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,NOT_MENTIONED,,,,,GROSS_TOTAL,,boston_childrens
21,,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,NOT_MENTIONED,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
21,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,,boston_childrens
21,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,,boston_childrens
21,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,,boston_childrens
21,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,,boston_childrens
21,,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,,boston_childrens
21,,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,,DEBULKING,SURGERY,,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,,DEBULKING,,,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,,MAPK,,,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,,MTOR,TARGETED_THERAPY,,DECLINING,boston_childrens
21,,PROGRESSION,,MTOR,,,DECLINING,boston_childrens
21,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
21,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
21,,PROGRESSION,,PLATINUM,,NOT_MENTIONED,DECLINING,boston_childrens
21,,PROGRESSION,,PLATINUM,,OTHER,,boston_childrens
21,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
21,,PROGRESSION,,TRAMETINIB,,,,boston_childrens
21,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
21,,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
21,,PROGRESSION,,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,,PROGRESSION,,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,,STABLE,NOT_MENTIONED,,,,IMPROVING,boston_childrens
21,,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
21,,STABLE,,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
21,,STABLE,,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
21,,STABLE,,OBSERVATION,,,IMPROVING,boston_childrens
21,,STABLE,,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
21,,STABLE,,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
21,,STABLE,,,OBSERVATION,,IMPROVING,boston_childrens
21,,STABLE,,,,OBSERVATION,IMPROVING,boston_childrens
21,,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
21,,,NOT_MENTIONED,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
21,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
21,,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
21,,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
21,,,NOT_MENTIONED,OBSERVATION,,,IMPROVING,boston_childrens
21,,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
21,,,NOT_MENTIONED,,OBSERVATION,,IMPROVING,boston_childrens
21,,,NOT_MENTIONED,,,OBSERVATION,IMPROVING,boston_childrens
21,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
21,,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,DECLINING,boston_childrens
21,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
21,,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,,boston_childrens
21,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,,boston_childrens
21,,,SYMPTOM_PRESENT,DEBULKING,,,,boston_childrens
21,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,boston_childrens
21,,,SYMPTOM_PRESENT,MAPK,,,,boston_childrens
21,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
21,,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,DECLINING,boston_childrens
21,,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,,boston_childrens
21,,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,,boston_childrens
21,,,,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
21,,,,ALKYLATING,,OTHER,DECLINING,boston_childrens
21,,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,,,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
21,,,,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,,,,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,boston_childrens
21,,,,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,,,,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,,,,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,,,,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
21,,,,MTOR,TARGETED_THERAPY,,DECLINING,boston_childrens
21,,,,MTOR,,,DECLINING,boston_childrens
21,,,,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,,,,,SURGERY,GROSS_TOTAL,,boston_childrens
21,,,,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
21,,,,,,GROSS_TOTAL,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,,,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,CARBOPLATIN,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,CARBOPLATIN,,
20,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
20,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,,,,
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,OTHER,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
20,AVAILABLE_AND_ELIGIBLE,,,,,,IMPROVING,
20,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,
20,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,,cumulus__none,,
20,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
20,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,NOT_MENTIONED,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,NOT_MENTIONED,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,DECLINING,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,,
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,DECLINING,
20,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,NOT_MENTIONED,,
20,NOT_MENTIONED,PROGRESSION,,BIOPSY,,NOT_MENTIONED,,
20,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
20,NOT_MENTIONED,PROGRESSION,,MEK,,cumulus__none,DECLINING,
20,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,
20,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,
20,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,cumulus__none,DECLINING,
20,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,,DECLINING,
20,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,NOT_MENTIONED,,
20,NOT_MENTIONED,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,
20,NOT_MENTIONED,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
20,NOT_MENTIONED,,NOT_MENTIONED,MTOR,,cumulus__none,,
20,NOT_MENTIONED,,NOT_MENTIONED,MTOR,,,NOT_MENTIONED,
20,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
20,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,NOT_MENTIONED,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,,NOT_MENTIONED,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,,,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,DECLINING,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,,
20,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN,DECLINING,
20,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
20,NOT_MENTIONED,,,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,
20,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
20,NOT_MENTIONED,,,CHEMOTHERAPY,,OTHER,DECLINING,
20,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
20,NOT_MENTIONED,,,MEK,,cumulus__none,DECLINING,
20,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,
20,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,
20,NOT_MENTIONED,,,OTHER TARGETED,,cumulus__none,DECLINING,
20,NOT_MENTIONED,,,OTHER TARGETED,,,DECLINING,
20,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,,,
20,NOT_MENTIONED,,,TRAMETINIB,,,,
20,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
20,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
20,NOT_MENTIONED,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,
20,NOT_MENTIONED,,,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,
20,NOT_MENTIONED,,,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
20,NOT_MENTIONED,,,,,GROSS_TOTAL,NOT_MENTIONED,
20,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
20,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
20,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
20,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,DECLINING,
20,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,NOT_MENTIONED,
20,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,NOT_MENTIONED,
20,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,
20,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,,
20,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,DECLINING,
20,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,DECLINING,
20,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
20,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,DECLINING,
20,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
20,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,
20,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,DECLINING,
20,,PROGRESSION,,BIOPSY,SURGERY,NOT_MENTIONED,,
20,,PROGRESSION,,BIOPSY,,NOT_MENTIONED,,
20,,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,
20,,PROGRESSION,,MTOR,,cumulus__none,DECLINING,
20,,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
20,,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,
20,,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,
20,,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,,,
20,,PROGRESSION,,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,
20,,PROGRESSION,,RADIOTHERAPY,,RADIOTHERAPY,,
20,,PROGRESSION,,RADIOTHERAPY,,,NOT_MENTIONED,
20,,PROGRESSION,,RADIOTHERAPY,,,,
20,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,
20,,PROGRESSION,,VINCA ALKALOID,,OTHER,DECLINING,
20,,PROGRESSION,,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
20,,PROGRESSION,,,RADIOTHERAPY,RADIOTHERAPY,,
20,,PROGRESSION,,,RADIOTHERAPY,,NOT_MENTIONED,
20,,PROGRESSION,,,RADIOTHERAPY,,,
20,,PROGRESSION,,,SURGERY,,DECLINING,
20,,PROGRESSION,,,,RADIOTHERAPY,NOT_MENTIONED,
20,,PROGRESSION,,,,RADIOTHERAPY,,
20,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
20,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
20,,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
20,,STABLE,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,
20,,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
20,,STABLE,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,
20,,STABLE,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,
20,,STABLE,NOT_MENTIONED,,,NOT_MENTIONED,,
20,,STABLE,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,
20,,STABLE,SYMPTOM_PRESENT,,,,IMPROVING,
20,,STABLE,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
20,,STABLE,,PLATINUM,CHEMOTHERAPY,,,
20,,STABLE,,PLATINUM,,,NOT_MENTIONED,
20,,STABLE,,PLATINUM,,,,
20,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
20,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
20,,STABLE,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
20,,STABLE,,VINCA ALKALOID,,NOT_MENTIONED,,
20,,STABLE,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
20,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
20,,,NOT_MENTIONED,PLATINUM,,OTHER,NOT_MENTIONED,
20,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
20,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,
20,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,,
20,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,,
20,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,NOT_MENTIONED,
20,,,SYMPTOM_PRESENT,BIOPSY,,,NOT_MENTIONED,
20,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
20,,,SYMPTOM_PRESENT,MAPK,,,NOT_MENTIONED,
20,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,DECLINING,
20,,,SYMPTOM_PRESENT,MTOR,,,DECLINING,
20,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
20,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,
20,,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,
20,,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,DECLINING,
20,,,SYMPTOM_PRESENT,,SURGERY,,DECLINING,
20,,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
20,,,,BRAF,,trametinib 0.5 MG Oral Tablet,,
20,,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
20,,,,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,
20,,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
20,,,,MAPK,,trametinib 0.5 MG Oral Tablet,,
20,,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
20,,,,MEK,,trametinib 0.5 MG Oral Tablet,,
20,,,,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,
20,,,,MTOR,,cumulus__none,DECLINING,
20,,,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
20,,,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,
20,,,,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,
20,,,,RADIOTHERAPY,RADIOTHERAPY,,,
20,,,,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,
20,,,,RADIOTHERAPY,,RADIOTHERAPY,,
20,,,,RADIOTHERAPY,,,NOT_MENTIONED,
20,,,,RADIOTHERAPY,,,,
20,,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,
20,,,,TOPOISOMERASE,,NOT_MENTIONED,,
20,,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
20,,,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
20,,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
20,,,,TRAMETINIB,,,NOT_MENTIONED,
20,,,,,CHEMOTHERAPY,,IMPROVING,
20,,,,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
20,,,,,RADIOTHERAPY,RADIOTHERAPY,,
20,,,,,RADIOTHERAPY,,NOT_MENTIONED,
20,,,,,RADIOTHERAPY,,,
20,,,,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
20,,,,,SURGERY,,DECLINING,
20,,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
20,,,,,,GROSS_TOTAL,NOT_MENTIONED,
20,,,,,,RADIOTHERAPY,NOT_MENTIONED,
20,,,,,,RADIOTHERAPY,,
20,,,,,,trametinib 0.5 MG Oral Tablet,,
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,,,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,cumulus__none,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,CARBOPLATIN,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,CARBOPLATIN,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,,,,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
20,AVAILABLE_AND_ELIGIBLE,,,,,,IMPROVING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
20,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,,cumulus__none,,boston_childrens
20,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
20,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,,boston_childrens
20,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,NOT_MENTIONED,,boston_childrens
20,NOT_MENTIONED,PROGRESSION,,BIOPSY,,NOT_MENTIONED,,boston_childrens
20,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,,MEK,,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,PROGRESSION,,OTHER TARGETED,,,DECLINING,boston_childrens
20,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
20,NOT_MENTIONED,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
20,NOT_MENTIONED,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,,NOT_MENTIONED,MTOR,,cumulus__none,,boston_childrens
20,NOT_MENTIONED,,NOT_MENTIONED,MTOR,,,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,,,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,DECLINING,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,DECLINING,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,,boston_childrens
20,NOT_MENTIONED,,SYMPTOM_PRESENT,,,CARBOPLATIN,DECLINING,boston_childrens
20,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,,,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
20,NOT_MENTIONED,,,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
20,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,,,MEK,,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,,,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,boston_childrens
20,NOT_MENTIONED,,,OTHER TARGETED,,cumulus__none,DECLINING,boston_childrens
20,NOT_MENTIONED,,,OTHER TARGETED,,,DECLINING,boston_childrens
20,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
20,NOT_MENTIONED,,,TRAMETINIB,,,,boston_childrens
20,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
20,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
20,NOT_MENTIONED,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
20,NOT_MENTIONED,,,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,boston_childrens
20,NOT_MENTIONED,,,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
20,NOT_MENTIONED,,,,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,DECLINING,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,DECLINING,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,DECLINING,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,DECLINING,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
20,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,DECLINING,boston_childrens
20,,PROGRESSION,,BIOPSY,SURGERY,NOT_MENTIONED,,boston_childrens
20,,PROGRESSION,,BIOPSY,,NOT_MENTIONED,,boston_childrens
20,,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
20,,PROGRESSION,,MTOR,,cumulus__none,DECLINING,boston_childrens
20,,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
20,,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,,,boston_childrens
20,,PROGRESSION,,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,,RADIOTHERAPY,,RADIOTHERAPY,,boston_childrens
20,,PROGRESSION,,RADIOTHERAPY,,,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,,RADIOTHERAPY,,,,boston_childrens
20,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
20,,PROGRESSION,,VINCA ALKALOID,,OTHER,DECLINING,boston_childrens
20,,PROGRESSION,,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,,,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
20,,PROGRESSION,,,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,,,RADIOTHERAPY,,,boston_childrens
20,,PROGRESSION,,,SURGERY,,DECLINING,boston_childrens
20,,PROGRESSION,,,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
20,,PROGRESSION,,,,RADIOTHERAPY,,boston_childrens
20,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
20,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
20,,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
20,,STABLE,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,boston_childrens
20,,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
20,,STABLE,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,boston_childrens
20,,STABLE,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
20,,STABLE,NOT_MENTIONED,,,NOT_MENTIONED,,boston_childrens
20,,STABLE,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,boston_childrens
20,,STABLE,SYMPTOM_PRESENT,,,,IMPROVING,boston_childrens
20,,STABLE,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
20,,STABLE,,PLATINUM,CHEMOTHERAPY,,,boston_childrens
20,,STABLE,,PLATINUM,,,NOT_MENTIONED,boston_childrens
20,,STABLE,,PLATINUM,,,,boston_childrens
20,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
20,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
20,,STABLE,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
20,,STABLE,,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
20,,STABLE,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
20,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
20,,,NOT_MENTIONED,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
20,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
20,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,boston_childrens
20,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
20,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,,boston_childrens
20,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
20,,,SYMPTOM_PRESENT,BIOPSY,,,NOT_MENTIONED,boston_childrens
20,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
20,,,SYMPTOM_PRESENT,MAPK,,,NOT_MENTIONED,boston_childrens
20,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,DECLINING,boston_childrens
20,,,SYMPTOM_PRESENT,MTOR,,,DECLINING,boston_childrens
20,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
20,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
20,,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
20,,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,DECLINING,boston_childrens
20,,,SYMPTOM_PRESENT,,SURGERY,,DECLINING,boston_childrens
20,,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
20,,,,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
20,,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
20,,,,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,boston_childrens
20,,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
20,,,,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
20,,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
20,,,,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
20,,,,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
20,,,,MTOR,,cumulus__none,DECLINING,boston_childrens
20,,,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
20,,,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
20,,,,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
20,,,,RADIOTHERAPY,RADIOTHERAPY,,,boston_childrens
20,,,,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
20,,,,RADIOTHERAPY,,RADIOTHERAPY,,boston_childrens
20,,,,RADIOTHERAPY,,,NOT_MENTIONED,boston_childrens
20,,,,RADIOTHERAPY,,,,boston_childrens
20,,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
20,,,,TOPOISOMERASE,,NOT_MENTIONED,,boston_childrens
20,,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
20,,,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
20,,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
20,,,,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
20,,,,,CHEMOTHERAPY,,IMPROVING,boston_childrens
20,,,,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
20,,,,,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
20,,,,,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
20,,,,,RADIOTHERAPY,,,boston_childrens
20,,,,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
20,,,,,SURGERY,,DECLINING,boston_childrens
20,,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
20,,,,,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
20,,,,,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
20,,,,,,RADIOTHERAPY,,boston_childrens
20,,,,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,OTHER,,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,cumulus__none,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,OTHER,,
19,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,CARBOPLATIN,,
19,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,OBSERVATION,OBSERVATION,,
19,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,OBSERVATION,,,
19,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,,OBSERVATION,,
19,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,,,,
19,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
19,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,VINBLASTINE,,
19,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,VINBLASTINE,,
19,AVAILABLE_AND_ELIGIBLE,,,,OBSERVATION,OBSERVATION,,
19,AVAILABLE_AND_ELIGIBLE,,,,OBSERVATION,,,
19,AVAILABLE_AND_ELIGIBLE,,,,,CARBOPLATIN,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,,,,,OBSERVATION,,
19,AVAILABLE_AND_ELIGIBLE,,,,,VINBLASTINE,,
19,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,DECLINING,
19,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,,DECLINING,
19,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,,DECLINING,
19,AVAILABLE_NOT_ELIGIBLE,,,,,,DECLINING,
19,NOT_AVAILABLE,PROGRESSION,,,,,,
19,NOT_AVAILABLE,,,,,,,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,,,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,VINBLASTINE,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,VINBLASTINE,,
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,,
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,DECLINING,
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,DECLINING,
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,
19,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,MTOR,,,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,OBSERVATION,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,,
19,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,,,
19,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,OBSERVATION,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,,,OBSERVATION,DECLINING,
19,NOT_MENTIONED,PROGRESSION,,,,,IMPROVING,
19,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,
19,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,NOT_MENTIONED,,
19,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,NOT_MENTIONED,,
19,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,,IMPROVING,
19,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
19,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,,,
19,NOT_MENTIONED,STABLE,,PLATINUM,,,NOT_MENTIONED,
19,NOT_MENTIONED,STABLE,,PLATINUM,,,,
19,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
19,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
19,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
19,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,NOT_MENTIONED,,
19,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
19,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,,
19,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,OTHER,,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,DECLINING,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,DECLINING,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,,DECLINING,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,DECLINING,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,,DECLINING,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,DECLINING,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,,DECLINING,
19,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OBSERVATION,DECLINING,
19,NOT_MENTIONED,,,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,
19,NOT_MENTIONED,,,ETOPOSIDE,CHEMOTHERAPY,,,
19,NOT_MENTIONED,,,ETOPOSIDE,,,NOT_MENTIONED,
19,NOT_MENTIONED,,,ETOPOSIDE,,,,
19,NOT_MENTIONED,,,GROSS TOTAL,SURGERY,GROSS_TOTAL,,
19,NOT_MENTIONED,,,GROSS TOTAL,SURGERY,,,
19,NOT_MENTIONED,,,GROSS TOTAL,,GROSS_TOTAL,,
19,NOT_MENTIONED,,,GROSS TOTAL,,,,
19,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
19,NOT_MENTIONED,,,MAPK,,,NOT_MENTIONED,
19,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,,DECLINING,
19,NOT_MENTIONED,,,MTOR,,,DECLINING,
19,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
19,NOT_MENTIONED,,,TOPOISOMERASE,,OTHER,NOT_MENTIONED,
19,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,
19,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,OTHER,,
19,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
19,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,
19,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,
19,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,,,
19,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
19,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,NOT_MENTIONED,
19,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,
19,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,DECLINING,
19,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,
19,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,DECLINING,
19,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,
19,,PROGRESSION,,ALKYLATING,,OTHER,DECLINING,
19,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
19,,PROGRESSION,,ANTIMETABOLITE,,NOT_MENTIONED,,
19,,PROGRESSION,,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
19,,PROGRESSION,,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,
19,,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
19,,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,,
19,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
19,,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,
19,,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
19,,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,,
19,,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
19,,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,,
19,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,
19,,PROGRESSION,,TOPOISOMERASE,,OTHER,,
19,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
19,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
19,,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
19,,PROGRESSION,,TRAMETINIB,,,NOT_MENTIONED,
19,,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
19,,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,,
19,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
19,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,
19,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,
19,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,,,
19,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
19,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,
19,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,
19,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,,,
19,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,
19,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,,,
19,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,
19,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,
19,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,
19,,STABLE,SYMPTOM_PRESENT,,,NOT_MENTIONED,,
19,,STABLE,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
19,,STABLE,,,CHEMOTHERAPY,OTHER,,
19,,STABLE,,,,OTHER,NOT_MENTIONED,
19,,STABLE,,,,OTHER,,
19,,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,
19,,,NOT_MENTIONED,MAPK,,,,
19,,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
19,,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,
19,,,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,
19,,,NOT_MENTIONED,OTHER TARGETED,,,,
19,,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,
19,,,NOT_MENTIONED,TRAMETINIB,,,,
19,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,
19,,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,DECLINING,
19,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
19,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
19,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,
19,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,
19,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
19,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,
19,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,
19,,,SYMPTOM_PRESENT,MTOR,,cumulus__none,DECLINING,
19,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
19,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,IMPROVING,
19,,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,IMPROVING,
19,,,SYMPTOM_PRESENT,OBSERVATION,,,IMPROVING,
19,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,
19,,,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,,
19,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,,
19,,,SYMPTOM_PRESENT,TRAMETINIB,,,,
19,,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,IMPROVING,
19,,,SYMPTOM_PRESENT,,OBSERVATION,,IMPROVING,
19,,,SYMPTOM_PRESENT,,,OBSERVATION,IMPROVING,
19,,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
19,,,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
19,,,,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,
19,,,,CHEMOTHERAPY,,,IMPROVING,
19,,,,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,
19,,,,ETOPOSIDE,CHEMOTHERAPY,,,
19,,,,ETOPOSIDE,,,NOT_MENTIONED,
19,,,,ETOPOSIDE,,,,
19,,,,GROSS TOTAL,SURGERY,GROSS_TOTAL,,
19,,,,GROSS TOTAL,SURGERY,,,
19,,,,GROSS TOTAL,,GROSS_TOTAL,,
19,,,,GROSS TOTAL,,,,
19,,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
19,,,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
19,,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
19,,,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
19,,,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
19,,,,TOPOISOMERASE,,OTHER,NOT_MENTIONED,
19,,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
19,,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
19,,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
19,,,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,OTHER,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,OTHER,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,CARBOPLATIN,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,OBSERVATION,,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,,OBSERVATION,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,,,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,,OBSERVATION,OBSERVATION,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,,OBSERVATION,,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,,,OBSERVATION,,boston_childrens
19,AVAILABLE_AND_ELIGIBLE,,,,,VINBLASTINE,,boston_childrens
19,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,DECLINING,boston_childrens
19,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,,DECLINING,boston_childrens
19,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,,DECLINING,boston_childrens
19,AVAILABLE_NOT_ELIGIBLE,,,,,,DECLINING,boston_childrens
19,NOT_AVAILABLE,PROGRESSION,,,,,,boston_childrens
19,NOT_AVAILABLE,,,,,,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,VINBLASTINE,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,MTOR,,,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,OBSERVATION,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,,,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,,,OBSERVATION,DECLINING,boston_childrens
19,NOT_MENTIONED,PROGRESSION,,,,,IMPROVING,boston_childrens
19,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,NOT_MENTIONED,,boston_childrens
19,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,NOT_MENTIONED,,boston_childrens
19,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,,IMPROVING,boston_childrens
19,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,,,boston_childrens
19,NOT_MENTIONED,STABLE,,PLATINUM,,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,STABLE,,PLATINUM,,,,boston_childrens
19,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
19,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
19,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
19,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,OTHER,,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,DECLINING,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,DECLINING,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,,DECLINING,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,DECLINING,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,DECLINING,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER TARGETED,,,DECLINING,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,,DECLINING,boston_childrens
19,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OBSERVATION,DECLINING,boston_childrens
19,NOT_MENTIONED,,,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,,,ETOPOSIDE,CHEMOTHERAPY,,,boston_childrens
19,NOT_MENTIONED,,,ETOPOSIDE,,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,,,ETOPOSIDE,,,,boston_childrens
19,NOT_MENTIONED,,,GROSS TOTAL,SURGERY,GROSS_TOTAL,,boston_childrens
19,NOT_MENTIONED,,,GROSS TOTAL,SURGERY,,,boston_childrens
19,NOT_MENTIONED,,,GROSS TOTAL,,GROSS_TOTAL,,boston_childrens
19,NOT_MENTIONED,,,GROSS TOTAL,,,,boston_childrens
19,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,,,MAPK,,,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,,DECLINING,boston_childrens
19,NOT_MENTIONED,,,MTOR,,,DECLINING,boston_childrens
19,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
19,NOT_MENTIONED,,,TOPOISOMERASE,,OTHER,NOT_MENTIONED,boston_childrens
19,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
19,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,OTHER,,boston_childrens
19,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
19,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
19,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,boston_childrens
19,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,,,boston_childrens
19,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
19,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,NOT_MENTIONED,boston_childrens
19,,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
19,,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,DECLINING,boston_childrens
19,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
19,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,DECLINING,boston_childrens
19,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
19,,PROGRESSION,,ALKYLATING,,OTHER,DECLINING,boston_childrens
19,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
19,,PROGRESSION,,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
19,,PROGRESSION,,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,,PROGRESSION,,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
19,,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,boston_childrens
19,,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,boston_childrens
19,,PROGRESSION,,TOPOISOMERASE,,OTHER,,boston_childrens
19,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
19,,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,,PROGRESSION,,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
19,,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
19,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
19,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
19,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,,,boston_childrens
19,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
19,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
19,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,,,boston_childrens
19,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,,,boston_childrens
19,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
19,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,boston_childrens
19,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,boston_childrens
19,,STABLE,SYMPTOM_PRESENT,,,NOT_MENTIONED,,boston_childrens
19,,STABLE,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
19,,STABLE,,,CHEMOTHERAPY,OTHER,,boston_childrens
19,,STABLE,,,,OTHER,NOT_MENTIONED,boston_childrens
19,,STABLE,,,,OTHER,,boston_childrens
19,,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,boston_childrens
19,,,NOT_MENTIONED,MAPK,,,,boston_childrens
19,,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
19,,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
19,,,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,boston_childrens
19,,,NOT_MENTIONED,OTHER TARGETED,,,,boston_childrens
19,,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
19,,,NOT_MENTIONED,TRAMETINIB,,,,boston_childrens
19,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
19,,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,DECLINING,boston_childrens
19,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
19,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
19,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,boston_childrens
19,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
19,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,boston_childrens
19,,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
19,,,SYMPTOM_PRESENT,MTOR,,cumulus__none,DECLINING,boston_childrens
19,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
19,,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
19,,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
19,,,SYMPTOM_PRESENT,OBSERVATION,,,IMPROVING,boston_childrens
19,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,boston_childrens
19,,,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,,boston_childrens
19,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
19,,,SYMPTOM_PRESENT,TRAMETINIB,,,,boston_childrens
19,,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
19,,,SYMPTOM_PRESENT,,OBSERVATION,,IMPROVING,boston_childrens
19,,,SYMPTOM_PRESENT,,,OBSERVATION,IMPROVING,boston_childrens
19,,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
19,,,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
19,,,,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,boston_childrens
19,,,,CHEMOTHERAPY,,,IMPROVING,boston_childrens
19,,,,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
19,,,,ETOPOSIDE,CHEMOTHERAPY,,,boston_childrens
19,,,,ETOPOSIDE,,,NOT_MENTIONED,boston_childrens
19,,,,ETOPOSIDE,,,,boston_childrens
19,,,,GROSS TOTAL,SURGERY,GROSS_TOTAL,,boston_childrens
19,,,,GROSS TOTAL,SURGERY,,,boston_childrens
19,,,,GROSS TOTAL,,GROSS_TOTAL,,boston_childrens
19,,,,GROSS TOTAL,,,,boston_childrens
19,,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
19,,,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
19,,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
19,,,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
19,,,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
19,,,,TOPOISOMERASE,,OTHER,NOT_MENTIONED,boston_childrens
19,,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
19,,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
19,,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
19,,,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,,
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,,
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,,,
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,,cumulus__none,,
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,,,,
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,,,
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,,NOT_MENTIONED,
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,,,
18,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
18,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,
18,AVAILABLE_AND_ELIGIBLE,,,MTOR,TARGETED_THERAPY,cumulus__none,,
18,AVAILABLE_AND_ELIGIBLE,,,MTOR,TARGETED_THERAPY,,,
18,AVAILABLE_AND_ELIGIBLE,,,MTOR,,cumulus__none,,
18,AVAILABLE_AND_ELIGIBLE,,,MTOR,,,,
18,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
18,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
18,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,,
18,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,cumulus__none,,
18,AVAILABLE_NOT_ELIGIBLE,,,,TARGETED_THERAPY,cumulus__none,,
18,AVAILABLE_NOT_ELIGIBLE,,,,,cumulus__none,,
18,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
18,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,
18,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
18,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
18,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,,DECLINING,
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,,
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,,
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,NOT_MENTIONED,
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,NOT_MENTIONED,
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,DECLINING,
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,DECLINING,
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,DECLINING,
18,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
18,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,
18,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,NOT_MENTIONED,,
18,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,OTHER,,
18,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
18,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,OTHER,DECLINING,
18,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,
18,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,,,
18,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,,,NOT_MENTIONED,
18,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,,,,
18,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
18,NOT_MENTIONED,PROGRESSION,,MAPK,,,NOT_MENTIONED,
18,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,
18,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,OTHER,,
18,NOT_MENTIONED,PROGRESSION,,,SURGERY,,DECLINING,
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,,,
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,,,
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,,,
18,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,
18,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,
18,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,
18,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
18,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,,IMPROVING,
18,NOT_MENTIONED,STABLE,,OBSERVATION,,OBSERVATION,IMPROVING,
18,NOT_MENTIONED,STABLE,,OBSERVATION,,,IMPROVING,
18,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
18,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,OTHER,,
18,NOT_MENTIONED,STABLE,,,OBSERVATION,OBSERVATION,IMPROVING,
18,NOT_MENTIONED,STABLE,,,OBSERVATION,,IMPROVING,
18,NOT_MENTIONED,STABLE,,,,OBSERVATION,IMPROVING,
18,NOT_MENTIONED,STABLE,,,,OTHER,NOT_MENTIONED,
18,NOT_MENTIONED,STABLE,,,,OTHER,,
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,SURGERY,,,
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,,
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,,,NOT_MENTIONED,
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,,,,
18,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
18,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,OTHER,NOT_MENTIONED,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,DECLINING,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,,DECLINING,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,NOT_MENTIONED,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,,NOT_MENTIONED,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,,NOT_MENTIONED,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,DECLINING,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,,DECLINING,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,,,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,
18,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,,DECLINING,
18,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
18,NOT_MENTIONED,,,ALKYLATING,,NOT_MENTIONED,DECLINING,
18,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
18,NOT_MENTIONED,,,BRAF,,trametinib 0.5 MG Oral Tablet,,
18,NOT_MENTIONED,,,DEBULKING,SURGERY,NOT_MENTIONED,,
18,NOT_MENTIONED,,,DEBULKING,,NOT_MENTIONED,,
18,NOT_MENTIONED,,,ENDOSCOPIC,SURGERY,,,
18,NOT_MENTIONED,,,ENDOSCOPIC,,,,
18,NOT_MENTIONED,,,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
18,NOT_MENTIONED,,,GROSS TOTAL,SURGERY,,NOT_MENTIONED,
18,NOT_MENTIONED,,,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,
18,NOT_MENTIONED,,,GROSS TOTAL,,,NOT_MENTIONED,
18,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
18,NOT_MENTIONED,,,MAPK,,trametinib 0.5 MG Oral Tablet,,
18,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
18,NOT_MENTIONED,,,MEK,,trametinib 0.5 MG Oral Tablet,,
18,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,
18,NOT_MENTIONED,,,TOPOISOMERASE,,NOT_MENTIONED,,
18,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
18,NOT_MENTIONED,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
18,NOT_MENTIONED,,,,SURGERY,,DECLINING,
18,NOT_MENTIONED,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
18,NOT_MENTIONED,,,,,trametinib 0.5 MG Oral Tablet,,
18,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
18,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
18,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
18,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,,
18,,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,
18,,PROGRESSION,NOT_MENTIONED,MAPK,,,,
18,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
18,,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
18,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,
18,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,,,
18,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,
18,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,DECLINING,
18,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,,
18,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,,
18,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
18,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,
18,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,NOT_MENTIONED,
18,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,NOT_MENTIONED,
18,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,,
18,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,,
18,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,DECLINING,
18,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
18,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,
18,,PROGRESSION,,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,
18,,PROGRESSION,,ANTIMETABOLITE,,OTHER,,
18,,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
18,,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
18,,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,
18,,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,,,
18,,PROGRESSION,,ETOPOSIDE,,,NOT_MENTIONED,
18,,PROGRESSION,,ETOPOSIDE,,,,
18,,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
18,,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
18,,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
18,,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
18,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
18,,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
18,,PROGRESSION,,,SURGERY,NOT_MENTIONED,DECLINING,
18,,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
18,,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
18,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
18,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,
18,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,
18,,STABLE,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
18,,STABLE,,PLATINUM,,NOT_MENTIONED,,
18,,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
18,,,NOT_MENTIONED,MAPK,,,NOT_MENTIONED,
18,,,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
18,,,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
18,,,NOT_MENTIONED,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
18,,,NOT_MENTIONED,NOT MENTIONED,SURGERY,,,
18,,,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
18,,,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,,
18,,,NOT_MENTIONED,NOT MENTIONED,,,NOT_MENTIONED,
18,,,NOT_MENTIONED,NOT MENTIONED,,,,
18,,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
18,,,NOT_MENTIONED,TRAMETINIB,,,NOT_MENTIONED,
18,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,,
18,,,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,,
18,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
18,,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,,
18,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,NOT_MENTIONED,
18,,,SYMPTOM_PRESENT,DEBULKING,,,NOT_MENTIONED,
18,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
18,,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,,
18,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
18,,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,,
18,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
18,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
18,,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
18,,,SYMPTOM_PRESENT,TRAMETINIB,,,NOT_MENTIONED,
18,,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,DECLINING,
18,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
18,,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,,
18,,,,DEBULKING,SURGERY,NOT_MENTIONED,,
18,,,,DEBULKING,,NOT_MENTIONED,,
18,,,,ENDOSCOPIC,SURGERY,,,
18,,,,ENDOSCOPIC,,,,
18,,,,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
18,,,,GROSS TOTAL,SURGERY,,NOT_MENTIONED,
18,,,,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,
18,,,,GROSS TOTAL,,,NOT_MENTIONED,
18,,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
18,,,,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,
18,,,,VINCA ALKALOID,CHEMOTHERAPY,,IMPROVING,
18,,,,VINCA ALKALOID,,,IMPROVING,
18,,,,,SURGERY,NOT_MENTIONED,DECLINING,
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,,cumulus__none,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,,,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,,NOT_MENTIONED,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,,MTOR,TARGETED_THERAPY,,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,,MTOR,,cumulus__none,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,,MTOR,,,,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
18,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
18,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,,boston_childrens
18,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,cumulus__none,,boston_childrens
18,AVAILABLE_NOT_ELIGIBLE,,,,TARGETED_THERAPY,cumulus__none,,boston_childrens
18,AVAILABLE_NOT_ELIGIBLE,,,,,cumulus__none,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,,DECLINING,boston_childrens
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,DECLINING,boston_childrens
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,DECLINING,boston_childrens
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
18,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,,DECLINING,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,OTHER,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,,,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,MAPK,,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,OTHER,,boston_childrens
18,NOT_MENTIONED,PROGRESSION,,,SURGERY,,DECLINING,boston_childrens
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,,,boston_childrens
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,,,boston_childrens
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,,,boston_childrens
18,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
18,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,boston_childrens
18,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,boston_childrens
18,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
18,NOT_MENTIONED,STABLE,,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
18,NOT_MENTIONED,STABLE,,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
18,NOT_MENTIONED,STABLE,,OBSERVATION,,,IMPROVING,boston_childrens
18,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,STABLE,,,CHEMOTHERAPY,OTHER,,boston_childrens
18,NOT_MENTIONED,STABLE,,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
18,NOT_MENTIONED,STABLE,,,OBSERVATION,,IMPROVING,boston_childrens
18,NOT_MENTIONED,STABLE,,,,OBSERVATION,IMPROVING,boston_childrens
18,NOT_MENTIONED,STABLE,,,,OTHER,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,STABLE,,,,OTHER,,boston_childrens
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,SURGERY,,,boston_childrens
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,NOT_MENTIONED,NOT MENTIONED,,,,boston_childrens
18,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,NOT_MENTIONED,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,DECLINING,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,,DECLINING,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,DECLINING,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,,DECLINING,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,,,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,boston_childrens
18,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,,DECLINING,boston_childrens
18,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
18,NOT_MENTIONED,,,ALKYLATING,,NOT_MENTIONED,DECLINING,boston_childrens
18,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,NOT_MENTIONED,,,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,NOT_MENTIONED,,,DEBULKING,SURGERY,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,,,DEBULKING,,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,,,ENDOSCOPIC,SURGERY,,,boston_childrens
18,NOT_MENTIONED,,,ENDOSCOPIC,,,,boston_childrens
18,NOT_MENTIONED,,,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,,GROSS TOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,,GROSS TOTAL,,,NOT_MENTIONED,boston_childrens
18,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,NOT_MENTIONED,,,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,NOT_MENTIONED,,,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,,,TOPOISOMERASE,,NOT_MENTIONED,,boston_childrens
18,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,NOT_MENTIONED,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,NOT_MENTIONED,,,,SURGERY,,DECLINING,boston_childrens
18,NOT_MENTIONED,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,NOT_MENTIONED,,,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
18,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
18,,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,boston_childrens
18,,PROGRESSION,NOT_MENTIONED,MAPK,,,,boston_childrens
18,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
18,,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
18,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
18,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,,,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,DECLINING,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,,boston_childrens
18,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
18,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,boston_childrens
18,,PROGRESSION,,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,ANTIMETABOLITE,,OTHER,,boston_childrens
18,,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,,,boston_childrens
18,,PROGRESSION,,ETOPOSIDE,,,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,ETOPOSIDE,,,,boston_childrens
18,,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
18,,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
18,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
18,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
18,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
18,,STABLE,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
18,,STABLE,,PLATINUM,,NOT_MENTIONED,,boston_childrens
18,,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
18,,,NOT_MENTIONED,MAPK,,,NOT_MENTIONED,boston_childrens
18,,,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
18,,,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
18,,,NOT_MENTIONED,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
18,,,NOT_MENTIONED,NOT MENTIONED,SURGERY,,,boston_childrens
18,,,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
18,,,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
18,,,NOT_MENTIONED,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
18,,,NOT_MENTIONED,NOT MENTIONED,,,,boston_childrens
18,,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
18,,,NOT_MENTIONED,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
18,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,,boston_childrens
18,,,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,,boston_childrens
18,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,NOT_MENTIONED,boston_childrens
18,,,SYMPTOM_PRESENT,DEBULKING,,,NOT_MENTIONED,boston_childrens
18,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
18,,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,,SYMPTOM_PRESENT,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
18,,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
18,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
18,,,,DEBULKING,SURGERY,NOT_MENTIONED,,boston_childrens
18,,,,DEBULKING,,NOT_MENTIONED,,boston_childrens
18,,,,ENDOSCOPIC,SURGERY,,,boston_childrens
18,,,,ENDOSCOPIC,,,,boston_childrens
18,,,,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
18,,,,GROSS TOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
18,,,,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
18,,,,GROSS TOTAL,,,NOT_MENTIONED,boston_childrens
18,,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
18,,,,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
18,,,,VINCA ALKALOID,CHEMOTHERAPY,,IMPROVING,boston_childrens
18,,,,VINCA ALKALOID,,,IMPROVING,boston_childrens
18,,,,,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,,DECLINING,
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,OTHER,,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,,cumulus__none,,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,,,,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,,,NOT_MENTIONED,
17,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,,DECLINING,
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,,cumulus__none,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,,,
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,DECLINING,
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,DECLINING,
17,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,,
17,NOT_MENTIONED,PROGRESSION,,DEBULKING,,NOT_MENTIONED,,
17,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,SURGERY,,,
17,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,,,,
17,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,
17,NOT_MENTIONED,PROGRESSION,,MTOR,,cumulus__none,DECLINING,
17,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,PLATINUM,,OTHER,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,,,
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,,RADIOTHERAPY,,
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,,,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,,,,
17,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
17,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,
17,NOT_MENTIONED,PROGRESSION,,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,,RADIOTHERAPY,RADIOTHERAPY,,
17,NOT_MENTIONED,PROGRESSION,,,RADIOTHERAPY,,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,,RADIOTHERAPY,,,
17,NOT_MENTIONED,PROGRESSION,,,SURGERY,GROSS_TOTAL,,
17,NOT_MENTIONED,PROGRESSION,,,SURGERY,NOT_MENTIONED,DECLINING,
17,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,PROGRESSION,,,,GROSS_TOTAL,,
17,NOT_MENTIONED,PROGRESSION,,,,RADIOTHERAPY,NOT_MENTIONED,
17,NOT_MENTIONED,PROGRESSION,,,,RADIOTHERAPY,,
17,NOT_MENTIONED,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,,IMPROVING,
17,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,
17,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
17,NOT_MENTIONED,STABLE,,PLATINUM,,NOT_MENTIONED,,
17,NOT_MENTIONED,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,
17,NOT_MENTIONED,,NOT_MENTIONED,MAPK,,,,
17,NOT_MENTIONED,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
17,NOT_MENTIONED,,NOT_MENTIONED,MTOR,,cumulus__none,NOT_MENTIONED,
17,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
17,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,IMPROVING,
17,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,IMPROVING,
17,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,,IMPROVING,
17,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
17,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,
17,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,
17,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,,,,
17,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,
17,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,,,,
17,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,IMPROVING,
17,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,,IMPROVING,
17,NOT_MENTIONED,,NOT_MENTIONED,,,OBSERVATION,IMPROVING,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,DECLINING,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,,
17,NOT_MENTIONED,,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,
17,NOT_MENTIONED,,,ENDOSCOPIC,,NOT_MENTIONED,,
17,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,
17,NOT_MENTIONED,,,MTOR,,cumulus__none,DECLINING,
17,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
17,NOT_MENTIONED,,,PLATINUM,,NOT_MENTIONED,DECLINING,
17,NOT_MENTIONED,,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
17,NOT_MENTIONED,,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,
17,NOT_MENTIONED,,,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,
17,NOT_MENTIONED,,,RADIOTHERAPY,RADIOTHERAPY,,,
17,NOT_MENTIONED,,,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,
17,NOT_MENTIONED,,,RADIOTHERAPY,,RADIOTHERAPY,,
17,NOT_MENTIONED,,,RADIOTHERAPY,,,NOT_MENTIONED,
17,NOT_MENTIONED,,,RADIOTHERAPY,,,,
17,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
17,NOT_MENTIONED,,,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,
17,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
17,NOT_MENTIONED,,,TRAMETINIB,,,NOT_MENTIONED,
17,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,
17,NOT_MENTIONED,,,VINCA ALKALOID,,OTHER,DECLINING,
17,NOT_MENTIONED,,,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
17,NOT_MENTIONED,,,,RADIOTHERAPY,RADIOTHERAPY,,
17,NOT_MENTIONED,,,,RADIOTHERAPY,,NOT_MENTIONED,
17,NOT_MENTIONED,,,,RADIOTHERAPY,,,
17,NOT_MENTIONED,,,,SURGERY,NOT_MENTIONED,DECLINING,
17,NOT_MENTIONED,,,,SURGERY,PARTIAL,,
17,NOT_MENTIONED,,,,,PARTIAL,,
17,NOT_MENTIONED,,,,,RADIOTHERAPY,NOT_MENTIONED,
17,NOT_MENTIONED,,,,,RADIOTHERAPY,,
17,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,MAPK,,,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
17,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,,NOT_MENTIONED,
17,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
17,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,,
17,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,,
17,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,,
17,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,,
17,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,,
17,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,OTHER,,
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,,
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,,
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,,NOT_MENTIONED,
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,,,
17,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
17,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
17,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,NOT_MENTIONED,
17,,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
17,,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,,
17,,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,,NOT_MENTIONED,
17,,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,,,
17,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,,PROGRESSION,SYMPTOM_PRESENT,,,RADIOTHERAPY,NOT_MENTIONED,
17,,PROGRESSION,SYMPTOM_PRESENT,,,RADIOTHERAPY,,
17,,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,,
17,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
17,,PROGRESSION,,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,
17,,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,,
17,,PROGRESSION,,DEBULKING,,NOT_MENTIONED,,
17,,PROGRESSION,,ENDOSCOPIC,SURGERY,,,
17,,PROGRESSION,,ENDOSCOPIC,,,,
17,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
17,,PROGRESSION,,PLATINUM,,OTHER,NOT_MENTIONED,
17,,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,,,
17,,PROGRESSION,,TEMOZOLOMIDE,,,,
17,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,
17,,PROGRESSION,,TOPOISOMERASE,,NOT_MENTIONED,,
17,,PROGRESSION,,,SURGERY,GROSS_TOTAL,,
17,,PROGRESSION,,,,GROSS_TOTAL,,
17,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
17,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,
17,,STABLE,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,
17,,STABLE,NOT_MENTIONED,PLATINUM,,,,
17,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
17,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
17,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
17,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,
17,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
17,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,
17,,STABLE,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,
17,,STABLE,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
17,,STABLE,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
17,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
17,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
17,,STABLE,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
17,,STABLE,,VINCA ALKALOID,,OTHER,,
17,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,
17,,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,
17,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,
17,,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
17,,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
17,,,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
17,,,NOT_MENTIONED,OTHER TARGETED,,,NOT_MENTIONED,
17,,,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
17,,,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,,
17,,,NOT_MENTIONED,TOPOISOMERASE,,,NOT_MENTIONED,
17,,,NOT_MENTIONED,TOPOISOMERASE,,,,
17,,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
17,,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
17,,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,
17,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,,
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,,
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,,,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,,,,
17,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,
17,,,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,,
17,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,,
17,,,SYMPTOM_PRESENT,,RADIOTHERAPY,,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,,RADIOTHERAPY,,,
17,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,,,RADIOTHERAPY,NOT_MENTIONED,
17,,,SYMPTOM_PRESENT,,,RADIOTHERAPY,,
17,,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
17,,,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,
17,,,,ENDOSCOPIC,,NOT_MENTIONED,,
17,,,,TEMOZOLOMIDE,CHEMOTHERAPY,,,
17,,,,TEMOZOLOMIDE,,,,
17,,,,,SURGERY,PARTIAL,,
17,,,,,,PARTIAL,,
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,,DECLINING,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,OTHER,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,cumulus__none,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,,cumulus__none,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,,,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
17,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,DEBULKING,,NOT_MENTIONED,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,SURGERY,,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,,,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,MTOR,,cumulus__none,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,RADIOTHERAPY,,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,,RADIOTHERAPY,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,RADIOTHERAPY,,,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,RADIOTHERAPY,,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,SURGERY,GROSS_TOTAL,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,,GROSS_TOTAL,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,,RADIOTHERAPY,,boston_childrens
17,NOT_MENTIONED,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,OBSERVATION,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,,IMPROVING,boston_childrens
17,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
17,NOT_MENTIONED,STABLE,,PLATINUM,,NOT_MENTIONED,,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,MAPK,,,,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,OBSERVATION,,,IMPROVING,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,,,,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,,,,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,,OBSERVATION,,IMPROVING,boston_childrens
17,NOT_MENTIONED,,NOT_MENTIONED,,,OBSERVATION,IMPROVING,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,NOT_MENTIONED,,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,boston_childrens
17,NOT_MENTIONED,,,ENDOSCOPIC,,NOT_MENTIONED,,boston_childrens
17,NOT_MENTIONED,,,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
17,NOT_MENTIONED,,,MTOR,,cumulus__none,DECLINING,boston_childrens
17,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
17,NOT_MENTIONED,,,PLATINUM,,NOT_MENTIONED,DECLINING,boston_childrens
17,NOT_MENTIONED,,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
17,NOT_MENTIONED,,,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,RADIOTHERAPY,RADIOTHERAPY,,,boston_childrens
17,NOT_MENTIONED,,,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,RADIOTHERAPY,,RADIOTHERAPY,,boston_childrens
17,NOT_MENTIONED,,,RADIOTHERAPY,,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,RADIOTHERAPY,,,,boston_childrens
17,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
17,NOT_MENTIONED,,,VINCA ALKALOID,,OTHER,DECLINING,boston_childrens
17,NOT_MENTIONED,,,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
17,NOT_MENTIONED,,,,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,,RADIOTHERAPY,,,boston_childrens
17,NOT_MENTIONED,,,,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
17,NOT_MENTIONED,,,,SURGERY,PARTIAL,,boston_childrens
17,NOT_MENTIONED,,,,,PARTIAL,,boston_childrens
17,NOT_MENTIONED,,,,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,NOT_MENTIONED,,,,,RADIOTHERAPY,,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,MAPK,,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,OTHER,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,,,RADIOTHERAPY,,boston_childrens
17,,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,,boston_childrens
17,,PROGRESSION,,DEBULKING,,NOT_MENTIONED,,boston_childrens
17,,PROGRESSION,,ENDOSCOPIC,SURGERY,,,boston_childrens
17,,PROGRESSION,,ENDOSCOPIC,,,,boston_childrens
17,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
17,,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,,,boston_childrens
17,,PROGRESSION,,TEMOZOLOMIDE,,,,boston_childrens
17,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
17,,PROGRESSION,,TOPOISOMERASE,,NOT_MENTIONED,,boston_childrens
17,,PROGRESSION,,,SURGERY,GROSS_TOTAL,,boston_childrens
17,,PROGRESSION,,,,GROSS_TOTAL,,boston_childrens
17,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
17,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,boston_childrens
17,,STABLE,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,boston_childrens
17,,STABLE,NOT_MENTIONED,PLATINUM,,,,boston_childrens
17,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
17,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
17,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
17,,STABLE,SYMPTOM_PRESENT,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,,STABLE,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,,STABLE,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
17,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
17,,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
17,,STABLE,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
17,,STABLE,,VINCA ALKALOID,,OTHER,,boston_childrens
17,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
17,,,NOT_MENTIONED,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,TOPOISOMERASE,,,,boston_childrens
17,,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
17,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,,boston_childrens
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,,boston_childrens
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,,,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,RADIOTHERAPY,,,,boston_childrens
17,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
17,,,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,,boston_childrens
17,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
17,,,SYMPTOM_PRESENT,,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,,RADIOTHERAPY,,,boston_childrens
17,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
17,,,SYMPTOM_PRESENT,,,RADIOTHERAPY,,boston_childrens
17,,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
17,,,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,boston_childrens
17,,,,ENDOSCOPIC,,NOT_MENTIONED,,boston_childrens
17,,,,TEMOZOLOMIDE,CHEMOTHERAPY,,,boston_childrens
17,,,,TEMOZOLOMIDE,,,,boston_childrens
17,,,,,SURGERY,PARTIAL,,boston_childrens
17,,,,,,PARTIAL,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,,,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,OTHER,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,,OBSERVATION,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,,,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,OBSERVATION,OBSERVATION,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,OBSERVATION,,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,DECLINING,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,OBSERVATION,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,VINBLASTINE,,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,cumulus__none,DECLINING,
16,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,
16,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,NOT_MENTIONED,,
16,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,,,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,,,OBSERVATION,,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,cumulus__none,DECLINING,
16,AVAILABLE_AND_ELIGIBLE,,,,,OBSERVATION,NOT_MENTIONED,
16,AVAILABLE_AND_ELIGIBLE,,,,,cumulus__none,DECLINING,
16,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,
16,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,
16,NOT_AVAILABLE,PROGRESSION,,,,,NOT_MENTIONED,
16,NOT_AVAILABLE,,,,,,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,OTHER,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,,,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,DECLINING,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,OTHER,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,,
16,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
16,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,DECLINING,
16,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,
16,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,,NOT_MENTIONED,,
16,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,OTHER,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,,,SURGERY,PARTIAL,,
16,NOT_MENTIONED,PROGRESSION,,,,GROSS_TOTAL,NOT_MENTIONED,
16,NOT_MENTIONED,PROGRESSION,,,,PARTIAL,,
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,,,
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,
16,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,
16,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,STABLE,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
16,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
16,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
16,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,OTHER,,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,,,,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,cumulus__none,DECLINING,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,IMPROVING,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,IMPROVING,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,,IMPROVING,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,,NOT_MENTIONED,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,IMPROVING,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,,IMPROVING,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,NOT_MENTIONED,
16,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OBSERVATION,IMPROVING,
16,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,NOT_MENTIONED,,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,NOT_MENTIONED,,,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,,,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,
16,NOT_MENTIONED,,,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,
16,NOT_MENTIONED,,,ENDOSCOPIC,,,NOT_MENTIONED,
16,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,NOT_MENTIONED,,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,NOT_MENTIONED,,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,NOT_MENTIONED,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,NOT_MENTIONED,,,,CHEMOTHERAPY,,IMPROVING,
16,NOT_MENTIONED,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,NOT_MENTIONED,,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
16,,PROGRESSION,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,
16,,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
16,,PROGRESSION,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,
16,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
16,,PROGRESSION,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,,
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,,,
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,,
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,,,
16,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
16,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
16,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
16,,PROGRESSION,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,
16,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,
16,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,,
16,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,,
16,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,,
16,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,,
16,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,,
16,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,
16,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,,
16,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,NOT_MENTIONED,
16,,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
16,,PROGRESSION,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,
16,,PROGRESSION,,ENDOSCOPIC,,NOT_MENTIONED,,
16,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
16,,PROGRESSION,,TOPOISOMERASE,,OTHER,NOT_MENTIONED,
16,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,
16,,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,DECLINING,
16,,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,DECLINING,
16,,PROGRESSION,,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
16,,PROGRESSION,,,SURGERY,PARTIAL,,
16,,PROGRESSION,,,,GROSS_TOTAL,NOT_MENTIONED,
16,,PROGRESSION,,,,PARTIAL,,
16,,PROGRESSION,,,,VINBLASTINE,DECLINING,
16,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
16,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,
16,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,
16,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,,,
16,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,
16,,STABLE,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
16,,STABLE,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
16,,STABLE,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
16,,STABLE,,ALKYLATING,CHEMOTHERAPY,,,
16,,STABLE,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
16,,STABLE,,ALKYLATING,,NOT_MENTIONED,,
16,,STABLE,,ALKYLATING,,,NOT_MENTIONED,
16,,STABLE,,ALKYLATING,,,,
16,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
16,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
16,,STABLE,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
16,,STABLE,,CHEMOTHERAPY,,OTHER,,
16,,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,,
16,,,NOT_MENTIONED,ANTIMETABOLITE,,,,
16,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
16,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
16,,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
16,,,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,
16,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,,
16,,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,,
16,,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,,
16,,,SYMPTOM_PRESENT,ENDOSCOPIC,,,,
16,,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,
16,,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,,
16,,,SYMPTOM_PRESENT,ETOPOSIDE,,,NOT_MENTIONED,
16,,,SYMPTOM_PRESENT,ETOPOSIDE,,,,
16,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,,
16,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,,
16,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
16,,,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,NOT_MENTIONED,
16,,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
16,,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,NOT_MENTIONED,
16,,,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,
16,,,,BRAF MEK COMBINATION,TARGETED_THERAPY,,,
16,,,,BRAF MEK COMBINATION,,cumulus__none,,
16,,,,BRAF MEK COMBINATION,,,,
16,,,,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
16,,,,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,
16,,,,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,
16,,,,ENDOSCOPIC,,,NOT_MENTIONED,
16,,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,
16,,,,VINCA ALKALOID,,VINBLASTINE,DECLINING,
16,,,,,CHEMOTHERAPY,VINBLASTINE,DECLINING,
16,,,,,,VINBLASTINE,DECLINING,
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,,,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,CARBOPLATIN,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,,OBSERVATION,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,,,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,OBSERVATION,OBSERVATION,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,OBSERVATION,,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,OBSERVATION,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,VINBLASTINE,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,cumulus__none,DECLINING,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,NOT_MENTIONED,,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,OBSERVATION,,,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,,OBSERVATION,,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,,,OBSERVATION,NOT_MENTIONED,boston_childrens
16,AVAILABLE_AND_ELIGIBLE,,,,,cumulus__none,DECLINING,boston_childrens
16,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,boston_childrens
16,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,,boston_childrens
16,NOT_AVAILABLE,PROGRESSION,,,,,NOT_MENTIONED,boston_childrens
16,NOT_AVAILABLE,,,,,,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,OTHER,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,,,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,DECLINING,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,OTHER,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,DECLINING,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,DECLINING,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,OTHER,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,,SURGERY,PARTIAL,,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,PROGRESSION,,,,PARTIAL,,boston_childrens
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,boston_childrens
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,,,boston_childrens
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,STABLE,,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
16,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,STABLE,,VINCA ALKALOID,,OTHER,,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,,,,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,MTOR,,cumulus__none,DECLINING,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,OBSERVATION,,,IMPROVING,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,,OBSERVATION,,IMPROVING,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,SYMPTOM_PRESENT,,,OBSERVATION,IMPROVING,boston_childrens
16,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,ENDOSCOPIC,,,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,,CHEMOTHERAPY,,IMPROVING,boston_childrens
16,NOT_MENTIONED,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,NOT_MENTIONED,,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,NOT_MENTIONED,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,SURGERY,,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,NOT_MENTIONED,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,NOT MENTIONED,,,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,boston_childrens
16,,PROGRESSION,,ENDOSCOPIC,,NOT_MENTIONED,,boston_childrens
16,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,,TOPOISOMERASE,,OTHER,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
16,,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,DECLINING,boston_childrens
16,,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
16,,PROGRESSION,,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,,,SURGERY,PARTIAL,,boston_childrens
16,,PROGRESSION,,,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
16,,PROGRESSION,,,,PARTIAL,,boston_childrens
16,,PROGRESSION,,,,VINBLASTINE,DECLINING,boston_childrens
16,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
16,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
16,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
16,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,,,boston_childrens
16,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
16,,STABLE,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,STABLE,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
16,,STABLE,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
16,,STABLE,,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
16,,STABLE,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,STABLE,,ALKYLATING,,NOT_MENTIONED,,boston_childrens
16,,STABLE,,ALKYLATING,,,NOT_MENTIONED,boston_childrens
16,,STABLE,,ALKYLATING,,,,boston_childrens
16,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
16,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
16,,STABLE,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
16,,STABLE,,CHEMOTHERAPY,,OTHER,,boston_childrens
16,,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
16,,,NOT_MENTIONED,ANTIMETABOLITE,,,,boston_childrens
16,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,,,SYMPTOM_PRESENT,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,,boston_childrens
16,,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,,boston_childrens
16,,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,,boston_childrens
16,,,SYMPTOM_PRESENT,ENDOSCOPIC,,,,boston_childrens
16,,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
16,,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,,boston_childrens
16,,,SYMPTOM_PRESENT,ETOPOSIDE,,,NOT_MENTIONED,boston_childrens
16,,,SYMPTOM_PRESENT,ETOPOSIDE,,,,boston_childrens
16,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,,boston_childrens
16,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,,boston_childrens
16,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
16,,,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,NOT_MENTIONED,boston_childrens
16,,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
16,,,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,boston_childrens
16,,,,BRAF MEK COMBINATION,TARGETED_THERAPY,,,boston_childrens
16,,,,BRAF MEK COMBINATION,,cumulus__none,,boston_childrens
16,,,,BRAF MEK COMBINATION,,,,boston_childrens
16,,,,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,,,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
16,,,,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,boston_childrens
16,,,,ENDOSCOPIC,,,NOT_MENTIONED,boston_childrens
16,,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
16,,,,VINCA ALKALOID,,VINBLASTINE,DECLINING,boston_childrens
16,,,,,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
16,,,,,,VINBLASTINE,DECLINING,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,STABLE,,,,,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,STABLE,,,,,,
15,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,
15,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,cumulus__none,,
15,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,VINBLASTINE,,
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,,IMPROVING,
15,AVAILABLE_AND_ELIGIBLE,,,MAPK,TARGETED_THERAPY,,,
15,AVAILABLE_AND_ELIGIBLE,,,MAPK,,,,
15,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
15,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
15,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,CHEMOTHERAPY,,,
15,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,,,,
15,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,,,,,VINBLASTINE,NOT_MENTIONED,
15,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,,
15,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,,,
15,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,,,
15,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,,,
15,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,,,,
15,AVAILABLE_NOT_ELIGIBLE,,,,CHEMOTHERAPY,,,
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,,
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,,
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,,
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,,,
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,,,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,SURGERY,GROSS_TOTAL,,
15,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,SURGERY,,,
15,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,,GROSS_TOTAL,,
15,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,,,,
15,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
15,NOT_MENTIONED,PROGRESSION,,PLATINUM,,NOT_MENTIONED,DECLINING,
15,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,
15,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,NOT_MENTIONED,,
15,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,
15,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,OTHER,DECLINING,
15,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,,,,
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,,,
15,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
15,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,,,
15,NOT_MENTIONED,STABLE,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,,ALKYLATING,,NOT_MENTIONED,,
15,NOT_MENTIONED,STABLE,,ALKYLATING,,,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,,ALKYLATING,,,,
15,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
15,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
15,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,OTHER,,
15,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
15,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,
15,NOT_MENTIONED,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
15,NOT_MENTIONED,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
15,NOT_MENTIONED,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,
15,NOT_MENTIONED,,NOT_MENTIONED,MAPK,,,NOT_MENTIONED,
15,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
15,NOT_MENTIONED,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,
15,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
15,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,
15,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,
15,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,,,NOT_MENTIONED,
15,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
15,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
15,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
15,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,,,NOT_MENTIONED,
15,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
15,NOT_MENTIONED,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,DECLINING,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,,,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,,,,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,DECLINING,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,DECLINING,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,PARTIAL,,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,,GROSS_TOTAL,,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,,PARTIAL,,
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
15,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,
15,NOT_MENTIONED,,,ALKYLATING,,OTHER,DECLINING,
15,NOT_MENTIONED,,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,
15,NOT_MENTIONED,,,BRAF MEK COMBINATION,TARGETED_THERAPY,,,
15,NOT_MENTIONED,,,BRAF MEK COMBINATION,,cumulus__none,,
15,NOT_MENTIONED,,,BRAF MEK COMBINATION,,,,
15,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
15,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,
15,NOT_MENTIONED,,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,NOT_MENTIONED,,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,
15,NOT_MENTIONED,,,CHEMOTHERAPY,,,IMPROVING,
15,NOT_MENTIONED,,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
15,NOT_MENTIONED,,,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,
15,NOT_MENTIONED,,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,NOT_MENTIONED,,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
15,NOT_MENTIONED,,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,NOT_MENTIONED,,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,
15,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,,,
15,NOT_MENTIONED,,,LOMUSTINE,,,,
15,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
15,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,
15,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
15,NOT_MENTIONED,,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,NOT_MENTIONED,,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,
15,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,,IMPROVING,
15,NOT_MENTIONED,,,VINCA ALKALOID,,,IMPROVING,
15,NOT_MENTIONED,,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,NOT_MENTIONED,,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
15,NOT_MENTIONED,,,,SURGERY,PARTIAL,NOT_MENTIONED,
15,NOT_MENTIONED,,,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,NOT_MENTIONED,,,,,Etoposide 20 MG/ML Injectable Solution,,
15,NOT_MENTIONED,,,,,PARTIAL,NOT_MENTIONED,
15,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
15,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,
15,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,,
15,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,,,
15,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,
15,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,,
15,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,,NOT_MENTIONED,
15,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,,,
15,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,
15,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,DECLINING,
15,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,DECLINING,
15,,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,DECLINING,
15,,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,
15,,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,,,
15,,PROGRESSION,,BRAF MEK COMBINATION,,cumulus__none,,
15,,PROGRESSION,,BRAF MEK COMBINATION,,,,
15,,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
15,,PROGRESSION,,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,
15,,PROGRESSION,,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,
15,,PROGRESSION,,ENDOSCOPIC,,,NOT_MENTIONED,
15,,PROGRESSION,,GROSS TOTAL,SURGERY,GROSS_TOTAL,,
15,,PROGRESSION,,GROSS TOTAL,SURGERY,,,
15,,PROGRESSION,,GROSS TOTAL,,GROSS_TOTAL,,
15,,PROGRESSION,,GROSS TOTAL,,,,
15,,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,
15,,PROGRESSION,,TEMOZOLOMIDE,,,NOT_MENTIONED,
15,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
15,,PROGRESSION,,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,
15,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
15,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,
15,,STABLE,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,
15,,STABLE,NOT_MENTIONED,,,OTHER,,
15,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
15,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
15,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
15,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,
15,,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,
15,,STABLE,SYMPTOM_PRESENT,PLATINUM,,,,
15,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
15,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,
15,,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,
15,,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
15,,,NOT_MENTIONED,ANTIMETABOLITE,,,NOT_MENTIONED,
15,,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,
15,,,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,,
15,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
15,,,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,
15,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,
15,,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,DECLINING,
15,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,DECLINING,
15,,,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,,
15,,,SYMPTOM_PRESENT,,SURGERY,PARTIAL,,
15,,,SYMPTOM_PRESENT,,,GROSS_TOTAL,,
15,,,SYMPTOM_PRESENT,,,PARTIAL,,
15,,,SYMPTOM_PRESENT,,,VINBLASTINE,DECLINING,
15,,,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
15,,,,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,
15,,,,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,
15,,,,BRAF MEK COMBINATION,,,NOT_MENTIONED,
15,,,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,,,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
15,,,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,,,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,
15,,,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
15,,,,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,
15,,,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,,,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
15,,,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,,,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,
15,,,,LOMUSTINE,CHEMOTHERAPY,,,
15,,,,LOMUSTINE,,,,
15,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
15,,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,
15,,,,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,
15,,,,TEMOZOLOMIDE,,,NOT_MENTIONED,
15,,,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,,,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
15,,,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,,,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,
15,,,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,,,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
15,,,,,SURGERY,PARTIAL,NOT_MENTIONED,
15,,,,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
15,,,,,,Etoposide 20 MG/ML Injectable Solution,,
15,,,,,,NOT_MENTIONED,IMPROVING,
15,,,,,,PARTIAL,NOT_MENTIONED,
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,STABLE,,,,,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,STABLE,,,,,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,cumulus__none,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,DECLINING,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,VINBLASTINE,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,,IMPROVING,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,MAPK,TARGETED_THERAPY,,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,MAPK,,,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,,,,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
15,AVAILABLE_AND_ELIGIBLE,,,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
15,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
15,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,,,boston_childrens
15,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,,,boston_childrens
15,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
15,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,,,,boston_childrens
15,AVAILABLE_NOT_ELIGIBLE,,,,CHEMOTHERAPY,,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,SURGERY,GROSS_TOTAL,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,SURGERY,,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,,GROSS_TOTAL,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,,,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,PLATINUM,,NOT_MENTIONED,DECLINING,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,NOT_MENTIONED,,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,OTHER,DECLINING,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,boston_childrens
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,,,,boston_childrens
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,,,boston_childrens
15,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
15,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
15,NOT_MENTIONED,STABLE,,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,,ALKYLATING,,NOT_MENTIONED,,boston_childrens
15,NOT_MENTIONED,STABLE,,ALKYLATING,,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,,ALKYLATING,,,,boston_childrens
15,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
15,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,OTHER,,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,MAPK,,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,OTHER TARGETED,,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
15,NOT_MENTIONED,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,DECLINING,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,,,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,,,,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,DECLINING,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,DECLINING,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,PARTIAL,,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,,GROSS_TOTAL,,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,,PARTIAL,,boston_childrens
15,NOT_MENTIONED,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
15,NOT_MENTIONED,,,ALKYLATING,,OTHER,DECLINING,boston_childrens
15,NOT_MENTIONED,,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,boston_childrens
15,NOT_MENTIONED,,,BRAF MEK COMBINATION,TARGETED_THERAPY,,,boston_childrens
15,NOT_MENTIONED,,,BRAF MEK COMBINATION,,cumulus__none,,boston_childrens
15,NOT_MENTIONED,,,BRAF MEK COMBINATION,,,,boston_childrens
15,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,boston_childrens
15,NOT_MENTIONED,,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,NOT_MENTIONED,,,CHEMOTHERAPY,,,IMPROVING,boston_childrens
15,NOT_MENTIONED,,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,NOT_MENTIONED,,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,,,boston_childrens
15,NOT_MENTIONED,,,LOMUSTINE,,,,boston_childrens
15,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
15,NOT_MENTIONED,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
15,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,NOT_MENTIONED,,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,,IMPROVING,boston_childrens
15,NOT_MENTIONED,,,VINCA ALKALOID,,,IMPROVING,boston_childrens
15,NOT_MENTIONED,,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,NOT_MENTIONED,,,,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,NOT_MENTIONED,,,,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,NOT_MENTIONED,,,,,PARTIAL,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,,,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,,,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,DECLINING,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
15,,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,DECLINING,boston_childrens
15,,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,boston_childrens
15,,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,,,boston_childrens
15,,PROGRESSION,,BRAF MEK COMBINATION,,cumulus__none,,boston_childrens
15,,PROGRESSION,,BRAF MEK COMBINATION,,,,boston_childrens
15,,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,,ENDOSCOPIC,,,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,,GROSS TOTAL,SURGERY,GROSS_TOTAL,,boston_childrens
15,,PROGRESSION,,GROSS TOTAL,SURGERY,,,boston_childrens
15,,PROGRESSION,,GROSS TOTAL,,GROSS_TOTAL,,boston_childrens
15,,PROGRESSION,,GROSS TOTAL,,,,boston_childrens
15,,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,,TEMOZOLOMIDE,,,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,,PROGRESSION,,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
15,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,boston_childrens
15,,STABLE,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,boston_childrens
15,,STABLE,NOT_MENTIONED,,,OTHER,,boston_childrens
15,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
15,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
15,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
15,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,boston_childrens
15,,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,,boston_childrens
15,,STABLE,SYMPTOM_PRESENT,PLATINUM,,,,boston_childrens
15,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
15,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,boston_childrens
15,,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,boston_childrens
15,,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
15,,,NOT_MENTIONED,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
15,,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,boston_childrens
15,,,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,,boston_childrens
15,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,,,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
15,,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,DECLINING,boston_childrens
15,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
15,,,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,,boston_childrens
15,,,SYMPTOM_PRESENT,,SURGERY,PARTIAL,,boston_childrens
15,,,SYMPTOM_PRESENT,,,GROSS_TOTAL,,boston_childrens
15,,,SYMPTOM_PRESENT,,,PARTIAL,,boston_childrens
15,,,SYMPTOM_PRESENT,,,VINBLASTINE,DECLINING,boston_childrens
15,,,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
15,,,,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
15,,,,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,boston_childrens
15,,,,BRAF MEK COMBINATION,,,NOT_MENTIONED,boston_childrens
15,,,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,,,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,,,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,,,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,,,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,,,,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
15,,,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,,,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,,,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,,,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,,,,LOMUSTINE,CHEMOTHERAPY,,,boston_childrens
15,,,,LOMUSTINE,,,,boston_childrens
15,,,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
15,,,,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
15,,,,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
15,,,,TEMOZOLOMIDE,,,NOT_MENTIONED,boston_childrens
15,,,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,,,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,,,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,,,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,,,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,,,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,,,,,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
15,,,,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
15,,,,,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
15,,,,,,NOT_MENTIONED,IMPROVING,boston_childrens
15,,,,,,PARTIAL,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,,DECLINING,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,TARGETED_THERAPY,,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,,,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,NOT_MENTIONED,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,,DECLINING,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,CARBOPLATIN,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,
14,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,CHEMOTHERAPY,,,
14,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,,,,
14,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
14,AVAILABLE_AND_ELIGIBLE,,,BRAF,,trametinib 0.5 MG Oral Tablet,,
14,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
14,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,,DECLINING,
14,AVAILABLE_AND_ELIGIBLE,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
14,AVAILABLE_AND_ELIGIBLE,,,MAPK,,trametinib 0.5 MG Oral Tablet,,
14,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
14,AVAILABLE_AND_ELIGIBLE,,,MEK,,trametinib 0.5 MG Oral Tablet,,
14,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
14,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,TARGETED_THERAPY,,,
14,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
14,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,,,,
14,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,,DECLINING,
14,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
14,AVAILABLE_AND_ELIGIBLE,,,,,trametinib 0.5 MG Oral Tablet,,
14,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,
14,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,
14,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,
14,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,,NOT_MENTIONED,
14,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,NOT_MENTIONED,,
14,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,
14,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,
14,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,
14,AVAILABLE_NOT_ELIGIBLE,,,,TARGETED_THERAPY,,NOT_MENTIONED,
14,AVAILABLE_NOT_ELIGIBLE,,,,,NOT_MENTIONED,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,,,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,DECLINING,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,DECLINING,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,DECLINING,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,PARTIAL,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,PARTIAL,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,RADIOTHERAPY,,
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,
14,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,,,
14,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,,cumulus__none,,
14,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,,,,
14,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
14,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,
14,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
14,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,
14,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,SURGERY,,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,,,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
14,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,
14,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,,,
14,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,,,,
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,
14,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,DECLINING,
14,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
14,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,DECLINING,
14,NOT_MENTIONED,PROGRESSION,,,SURGERY,PARTIAL,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,,,Etoposide 20 MG/ML Injectable Solution,,
14,NOT_MENTIONED,PROGRESSION,,,,PARTIAL,NOT_MENTIONED,
14,NOT_MENTIONED,PROGRESSION,,,,VINBLASTINE,DECLINING,
14,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,
14,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,OTHER,,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,OTHER,,
14,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,OTHER,,
14,NOT_MENTIONED,STABLE,,ALKYLATING,,OTHER,NOT_MENTIONED,
14,NOT_MENTIONED,STABLE,,ALKYLATING,,OTHER,,
14,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,,
14,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,,,,
14,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,,,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,,,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,,,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,,RADIOTHERAPY,,,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,,,GROSS_TOTAL,NOT_MENTIONED,
14,NOT_MENTIONED,,SYMPTOM_PRESENT,,,RADIOTHERAPY,,
14,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
14,NOT_MENTIONED,,,ALKYLATING,,Lomustine 10 MG Oral Capsule,,
14,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
14,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
14,NOT_MENTIONED,,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,
14,NOT_MENTIONED,,,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,
14,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
14,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,
14,NOT_MENTIONED,,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,
14,NOT_MENTIONED,,,LOMUSTINE,,,NOT_MENTIONED,
14,NOT_MENTIONED,,,TEMOZOLOMIDE,CHEMOTHERAPY,,,
14,NOT_MENTIONED,,,TEMOZOLOMIDE,,,,
14,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,
14,NOT_MENTIONED,,,VINCA ALKALOID,,VINBLASTINE,DECLINING,
14,NOT_MENTIONED,,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
14,NOT_MENTIONED,,,,CHEMOTHERAPY,VINBLASTINE,DECLINING,
14,NOT_MENTIONED,,,,,Lomustine 10 MG Oral Capsule,,
14,NOT_MENTIONED,,,,,VINBLASTINE,DECLINING,
14,,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
14,,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,,
14,,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,,,NOT_MENTIONED,
14,,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,,,,
14,,PROGRESSION,NOT_MENTIONED,,,,IMPROVING,
14,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
14,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,
14,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,
14,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,,
14,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,DECLINING,
14,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,DECLINING,
14,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,
14,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,NOT_MENTIONED,
14,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,
14,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,,
14,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,DECLINING,
14,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,DECLINING,
14,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
14,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,PARTIAL,,
14,,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,DECLINING,
14,,PROGRESSION,SYMPTOM_PRESENT,,,PARTIAL,,
14,,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
14,,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,
14,,PROGRESSION,,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,
14,,PROGRESSION,,BRAF MEK COMBINATION,,,NOT_MENTIONED,
14,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
14,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
14,,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,
14,,PROGRESSION,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,,PROGRESSION,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,
14,,PROGRESSION,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
14,,PROGRESSION,,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,
14,,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
14,,PROGRESSION,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,,PROGRESSION,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,
14,,PROGRESSION,,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
14,,PROGRESSION,,GROSS TOTAL,SURGERY,,NOT_MENTIONED,
14,,PROGRESSION,,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,
14,,PROGRESSION,,GROSS TOTAL,,,NOT_MENTIONED,
14,,PROGRESSION,,MAPK,TARGETED_THERAPY,,DECLINING,
14,,PROGRESSION,,MAPK,,,DECLINING,
14,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
14,,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,
14,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
14,,PROGRESSION,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,,PROGRESSION,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,
14,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,DECLINING,
14,,PROGRESSION,,TRAMETINIB,,,DECLINING,
14,,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
14,,PROGRESSION,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,,PROGRESSION,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
14,,PROGRESSION,,,SURGERY,PARTIAL,NOT_MENTIONED,
14,,PROGRESSION,,,,BEVACIZUMAB,DECLINING,
14,,PROGRESSION,,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
14,,PROGRESSION,,,,Etoposide 20 MG/ML Injectable Solution,,
14,,PROGRESSION,,,,PARTIAL,NOT_MENTIONED,
14,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
14,,STABLE,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
14,,STABLE,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,
14,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
14,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
14,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
14,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,
14,,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
14,,STABLE,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,
14,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
14,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
14,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,
14,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
14,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,
14,,STABLE,SYMPTOM_PRESENT,,,OTHER,,
14,,STABLE,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
14,,STABLE,,ALKYLATING,CHEMOTHERAPY,OTHER,,
14,,STABLE,,ALKYLATING,,OTHER,NOT_MENTIONED,
14,,STABLE,,ALKYLATING,,OTHER,,
14,,STABLE,,PLATINUM,CHEMOTHERAPY,OTHER,,
14,,STABLE,,PLATINUM,,OTHER,,
14,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
14,,,NOT_MENTIONED,CHEMOTHERAPY,,,DECLINING,
14,,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
14,,,NOT_MENTIONED,,CHEMOTHERAPY,,DECLINING,
14,,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,DECLINING,
14,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
14,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,
14,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,
14,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,IMPROVING,
14,,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,,
14,,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,,
14,,,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,,
14,,,SYMPTOM_PRESENT,GROSS TOTAL,,,,
14,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,,
14,,,SYMPTOM_PRESENT,LOMUSTINE,,,,
14,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,DECLINING,
14,,,SYMPTOM_PRESENT,MAPK,,,DECLINING,
14,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,
14,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,NOT_MENTIONED,
14,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,DECLINING,
14,,,SYMPTOM_PRESENT,TRAMETINIB,,,DECLINING,
14,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
14,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,IMPROVING,
14,,,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
14,,,SYMPTOM_PRESENT,,,BEVACIZUMAB,DECLINING,
14,,,SYMPTOM_PRESENT,,,GROSS_TOTAL,NOT_MENTIONED,
14,,,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
14,,,,ALKYLATING,,Lomustine 10 MG Oral Capsule,,
14,,,,ANTIMETABOLITE,CHEMOTHERAPY,,DECLINING,
14,,,,ANTIMETABOLITE,,,DECLINING,
14,,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
14,,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,
14,,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
14,,,,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,
14,,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,IMPROVING,
14,,,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,
14,,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
14,,,,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,
14,,,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,
14,,,,LOMUSTINE,,,NOT_MENTIONED,
14,,,,MAPK,TARGETED_THERAPY,,DECLINING,
14,,,,MAPK,,,DECLINING,
14,,,,PLATINUM,CHEMOTHERAPY,,IMPROVING,
14,,,,PLATINUM,,,IMPROVING,
14,,,,TOPOISOMERASE,CHEMOTHERAPY,,DECLINING,
14,,,,TOPOISOMERASE,,,DECLINING,
14,,,,TRAMETINIB,TARGETED_THERAPY,,DECLINING,
14,,,,TRAMETINIB,,,DECLINING,
14,,,,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
14,,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,
14,,,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
14,,,,,TARGETED_THERAPY,,IMPROVING,
14,,,,,,BEVACIZUMAB,DECLINING,
14,,,,,,CARBOPLATIN_VINCRISTINE,IMPROVING,
14,,,,,,Lomustine 10 MG Oral Capsule,,
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,,DECLINING,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,TARGETED_THERAPY,,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,,,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,NOT_MENTIONED,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,,DECLINING,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,cumulus__none,DECLINING,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,,,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,,DECLINING,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,,,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,,DECLINING,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,AVAILABLE_AND_ELIGIBLE,,,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
14,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,boston_childrens
14,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,boston_childrens
14,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
14,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,NOT_MENTIONED,,boston_childrens
14,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
14,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,,boston_childrens
14,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,,boston_childrens
14,AVAILABLE_NOT_ELIGIBLE,,,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
14,AVAILABLE_NOT_ELIGIBLE,,,,,NOT_MENTIONED,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,OTHER,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,PARTIAL,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,PARTIAL,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,RADIOTHERAPY,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,,cumulus__none,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,,,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,GROSS TOTAL,,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,,,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,,,PARTIAL,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,PROGRESSION,,,,VINBLASTINE,DECLINING,boston_childrens
14,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,boston_childrens
14,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,OTHER,,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,OTHER,,boston_childrens
14,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
14,NOT_MENTIONED,STABLE,,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,STABLE,,ALKYLATING,,OTHER,,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,,,,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,,,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,,,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,,,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,,RADIOTHERAPY,,,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,SYMPTOM_PRESENT,,,RADIOTHERAPY,,boston_childrens
14,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
14,NOT_MENTIONED,,,ALKYLATING,,Lomustine 10 MG Oral Capsule,,boston_childrens
14,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
14,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
14,NOT_MENTIONED,,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,boston_childrens
14,NOT_MENTIONED,,,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,boston_childrens
14,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
14,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,boston_childrens
14,NOT_MENTIONED,,,LOMUSTINE,,,NOT_MENTIONED,boston_childrens
14,NOT_MENTIONED,,,TEMOZOLOMIDE,CHEMOTHERAPY,,,boston_childrens
14,NOT_MENTIONED,,,TEMOZOLOMIDE,,,,boston_childrens
14,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
14,NOT_MENTIONED,,,VINCA ALKALOID,,VINBLASTINE,DECLINING,boston_childrens
14,NOT_MENTIONED,,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
14,NOT_MENTIONED,,,,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
14,NOT_MENTIONED,,,,,Lomustine 10 MG Oral Capsule,,boston_childrens
14,NOT_MENTIONED,,,,,VINBLASTINE,DECLINING,boston_childrens
14,,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
14,,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,,,,boston_childrens
14,,PROGRESSION,NOT_MENTIONED,,,,IMPROVING,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,DECLINING,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,DECLINING,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,DECLINING,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,DECLINING,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,PARTIAL,,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,DECLINING,boston_childrens
14,,PROGRESSION,SYMPTOM_PRESENT,,,PARTIAL,,boston_childrens
14,,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,BRAF MEK COMBINATION,,,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
14,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,boston_childrens
14,,PROGRESSION,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,,PROGRESSION,,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,,PROGRESSION,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,,PROGRESSION,,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,GROSS TOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,GROSS TOTAL,,,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,MAPK,TARGETED_THERAPY,,DECLINING,boston_childrens
14,,PROGRESSION,,MAPK,,,DECLINING,boston_childrens
14,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
14,,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
14,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,,PROGRESSION,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,DECLINING,boston_childrens
14,,PROGRESSION,,TRAMETINIB,,,DECLINING,boston_childrens
14,,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
14,,PROGRESSION,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,,PROGRESSION,,,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,,,BEVACIZUMAB,DECLINING,boston_childrens
14,,PROGRESSION,,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
14,,PROGRESSION,,,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
14,,PROGRESSION,,,,PARTIAL,NOT_MENTIONED,boston_childrens
14,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
14,,STABLE,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,,STABLE,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,boston_childrens
14,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
14,,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
14,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
14,,STABLE,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,boston_childrens
14,,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
14,,STABLE,SYMPTOM_PRESENT,PLATINUM,,,NOT_MENTIONED,boston_childrens
14,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
14,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
14,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
14,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,boston_childrens
14,,STABLE,SYMPTOM_PRESENT,,,OTHER,,boston_childrens
14,,STABLE,,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
14,,STABLE,,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
14,,STABLE,,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
14,,STABLE,,ALKYLATING,,OTHER,,boston_childrens
14,,STABLE,,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
14,,STABLE,,PLATINUM,,OTHER,,boston_childrens
14,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
14,,,NOT_MENTIONED,CHEMOTHERAPY,,,DECLINING,boston_childrens
14,,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
14,,,NOT_MENTIONED,,CHEMOTHERAPY,,DECLINING,boston_childrens
14,,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
14,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
14,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,boston_childrens
14,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,boston_childrens
14,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,IMPROVING,boston_childrens
14,,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,,boston_childrens
14,,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,,boston_childrens
14,,,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,,boston_childrens
14,,,SYMPTOM_PRESENT,GROSS TOTAL,,,,boston_childrens
14,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,,boston_childrens
14,,,SYMPTOM_PRESENT,LOMUSTINE,,,,boston_childrens
14,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,DECLINING,boston_childrens
14,,,SYMPTOM_PRESENT,MAPK,,,DECLINING,boston_childrens
14,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
14,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,NOT_MENTIONED,boston_childrens
14,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,DECLINING,boston_childrens
14,,,SYMPTOM_PRESENT,TRAMETINIB,,,DECLINING,boston_childrens
14,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
14,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,IMPROVING,boston_childrens
14,,,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
14,,,SYMPTOM_PRESENT,,,BEVACIZUMAB,DECLINING,boston_childrens
14,,,SYMPTOM_PRESENT,,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
14,,,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
14,,,,ALKYLATING,,Lomustine 10 MG Oral Capsule,,boston_childrens
14,,,,ANTIMETABOLITE,CHEMOTHERAPY,,DECLINING,boston_childrens
14,,,,ANTIMETABOLITE,,,DECLINING,boston_childrens
14,,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
14,,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
14,,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
14,,,,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,boston_childrens
14,,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
14,,,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,boston_childrens
14,,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
14,,,,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
14,,,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,boston_childrens
14,,,,LOMUSTINE,,,NOT_MENTIONED,boston_childrens
14,,,,MAPK,TARGETED_THERAPY,,DECLINING,boston_childrens
14,,,,MAPK,,,DECLINING,boston_childrens
14,,,,PLATINUM,CHEMOTHERAPY,,IMPROVING,boston_childrens
14,,,,PLATINUM,,,IMPROVING,boston_childrens
14,,,,TOPOISOMERASE,CHEMOTHERAPY,,DECLINING,boston_childrens
14,,,,TOPOISOMERASE,,,DECLINING,boston_childrens
14,,,,TRAMETINIB,TARGETED_THERAPY,,DECLINING,boston_childrens
14,,,,TRAMETINIB,,,DECLINING,boston_childrens
14,,,,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
14,,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
14,,,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
14,,,,,TARGETED_THERAPY,,IMPROVING,boston_childrens
14,,,,,,BEVACIZUMAB,DECLINING,boston_childrens
14,,,,,,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
14,,,,,,Lomustine 10 MG Oral Capsule,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,,,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,,cumulus__none,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TOPOISOMERASE,,,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,,,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,OBSERVATION,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,NOT_MENTIONED,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,OBSERVATION,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,CARBOPLATIN,,
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,,IMPROVING,
13,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,,,BRAF,,,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,,,MAPK,,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,,,MTOR,,cumulus__none,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,,,MTOR,,,NOT_MENTIONED,
13,AVAILABLE_AND_ELIGIBLE,,,,,NOT_MENTIONED,DECLINING,
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,,
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,,
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,,,
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,BRAF,,,,
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,cumulus__none,NOT_MENTIONED,
13,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,
13,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,NOT_MENTIONED,,
13,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,cumulus__none,,
13,AVAILABLE_NOT_ELIGIBLE,,,BRAF,TARGETED_THERAPY,,,
13,AVAILABLE_NOT_ELIGIBLE,,,BRAF,,,,
13,AVAILABLE_NOT_ELIGIBLE,,,OBSERVATION,OBSERVATION,OBSERVATION,,
13,AVAILABLE_NOT_ELIGIBLE,,,OBSERVATION,OBSERVATION,,,
13,AVAILABLE_NOT_ELIGIBLE,,,OBSERVATION,,OBSERVATION,,
13,AVAILABLE_NOT_ELIGIBLE,,,OBSERVATION,,,,
13,AVAILABLE_NOT_ELIGIBLE,,,,OBSERVATION,OBSERVATION,,
13,AVAILABLE_NOT_ELIGIBLE,,,,OBSERVATION,,,
13,AVAILABLE_NOT_ELIGIBLE,,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
13,AVAILABLE_NOT_ELIGIBLE,,,,,OBSERVATION,,
13,AVAILABLE_NOT_ELIGIBLE,,,,,cumulus__none,NOT_MENTIONED,
13,NOT_AVAILABLE,PROGRESSION,SYMPTOM_PRESENT,,,,,
13,NOT_AVAILABLE,,SYMPTOM_PRESENT,,,,,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,,IMPROVING,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,DECLINING,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,DECLINING,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,GROSS_TOTAL,,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,RADIOTHERAPY,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,DECLINING,
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,,IMPROVING,
13,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,
13,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,OTHER,DECLINING,
13,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
13,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,
13,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,SUBTOTAL,,
13,NOT_MENTIONED,PROGRESSION,,DEBULKING,,SUBTOTAL,,
13,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,
13,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,,,NOT_MENTIONED,
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,
13,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
13,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,
13,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
13,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,
13,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
13,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,OTHER,,
13,NOT_MENTIONED,STABLE,,PLATINUM,,OTHER,NOT_MENTIONED,
13,NOT_MENTIONED,STABLE,,PLATINUM,,OTHER,,
13,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
13,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,,,NOT_MENTIONED,
13,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,,NOT_MENTIONED,
13,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,,,
13,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,,NOT_MENTIONED,
13,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,,,
13,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
13,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,SURGERY,,,
13,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,,,NOT_MENTIONED,
13,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,,,,
13,NOT_MENTIONED,,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
13,NOT_MENTIONED,,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,,
13,NOT_MENTIONED,,NOT_MENTIONED,TOPOISOMERASE,,,NOT_MENTIONED,
13,NOT_MENTIONED,,NOT_MENTIONED,TOPOISOMERASE,,,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,DECLINING,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,,,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,,,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,,,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,,,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,DECLINING,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,DECLINING,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,RADIOTHERAPY,,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,,RADIOTHERAPY,NOT_MENTIONED,
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,,VINBLASTINE,DECLINING,
13,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,NOT_MENTIONED,,,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,NOT_MENTIONED,,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,NOT_MENTIONED,,,DEBULKING,SURGERY,SUBTOTAL,,
13,NOT_MENTIONED,,,DEBULKING,,SUBTOTAL,,
13,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,NOT_MENTIONED,,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,NOT_MENTIONED,,,PARTIAL,SURGERY,PARTIAL,,
13,NOT_MENTIONED,,,PARTIAL,SURGERY,,,
13,NOT_MENTIONED,,,PARTIAL,,PARTIAL,,
13,NOT_MENTIONED,,,PARTIAL,,,,
13,NOT_MENTIONED,,,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,
13,NOT_MENTIONED,,,TEMOZOLOMIDE,,,NOT_MENTIONED,
13,NOT_MENTIONED,,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,NOT_MENTIONED,,,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,OTHER,PROGRESSION,,,,,,
13,OTHER,,,,,,,
13,,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,,
13,,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,,,,
13,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
13,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,OTHER,NOT_MENTIONED,
13,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
13,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,NOT_MENTIONED,
13,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,,
13,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,SYMPTOM_PRESENT,,,GROSS_TOTAL,,
13,,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,DECLINING,
13,,PROGRESSION,,ANTIMETABOLITE,,,DECLINING,
13,,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,,DEBULKING,SURGERY,SUBTOTAL,,
13,,PROGRESSION,,DEBULKING,,SUBTOTAL,,
13,,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,DECLINING,
13,,PROGRESSION,,NOT MENTIONED,,,DECLINING,
13,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,DECLINING,
13,,PROGRESSION,,TOPOISOMERASE,,,DECLINING,
13,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
13,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
13,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
13,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,
13,,STABLE,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
13,,STABLE,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,
13,,STABLE,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,
13,,STABLE,NOT_MENTIONED,ALKYLATING,,,,
13,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
13,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
13,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
13,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,
13,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
13,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,IMPROVING,
13,,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,IMPROVING,
13,,STABLE,NOT_MENTIONED,OBSERVATION,,,IMPROVING,
13,,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,IMPROVING,
13,,STABLE,NOT_MENTIONED,,OBSERVATION,,IMPROVING,
13,,STABLE,NOT_MENTIONED,,,OBSERVATION,IMPROVING,
13,,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
13,,STABLE,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,
13,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
13,,STABLE,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,
13,,STABLE,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
13,,STABLE,,PLATINUM,,OTHER,NOT_MENTIONED,
13,,,NOT_MENTIONED,BIOPSY,SURGERY,,NOT_MENTIONED,
13,,,NOT_MENTIONED,BIOPSY,SURGERY,,,
13,,,NOT_MENTIONED,BIOPSY,,,NOT_MENTIONED,
13,,,NOT_MENTIONED,BIOPSY,,,,
13,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
13,,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
13,,,NOT_MENTIONED,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
13,,,NOT_MENTIONED,CRANIOTOMY,SURGERY,,,
13,,,NOT_MENTIONED,CRANIOTOMY,,,NOT_MENTIONED,
13,,,NOT_MENTIONED,CRANIOTOMY,,,,
13,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
13,,,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,,
13,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,DECLINING,
13,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,DECLINING,
13,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,,
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,,
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,,
13,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
13,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,
13,,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,ENDOSCOPIC,,,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,GROSS TOTAL,,,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
13,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,
13,,,SYMPTOM_PRESENT,LOMUSTINE,,,NOT_MENTIONED,
13,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,DECLINING,
13,,,SYMPTOM_PRESENT,NOT MENTIONED,,,DECLINING,
13,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,DECLINING,
13,,,SYMPTOM_PRESENT,TOPOISOMERASE,,,DECLINING,
13,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,,
13,,,SYMPTOM_PRESENT,VINCRISTINE,,,,
13,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
13,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,,
13,,,SYMPTOM_PRESENT,,,NOT_MENTIONED,IMPROVING,
13,,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,,,,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,,,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,,,,DEBULKING,SURGERY,SUBTOTAL,,
13,,,,DEBULKING,,SUBTOTAL,,
13,,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,,,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,,NOT MENTIONED,,NOT_MENTIONED,DECLINING,
13,,,,NOT MENTIONED,,,DECLINING,
13,,,,PARTIAL,SURGERY,PARTIAL,,
13,,,,PARTIAL,SURGERY,,,
13,,,,PARTIAL,,PARTIAL,,
13,,,,PARTIAL,,,,
13,,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,,VINCRISTINE,CHEMOTHERAPY,,,
13,,,,VINCRISTINE,,,,
13,,,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,,,,,TARGETED_THERAPY,cumulus__none,IMPROVING,
13,,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
13,,,,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
13,,,,,,cumulus__none,IMPROVING,
13,,,,,,trametinib 0.5 MG Oral Tablet,DECLINING,
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,,,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MTOR,,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,OBSERVATION,,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TOPOISOMERASE,,,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,,,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,OBSERVATION,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,NOT_MENTIONED,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,OBSERVATION,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,NOT_MENTIONED,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,CARBOPLATIN,,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,,IMPROVING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,,BRAF,,,DECLINING,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,,MAPK,,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,,MTOR,,,NOT_MENTIONED,boston_childrens
13,AVAILABLE_AND_ELIGIBLE,,,,,NOT_MENTIONED,DECLINING,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,cumulus__none,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,BRAF,,,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,cumulus__none,NOT_MENTIONED,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,cumulus__none,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,NOT_MENTIONED,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,cumulus__none,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,BRAF,TARGETED_THERAPY,,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,BRAF,,,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,OBSERVATION,OBSERVATION,,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,OBSERVATION,,OBSERVATION,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,OBSERVATION,,,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,,OBSERVATION,OBSERVATION,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,,OBSERVATION,,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,,,OBSERVATION,,boston_childrens
13,AVAILABLE_NOT_ELIGIBLE,,,,,cumulus__none,NOT_MENTIONED,boston_childrens
13,NOT_AVAILABLE,PROGRESSION,SYMPTOM_PRESENT,,,,,boston_childrens
13,NOT_AVAILABLE,,SYMPTOM_PRESENT,,,,,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,,IMPROVING,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,RADIOTHERAPY,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,DECLINING,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,GROSS_TOTAL,,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,DECLINING,boston_childrens
13,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,,IMPROVING,boston_childrens
13,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
13,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,OTHER,DECLINING,boston_childrens
13,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
13,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,boston_childrens
13,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,SUBTOTAL,,boston_childrens
13,NOT_MENTIONED,PROGRESSION,,DEBULKING,,SUBTOTAL,,boston_childrens
13,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,boston_childrens
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,STABLE,NOT_MENTIONED,VINCA ALKALOID,,OTHER,,boston_childrens
13,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
13,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,boston_childrens
13,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,STABLE,,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
13,NOT_MENTIONED,STABLE,,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,STABLE,,PLATINUM,,OTHER,,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,,,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,,,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,SURGERY,,,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,,,,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,NOT_MENTIONED,TOPOISOMERASE,,,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,OTHER,DECLINING,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,GROSS TOTAL,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,RADIOTHERAPY,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,DECLINING,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,DECLINING,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,RADIOTHERAPY,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,RADIOTHERAPY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,,RADIOTHERAPY,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,SYMPTOM_PRESENT,,,VINBLASTINE,DECLINING,boston_childrens
13,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,,DEBULKING,SURGERY,SUBTOTAL,,boston_childrens
13,NOT_MENTIONED,,,DEBULKING,,SUBTOTAL,,boston_childrens
13,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,,PARTIAL,SURGERY,PARTIAL,,boston_childrens
13,NOT_MENTIONED,,,PARTIAL,SURGERY,,,boston_childrens
13,NOT_MENTIONED,,,PARTIAL,,PARTIAL,,boston_childrens
13,NOT_MENTIONED,,,PARTIAL,,,,boston_childrens
13,NOT_MENTIONED,,,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,,TEMOZOLOMIDE,,,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,NOT_MENTIONED,,,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,OTHER,PROGRESSION,,,,,,boston_childrens
13,OTHER,,,,,,,boston_childrens
13,,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
13,,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,,,,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,NOT_MENTIONED,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,,,GROSS_TOTAL,,boston_childrens
13,,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,DECLINING,boston_childrens
13,,PROGRESSION,,ANTIMETABOLITE,,,DECLINING,boston_childrens
13,,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,,DEBULKING,SURGERY,SUBTOTAL,,boston_childrens
13,,PROGRESSION,,DEBULKING,,SUBTOTAL,,boston_childrens
13,,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,DECLINING,boston_childrens
13,,PROGRESSION,,NOT MENTIONED,,,DECLINING,boston_childrens
13,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,,DECLINING,boston_childrens
13,,PROGRESSION,,TOPOISOMERASE,,,DECLINING,boston_childrens
13,,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
13,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
13,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
13,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
13,,STABLE,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
13,,STABLE,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,boston_childrens
13,,STABLE,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,boston_childrens
13,,STABLE,NOT_MENTIONED,ALKYLATING,,,,boston_childrens
13,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
13,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
13,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
13,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,boston_childrens
13,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
13,,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
13,,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
13,,STABLE,NOT_MENTIONED,OBSERVATION,,,IMPROVING,boston_childrens
13,,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
13,,STABLE,NOT_MENTIONED,,OBSERVATION,,IMPROVING,boston_childrens
13,,STABLE,NOT_MENTIONED,,,OBSERVATION,IMPROVING,boston_childrens
13,,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
13,,STABLE,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,boston_childrens
13,,STABLE,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
13,,STABLE,SYMPTOM_PRESENT,,,OTHER,NOT_MENTIONED,boston_childrens
13,,STABLE,,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
13,,STABLE,,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
13,,,NOT_MENTIONED,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
13,,,NOT_MENTIONED,BIOPSY,SURGERY,,,boston_childrens
13,,,NOT_MENTIONED,BIOPSY,,,NOT_MENTIONED,boston_childrens
13,,,NOT_MENTIONED,BIOPSY,,,,boston_childrens
13,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
13,,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
13,,,NOT_MENTIONED,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
13,,,NOT_MENTIONED,CRANIOTOMY,SURGERY,,,boston_childrens
13,,,NOT_MENTIONED,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
13,,,NOT_MENTIONED,CRANIOTOMY,,,,boston_childrens
13,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
13,,,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,,boston_childrens
13,,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,boston_childrens
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,,boston_childrens
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,,boston_childrens
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,,boston_childrens
13,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
13,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,boston_childrens
13,,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,ENDOSCOPIC,,,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,GROSS TOTAL,,,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
13,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,boston_childrens
13,,,SYMPTOM_PRESENT,LOMUSTINE,,,NOT_MENTIONED,boston_childrens
13,,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,NOT MENTIONED,,,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,TOPOISOMERASE,,,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,,boston_childrens
13,,,SYMPTOM_PRESENT,VINCRISTINE,,,,boston_childrens
13,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
13,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,,boston_childrens
13,,,SYMPTOM_PRESENT,,,NOT_MENTIONED,IMPROVING,boston_childrens
13,,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,,,,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,,,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,,,,DEBULKING,SURGERY,SUBTOTAL,,boston_childrens
13,,,,DEBULKING,,SUBTOTAL,,boston_childrens
13,,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,,,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,,NOT MENTIONED,,NOT_MENTIONED,DECLINING,boston_childrens
13,,,,NOT MENTIONED,,,DECLINING,boston_childrens
13,,,,PARTIAL,SURGERY,PARTIAL,,boston_childrens
13,,,,PARTIAL,SURGERY,,,boston_childrens
13,,,,PARTIAL,,PARTIAL,,boston_childrens
13,,,,PARTIAL,,,,boston_childrens
13,,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,,VINCRISTINE,CHEMOTHERAPY,,,boston_childrens
13,,,,VINCRISTINE,,,,boston_childrens
13,,,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,,,,,TARGETED_THERAPY,cumulus__none,IMPROVING,boston_childrens
13,,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
13,,,,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
13,,,,,,cumulus__none,IMPROVING,boston_childrens
13,,,,,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,OTHER,,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,,,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,cumulus__none,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,OTHER,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,OTHER,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,VINBLASTINE,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,,IMPROVING,
12,AVAILABLE_AND_ELIGIBLE,STABLE,NOT_MENTIONED,,,,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,,,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,,,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,CARBOPLATIN,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,CARBOPLATIN,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,OBSERVATION,,
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,OTHER,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
12,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,,NOT_MENTIONED,,
12,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,,,MEK,,cumulus__none,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,MEK,,,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,OTHER,,
12,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,OTHER,,
12,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,,,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,OTHER,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
12,AVAILABLE_AND_ELIGIBLE,,,,,OTHER,DECLINING,
12,AVAILABLE_AND_ELIGIBLE,,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
12,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,,,
12,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MEK,,,,
12,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,,
12,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,OTHER,,
12,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,OTHER,,
12,AVAILABLE_NOT_ELIGIBLE,,NOT_MENTIONED,,,,,
12,AVAILABLE_NOT_ELIGIBLE,,,MEK,TARGETED_THERAPY,,,
12,AVAILABLE_NOT_ELIGIBLE,,,MEK,,,,
12,AVAILABLE_NOT_ELIGIBLE,,,,CHEMOTHERAPY,NOT_MENTIONED,,
12,AVAILABLE_NOT_ELIGIBLE,,,,CHEMOTHERAPY,OTHER,,
12,AVAILABLE_NOT_ELIGIBLE,,,,,OTHER,,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,,,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,,,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,OTHER,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,GROSS_TOTAL,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,,DEBULKING,,SUBTOTAL,NOT_MENTIONED,
12,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,,,
12,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,,,,
12,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,,MAPK,,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,
12,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,DECLINING,
12,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,,PARTIAL,SURGERY,PARTIAL,,
12,NOT_MENTIONED,PROGRESSION,,PARTIAL,SURGERY,,,
12,NOT_MENTIONED,PROGRESSION,,PARTIAL,,PARTIAL,,
12,NOT_MENTIONED,PROGRESSION,,PARTIAL,,,,
12,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,DECLINING,
12,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,,DECLINING,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,,,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,
12,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
12,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,,DECLINING,
12,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
12,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,,DECLINING,
12,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,,IMPROVING,
12,NOT_MENTIONED,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,,DECLINING,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,,
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,NOT_MENTIONED,,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
12,NOT_MENTIONED,,,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,
12,NOT_MENTIONED,,,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,
12,NOT_MENTIONED,,,BRAF MEK COMBINATION,,,NOT_MENTIONED,
12,NOT_MENTIONED,,,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,
12,NOT_MENTIONED,,,DEBULKING,,SUBTOTAL,NOT_MENTIONED,
12,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,,DECLINING,
12,NOT_MENTIONED,,,MAPK,,,DECLINING,
12,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,
12,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,,DECLINING,
12,NOT_MENTIONED,,,NOT MENTIONED,,NOT_MENTIONED,DECLINING,
12,NOT_MENTIONED,,,NOT MENTIONED,,,DECLINING,
12,NOT_MENTIONED,,,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,
12,NOT_MENTIONED,,,PARTIAL,SURGERY,,NOT_MENTIONED,
12,NOT_MENTIONED,,,PARTIAL,,PARTIAL,NOT_MENTIONED,
12,NOT_MENTIONED,,,PARTIAL,,,NOT_MENTIONED,
12,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,,DECLINING,
12,NOT_MENTIONED,,,TRAMETINIB,,,DECLINING,
12,NOT_MENTIONED,,,VINCRISTINE,CHEMOTHERAPY,,,
12,NOT_MENTIONED,,,VINCRISTINE,,,,
12,NOT_MENTIONED,,,,,NOT_MENTIONED,IMPROVING,
12,,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
12,,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,,,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,,
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,,
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,,
12,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,
12,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,,
12,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,,
12,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,,
12,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,,
12,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,,
12,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,,
12,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,,,
12,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,,
12,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,,,
12,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,,
12,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,,,,
12,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,,
12,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,DECLINING,
12,,PROGRESSION,SYMPTOM_PRESENT,,,GROSS_TOTAL,NOT_MENTIONED,
12,,PROGRESSION,SYMPTOM_PRESENT,,,TPCV,,
12,,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,
12,,PROGRESSION,,BIOPSY,SURGERY,,DECLINING,
12,,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,DECLINING,
12,,PROGRESSION,,BIOPSY,,,DECLINING,
12,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,
12,,PROGRESSION,,CHEMOTHERAPY,,TPCV,,
12,,PROGRESSION,,CRANIOTOMY,SURGERY,,DECLINING,
12,,PROGRESSION,,CRANIOTOMY,,,DECLINING,
12,,PROGRESSION,,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,
12,,PROGRESSION,,DEBULKING,,SUBTOTAL,NOT_MENTIONED,
12,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,,,
12,,PROGRESSION,,LOMUSTINE,,,,
12,,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,
12,,PROGRESSION,,NOT MENTIONED,SURGERY,,DECLINING,
12,,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
12,,PROGRESSION,,OBSERVATION,OBSERVATION,,IMPROVING,
12,,PROGRESSION,,OBSERVATION,,OBSERVATION,IMPROVING,
12,,PROGRESSION,,OBSERVATION,,,IMPROVING,
12,,PROGRESSION,,PARTIAL,SURGERY,PARTIAL,,
12,,PROGRESSION,,PARTIAL,SURGERY,,,
12,,PROGRESSION,,PARTIAL,,PARTIAL,,
12,,PROGRESSION,,PARTIAL,,,,
12,,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,,,
12,,PROGRESSION,,VINCRISTINE,,,,
12,,PROGRESSION,,,CHEMOTHERAPY,TPCV,,
12,,PROGRESSION,,,OBSERVATION,OBSERVATION,IMPROVING,
12,,PROGRESSION,,,OBSERVATION,,IMPROVING,
12,,PROGRESSION,,,SURGERY,BIOPSY_ONLY,DECLINING,
12,,PROGRESSION,,,,BIOPSY_ONLY,DECLINING,
12,,PROGRESSION,,,,OBSERVATION,IMPROVING,
12,,PROGRESSION,,,,TPCV,,
12,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
12,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,IMPROVING,
12,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,IMPROVING,
12,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,IMPROVING,
12,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,IMPROVING,
12,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,IMPROVING,
12,,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,IMPROVING,
12,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
12,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
12,,STABLE,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
12,,STABLE,,CHEMOTHERAPY,,NOT_MENTIONED,,
12,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
12,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
12,,,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
12,,,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,,
12,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
12,,,NOT_MENTIONED,VINCA ALKALOID,,,DECLINING,
12,,,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
12,,,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,,
12,,,NOT_MENTIONED,,CHEMOTHERAPY,,IMPROVING,
12,,,NOT_MENTIONED,,,BEVACIZUMAB,NOT_MENTIONED,
12,,,NOT_MENTIONED,,,BEVACIZUMAB,,
12,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,
12,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,DECLINING,
12,,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,DECLINING,
12,,,SYMPTOM_PRESENT,BIOPSY,,,DECLINING,
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,,
12,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,DECLINING,
12,,,SYMPTOM_PRESENT,CRANIOTOMY,,,DECLINING,
12,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,,
12,,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,,
12,,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
12,,,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,
12,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,
12,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,DECLINING,
12,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
12,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,
12,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
12,,,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,
12,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,IMPROVING,
12,,,SYMPTOM_PRESENT,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,SYMPTOM_PRESENT,VINCA ALKALOID,,,IMPROVING,
12,,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,SYMPTOM_PRESENT,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
12,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,,
12,,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,DECLINING,
12,,,SYMPTOM_PRESENT,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,DECLINING,
12,,,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,,
12,,,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
12,,,SYMPTOM_PRESENT,,,TPCV,,
12,,,,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,
12,,,,BIOPSY,SURGERY,,DECLINING,
12,,,,BIOPSY,,BIOPSY_ONLY,DECLINING,
12,,,,BIOPSY,,,DECLINING,
12,,,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,
12,,,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,,CHEMOTHERAPY,,TPCV,,
12,,,,CRANIOTOMY,SURGERY,,DECLINING,
12,,,,CRANIOTOMY,,,DECLINING,
12,,,,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,
12,,,,DEBULKING,,SUBTOTAL,NOT_MENTIONED,
12,,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,
12,,,,NOT MENTIONED,SURGERY,,DECLINING,
12,,,,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,
12,,,,PARTIAL,SURGERY,,NOT_MENTIONED,
12,,,,PARTIAL,,PARTIAL,NOT_MENTIONED,
12,,,,PARTIAL,,,NOT_MENTIONED,
12,,,,PLATINUM,CHEMOTHERAPY,OTHER,DECLINING,
12,,,,PLATINUM,,OTHER,DECLINING,
12,,,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,
12,,,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,,VINCRISTINE,,,NOT_MENTIONED,
12,,,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,,,CHEMOTHERAPY,TPCV,,
12,,,,,SURGERY,BIOPSY_ONLY,DECLINING,
12,,,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
12,,,,,,BIOPSY_ONLY,DECLINING,
12,,,,,,TPCV,,
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,OTHER,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,OTHER,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,,,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,cumulus__none,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,OTHER,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,,IMPROVING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,STABLE,NOT_MENTIONED,,,,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,,,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,,,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,CARBOPLATIN,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,OBSERVATION,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,OTHER,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,MEK,,cumulus__none,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,MEK,,,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,PLATINUM,,OTHER,,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,,,OTHER,DECLINING,boston_childrens
12,AVAILABLE_AND_ELIGIBLE,,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,,,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MEK,,,,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,OTHER,,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,OTHER,,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,,NOT_MENTIONED,,,,,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,,,MEK,TARGETED_THERAPY,,,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,,,MEK,,,,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,,,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,,,,CHEMOTHERAPY,OTHER,,boston_childrens
12,AVAILABLE_NOT_ELIGIBLE,,,,,OTHER,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,OTHER,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,DEBULKING,,SUBTOTAL,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,,,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,MAPK,,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,SURGERY,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,NOT_MENTIONED,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,NOT MENTIONED,,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,PARTIAL,SURGERY,PARTIAL,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,PARTIAL,SURGERY,,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,PARTIAL,,PARTIAL,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,PARTIAL,,,,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,DECLINING,boston_childrens
12,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,,DECLINING,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,NOT_MENTIONED,,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,,,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,,boston_childrens
12,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
12,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,,DECLINING,boston_childrens
12,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
12,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,,DECLINING,boston_childrens
12,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,,IMPROVING,boston_childrens
12,NOT_MENTIONED,,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,NOT_MENTIONED,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,NOT MENTIONED,,,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,,DECLINING,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,NOT_MENTIONED,,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,BRAF MEK COMBINATION,,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,DEBULKING,,SUBTOTAL,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,,DECLINING,boston_childrens
12,NOT_MENTIONED,,,MAPK,,,DECLINING,boston_childrens
12,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
12,NOT_MENTIONED,,,NOT MENTIONED,SURGERY,,DECLINING,boston_childrens
12,NOT_MENTIONED,,,NOT MENTIONED,,NOT_MENTIONED,DECLINING,boston_childrens
12,NOT_MENTIONED,,,NOT MENTIONED,,,DECLINING,boston_childrens
12,NOT_MENTIONED,,,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,PARTIAL,SURGERY,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,PARTIAL,,PARTIAL,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,PARTIAL,,,NOT_MENTIONED,boston_childrens
12,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,,DECLINING,boston_childrens
12,NOT_MENTIONED,,,TRAMETINIB,,,DECLINING,boston_childrens
12,NOT_MENTIONED,,,VINCRISTINE,CHEMOTHERAPY,,,boston_childrens
12,NOT_MENTIONED,,,VINCRISTINE,,,,boston_childrens
12,NOT_MENTIONED,,,,,NOT_MENTIONED,IMPROVING,boston_childrens
12,,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,,,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,DECLINING,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,SYMPTOM_PRESENT,,,TPCV,,boston_childrens
12,,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
12,,PROGRESSION,,BIOPSY,SURGERY,,DECLINING,boston_childrens
12,,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,DECLINING,boston_childrens
12,,PROGRESSION,,BIOPSY,,,DECLINING,boston_childrens
12,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,boston_childrens
12,,PROGRESSION,,CHEMOTHERAPY,,TPCV,,boston_childrens
12,,PROGRESSION,,CRANIOTOMY,SURGERY,,DECLINING,boston_childrens
12,,PROGRESSION,,CRANIOTOMY,,,DECLINING,boston_childrens
12,,PROGRESSION,,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,,DEBULKING,,SUBTOTAL,NOT_MENTIONED,boston_childrens
12,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,,,boston_childrens
12,,PROGRESSION,,LOMUSTINE,,,,boston_childrens
12,,PROGRESSION,,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
12,,PROGRESSION,,NOT MENTIONED,SURGERY,,DECLINING,boston_childrens
12,,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
12,,PROGRESSION,,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
12,,PROGRESSION,,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
12,,PROGRESSION,,OBSERVATION,,,IMPROVING,boston_childrens
12,,PROGRESSION,,PARTIAL,SURGERY,PARTIAL,,boston_childrens
12,,PROGRESSION,,PARTIAL,SURGERY,,,boston_childrens
12,,PROGRESSION,,PARTIAL,,PARTIAL,,boston_childrens
12,,PROGRESSION,,PARTIAL,,,,boston_childrens
12,,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,,,boston_childrens
12,,PROGRESSION,,VINCRISTINE,,,,boston_childrens
12,,PROGRESSION,,,CHEMOTHERAPY,TPCV,,boston_childrens
12,,PROGRESSION,,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
12,,PROGRESSION,,,OBSERVATION,,IMPROVING,boston_childrens
12,,PROGRESSION,,,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
12,,PROGRESSION,,,,BIOPSY_ONLY,DECLINING,boston_childrens
12,,PROGRESSION,,,,OBSERVATION,IMPROVING,boston_childrens
12,,PROGRESSION,,,,TPCV,,boston_childrens
12,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
12,,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
12,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
12,,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,IMPROVING,boston_childrens
12,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
12,,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,IMPROVING,boston_childrens
12,,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,IMPROVING,boston_childrens
12,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
12,,STABLE,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,,STABLE,,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
12,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
12,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
12,,,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
12,,,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
12,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
12,,,NOT_MENTIONED,VINCA ALKALOID,,,DECLINING,boston_childrens
12,,,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
12,,,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
12,,,NOT_MENTIONED,,CHEMOTHERAPY,,IMPROVING,boston_childrens
12,,,NOT_MENTIONED,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
12,,,NOT_MENTIONED,,,BEVACIZUMAB,,boston_childrens
12,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,BIOPSY,,,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,boston_childrens
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,,boston_childrens
12,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,CRANIOTOMY,,,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,,boston_childrens
12,,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,,boston_childrens
12,,,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,,,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,NOT MENTIONED,SURGERY,,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,,,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,IMPROVING,boston_childrens
12,,,SYMPTOM_PRESENT,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,SYMPTOM_PRESENT,VINCA ALKALOID,,,IMPROVING,boston_childrens
12,,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,SYMPTOM_PRESENT,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,,boston_childrens
12,,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,DECLINING,boston_childrens
12,,,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
12,,,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
12,,,SYMPTOM_PRESENT,,,TPCV,,boston_childrens
12,,,,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
12,,,,BIOPSY,SURGERY,,DECLINING,boston_childrens
12,,,,BIOPSY,,BIOPSY_ONLY,DECLINING,boston_childrens
12,,,,BIOPSY,,,DECLINING,boston_childrens
12,,,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,boston_childrens
12,,,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,,CHEMOTHERAPY,,TPCV,,boston_childrens
12,,,,CRANIOTOMY,SURGERY,,DECLINING,boston_childrens
12,,,,CRANIOTOMY,,,DECLINING,boston_childrens
12,,,,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
12,,,,DEBULKING,,SUBTOTAL,NOT_MENTIONED,boston_childrens
12,,,,NOT MENTIONED,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
12,,,,NOT MENTIONED,SURGERY,,DECLINING,boston_childrens
12,,,,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
12,,,,PARTIAL,SURGERY,,NOT_MENTIONED,boston_childrens
12,,,,PARTIAL,,PARTIAL,NOT_MENTIONED,boston_childrens
12,,,,PARTIAL,,,NOT_MENTIONED,boston_childrens
12,,,,PLATINUM,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
12,,,,PLATINUM,,OTHER,DECLINING,boston_childrens
12,,,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
12,,,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,,VINCRISTINE,,,NOT_MENTIONED,boston_childrens
12,,,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,,,CHEMOTHERAPY,TPCV,,boston_childrens
12,,,,,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
12,,,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
12,,,,,,BIOPSY_ONLY,DECLINING,boston_childrens
12,,,,,,TPCV,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MAPK,,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,PLATINUM,,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,IMPROVING,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,,NOT_MENTIONED,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,cumulus__none,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,STABLE,NOT_MENTIONED,,,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,,
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,,
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,VINBLASTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,VINBLASTINE,,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,,,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,TOPOISOMERASE,,,,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,,,BRAF,,cumulus__none,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,
11,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,,NOT_MENTIONED,,
11,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,,,NOT_MENTIONED,
11,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,,DECLINING,
11,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MEK,,cumulus__none,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MTOR,,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,OBSERVATION,,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,OBSERVATION,,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,OBSERVATION,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,OBSERVATION,,,
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,,,
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,,,
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,OBSERVATION,,
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,OTHER,,
11,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,,,
11,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,,,,
11,AVAILABLE_NOT_ELIGIBLE,,,MEK,TARGETED_THERAPY,cumulus__none,,
11,AVAILABLE_NOT_ELIGIBLE,,,MEK,,cumulus__none,,
11,AVAILABLE_NOT_ELIGIBLE,,,MTOR,TARGETED_THERAPY,,,
11,AVAILABLE_NOT_ELIGIBLE,,,MTOR,,,,
11,AVAILABLE_NOT_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,,,
11,AVAILABLE_NOT_ELIGIBLE,,,VINCA ALKALOID,,,,
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,,
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,,,,
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,,,
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,,,,
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,SURGERY,,,
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,,,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,,,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,TPCV,,
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,BIOPSY,,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,
11,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,TPCV,,
11,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,DEBULKING,,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,,PARTIAL,SURGERY,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,,PARTIAL,,PARTIAL,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,,PARTIAL,,,NOT_MENTIONED,
11,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,,,
11,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,,,,
11,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,TPCV,,
11,NOT_MENTIONED,PROGRESSION,,,SURGERY,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,,,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,PROGRESSION,,,,Lomustine 10 MG Oral Capsule,,
11,NOT_MENTIONED,PROGRESSION,,,,TPCV,,
11,NOT_MENTIONED,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
11,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,
11,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,
11,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,OTHER,,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,IMPROVING,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,IMPROVING,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,IMPROVING,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,IMPROVING,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,IMPROVING,
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,IMPROVING,
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,,
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,,IMPROVING,
11,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
11,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,IMPROVING,
11,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,,DECLINING,
11,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,,IMPROVING,
11,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
11,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,,
11,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
11,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,GROSS_TOTAL,,
11,NOT_MENTIONED,,NOT_MENTIONED,,,BEVACIZUMAB,NOT_MENTIONED,
11,NOT_MENTIONED,,NOT_MENTIONED,,,BEVACIZUMAB,,
11,NOT_MENTIONED,,NOT_MENTIONED,,,GROSS_TOTAL,NOT_MENTIONED,
11,NOT_MENTIONED,,NOT_MENTIONED,,,GROSS_TOTAL,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,SURGERY,,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,,,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCRISTINE,,,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,PARTIAL,NOT_MENTIONED,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,,NOT_MENTIONED,IMPROVING,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,,PARTIAL,NOT_MENTIONED,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,,TPCV,,
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,,,BIOPSY,SURGERY,,DECLINING,
11,NOT_MENTIONED,,,BIOPSY,,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,,,BIOPSY,,,DECLINING,
11,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,
11,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,
11,NOT_MENTIONED,,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,NOT_MENTIONED,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,IMPROVING,
11,NOT_MENTIONED,,,CHEMOTHERAPY,,TPCV,,
11,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,,DECLINING,
11,NOT_MENTIONED,,,CRANIOTOMY,,,DECLINING,
11,NOT_MENTIONED,,,DEBULKING,SURGERY,,DECLINING,
11,NOT_MENTIONED,,,DEBULKING,,,DECLINING,
11,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,,DECLINING,
11,NOT_MENTIONED,,,OTHER SURGERY,,,DECLINING,
11,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,,IMPROVING,
11,NOT_MENTIONED,,,PLATINUM,,,IMPROVING,
11,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,NOT_MENTIONED,,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,NOT_MENTIONED,,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,NOT_MENTIONED,,,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,
11,NOT_MENTIONED,,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,NOT_MENTIONED,,,VINCRISTINE,,,NOT_MENTIONED,
11,NOT_MENTIONED,,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,
11,NOT_MENTIONED,,,,CHEMOTHERAPY,TPCV,,
11,NOT_MENTIONED,,,,SURGERY,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,
11,NOT_MENTIONED,,,,TARGETED_THERAPY,,IMPROVING,
11,NOT_MENTIONED,,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,NOT_MENTIONED,,,,,BIOPSY_ONLY,DECLINING,
11,NOT_MENTIONED,,,,,CARBOPLATIN_VINCRISTINE,IMPROVING,
11,NOT_MENTIONED,,,,,TPCV,,
11,NOT_MENTIONED,,,,,trametinib 0.5 MG Oral Tablet,DECLINING,
11,OTHER,PROGRESSION,SYMPTOM_PRESENT,,,,,
11,OTHER,,SYMPTOM_PRESENT,,,,,
11,,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,,NOT_MENTIONED,
11,,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,,,
11,,PROGRESSION,NOT_MENTIONED,BIOPSY,,,NOT_MENTIONED,
11,,PROGRESSION,NOT_MENTIONED,BIOPSY,,,,
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,,
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,DECLINING,
11,,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,SURGERY,,NOT_MENTIONED,
11,,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,SURGERY,,,
11,,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,,,NOT_MENTIONED,
11,,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,,,,
11,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,,
11,,PROGRESSION,NOT_MENTIONED,PLATINUM,,OTHER,,
11,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
11,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,,
11,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
11,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,DECLINING,
11,,PROGRESSION,NOT_MENTIONED,,,BEVACIZUMAB,NOT_MENTIONED,
11,,PROGRESSION,NOT_MENTIONED,,,BEVACIZUMAB,,
11,,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,DECLINING,
11,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,
11,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,DECLINING,
11,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,DECLINING,
11,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,DECLINING,
11,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
11,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,
11,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,DECLINING,
11,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,DECLINING,
11,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,DECLINING,
11,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,DECLINING,
11,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
11,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,
11,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB_IRINOTECAN,,
11,,PROGRESSION,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,
11,,PROGRESSION,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,,
11,,PROGRESSION,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,SYMPTOM_PRESENT,,,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,,ALKYLATING,,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,,ALKYLATING,,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
11,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,
11,,PROGRESSION,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,
11,,PROGRESSION,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,,CHEMOTHERAPY,,,IMPROVING,
11,,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,
11,,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,DECLINING,
11,,PROGRESSION,,DEBULKING,SURGERY,,DECLINING,
11,,PROGRESSION,,DEBULKING,,,DECLINING,
11,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,
11,,PROGRESSION,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,,LOMUSTINE,,,NOT_MENTIONED,
11,,PROGRESSION,,OTHER SURGERY,SURGERY,,DECLINING,
11,,PROGRESSION,,OTHER SURGERY,,,DECLINING,
11,,PROGRESSION,,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,
11,,PROGRESSION,,PARTIAL,SURGERY,,NOT_MENTIONED,
11,,PROGRESSION,,PARTIAL,,PARTIAL,NOT_MENTIONED,
11,,PROGRESSION,,PARTIAL,,,NOT_MENTIONED,
11,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,OTHER,DECLINING,
11,,PROGRESSION,,PLATINUM,,OTHER,DECLINING,
11,,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,,DECLINING,
11,,PROGRESSION,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,,TEMOZOLOMIDE,,,DECLINING,
11,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,
11,,PROGRESSION,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,,VINCRISTINE,,,NOT_MENTIONED,
11,,PROGRESSION,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
11,,PROGRESSION,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,PROGRESSION,,,CHEMOTHERAPY,,IMPROVING,
11,,PROGRESSION,,,CLINICAL_TRIAL,,,
11,,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,IMPROVING,
11,,PROGRESSION,,,TARGETED_THERAPY,,IMPROVING,
11,,PROGRESSION,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
11,,PROGRESSION,,,,BEVACIZUMAB_IRINOTECAN,,
11,,PROGRESSION,,,,Lomustine 10 MG Oral Capsule,,
11,,PROGRESSION,,,,cumulus__none,IMPROVING,
11,,PROGRESSION,,,,temozolomide 100 MG Oral Capsule,,
11,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
11,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,
11,,STABLE,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,
11,,STABLE,NOT_MENTIONED,ALKYLATING,,OTHER,,
11,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,,
11,,STABLE,NOT_MENTIONED,PLATINUM,,OTHER,,
11,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
11,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,
11,,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
11,,STABLE,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
11,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
11,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,
11,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,
11,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,
11,,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
11,,,NOT_MENTIONED,ANTIMETABOLITE,,NOT_MENTIONED,,
11,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,
11,,,NOT_MENTIONED,CHEMOTHERAPY,,,IMPROVING,
11,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,IMPROVING,
11,,,NOT_MENTIONED,VINCA ALKALOID,,,IMPROVING,
11,,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,DECLINING,
11,,,NOT_MENTIONED,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
11,,,NOT_MENTIONED,,SURGERY,GROSS_TOTAL,,
11,,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,IMPROVING,
11,,,NOT_MENTIONED,,TARGETED_THERAPY,,IMPROVING,
11,,,NOT_MENTIONED,,,GROSS_TOTAL,NOT_MENTIONED,
11,,,NOT_MENTIONED,,,GROSS_TOTAL,,
11,,,NOT_MENTIONED,,,NOT_MENTIONED,DECLINING,
11,,,NOT_MENTIONED,,,OTHER,DECLINING,
11,,,NOT_MENTIONED,,,cumulus__none,IMPROVING,
11,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,,SYMPTOM_PRESENT,ALKYLATING,,temozolomide 100 MG Oral Capsule,,
11,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
11,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,
11,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,
11,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,
11,,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,DECLINING,
11,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,DECLINING,
11,,,SYMPTOM_PRESENT,DEBULKING,,,DECLINING,
11,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,DECLINING,
11,,,SYMPTOM_PRESENT,OTHER SURGERY,,,DECLINING,
11,,,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,,
11,,,SYMPTOM_PRESENT,PARTIAL,SURGERY,,,
11,,,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,,
11,,,SYMPTOM_PRESENT,PARTIAL,,,,
11,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,IMPROVING,
11,,,SYMPTOM_PRESENT,PLATINUM,,,IMPROVING,
11,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,DECLINING,
11,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,
11,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,DECLINING,
11,,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,
11,,,SYMPTOM_PRESENT,VINCRISTINE,,,NOT_MENTIONED,
11,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
11,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,,SYMPTOM_PRESENT,,SURGERY,PARTIAL,NOT_MENTIONED,
11,,,SYMPTOM_PRESENT,,,BEVACIZUMAB_IRINOTECAN,,
11,,,SYMPTOM_PRESENT,,,PARTIAL,NOT_MENTIONED,
11,,,SYMPTOM_PRESENT,,,temozolomide 100 MG Oral Capsule,,
11,,,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,,,ALKYLATING,,temozolomide 100 MG Oral Capsule,,
11,,,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
11,,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
11,,,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
11,,,,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,
11,,,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,
11,,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,
11,,,,CRANIOTOMY,,NOT_MENTIONED,DECLINING,
11,,,,DEBULKING,SURGERY,,DECLINING,
11,,,,DEBULKING,,,DECLINING,
11,,,,OTHER SURGERY,SURGERY,,DECLINING,
11,,,,OTHER SURGERY,,,DECLINING,
11,,,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,,,TEMOZOLOMIDE,CHEMOTHERAPY,,DECLINING,
11,,,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,
11,,,,TEMOZOLOMIDE,,,DECLINING,
11,,,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
11,,,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
11,,,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
11,,,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
11,,,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
11,,,,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
11,,,,,CHEMOTHERAPY,NOT_MENTIONED,IMPROVING,
11,,,,,CHEMOTHERAPY,OTHER,IMPROVING,
11,,,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
11,,,,,CLINICAL_TRIAL,,,
11,,,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
11,,,,,,BEVACIZUMAB_IRINOTECAN,,
11,,,,,,OTHER,IMPROVING,
11,,,,,,temozolomide 100 MG Oral Capsule,,
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MAPK,,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,PLATINUM,,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,TRAMETINIB,,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ANTIMETABOLITE,,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,BRAF,,,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,,IMPROVING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,cumulus__none,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,PLATINUM,,CARBOPLATIN_VINCRISTINE,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,STABLE,NOT_MENTIONED,,,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,VINCA ALKALOID,,VINBLASTINE,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,CHEMOTHERAPY,VINBLASTINE,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,VINBLASTINE,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,BRAF,,,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,,cumulus__none,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MTOR,,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,TOPOISOMERASE,,,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,BRAF,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,BRAF,,cumulus__none,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,,NOT_MENTIONED,,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,VINCA ALKALOID,,,DECLINING,boston_childrens
11,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,OBSERVATION,,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,OBSERVATION,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,OTHER,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MEK,,cumulus__none,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MTOR,,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,OBSERVATION,OBSERVATION,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,OBSERVATION,,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,OBSERVATION,,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,VINCA ALKALOID,,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,OBSERVATION,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,OBSERVATION,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,CHEMOTHERAPY,OTHER,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,OBSERVATION,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,OTHER,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,,MEK,TARGETED_THERAPY,cumulus__none,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,,MEK,,cumulus__none,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,,MTOR,TARGETED_THERAPY,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,,MTOR,,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
11,AVAILABLE_NOT_ELIGIBLE,,,VINCA ALKALOID,,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,SURGERY,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BIOPSY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,TPCV,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,BIOPSY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,BIOPSY,,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,BIOPSY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,BRAF MEK COMBINATION,,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,TPCV,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,DEBULKING,,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,PARTIAL,SURGERY,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,PARTIAL,,PARTIAL,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,PARTIAL,,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,,,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,TPCV,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,,,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,,,TPCV,,boston_childrens
11,NOT_MENTIONED,PROGRESSION,,,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
11,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,STABLE,NOT_MENTIONED,ALKYLATING,,OTHER,,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,OBSERVATION,,,IMPROVING,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,OBSERVATION,,IMPROVING,boston_childrens
11,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,,,OBSERVATION,IMPROVING,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,CHEMOTHERAPY,,,IMPROVING,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,IMPROVING,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,,DECLINING,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,VINCA ALKALOID,,,IMPROVING,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,GROSS_TOTAL,,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,,,BEVACIZUMAB,,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,,NOT_MENTIONED,,,GROSS_TOTAL,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BIOPSY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,SURGERY,,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,,,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCRISTINE,,,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,,NOT_MENTIONED,IMPROVING,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,,PARTIAL,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,,TPCV,,boston_childrens
11,NOT_MENTIONED,,SYMPTOM_PRESENT,,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,,BIOPSY,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,,,BIOPSY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,,,BIOPSY,,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,,,BIOPSY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,,BRAF,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
11,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,,boston_childrens
11,NOT_MENTIONED,,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,NOT_MENTIONED,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
11,NOT_MENTIONED,,,CHEMOTHERAPY,,TPCV,,boston_childrens
11,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,,,CRANIOTOMY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,,,DEBULKING,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,,,DEBULKING,,,DECLINING,boston_childrens
11,NOT_MENTIONED,,,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,,MAPK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,,MEK,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,,DECLINING,boston_childrens
11,NOT_MENTIONED,,,OTHER SURGERY,,,DECLINING,boston_childrens
11,NOT_MENTIONED,,,PLATINUM,CHEMOTHERAPY,,IMPROVING,boston_childrens
11,NOT_MENTIONED,,,PLATINUM,,,IMPROVING,boston_childrens
11,NOT_MENTIONED,,,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,NOT_MENTIONED,,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,NOT_MENTIONED,,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,NOT_MENTIONED,,,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,NOT_MENTIONED,,,VINCRISTINE,,,NOT_MENTIONED,boston_childrens
11,NOT_MENTIONED,,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,NOT_MENTIONED,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
11,NOT_MENTIONED,,,,CHEMOTHERAPY,TPCV,,boston_childrens
11,NOT_MENTIONED,,,,SURGERY,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,,,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,NOT_MENTIONED,,,,TARGETED_THERAPY,,IMPROVING,boston_childrens
11,NOT_MENTIONED,,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,NOT_MENTIONED,,,,,BIOPSY_ONLY,DECLINING,boston_childrens
11,NOT_MENTIONED,,,,,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
11,NOT_MENTIONED,,,,,TPCV,,boston_childrens
11,NOT_MENTIONED,,,,,trametinib 0.5 MG Oral Tablet,DECLINING,boston_childrens
11,OTHER,PROGRESSION,SYMPTOM_PRESENT,,,,,boston_childrens
11,OTHER,,SYMPTOM_PRESENT,,,,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,BIOPSY,,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,BIOPSY,,,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,DECLINING,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,,DECLINING,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,SURGERY,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,SURGERY,,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,CRANIOTOMY,,,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,PLATINUM,,OTHER,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,,DECLINING,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,,,BEVACIZUMAB,,boston_childrens
11,,PROGRESSION,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,DECLINING,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,,DECLINING,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,,DECLINING,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,ENDOSCOPIC,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,ETOPOSIDE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,GROSS TOTAL,,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,DECLINING,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,,DECLINING,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,DECLINING,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,DECLINING,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,,Etoposide 20 MG/ML Injectable Solution,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,SYMPTOM_PRESENT,,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,ALKYLATING,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,ALKYLATING,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,boston_childrens
11,,PROGRESSION,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,PROGRESSION,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,CHEMOTHERAPY,,,IMPROVING,boston_childrens
11,,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
11,,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,DECLINING,boston_childrens
11,,PROGRESSION,,DEBULKING,SURGERY,,DECLINING,boston_childrens
11,,PROGRESSION,,DEBULKING,,,DECLINING,boston_childrens
11,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,LOMUSTINE,,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,,OTHER SURGERY,SURGERY,,DECLINING,boston_childrens
11,,PROGRESSION,,OTHER SURGERY,,,DECLINING,boston_childrens
11,,PROGRESSION,,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,,PARTIAL,SURGERY,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,,PARTIAL,,PARTIAL,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,,PARTIAL,,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,,PLATINUM,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
11,,PROGRESSION,,PLATINUM,,OTHER,DECLINING,boston_childrens
11,,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,,DECLINING,boston_childrens
11,,PROGRESSION,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,TEMOZOLOMIDE,,,DECLINING,boston_childrens
11,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,,VINCRISTINE,,,NOT_MENTIONED,boston_childrens
11,,PROGRESSION,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,PROGRESSION,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,,CHEMOTHERAPY,,IMPROVING,boston_childrens
11,,PROGRESSION,,,CLINICAL_TRIAL,,,boston_childrens
11,,PROGRESSION,,,TARGETED_THERAPY,cumulus__none,IMPROVING,boston_childrens
11,,PROGRESSION,,,TARGETED_THERAPY,,IMPROVING,boston_childrens
11,,PROGRESSION,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
11,,PROGRESSION,,,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,PROGRESSION,,,,Lomustine 10 MG Oral Capsule,,boston_childrens
11,,PROGRESSION,,,,cumulus__none,IMPROVING,boston_childrens
11,,PROGRESSION,,,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
11,,STABLE,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
11,,STABLE,NOT_MENTIONED,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
11,,STABLE,NOT_MENTIONED,ALKYLATING,,OTHER,,boston_childrens
11,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
11,,STABLE,NOT_MENTIONED,PLATINUM,,OTHER,,boston_childrens
11,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
11,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,,boston_childrens
11,,STABLE,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,,STABLE,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
11,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
11,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,OTHER,,boston_childrens
11,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,NOT_MENTIONED,boston_childrens
11,,STABLE,SYMPTOM_PRESENT,VINCA ALKALOID,,OTHER,,boston_childrens
11,,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
11,,,NOT_MENTIONED,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
11,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,boston_childrens
11,,,NOT_MENTIONED,CHEMOTHERAPY,,,IMPROVING,boston_childrens
11,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,IMPROVING,boston_childrens
11,,,NOT_MENTIONED,VINCA ALKALOID,,,IMPROVING,boston_childrens
11,,,NOT_MENTIONED,,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
11,,,NOT_MENTIONED,,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
11,,,NOT_MENTIONED,,SURGERY,GROSS_TOTAL,,boston_childrens
11,,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,IMPROVING,boston_childrens
11,,,NOT_MENTIONED,,TARGETED_THERAPY,,IMPROVING,boston_childrens
11,,,NOT_MENTIONED,,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
11,,,NOT_MENTIONED,,,GROSS_TOTAL,,boston_childrens
11,,,NOT_MENTIONED,,,NOT_MENTIONED,DECLINING,boston_childrens
11,,,NOT_MENTIONED,,,OTHER,DECLINING,boston_childrens
11,,,NOT_MENTIONED,,,cumulus__none,IMPROVING,boston_childrens
11,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,SYMPTOM_PRESENT,ALKYLATING,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
11,,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,DECLINING,boston_childrens
11,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,,DECLINING,boston_childrens
11,,,SYMPTOM_PRESENT,DEBULKING,,,DECLINING,boston_childrens
11,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,,DECLINING,boston_childrens
11,,,SYMPTOM_PRESENT,OTHER SURGERY,,,DECLINING,boston_childrens
11,,,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,,boston_childrens
11,,,SYMPTOM_PRESENT,PARTIAL,SURGERY,,,boston_childrens
11,,,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,,boston_childrens
11,,,SYMPTOM_PRESENT,PARTIAL,,,,boston_childrens
11,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,,IMPROVING,boston_childrens
11,,,SYMPTOM_PRESENT,PLATINUM,,,IMPROVING,boston_childrens
11,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,,DECLINING,boston_childrens
11,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,,DECLINING,boston_childrens
11,,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
11,,,SYMPTOM_PRESENT,VINCRISTINE,,,NOT_MENTIONED,boston_childrens
11,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,SYMPTOM_PRESENT,,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
11,,,SYMPTOM_PRESENT,,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,,SYMPTOM_PRESENT,,,PARTIAL,NOT_MENTIONED,boston_childrens
11,,,SYMPTOM_PRESENT,,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,,ALKYLATING,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
11,,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
11,,,,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
11,,,,CRANIOTOMY,,NOT_MENTIONED,DECLINING,boston_childrens
11,,,,DEBULKING,SURGERY,,DECLINING,boston_childrens
11,,,,DEBULKING,,,DECLINING,boston_childrens
11,,,,OTHER SURGERY,SURGERY,,DECLINING,boston_childrens
11,,,,OTHER SURGERY,,,DECLINING,boston_childrens
11,,,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,,TEMOZOLOMIDE,CHEMOTHERAPY,,DECLINING,boston_childrens
11,,,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,,TEMOZOLOMIDE,,,DECLINING,boston_childrens
11,,,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
11,,,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
11,,,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
11,,,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
11,,,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
11,,,,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,,,,CHEMOTHERAPY,NOT_MENTIONED,IMPROVING,boston_childrens
11,,,,,CHEMOTHERAPY,OTHER,IMPROVING,boston_childrens
11,,,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
11,,,,,CLINICAL_TRIAL,,,boston_childrens
11,,,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
11,,,,,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
11,,,,,,OTHER,IMPROVING,boston_childrens
11,,,,,,temozolomide 100 MG Oral Capsule,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MTOR,,cumulus__none,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MTOR,,,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,OTHER,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,STABLE,,CHEMOTHERAPY,,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,STABLE,,CHEMOTHERAPY,,,,
10,AVAILABLE_AND_ELIGIBLE,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,STABLE,,VINCA ALKALOID,,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,STABLE,,VINCA ALKALOID,,,,
10,AVAILABLE_AND_ELIGIBLE,STABLE,,,CHEMOTHERAPY,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,STABLE,,,CHEMOTHERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,ALKYLATING,,,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MTOR,,cumulus__none,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MTOR,,,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OBSERVATION,,,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OTHER TARGETED,,,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,OBSERVATION,,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,OBSERVATION,,
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MAPK,,,,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,OTHER,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
10,AVAILABLE_AND_ELIGIBLE,,,,,CARBOPLATIN_VINCRISTINE,DECLINING,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,,OTHER,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,OTHER,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MTOR,,cumulus__none,,
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,NOT_MENTIONED,DECLINING,
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,,,
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,,,
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,
10,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
10,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,OTHER,,
10,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,,NOT_MENTIONED,,
10,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,,OTHER,,
10,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
10,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,
10,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,,NOT_MENTIONED,,
10,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,,OTHER,,
10,AVAILABLE_NOT_ELIGIBLE,,,MTOR,TARGETED_THERAPY,cumulus__none,,
10,AVAILABLE_NOT_ELIGIBLE,,,MTOR,,cumulus__none,,
10,AVAILABLE_NOT_ELIGIBLE,,,,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,,,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,,,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,,,,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,BEVACIZUMAB,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,BEVACIZUMAB,,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,BIOPSY_ONLY,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,BIOPSY_ONLY,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,SURGERY,,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,,,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,PARTIAL,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,PARTIAL,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,,DEBULKING,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
10,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,,IMPROVING,
10,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,OBSERVATION,IMPROVING,
10,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,,IMPROVING,
10,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,,,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,OBSERVATION,IMPROVING,
10,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,,IMPROVING,
10,NOT_MENTIONED,PROGRESSION,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,PROGRESSION,,,,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,PROGRESSION,,,,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,PROGRESSION,,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,,,OBSERVATION,IMPROVING,
10,NOT_MENTIONED,PROGRESSION,,,,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,PROGRESSION,,,,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,IMPROVING,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,IMPROVING,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,,IMPROVING,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,OTHER,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,OTHER,,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,IMPROVING,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,,IMPROVING,
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,OBSERVATION,IMPROVING,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,,,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
10,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
10,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,NOT_MENTIONED,,
10,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,
10,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,,OTHER,,
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,,
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,NOT_MENTIONED,,
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,,
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,NOT_MENTIONED,,
10,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,SURGERY,NOT_MENTIONED,,
10,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,,NOT_MENTIONED,,
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,SURGERY,GROSS_TOTAL,,
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,SURGERY,,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,SURGERY,,,
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,,GROSS_TOTAL,,
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,,,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,,,,
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,SURGERY,SUBTOTAL,,
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,SURGERY,,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,SURGERY,,,
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,,SUBTOTAL,,
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,,,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,,,,
10,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,,
10,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,SUBTOTAL,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,SUBTOTAL,,
10,NOT_MENTIONED,,NOT_MENTIONED,,,BIOPSY_ONLY,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,,,BIOPSY_ONLY,,
10,NOT_MENTIONED,,NOT_MENTIONED,,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,NOT_MENTIONED,,,SUBTOTAL,NOT_MENTIONED,
10,NOT_MENTIONED,,NOT_MENTIONED,,,SUBTOTAL,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,IMPROVING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,SURGERY,,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,,,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,IMPROVING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,
10,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,,,ALKYLATING,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,ALKYLATING,,Lomustine 40 MG Oral Capsule,,
10,NOT_MENTIONED,,,ALKYLATING,,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,,DECLINING,
10,NOT_MENTIONED,,,ANTIMETABOLITE,,,DECLINING,
10,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,,
10,NOT_MENTIONED,,,BRAF,,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,BRAF,,dabrafenib 50 MG Oral Capsule,,
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,NOT_MENTIONED,,,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,,,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,,,CHEMOTHERAPY,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,CHEMOTHERAPY,,Lomustine 40 MG Oral Capsule,,
10,NOT_MENTIONED,,,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,,CRANIOTOMY,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,,DEBULKING,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,
10,NOT_MENTIONED,,,LOMUSTINE,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,LOMUSTINE,,Lomustine 40 MG Oral Capsule,,
10,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,,OTHER SURGERY,,NOT_MENTIONED,DECLINING,
10,NOT_MENTIONED,,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,NOT_MENTIONED,,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,NOT_MENTIONED,,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,NOT_MENTIONED,,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,NOT_MENTIONED,,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,NOT_MENTIONED,,,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,,,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,,,,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,
10,NOT_MENTIONED,,,,CHEMOTHERAPY,OTHER,IMPROVING,
10,NOT_MENTIONED,,,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,
10,NOT_MENTIONED,,,,TARGETED_THERAPY,cumulus__none,IMPROVING,
10,NOT_MENTIONED,,,,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,,
10,NOT_MENTIONED,,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,NOT_MENTIONED,,,,,BEVACIZUMAB,DECLINING,
10,NOT_MENTIONED,,,,,BEVACIZUMAB_IRINOTECAN,,
10,NOT_MENTIONED,,,,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,,,Lomustine 40 MG Oral Capsule,,
10,NOT_MENTIONED,,,,,OTHER,IMPROVING,
10,NOT_MENTIONED,,,,,TPCV,NOT_MENTIONED,
10,NOT_MENTIONED,,,,,cumulus__none,IMPROVING,
10,NOT_MENTIONED,,,,,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,
10,NOT_MENTIONED,,,,,dabrafenib 50 MG Oral Capsule,,
10,NOT_MENTIONED,,,,,temozolomide 100 MG Oral Capsule,,
10,OTHER,PROGRESSION,,,,,NOT_MENTIONED,
10,OTHER,,,,,,NOT_MENTIONED,
10,,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
10,,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,,
10,,PROGRESSION,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
10,,PROGRESSION,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,,
10,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,
10,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,
10,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
10,,PROGRESSION,NOT_MENTIONED,PLATINUM,,OTHER,NOT_MENTIONED,
10,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,
10,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,DECLINING,
10,,PROGRESSION,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
10,,PROGRESSION,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,,
10,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,DECLINING,
10,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,DECLINING,
10,,PROGRESSION,NOT_MENTIONED,,,BIOPSY_ONLY,NOT_MENTIONED,
10,,PROGRESSION,NOT_MENTIONED,,,BIOPSY_ONLY,,
10,,PROGRESSION,NOT_MENTIONED,,,cumulus__none,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,,
10,,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,SURGERY,,,
10,,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,,
10,,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,,,,
10,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,OTHER,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,,,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,,CLINICAL_TRIAL,,,
10,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,PARTIAL,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,,,PARTIAL,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,,,SUBTOTAL,DECLINING,
10,,PROGRESSION,SYMPTOM_PRESENT,,,TPCV,NOT_MENTIONED,
10,,PROGRESSION,SYMPTOM_PRESENT,,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,ALKYLATING,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,ALKYLATING,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,AVAILABLE AND ELIGIBLE,CLINICAL_TRIAL,AVAILABLE_AND_ELIGIBLE,,
10,,PROGRESSION,,AVAILABLE AND ELIGIBLE,CLINICAL_TRIAL,,,
10,,PROGRESSION,,AVAILABLE AND ELIGIBLE,,AVAILABLE_AND_ELIGIBLE,,
10,,PROGRESSION,,AVAILABLE AND ELIGIBLE,,,,
10,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,PROGRESSION,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,
10,,PROGRESSION,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,
10,,PROGRESSION,,DEBULKING,,NOT_MENTIONED,DECLINING,
10,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,,DECLINING,
10,,PROGRESSION,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,LOMUSTINE,,,DECLINING,
10,,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,
10,,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,DECLINING,
10,,PROGRESSION,,SUBTOTAL,SURGERY,SUBTOTAL,DECLINING,
10,,PROGRESSION,,SUBTOTAL,SURGERY,,DECLINING,
10,,PROGRESSION,,SUBTOTAL,,SUBTOTAL,DECLINING,
10,,PROGRESSION,,SUBTOTAL,,,DECLINING,
10,,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
10,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,DECLINING,
10,,PROGRESSION,,TOPOISOMERASE,,NOT_MENTIONED,DECLINING,
10,,PROGRESSION,,TOPOISOMERASE,,OTHER,DECLINING,
10,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,PROGRESSION,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,PROGRESSION,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,PROGRESSION,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,PROGRESSION,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,,PROGRESSION,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,,CLINICAL_TRIAL,AVAILABLE_AND_ELIGIBLE,,
10,,PROGRESSION,,,SURGERY,SUBTOTAL,DECLINING,
10,,PROGRESSION,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,PROGRESSION,,,,AVAILABLE_AND_ELIGIBLE,,
10,,PROGRESSION,,,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,PROGRESSION,,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,
10,,PROGRESSION,,,,SUBTOTAL,DECLINING,
10,,PROGRESSION,,,,TPCV,NOT_MENTIONED,
10,,PROGRESSION,,,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
10,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,
10,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,
10,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,,
10,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
10,,STABLE,NOT_MENTIONED,PLATINUM,,OTHER,NOT_MENTIONED,
10,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
10,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
10,,STABLE,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
10,,STABLE,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,,,
10,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,
10,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,
10,,STABLE,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
10,,STABLE,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,
10,,STABLE,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,
10,,STABLE,,,,CARBOPLATIN_VINCRISTINE,,
10,,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,
10,,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,
10,,,NOT_MENTIONED,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,
10,,,NOT_MENTIONED,ANTIMETABOLITE,,OTHER,,
10,,,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
10,,,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,,
10,,,NOT_MENTIONED,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
10,,,NOT_MENTIONED,BIOPSY,SURGERY,NOT_MENTIONED,,
10,,,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,
10,,,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,,
10,,,NOT_MENTIONED,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,
10,,,NOT_MENTIONED,BIOPSY,,NOT_MENTIONED,,
10,,,NOT_MENTIONED,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,
10,,,NOT_MENTIONED,BRAF MEK COMBINATION,TARGETED_THERAPY,,,
10,,,NOT_MENTIONED,BRAF MEK COMBINATION,,cumulus__none,,
10,,,NOT_MENTIONED,BRAF MEK COMBINATION,,,,
10,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,
10,,,NOT_MENTIONED,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,NOT_MENTIONED,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,DECLINING,
10,,,NOT_MENTIONED,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,
10,,,NOT_MENTIONED,CRANIOTOMY,SURGERY,NOT_MENTIONED,,
10,,,NOT_MENTIONED,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,
10,,,NOT_MENTIONED,CRANIOTOMY,,NOT_MENTIONED,,
10,,,NOT_MENTIONED,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,
10,,,NOT_MENTIONED,GROSS TOTAL,SURGERY,GROSS_TOTAL,,
10,,,NOT_MENTIONED,GROSS TOTAL,SURGERY,,NOT_MENTIONED,
10,,,NOT_MENTIONED,GROSS TOTAL,SURGERY,,,
10,,,NOT_MENTIONED,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,
10,,,NOT_MENTIONED,GROSS TOTAL,,GROSS_TOTAL,,
10,,,NOT_MENTIONED,GROSS TOTAL,,,NOT_MENTIONED,
10,,,NOT_MENTIONED,GROSS TOTAL,,,,
10,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,DECLINING,
10,,,NOT_MENTIONED,PLATINUM,,,DECLINING,
10,,,NOT_MENTIONED,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,
10,,,NOT_MENTIONED,SUBTOTAL,SURGERY,SUBTOTAL,,
10,,,NOT_MENTIONED,SUBTOTAL,SURGERY,,NOT_MENTIONED,
10,,,NOT_MENTIONED,SUBTOTAL,SURGERY,,,
10,,,NOT_MENTIONED,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,
10,,,NOT_MENTIONED,SUBTOTAL,,SUBTOTAL,,
10,,,NOT_MENTIONED,SUBTOTAL,,,NOT_MENTIONED,
10,,,NOT_MENTIONED,SUBTOTAL,,,,
10,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,,,NOT_MENTIONED,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,NOT_MENTIONED,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,,,NOT_MENTIONED,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,NOT_MENTIONED,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,,,NOT_MENTIONED,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,
10,,,NOT_MENTIONED,VINCRISTINE,CHEMOTHERAPY,,,
10,,,NOT_MENTIONED,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,NOT_MENTIONED,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,,,NOT_MENTIONED,VINCRISTINE,,,NOT_MENTIONED,
10,,,NOT_MENTIONED,VINCRISTINE,,,,
10,,,NOT_MENTIONED,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,NOT_MENTIONED,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
10,,,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,
10,,,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,,
10,,,NOT_MENTIONED,,SURGERY,SUBTOTAL,NOT_MENTIONED,
10,,,NOT_MENTIONED,,SURGERY,SUBTOTAL,,
10,,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,DECLINING,
10,,,NOT_MENTIONED,,TARGETED_THERAPY,,DECLINING,
10,,,NOT_MENTIONED,,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,NOT_MENTIONED,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,
10,,,NOT_MENTIONED,,,BIOPSY_ONLY,NOT_MENTIONED,
10,,,NOT_MENTIONED,,,BIOPSY_ONLY,,
10,,,NOT_MENTIONED,,,SUBTOTAL,NOT_MENTIONED,
10,,,NOT_MENTIONED,,,SUBTOTAL,,
10,,,NOT_MENTIONED,,,cumulus__none,DECLINING,
10,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,SYMPTOM_PRESENT,ALKYLATING,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,IMPROVING,
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,
10,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,DECLINING,
10,,,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,DECLINING,
10,,,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,SYMPTOM_PRESENT,LOMUSTINE,,,DECLINING,
10,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,
10,,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,DECLINING,
10,,,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,PARTIAL,SURGERY,,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,PARTIAL,,,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,DECLINING,
10,,,SYMPTOM_PRESENT,PLATINUM,,OTHER,DECLINING,
10,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,DECLINING,
10,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,DECLINING,
10,,,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,DECLINING,
10,,,SYMPTOM_PRESENT,SUBTOTAL,,,DECLINING,
10,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,
10,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,,CLINICAL_TRIAL,,,
10,,,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,DECLINING,
10,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,IMPROVING,
10,,,SYMPTOM_PRESENT,,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,IMPROVING,
10,,,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,SYMPTOM_PRESENT,,,SUBTOTAL,DECLINING,
10,,,SYMPTOM_PRESENT,,,TPCV,NOT_MENTIONED,
10,,,SYMPTOM_PRESENT,,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,,ALKYLATING,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,,,,ALKYLATING,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,
10,,,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,,ALKYLATING,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,,ALKYLATING,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,,,,ALKYLATING,,Lomustine 40 MG Oral Capsule,,
10,,,,ALKYLATING,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
10,,,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,DECLINING,
10,,,,ANTIMETABOLITE,,NOT_MENTIONED,DECLINING,
10,,,,ANTIMETABOLITE,,OTHER,DECLINING,
10,,,,AVAILABLE AND ELIGIBLE,CLINICAL_TRIAL,AVAILABLE_AND_ELIGIBLE,,
10,,,,AVAILABLE AND ELIGIBLE,CLINICAL_TRIAL,,,
10,,,,AVAILABLE AND ELIGIBLE,,AVAILABLE_AND_ELIGIBLE,,
10,,,,AVAILABLE AND ELIGIBLE,,,,
10,,,,BRAF,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,
10,,,,BRAF,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,,
10,,,,BRAF,,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,
10,,,,BRAF,,dabrafenib 50 MG Oral Capsule,,
10,,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,
10,,,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,,,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,,CHEMOTHERAPY,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,,,,CHEMOTHERAPY,,Lomustine 40 MG Oral Capsule,,
10,,,,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,
10,,,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,
10,,,,DEBULKING,,NOT_MENTIONED,DECLINING,
10,,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,
10,,,,LOMUSTINE,CHEMOTHERAPY,,DECLINING,
10,,,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,,LOMUSTINE,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,,,,LOMUSTINE,,Lomustine 40 MG Oral Capsule,,
10,,,,LOMUSTINE,,,DECLINING,
10,,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,
10,,,,OTHER SURGERY,,NOT_MENTIONED,DECLINING,
10,,,,SUBTOTAL,SURGERY,SUBTOTAL,DECLINING,
10,,,,SUBTOTAL,SURGERY,,DECLINING,
10,,,,SUBTOTAL,,SUBTOTAL,DECLINING,
10,,,,SUBTOTAL,,,DECLINING,
10,,,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,
10,,,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,DECLINING,
10,,,,TOPOISOMERASE,,NOT_MENTIONED,DECLINING,
10,,,,TOPOISOMERASE,,OTHER,DECLINING,
10,,,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,,,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,,,,,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,
10,,,,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,
10,,,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,,,,,CLINICAL_TRIAL,AVAILABLE_AND_ELIGIBLE,,
10,,,,,SURGERY,SUBTOTAL,DECLINING,
10,,,,,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,
10,,,,,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,,
10,,,,,,AVAILABLE_AND_ELIGIBLE,,
10,,,,,,Lomustine 10 MG Oral Capsule,DECLINING,
10,,,,,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,
10,,,,,,Lomustine 40 MG Oral Capsule,,
10,,,,,,SUBTOTAL,DECLINING,
10,,,,,,TPCV,NOT_MENTIONED,
10,,,,,,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,
10,,,,,,dabrafenib 50 MG Oral Capsule,,
10,,,,,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,BRAF,,cumulus__none,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MTOR,,cumulus__none,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,MTOR,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,OTHER TARGETED,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,NOT_MENTIONED,PLATINUM,,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MAPK,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,MEK,,,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,VINBLASTINE,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,VINBLASTINE,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,VINBLASTINE,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,PROGRESSION,,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,STABLE,,CHEMOTHERAPY,,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,STABLE,,CHEMOTHERAPY,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,STABLE,,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,STABLE,,VINCA ALKALOID,,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,STABLE,,VINCA ALKALOID,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,STABLE,,,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,STABLE,,,CHEMOTHERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,ALKYLATING,,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,ALKYLATING,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,BRAF,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MAPK,,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MEK,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MTOR,TARGETED_THERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MTOR,,cumulus__none,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,MTOR,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OBSERVATION,OBSERVATION,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OBSERVATION,,OBSERVATION,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OBSERVATION,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,cumulus__none,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OTHER TARGETED,TARGETED_THERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OTHER TARGETED,,cumulus__none,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,OTHER TARGETED,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,PLATINUM,,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,TRAMETINIB,,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,OBSERVATION,OBSERVATION,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,OBSERVATION,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,TARGETED_THERAPY,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,OBSERVATION,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,NOT_MENTIONED,,,trametinib 0.5 MG Oral Tablet,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,ANTIMETABOLITE,,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MAPK,TARGETED_THERAPY,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MAPK,,,,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,TARGETED_THERAPY,,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,cumulus__none,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,MEK,,,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,OBSERVATION,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,OBSERVATION,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,OBSERVATION,,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,PLATINUM,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,OBSERVATION,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,OBSERVATION,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,SYMPTOM_PRESENT,,,OBSERVATION,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
10,AVAILABLE_AND_ELIGIBLE,,,,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,NOT_MENTIONED,,,,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,ALKYLATING,,OTHER,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,CHEMOTHERAPY,,OTHER,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,MTOR,,cumulus__none,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,PROGRESSION,,,,NOT_MENTIONED,DECLINING,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,ALKYLATING,,,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,VINCA ALKALOID,,,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,SYMPTOM_PRESENT,,,NOT_MENTIONED,DECLINING,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,ALKYLATING,,OTHER,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,CHEMOTHERAPY,,OTHER,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,MTOR,TARGETED_THERAPY,cumulus__none,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,MTOR,,cumulus__none,,boston_childrens
10,AVAILABLE_NOT_ELIGIBLE,,,,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,ANTIMETABOLITE,,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,BEVACIZUMAB,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,CHEMOTHERAPY,,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,TOPOISOMERASE,,,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,CHEMOTHERAPY,BEVACIZUMAB,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,BEVACIZUMAB,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,BEVACIZUMAB,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,NOT_MENTIONED,,,BIOPSY_ONLY,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,SURGERY,,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,,,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,TOPOISOMERASE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,PARTIAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,SYMPTOM_PRESENT,,,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,ALKYLATING,,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,CRANIOTOMY,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,DEBULKING,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,OBSERVATION,,,IMPROVING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,VINCRISTINE,,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,OBSERVATION,,IMPROVING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,,OBSERVATION,IMPROVING,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,PROGRESSION,,,,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,OBSERVATION,,IMPROVING,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,OBSERVATION,IMPROVING,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,OBSERVATION,,,IMPROVING,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,PLATINUM,,OTHER,,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,OBSERVATION,IMPROVING,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,,OBSERVATION,,IMPROVING,boston_childrens
10,NOT_MENTIONED,STABLE,NOT_MENTIONED,,,OBSERVATION,IMPROVING,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,ALKYLATING,,,,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
10,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,STABLE,,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,ANTIMETABOLITE,,OTHER,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,SURGERY,NOT_MENTIONED,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,BIOPSY,,NOT_MENTIONED,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,SURGERY,NOT_MENTIONED,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,CRANIOTOMY,,NOT_MENTIONED,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,SURGERY,GROSS_TOTAL,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,SURGERY,,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,,GROSS_TOTAL,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,GROSS TOTAL,,,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,SURGERY,SUBTOTAL,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,SURGERY,,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,,SUBTOTAL,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,SUBTOTAL,,,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,,SURGERY,SUBTOTAL,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,,,BIOPSY_ONLY,,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,,,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,NOT_MENTIONED,,,SUBTOTAL,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,TARGETED_THERAPY,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,cumulus__none,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,BRAF MEK COMBINATION,,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,,IMPROVING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CHEMOTHERAPY,,,IMPROVING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,CRANIOTOMY,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,SURGERY,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,PARTIAL,,,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,CHEMOTHERAPY,,IMPROVING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,,SYMPTOM_PRESENT,,,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,ALKYLATING,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,ALKYLATING,,Lomustine 40 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,ALKYLATING,,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,ANTIMETABOLITE,CHEMOTHERAPY,,DECLINING,boston_childrens
10,NOT_MENTIONED,,,ANTIMETABOLITE,,,DECLINING,boston_childrens
10,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,BRAF,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,BRAF,,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,BRAF,,dabrafenib 50 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,,Lomustine 40 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,CRANIOTOMY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,,CRANIOTOMY,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,,DEBULKING,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,LOMUSTINE,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,LOMUSTINE,,Lomustine 40 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,,OTHER SURGERY,,NOT_MENTIONED,DECLINING,boston_childrens
10,NOT_MENTIONED,,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,,CHEMOTHERAPY,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,,,,CHEMOTHERAPY,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,,,,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,,CHEMOTHERAPY,OTHER,IMPROVING,boston_childrens
10,NOT_MENTIONED,,,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,,TARGETED_THERAPY,cumulus__none,IMPROVING,boston_childrens
10,NOT_MENTIONED,,,,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,,,BEVACIZUMAB,DECLINING,boston_childrens
10,NOT_MENTIONED,,,,,BEVACIZUMAB_IRINOTECAN,,boston_childrens
10,NOT_MENTIONED,,,,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,,,Lomustine 40 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,,,OTHER,IMPROVING,boston_childrens
10,NOT_MENTIONED,,,,,TPCV,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,,,cumulus__none,IMPROVING,boston_childrens
10,NOT_MENTIONED,,,,,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,NOT_MENTIONED,,,,,dabrafenib 50 MG Oral Capsule,,boston_childrens
10,NOT_MENTIONED,,,,,temozolomide 100 MG Oral Capsule,,boston_childrens
10,OTHER,PROGRESSION,,,,,NOT_MENTIONED,boston_childrens
10,OTHER,,,,,,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,DECLINING,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,,DECLINING,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,VINCA ALKALOID,,,DECLINING,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,,TARGETED_THERAPY,,DECLINING,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,,,BIOPSY_ONLY,,boston_childrens
10,,PROGRESSION,NOT_MENTIONED,,,cumulus__none,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,ALKYLATING,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,LOMUSTINE,,,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,SURGERY,,,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,PARTIAL,,,,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,PLATINUM,,OTHER,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,SUBTOTAL,,,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,VINCRISTINE,,,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,CLINICAL_TRIAL,,,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,,PARTIAL,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,,SUBTOTAL,DECLINING,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,,TPCV,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,SYMPTOM_PRESENT,,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,ALKYLATING,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,,ALKYLATING,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,ALKYLATING,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,AVAILABLE AND ELIGIBLE,CLINICAL_TRIAL,AVAILABLE_AND_ELIGIBLE,,boston_childrens
10,,PROGRESSION,,AVAILABLE AND ELIGIBLE,CLINICAL_TRIAL,,,boston_childrens
10,,PROGRESSION,,AVAILABLE AND ELIGIBLE,,AVAILABLE_AND_ELIGIBLE,,boston_childrens
10,,PROGRESSION,,AVAILABLE AND ELIGIBLE,,,,boston_childrens
10,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,,PROGRESSION,,DEBULKING,,NOT_MENTIONED,DECLINING,boston_childrens
10,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,LOMUSTINE,CHEMOTHERAPY,,DECLINING,boston_childrens
10,,PROGRESSION,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,LOMUSTINE,,,DECLINING,boston_childrens
10,,PROGRESSION,,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,,PROGRESSION,,OTHER SURGERY,,NOT_MENTIONED,DECLINING,boston_childrens
10,,PROGRESSION,,SUBTOTAL,SURGERY,SUBTOTAL,DECLINING,boston_childrens
10,,PROGRESSION,,SUBTOTAL,SURGERY,,DECLINING,boston_childrens
10,,PROGRESSION,,SUBTOTAL,,SUBTOTAL,DECLINING,boston_childrens
10,,PROGRESSION,,SUBTOTAL,,,DECLINING,boston_childrens
10,,PROGRESSION,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
10,,PROGRESSION,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
10,,PROGRESSION,,TOPOISOMERASE,,NOT_MENTIONED,DECLINING,boston_childrens
10,,PROGRESSION,,TOPOISOMERASE,,OTHER,DECLINING,boston_childrens
10,,PROGRESSION,,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,,CLINICAL_TRIAL,AVAILABLE_AND_ELIGIBLE,,boston_childrens
10,,PROGRESSION,,,SURGERY,SUBTOTAL,DECLINING,boston_childrens
10,,PROGRESSION,,,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,,,AVAILABLE_AND_ELIGIBLE,,boston_childrens
10,,PROGRESSION,,,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,PROGRESSION,,,,Lomustine 10 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,,,SUBTOTAL,DECLINING,boston_childrens
10,,PROGRESSION,,,,TPCV,NOT_MENTIONED,boston_childrens
10,,PROGRESSION,,,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
10,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,,STABLE,NOT_MENTIONED,CHEMOTHERAPY,,NOT_MENTIONED,,boston_childrens
10,,STABLE,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
10,,STABLE,NOT_MENTIONED,PLATINUM,,OTHER,NOT_MENTIONED,boston_childrens
10,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
10,,STABLE,NOT_MENTIONED,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
10,,STABLE,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
10,,STABLE,NOT_MENTIONED,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,NOT_MENTIONED,,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,OTHER,,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,,,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,NOT_MENTIONED,,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,OTHER,NOT_MENTIONED,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,OTHER,,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,,NOT_MENTIONED,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,ALKYLATING,,,,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,NOT_MENTIONED,boston_childrens
10,,STABLE,SYMPTOM_PRESENT,CHEMOTHERAPY,,OTHER,NOT_MENTIONED,boston_childrens
10,,STABLE,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
10,,STABLE,,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,,boston_childrens
10,,STABLE,,,,CARBOPLATIN_VINCRISTINE,NOT_MENTIONED,boston_childrens
10,,STABLE,,,,CARBOPLATIN_VINCRISTINE,,boston_childrens
10,,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,,boston_childrens
10,,,NOT_MENTIONED,ANTIMETABOLITE,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,ANTIMETABOLITE,,OTHER,,boston_childrens
10,,,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,BIOPSY,SURGERY,BIOPSY_ONLY,,boston_childrens
10,,,NOT_MENTIONED,BIOPSY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,BIOPSY,SURGERY,NOT_MENTIONED,,boston_childrens
10,,,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,BIOPSY,,BIOPSY_ONLY,,boston_childrens
10,,,NOT_MENTIONED,BIOPSY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,BIOPSY,,NOT_MENTIONED,,boston_childrens
10,,,NOT_MENTIONED,BRAF MEK COMBINATION,TARGETED_THERAPY,cumulus__none,,boston_childrens
10,,,NOT_MENTIONED,BRAF MEK COMBINATION,TARGETED_THERAPY,,,boston_childrens
10,,,NOT_MENTIONED,BRAF MEK COMBINATION,,cumulus__none,,boston_childrens
10,,,NOT_MENTIONED,BRAF MEK COMBINATION,,,,boston_childrens
10,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,,,NOT_MENTIONED,CHEMOTHERAPY,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
10,,,NOT_MENTIONED,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,,,NOT_MENTIONED,CHEMOTHERAPY,,OTHER,DECLINING,boston_childrens
10,,,NOT_MENTIONED,CRANIOTOMY,SURGERY,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,CRANIOTOMY,SURGERY,NOT_MENTIONED,,boston_childrens
10,,,NOT_MENTIONED,CRANIOTOMY,,NOT_MENTIONED,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,CRANIOTOMY,,NOT_MENTIONED,,boston_childrens
10,,,NOT_MENTIONED,GROSS TOTAL,SURGERY,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,GROSS TOTAL,SURGERY,GROSS_TOTAL,,boston_childrens
10,,,NOT_MENTIONED,GROSS TOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,GROSS TOTAL,SURGERY,,,boston_childrens
10,,,NOT_MENTIONED,GROSS TOTAL,,GROSS_TOTAL,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,GROSS TOTAL,,GROSS_TOTAL,,boston_childrens
10,,,NOT_MENTIONED,GROSS TOTAL,,,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,GROSS TOTAL,,,,boston_childrens
10,,,NOT_MENTIONED,PLATINUM,CHEMOTHERAPY,,DECLINING,boston_childrens
10,,,NOT_MENTIONED,PLATINUM,,,DECLINING,boston_childrens
10,,,NOT_MENTIONED,SUBTOTAL,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,SUBTOTAL,SURGERY,SUBTOTAL,,boston_childrens
10,,,NOT_MENTIONED,SUBTOTAL,SURGERY,,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,SUBTOTAL,SURGERY,,,boston_childrens
10,,,NOT_MENTIONED,SUBTOTAL,,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,SUBTOTAL,,SUBTOTAL,,boston_childrens
10,,,NOT_MENTIONED,SUBTOTAL,,,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,SUBTOTAL,,,,boston_childrens
10,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,,,NOT_MENTIONED,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,,,NOT_MENTIONED,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,,,NOT_MENTIONED,VINCRISTINE,CHEMOTHERAPY,,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,VINCRISTINE,CHEMOTHERAPY,,,boston_childrens
10,,,NOT_MENTIONED,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,,,NOT_MENTIONED,VINCRISTINE,,,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,VINCRISTINE,,,,boston_childrens
10,,,NOT_MENTIONED,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,,,NOT_MENTIONED,,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
10,,,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,,SURGERY,BIOPSY_ONLY,,boston_childrens
10,,,NOT_MENTIONED,,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,,SURGERY,SUBTOTAL,,boston_childrens
10,,,NOT_MENTIONED,,TARGETED_THERAPY,cumulus__none,DECLINING,boston_childrens
10,,,NOT_MENTIONED,,TARGETED_THERAPY,,DECLINING,boston_childrens
10,,,NOT_MENTIONED,,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,,,2 ML Vincristine Sulfate 1 MG/ML Injection,,boston_childrens
10,,,NOT_MENTIONED,,,BIOPSY_ONLY,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,,,BIOPSY_ONLY,,boston_childrens
10,,,NOT_MENTIONED,,,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,,,NOT_MENTIONED,,,SUBTOTAL,,boston_childrens
10,,,NOT_MENTIONED,,,cumulus__none,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,ALKYLATING,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,ALKYLATING,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,DEBULKING,SURGERY,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,DEBULKING,,NOT_MENTIONED,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,DEBULKING,,SUBTOTAL,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,LOMUSTINE,CHEMOTHERAPY,,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,LOMUSTINE,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,LOMUSTINE,,,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,OTHER SURGERY,,NOT_MENTIONED,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,PARTIAL,SURGERY,PARTIAL,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,PARTIAL,SURGERY,,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,PARTIAL,,PARTIAL,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,PARTIAL,,,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,PLATINUM,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,PLATINUM,,OTHER,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,SUBTOTAL,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,SUBTOTAL,SURGERY,,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,SUBTOTAL,,SUBTOTAL,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,SUBTOTAL,,,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,VINCA ALKALOID,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,VINCA ALKALOID,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,VINCRISTINE,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,VINCRISTINE,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
10,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,,CLINICAL_TRIAL,,,boston_childrens
10,,,SYMPTOM_PRESENT,,SURGERY,SUBTOTAL,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,,TARGETED_THERAPY,,IMPROVING,boston_childrens
10,,,SYMPTOM_PRESENT,,,2 ML Vincristine Sulfate 1 MG/ML Injection,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,,,CARBOPLATIN_VINCRISTINE,IMPROVING,boston_childrens
10,,,SYMPTOM_PRESENT,,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,,,SUBTOTAL,DECLINING,boston_childrens
10,,,SYMPTOM_PRESENT,,,TPCV,NOT_MENTIONED,boston_childrens
10,,,SYMPTOM_PRESENT,,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,ALKYLATING,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,,ALKYLATING,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,ALKYLATING,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,boston_childrens
10,,,,ALKYLATING,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,ALKYLATING,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,,ALKYLATING,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,ALKYLATING,,Lomustine 40 MG Oral Capsule,,boston_childrens
10,,,,ALKYLATING,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,ANTIMETABOLITE,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
10,,,,ANTIMETABOLITE,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
10,,,,ANTIMETABOLITE,,NOT_MENTIONED,DECLINING,boston_childrens
10,,,,ANTIMETABOLITE,,OTHER,DECLINING,boston_childrens
10,,,,AVAILABLE AND ELIGIBLE,CLINICAL_TRIAL,AVAILABLE_AND_ELIGIBLE,,boston_childrens
10,,,,AVAILABLE AND ELIGIBLE,CLINICAL_TRIAL,,,boston_childrens
10,,,,AVAILABLE AND ELIGIBLE,,AVAILABLE_AND_ELIGIBLE,,boston_childrens
10,,,,AVAILABLE AND ELIGIBLE,,,,boston_childrens
10,,,,BRAF,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,BRAF,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,,boston_childrens
10,,,,BRAF,,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,BRAF,,dabrafenib 50 MG Oral Capsule,,boston_childrens
10,,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,CHEMOTHERAPY,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,boston_childrens
10,,,,CHEMOTHERAPY,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,,,,CHEMOTHERAPY,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,CHEMOTHERAPY,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,,CHEMOTHERAPY,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,CHEMOTHERAPY,,Lomustine 40 MG Oral Capsule,,boston_childrens
10,,,,CHEMOTHERAPY,,TPCV,NOT_MENTIONED,boston_childrens
10,,,,CHEMOTHERAPY,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,DEBULKING,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,,,,DEBULKING,,NOT_MENTIONED,DECLINING,boston_childrens
10,,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,LOMUSTINE,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,boston_childrens
10,,,,LOMUSTINE,CHEMOTHERAPY,,DECLINING,boston_childrens
10,,,,LOMUSTINE,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,,LOMUSTINE,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,LOMUSTINE,,Lomustine 40 MG Oral Capsule,,boston_childrens
10,,,,LOMUSTINE,,,DECLINING,boston_childrens
10,,,,OTHER SURGERY,SURGERY,NOT_MENTIONED,DECLINING,boston_childrens
10,,,,OTHER SURGERY,,NOT_MENTIONED,DECLINING,boston_childrens
10,,,,SUBTOTAL,SURGERY,SUBTOTAL,DECLINING,boston_childrens
10,,,,SUBTOTAL,SURGERY,,DECLINING,boston_childrens
10,,,,SUBTOTAL,,SUBTOTAL,DECLINING,boston_childrens
10,,,,SUBTOTAL,,,DECLINING,boston_childrens
10,,,,TEMOZOLOMIDE,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,TEMOZOLOMIDE,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,TOPOISOMERASE,CHEMOTHERAPY,NOT_MENTIONED,DECLINING,boston_childrens
10,,,,TOPOISOMERASE,CHEMOTHERAPY,OTHER,DECLINING,boston_childrens
10,,,,TOPOISOMERASE,,NOT_MENTIONED,DECLINING,boston_childrens
10,,,,TOPOISOMERASE,,OTHER,DECLINING,boston_childrens
10,,,,,CHEMOTHERAPY,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,,,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,,CHEMOTHERAPY,Lomustine 40 MG Oral Capsule,,boston_childrens
10,,,,,CHEMOTHERAPY,TPCV,NOT_MENTIONED,boston_childrens
10,,,,,CHEMOTHERAPY,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,,CLINICAL_TRIAL,AVAILABLE_AND_ELIGIBLE,,boston_childrens
10,,,,,SURGERY,SUBTOTAL,DECLINING,boston_childrens
10,,,,,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,,TARGETED_THERAPY,dabrafenib 50 MG Oral Capsule,,boston_childrens
10,,,,,,AVAILABLE_AND_ELIGIBLE,,boston_childrens
10,,,,,,Lomustine 10 MG Oral Capsule,DECLINING,boston_childrens
10,,,,,,Lomustine 40 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,,,Lomustine 40 MG Oral Capsule,,boston_childrens
10,,,,,,SUBTOTAL,DECLINING,boston_childrens
10,,,,,,TPCV,NOT_MENTIONED,boston_childrens
10,,,,,,dabrafenib 50 MG Oral Capsule,NOT_MENTIONED,boston_childrens
10,,,,,,dabrafenib 50 MG Oral Capsule,,boston_childrens
10,,,,,,temozolomide 100 MG Oral Capsule,NOT_MENTIONED,boston_childrens
`;var Xo={exports:{}},oP=Xo.exports,uS;function AP(){return uS||(uS=1,(function(G,U){(function(p,f){G.exports=f(p._Highcharts,p._Highcharts.SeriesRegistry,p._Highcharts.Point,p._Highcharts.Color,p._Highcharts.SVGElement)})("u"<typeof window?oP:window,(p,f,v,F,Q)=>(()=>{var sE,q,k={28:UE=>{UE.exports=Q},260:UE=>{UE.exports=v},512:UE=>{UE.exports=f},620:UE=>{UE.exports=F},944:UE=>{UE.exports=p}},_E={};function IE(UE){var nE=_E[UE];if(nE!==void 0)return nE.exports;var uE=_E[UE]={exports:{}};return k[UE](uE,uE.exports,IE),uE.exports}IE.n=UE=>{var nE=UE&&UE.__esModule?()=>UE.default:()=>UE;return IE.d(nE,{a:nE}),nE},IE.d=(UE,nE)=>{for(var uE in nE)IE.o(nE,uE)&&!IE.o(UE,uE)&&Object.defineProperty(UE,uE,{enumerable:!0,get:nE[uE]})},IE.o=(UE,nE)=>Object.prototype.hasOwnProperty.call(UE,nE);var CE={};IE.d(CE,{default:()=>NT});var HE=IE(944),fE=IE.n(HE),zE=IE(512),wE=IE.n(zE);let{series:{prototype:$E,prototype:{pointClass:{prototype:DE}}}}=wE(),{defined:xE,extend:gE,find:PN,merge:$N,pick:cE}=fE();(function(UE){function nE(){return this.data=[].concat(this.points||[],this.nodes),$E.destroy.apply(this,arguments)}function uE(){this.nodes&&(this.nodes.forEach(kE=>{kE.destroy()}),this.nodes.length=0),$E.setData.apply(this,arguments)}function YE(kE){let jE=arguments,BE=this.isNode?this.linksTo.concat(this.linksFrom):[this.fromNode,this.toNode];kE!=="select"&&BE.forEach(KE=>{KE&&KE.series&&(DE.setState.apply(KE,jE),!KE.isNode&&(KE.fromNode.graphic&&DE.setState.apply(KE.fromNode,jE),KE.toNode&&KE.toNode.graphic&&DE.setState.apply(KE.toNode,jE)))}),DE.setState.apply(this,jE)}function EN(kE,jE,BE,KE){let SN=this.series.options.nodes,TN=this.series.options.data,QE=TN?.length||0,nN=TN?.[this.index];if(DE.update.call(this,kE,!this.isNode&&jE,BE,KE),this.isNode){let SO=(SN||[]).reduce((qN,GN,wN)=>this.id===GN.id?wN:qN,-1),_N=$N(SN&&SN[SO]||{},TN?.[this.index]||{});TN&&(nN?TN[this.index]=nN:TN.length=QE),SN?SO>=0?SN[SO]=_N:SN.push(_N):this.series.options.nodes=[_N],cE(jE,!0)&&this.series.chart.redraw(BE)}}UE.compose=function(kE,jE){let BE=kE.prototype,KE=jE.prototype;return BE.setNodeState=YE,BE.setState=YE,BE.update=EN,KE.destroy=nE,KE.setData=uE,jE},UE.createNode=function(kE){let jE=this.pointClass,BE=(TN,QE)=>PN(TN,nN=>nN.id===QE),KE=BE(this.nodes,kE),SN;if(!KE){SN=this.options.nodes&&BE(this.options.nodes,kE);let TN=new jE(this,gE({className:"highcharts-node",isNode:!0,id:kE,y:1},SN));TN.linksTo=[],TN.linksFrom=[],TN.getSum=function(){let QE=0,nN=0;return TN.linksTo.forEach(SO=>{QE+=SO.weight||0}),TN.linksFrom.forEach(SO=>{nN+=SO.weight||0}),Math.max(QE,nN)},TN.offset=function(QE,nN){let SO=0;for(let _N=0;_N<TN[nN].length;_N++){if(TN[nN][_N]===QE)return SO;SO+=TN[nN][_N].weight}},TN.hasShape=function(){let QE=0;return TN.linksTo.forEach(nN=>{nN.outgoing&&QE++}),!TN.linksTo.length||QE!==TN.linksTo.length},TN.index=this.nodes.push(TN)-1,KE=TN}return KE.formatPrefix="node",KE.name=KE.name||KE.options.id||"",KE.mass=cE(KE.options.mass,KE.options.marker&&KE.options.marker.radius,this.options.marker&&this.options.marker.radius,4),KE},UE.destroy=nE,UE.generatePoints=function(){let kE=this.chart,jE={};$E.generatePoints.call(this),this.nodes||(this.nodes=[]),this.colorCounter=0,this.nodes.forEach(BE=>{BE.linksFrom.length=0,BE.linksTo.length=0,BE.level=BE.options.level}),this.points.forEach(BE=>{xE(BE.from)&&(jE[BE.from]||(jE[BE.from]=this.createNode(BE.from)),jE[BE.from].linksFrom.push(BE),BE.fromNode=jE[BE.from],kE.styledMode?BE.colorIndex=cE(BE.options.colorIndex,jE[BE.from].colorIndex):BE.color=BE.options.color||jE[BE.from].color),xE(BE.to)&&(jE[BE.to]||(jE[BE.to]=this.createNode(BE.to)),jE[BE.to].linksTo.push(BE),BE.toNode=jE[BE.to]),BE.name=BE.name||BE.id},this),this.nodeLookup=jE},UE.setNodeState=YE,UE.updateNode=EN})(sE||(sE={}));let pN=sE;var xN=IE(260),mO=IE.n(xN);let{column:WO}=wE().seriesTypes,{defined:vO}=fE();class bT extends WO.prototype.pointClass{applyOptions(nE,uE){return mO().prototype.applyOptions.call(this,nE,uE),vO(this.options.level)&&(this.options.column=this.column=this.options.level),this}getClassName(){return(this.isNode?"highcharts-node ":"highcharts-link ")+mO().prototype.getClassName.call(this)}getFromNode(){let nE=-1,uE;for(let YE=0;YE<this.linksTo.length;YE++){let EN=this.linksTo[YE];EN.fromNode.column>nE&&EN.fromNode!==this&&(nE=(uE=EN.fromNode).column)}return{fromNode:uE,fromColumn:nE}}setNodeColumn(){vO(this.options.column)||(this.linksTo.length===0?this.column=0:this.column=this.getFromNode().fromColumn+1)}isValid(){return this.isNode||typeof this.weight=="number"}}let{defined:EO,getAlignFactor:lT,relativeLength:rE}=fE();var pE=q||(q={});pE.compose=function(UE,nE){return UE.sankeyColumn=new MN(UE,nE),UE};class MN{constructor(nE,uE){this.points=nE,this.series=uE}getTranslationFactor(nE){let uE=this.points,YE=uE.slice(),EN=nE.chart,kE=nE.options.minLinkWidth||0,jE,BE=0,KE,SN=(EN.plotSizeY||0)-(nE.options.borderWidth||0)-(uE.length-1)*nE.nodePadding;for(;uE.length;){for(BE=SN/uE.sankeyColumn.sum(),jE=!1,KE=uE.length;KE--;)uE[KE].getSum()*BE<kE&&(uE.splice(KE,1),SN=Math.max(0,SN-kE),jE=!0);if(!jE)break}for(let TN of(uE.length=0,YE))uE.push(TN);return BE}top(nE){let uE=this.series,YE=uE.nodePadding,EN=this.points.reduce((kE,jE)=>(kE>0&&(kE+=YE),kE+=Math.max(jE.getSum()*nE,uE.options.minLinkWidth||0)),0);return lT(uE.options.nodeAlignment||"center")*((uE.chart.plotSizeY||0)-EN)}left(nE){let uE=this.series,YE=uE.chart,EN=uE.options.equalNodes,kE=YE.inverted?YE.plotHeight:YE.plotWidth,jE=uE.nodePadding,BE=this.points.reduce((KE,SN)=>(KE>0&&(KE+=jE),KE+=EN?kE/SN.series.nodes.length-jE:Math.max(SN.getSum()*nE,uE.options.minLinkWidth||0)),0);return((YE.plotSizeX||0)-Math.round(BE))/2}sum(){return this.points.reduce((nE,uE)=>nE+uE.getSum(),0)}offset(nE,uE){let YE=this.points,EN=this.series,kE=EN.nodePadding,jE=0,BE;if(EN.is("organization")&&nE.hangsFrom)return{absoluteTop:nE.hangsFrom.nodeY};for(let KE=0;KE<YE.length;KE++){let SN=YE[KE].getSum(),TN=Math.max(SN*uE,EN.options.minLinkWidth||0),QE=nE.options[EN.chart.inverted?"offsetHorizontal":"offsetVertical"],nN=nE.options.offset||0;if(BE=SN?TN+kE:0,YE[KE]===nE)return{relativeTop:jE+(EO(QE)?rE(QE,TN):rE(nN,BE))};jE+=BE}}}pE.SankeyColumnAdditions=MN;let VN=q;var vN=IE(620),EE=IE.n(vN);let{extend:z,isArray:yE,isNumber:FE,isObject:sN,merge:rN,pick:KN,relativeLength:YO}=fE();var _O=IE(28),mT=IE.n(_O);let{deg2rad:HO}=fE(),{addEvent:vn,merge:bI,uniqueKey:RT,defined:mI,extend:un}=fE();function II(UE,nE){nE=bI(!0,{enabled:!0,attributes:{dy:-5,startOffset:"50%",textAnchor:"middle"}},nE);let uE=this.renderer.url,YE=this.text||this,EN=YE.textPath,{attributes:kE,enabled:jE}=nE;if(UE=UE||EN&&EN.path,EN&&EN.undo(),UE&&jE){let BE=vn(YE,"afterModifyTree",KE=>{if(UE&&jE){let SN=UE.attr("id");SN||UE.attr("id",SN=RT());let TN={x:0,y:0};mI(kE.dx)&&(TN.dx=kE.dx,delete kE.dx),mI(kE.dy)&&(TN.dy=kE.dy,delete kE.dy),YE.attr(TN),this.attr({transform:""}),this.box&&(this.box=this.box.destroy());let QE=KE.nodes.slice(0);KE.nodes.length=0,KE.nodes[0]={tagName:"textPath",attributes:un(kE,{"text-anchor":kE.textAnchor,href:`${uE}#${SN}`}),children:QE}}});YE.textPath={path:UE,undo:BE}}else YE.attr({dx:0,dy:0}),delete YE.textPath;return this.added&&(YE.textCache="",this.renderer.buildText(YE)),this}function tI(UE){let nE=UE.bBox,uE=this.element?.querySelector("textPath");if(uE){let YE=[],{b:EN,h:kE}=this.renderer.fontMetrics(this.element),jE=kE-EN,BE=RegExp('(<tspan>|<tspan(?!\\sclass="highcharts-br")[^>]*>|<\\/tspan>)',"g"),KE=uE.innerHTML.replace(BE,"").split(/<tspan class="highcharts-br"[^>]*>/),SN=KE.length,TN=(QE,nN)=>{let{x:SO,y:_N}=nN,qN=(uE.getRotationOfChar(QE)-90)*HO,GN=Math.cos(qN),wN=Math.sin(qN);return[[SO-jE*GN,_N-jE*wN],[SO+EN*GN,_N+EN*wN]]};for(let QE=0,nN=0;nN<SN;nN++){let SO=KE[nN].length;for(let _N=0;_N<SO;_N+=5)try{let qN=QE+_N+nN,[GN,wN]=TN(qN,uE.getStartPositionOfChar(qN));_N===0?(YE.push(wN),YE.push(GN)):(nN===0&&YE.unshift(wN),nN===SN-1&&YE.push(GN))}catch{break}QE+=SO-1;try{let _N=QE+nN,qN=uE.getEndPositionOfChar(_N),[GN,wN]=TN(_N,qN);YE.unshift(wN),YE.unshift(GN)}catch{break}}YE.length&&YE.push(YE[0].slice()),nE.polygon=YE}return nE}function rT(UE){let nE=UE.labelOptions,uE=UE.point,YE=nE[uE.formatPrefix+"TextPath"]||nE.textPath;YE&&!nE.useHTML&&(this.setTextPath(uE.getDataLabelPath?.(this)||uE.graphic,YE),uE.dataLabelPath&&!YE.enabled&&(uE.dataLabelPath=uE.dataLabelPath.destroy()))}let{column:fT,line:PT}=wE().seriesTypes,{parse:we}=EE(),{getLevelOptions:zT,getNodeWidth:sT}={getLevelOptions:function(UE){let nE,uE,YE,EN,kE,jE,BE={};if(sN(UE))for(EN=FE(UE.from)?UE.from:1,jE=UE.levels,uE={},nE=sN(UE.defaults)?UE.defaults:{},yE(jE)&&(uE=jE.reduce((KE,SN)=>{let TN,QE,nN;return sN(SN)&&FE(SN.level)&&(QE=KN((nN=rN({},SN)).levelIsConstant,nE.levelIsConstant),delete nN.levelIsConstant,delete nN.level,sN(KE[TN=SN.level+(QE?0:EN-1)])?rN(!0,KE[TN],nN):KE[TN]=nN),KE},{})),kE=FE(UE.to)?UE.to:1,YE=0;YE<=kE;YE++)BE[YE]=rN({},nE,sN(uE[YE])?uE[YE]:{});return BE},getNodeWidth:function(UE,nE){let{chart:uE,options:YE}=UE,{nodeDistance:EN=0,nodeWidth:kE=0}=YE,{plotSizeX:jE=1}=uE;if(kE==="auto"){if(typeof EN=="string"&&/%$/.test(EN))return jE/(nE+parseFloat(EN)/100*(nE-1));let BE=Number(EN);return(jE+BE)/(nE||1)-BE}return YO(kE,jE)}},{clamp:Ee,crisp:Ne,extend:tN,isObject:fI,merge:pI,pick:eI,relativeLength:VI,stableSort:Oe}=fE();({compose:function(UE){vn(UE,"afterGetBBox",tI),vn(UE,"beforeAddingDataLabel",rT);let nE=UE.prototype;nE.setTextPath||(nE.setTextPath=II)}}).compose(mT());class pT extends fT{static getDLOptions(nE){let uE=fI(nE.optionsPoint)?nE.optionsPoint.dataLabels:{},YE=fI(nE.level)?nE.level.dataLabels:{};return pI({style:{}},YE,uE,{zIndex:YE?.zIndex})}createNodeColumns(){let nE=[];for(let uE of this.nodes)uE.setNodeColumn(),nE[uE.column]||(nE[uE.column]=VN.compose([],this)),nE[uE.column].push(uE);for(let uE=0;uE<nE.length;uE++)nE[uE]===void 0&&(nE[uE]=VN.compose([],this));return nE}order(nE,uE){if(nE.level===void 0)for(let YE of(nE.level=uE,nE.linksFrom))YE.toNode&&this.order(YE.toNode,uE+1)}generatePoints(){if(pN.generatePoints.apply(this,arguments),this.orderNodes){for(let nE of this.nodes)nE.linksTo.length===0&&this.order(nE,0);Oe(this.nodes,(nE,uE)=>nE.level-uE.level)}}getNodePadding(){let nE=this.options.nodePadding||0;if(this.nodeColumns){let uE=this.nodeColumns.reduce((YE,EN)=>Math.max(YE,EN.length),0);uE*nE>this.chart.plotSizeY&&(nE=this.chart.plotSizeY/uE)}return nE}hasData(){return!!this.dataTable.rowCount}pointAttribs(nE,uE){if(!nE)return{};let YE=this,EN=nE.isNode?nE.level:nE.fromNode.level,kE=YE.mapOptionsToLevel[EN||0]||{},jE=nE.options,BE=kE.states&&kE.states[uE||""]||{},KE=["colorByPoint","borderColor","borderWidth","linkOpacity","opacity"].reduce((TN,QE)=>(TN[QE]=eI(BE[QE],jE[QE],kE[QE],YE.options[QE]),TN),{}),SN=eI(BE.color,jE.color,KE.colorByPoint?nE.color:kE.color);return nE.isNode?{fill:SN,stroke:KE.borderColor,"stroke-width":KE.borderWidth,opacity:KE.opacity}:{fill:SN,"fill-opacity":KE.linkOpacity}}drawTracker(){fT.prototype.drawTracker.call(this,this.points),fT.prototype.drawTracker.call(this,this.nodes)}drawPoints(){fT.prototype.drawPoints.call(this,this.points),fT.prototype.drawPoints.call(this,this.nodes)}drawDataLabels(){fT.prototype.drawDataLabels.call(this,this.points),fT.prototype.drawDataLabels.call(this,this.nodes)}translate(){this.generatePoints(),this.nodeColumns=this.createNodeColumns();let nE=this,uE=this.chart,YE=this.options,EN=this.nodeColumns,kE=EN.length;for(let jE of(this.nodeWidth=sT(this,kE),this.nodePadding=this.getNodePadding(),this.translationFactor=EN.reduce((BE,KE)=>Math.min(BE,KE.sankeyColumn.getTranslationFactor(nE)),1/0),this.colDistance=(uE.plotSizeX-this.nodeWidth-YE.borderWidth)/Math.max(1,EN.length-1),nE.mapOptionsToLevel=zT({from:1,levels:YE.levels,to:EN.length-1,defaults:{borderColor:YE.borderColor,borderRadius:YE.borderRadius,borderWidth:YE.borderWidth,color:nE.color,colorByPoint:YE.colorByPoint,levelIsConstant:!0,linkColor:YE.linkColor,linkLineWidth:YE.linkLineWidth,linkOpacity:YE.linkOpacity,states:YE.states}}),EN))for(let BE of jE)nE.translateNode(BE,jE);for(let jE of this.nodes)for(let BE of jE.linksFrom)(BE.weight||BE.isNull)&&BE.to&&(nE.translateLink(BE),BE.allowShadow=!1)}translateLink(nE){let uE=(OT,TT)=>{let FT=OT.offset(nE,TT)*BE;return Math.min(OT.nodeY+FT,OT.nodeY+(OT.shapeArgs&&OT.shapeArgs.height||0)-_N)},YE=nE.fromNode,EN=nE.toNode,kE=this.chart,{inverted:jE}=kE,BE=this.translationFactor,KE=this.options,SN=eI(nE.linkColorMode,KE.linkColorMode),TN=(kE.inverted?-this.colDistance:this.colDistance)*KE.curveFactor,QE=YE.nodeX,nN=EN.nodeX,SO=nE.outgoing,_N=Math.max(nE.weight*BE,this.options.minLinkWidth),qN=uE(YE,"linksFrom"),GN=uE(EN,"linksTo"),wN=this.nodeWidth,fO=nN>QE+wN;if(kE.inverted&&(qN=kE.plotSizeY-qN,GN=(kE.plotSizeY||0)-GN,wN=-wN,_N=-_N,fO=QE>nN),nE.shapeType="path",nE.linkBase=[qN,qN+_N,GN,GN+_N],fO&&typeof GN=="number")nE.shapeArgs={d:[["M",QE+wN,qN],["C",QE+wN+TN,qN,nN-TN,GN,nN,GN],["L",nN+(SO?wN:0),GN+_N/2],["L",nN,GN+_N],["C",nN-TN,GN+_N,QE+wN+TN,qN+_N,QE+wN,qN+_N],["Z"]]};else if(typeof GN=="number"){let OT=kE.plotHeight-qN-_N,TT=nN-20-_N,FT=nN-20,Kn=QE+wN,WN=Kn+20,aO=WN+_N,QO=qN,dT=qN+_N,QN=dT+20,MI=QN+OT,VT=MI+20,jT=VT+_N,rn=GN,lO=rn+_N,ZT=lO+20,wn=dT-.7*_N,RI=VT+.7*_N,sI=lO-.7*_N,dO=nN-.7*_N,lt=Kn+.7*_N;nE.shapeArgs={d:[["M",Kn,QO],["C",lt,QO,aO,wn,aO,QN],["L",aO,MI],["C",aO,RI,lt,jT,Kn,jT],["L",nN,jT],["C",dO,jT,TT,RI,TT,MI],["L",TT,ZT],["C",TT,sI,dO,rn,nN,rn],["L",nN,lO],["C",FT,lO,FT,lO,FT,ZT],["L",FT,MI],["C",FT,VT,FT,VT,nN,VT],["L",Kn,VT],["C",WN,VT,WN,VT,WN,MI],["L",WN,QN],["C",WN,dT,WN,dT,Kn,dT],["Z"]]}}if(nE.dlBox={x:QE+(nN-QE+wN)/2,y:qN+(GN-qN)/2,height:_N,width:0},nE.tooltipPos=kE.inverted?[kE.plotSizeY-nE.dlBox.y-_N/2,kE.plotSizeX-nE.dlBox.x]:[nE.dlBox.x,nE.dlBox.y+_N/2],nE.y=nE.plotY=1,nE.x=nE.plotX=1,!nE.options.color){if(SN==="from")nE.color=YE.color;else if(SN==="to")nE.color=EN.color;else if(SN==="gradient"){let OT=we(YE.color).get(),TT=we(EN.color).get();nE.color={linearGradient:{x1:1,x2:0,y1:0,y2:0},stops:[[0,jE?OT:TT],[1,jE?TT:OT]]}}}}translateNode(nE,uE){let YE=this.translationFactor,EN=this.chart,kE=this.options,{borderRadius:jE,borderWidth:BE=0}=kE,KE=nE.getSum(),SN=Math.max(Math.round(KE*YE),this.options.minLinkWidth),TN=Math.round(this.nodeWidth),QE=uE.sankeyColumn.offset(nE,YE),nN=Ne(eI(QE.absoluteTop,uE.sankeyColumn.top(YE)+QE.relativeTop),BE),SO=Ne(this.colDistance*nE.column+BE/2,BE)+VI(nE.options[EN.inverted?"offsetVertical":"offsetHorizontal"]||0,TN),_N=EN.inverted?EN.plotSizeX-SO:SO;if(nE.sum=KE,KE){nE.shapeType="roundedRect",nE.nodeX=_N,nE.nodeY=nN;let qN=_N,GN=nN,wN=nE.options.width||kE.width||TN,fO=nE.options.height||kE.height||SN,OT=Ee(VI(typeof jE=="object"?jE.radius:jE||0,wN),0,SN/2);EN.inverted&&(qN=_N-TN,GN=EN.plotSizeY-nN-SN,wN=nE.options.height||kE.height||TN,fO=nE.options.width||kE.width||SN),nE.dlOptions={...pT.getDLOptions({level:this.mapOptionsToLevel[nE.level],optionsPoint:nE.options}),zIndex:void 0},nE.plotX=1,nE.plotY=1,nE.tooltipPos=EN.inverted?[EN.plotSizeY-GN-fO/2,EN.plotSizeX-qN-wN/2]:[qN+wN/2,GN+fO/2],nE.shapeArgs={x:qN,y:GN,width:wN,height:fO,r:OT,display:nE.hasShape()?"":"none"}}else nE.dlOptions={enabled:!1}}}pT.defaultOptions=pI(fT.defaultOptions,{borderWidth:0,colorByPoint:!0,curveFactor:.33,dataLabels:{enabled:!0,backgroundColor:"none",crop:!1,nodeFormat:void 0,nodeFormatter:function(){return this.point.name},format:void 0,formatter:function(){},inside:!0},inactiveOtherPoints:!0,linkColorMode:"from",linkOpacity:.5,opacity:1,minLinkWidth:0,nodeAlignment:"center",nodeWidth:20,nodePadding:10,nodeDistance:30,showInLegend:!1,states:{hover:{linkOpacity:1,opacity:1},inactive:{linkOpacity:.1,opacity:.1,animation:{duration:50}}},tooltip:{followPointer:!0,headerFormat:'<span style="font-size: 0.8em">{series.name}</span><br/>',pointFormat:"{point.fromNode.name}  {point.toNode.name}: <b>{point.weight}</b><br/>",nodeFormat:"{point.name}: <b>{point.sum}</b><br/>"}}),pN.compose(bT,pT),tN(pT.prototype,{animate:PT.prototype.animate,createNode:pN.createNode,forceDL:!0,invertible:!0,isCartesian:!1,orderNodes:!0,noSharedTooltip:!0,pointArrayMap:["from","to","weight"],pointClass:bT,searchPoint:fE().noop}),wE().registerSeriesType("sankey",pT);let NT=fE();return CE.default})())})(Xo)),Xo.exports}AP();var qo={exports:{}},SP=qo.exports,YS;function lP(){return YS||(YS=1,(function(G,U){(function(p,f){G.exports=f(p._Highcharts,p._Highcharts.Templating,p._Highcharts.AST,p._Highcharts.Legend,p._Highcharts.Axis,p._Highcharts.Color,p._Highcharts.SeriesRegistry,p._Highcharts.RendererRegistry,p._Highcharts.SVGRenderer,p._Highcharts.Point,p._Highcharts.Series)})("u"<typeof window?SP:window,(p,f,v,F,Q,sE,q,k,_E,IE,CE)=>(()=>{let HE;var fE,zE,wE,$E,DE={260:a=>{a.exports=IE},512:a=>{a.exports=q},532:a=>{a.exports=Q},540:a=>{a.exports=_E},608:a=>{a.exports=k},620:a=>{a.exports=sE},632:a=>{a.exports=F},660:a=>{a.exports=v},820:a=>{a.exports=CE},944:a=>{a.exports=p},984:a=>{a.exports=f}},xE={};function gE(a){var _=xE[a];if(_!==void 0)return _.exports;var r=xE[a]={exports:{}};return DE[a](r,r.exports,gE),r.exports}gE.n=a=>{var _=a&&a.__esModule?()=>a.default:()=>a;return gE.d(_,{a:_}),_},gE.d=(a,_)=>{for(var r in _)gE.o(_,r)&&!gE.o(a,r)&&Object.defineProperty(a,r,{enumerable:!0,get:_[r]})},gE.o=(a,_)=>Object.prototype.hasOwnProperty.call(a,_);var PN={};gE.d(PN,{default:()=>Et});var $N=gE(944),cE=gE.n($N);let{doc:pN,win:xN}=cE(),{css:mO}=cE(),WO=xN.EventTarget&&new xN.EventTarget||"none";function vO(a){if(typeof xN.MouseEvent=="function")return new xN.MouseEvent(a.type,a);if(pN?.createEvent){let _=pN.createEvent("MouseEvent");if(_.initMouseEvent)return _.initMouseEvent(a.type,a.bubbles,a.cancelable,a.view||xN,a.detail,a.screenX,a.screenY,a.clientX,a.clientY,a.ctrlKey,a.altKey,a.shiftKey,a.metaKey,a.button,a.relatedTarget),_}return bT(a.type)}function bT(a,_,r){let L=_||{x:0,y:0};if(typeof xN.MouseEvent=="function")return new xN.MouseEvent(a,{bubbles:!0,cancelable:!0,composed:!0,button:0,buttons:1,relatedTarget:r||WO,view:xN,detail:+(a==="click"),screenX:L.x,screenY:L.y,clientX:L.x,clientY:L.y});if(pN?.createEvent){let u=pN.createEvent("MouseEvent");if(u.initMouseEvent)return u.initMouseEvent(a,!0,!0,xN,+(a==="click"),L.x,L.y,L.x,L.y,!1,!1,!1,!1,0,null),u}return{type:a}}let EO={addClass:function(a,_){a.classList?a.classList.add(_):0>a.className.indexOf(_)&&(a.className+=" "+_)},cloneMouseEvent:vO,cloneTouchEvent:function(a){let _=L=>{let u=[];for(let m=0;m<L.length;++m){let b=L.item(m);b&&u.push(b)}return u};if(typeof xN.TouchEvent=="function"){let L=new xN.TouchEvent(a.type,{touches:_(a.touches),targetTouches:_(a.targetTouches),changedTouches:_(a.changedTouches),ctrlKey:a.ctrlKey,shiftKey:a.shiftKey,altKey:a.altKey,metaKey:a.metaKey,bubbles:a.bubbles,cancelable:a.cancelable,composed:a.composed,detail:a.detail,view:a.view});return a.defaultPrevented&&L.preventDefault(),L}let r=vO(a);return r.touches=a.touches,r.changedTouches=a.changedTouches,r.targetTouches=a.targetTouches,r},escapeStringForHTML:function(a){return a.replace(/&/g,"&amp;").replace(/</g,"&lt;").replace(/>/g,"&gt;").replace(/"/g,"&quot;").replace(/'/g,"&#x27;").replace(/\//g,"&#x2F;")},getElement:function(a){return pN.getElementById(a)},getFakeMouseEvent:bT,getHeadingTagNameForElement:function(a){let _=u=>"h"+Math.min(6,parseInt(u.slice(1),10)+1),r=u=>/^H[1-6]$/i.test(u),L=u=>{let m=(K=>{let w=K;for(;w=w.previousSibling;){let OE=w.tagName||"";if(r(OE))return OE}return""})(u);if(m)return _(m);let b=u.parentElement;if(!b)return"h6";let y=b.tagName;return r(y)?_(y):L(b)};return L(a)},removeChildNodes:function(a){for(;a.lastChild;)a.removeChild(a.lastChild)},removeClass:function(a,_){a.classList?a.classList.remove(_):a.className=a.className.replace(RegExp(_,"g"),"")},removeElement:function(a){a&&a.parentNode&&a.parentNode.removeChild(a)},reverseChildNodes:function(a){let _=a.childNodes.length;for(;_--;)a.appendChild(a.childNodes[_])},simulatedEventTarget:WO,stripHTMLTagsFromString:function(a,_=!1){return typeof a=="string"?_?a.replace(/<\/?[^>]+(>|$)/g,""):a.replace(/<\/?(?!\s)[^>]+(>|$)/g,""):a},visuallyHideElement:function(a){mO(a,{position:"absolute",width:"1px",height:"1px",overflow:"hidden",whiteSpace:"nowrap",clip:"rect(1px, 1px, 1px, 1px)",marginTop:"-3px","-ms-filter":"progid:DXImageTransform.Microsoft.Alpha(Opacity=1)",filter:"alpha(opacity=1)",opacity:.01})}};var lT=gE(984),rE=gE.n(lT);let{format:pE}=rE(),{getNestedProperty:MN,pick:VN}=cE();var vN=fE||(fE={});function EE(a,_,r){let L=(K,w)=>{let OE=K.slice(w||0),tE=OE.indexOf("{"),ME=OE.indexOf("}");if(tE>-1&&ME>tE)return{statement:OE.substring(tE+1,ME),begin:w+tE+1,end:w+ME}},u=[],m,b,y=0;do m=L(a,y),(b=a.substring(y,m&&m.begin-1)).length&&u.push({value:b,type:"constant"}),m&&u.push({value:m.statement,type:"statement"}),y=m?m.end+1:y+1;while(m);return u.forEach(K=>{K.type==="statement"&&(K.value=(function(w,OE){let tE,ME,AE=w.indexOf("#each("),bE=w.indexOf("#plural("),VE=w.indexOf("["),ZE=w.indexOf("]");if(AE>-1){let LN=w.slice(AE).indexOf(")")+AE,RN=w.substring(0,AE),qE=w.substring(LN+1),uN=w.substring(AE+6,LN).split(","),HN=Number(uN[1]),BN;if(ME="",tE=MN(uN[0],OE)){BN=(HN=isNaN(HN)?tE.length:HN)<0?tE.length+HN:Math.min(HN,tE.length);for(let CN=0;CN<BN;++CN)ME+=RN+tE[CN]+qE}return ME.length?ME:""}if(bE>-1){var aN;let LN=w.slice(bE).indexOf(")")+bE,RN=w.substring(bE+8,LN).split(",");switch(Number(MN(RN[0],OE))){case 0:ME=VN(RN[4],RN[1]);break;case 1:ME=VN(RN[2],RN[1]);break;case 2:ME=VN(RN[3],RN[1]);break;default:ME=RN[1]}return ME?(aN=ME).trim&&aN.trim()||aN.replace(/^\s+|\s+$/g,""):""}if(VE>-1){let LN,RN=w.substring(0,VE),qE=Number(w.substring(VE+1,ZE));return tE=MN(RN,OE),!isNaN(qE)&&tE&&(qE<0?(LN=tE[tE.length+qE])===void 0&&(LN=tE[0]):(LN=tE[qE])===void 0&&(LN=tE[tE.length-1])),LN!==void 0?LN:""}return"{"+w+"}"})(K.value,_))}),pE(u.reduce((K,w)=>K+w.value,""),_,r)}function z(a,_){let r=a.split("."),L=this.options.lang,u=0;for(;u<r.length;++u)L=L&&L[r[u]];return typeof L=="string"?EE(L,_,this):""}vN.compose=function(a){let _=a.prototype;_.langFormat||(_.langFormat=z)},vN.i18nFormat=EE;let yE=fE,{doc:FE}=cE(),{stripHTMLTagsFromString:sN}=EO,{defined:rN,find:KN,fireEvent:YO}=cE();function _O(a){if(a.points&&a.points.length){let _=KN(a.points,r=>!!r.graphic);return _&&_.graphic&&_.graphic.element}}function mT(a){let _=_O(a);return _&&_.parentNode||a.graph&&a.graph.element||a.group&&a.group.element}let HO={fireEventOnWrappedOrUnwrappedElement:function a(_,r){let L=r.type,u=_.hcEvents;FE?.createEvent&&(_.dispatchEvent||_.fireEvent)?_.dispatchEvent?_.dispatchEvent(r):_.fireEvent(L,r):u&&u[L]?YO(_,L,r):_.element&&a(_.element,r)},getChartTitle:function(a){return sN(a.options.title.text||a.langFormat("accessibility.defaultChartTitle",{chart:a}),a.renderer.forExport)},getAxisDescription:function(a){return a&&(a.options.accessibility?.description||a.axisTitle?.textStr||a.options.id||a.categories&&a.chart.langFormat("accessibility.axis.defaultAxisNames.categories",{})||a.dateTime&&a.chart.langFormat("accessibility.axis.defaultAxisNames.time",{})||a.chart.langFormat("accessibility.axis.defaultAxisNames.values",{}))},getAxisRangeDescription:function(a){var _,r,L;let u,m,b,y,K,w,OE,tE,ME,AE,bE,VE,ZE=a.options||{};return ZE.accessibility&&ZE.accessibility.rangeDescription!==void 0?ZE.accessibility.rangeDescription:a.categories?(u=(_=a).chart,_.dataMax&&_.dataMin?u.langFormat("accessibility.axis.rangeCategories",{chart:u,axis:_,numCategories:_.dataMax-_.dataMin+1}):""):a.dateTime&&(a.min===0||a.dataMin===0)?(m=(r=a).chart,b={},y=r.dataMin||r.min||0,K=r.dataMax||r.max||0,w="Seconds",b.Seconds=(K-y)/1e3,b.Minutes=b.Seconds/60,b.Hours=b.Minutes/60,b.Days=b.Hours/24,["Minutes","Hours","Days"].forEach(function(aN){b[aN]>2&&(w=aN)}),OE=b[w].toFixed(+(w!=="Seconds"&&w!=="Minutes")),m.langFormat("accessibility.axis.timeRange"+w,{chart:m,axis:r,range:OE.replace(".0","")})):(AE=(ME=(tE=(L=a).chart).options)&&ME.accessibility&&ME.accessibility.screenReaderSection.axisRangeDateFormat||"",bE={min:L.dataMin||L.min||0,max:L.dataMax||L.max||0},VE=function(aN){return L.dateTime?tE.time.dateFormat(AE,bE[aN]):bE[aN].toString()},tE.langFormat("accessibility.axis.rangeFromTo",{chart:tE,axis:L,rangeFrom:VE("min"),rangeTo:VE("max")}))},getPointFromXY:function(a,_,r){let L=a.length,u;for(;L--;)if(u=KN(a[L].points||[],function(m){return m.x===_&&m.y===r}))return u},getSeriesFirstPointElement:_O,getSeriesFromName:function(a,_){return _?(a.series||[]).filter(function(r){return r.name===_}):a.series},getSeriesA11yElement:mT,unhideChartElementFromAT:function a(_,r){r.setAttribute("aria-hidden",!1),r!==_.renderTo&&r.parentNode&&r.parentNode!==FE.body&&(Array.prototype.forEach.call(r.parentNode.childNodes,function(L){L.hasAttribute("aria-hidden")||L.setAttribute("aria-hidden",!0)}),a(_,r.parentNode))},hideSeriesFromAT:function(a){let _=mT(a);_&&_.setAttribute("aria-hidden",!0)},scrollAxisToPoint:function(a){let _=a.series.xAxis,r=a.series.yAxis,L=_&&_.scrollbar?_:r,u=L&&L.scrollbar;if(u&&rN(u.to)&&rN(u.from)){let m=u.to-u.from,b=(function(y,K){if(!rN(y.dataMin)||!rN(y.dataMax))return 0;let w=y.toPixels(y.dataMin),OE=y.toPixels(y.dataMax),tE=y.coll==="xAxis"?"x":"y";return(y.toPixels(K[tE]||0)-w)/(OE-w)})(L,a);u.updatePosition(b-m/2,b+m/2),YO(u,"changed",{from:u.from,to:u.to,trigger:"scrollbar",DOMEvent:null})}}},{doc:vn}=cE(),{removeElement:bI}=EO,RT=class{constructor(){this.elements=[]}createElement(){let a=vn.createElement.apply(vn,arguments);return this.elements.push(a),a}removeElement(a){bI(a),this.elements.splice(this.elements.indexOf(a),1)}destroyCreatedElements(){this.elements.forEach(function(a){bI(a)}),this.elements=[]}},{addEvent:mI}=cE(),un=class{constructor(){this.eventRemovers=[]}addEvent(){let a=mI.apply(cE(),arguments);return this.eventRemovers.push({element:arguments[0],remover:a}),a}removeEvent(a){let _=this.eventRemovers.map(r=>r.remover).indexOf(a);this.eventRemovers[_].remover(),this.eventRemovers.splice(_,1)}removeAddedEvents(){this.eventRemovers.map(a=>a.remover).forEach(a=>a()),this.eventRemovers=[]}},{fireEventOnWrappedOrUnwrappedElement:II}=HO,{getFakeMouseEvent:tI}=EO,rT=class{destroy(){}getKeyboardNavigation(){return[]}init(){}onChartRender(){}onChartUpdate(){}initBase(a,_){this.chart=a,this.eventProvider=new un,this.domElementProvider=new RT,this.proxyProvider=_,this.keyCodes={left:37,right:39,up:38,down:40,enter:13,space:32,esc:27,tab:9,pageUp:33,pageDown:34,end:35,home:36}}addEvent(a,_,r,L){return this.eventProvider.addEvent(a,_,r,L)}createElement(a,_){return this.domElementProvider.createElement(a,_)}fakeClickEvent(a){II(a,tI("click"))}destroyBase(){this.domElementProvider.destroyCreatedElements(),this.eventProvider.removeAddedEvents()}},{find:fT}=cE(),PT=class{constructor(a,_){this.chart=a,this.keyCodeMap=_.keyCodeMap||[],this.validate=_.validate,this.init=_.init,this.terminate=_.terminate,this.response={success:1,prev:2,next:3,noHandler:4,fail:5}}run(a){let _=a.which||a.keyCode,r=this.response.noHandler,L=fT(this.keyCodeMap,function(u){return u[0].indexOf(_)>-1});return L?r=L[1].call(this,_,a):_===9&&(r=this.response[a.shiftKey?"prev":"next"]),r}},{unhideChartElementFromAT:we,getChartTitle:zT}=HO,{doc:sT}=cE(),{stripHTMLTagsFromString:Ee}=EO,Ne=class extends rT{onChartUpdate(){this.handleSVGTitleElement(),this.setSVGContainerLabel(),this.setGraphicContainerAttrs(),this.setRenderToAttrs(),this.makeCreditsAccessible()}handleSVGTitleElement(){let a=this.chart,_="highcharts-title-"+a.index,r=Ee(a.langFormat("accessibility.svgContainerTitle",{chartTitle:zT(a)}));if(r.length){let L=this.svgTitleElement=this.svgTitleElement||sT.createElementNS("http://www.w3.org/2000/svg","title");L.textContent=r,L.id=_,a.renderTo.insertBefore(L,a.renderTo.firstChild)}}setSVGContainerLabel(){let a=this.chart,_=a.langFormat("accessibility.svgContainerLabel",{chartTitle:zT(a)});a.renderer.box&&_.length&&a.renderer.box.setAttribute("aria-label",_)}setGraphicContainerAttrs(){let a=this.chart,_=a.langFormat("accessibility.graphicContainerLabel",{chartTitle:zT(a)});_.length&&a.container.setAttribute("aria-label",_)}setRenderToAttrs(){let a=this.chart,_=a.options.accessibility.landmarkVerbosity!=="disabled",r=a.langFormat("accessibility.chartContainerLabel",{title:zT(a),chart:a});r&&(a.renderTo.setAttribute("role",_?"region":"group"),a.renderTo.setAttribute("aria-label",r))}makeCreditsAccessible(){let a=this.chart,_=a.credits;_&&(_.textStr&&_.element.setAttribute("aria-label",a.langFormat("accessibility.credits",{creditsStr:Ee(_.textStr,a.renderer.forExport)})),we(a,_.element))}getKeyboardNavigation(){let a=this.chart;return new PT(a,{keyCodeMap:[],validate:function(){return!0},init:function(){let _=a.accessibility;_&&_.keyboardNavigation.tabindexContainer.focus()}})}destroy(){this.chart.renderTo.setAttribute("aria-hidden",!0)}},{addEvent:tN,pick:fI}=cE();(function(a){let _=["x","y","transform","width","height","r","d","stroke-width"];function r(){let b=this.focusElement,y=this.options.accessibility.keyboardNavigation.focusBorder;b&&(b.removeFocusBorder(),y.enabled&&b.addFocusBorder(y.margin,{stroke:y.style.color,strokeWidth:y.style.lineWidth,r:y.style.borderRadius}))}function L(b,y){let K=this.options.accessibility.keyboardNavigation.focusBorder,w=y||b.element;w&&w.focus&&(w.hcEvents&&w.hcEvents.focusin||tN(w,"focusin",function(){}),w.focus(),K.hideBrowserFocusOutline&&(w.style.outline="none")),this.focusElement&&this.focusElement.removeFocusBorder(),this.focusElement=b,tN(this,"endResize",function(){this.renderFocusBorder()}),this.renderFocusBorder()}function u(b,y){this.focusBorder&&this.removeFocusBorder();let K=this.getBBox(),w=fI(b,3),OE=this.parentGroup,tE=this.scaleX||OE&&OE.scaleX,ME=this.scaleY||OE&&OE.scaleY,AE=(tE?!ME:ME)?Math.abs(tE||ME||1):(Math.abs(tE||1)+Math.abs(ME||1))/2,bE=this.renderer.fontMetrics(this).h;K.x+=this.translateX?this.translateX:0,K.y+=this.translateY?this.translateY:0;let VE=K.x-w,ZE=K.y-w,aN=K.width+2*w,LN=K.height+2*w,RN=!!this.text;if(this.element.nodeName==="text"||RN){let qE,uN,HN=!!this.rotation,BN=RN?{x:+!!HN,y:0}:(qE=0,uN=0,this.attr("text-anchor")==="middle"?qE=uN=.5:this.rotation?qE=.25:uN=.75,{x:qE,y:uN}),CN=+this.attr("x"),iO=+this.attr("y");if(isNaN(CN)||(VE=CN-K.width*BN.x-w),isNaN(iO)||(ZE=iO-(this.attr("text-anchor")==="start"?bE:K.height)*BN.y-w),RN&&HN){let cT=aN;aN=LN,LN=cT,isNaN(CN)||(VE=CN-K.height*BN.x-w),isNaN(iO)||(ZE=iO-K.width*BN.y-w)}}this.focusBorder=this.renderer.rect(VE,ZE,aN,LN,parseInt((y&&y.r||0).toString(),10)/AE).addClass("highcharts-focus-border").attr({zIndex:99}).add(OE),this.renderer.styledMode||this.focusBorder.attr({stroke:y&&y.stroke,"stroke-width":(y&&y.strokeWidth||0)/AE}),(function(qE,...uN){qE.focusBorderUpdateHooks||(qE.focusBorderUpdateHooks={},_.forEach(HN=>{let BN=HN+"Setter",CN=qE[BN]||qE._defaultSetter;qE.focusBorderUpdateHooks[BN]=CN,qE[BN]=function(){let iO=CN.apply(qE,arguments);return qE.addFocusBorder.apply(qE,uN),iO}}))})(this,b,y),(function(qE){if(qE.focusBorderDestroyHook)return;let uN=qE.destroy;qE.destroy=function(){return qE.focusBorder&&qE.focusBorder.destroy&&qE.focusBorder.destroy(),uN.apply(qE,arguments)},qE.focusBorderDestroyHook=uN})(this)}function m(){var b;b=this,b.focusBorderUpdateHooks&&(Object.keys(b.focusBorderUpdateHooks).forEach(y=>{let K=b.focusBorderUpdateHooks[y];K===b._defaultSetter?delete b[y]:b[y]=K}),delete b.focusBorderUpdateHooks),this.focusBorderDestroyHook&&(this.destroy=this.focusBorderDestroyHook,delete this.focusBorderDestroyHook),this.focusBorder&&(this.focusBorder.destroy(),delete this.focusBorder)}a.compose=function(b,y){let K=b.prototype,w=y.prototype;K.renderFocusBorder||(K.renderFocusBorder=r,K.setFocusToElement=L),w.addFocusBorder||(w.addFocusBorder=u,w.removeFocusBorder=m)}})(zE||(zE={}));let pI=zE;var eI=gE(660),VI=gE.n(eI);let{doc:Oe}=cE(),{addClass:pT,visuallyHideElement:NT}=EO,{attr:UE}=cE(),nE=class{constructor(a,_){this.chart=a,this.domElementProvider=new RT,this.announceRegion=this.addAnnounceRegion(_)}destroy(){this.domElementProvider.destroyCreatedElements()}announce(a){VI().setElementHTML(this.announceRegion,a),this.clearAnnouncementRegionTimer&&clearTimeout(this.clearAnnouncementRegionTimer),this.clearAnnouncementRegionTimer=setTimeout(()=>{this.announceRegion.innerHTML=VI().emptyHTML,delete this.clearAnnouncementRegionTimer},3e3)}addAnnounceRegion(a){let _=this.chart.announcerContainer||this.createAnnouncerContainer(),r=this.domElementProvider.createElement("div");return UE(r,{"aria-hidden":!1,"aria-live":a,"aria-atomic":!0}),this.chart.styledMode?pT(r,"highcharts-visually-hidden"):NT(r),_.appendChild(r),r}createAnnouncerContainer(){let a=this.chart,_=Oe.createElement("div");return UE(_,{"aria-hidden":!1,class:"highcharts-announcer-container"}),_.style.position="relative",a.renderTo.insertBefore(_,a.renderTo.firstChild),a.announcerContainer=_,_}},{escapeStringForHTML:uE,stripHTMLTagsFromString:YE}=EO;function EN(a){return(a.annotations||[]).reduce((_,r)=>(r.options&&r.options.visible!==!1&&(_=_.concat(r.labels)),_),[])}function kE(a){return a.options&&a.options.accessibility&&a.options.accessibility.description||a.graphic&&a.graphic.text&&a.graphic.text.textStr||""}function jE(a){let _=a.options&&a.options.accessibility&&a.options.accessibility.description;if(_)return _;let r=a.chart,L=kE(a),u=a.points.filter(K=>!!K.graphic).map(K=>{let w=K.accessibility&&K.accessibility.valueDescription||K.graphic&&K.graphic.element&&K.graphic.element.getAttribute("aria-label")||"",OE=K&&K.series.name||"";return(OE?OE+", ":"")+"data point "+w}).filter(K=>!!K),m=u.length,b=m>1?"MultiplePoints":m?"SinglePoint":"NoPoints",y={annotationText:L,annotation:a,numPoints:m,annotationPoint:u[0],additionalAnnotationPoints:u.slice(1)};return r.langFormat("accessibility.screenReaderSection.annotations.description"+b,y)}function BE(a){return EN(a).map(_=>{let r=uE(YE(jE(_),a.renderer.forExport));return r?`<li>${r}</li>`:""})}let KE={getAnnotationsInfoHTML:function(a){let _=a.annotations;return _&&_.length?`<ul style="list-style-type: none">${BE(a).join(" ")}</ul>`:""},getPointAnnotationTexts:function(a){let _=EN(a.series.chart).filter(r=>r.points.indexOf(a)>-1);return _.length?_.map(r=>`${kE(r)}`):[]}},{getAnnotationsInfoHTML:SN}=KE,{getAxisDescription:TN,getAxisRangeDescription:QE,getChartTitle:nN,unhideChartElementFromAT:SO}=HO,{format:_N}=rE(),{doc:qN}=cE(),{addClass:GN,getElement:wN,getHeadingTagNameForElement:fO,stripHTMLTagsFromString:OT,visuallyHideElement:TT}=EO,{attr:FT,pick:Kn,replaceNested:WN}=cE();function aO(a){return WN(a,[/<([\w\-.:!]+)\b[^<>]*>\s*<\/\1>/g,""])}let QO=class extends rT{constructor(){super(...arguments),this.screenReaderSections={}}init(){let a=this.chart,_=this;this.initRegionsDefinitions(),this.addEvent(a,"afterGetTableAST",function(r){_.onDataTableCreated(r)}),this.addEvent(a,"afterViewData",function(r){r.wasHidden&&(_.dataTableDiv=r.element,setTimeout(function(){_.focusDataTable()},300))}),this.addEvent(a,"afterHideData",function(){_.viewDataTableButton&&_.viewDataTableButton.setAttribute("aria-expanded","false")}),a.exporting&&this.addEvent(a,"afterPrint",function(){_.updateAllScreenReaderSections()}),this.announcer=new nE(a,"assertive")}initRegionsDefinitions(){let a=this,_=this.chart.options.accessibility;this.screenReaderSections={before:{element:null,buildContent:function(r){let L=_.screenReaderSection.beforeChartFormatter;return L?L(r):a.defaultBeforeChartFormatter(r)},insertIntoDOM:function(r,L){L.renderTo.insertBefore(r,L.renderTo.firstChild)},afterInserted:function(){a.sonifyButtonId!==void 0&&a.initSonifyButton(a.sonifyButtonId),a.dataTableButtonId!==void 0&&a.initDataTableButton(a.dataTableButtonId)}},after:{element:null,buildContent:function(r){let L=_.screenReaderSection.afterChartFormatter;return L?L(r):a.defaultAfterChartFormatter()},insertIntoDOM:function(r,L){L.renderTo.insertBefore(r,L.container.nextSibling)},afterInserted:function(){a.chart.accessibility&&_.keyboardNavigation.enabled&&a.chart.accessibility.keyboardNavigation.updateExitAnchor()}}}}onChartRender(){this.linkedDescriptionElement=this.getLinkedDescriptionElement(),this.setLinkedDescriptionAttrs(),this.updateAllScreenReaderSections()}updateAllScreenReaderSections(){let a=this;Object.keys(this.screenReaderSections).forEach(function(_){a.updateScreenReaderSection(_)})}getLinkedDescriptionElement(){let a=this.chart.options.accessibility.linkedDescription;if(!a)return;if(typeof a!="string")return a;let _=_N(a,this.chart),r=qN.querySelectorAll(_);if(r.length===1)return r[0]}setLinkedDescriptionAttrs(){let a=this.linkedDescriptionElement;a&&(a.setAttribute("aria-hidden","true"),GN(a,"highcharts-linked-description"))}updateScreenReaderSection(a){let _=this.chart,r=this.screenReaderSections[a],L=r.buildContent(_),u=r.element=r.element||this.createElement("div"),m=u.firstChild||this.createElement("div");L?(this.setScreenReaderSectionAttribs(u,a),VI().setElementHTML(m,L),u.appendChild(m),r.insertIntoDOM(u,_),_.styledMode?GN(m,"highcharts-visually-hidden"):TT(m),SO(_,m),r.afterInserted&&r.afterInserted()):(u.parentNode&&u.parentNode.removeChild(u),r.element=null)}setScreenReaderSectionAttribs(a,_){let r=this.chart,L=r.langFormat("accessibility.screenReaderSection."+_+"RegionLabel",{chart:r,chartTitle:nN(r)});FT(a,{id:`highcharts-screen-reader-region-${_}-${r.index}`,"aria-label":L||void 0}),a.style.position="relative",L&&a.setAttribute("role",r.options.accessibility.landmarkVerbosity==="all"?"region":"group")}defaultBeforeChartFormatter(){let a=this.chart,_=a.options.accessibility.screenReaderSection.beforeChartFormat;if(!_)return"";let r=this.getAxesDescription(),L=a.sonify&&a.options.sonification&&a.options.sonification.enabled,u="highcharts-a11y-sonify-data-btn-"+a.index,m="hc-linkto-highcharts-data-table-"+a.index,b=SN(a),y=a.langFormat("accessibility.screenReaderSection.annotations.heading",{chart:a}),K={headingTagName:fO(a.renderTo),chartTitle:nN(a),typeDescription:this.getTypeDescriptionText(),chartSubtitle:this.getSubtitleText(),chartLongdesc:this.getLongdescText(),xAxisDescription:r.xAxis,yAxisDescription:r.yAxis,playAsSoundButton:L?this.getSonifyButtonText(u):"",viewTableButton:a.exporting?.getCSV?this.getDataTableButtonText(m):"",annotationsTitle:b?y:"",annotationsList:b},w=yE.i18nFormat(_,K,a);return this.dataTableButtonId=m,this.sonifyButtonId=u,aO(w)}defaultAfterChartFormatter(){let a=this.chart,_=a.options.accessibility.screenReaderSection.afterChartFormat;if(!_)return"";let r={endOfChartMarker:this.getEndOfChartMarkerText()};return aO(yE.i18nFormat(_,r,a))}getLinkedDescription(){let a=this.linkedDescriptionElement;return OT(a&&a.innerHTML||"",this.chart.renderer.forExport)}getLongdescText(){let a=this.chart.options,_=a.caption,r=_&&_.text,L=this.getLinkedDescription();return a.accessibility.description||L||r||""}getTypeDescriptionText(){let a=this.chart;return a.types?a.options.accessibility.typeDescription||(function(_,r){let L,u,m,b=r[0],y=_.series&&_.series[0]||{},K=_.mapView&&_.mapView.geoMap&&_.mapView.geoMap.title,w={numSeries:_.series.length,numPoints:y.points&&y.points.length,chart:_,mapTitle:K};return b?b==="map"||b==="tiledwebmap"?w.mapTitle?_.langFormat("accessibility.chartTypes.mapTypeDescription",w):_.langFormat("accessibility.chartTypes.unknownMap",w):_.types.length>1?_.langFormat("accessibility.chartTypes.combinationChart",w):(L=r[0],u=_.langFormat("accessibility.seriesTypeDescriptions."+L,w),m=_.series&&_.series.length<2?"Single":"Multiple",(_.langFormat("accessibility.chartTypes."+L+m,w)||_.langFormat("accessibility.chartTypes.default"+m,w))+(u?" "+u:"")):_.langFormat("accessibility.chartTypes.emptyChart",w)})(a,a.types):""}getDataTableButtonText(a){let _=this.chart;return'<button id="'+a+'">'+_.langFormat("accessibility.table.viewAsDataTableButtonText",{chart:_,chartTitle:nN(_)})+"</button>"}getSonifyButtonText(a){let _=this.chart;return _.options.sonification&&_.options.sonification.enabled===!1?"":'<button id="'+a+'">'+_.langFormat("accessibility.sonification.playAsSoundButtonText",{chart:_,chartTitle:nN(_)})+"</button>"}getSubtitleText(){let a=this.chart.options.subtitle;return OT(a&&a.text||"",this.chart.renderer.forExport)}getEndOfChartMarkerText(){let a=wN(`highcharts-end-of-chart-marker-${this.chart.index}`);if(a)return a.outerHTML;let _=this.chart,r=_.langFormat("accessibility.screenReaderSection.endOfChartMarker",{chart:_});return'<div id="highcharts-end-of-chart-marker-'+_.index+'">'+r+"</div>"}onDataTableCreated(a){let _=this.chart;if(_.options.accessibility.enabled){this.viewDataTableButton&&this.viewDataTableButton.setAttribute("aria-expanded","true");let r=a.tree.attributes||{};r.tabindex=-1,r.summary=_.langFormat("accessibility.table.tableSummary",{chart:_}),a.tree.attributes=r}}focusDataTable(){let a=this.dataTableDiv,_=a&&a.getElementsByTagName("table")[0];_&&_.focus&&_.focus()}initSonifyButton(a){let _=this.sonifyButton=wN(a),r=this.chart,L=u=>{_&&(_.setAttribute("aria-hidden","true"),_.setAttribute("aria-label","")),u.preventDefault(),u.stopPropagation();let m=r.langFormat("accessibility.sonification.playAsSoundClickAnnouncement",{chart:r});this.announcer.announce(m),setTimeout(()=>{_&&(_.removeAttribute("aria-hidden"),_.removeAttribute("aria-label")),r.sonify&&r.sonify()},1e3)};_&&r&&(_.setAttribute("tabindex",-1),_.onclick=function(u){(r.options.accessibility&&r.options.accessibility.screenReaderSection.onPlayAsSoundClick||L).call(this,u,r)})}initDataTableButton(a){let _=this.viewDataTableButton=wN(a),r=this.chart,L=a.replace("hc-linkto-","");_&&(FT(_,{tabindex:-1,"aria-expanded":!!wN(L)}),_.onclick=r.options.accessibility.screenReaderSection.onViewDataTableClick||function(){r.exporting?.viewData()})}getAxesDescription(){let a=this.chart,_=function(y,K){let w=a[y];return w.length>1||w[0]&&Kn(w[0].options.accessibility&&w[0].options.accessibility.enabled,K)},r=!!a.types&&0>a.types.indexOf("map")&&0>a.types.indexOf("treemap")&&0>a.types.indexOf("tilemap"),L=!!a.hasCartesianSeries,u=_("xAxis",!a.angular&&L&&r),m=_("yAxis",L&&r),b={};return u&&(b.xAxis=this.getAxisDescriptionText("xAxis")),m&&(b.yAxis=this.getAxisDescriptionText("yAxis")),b}getAxisDescriptionText(a){let _=this.chart,r=_[a];return _.langFormat("accessibility.axis."+a+"Description"+(r.length>1?"Plural":"Singular"),{chart:_,names:r.map(function(L){return TN(L)}),ranges:r.map(function(L){return QE(L)}),numAxes:r.length})}destroy(){this.announcer&&this.announcer.destroy()}},{attr:dT}=cE(),{getChartTitle:QN,unhideChartElementFromAT:MI}=HO,{getFakeMouseEvent:VT}=EO;function jT(a){return a.exporting?.svgElements?.[0]}class rn extends rT{init(){let _=this.chart,r=this;this.addEvent(_,"exportMenuShown",function(){r.onMenuShown()}),this.addEvent(_,"exportMenuHidden",function(){r.onMenuHidden()}),this.createProxyGroup()}onMenuHidden(){let _=this.chart.exporting?.contextMenuEl;_&&_.setAttribute("aria-hidden","true"),this.setExportButtonExpandedState("false")}onMenuShown(){let _=this.chart,r=_.exporting?.contextMenuEl;r&&(this.addAccessibleContextMenuAttribs(),MI(_,r)),this.setExportButtonExpandedState("true")}setExportButtonExpandedState(_){this.exportButtonProxy&&this.exportButtonProxy.innerElement.setAttribute("aria-expanded",_)}onChartRender(){let _=this.chart,r=_.focusElement,L=_.accessibility;this.proxyProvider.clearGroup("chartMenu"),this.proxyMenuButton(),this.exportButtonProxy&&r&&r===_.exporting?.group&&(r.focusBorder?_.setFocusToElement(r,this.exportButtonProxy.innerElement):L&&L.keyboardNavigation.tabindexContainer.focus())}proxyMenuButton(){let _,r,L=this.chart,u=this.proxyProvider,m=jT(L);_=L.options.exporting,r=jT(L),_&&_.enabled!==!1&&_.accessibility&&_.accessibility.enabled&&r&&r.element&&m&&(this.exportButtonProxy=u.addProxyElement("chartMenu",{click:m},"button",{"aria-label":L.langFormat("accessibility.exporting.menuButtonLabel",{chart:L,chartTitle:QN(L)}),"aria-expanded":!1,title:L.options.lang.contextButtonTitle||null}))}createProxyGroup(){this.chart&&this.proxyProvider&&this.proxyProvider.addGroup("chartMenu")}addAccessibleContextMenuAttribs(){let _=this.chart,r=_.exporting?.divElements;if(r&&r.length){r.forEach(u=>{u&&(u.tagName!=="LI"||u.children&&u.children.length?u.setAttribute("aria-hidden","true"):u.setAttribute("tabindex",-1))});let L=r[0]&&r[0].parentNode;L&&dT(L,{"aria-hidden":void 0,"aria-label":_.langFormat("accessibility.exporting.chartMenuLabel",{chart:_}),role:"list"})}}getKeyboardNavigation(){let _=this.keyCodes,r=this.chart,L=this;return new PT(r,{keyCodeMap:[[[_.left,_.up],function(){return L.onKbdPrevious(this)}],[[_.right,_.down],function(){return L.onKbdNext(this)}],[[_.enter,_.space],function(){return L.onKbdClick(this)}]],validate:function(){return!!r.exporting&&r.options.exporting?.buttons?.contextButton.enabled!==!1&&r.options.exporting.enabled!==!1&&(r.options.exporting.accessibility?.enabled||!1)!==!1},init:function(){let u=L.exportButtonProxy,m=L.chart.exporting?.group;u&&m&&r.setFocusToElement(m,u.innerElement)},terminate:function(){r.hideExportMenu()}})}onKbdPrevious(_){let r=this.chart,L=r.options.accessibility,u=_.response,m=r.highlightedExportItemIx||0;for(;m--;)if(r.highlightExportItem(m))return u.success;return L.keyboardNavigation.wrapAround?(r.highlightLastExportItem(),u.success):u.prev}onKbdNext(_){let r=this.chart,L=r.options.accessibility,u=_.response;for(let m=(r.highlightedExportItemIx||0)+1;m<(r.exporting?.divElements?.length||0);++m)if(r.highlightExportItem(m))return u.success;return L.keyboardNavigation.wrapAround?(r.highlightExportItem(0),u.success):u.next}onKbdClick(_){let r=this.chart,L=r.highlightedExportItemIx!==void 0&&r.exporting?.divElements?.[r.highlightedExportItemIx],u=jT(r)?.element;return r.exporting?.openMenu?L&&this.fakeClickEvent(L):(u&&this.fakeClickEvent(u),r.highlightExportItem(0)),_.response.success}}(function(a){function _(){let m=jT(this);if(m){let b=m.element;b.onclick&&(b.onclick=function(){VT("click")})}}function r(){let m=this.exporting?.divElements;m&&this.exporting?.contextMenuEl&&this.exporting?.openMenu&&(m.forEach(b=>{b&&b.className==="highcharts-menu-item"&&b.onmouseout&&b.onmouseout(VT("mouseout"))}),this.highlightedExportItemIx=0,this.exporting.contextMenuEl.hideMenu(),this.container.focus())}function L(m){let b=this.exporting?.divElements?.[m],y=this.highlightedExportItemIx!==void 0&&this.exporting?.divElements?.[this.highlightedExportItemIx];if(b&&b.tagName==="LI"&&!(b.children&&b.children.length)){let K=!!(this.renderTo.getElementsByTagName("g")[0]||{}).focus;return b.focus&&K&&b.focus(),y&&y.onmouseout&&y.onmouseout(VT("mouseout")),b.onmouseover&&b.onmouseover(VT("mouseover")),this.highlightedExportItemIx=m,!0}return!1}function u(){if(this.exporting?.divElements){let m=this.exporting?.divElements.length;for(;m--;)if(this.highlightExportItem(m))return!0}return!1}a.compose=function(m){let b=m.prototype;b.hideExportMenu||(b.hideExportMenu=r,b.highlightExportItem=L,b.highlightLastExportItem=u,b.showExportMenu=_)}})(rn||(rn={}));let lO=rn,{doc:ZT,win:wn}=cE(),{addEvent:RI,defined:sI,fireEvent:dO}=cE(),{getElement:lt,simulatedEventTarget:FR}=EO;class kn{constructor(_,r){this.currentModuleIx=NaN,this.modules=[],this.init(_,r)}init(_,r){let L=this.eventProvider=new un;this.chart=_,this.components=r,this.modules=[],this.currentModuleIx=0,this.update(),L.addEvent(this.tabindexContainer,"keydown",u=>this.onKeydown(u)),L.addEvent(this.tabindexContainer,"focus",u=>this.onFocus(u)),["mouseup","touchend"].forEach(u=>L.addEvent(ZT,u,m=>this.onMouseUp(m))),["mousedown","touchstart"].forEach(u=>L.addEvent(_.renderTo,u,()=>{this.isClickingChart=!0}))}update(_){let r=this.chart.options.accessibility,L=r&&r.keyboardNavigation,u=this.components;this.updateContainerTabindex(),L&&L.enabled&&_&&_.length?(this.modules=_.reduce(function(m,b){let y=u[b].getKeyboardNavigation();return m.concat(y)},[]),this.updateExitAnchor()):(this.modules=[],this.currentModuleIx=0,this.removeExitAnchor())}updateExitAnchor(){let _=lt(`highcharts-end-of-chart-marker-${this.chart.index}`);this.removeExitAnchor(),_?(this.makeElementAnExitAnchor(_),this.exitAnchor=_):this.createExitAnchor()}move(_){let r=this.modules&&this.modules[this.currentModuleIx];r&&r.terminate&&r.terminate(_),this.chart.focusElement&&this.chart.focusElement.removeFocusBorder(),this.currentModuleIx+=_;let L=this.modules&&this.modules[this.currentModuleIx];if(L){if(L.validate&&!L.validate())return this.move(_);if(L.init)return L.init(_),!0}return this.currentModuleIx=0,this.exiting=!0,_>0?this.exitAnchor&&this.exitAnchor.focus():this.tabindexContainer.focus(),!1}onFocus(_){let r=this.chart,L=_.relatedTarget&&r.container.contains(_.relatedTarget),u=r.options.accessibility,m=u&&u.keyboardNavigation;if(m&&m.enabled&&!this.exiting&&!this.tabbingInBackwards&&!this.isClickingChart&&!L){let b=this.getFirstValidModuleIx();b!==null&&(this.currentModuleIx=b,this.modules[b].init(1))}this.keyboardReset=!1,this.exiting=!1}onMouseUp(_){if(delete this.isClickingChart,!this.keyboardReset&&_.relatedTarget!==FR){let r=this.chart;if(!_.target||!r.container.contains(_.target)){let L=this.modules&&this.modules[this.currentModuleIx||0];L&&L.terminate&&L.terminate(),this.currentModuleIx=0}r.focusElement&&(r.focusElement.removeFocusBorder(),delete r.focusElement),this.keyboardReset=!0}}onKeydown(_){let r,L=_||wn.event,u=this.modules&&this.modules.length&&this.modules[this.currentModuleIx],m=L.target;if((!m||m.nodeName!=="INPUT"||m.classList.contains("highcharts-a11y-proxy-element"))&&(this.keyboardReset=!1,this.exiting=!1,u)){let b=u.run(L);b===u.response.success?r=!0:b===u.response.prev?r=this.move(-1):b===u.response.next&&(r=this.move(1)),r&&(L.preventDefault(),L.stopPropagation())}}updateContainerTabindex(){let _,r=this.chart.options.accessibility,L=r&&r.keyboardNavigation,u=!(L&&L.enabled===!1),m=this.chart,b=m.container;m.renderTo.hasAttribute("tabindex")?(b.removeAttribute("tabindex"),_=m.renderTo):_=b,this.tabindexContainer=_;let y=_.getAttribute("tabindex");u&&!y?_.setAttribute("tabindex","0"):u||m.container.removeAttribute("tabindex")}createExitAnchor(){let _=this.chart,r=this.exitAnchor=ZT.createElement("div");_.renderTo.appendChild(r),this.makeElementAnExitAnchor(r)}makeElementAnExitAnchor(_){let r=this.tabindexContainer.getAttribute("tabindex")||0;_.setAttribute("class","highcharts-exit-anchor"),_.setAttribute("tabindex",r),_.setAttribute("aria-hidden",!1),this.addExitAnchorEventsToEl(_)}removeExitAnchor(){if(this.exitAnchor){let _=this.eventProvider.eventRemovers.find(r=>r.element===this.exitAnchor);_&&sI(_.remover)&&this.eventProvider.removeEvent(_.remover),this.exitAnchor.parentNode&&this.exitAnchor.parentNode.removeChild(this.exitAnchor),delete this.exitAnchor}}addExitAnchorEventsToEl(_){let r=this.chart,L=this;this.eventProvider.addEvent(_,"focus",function(u){let m=u||wn.event,b=!(m.relatedTarget&&r.container.contains(m.relatedTarget)||L.exiting);if(r.focusElement&&delete r.focusElement,b){if(L.tabbingInBackwards=!0,L.tabindexContainer.focus(),delete L.tabbingInBackwards,m.preventDefault(),L.modules&&L.modules.length){L.currentModuleIx=L.modules.length-1;let y=L.modules[L.currentModuleIx];y&&y.validate&&!y.validate()?L.move(-1):y&&y.init(-1)}}else L.exiting=!1})}getFirstValidModuleIx(){let _=this.modules.length;for(let r=0;r<_;++r){let L=this.modules[r];if(!L.validate||L.validate())return r}return null}destroy(){this.removeExitAnchor(),this.eventProvider.removeAddedEvents(),this.chart.container.removeAttribute("tabindex")}}function _I(){let a=this;dO(this,"dismissPopupContent",{},function(){a.tooltip&&a.tooltip.hide(0),a.hideExportMenu()})}function jR(a){(a.which||a.keyCode)===27&&cE().charts&&cE().charts.forEach(_=>{_&&_.dismissPopupContent&&_.dismissPopupContent()})}(kn||(kn={})).compose=function(a){lO.compose(a);let _=a.prototype;return!_.dismissPopupContent&&(_.dismissPopupContent=_I,ZT&&RI(ZT,"keydown",jR)),a};let FO=kn;var zM=gE(632),FM=gE.n(zM);let{animObject:ke}=cE(),{doc:ze}=cE(),{addEvent:zn,fireEvent:gT,isNumber:ZR,pick:XR,syncTimeout:Fe}=cE(),{getChartTitle:qR}=HO,{stripHTMLTagsFromString:gI,addClass:je,removeClass:XT}=EO;function NO(a){let _=a.legend&&a.legend.allItems,r=a.options.legend.accessibility||{},L=a.colorAxis&&a.colorAxis.some(u=>!u.dataClasses||!u.dataClasses.length);return!!(_&&_.length&&!L&&r.enabled!==!1)}function Te(a,_){let r=_.legendItem||{};for(let L of(_.setState(a?"hover":"",!0),["group","label","symbol"])){let u=r[L],m=u&&u.element||u;m&&gT(m,a?"mouseover":"mouseout")}}class rt extends rT{constructor(){super(...arguments),this.highlightedLegendItemIx=NaN,this.proxyGroup=null}init(){let _=this;this.recreateProxies(),this.addEvent(FM(),"afterScroll",function(){this.chart===_.chart&&(_.proxyProvider.updateGroupProxyElementPositions("legend"),_.updateLegendItemProxyVisibility(),_.highlightedLegendItemIx>-1&&this.chart.highlightLegendItem(_.highlightedLegendItemIx))}),this.addEvent(FM(),"afterPositionItem",function(r){this.chart===_.chart&&this.chart.renderer&&_.updateProxyPositionForItem(r.item)}),this.addEvent(FM(),"afterRender",function(){this.chart===_.chart&&this.chart.renderer&&_.recreateProxies()&&Fe(()=>_.proxyProvider.updateGroupProxyElementPositions("legend"),ke(XR(this.chart.renderer.globalAnimation,!0)).duration)})}updateLegendItemProxyVisibility(){let _,r=this.chart,L=r.legend,u=L.allItems||[],m=L.currentPage||1,b=L.clipHeight||0;u.forEach(y=>{if(y.a11yProxyElement){let K=L.pages&&L.pages.length,w=y.a11yProxyElement.element,OE=!1;if(_=y.legendItem||{},K){let tE=_.pageIx||0;OE=(_.y||0)+(_.label?Math.round(_.label.getBBox().height):0)-L.pages[tE]>b||tE!==m-1}OE?r.styledMode?je(w,"highcharts-a11y-invisible"):w.style.visibility="hidden":(XT(w,"highcharts-a11y-invisible"),w.style.visibility="")}})}onChartRender(){NO(this.chart)||this.removeProxies()}highlightAdjacentLegendPage(_){let r=this.chart,L=r.legend,u=(L.currentPage||1)+_,m=L.pages||[];if(u>0&&u<=m.length){let b=0;for(let y of L.allItems)((y.legendItem||{}).pageIx||0)+1===u&&r.highlightLegendItem(b)&&(this.highlightedLegendItemIx=b),++b}}updateProxyPositionForItem(_){_.a11yProxyElement&&_.a11yProxyElement.refreshPosition()}recreateProxies(){let _=ze.activeElement,r=this.proxyGroup,L=_&&r&&r.contains(_);return this.removeProxies(),!!NO(this.chart)&&(this.addLegendProxyGroup(),this.proxyLegendItems(),this.updateLegendItemProxyVisibility(),this.updateLegendTitle(),L&&this.chart.highlightLegendItem(this.highlightedLegendItemIx),!0)}removeProxies(){this.proxyProvider.removeGroup("legend")}updateLegendTitle(){let _=this.chart,r=gI((_.legend&&_.legend.options.title&&_.legend.options.title.text||"").replace(/<br ?\/?>/g," "),_.renderer.forExport),L=_.langFormat("accessibility.legend.legendLabel"+(r?"":"NoTitle"),{chart:_,legendTitle:r,chartTitle:qR(_)});this.proxyProvider.updateGroupAttrs("legend",{"aria-label":L})}addLegendProxyGroup(){let _=this.chart.options.accessibility.landmarkVerbosity==="all"?"region":null;this.proxyGroup=this.proxyProvider.addGroup("legend","ul",{"aria-label":"_placeholder_",role:_})}proxyLegendItems(){let _,r=this;((this.chart.legend||{}).allItems||[]).forEach(L=>{(_=L.legendItem||{}).label&&_.label.element&&r.proxyLegendItem(L)})}proxyLegendItem(_){let r=_.legendItem||{},L=_.legendItem?.label,u=L?.element,m=r.label?.styles?.textOverflow==="ellipsis";if(!r.label||!r.group)return;let b=this.chart.langFormat("accessibility.legend.legendItem",{chart:this.chart,itemName:gI(_.name,this.chart.renderer.forExport),item:_}),y={tabindex:-1,"aria-pressed":_.visible,"aria-label":b,title:""};m&&(u.textContent||"").indexOf("")!==-1&&(y.title=L?.textStr);let K=r.group.div?r.label:r.group;_.a11yProxyElement=this.proxyProvider.addProxyElement("legend",{click:r.label,visual:K.element},"button",y)}getKeyboardNavigation(){let _=this.keyCodes,r=this,L=this.chart;return new PT(L,{keyCodeMap:[[[_.left,_.right,_.up,_.down],function(u){return r.onKbdArrowKey(this,u)}],[[_.enter,_.space],function(){return r.onKbdClick(this)}],[[_.pageDown,_.pageUp],function(u){let m=u===_.pageDown?1:-1;return r.highlightAdjacentLegendPage(m),this.response.success}]],validate:function(){return r.shouldHaveLegendNavigation()},init:function(){L.highlightLegendItem(0),r.highlightedLegendItemIx=0},terminate:function(){r.highlightedLegendItemIx=-1,L.legend.allItems.forEach(u=>Te(!1,u))}})}onKbdArrowKey(_,r){let{keyCodes:{left:L,up:u},highlightedLegendItemIx:m,chart:b}=this,y=b.legend.allItems.length,K=b.options.accessibility.keyboardNavigation.wrapAround,w=r===L||r===u?-1:1;return b.highlightLegendItem(m+w)?this.highlightedLegendItemIx+=w:K&&y>1&&(this.highlightedLegendItemIx=w>0?0:y-1,b.highlightLegendItem(this.highlightedLegendItemIx)),_.response.success}onKbdClick(_){let r=this.chart.legend.allItems[this.highlightedLegendItemIx];return r&&r.a11yProxyElement&&r.a11yProxyElement.click(),_.response.success}shouldHaveLegendNavigation(){if(!NO(this.chart))return!1;let _=this.chart,r=(_.options.legend||{}).accessibility||{};return!!(_.legend.display&&r.keyboardNavigation&&r.keyboardNavigation.enabled)}destroy(){this.removeProxies()}}function Pt(a){let _=this.legend.allItems,r=this.accessibility&&this.accessibility.components.legend.highlightedLegendItemIx,L=_[a],u=L?.legendItem||{};if(L){var m;let b,y;ZR(r)&&_[r]&&Te(!1,_[r]),m=this.legend,b=(m.allItems[a].legendItem||{}).pageIx,y=m.currentPage,b!==void 0&&b+1!==y&&m.scroll(1+b-y);let K=u.label,w=L.a11yProxyElement&&L.a11yProxyElement.innerElement;return K&&K.element&&w&&this.setFocusToElement(K,w),Te(!0,L),!0}return!1}function WR(a){let _=this.chart.options.accessibility,r=a.item;_.enabled&&r&&r.a11yProxyElement&&r.a11yProxyElement.innerElement.setAttribute("aria-pressed",a.visible?"true":"false")}(rt||(rt={})).compose=function(a,_){let r=a.prototype;r.highlightLegendItem||(r.highlightLegendItem=Pt,zn(_,"afterColorizeItem",WR))};let jM=rt;var at=gE(532),ZM=gE.n(at);let{isTouchDevice:XM}=cE(),{addEvent:yI,merge:Ze,pick:qM}=cE(),Xe=[];function ne(){this.navigator&&this.navigator.setBaseSeries(null,!1)}function qT(){let a,_,r,L=this.legend,u=this.navigator;if(u){a=L&&L.options,_=u.xAxis,r=u.yAxis;let{scrollbarHeight:m,scrollButtonSize:b}=u;this.inverted?(u.left=u.opposite?this.chartWidth-m-u.height:this.spacing[3]+m,u.top=this.plotTop+b):(u.left=qM(_.left,this.plotLeft+b),u.top=u.navigatorOptions.top||this.chartHeight-u.height-m-(this.scrollbar?.options.margin||0)-this.spacing[2]-(this.rangeSelector&&this.extraBottomMargin?this.rangeSelector.getHeight():0)-(a&&a.verticalAlign==="bottom"&&a.layout!=="proximate"&&a.enabled&&!a.floating?L.legendHeight+qM(a.margin,10):0)-(this.titleOffset?this.titleOffset[2]:0)),_&&r&&(this.inverted?_.options.left=r.options.left=u.left:_.options.top=r.options.top=u.top,_.setAxisSize(),r.setAxisSize())}}function qe(a){!this.navigator&&!this.scroller&&(this.options.navigator.enabled||this.options.scrollbar.enabled)&&(this.scroller=this.navigator=new HE(this),qM(a.redraw,!0)&&this.redraw(a.animation))}function GT(){let a=this.options;(a.navigator.enabled||a.scrollbar.enabled)&&(this.scroller=this.navigator=new HE(this))}function Yn(){let a=this.options,_=a.navigator,r=a.rangeSelector;if((_&&_.enabled||r&&r.enabled)&&(!XM&&this.zooming.type==="x"||XM&&this.zooming.pinchType==="x"))return!1}function Dt(a){let _=a.navigator;if(_&&a.xAxis[0]){let r=a.xAxis[0].getExtremes();_.render(r.min,r.max)}}function QR(a){let _=a.options.navigator||{},r=a.options.scrollbar||{};!this.navigator&&!this.scroller&&(_.enabled||r.enabled)&&(Ze(!0,this.options.navigator,_),Ze(!0,this.options.scrollbar,r),delete a.options.navigator,delete a.options.scrollbar)}let WM=function(a,_){if(cE().pushUnique(Xe,a)){let r=a.prototype;HE=_,r.callbacks.push(Dt),yI(a,"afterAddSeries",ne),yI(a,"afterSetChartSize",qT),yI(a,"afterUpdate",qe),yI(a,"beforeRender",GT),yI(a,"beforeShowResetZoom",Yn),yI(a,"update",QR)}},{isTouchDevice:We}=cE(),{addEvent:Fn,correctFloat:Hn,defined:Ie,isNumber:UI,pick:Cn}=cE();function iI(){this.navigatorAxis||(this.navigatorAxis=new xI(this))}function Qe(a){let _,r=this.chart,L=r.options,u=L.navigator,m=this.navigatorAxis,b=r.zooming.pinchType,y=L.rangeSelector,K=r.zooming.type;if(this.isXAxis&&(u?.enabled||y?.enabled)){if(K==="y"&&a.trigger==="zoom")_=!1;else if((a.trigger==="zoom"&&K==="xy"||We&&b==="xy")&&this.options.range){let w=m.previousZoom;Ie(a.min)?m.previousZoom=[this.min,this.max]:w&&(a.min=w[0],a.max=w[1],m.previousZoom=void 0)}}_!==void 0&&a.preventDefault()}class xI{static compose(_){_.keepProps.includes("navigatorAxis")||(_.keepProps.push("navigatorAxis"),Fn(_,"init",iI),Fn(_,"setExtremes",Qe))}constructor(_){this.axis=_}destroy(){this.axis=void 0}toFixedRange(_,r,L,u){let m=this.axis,b=(m.pointRange||0)/2,y=Cn(L,m.translate(_,!0,!m.horiz)),K=Cn(u,m.translate(r,!0,!m.horiz));return Ie(L)||(y=Hn(y+b)),Ie(u)||(K=Hn(K-b)),UI(y)&&UI(K)||(y=K=void 0),{min:y,max:K}}}var Je=gE(620),$e=gE.n(Je),JR=gE(512),nT=gE.n(JR);let{parse:vI}=$e(),{seriesTypes:KI}=nT(),Lt={height:40,margin:22,maskInside:!0,handles:{width:7,borderRadius:0,height:15,symbols:["navigator-handle","navigator-handle"],enabled:!0,lineWidth:1,backgroundColor:"#f2f2f2",borderColor:"#999999"},maskFill:vI("#667aff").setOpacity(.3).get(),outlineColor:"#999999",outlineWidth:1,series:{type:KI.areaspline===void 0?"line":"areaspline",fillOpacity:.05,lineWidth:1,compare:null,sonification:{enabled:!1},dataGrouping:{approximation:"average",enabled:!0,groupPixelWidth:2,firstAnchor:"firstPoint",anchor:"middle",lastAnchor:"lastPoint",units:[["millisecond",[1,2,5,10,20,25,50,100,200,500]],["second",[1,2,5,10,15,30]],["minute",[1,2,5,10,15,30]],["hour",[1,2,3,4,6,8,12]],["day",[1,2,3,4]],["week",[1,2,3]],["month",[1,3,6]],["year",null]]},dataLabels:{enabled:!1,zIndex:2},id:"highcharts-navigator-series",className:"highcharts-navigator-series",lineColor:null,marker:{enabled:!1},threshold:null},xAxis:{className:"highcharts-navigator-xaxis",tickLength:0,lineWidth:0,gridLineColor:"#e6e6e6",id:"navigator-x-axis",gridLineWidth:1,tickPixelInterval:200,labels:{align:"left",style:{color:"#000000",fontSize:"0.7em",opacity:.6,textOutline:"2px contrast"},x:3,y:-4},crosshair:!1},yAxis:{className:"highcharts-navigator-yaxis",gridLineWidth:0,startOnTick:!1,endOnTick:!1,minPadding:.1,id:"navigator-y-axis",maxPadding:.1,labels:{enabled:!1},crosshair:!1,title:{text:void 0},tickLength:0,tickWidth:0}},{defined:jn,isNumber:$R,pick:ct}=cE(),{relativeLength:wI}=cE(),ht={"navigator-handle":function(a,_,r,L,u={}){var m,b,y,K;let w=u.width?u.width/2:r,OE=wI(u.borderRadius||0,Math.min(2*w,L));return[["M",-1.5,(L=u.height||L)/2-3.5],["L",-1.5,L/2+4.5],["M",.5,L/2-3.5],["L",.5,L/2+4.5],...(m=-w-1,b=2*w+1,y=L,K={r:OE},K?.r?(function(tE,ME,AE,bE,VE){let ZE=VE?.r||0;return[["M",tE+ZE,ME],["L",tE+AE-ZE,ME],["A",ZE,ZE,0,0,1,tE+AE,ME+ZE],["L",tE+AE,ME+bE-ZE],["A",ZE,ZE,0,0,1,tE+AE-ZE,ME+bE],["L",tE+ZE,ME+bE],["A",ZE,ZE,0,0,1,tE,ME+bE-ZE],["L",tE,ME+ZE],["A",ZE,ZE,0,0,1,tE+ZE,ME],["Z"]]})(m,.5,b,y,K):[["M",m,.5],["L",m+b,.5],["L",m+b,.5+y],["L",m,.5+y],["Z"]])]}};var QM=gE(608),Es=gE.n(QM);let{defined:Ns}=cE(),{defaultOptions:o_}=cE(),{composed:EM}=cE(),{getRendererType:JM}=Es(),{setFixedRange:dt}={setFixedRange:function(a){let _=this.xAxis[0];Ns(_.dataMax)&&Ns(_.dataMin)&&a?this.fixedRange=Math.min(a,_.dataMax-_.dataMin):this.fixedRange=a}},{addEvent:kI,extend:te,pushUnique:A_}=cE();function Os(){this.chart.navigator&&!this.options.isInternal&&this.chart.navigator.setBaseSeries(null,!1)}let S_=function(a,_,r){xI.compose(_),A_(EM,"Navigator")&&(a.prototype.setFixedRange=dt,te(JM().prototype.symbols,ht),te(o_,{navigator:Lt}),kI(r,"afterUpdate",Os))},{composed:Ts}=cE(),{addEvent:CO,correctFloat:Pn,defined:Bn,pick:ns,pushUnique:Is}=cE();(function(a){let _;function r(b){let y=ns(b.options?.min,b.min),K=ns(b.options?.max,b.max);return{axisMin:y,axisMax:K,scrollMin:Bn(b.dataMin)?Math.min(y,b.min??1/0,b.dataMin,b.threshold??1/0):y,scrollMax:b.treeGrid?.adjustedMax??(Bn(b.dataMax)?Math.max(K,b.max??-1/0,b.dataMax,b.threshold??-1/0):K)}}function L(){let b=this.scrollbar,y=b&&!b.options.opposite,K=this.horiz?2:y?3:1;b&&(this.chart.scrollbarsOffsets=[0,0],this.chart.axisOffset[K]+=b.size+(b.options.margin||0))}function u(){let b=this;b.options?.scrollbar?.enabled&&(b.options.scrollbar.vertical=!b.horiz,b.options.startOnTick=b.options.endOnTick=!1,b.scrollbar=new _(b.chart.renderer,b.options.scrollbar,b.chart),CO(b.scrollbar,"changed",function(y){let K,w,{axisMin:OE,axisMax:tE,scrollMin:ME,scrollMax:AE}=r(b),bE=b.toPixels(ME),VE=b.toPixels(AE)-bE;if(Bn(OE)&&Bn(tE))if(b.horiz&&!b.reversed||!b.horiz&&b.reversed?(K=Math.min(AE,b.toValue(bE+VE*this.to)),w=Math.max(ME,b.toValue(bE+VE*this.from))):(K=Math.min(AE,b.toValue(bE+VE*(1-this.from))),w=Math.max(ME,b.toValue(bE+VE*(1-this.to)))),this.shouldUpdateExtremes(y.DOMType)){let ZE=y.DOMType!=="mousemove"&&y.DOMType!=="touchmove"&&void 0;b.setExtremes(Pn(w),Pn(K),!0,ZE,y)}else this.setRange(this.from,this.to)}))}function m(){let b,y,K,{scrollMin:w,scrollMax:OE}=r(this),tE=this.scrollbar,ME=(this.axisTitleMargin||0)+(this.titleOffset||0),AE=this.chart.scrollbarsOffsets,bE=this.options.margin||0;if(tE&&AE){if(this.horiz)this.opposite||(AE[1]+=ME),tE.position(this.left,this.top+this.height+2+AE[1]-(this.opposite?bE:0),this.width,this.height),this.opposite||(AE[1]+=bE),b=1;else{let VE;this.opposite&&(AE[0]+=ME),VE=tE.options.opposite?this.left+this.width+2+AE[0]-(this.opposite?0:bE):this.opposite?0:bE,tE.position(VE,this.top,this.width,this.height),this.opposite&&(AE[0]+=bE),b=0}if(AE[b]+=tE.size+(tE.options.margin||0),isNaN(w)||isNaN(OE)||!Bn(this.min)||!Bn(this.max)||Bn(this.dataMin)&&this.dataMin===this.dataMax)tE.setRange(0,1);else if(this.min===this.max){let VE=this.pointRange/(this.dataMax+1);y=VE*this.min,K=VE*(this.max+1),tE.setRange(y,K)}else y=(this.toPixels(this.min)-this.toPixels(w))/(this.toPixels(OE)-this.toPixels(w)),K=(this.toPixels(this.max)-this.toPixels(w))/(this.toPixels(OE)-this.toPixels(w)),this.horiz&&!this.reversed||!this.horiz&&this.reversed?tE.setRange(y,K):tE.setRange(1-K,1-y)}}a.compose=function(b,y){Is(Ts,"Axis.Scrollbar")&&(_=y,CO(b,"afterGetOffset",L),CO(b,"afterInit",u),CO(b,"afterRender",m))}})(wE||(wE={}));let ee=wE,NM={height:10,barBorderRadius:5,buttonBorderRadius:0,buttonsEnabled:!1,liveRedraw:void 0,margin:void 0,minWidth:6,opposite:!0,step:.2,zIndex:3,barBackgroundColor:"#cccccc",barBorderWidth:0,barBorderColor:"#cccccc",buttonArrowColor:"#333333",buttonBackgroundColor:"#e6e6e6",buttonBorderColor:"#cccccc",buttonBorderWidth:1,rifleColor:"none",trackBackgroundColor:"rgba(255, 255, 255, 0.001)",trackBorderColor:"#cccccc",trackBorderRadius:5,trackBorderWidth:1},{defaultOptions:Me}=cE(),{composed:ts}=cE(),{addEvent:zI,correctFloat:oI,crisp:OM,defined:Gt,destroyObjectProperties:es,extend:Ms,fireEvent:FI,merge:Re,pick:an,pushUnique:l_,removeEvent:$M}=cE();class Zn{static compose(_){ee.compose(_,Zn),l_(ts,"Scrollbar")&&Ms(Me,{scrollbar:NM})}static swapXY(_,r){return r&&_.forEach(L=>{let u,m=L.length;for(let b=0;b<m;b+=2)typeof(u=L[b+1])=="number"&&(L[b+1]=L[b+2],L[b+2]=u)}),_}constructor(_,r,L){this._events=[],this.chartX=0,this.chartY=0,this.from=0,this.scrollbarButtons=[],this.scrollbarLeft=0,this.scrollbarStrokeWidth=1,this.scrollbarTop=0,this.size=0,this.to=0,this.trackBorderWidth=1,this.x=0,this.y=0,this.init(_,r,L)}addEvents(){let _=this.options.inverted?[1,0]:[0,1],r=this.scrollbarButtons,L=this.scrollbarGroup.element,u=this.track.element,m=this.mouseDownHandler.bind(this),b=this.mouseMoveHandler.bind(this),y=this.mouseUpHandler.bind(this),K=[[r[_[0]].element,"click",this.buttonToMinClick.bind(this)],[r[_[1]].element,"click",this.buttonToMaxClick.bind(this)],[u,"click",this.trackClick.bind(this)],[L,"mousedown",m],[L.ownerDocument,"mousemove",b],[L.ownerDocument,"mouseup",y],[L,"touchstart",m],[L.ownerDocument,"touchmove",b],[L.ownerDocument,"touchend",y]];K.forEach(function(w){zI.apply(null,w)}),this._events=K}buttonToMaxClick(_){let r=(this.to-this.from)*an(this.options.step,.2);this.updatePosition(this.from+r,this.to+r),FI(this,"changed",{from:this.from,to:this.to,trigger:"scrollbar",DOMEvent:_})}buttonToMinClick(_){let r=oI(this.to-this.from)*an(this.options.step,.2);this.updatePosition(oI(this.from-r),oI(this.to-r)),FI(this,"changed",{from:this.from,to:this.to,trigger:"scrollbar",DOMEvent:_})}cursorToScrollbarPosition(_){let r=this.options,L=r.minWidth>this.calculatedWidth?r.minWidth:0;return{chartX:(_.chartX-this.x-this.xOffset)/(this.barWidth-L),chartY:(_.chartY-this.y-this.yOffset)/(this.barWidth-L)}}destroy(){let _=this,r=_.chart.scroller;_.removeEvents(),["track","scrollbarRifles","scrollbar","scrollbarGroup","group"].forEach(function(L){_[L]&&_[L].destroy&&(_[L]=_[L].destroy())}),r&&_===r.scrollbar&&(r.scrollbar=null,es(r.scrollbarButtons))}drawScrollbarButton(_){let r=this.renderer,L=this.scrollbarButtons,u=this.options,m=this.size,b=r.g().add(this.group);if(L.push(b),u.buttonsEnabled){let y=r.rect().addClass("highcharts-scrollbar-button").add(b);this.chart.styledMode||y.attr({stroke:u.buttonBorderColor,"stroke-width":u.buttonBorderWidth,fill:u.buttonBackgroundColor}),y.attr(y.crisp({x:-.5,y:-.5,width:m,height:m,r:u.buttonBorderRadius},y.strokeWidth()));let K=r.path(Zn.swapXY([["M",m/2+(_?-1:1),m/2-3],["L",m/2+(_?-1:1),m/2+3],["L",m/2+(_?2:-2),m/2]],u.vertical)).addClass("highcharts-scrollbar-arrow").add(L[_]);this.chart.styledMode||K.attr({fill:u.buttonArrowColor})}}init(_,r,L){this.scrollbarButtons=[],this.renderer=_,this.userOptions=r,this.options=Re(NM,Me.scrollbar,r),this.options.margin=an(this.options.margin,10),this.chart=L,this.size=an(this.options.size,this.options.height),r.enabled&&(this.render(),this.addEvents())}mouseDownHandler(_){let r=this.chart.pointer?.normalize(_)||_,L=this.cursorToScrollbarPosition(r);this.chartX=L.chartX,this.chartY=L.chartY,this.initPositions=[this.from,this.to],this.grabbedCenter=!0}mouseMoveHandler(_){let r,L=this.chart.pointer?.normalize(_)||_,u=this.options.vertical?"chartY":"chartX",m=this.initPositions||[];this.grabbedCenter&&(!_.touches||_.touches[0][u]!==0)&&(r=this.cursorToScrollbarPosition(L)[u]-this[u],this.hasDragged=!0,this.updatePosition(m[0]+r,m[1]+r),this.hasDragged&&FI(this,"changed",{from:this.from,to:this.to,trigger:"scrollbar",DOMType:_.type,DOMEvent:_}))}mouseUpHandler(_){this.hasDragged&&FI(this,"changed",{from:this.from,to:this.to,trigger:"scrollbar",DOMType:_.type,DOMEvent:_}),this.grabbedCenter=this.hasDragged=this.chartX=this.chartY=null}position(_,r,L,u){let{buttonsEnabled:m,margin:b=0,vertical:y}=this.options,K=this.rendered?"animate":"attr",w=u,OE=0;this.group.show(),this.x=_,this.y=r+this.trackBorderWidth,this.width=L,this.height=u,this.xOffset=w,this.yOffset=OE,y?(this.width=this.yOffset=L=OE=this.size,this.xOffset=w=0,this.yOffset=OE=m?this.size:0,this.barWidth=u-(m?2*L:0),this.x=_+=b):(this.height=u=this.size,this.xOffset=w=m?this.size:0,this.barWidth=L-(m?2*u:0),this.y=this.y+b),this.group[K]({translateX:_,translateY:this.y}),this.track[K]({width:L,height:u}),this.scrollbarButtons[1][K]({translateX:y?0:L-w,translateY:y?u-OE:0})}removeEvents(){this._events.forEach(function(_){$M.apply(null,_)}),this._events.length=0}render(){let _=this.renderer,r=this.options,L=this.size,u=this.chart.styledMode,m=_.g("scrollbar").attr({zIndex:r.zIndex}).hide().add();this.group=m,this.track=_.rect().addClass("highcharts-scrollbar-track").attr({r:r.trackBorderRadius||0,height:L,width:L}).add(m),u||this.track.attr({fill:r.trackBackgroundColor,stroke:r.trackBorderColor,"stroke-width":r.trackBorderWidth});let b=this.trackBorderWidth=this.track.strokeWidth();this.track.attr({x:-OM(0,b),y:-OM(0,b)}),this.scrollbarGroup=_.g().add(m),this.scrollbar=_.rect().addClass("highcharts-scrollbar-thumb").attr({height:L-b,width:L-b,r:r.barBorderRadius||0}).add(this.scrollbarGroup),this.scrollbarRifles=_.path(Zn.swapXY([["M",-3,L/4],["L",-3,2*L/3],["M",0,L/4],["L",0,2*L/3],["M",3,L/4],["L",3,2*L/3]],r.vertical)).addClass("highcharts-scrollbar-rifles").add(this.scrollbarGroup),u||(this.scrollbar.attr({fill:r.barBackgroundColor,stroke:r.barBorderColor,"stroke-width":r.barBorderWidth}),this.scrollbarRifles.attr({stroke:r.rifleColor,"stroke-width":1})),this.scrollbarStrokeWidth=this.scrollbar.strokeWidth(),this.scrollbarGroup.translate(-OM(0,this.scrollbarStrokeWidth),-OM(0,this.scrollbarStrokeWidth)),this.drawScrollbarButton(0),this.drawScrollbarButton(1)}setRange(_,r){let L,u,m=this.options,b=m.vertical,y=m.minWidth,K=this.barWidth,w=!this.rendered||this.hasDragged||this.chart.navigator&&this.chart.navigator.hasDragged?"attr":"animate";if(!Gt(K))return;let OE=K*Math.min(r,1);L=Math.ceil(K*(_=Math.max(_,0))),this.calculatedWidth=u=oI(OE-L),u<y&&(L=(K-y+u)*_,u=y);let tE=Math.floor(L+this.xOffset+this.yOffset),ME=u/2-.5;this.from=_,this.to=r,b?(this.scrollbarGroup[w]({translateY:tE}),this.scrollbar[w]({height:u}),this.scrollbarRifles[w]({translateY:ME}),this.scrollbarTop=tE,this.scrollbarLeft=0):(this.scrollbarGroup[w]({translateX:tE}),this.scrollbar[w]({width:u}),this.scrollbarRifles[w]({translateX:ME}),this.scrollbarLeft=tE,this.scrollbarTop=0),u<=12?this.scrollbarRifles.hide():this.scrollbarRifles.show(),m.showFull===!1&&(_<=0&&r>=1?this.group.hide():this.group.show()),this.rendered=!0}shouldUpdateExtremes(_){return an(this.options.liveRedraw,cE().svg&&!cE().isTouchDevice&&!this.chart.boosted)||_==="mouseup"||_==="touchend"||!Gt(_)}trackClick(_){let r=this.chart.pointer?.normalize(_)||_,L=this.to-this.from,u=this.y+this.scrollbarTop,m=this.x+this.scrollbarLeft;this.options.vertical&&r.chartY>u||!this.options.vertical&&r.chartX>m?this.updatePosition(this.from+L,this.to+L):this.updatePosition(this.from-L,this.to-L),FI(this,"changed",{from:this.from,to:this.to,trigger:"scrollbar",DOMEvent:_})}update(_){this.destroy(),this.init(this.chart.renderer,Re(!0,this.options,_),this.chart)}updatePosition(_,r){r>1&&(_=oI(1-oI(r-_)),r=1),_<0&&(r=oI(r-_),_=0),this.from=_,this.to=r}}Zn.defaultOptions=NM;var Rs=gE(540),ss=gE.n(Rs);let{defaultOptions:TM}=cE(),{isTouchDevice:ut}=cE(),{prototype:{symbols:_s}}=ss(),{addEvent:jO,clamp:is,correctFloat:se,defined:jI,destroyObjectProperties:Yt,erase:aT,extend:os,find:_e,fireEvent:nM,isArray:ER,isNumber:WT,merge:bn,pick:_T,removeEvent:AI,splat:Ht}=cE();function IM(a,..._){let r=[].filter.call(_,WT);if(r.length)return Math[a].apply(0,r)}class ie{static compose(_,r,L){WM(_,ie),S_(_,r,L)}constructor(_){this.isDirty=!1,this.scrollbarHeight=0,this.init(_)}drawHandle(_,r,L,u){let m=this.navigatorOptions.handles.height;this.handles[r][u](L?{translateX:Math.round(this.left+this.height/2),translateY:Math.round(this.top+parseInt(_,10)+.5-m)}:{translateX:Math.round(this.left+parseInt(_,10)),translateY:Math.round(this.top+this.height/2-m/2-1)})}drawOutline(_,r,L,u){let m=this.navigatorOptions.maskInside,b=this.outline.strokeWidth(),y=b/2,K=b%2/2,w=this.scrollButtonSize,OE=this.size,tE=this.top,ME=this.height,AE=tE-y,bE=tE+ME,VE=this.left,ZE,aN;L?(ZE=tE+r+K,r=tE+_+K,aN=[["M",VE+ME,tE-w-K],["L",VE+ME,ZE],["L",VE,ZE],["M",VE,r],["L",VE+ME,r],["L",VE+ME,tE+OE+w]],m&&aN.push(["M",VE+ME,ZE-y],["L",VE+ME,r+y])):(VE-=w,_+=VE+w-K,r+=VE+w-K,aN=[["M",VE,AE],["L",_,AE],["L",_,bE],["M",r,bE],["L",r,AE],["L",VE+OE+2*w,AE]],m&&aN.push(["M",_-y,AE],["L",r+y,AE])),this.outline[u]({d:aN})}drawMasks(_,r,L,u){let m,b,y,K,w=this.left,OE=this.top,tE=this.height;L?(y=[w,w,w],K=[OE,OE+_,OE+r],b=[tE,tE,tE],m=[_,r-_,this.size-r]):(y=[w,w+_,w+r],K=[OE,OE,OE],b=[_,r-_,this.size-r],m=[tE,tE,tE]),this.shades.forEach((ME,AE)=>{ME[u]({x:y[AE],y:K[AE],width:b[AE],height:m[AE]})})}renderElements(){let _=this,r=_.navigatorOptions,L=r.maskInside,u=_.chart,m=u.inverted,b=u.renderer,y={cursor:m?"ns-resize":"ew-resize"},K=_.navigatorGroup??(_.navigatorGroup=b.g("navigator").attr({zIndex:8,visibility:"hidden"}).add());if([!L,L,!L].forEach((w,OE)=>{let tE=_.shades[OE]??(_.shades[OE]=b.rect().addClass("highcharts-navigator-mask"+(OE===1?"-inside":"-outside")).add(K));u.styledMode||(tE.attr({fill:w?r.maskFill:"rgba(0,0,0,0)"}),OE===1&&tE.css(y))}),_.outline||(_.outline=b.path().addClass("highcharts-navigator-outline").add(K)),u.styledMode||_.outline.attr({"stroke-width":r.outlineWidth,stroke:r.outlineColor}),r.handles?.enabled){let w=r.handles,{height:OE,width:tE}=w;[0,1].forEach(ME=>{let AE=w.symbols[ME];if(_.handles[ME]&&_.handles[ME].symbolUrl===AE){if(!_.handles[ME].isImg&&_.handles[ME].symbolName!==AE){let bE=_s[AE].call(_s,-tE/2-1,0,tE,OE);_.handles[ME].attr({d:bE}),_.handles[ME].symbolName=AE}}else _.handles[ME]?.destroy(),_.handles[ME]=b.symbol(AE,-tE/2-1,0,tE,OE,w),_.handles[ME].attr({zIndex:7-ME}).addClass("highcharts-navigator-handle highcharts-navigator-handle-"+["left","right"][ME]).add(K),_.addMouseEvents();u.inverted&&_.handles[ME].attr({rotation:90,rotationOriginX:Math.floor(-tE/2),rotationOriginY:(OE+tE)/2}),u.styledMode||_.handles[ME].attr({fill:w.backgroundColor,stroke:w.borderColor,"stroke-width":w.lineWidth,width:w.width,height:w.height,x:-tE/2-1,y:0}).css(y)})}}update(_,r=!1){let L=this.chart,u=L.options.chart.inverted!==L.scrollbar?.options.vertical;if(bn(!0,L.options.navigator,_),this.navigatorOptions=L.options.navigator||{},this.setOpposite(),jI(_.enabled)||u)return this.destroy(),this.navigatorEnabled=_.enabled||this.navigatorEnabled,this.init(L);if(this.navigatorEnabled&&(this.isDirty=!0,_.adaptToUpdatedData===!1&&this.baseSeries.forEach(m=>{AI(m,"updatedData",this.updatedDataHandler)},this),_.adaptToUpdatedData&&this.baseSeries.forEach(m=>{m.eventsToUnbind.push(jO(m,"updatedData",this.updatedDataHandler))},this),(_.series||_.baseSeries)&&this.setBaseSeries(void 0,!1),_.height||_.xAxis||_.yAxis)){this.height=_.height??this.height;let m=this.getXAxisOffsets();this.xAxis.update({..._.xAxis,offsets:m,[L.inverted?"width":"height"]:this.height,[L.inverted?"height":"width"]:void 0},!1),this.yAxis.update({..._.yAxis,[L.inverted?"width":"height"]:this.height},!1)}r&&L.redraw()}render(_,r,L,u){let m=this.chart,b=this.xAxis,y=b.pointRange||0,K=b.navigatorAxis.fake?m.xAxis[0]:b,w=this.navigatorEnabled,OE=this.rendered,tE=m.inverted,ME=m.xAxis[0].minRange,AE=m.xAxis[0].options.maxRange,bE=this.scrollButtonSize,VE,ZE,aN,LN=this.scrollbarHeight,RN,qE;if(this.hasDragged&&!jI(L))return;if(this.isDirty&&this.renderElements(),_=se(_-y/2),r=se(r+y/2),!WT(_)||!WT(r))if(OE)L=0,u=_T(b.width,K.width);else return;this.left=_T(b.left,m.plotLeft+bE+(tE?m.plotWidth:0));let uN=this.size=RN=_T(b.len,(tE?m.plotHeight:m.plotWidth)-2*bE);VE=tE?LN:RN+2*bE,L=_T(L,b.toPixels(_,!0)),u=_T(u,b.toPixels(r,!0)),WT(L)&&Math.abs(L)!==1/0||(L=0,u=VE);let HN=b.toValue(L,!0),BN=b.toValue(u,!0),CN=Math.abs(se(BN-HN));CN<ME?this.grabbedLeft?L=b.toPixels(BN-ME-y,!0):this.grabbedRight&&(u=b.toPixels(HN+ME+y,!0)):jI(AE)&&se(CN-y)>AE&&(this.grabbedLeft?L=b.toPixels(BN-AE-y,!0):this.grabbedRight&&(u=b.toPixels(HN+AE+y,!0))),this.zoomedMax=is(Math.max(L,u),0,uN),this.zoomedMin=is(this.fixedWidth?this.zoomedMax-this.fixedWidth:Math.min(L,u),0,uN),this.range=this.zoomedMax-this.zoomedMin,uN=Math.round(this.zoomedMax);let iO=Math.round(this.zoomedMin);w&&(this.navigatorGroup.attr({visibility:"inherit"}),qE=OE&&!this.hasDragged?"animate":"attr",this.drawMasks(iO,uN,tE,qE),this.drawOutline(iO,uN,tE,qE),this.navigatorOptions.handles.enabled&&(this.drawHandle(iO,0,tE,qE),this.drawHandle(uN,1,tE,qE))),this.scrollbar&&(tE?(aN=this.top-bE,ZE=this.left-LN+(w||!K.opposite?0:(K.titleOffset||0)+K.axisTitleMargin),LN=RN+2*bE):(aN=this.top+(w?this.height:-LN),ZE=this.left-bE),this.scrollbar.position(ZE,aN,VE,LN),this.scrollbar.setRange(this.zoomedMin/(RN||1),this.zoomedMax/(RN||1))),this.rendered=!0,this.isDirty=!1,nM(this,"afterRender")}addMouseEvents(){let _=this,r=_.chart,L=r.container,u=[],m,b;_.mouseMoveHandler=m=function(y){_.onMouseMove(y)},_.mouseUpHandler=b=function(y){_.onMouseUp(y)},(u=_.getPartsEvents("mousedown")).push(jO(r.renderTo,"mousemove",m),jO(L.ownerDocument,"mouseup",b),jO(r.renderTo,"touchmove",m),jO(L.ownerDocument,"touchend",b)),u.concat(_.getPartsEvents("touchstart")),_.eventsToUnbind=u,_.series&&_.series[0]&&u.push(jO(_.series[0].xAxis,"foundExtremes",function(){r.navigator.modifyNavigatorAxisExtremes()}))}getPartsEvents(_){let r=this,L=[];return["shades","handles"].forEach(function(u){r[u].forEach(function(m,b){L.push(jO(m.element,_,function(y){r[u+"Mousedown"](y,b)}))})}),L}shadesMousedown(_,r){_=this.chart.pointer?.normalize(_)||_;let L=this.chart,u=this.xAxis,m=this.zoomedMin,b=this.size,y=this.range,K=this.left,w=_.chartX,OE,tE,ME,AE;L.inverted&&(w=_.chartY,K=this.top),r===1?(this.grabbedCenter=w,this.fixedWidth=y,this.dragOffset=w-m):(AE=w-K-y/2,r===0?AE=Math.max(0,AE):r===2&&AE+y>=b&&(AE=b-y,this.reversedExtremes?(AE-=y,tE=this.getUnionExtremes().dataMin):OE=this.getUnionExtremes().dataMax),AE!==m&&(this.fixedWidth=y,jI((ME=u.navigatorAxis.toFixedRange(AE,AE+y,tE,OE)).min)&&nM(this,"setRange",{min:Math.min(ME.min,ME.max),max:Math.max(ME.min,ME.max),redraw:!0,eventArguments:{trigger:"navigator"}})))}handlesMousedown(_,r){_=this.chart.pointer?.normalize(_)||_;let L=this.chart,u=L.xAxis[0],m=this.reversedExtremes;r===0?(this.grabbedLeft=!0,this.otherHandlePos=this.zoomedMax,this.fixedExtreme=m?u.min:u.max):(this.grabbedRight=!0,this.otherHandlePos=this.zoomedMin,this.fixedExtreme=m?u.max:u.min),L.setFixedRange(void 0)}onMouseMove(_){let r=this,L=r.chart,u=r.navigatorSize,m=r.range,b=r.dragOffset,y=L.inverted,K=r.left,w;(!_.touches||_.touches[0].pageX!==0)&&(w=(_=L.pointer?.normalize(_)||_).chartX,y&&(K=r.top,w=_.chartY),r.grabbedLeft?(r.hasDragged=!0,r.render(0,0,w-K,r.otherHandlePos)):r.grabbedRight?(r.hasDragged=!0,r.render(0,0,r.otherHandlePos,w-K)):r.grabbedCenter&&(r.hasDragged=!0,w<b?w=b:w>u+b-m&&(w=u+b-m),r.render(0,0,w-b,w-b+m)),r.hasDragged&&r.scrollbar&&_T(r.scrollbar.options.liveRedraw,!ut&&!this.chart.boosted)&&(_.DOMType=_.type,setTimeout(function(){r.onMouseUp(_)},0)))}onMouseUp(_){let r,L,u,m,b,y,K=this.chart,w=this.xAxis,OE=this.scrollbar,tE=_.DOMEvent||_,ME=K.inverted,AE=this.rendered&&!this.hasDragged?"animate":"attr";(this.hasDragged&&(!OE||!OE.hasDragged)||_.trigger==="scrollbar")&&(u=this.getUnionExtremes(),this.zoomedMin===this.otherHandlePos?m=this.fixedExtreme:this.zoomedMax===this.otherHandlePos&&(b=this.fixedExtreme),this.zoomedMax===this.size&&(b=this.reversedExtremes?u.dataMin:u.dataMax),this.zoomedMin===0&&(m=this.reversedExtremes?u.dataMax:u.dataMin),jI((y=w.navigatorAxis.toFixedRange(this.zoomedMin,this.zoomedMax,m,b)).min)&&nM(this,"setRange",{min:Math.min(y.min,y.max),max:Math.max(y.min,y.max),redraw:!0,animation:!this.hasDragged&&null,eventArguments:{trigger:"navigator",triggerOp:"navigator-drag",DOMEvent:tE}})),_.DOMType!=="mousemove"&&_.DOMType!=="touchmove"&&(this.grabbedLeft=this.grabbedRight=this.grabbedCenter=this.fixedWidth=this.fixedExtreme=this.otherHandlePos=this.hasDragged=this.dragOffset=null),this.navigatorEnabled&&WT(this.zoomedMin)&&WT(this.zoomedMax)&&(L=Math.round(this.zoomedMin),r=Math.round(this.zoomedMax),this.shades&&this.drawMasks(L,r,ME,AE),this.outline&&this.drawOutline(L,r,ME,AE),this.navigatorOptions.handles.enabled&&Object.keys(this.handles).length===this.handles.length&&(this.drawHandle(L,0,ME,AE),this.drawHandle(r,1,ME,AE)))}removeEvents(){this.eventsToUnbind&&(this.eventsToUnbind.forEach(function(_){_()}),this.eventsToUnbind=void 0),this.removeBaseSeriesEvents()}removeBaseSeriesEvents(){let _=this.baseSeries||[];this.navigatorEnabled&&_[0]&&(this.navigatorOptions.adaptToUpdatedData!==!1&&_.forEach(function(r){AI(r,"updatedData",this.updatedDataHandler)},this),_[0].xAxis&&AI(_[0].xAxis,"foundExtremes",this.modifyBaseAxisExtremes))}getXAxisOffsets(){return this.chart.inverted?[this.scrollButtonSize,0,-this.scrollButtonSize,0]:[0,-this.scrollButtonSize,0,this.scrollButtonSize]}init(_){let r=_.options,L=r.navigator||{},u=L.enabled,m=r.scrollbar||{},b=m.enabled,y=u&&L.height||0,K=b&&m.height||0,w=m.buttonsEnabled&&K||0;this.handles=[],this.shades=[],this.chart=_,this.setBaseSeries(),this.height=y,this.scrollbarHeight=K,this.scrollButtonSize=w,this.scrollbarEnabled=b,this.navigatorEnabled=u,this.navigatorOptions=L,this.scrollbarOptions=m,this.setOpposite();let OE=this,tE=OE.baseSeries,ME=_.xAxis.length,AE=_.yAxis.length,bE=tE&&tE[0]&&tE[0].xAxis||_.xAxis[0]||{options:{}};if(_.isDirtyBox=!0,OE.navigatorEnabled){let VE=this.getXAxisOffsets();OE.xAxis=new(ZM())(_,bn({breaks:bE.options.breaks,ordinal:bE.options.ordinal,overscroll:bE.options.overscroll},L.xAxis,{type:"datetime",yAxis:L.yAxis?.id,index:ME,isInternal:!0,offset:0,keepOrdinalPadding:!0,startOnTick:!1,endOnTick:!1,minPadding:bE.options.ordinal?0:bE.options.minPadding,maxPadding:bE.options.ordinal?0:bE.options.maxPadding,zoomEnabled:!1},_.inverted?{offsets:VE,width:y}:{offsets:VE,height:y}),"xAxis"),OE.yAxis=new(ZM())(_,bn(L.yAxis,{alignTicks:!1,offset:0,index:AE,isInternal:!0,reversed:_T(L.yAxis&&L.yAxis.reversed,_.yAxis[0]&&_.yAxis[0].reversed,!1),zoomEnabled:!1},_.inverted?{width:y}:{height:y}),"yAxis"),tE||L.series.data?OE.updateNavigatorSeries(!1):_.series.length===0&&(OE.unbindRedraw=jO(_,"beforeRedraw",function(){_.series.length>0&&!OE.series&&(OE.setBaseSeries(),OE.unbindRedraw())})),OE.reversedExtremes=_.inverted&&!OE.xAxis.reversed||!_.inverted&&OE.xAxis.reversed,OE.renderElements(),OE.addMouseEvents()}else OE.xAxis={chart:_,navigatorAxis:{fake:!0},translate:function(VE,ZE){let aN=_.xAxis[0],LN=aN.getExtremes(),RN=aN.len-2*w,qE=IM("min",aN.options.min,LN.dataMin),uN=IM("max",aN.options.max,LN.dataMax)-qE;return ZE?VE*uN/RN+qE:RN*(VE-qE)/uN},toPixels:function(VE){return this.translate(VE)},toValue:function(VE){return this.translate(VE,!0)}},OE.xAxis.navigatorAxis.axis=OE.xAxis,OE.xAxis.navigatorAxis.toFixedRange=xI.prototype.toFixedRange.bind(OE.xAxis.navigatorAxis);if(_.options.scrollbar?.enabled){let VE=bn(_.options.scrollbar,{vertical:_.inverted});WT(VE.margin)||(VE.margin=_.inverted?-3:3),_.scrollbar=OE.scrollbar=new Zn(_.renderer,VE,_),jO(OE.scrollbar,"changed",function(ZE){let aN=OE.size,LN=aN*this.to,RN=aN*this.from;OE.hasDragged=OE.scrollbar.hasDragged,OE.render(0,0,RN,LN),this.shouldUpdateExtremes(ZE.DOMType)&&setTimeout(function(){OE.onMouseUp(ZE)})})}OE.addBaseSeriesEvents(),OE.addChartEvents()}setOpposite(){let _=this.navigatorOptions,r=this.navigatorEnabled,L=this.chart;this.opposite=_T(_.opposite,!!(!r&&L.inverted))}getUnionExtremes(_){let r,L=this.chart.xAxis[0],u=this.chart.time,m=this.xAxis,b=m.options,y=L.options;return _&&L.dataMin===null||(r={dataMin:_T(u.parse(b?.min),IM("min",u.parse(y.min),L.dataMin,m.dataMin,m.min)),dataMax:_T(u.parse(b?.max),IM("max",u.parse(y.max),L.dataMax,m.dataMax,m.max))}),r}setBaseSeries(_,r){let L=this.chart,u=this.baseSeries=[];_=_||L.options&&L.options.navigator.baseSeries||(L.series.length?_e(L.series,m=>!m.options.isInternal).index:0),(L.series||[]).forEach((m,b)=>{!m.options.isInternal&&(m.options.showInNavigator||(b===_||m.options.id===_)&&m.options.showInNavigator!==!1)&&u.push(m)}),this.xAxis&&!this.xAxis.navigatorAxis.fake&&this.updateNavigatorSeries(!0,r)}updateNavigatorSeries(_,r){let L=this,u=L.chart,m=L.baseSeries,b={enableMouseTracking:!1,index:null,linkedTo:null,group:"nav",padXAxis:!1,xAxis:this.navigatorOptions.xAxis?.id,yAxis:this.navigatorOptions.yAxis?.id,showInLegend:!1,stacking:void 0,isInternal:!0,states:{inactive:{opacity:1}}},y=L.series=(L.series||[]).filter(ME=>{let AE=ME.baseSeries;return!(0>m.indexOf(AE))||(AE&&(AI(AE,"updatedData",L.updatedDataHandler),delete AE.navigatorSeries),ME.chart&&ME.destroy(),!1)}),K,w,OE=L.navigatorOptions.series,tE;m&&m.length&&m.forEach(ME=>{let AE=ME.navigatorSeries,bE=os({color:ME.color,visible:ME.visible},ER(OE)?TM.navigator.series:OE);if(AE&&L.navigatorOptions.adaptToUpdatedData===!1)return;b.name="Navigator "+m.length,tE=(K=ME.options||{}).navigatorOptions||{},bE.dataLabels=Ht(bE.dataLabels),(w=bn(K,b,bE,tE)).pointRange=_T(bE.pointRange,tE.pointRange,TM.plotOptions[w.type||"line"].pointRange);let VE=tE.data||bE.data;L.hasNavigatorData=L.hasNavigatorData||!!VE,w.data=VE||K.data?.slice(0),AE&&AE.options?AE.update(w,r):(ME.navigatorSeries=u.initSeries(w),u.setSortedData(),ME.navigatorSeries.baseSeries=ME,y.push(ME.navigatorSeries))}),(OE.data&&!(m&&m.length)||ER(OE))&&(L.hasNavigatorData=!1,(OE=Ht(OE)).forEach((ME,AE)=>{b.name="Navigator "+(y.length+1),(w=bn(TM.navigator.series,{color:u.series[AE]&&!u.series[AE].options.isInternal&&u.series[AE].color||u.options.colors[AE]||u.options.colors[0]},b,ME)).data=ME.data,w.data&&(L.hasNavigatorData=!0,y.push(u.initSeries(w)))})),_&&this.addBaseSeriesEvents()}addBaseSeriesEvents(){let _=this,r=_.baseSeries||[];r[0]&&r[0].xAxis&&r[0].eventsToUnbind.push(jO(r[0].xAxis,"foundExtremes",this.modifyBaseAxisExtremes)),r.forEach(L=>{L.eventsToUnbind.push(jO(L,"show",function(){this.navigatorSeries&&this.navigatorSeries.setVisible(!0,!1)})),L.eventsToUnbind.push(jO(L,"hide",function(){this.navigatorSeries&&this.navigatorSeries.setVisible(!1,!1)})),this.navigatorOptions.adaptToUpdatedData!==!1&&L.xAxis&&L.eventsToUnbind.push(jO(L,"updatedData",this.updatedDataHandler)),L.eventsToUnbind.push(jO(L,"remove",function(){r&&aT(r,L),this.navigatorSeries&&_.series&&(aT(_.series,this.navigatorSeries),jI(this.navigatorSeries.options)&&this.navigatorSeries.remove(!1),delete this.navigatorSeries)}))})}getBaseSeriesMin(_){return this.baseSeries.reduce(function(r,L){return Math.min(r,L.getColumn("x")[0]??r)},_)}modifyNavigatorAxisExtremes(){let _=this.xAxis;if(_.getExtremes!==void 0){let r=this.getUnionExtremes(!0);r&&(r.dataMin!==_.min||r.dataMax!==_.max)&&(_.min=r.dataMin,_.max=r.dataMax)}}modifyBaseAxisExtremes(){let _,r,L=this.chart.navigator,u=this.getExtremes(),m=u.min,b=u.max,y=u.dataMin,K=u.dataMax,w=b-m,OE=L.stickToMin,tE=L.stickToMax,ME=_T(this.ordinal?.convertOverscroll(this.options.overscroll),0),AE=L.series&&L.series[0],bE=!!this.setExtremes;!(this.eventArgs&&this.eventArgs.trigger==="rangeSelectorButton")&&(OE&&(_=(r=y)+w),tE&&(_=K+ME,OE||(r=Math.max(y,_-w,L.getBaseSeriesMin(AE&&AE.xData?AE.xData[0]:-Number.MAX_VALUE)))),bE&&(OE||tE)&&WT(r)&&(this.min=this.userMin=r,this.max=this.userMax=_)),L.stickToMin=L.stickToMax=null}updatedDataHandler(){let _=this.chart.navigator,r=this.navigatorSeries,L=_.reversedExtremes?Math.round(_.zoomedMin)===0:Math.round(_.zoomedMax)>=Math.round(_.size);_.stickToMax=_T(this.chart.options.navigator&&this.chart.options.navigator.stickToMax,L),_.stickToMin=_.shouldStickToMin(this,_),r&&!_.hasNavigatorData&&(r.options.pointStart=this.getColumn("x")[0],r.setData(this.options.data,!1,null,!1))}shouldStickToMin(_,r){let L=r.getBaseSeriesMin(_.getColumn("x")[0]),u=_.xAxis,m=u.max,b=u.min,y=u.options.range;return!!(WT(m)&&WT(b))&&(y&&m-L>0?m-L<y:b<=L)}addChartEvents(){this.eventsToUnbind||(this.eventsToUnbind=[]),this.eventsToUnbind.push(jO(this.chart,"redraw",function(){let _=this.navigator,r=_&&(_.baseSeries&&_.baseSeries[0]&&_.baseSeries[0].xAxis||this.xAxis[0]);r&&_.render(r.min,r.max)}),jO(this.chart,"getMargins",function(){let _=this.navigator,r=_.opposite?"plotTop":"marginBottom";this.inverted&&(r=_.opposite?"marginRight":"plotLeft"),this[r]=(this[r]||0)+(_.navigatorEnabled||!this.inverted?_.height+(this.scrollbar?.options.margin||0)+_.scrollbarHeight:0)+(_.navigatorOptions.margin||0)}),jO(ie,"setRange",function(_){this.chart.xAxis[0].setExtremes(_.min,_.max,_.redraw,_.animation,_.eventArguments)}))}destroy(){this.removeEvents(),this.xAxis&&(aT(this.chart.xAxis,this.xAxis),aT(this.chart.axes,this.xAxis)),this.yAxis&&(aT(this.chart.yAxis,this.yAxis),aT(this.chart.axes,this.yAxis)),(this.series||[]).forEach(_=>{_.destroy&&_.destroy()}),["series","xAxis","yAxis","shades","outline","scrollbarTrack","scrollbarRifles","scrollbarGroup","scrollbar","navigatorGroup","rendered"].forEach(_=>{this[_]&&this[_].destroy&&this[_].destroy(),this[_]=null}),[this.handles].forEach(_=>{Yt(_)}),this.baseSeries.forEach(_=>{_.navigatorSeries=void 0}),this.navigatorEnabled=!1}}let{animObject:tM}=cE(),{format:Xn}=rE(),{clamp:r_,pick:ZO,syncTimeout:oe}=cE(),{getFakeMouseEvent:SI}=EO,{getAxisRangeDescription:Ct,fireEventOnWrappedOrUnwrappedElement:As}=HO,eM=class extends rT{init(){let a=this.chart,_=this;this.announcer=new nE(a,"polite"),this.addEvent(ie,"afterRender",function(){this.chart===_.chart&&this.chart.renderer&&oe(()=>{_.proxyProvider.updateGroupProxyElementPositions("navigator"),_.updateHandleValues()},tM(ZO(this.chart.renderer.globalAnimation,!0)).duration)})}onChartUpdate(){let a=this.chart,_=a.options,r=_.navigator;if(r.enabled&&r.accessibility?.enabled){let L=_.accessibility.landmarkVerbosity,u=_.lang.accessibility?.navigator.groupLabel;this.proxyProvider.removeGroup("navigator"),this.proxyProvider.addGroup("navigator","div",{role:L==="all"?"region":"group","aria-label":Xn(u,{chart:a},a)});let m=_.lang.accessibility?.navigator.handleLabel;[0,1].forEach(b=>{let y=this.getHandleByIx(b);if(y){let K=this.proxyProvider.addProxyElement("navigator",{click:y},"input",{type:"range","aria-label":Xn(m,{handleIx:b,chart:a},a)});this[b?"maxHandleProxy":"minHandleProxy"]=K.innerElement,K.innerElement.style.pointerEvents="none",K.innerElement.oninput=()=>this.updateNavigator()}}),this.updateHandleValues()}else this.proxyProvider.removeGroup("navigator")}getNavigatorHandleNavigation(a){let _=this,r=this.chart,L=a?this.maxHandleProxy:this.minHandleProxy,u=this.keyCodes;return new PT(r,{keyCodeMap:[[[u.left,u.right,u.up,u.down],function(m){if(L){let b=m===u.left||m===u.up?-1:1;L.value=""+r_(parseFloat(L.value)+b,0,100),_.updateNavigator(()=>{let y=_.getHandleByIx(a);y&&r.setFocusToElement(y,L)})}return this.response.success}]],init:()=>{r.setFocusToElement(this.getHandleByIx(a),L)},validate:()=>!!(this.getHandleByIx(a)&&L&&r.options.navigator.accessibility?.enabled)})}getKeyboardNavigation(){return[this.getNavigatorHandleNavigation(0),this.getNavigatorHandleNavigation(1)]}destroy(){this.updateNavigatorThrottleTimer&&clearTimeout(this.updateNavigatorThrottleTimer),this.proxyProvider.removeGroup("navigator"),this.announcer&&this.announcer.destroy()}updateHandleValues(){let a=this.chart.navigator;if(a&&this.minHandleProxy&&this.maxHandleProxy){let _=a.size;this.minHandleProxy.value=""+Math.round(a.zoomedMin/_*100),this.maxHandleProxy.value=""+Math.round(a.zoomedMax/_*100)}}getHandleByIx(a){let _=this.chart.navigator;return _&&_.handles&&_.handles[a]}updateNavigator(a){let _=r=>{let L=this.chart,{navigator:u,pointer:m}=L,b=this.chart.accessibility?.keyboardNavigation;if(u&&m&&this.minHandleProxy&&this.maxHandleProxy){let y=m.getChartPosition(),K=parseFloat(this.minHandleProxy.value)/100*u.size,w=parseFloat(this.maxHandleProxy.value)/100*u.size;[[0,"mousedown",u.zoomedMin],[0,"mousemove",K],[0,"mouseup",K],[1,"mousedown",u.zoomedMax],[1,"mousemove",w],[1,"mouseup",w]].forEach(([ME,AE,bE])=>{let VE=this.getHandleByIx(ME)?.element;VE&&As(VE,SI(AE,{x:y.left+u.left+bE,y:y.top+u.top},VE))}),b&&(b.keyboardReset=!1),r&&r();let OE=L.options.lang.accessibility?.navigator.changeAnnouncement,tE=Ct(L.xAxis[0]);this.announcer.announce(Xn(OE,{axisRangeDescription:tE,chart:L},L))}};this.updateNavigatorThrottleTimer&&clearTimeout(this.updateNavigatorThrottleTimer),this.updateNavigatorThrottleTimer=setTimeout(_.bind(this,a),20)}},{getPointAnnotationTexts:Ae}=KE,{getAxisDescription:P_,getSeriesFirstPointElement:Bt,getSeriesA11yElement:NR,unhideChartElementFromAT:lI}=HO,{format:bt,numberFormat:Ss}=rE(),{reverseChildNodes:ZI,stripHTMLTagsFromString:uT}=EO,{find:OR,isNumber:TR,isString:rI,pick:PI,defined:aI}=cE();function nR(a){let _=a.chart.options.accessibility.series.pointDescriptionEnabledThreshold;return!!(_!==!1&&a.points&&a.points.length>=+_)}function ls(a,_){let r=a.series,L=r.chart,u=L.options.accessibility.point||{},m=r.options.accessibility&&r.options.accessibility.point||{},b=r.tooltipOptions||{},y=L.options.lang;return TR(_)?Ss(_,m.valueDecimals||u.valueDecimals||b.valueDecimals||-1,y.decimalPoint,y.accessibility.thousandsSep||y.thousandsSep):_}function IR(a,_){let r=a[_];return a.chart.langFormat("accessibility.series."+_+"Description",{name:P_(r),series:a})}function rs(a){let _,r,L,u,m,b,y,K,w,OE,tE,ME,AE=a.series,bE=AE.chart.series.length>1||AE.options.name,VE=(b=(m=a.series).chart,K=(y=m.options.accessibility)&&y.point&&y.point.valueDescriptionFormat||b.options.accessibility.point.valueDescriptionFormat,OE=(w=PI(m.xAxis&&m.xAxis.options.accessibility&&m.xAxis.options.accessibility.enabled,!b.angular&&m.type!=="flowmap"))?(_=(function(RN){let qE=RN.series,uN=qE.chart,HN=qE.options.accessibility&&qE.options.accessibility.point||{},BN=uN.options.accessibility.point||{},CN=qE.xAxis&&qE.xAxis.dateTime;if(CN){let iO=CN.getXDateFormat(RN.x||0,uN.options.tooltip.dateTimeLabelFormats),cT=HN.dateFormatter&&HN.dateFormatter(RN)||BN.dateFormatter&&BN.dateFormatter(RN)||HN.dateFormat||BN.dateFormat||iO;return uN.time.dateFormat(cT,RN.x||0,void 0)}})(a),r=(a.series.xAxis||{}).categories&&aI(a.category)&&(""+a.category).replace("<br/>"," "),L=aI(a.id)&&0>(""+a.id).indexOf("highcharts-"),u="x, "+a.x,a.name||_||r||(L?a.id:u)):"",bt(K,{point:a,index:aI(a.index)?a.index+1:"",xDescription:OE,value:(function(RN){let qE=RN.series,uN=qE.chart.options.accessibility.point||{},HN=qE.chart.options.accessibility&&qE.chart.options.accessibility.point||{},BN=qE.tooltipOptions||{},CN=HN.valuePrefix||uN.valuePrefix||BN.valuePrefix||"",iO=HN.valueSuffix||uN.valueSuffix||BN.valueSuffix||"",cT=RN.value!==void 0?"value":"y",oO=ls(RN,RN[cT]);if(RN.isNull)return qE.chart.langFormat("accessibility.series.nullPointValue",{point:RN});if(qE.pointArrayMap){let rO,YT,$n;return rO=CN||"",YT=iO||"",$n=function(wT){let $O=ls(RN,PI(RN[wT],RN.options[wT]));return $O!==void 0?wT+": "+rO+$O+YT:$O},RN.series.pointArrayMap.reduce(function(wT,$O){let IO=$n($O);return IO?wT+(wT.length?", ":"")+IO:wT},"")}return CN+oO+iO})(a),separator:w?", ":""},b)),ZE=a.options&&a.options.accessibility&&a.options.accessibility.description,aN=bE?" "+AE.name+".":"",LN=(tE=a.series.chart,(ME=Ae(a)).length?tE.langFormat("accessibility.series.pointAnnotationsDescription",{point:a,annotations:ME}):"");return a.accessibility=a.accessibility||{},a.accessibility.valueDescription=VE,VE+(ZE?" "+ZE:"")+aN+(LN?" "+LN:"")}function DI(a){let _,r=a.chart,L=r.types||[],u=(_=(a.options.accessibility||{}).description)&&a.chart.langFormat("accessibility.series.description",{description:_,series:a})||"",m=function(AE){return r[AE]&&r[AE].length>1&&a[AE]},b=a.index+1,y=IR(a,"xAxis"),K=IR(a,"yAxis"),w={seriesNumber:b,series:a,chart:r},OE=L.length>1?"Combination":"",tE=r.langFormat("accessibility.series.summary."+a.type+OE,w)||r.langFormat("accessibility.series.summary.default"+OE,w),ME=(m("yAxis")?" "+K+".":"")+(m("xAxis")?" "+y+".":"");return bt(PI(a.options.accessibility&&a.options.accessibility.descriptionFormat,r.options.accessibility.series.descriptionFormat,""),{seriesDescription:tE,authorDescription:u?" "+u:"",axisDescription:ME,series:a,chart:r,seriesNumber:b},void 0)}let mn={defaultPointDescriptionFormatter:rs,defaultSeriesDescriptionFormatter:DI,describeSeries:function(a){let _=a.chart,r=Bt(a),L=NR(a),u=_.is3d&&_.is3d();if(L){let m,b,y,K,w,OE,tE,ME,AE,bE,VE;if(L.lastChild!==r||u||ZI(L),m=a.options.accessibility||{},y=!nR(a)&&!m.exposeAsGroupOnly,b=a.chart.options.accessibility.keyboardNavigation.seriesNavigation,K=!!(a.points&&(a.points.length<+b.pointNavigationEnabledThreshold||b.pointNavigationEnabledThreshold===!1)),w=a.chart.options.accessibility.point.describeNull,(y||K)&&a.points.forEach(ZE=>{let aN,LN,RN,qE,uN,HN=ZE.graphic&&ZE.graphic.element||(LN=(aN=ZE.series)&&aN.chart,RN=aN&&aN.is("sunburst"),qE=ZE.isNull,uN=LN&&LN.options.accessibility.point.describeNull,qE&&!RN&&uN&&(function(CN){let iO,cT=CN.series,oO=(function($O){let IO=$O.index;if(!$O.series||!$O.series.data||!aI(IO))return null;let VO=$O.series.options?.nullInteraction;return OR($O.series.data,function(pn){return!!(pn&&pn.index!==void 0&&(VO||pn.index>IO)&&pn.graphic&&pn.graphic.element)})||null})(CN),rO=oO&&oO.graphic,YT=rO?rO.parentGroup:cT.graph||cT.group,$n=oO?{x:PI(CN.plotX,oO.plotX,0),y:PI(CN.plotY,oO.plotY,0)}:{x:PI(CN.plotX,0),y:PI(CN.plotY,0)},wT=((iO=CN.series.chart.renderer.rect($n.x,$n.y,1,1)).attr({class:"highcharts-a11y-mock-point",fill:"none",opacity:0,"fill-opacity":0,"stroke-opacity":0}),iO);if(YT&&YT.element)return CN.graphic=wT,CN.hasMockGraphic=!0,wT.add(YT),YT.element.insertBefore(wT.element,rO?rO.element:null),wT.element})(ZE)),BN=ZE.options&&ZE.options.accessibility&&ZE.options.accessibility.enabled===!1;if(HN){if(ZE.isNull&&!w)return void HN.setAttribute("aria-hidden",!0);if(HN.setAttribute("tabindex","-1"),a.chart.styledMode||(HN.style.outline="none"),y&&!BN){let CN,iO,cT,oO;CN=ZE.series,iO=CN.options.accessibility?.point||{},cT=CN.chart.options.accessibility.point||{},oO=uT(rI(iO.descriptionFormat)&&bt(iO.descriptionFormat,ZE,CN.chart)||iO.descriptionFormatter?.(ZE)||rI(cT.descriptionFormat)&&bt(cT.descriptionFormat,ZE,CN.chart)||cT.descriptionFormatter?.(ZE)||rs(ZE),CN.chart.renderer.forExport),HN.setAttribute("role","img"),HN.setAttribute("aria-label",oO)}else HN.setAttribute("aria-hidden",!0)}}),lI(_,L),ME=(tE=(OE=a.chart).options.chart).options3d&&tE.options3d.enabled,AE=OE.series.length>1,bE=OE.options.accessibility.series.describeSingleSeries,VE=(a.options.accessibility||{}).exposeAsGroupOnly,!(ME&&AE)&&(AE||bE||VE||nR(a))){let ZE,aN,LN;ZE=a.options.accessibility||{},LN=(aN=a.chart.options.accessibility).landmarkVerbosity,ZE.exposeAsGroupOnly?L.setAttribute("role","img"):LN==="all"?L.setAttribute("role","region"):L.setAttribute("role","group"),L.setAttribute("tabindex","-1"),a.chart.styledMode||(L.style.outline="none"),L.setAttribute("aria-label",uT(aN.series.descriptionFormatter&&aN.series.descriptionFormatter(a)||DI(a),a.chart.renderer.forExport))}else L.removeAttribute("aria-label")}}},{composed:tR}=cE(),{addEvent:QT,defined:Se,pushUnique:JT}=cE(),{getChartTitle:mt}=HO,{defaultPointDescriptionFormatter:ft,defaultSeriesDescriptionFormatter:pt}=mn;function Vt(a){return!!a.options.accessibility.announceNewData.enabled}class LI{constructor(_){this.dirty={allSeries:{}},this.lastAnnouncementTime=0,this.chart=_}init(){let _=this.chart,r=_.options.accessibility.announceNewData.interruptUser?"assertive":"polite";this.lastAnnouncementTime=0,this.dirty={allSeries:{}},this.eventProvider=new un,this.announcer=new nE(_,r),this.addEventListeners()}destroy(){this.eventProvider.removeAddedEvents(),this.announcer.destroy()}addEventListeners(){let _=this,r=this.chart,L=this.eventProvider;L.addEvent(r,"afterApplyDrilldown",function(){_.lastAnnouncementTime=0}),L.addEvent(r,"afterAddSeries",function(u){_.onSeriesAdded(u.series)}),L.addEvent(r,"redraw",function(){_.announceDirtyData()})}onSeriesAdded(_){Vt(this.chart)&&(this.dirty.hasDirty=!0,this.dirty.allSeries[_.name+_.index]=_,this.dirty.newSeries=Se(this.dirty.newSeries)?void 0:_)}announceDirtyData(){let _=this.chart,r=this;if(_.options.accessibility.announceNewData&&this.dirty.hasDirty){var L;let u,m=this.dirty.newPoint;m&&(m=(u=(L=m).series.data.filter(b=>L.x===b.x&&L.y===b.y)).length===1?u[0]:L),this.queueAnnouncement(Object.keys(this.dirty.allSeries).map(b=>r.dirty.allSeries[b]),this.dirty.newSeries,m),this.dirty={allSeries:{}}}}queueAnnouncement(_,r,L){let u=this.chart.options.accessibility.announceNewData;if(u.enabled){var m;let b,y=+new Date,K=y-this.lastAnnouncementTime,w=Math.max(0,u.minAnnounceInterval-K),OE=(m=this.queuedAnnouncement&&this.queuedAnnouncement.series,Object.keys(b=(m||[]).concat(_||[]).reduce((ME,AE)=>(ME[AE.name+AE.index]=AE,ME),{})).map(ME=>b[ME])),tE=this.buildAnnouncementMessage(OE,r,L);tE&&(this.queuedAnnouncement&&clearTimeout(this.queuedAnnouncementTimer),this.queuedAnnouncement={time:y,message:tE,series:OE},this.queuedAnnouncementTimer=setTimeout(()=>{this&&this.announcer&&(this.lastAnnouncementTime=+new Date,this.announcer.announce(this.queuedAnnouncement.message),delete this.queuedAnnouncement,delete this.queuedAnnouncementTimer)},w))}}buildAnnouncementMessage(_,r,L){let u=this.chart,m=u.options.accessibility.announceNewData;if(m.announcementFormatter){let w=m.announcementFormatter(_,r,L);if(w!==!1)return w.length?w:null}let b=cE().charts&&cE().charts.length>1?"Multiple":"Single",y=r?"newSeriesAnnounce"+b:L?"newPointAnnounce"+b:"newDataAnnounce",K=mt(u);return u.langFormat("accessibility.announceNewData."+y,{chartTitle:K,seriesDesc:r?pt(r):null,pointDesc:L?ft(L):null,point:L,series:r})}}function qn(a){let _=this.chart,r=_.accessibility?.components.series.newDataAnnouncer;r&&r.chart===_&&Vt(_)&&(r.dirty.newPoint=Se(r.dirty.newPoint)?void 0:a.point)}function Ps(){let a=this.chart,_=a.accessibility?.components.series.newDataAnnouncer;_&&_.chart===a&&Vt(a)&&(_.dirty.hasDirty=!0,_.dirty.allSeries[this.name+this.index]=this)}(LI||(LI={})).compose=function(a){JT(tR,"A11y.NDA")&&(QT(a,"addPoint",qn),QT(a,"updatedData",Ps))};let XI=LI,{doc:$T,win:a_}=cE(),{attr:iT,css:MM,merge:Wn}=cE(),{fireEventOnWrappedOrUnwrappedElement:En}=HO,{cloneMouseEvent:Qn,cloneTouchEvent:qI,getFakeMouseEvent:RM,removeElement:as}=EO,le=class{constructor(a,_,r="button",L,u){this.chart=a,this.target=_,this.eventProvider=new un;const m=this.innerElement=$T.createElement(r),b=this.element=L?$T.createElement(L):m;a.styledMode||this.hideElementVisually(m),L&&(L!=="li"||a.styledMode||(b.style.listStyle="none"),b.appendChild(m),this.element=b),this.updateTarget(_,u)}click(){let a=this.getTargetPosition();a.x+=a.width/2,a.y+=a.height/2;let _=RM("click",a);En(this.target.click,_)}updateTarget(a,_){this.target=a,this.updateCSSClassName();let r=_||{};Object.keys(r).forEach(u=>{r[u]===null&&delete r[u]});let L=this.getTargetAttr(a.click,"aria-label");iT(this.innerElement,Wn(L?{"aria-label":L}:{},r)),this.eventProvider.removeAddedEvents(),this.addProxyEventsToElement(this.innerElement,a.click),this.refreshPosition()}refreshPosition(){let a=this.getTargetPosition();MM(this.innerElement,{width:(a.width||1)+"px",height:(a.height||1)+"px",left:(Math.round(a.x)||0)+"px",top:(Math.round(a.y)||0)+"px"})}remove(){this.eventProvider.removeAddedEvents(),as(this.element)}updateCSSClassName(){let a=m=>m.indexOf("highcharts-no-tooltip")>-1,_=this.chart.legend,r=_.group&&_.group.div,L=a(r&&r.className||""),u=a(this.getTargetAttr(this.target.click,"class")||"");this.innerElement.className=L||u?"highcharts-a11y-proxy-element highcharts-no-tooltip":"highcharts-a11y-proxy-element"}addProxyEventsToElement(a,_){["click","touchstart","touchend","touchcancel","touchmove","mouseover","mouseenter","mouseleave","mouseout"].forEach(r=>{let L=r.indexOf("touch")===0;this.eventProvider.addEvent(a,r,u=>{let m=L?qI(u):Qn(u);_&&En(_,m),u.stopPropagation(),L||u.preventDefault()},{passive:!1})})}hideElementVisually(a){MM(a,{borderWidth:0,backgroundColor:"transparent",cursor:"pointer",outline:"none",opacity:.001,filter:"alpha(opacity=1)",zIndex:999,overflow:"hidden",padding:0,margin:0,display:"block",position:"absolute","-ms-filter":"progid:DXImageTransform.Microsoft.Alpha(Opacity=1)"})}getTargetPosition(){let a=this.target.click,_=a.element?a.element:a,r=this.target.visual||_,L=this.chart.renderTo,u=this.chart.pointer;if(L&&r?.getBoundingClientRect&&u){let m=a_.scrollY||$T.documentElement.scrollTop,b=r.getBoundingClientRect(),y=u.getChartPosition();return{x:(b.left-y.left)/y.scaleX,y:(b.top+m-y.top)/y.scaleY,width:b.right/y.scaleX-b.left/y.scaleX,height:b.bottom/y.scaleY-b.top/y.scaleY}}return{x:0,y:0,width:1,height:1}}getTargetAttr(a,_){return a.element?a.element.getAttribute(_):a.getAttribute(_)}},{doc:Ds}=cE(),{attr:yT,css:WI}=cE(),{unhideChartElementFromAT:QI}=HO,{removeChildNodes:cI}=EO,IT=class{constructor(a){this.chart=a,this.domElementProvider=new RT,this.groups={},this.groupOrder=[],this.beforeChartProxyPosContainer=this.createProxyPosContainer("before"),this.afterChartProxyPosContainer=this.createProxyPosContainer("after"),this.update()}addProxyElement(a,_,r="button",L){let u=this.groups[a];if(!u)throw Error("ProxyProvider.addProxyElement: Invalid group key "+a);let m=u.type==="ul"||u.type==="ol"?"li":void 0,b=new le(this.chart,_,r,m,L);return u.proxyContainerElement.appendChild(b.element),u.proxyElements.push(b),b}addGroup(a,_="div",r){let L,u=this.groups[a];if(u)return u.groupElement;let m=this.domElementProvider.createElement(_);return r&&r.role&&_!=="div"?(L=this.domElementProvider.createElement("div")).appendChild(m):L=m,L.className="highcharts-a11y-proxy-group highcharts-a11y-proxy-group-"+a.replace(/\W/g,"-"),this.groups[a]={proxyContainerElement:m,groupElement:L,type:_,proxyElements:[]},yT(L,r||{}),_==="ul"&&m.setAttribute("role","list"),this.afterChartProxyPosContainer.appendChild(L),this.updateGroupOrder(this.groupOrder),L}updateGroupAttrs(a,_){let r=this.groups[a];if(!r)throw Error("ProxyProvider.updateGroupAttrs: Invalid group key "+a);yT(r.groupElement,_)}updateGroupOrder(a){if(this.groupOrder=a.slice(),this.isDOMOrderGroupOrder())return;let _=a.indexOf("series"),r=_>-1?a.slice(0,_):a,L=_>-1?a.slice(_+1):[],u=Ds.activeElement;["before","after"].forEach(m=>{let b=this[m==="before"?"beforeChartProxyPosContainer":"afterChartProxyPosContainer"];cI(b),(m==="before"?r:L).forEach(y=>{let K=this.groups[y];K&&b.appendChild(K.groupElement)})}),(this.beforeChartProxyPosContainer.contains(u)||this.afterChartProxyPosContainer.contains(u))&&u&&u.focus&&u.focus()}clearGroup(a){let _=this.groups[a];if(!_)throw Error("ProxyProvider.clearGroup: Invalid group key "+a);cI(_.proxyContainerElement)}removeGroup(a){let _=this.groups[a];_&&(this.domElementProvider.removeElement(_.groupElement),_.groupElement!==_.proxyContainerElement&&this.domElementProvider.removeElement(_.proxyContainerElement),delete this.groups[a])}update(){this.updatePosContainerPositions(),this.updateGroupOrder(this.groupOrder),this.updateProxyElementPositions()}updateProxyElementPositions(){Object.keys(this.groups).forEach(this.updateGroupProxyElementPositions.bind(this))}updateGroupProxyElementPositions(a){let _=this.groups[a];_&&_.proxyElements.forEach(r=>r.refreshPosition())}destroy(){this.domElementProvider.destroyCreatedElements()}createProxyPosContainer(a){let _=this.domElementProvider.createElement("div");return _.setAttribute("aria-hidden","false"),_.className="highcharts-a11y-proxy-container"+(a?"-"+a:""),WI(_,{top:"0",left:"0"}),this.chart.styledMode||(_.style.whiteSpace="nowrap",_.style.position="absolute"),_}getCurrentGroupOrderInDOM(){let a=u=>{let m=Object.keys(this.groups),b=m.length;for(;b--;){let y=m[b],K=this.groups[y];if(K&&u===K.groupElement)return y}},_=u=>{let m=[],b=u.children;for(let y=0;y<b.length;++y){let K=a(b[y]);K&&m.push(K)}return m},r=_(this.beforeChartProxyPosContainer),L=_(this.afterChartProxyPosContainer);return r.push("series"),r.concat(L)}isDOMOrderGroupOrder(){let a=this.getCurrentGroupOrderInDOM(),_=this.groupOrder.filter(L=>L==="series"||!!this.groups[L]),r=a.length;if(r!==_.length)return!1;for(;r--;)if(a[r]!==_[r])return!1;return!0}updatePosContainerPositions(){let a=this.chart;if(a.renderer.forExport)return;let _=a.renderer.box;a.container.insertBefore(this.afterChartProxyPosContainer,_.nextSibling),a.container.insertBefore(this.beforeChartProxyPosContainer,_),QI(this.chart,this.afterChartProxyPosContainer),QI(this.chart,this.beforeChartProxyPosContainer)}},{unhideChartElementFromAT:hN,getAxisRangeDescription:Nn}=HO,{addEvent:On,attr:UT}=cE();class DT extends rT{init(){let _=this.chart;this.announcer=new nE(_,"polite")}onChartUpdate(){let _=this.chart,r=this,L=_.rangeSelector;L&&(this.updateSelectorVisibility(),this.setDropdownAttrs(),L.buttons&&L.buttons.length&&L.buttons.forEach(u=>{r.setRangeButtonAttrs(u)}),L.maxInput&&L.minInput&&["minInput","maxInput"].forEach(function(u,m){let b=L[u];b&&(hN(_,b),r.setRangeInputAttrs(b,"accessibility.rangeSelector."+(m?"max":"min")+"InputLabel"))}))}updateSelectorVisibility(){let _=this.chart,r=_.rangeSelector,L=r&&r.dropdown,u=r&&r.buttons||[];r&&r.hasVisibleDropdown&&L?(hN(_,L),u.forEach(m=>m.element.setAttribute("aria-hidden",!0))):(L&&L.setAttribute("aria-hidden",!0),u.forEach(m=>hN(_,m.element)))}setDropdownAttrs(){let _=this.chart,r=_.rangeSelector&&_.rangeSelector.dropdown;if(r){let L=_.langFormat("accessibility.rangeSelector.dropdownLabel",{rangeTitle:_.options.lang.rangeSelectorZoom});r.setAttribute("aria-label",L),r.setAttribute("tabindex",-1)}}setRangeButtonAttrs(_){UT(_.element,{tabindex:-1,role:"button"})}setRangeInputAttrs(_,r){let L=this.chart;UT(_,{tabindex:-1,"aria-label":L.langFormat(r,{chart:L})})}onButtonNavKbdArrowKey(_,r){let L=_.response,u=this.keyCodes,m=this.chart,b=m.options.accessibility.keyboardNavigation.wrapAround,y=r===u.left||r===u.up?-1:1;return m.highlightRangeSelectorButton(m.highlightedRangeSelectorItemIx+y)?L.success:b?(_.init(y),L.success):L[y>0?"next":"prev"]}onButtonNavKbdClick(_){let r=_.response,L=this.chart;return L.oldRangeSelectorItemState!==3&&this.fakeClickEvent(L.rangeSelector.buttons[L.highlightedRangeSelectorItemIx].element),r.success}onAfterBtnClick(){let _=this.chart,r=Nn(_.xAxis[0]),L=_.langFormat("accessibility.rangeSelector.clickButtonAnnouncement",{chart:_,axisRangeDescription:r});L&&this.announcer.announce(L)}onInputKbdMove(_){let r=this.chart,L=r.rangeSelector,u=r.highlightedInputRangeIx=(r.highlightedInputRangeIx||0)+_;if(u>1||u<0){if(r.accessibility)return r.accessibility.keyboardNavigation.exiting=!0,r.accessibility.keyboardNavigation.tabindexContainer.focus(),r.accessibility.keyboardNavigation.move(_)}else if(L){let m=L[u?"maxDateBox":"minDateBox"],b=L[u?"maxInput":"minInput"];m&&b&&r.setFocusToElement(m,b)}return!0}onInputNavInit(_){let r=this,L=this.chart,u=_>0?0:1,m=L.rangeSelector,b=m&&m[u?"maxDateBox":"minDateBox"],y=m&&m.minInput,K=m&&m.maxInput;if(L.highlightedInputRangeIx=u,b&&y&&K){L.setFocusToElement(b,u?K:y),this.removeInputKeydownHandler&&this.removeInputKeydownHandler();let w=ME=>{(ME.which||ME.keyCode)===this.keyCodes.tab&&r.onInputKbdMove(ME.shiftKey?-1:1)&&(ME.preventDefault(),ME.stopPropagation())},OE=On(y,"keydown",w),tE=On(K,"keydown",w);this.removeInputKeydownHandler=()=>{OE(),tE()}}}onInputNavTerminate(){let _=this.chart.rangeSelector||{};_.maxInput&&_.hideInput("max"),_.minInput&&_.hideInput("min"),this.removeInputKeydownHandler&&(this.removeInputKeydownHandler(),delete this.removeInputKeydownHandler)}initDropdownNav(){let _=this.chart,r=_.rangeSelector,L=r&&r.dropdown;r&&L&&(_.setFocusToElement(r.buttonGroup,L),this.removeDropdownKeydownHandler&&this.removeDropdownKeydownHandler(),this.removeDropdownKeydownHandler=On(L,"keydown",u=>{let m=(u.which||u.keyCode)===this.keyCodes.tab,b=_.accessibility;m&&(u.preventDefault(),u.stopPropagation(),b&&b.keyboardNavigation.move(u.shiftKey?-1:1))}))}getRangeSelectorButtonNavigation(){let _=this.chart,r=this.keyCodes,L=this;return new PT(_,{keyCodeMap:[[[r.left,r.right,r.up,r.down],function(u){return L.onButtonNavKbdArrowKey(this,u)}],[[r.enter,r.space],function(){return L.onButtonNavKbdClick(this)}]],validate:function(){return!!(_.rangeSelector&&_.rangeSelector.buttons&&_.rangeSelector.buttons.length)},init:function(u){let m=_.rangeSelector;if(m&&m.hasVisibleDropdown)L.initDropdownNav();else if(m){let b=m.buttons.length-1;_.highlightRangeSelectorButton(u>0?0:b)}},terminate:function(){L.removeDropdownKeydownHandler&&(L.removeDropdownKeydownHandler(),delete L.removeDropdownKeydownHandler)}})}getRangeSelectorInputNavigation(){let _=this.chart,r=this;return new PT(_,{keyCodeMap:[],validate:function(){return!!(_.rangeSelector&&_.rangeSelector.inputGroup&&_.rangeSelector.inputGroup.element.style.visibility!=="hidden"&&_.options.rangeSelector.inputEnabled!==!1&&_.rangeSelector.minInput&&_.rangeSelector.maxInput)},init:function(L){r.onInputNavInit(L)},terminate:function(){r.onInputNavTerminate()}})}getKeyboardNavigation(){return[this.getRangeSelectorButtonNavigation(),this.getRangeSelectorInputNavigation()]}destroy(){this.removeDropdownKeydownHandler&&this.removeDropdownKeydownHandler(),this.removeInputKeydownHandler&&this.removeInputKeydownHandler(),this.announcer&&this.announcer.destroy()}}function FN(a){let _=this.rangeSelector&&this.rangeSelector.buttons||[],r=this.highlightedRangeSelectorItemIx,L=this.rangeSelector&&this.rangeSelector.selected;return r!==void 0&&_[r]&&r!==L&&_[r].setState(this.oldRangeSelectorItemState||0),this.highlightedRangeSelectorItemIx=a,!!_[a]&&(this.setFocusToElement(_[a].box,_[a].element),a!==L&&(this.oldRangeSelectorItemState=_[a].state,_[a].setState(1)),!0)}function eR(){let a=this.chart.accessibility;if(a&&a.components.rangeSelector)return a.components.rangeSelector.onAfterBtnClick()}(DT||(DT={})).compose=function(a,_){let r=a.prototype;r.highlightRangeSelectorButton||(r.highlightRangeSelectorButton=FN,On(_,"afterBtnClick",eR))};let sM=DT,{composed:_M}=cE(),{addEvent:IN,merge:pO,pushUnique:nO}=cE();(function(a){function _(K){pO(!0,K,{marker:{enabled:!0,states:{normal:{opacity:0}}}})}function r(K){return K.marker.states&&K.marker.states.normal&&K.marker.states.normal.opacity}function L(K){return!!(K._hasPointMarkers&&K.points&&K.points.length)}function u(){this.chart.styledMode&&(this.markerGroup&&this.markerGroup[this.a11yMarkersForced?"addClass":"removeClass"]("highcharts-a11y-markers-hidden"),L(this)&&this.points.forEach(K=>{K.graphic&&(K.graphic[K.hasForcedA11yMarker?"addClass":"removeClass"]("highcharts-a11y-marker-hidden"),K.graphic[K.hasForcedA11yMarker===!1?"addClass":"removeClass"]("highcharts-a11y-marker-visible"))}))}function m(K){this.resetA11yMarkerOptions=pO(K.options.marker||{},this.userOptions.marker||{})}function b(){let K=this.options;(function(w){let OE,tE=w.chart.options.accessibility.enabled,ME=(w.options.accessibility&&w.options.accessibility.enabled)!==!1;return tE&&ME&&(OE=w.chart.options.accessibility,w.points.length<OE.series.pointDescriptionEnabledThreshold||OE.series.pointDescriptionEnabledThreshold===!1)})(this)?(K.marker&&K.marker.enabled===!1&&(this.a11yMarkersForced=!0,_(this.options)),L(this)&&(function(w){let OE=w.points.length;for(;OE--;){let ME=w.points[OE],AE=ME.options,bE=ME.hasForcedA11yMarker;if(delete ME.hasForcedA11yMarker,AE.marker){var tE;let VE=bE&&r(AE)===0;AE.marker.enabled&&!VE?(pO(!0,(tE=AE).marker,{states:{normal:{opacity:r(tE)||1}}}),ME.hasForcedA11yMarker=!1):AE.marker.enabled===!1&&(_(AE),ME.hasForcedA11yMarker=!0)}}})(this)):this.a11yMarkersForced&&(delete this.a11yMarkersForced,this.isDirty=!0,(function(w){let OE=w.resetA11yMarkerOptions;if(OE){let tE=OE.states&&OE.states.normal&&OE.states.normal.opacity;w.chart.styledMode&&OE.enabled===!1&&w.points&&w.points.forEach(ME=>{ME.graphic&&(ME.graphic=ME.graphic.destroy())}),w.userOptions&&w.userOptions.marker&&(w.userOptions.marker.enabled=!0),w.update({marker:{enabled:OE.enabled,states:{normal:{opacity:tE}}}})}})(this),K.marker&&K.marker.enabled===!1&&delete this.resetA11yMarkerOptions)}function y(){this.boosted&&this.a11yMarkersForced&&(pO(!0,this.options,{marker:{enabled:!1}}),delete this.a11yMarkersForced)}a.compose=function(K){nO(_M,"A11y.FM")&&(IN(K,"afterSetOptions",m),IN(K,"render",b),IN(K,"afterRender",u),IN(K,"renderCanvas",y))}})($E||($E={}));let gN=$E;var Dn=gE(260),iN=gE.n(Dn),gt=gE(820),hI=gE.n(gt);let{seriesTypes:MR}=nT(),{doc:Ls}=cE(),{defined:LT,fireEvent:Tn}=cE(),{getPointFromXY:RR,getSeriesFromName:re,scrollAxisToPoint:sR}=HO;function Ln(a){let _=a.index,r=a.series.points,L=r.length;if(r[_]===a)return _;for(;L--;)if(r[L]===a)return L}function xT(a){let _=a.chart.options.accessibility.keyboardNavigation.seriesNavigation,r=a.options.accessibility||{},L=r.keyboardNavigation;return L&&L.enabled===!1||r.enabled===!1||a.options.enableMouseTracking===!1||!a.visible||_.pointNavigationEnabledThreshold&&+_.pointNavigationEnabledThreshold<=a.points.length}function vT(a){let _=a.series,r=_.options.nullInteraction,L=a.options.accessibility,u=_.chart.options.accessibility,m=L?.enabled===!1;return u.keyboardNavigation.seriesNavigation.skipNullPoints??(!(!a.isNull||r)&&a.visible===!1||a.isInside===!1||m||xT(_))}function nn(a){let _=a.series||[],r=_.length;for(let L=0;L<r;++L)if(!xT(_[L])){let u=(function(m){let b=m.points||[],y=b.length;for(let K=0;K<y;++K)if(!vT(b[K]))return b[K];return null})(_[L]);if(u)return u}return null}function iM(a){let _=a.series.length,r=!1;for(;_--&&(a.highlightedPoint=a.series[_].points[a.series[_].points.length-1],!(r=a.series[_].highlightNextValidPoint())););return r}function Pe(a){delete a.highlightedPoint;let _=nn(a);return!!_&&_.highlight()}class dI{constructor(_,r){this.keyCodes=r,this.chart=_}init(){let _=this,r=this.chart,L=this.eventProvider=new un;L.addEvent(hI(),"destroy",function(){return _.onSeriesDestroy(this)}),L.addEvent(r,"afterApplyDrilldown",function(){let u;(u=nn(this))&&u.highlight(!1)}),L.addEvent(r,"drilldown",function(u){let m=u.point,b=m.series;_.lastDrilledDownPoint={x:m.x,y:m.y,seriesName:b?b.name:""}}),L.addEvent(r,"drillupall",function(){setTimeout(function(){_.onDrillupAll()},10)}),L.addEvent(iN(),"afterSetState",function(){let u=this.graphic&&this.graphic.element,m=Ls.activeElement,b=m&&m.getAttribute("class"),y=b&&b.indexOf("highcharts-a11y-proxy-element")>-1;r.highlightedPoint===this&&m!==u&&!y&&u&&u.focus&&u.focus()})}onDrillupAll(){let _,r=this.lastDrilledDownPoint,L=this.chart,u=r&&re(L,r.seriesName);r&&u&&LT(r.x)&&LT(r.y)&&(_=RR(u,r.x,r.y)),_=_||nn(L),L.container&&L.container.focus(),_&&_.highlight&&_.highlight(!1)}getKeyboardNavigationHandler(){let _=this,r=this.keyCodes,L=this.chart,u=L.inverted;return new PT(L,{keyCodeMap:[[u?[r.up,r.down]:[r.left,r.right],function(m){return _.onKbdSideways(this,m)}],[u?[r.left,r.right]:[r.up,r.down],function(m){return _.onKbdVertical(this,m)}],[[r.enter,r.space],function(m,b){let y=L.highlightedPoint;if(y){let{plotLeft:K,plotTop:w}=this.chart,{plotX:OE=0,plotY:tE=0}=y;b={...b,chartX:K+OE,chartY:w+tE,point:y,target:y.graphic?.element||b.target},Tn(y.series,"click",b),y.firePointEvent("click",b)}return this.response.success}],[[r.home],function(){return Pe(L),this.response.success}],[[r.end],function(){return iM(L),this.response.success}],[[r.pageDown,r.pageUp],function(m){return L.highlightAdjacentSeries(m===r.pageDown),this.response.success}]],init:function(){return _.onHandlerInit(this)},validate:function(){return!!nn(L)},terminate:function(){return _.onHandlerTerminate()}})}onKbdSideways(_,r){let L=this.keyCodes,u=r===L.right||r===L.down;return this.attemptHighlightAdjacentPoint(_,u)}onHandlerInit(_){let r=this.chart;return r.options.accessibility.keyboardNavigation.seriesNavigation.rememberPointFocus&&r.highlightedPoint?r.highlightedPoint.highlight():Pe(r),_.response.success}onKbdVertical(_,r){let L=this.chart,u=this.keyCodes,m=r===u.down||r===u.right,b=L.options.accessibility.keyboardNavigation.seriesNavigation;if(b.mode&&b.mode==="serialize")return this.attemptHighlightAdjacentPoint(_,m);let y=L.highlightedPoint&&L.highlightedPoint.series.keyboardMoveVertical?"highlightAdjacentPointVertical":"highlightAdjacentSeries";return L[y](m),_.response.success}onHandlerTerminate(){let _=this.chart,r=_.options.accessibility.keyboardNavigation;_.tooltip&&_.tooltip.hide(0);let L=_.highlightedPoint&&_.highlightedPoint.series;L&&L.onMouseOut&&L.onMouseOut(),_.highlightedPoint&&_.highlightedPoint.onMouseOut&&_.highlightedPoint.onMouseOut(),r.seriesNavigation.rememberPointFocus||delete _.highlightedPoint}attemptHighlightAdjacentPoint(_,r){let L=this.chart,u=L.options.accessibility.keyboardNavigation.wrapAround;return L.highlightAdjacentPoint(r)||u&&(r?Pe(L):iM(L))?_.response.success:_.response[r?"next":"prev"]}onSeriesDestroy(_){let r=this.chart;r.highlightedPoint&&r.highlightedPoint.series===_&&(delete r.highlightedPoint,r.focusElement&&r.focusElement.removeFocusBorder())}destroy(){this.eventProvider.removeAddedEvents()}}(function(a){function _(b){let y,K,w=this.series,OE=this.highlightedPoint,tE=OE&&Ln(OE)||0,ME=OE&&OE.series.points||[],AE=this.series&&this.series[this.series.length-1],bE=AE&&AE.points&&AE.points[AE.points.length-1];if(!w[0]||!w[0].points)return!1;if(OE){if(y=w[OE.series.index+(b?1:-1)],(K=ME[tE+(b?1:-1)])||!y||(K=y.points[b?0:y.points.length-1]),!K)return!1}else K=b?w[0].points[0]:bE;return vT(K)?(xT(y=K.series)?this.highlightedPoint=b?y.points[y.points.length-1]:y.points[0]:this.highlightedPoint=K,this.highlightAdjacentPoint(b)):K.highlight()}function r(b){let y=this.highlightedPoint,K=1/0,w;return!!LT(y.plotX)&&!!LT(y.plotY)&&(this.series.forEach(OE=>{xT(OE)||OE.points.forEach(tE=>{if(!LT(tE.plotY)||!LT(tE.plotX)||tE===y)return;let ME=tE.plotY-y.plotY,AE=Math.abs(tE.plotX-y.plotX),bE=Math.abs(ME)*Math.abs(ME)+AE*AE*4;OE.yAxis&&OE.yAxis.reversed&&(ME*=-1),!(ME<=0&&b||ME>=0&&!b||bE<5||vT(tE))&&bE<K&&(K=bE,w=tE)})}),!!w&&w.highlight())}function L(b){let y,K,w,OE=this.highlightedPoint,tE=this.series&&this.series[this.series.length-1],ME=tE&&tE.points&&tE.points[tE.points.length-1];return this.highlightedPoint?!!(y=this.series[OE.series.index+(b?-1:1)])&&!!(K=(function(AE,bE,VE,ZE){let aN=1/0,LN,RN,qE,uN=bE.points.length,HN=BN=>!(LT(BN.plotX)&&LT(BN.plotY));if(!HN(AE)){for(;uN--;)!HN(LN=bE.points[uN])&&(qE=(AE.plotX-LN.plotX)*(AE.plotX-LN.plotX)*4+(AE.plotY-LN.plotY)*(AE.plotY-LN.plotY)*1)<aN&&(aN=qE,RN=uN);return LT(RN)?bE.points[RN]:void 0}})(OE,y))&&(xT(y)?(K.highlight(),(w=this.highlightAdjacentSeries(b))?w:(OE.highlight(),!1)):(K.highlight(),K.series.highlightNextValidPoint())):(y=b?this.series&&this.series[0]:tE,!!(K=b?y&&y.points&&y.points[0]:ME)&&K.highlight())}function u(b=!0){let y=this.series.chart,K=y.tooltip?.label?.element;(!this.isNull||this.series.options?.nullInteraction)&&b?this.onMouseOver():y.tooltip&&y.tooltip.hide(0),sR(this),this.graphic&&(y.setFocusToElement(this.graphic),!b&&y.focusElement&&y.focusElement.removeFocusBorder()),y.highlightedPoint=this;let w=K?.getBoundingClientRect().top;if(K&&w&&w<0){let OE=window.scrollY;window.scrollTo({behavior:"smooth",top:OE+w})}return this}function m(){let b=this.chart.highlightedPoint,y=(b&&b.series)===this?Ln(b):0,K=this.points,w=K.length;if(K&&w){for(let OE=y;OE<w;++OE)if(!vT(K[OE]))return K[OE].highlight();for(let OE=y;OE>=0;--OE)if(!vT(K[OE]))return K[OE].highlight()}return!1}a.compose=function(b,y,K){let w=b.prototype,OE=y.prototype,tE=K.prototype;w.highlightAdjacentPoint||(w.highlightAdjacentPoint=_,w.highlightAdjacentPointVertical=r,w.highlightAdjacentSeries=L,OE.highlight=u,tE.keyboardMoveVertical=!0,["column","gantt","pie"].forEach(ME=>{MR[ME]&&(MR[ME].prototype.keyboardMoveVertical=!1)}),tE.highlightNextValidPoint=m)}})(dI||(dI={}));let ae=dI,{hideSeriesFromAT:GI}=HO,{describeSeries:tT}=mn,De=class extends rT{static compose(a,_,r){XI.compose(r),gN.compose(r),ae.compose(a,_,r)}init(){this.newDataAnnouncer=new XI(this.chart),this.newDataAnnouncer.init(),this.keyboardNavigation=new ae(this.chart,this.keyCodes),this.keyboardNavigation.init(),this.hideTooltipFromATWhenShown(),this.hideSeriesLabelsFromATWhenShown()}hideTooltipFromATWhenShown(){let a=this;this.chart.tooltip&&this.addEvent(this.chart.tooltip.constructor,"refresh",function(){this.chart===a.chart&&this.label&&this.label.element&&this.label.element.setAttribute("aria-hidden",!0)})}hideSeriesLabelsFromATWhenShown(){this.addEvent(this.chart,"afterDrawSeriesLabels",function(){this.series.forEach(function(a){a.labelBySeries&&a.labelBySeries.attr("aria-hidden",!0)})})}onChartRender(){this.chart.series.forEach(function(a){(a.options.accessibility&&a.options.accessibility.enabled)!==!1&&a.visible&&a.getPointsCollection().length!==0?tT(a):GI(a)})}getKeyboardNavigation(){return this.keyboardNavigation.getKeyboardNavigationHandler()}destroy(){this.newDataAnnouncer.destroy(),this.keyboardNavigation.destroy()}},{unhideChartElementFromAT:_R}=HO,{getFakeMouseEvent:oM}=EO,{attr:fn,pick:D_}=cE(),KO=class extends rT{constructor(){super(...arguments),this.focusedMapNavButtonIx=-1}init(){let a=this,_=this.chart;this.proxyProvider.addGroup("zoom","div"),["afterShowResetZoom","afterApplyDrilldown","drillupall"].forEach(r=>{a.addEvent(_,r,function(){a.updateProxyOverlays()})})}onChartUpdate(){let a=this.chart,_=this;a.mapNavigation&&a.mapNavigation.navButtons.forEach((r,L)=>{_R(a,r.element),_.setMapNavButtonAttrs(r.element,"accessibility.zoom.mapZoom"+(L?"Out":"In"))})}setMapNavButtonAttrs(a,_){let r=this.chart;fn(a,{tabindex:-1,role:"button","aria-label":r.langFormat(_,{chart:r})})}onChartRender(){this.updateProxyOverlays()}updateProxyOverlays(){let a=this.chart;if(this.proxyProvider.clearGroup("zoom"),a.resetZoomButton&&this.createZoomProxyButton(a.resetZoomButton,"resetZoomProxyButton",a.langFormat("accessibility.zoom.resetZoomButton",{chart:a})),a.drillUpButton&&a.breadcrumbs&&a.breadcrumbs.list){let _=a.breadcrumbs.list[a.breadcrumbs.list.length-1];this.createZoomProxyButton(a.drillUpButton,"drillUpProxyButton",a.langFormat("accessibility.drillUpButton",{chart:a,buttonText:a.breadcrumbs.getButtonText(_)}))}}createZoomProxyButton(a,_,r){this[_]=this.proxyProvider.addProxyElement("zoom",{click:a},"button",{"aria-label":r,tabindex:-1})}getMapZoomNavigation(){let a=this.keyCodes,_=this.chart,r=this;return new PT(_,{keyCodeMap:[[[a.up,a.down,a.left,a.right],function(L){return r.onMapKbdArrow(this,L)}],[[a.tab],function(L,u){return r.onMapKbdTab(this,u)}],[[a.space,a.enter],function(){return r.onMapKbdClick(this)}]],validate:function(){return!!(_.mapView&&_.mapNavigation&&_.mapNavigation.navButtons.length)},init:function(L){return r.onMapNavInit(L)}})}onMapKbdArrow(a,_){let r=this.chart,L=this.keyCodes,u=r.container,m=_===L.up||_===L.down,b=_===L.left||_===L.up?1:-1,y=(m?r.plotHeight:r.plotWidth)/10*b,K=10*Math.random(),w={x:u.offsetLeft+r.plotLeft+r.plotWidth/2+K,y:u.offsetTop+r.plotTop+r.plotHeight/2+K},OE=m?{x:w.x,y:w.y+y}:{x:w.x+y,y:w.y};return[oM("mousedown",w),oM("mousemove",OE),oM("mouseup",OE)].forEach(tE=>u.dispatchEvent(tE)),a.response.success}onMapKbdTab(a,_){let r=this.chart,L=a.response,u=_.shiftKey,m=u&&!this.focusedMapNavButtonIx||!u&&this.focusedMapNavButtonIx;if(r.mapNavigation.navButtons[this.focusedMapNavButtonIx].setState(0),m)return r.mapView&&r.mapView.zoomBy(),L[u?"prev":"next"];this.focusedMapNavButtonIx+=u?-1:1;let b=r.mapNavigation.navButtons[this.focusedMapNavButtonIx];return r.setFocusToElement(b.box,b.element),b.setState(2),L.success}onMapKbdClick(a){let _=this.chart.mapNavigation.navButtons[this.focusedMapNavButtonIx].element;return this.fakeClickEvent(_),a.response.success}onMapNavInit(a){let _=this.chart,r=_.mapNavigation.navButtons[0],L=_.mapNavigation.navButtons[1],u=a>0?r:L;_.setFocusToElement(u.box,u.element),u.setState(2),this.focusedMapNavButtonIx=a>0?0:1}simpleButtonNavigation(a,_,r){let L=this.keyCodes,u=this,m=this.chart;return new PT(m,{keyCodeMap:[[[L.tab,L.up,L.down,L.left,L.right],function(b,y){let K=b===L.tab&&y.shiftKey||b===L.left||b===L.up;return this.response[K?"prev":"next"]}],[[L.space,L.enter],function(){return D_(r(this,m),this.response.success)}]],validate:function(){return m[a]&&m[a].box&&u[_].innerElement},init:function(){m.setFocusToElement(m[a].box,u[_].innerElement)}})}getKeyboardNavigation(){return[this.simpleButtonNavigation("resetZoomButton","resetZoomProxyButton",function(a,_){_.zoomOut()}),this.simpleButtonNavigation("drillUpButton","drillUpProxyButton",function(a,_){return _.drillUp(),a.response.prev}),this.getMapZoomNavigation()]}},{doc:Le,isMS:yt,win:uI}=cE(),iR=function(){if(yt&&uI.getComputedStyle){let a=Le.createElement("div");a.style.backgroundImage="url(data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==)",Le.body.appendChild(a);let _=(a.currentStyle||uI.getComputedStyle(a)).backgroundImage;return Le.body.removeChild(a),_==="none"}return uI.matchMedia&&uI.matchMedia("(forced-colors: active)").matches},Jn=function(a){a.highContrastModeActive=!0;let _=a.options.accessibility.highContrastTheme;a.update(_,!1);let r=_.colors?.length>1;a.series.forEach(function(L){let u=_.plotOptions[L.type]||{},m=r&&L.colorIndex!==void 0?_.colors[L.colorIndex]:u.color||"window",b={color:u.color||"windowText",colors:r?_.colors:[u.color||"windowText"],borderColor:u.borderColor||"window",fillColor:m};L.update(b,!1),L.points&&L.points.forEach(function(y){y.options&&y.options.color&&y.update({color:u.color||"windowText",borderColor:u.borderColor||"window"},!1)})}),a.redraw()},Ut={chart:{backgroundColor:"window"},title:{style:{color:"windowText"}},subtitle:{style:{color:"windowText"}},colorAxis:{minColor:"windowText",maxColor:"windowText",stops:[],dataClasses:[]},colors:["windowText"],xAxis:{gridLineColor:"windowText",labels:{style:{color:"windowText"}},lineColor:"windowText",minorGridLineColor:"windowText",tickColor:"windowText",title:{style:{color:"windowText"}}},yAxis:{gridLineColor:"windowText",labels:{style:{color:"windowText"}},lineColor:"windowText",minorGridLineColor:"windowText",tickColor:"windowText",title:{style:{color:"windowText"}}},tooltip:{backgroundColor:"window",borderColor:"windowText",style:{color:"windowText"}},plotOptions:{series:{lineColor:"windowText",fillColor:"window",borderColor:"windowText",edgeColor:"windowText",borderWidth:1,dataLabels:{connectorColor:"windowText",color:"windowText",style:{color:"windowText",textOutline:"none"}},marker:{lineColor:"windowText",fillColor:"windowText"}},pie:{color:"window",colors:["window"],borderColor:"windowText",borderWidth:1},boxplot:{fillColor:"window"},candlestick:{lineColor:"windowText",fillColor:"window"},errorbar:{fillColor:"window"}},legend:{backgroundColor:"window",itemStyle:{color:"windowText"},itemHoverStyle:{color:"windowText"},itemHiddenStyle:{color:"#555"},title:{style:{color:"windowText"}}},credits:{style:{color:"windowText"}},drilldown:{activeAxisLabelStyle:{color:"windowText"},activeDataLabelStyle:{color:"windowText"}},navigation:{buttonOptions:{symbolStroke:"windowText",theme:{fill:"window"}}},rangeSelector:{buttonTheme:{fill:"window",stroke:"windowText",style:{color:"windowText"},states:{hover:{fill:"window",stroke:"windowText",style:{color:"windowText"}},select:{fill:"#444",stroke:"windowText",style:{color:"windowText"}}}},inputBoxBorderColor:"windowText",inputStyle:{backgroundColor:"window",color:"windowText"},labelStyle:{color:"windowText"}},navigator:{handles:{backgroundColor:"window",borderColor:"windowText"},outlineColor:"windowText",maskFill:"transparent",series:{color:"windowText",lineColor:"windowText"},xAxis:{gridLineColor:"windowText"}},scrollbar:{barBackgroundColor:"#444",barBorderColor:"windowText",buttonArrowColor:"windowText",buttonBackgroundColor:"window",buttonBorderColor:"windowText",rifleColor:"windowText",trackBackgroundColor:"window",trackBorderColor:"windowText"}},{error:ce,pick:cs}=cE();function hs(a,_,r){let L=a,u,m=0;for(;m<_.length-1;++m)L=L[u=_[m]]=cs(L[u],{});L[_[_.length-1]]=r}function he(a,_,r,L){function u(y,K){return K.reduce(function(w,OE){return w[OE]},y)}let m=u(a.options,_),b=u(a.options,r);Object.keys(L).forEach(function(y){let K=m[y];K!==void 0&&(hs(b,L[y],K),ce(32,!1,a,{[_.join(".")+"."+y]:r.join(".")+"."+L[y].join(".")}))})}let JI=function(a){let _,r,L;_=a.options.chart,r=a.options.accessibility||{},["description","typeDescription"].forEach(function(u){_[u]&&(r[u]=_[u],ce(32,!1,a,{[`chart.${u}`]:`use accessibility.${u}`}))}),a.axes.forEach(function(u){let m=u.options;m&&m.description&&(m.accessibility=m.accessibility||{},m.accessibility.description=m.description,ce(32,!1,a,{"axis.description":"use axis.accessibility.description"}))}),a.series&&(L={description:["accessibility","description"],exposeElementToA11y:["accessibility","exposeAsGroupOnly"],pointDescriptionFormatter:["accessibility","point","descriptionFormatter"],skipKeyboardNavigation:["accessibility","keyboardNavigation","enabled"],"accessibility.pointDescriptionFormatter":["accessibility","point","descriptionFormatter"]},a.series.forEach(function(u){Object.keys(L).forEach(function(m){let b=u.options[m];m==="accessibility.pointDescriptionFormatter"&&(b=u.options.accessibility&&u.options.accessibility.pointDescriptionFormatter),b!==void 0&&(hs(u.options,L[m],m==="skipKeyboardNavigation"?!b:b),ce(32,!1,a,{[`series.${m}`]:"series."+L[m].join(".")}))})})),he(a,["accessibility"],["accessibility"],{pointDateFormat:["point","dateFormat"],pointDateFormatter:["point","dateFormatter"],pointDescriptionFormatter:["point","descriptionFormatter"],pointDescriptionThreshold:["series","pointDescriptionEnabledThreshold"],pointNavigationThreshold:["keyboardNavigation","seriesNavigation","pointNavigationEnabledThreshold"],pointValueDecimals:["point","valueDecimals"],pointValuePrefix:["point","valuePrefix"],pointValueSuffix:["point","valueSuffix"],screenReaderSectionFormatter:["screenReaderSection","beforeChartFormatter"],describeSingleSeries:["series","describeSingleSeries"],seriesDescriptionFormatter:["series","descriptionFormatter"],onTableAnchorClick:["screenReaderSection","onViewDataTableClick"],axisRangeDateFormat:["screenReaderSection","axisRangeDateFormat"]}),he(a,["accessibility","keyboardNavigation"],["accessibility","keyboardNavigation","seriesNavigation"],{skipNullPoints:["skipNullPoints"],mode:["mode"]}),he(a,["lang","accessibility"],["lang","accessibility"],{legendItem:["legend","legendItem"],legendLabel:["legend","legendLabel"],mapZoomIn:["zoom","mapZoomIn"],mapZoomOut:["zoom","mapZoomOut"],resetZoomButton:["zoom","resetZoomButton"],screenReaderRegionLabel:["screenReaderSection","beforeRegionLabel"],rangeSelectorButton:["rangeSelector","buttonText"],rangeSelectorMaxInput:["rangeSelector","maxInputLabel"],rangeSelectorMinInput:["rangeSelector","minInputLabel"],svgContainerEnd:["screenReaderSection","endOfChartMarker"],viewAsDataTable:["table","viewAsDataTableButtonText"],tableSummary:["table","tableSummary"]})},{defaultOptions:oR}=cE(),{doc:de}=cE(),{addEvent:KT,extend:$I,fireEvent:YI,merge:Ge}=cE(),{removeElement:AM}=EO;class xt{constructor(_){this.init(_)}init(_){if(this.chart=_,!de?.addEventListener){this.zombie=!0,this.components={},_.renderTo.setAttribute("aria-hidden",!0);return}JI(_),this.proxyProvider=new IT(this.chart),this.initComponents(),this.keyboardNavigation=new FO(_,this.components)}initComponents(){let _=this.chart,r=this.proxyProvider,L=_.options.accessibility;this.components={container:new Ne,infoRegions:new QO,legend:new jM,chartMenu:new lO,rangeSelector:new sM,series:new De,zoom:new KO,navigator:new eM},L.customComponents&&$I(this.components,L.customComponents);let u=this.components;this.getComponentOrder().forEach(function(m){u[m].initBase(_,r),u[m].init()})}getComponentOrder(){return this.components?this.components.series?["series"].concat(Object.keys(this.components).filter(_=>_!=="series")):Object.keys(this.components):[]}update(){let _=this.components,r=this.chart,L=r.options.accessibility;YI(r,"beforeA11yUpdate"),r.types=this.getChartTypes();let u=L.keyboardNavigation.order;this.proxyProvider.updateGroupOrder(u),this.getComponentOrder().forEach(function(m){_[m].onChartUpdate(),YI(r,"afterA11yComponentUpdate",{name:m,component:_[m]})}),this.keyboardNavigation.update(u),!r.highContrastModeActive&&L.highContrastMode!==!1&&(iR()||L.highContrastMode===!0)&&Jn(r),YI(r,"afterA11yUpdate",{accessibility:this})}destroy(){let _=this.chart||{},r=this.components;Object.keys(r).forEach(function(L){r[L].destroy(),r[L].destroyBase()}),this.proxyProvider&&this.proxyProvider.destroy(),_.announcerContainer&&AM(_.announcerContainer),this.keyboardNavigation&&this.keyboardNavigation.destroy(),_.renderTo&&_.renderTo.setAttribute("aria-hidden",!0),_.focusElement&&_.focusElement.removeFocusBorder()}getChartTypes(){let _={};return this.chart.series.forEach(function(r){_[r.type]=1}),Object.keys(_)}}(function(a){function _(){this.accessibility&&this.accessibility.destroy()}function r(){this.a11yDirty&&this.renderTo&&(delete this.a11yDirty,this.updateA11yEnabled());let b=this.accessibility;b&&!b.zombie&&(b.proxyProvider.updateProxyElementPositions(),b.getComponentOrder().forEach(function(y){b.components[y].onChartRender()}))}function L(b){let y=b.options.accessibility;y&&(y.customComponents&&(this.options.accessibility.customComponents=y.customComponents,delete y.customComponents),Ge(!0,this.options.accessibility,y),this.accessibility&&this.accessibility.destroy&&(this.accessibility.destroy(),delete this.accessibility)),this.a11yDirty=!0}function u(){let b=this.accessibility,y=this.options.accessibility,K=this.renderer.boxWrapper.element,w=this.title;if(y&&y.enabled)b&&!b.zombie?b.update():(this.accessibility=b=new a(this),b&&!b.zombie&&b.update(),K.getAttribute("role")==="img"&&K.removeAttribute("role"));else if(b)b.destroy&&b.destroy(),delete this.accessibility;else{this.renderTo.setAttribute("role","img"),this.renderTo.setAttribute("aria-hidden",!1),this.renderTo.setAttribute("aria-label",(w&&w.element.textContent||"").replace(/</g,"&lt;")),K.setAttribute("aria-hidden",!0);let OE=document.getElementsByClassName("highcharts-description")[0];OE&&(OE.setAttribute("aria-hidden",!1),OE.classList.remove("highcharts-linked-description"))}}function m(){this.series.chart.accessibility&&(this.series.chart.a11yDirty=!0)}a.i18nFormat=yE.i18nFormat,a.compose=function(b,y,K,w,OE,tE){FO.compose(b),XI.compose(w),jM.compose(b,y),lO.compose(b),De.compose(b,K,w),yE.compose(b),pI.compose(b,OE),tE&&sM.compose(b,tE);let ME=b.prototype;ME.updateA11yEnabled||(ME.updateA11yEnabled=u,KT(b,"destroy",_),KT(b,"render",r),KT(b,"update",L),["addSeries","init"].forEach(AE=>{KT(b,AE,function(){this.a11yDirty=!0})}),["afterApplyDrilldown","drillupall"].forEach(AE=>{KT(b,AE,function(){let bE=this.accessibility;bE&&!bE.zombie&&bE.update()})}),KT(K,"update",m),["update","updatedData","remove"].forEach(AE=>{KT(w,AE,function(){this.chart.accessibility&&(this.chart.a11yDirty=!0)})}))}})(xt||(xt={})),Ge(!0,oR,{accessibility:{enabled:!0,screenReaderSection:{beforeChartFormat:"<{headingTagName}>{chartTitle}</{headingTagName}><div>{typeDescription}</div><div>{chartSubtitle}</div><div>{chartLongdesc}</div><div>{playAsSoundButton}</div><div>{viewTableButton}</div><div>{xAxisDescription}</div><div>{yAxisDescription}</div><div>{annotationsTitle}{annotationsList}</div>",afterChartFormat:"{endOfChartMarker}",axisRangeDateFormat:"%Y-%m-%d %H:%M:%S"},series:{descriptionFormat:"{seriesDescription}{authorDescription}{axisDescription}",describeSingleSeries:!1,pointDescriptionEnabledThreshold:200},point:{valueDescriptionFormat:"{xDescription}{separator}{value}.",describeNull:!0},landmarkVerbosity:"all",linkedDescription:'*[data-highcharts-chart="{index}"] + .highcharts-description',highContrastMode:"auto",keyboardNavigation:{enabled:!0,focusBorder:{enabled:!0,hideBrowserFocusOutline:!0,style:{color:"#334eff",lineWidth:2,borderRadius:3},margin:2},order:["series","zoom","rangeSelector","navigator","legend","chartMenu"],wrapAround:!0,seriesNavigation:{skipNullPoints:void 0,pointNavigationEnabledThreshold:!1,rememberPointFocus:!1}},announceNewData:{enabled:!1,minAnnounceInterval:5e3,interruptUser:!1}},legend:{accessibility:{enabled:!0,keyboardNavigation:{enabled:!0}}},exporting:{accessibility:{enabled:!0}},navigator:{accessibility:{enabled:!0}}},{accessibility:{highContrastTheme:Ut},lang:{accessibility:{defaultChartTitle:"Chart",chartContainerLabel:"{title}. Highcharts interactive chart.",svgContainerLabel:"Interactive chart",drillUpButton:"{buttonText}",credits:"Chart credits: {creditsStr}",thousandsSep:",",svgContainerTitle:"",graphicContainerLabel:"",screenReaderSection:{beforeRegionLabel:"",afterRegionLabel:"",annotations:{heading:"Chart annotations summary",descriptionSinglePoint:"{annotationText}. Related to {annotationPoint}",descriptionMultiplePoints:"{annotationText}. Related to {annotationPoint}{#each additionalAnnotationPoints}, also related to {this}{/each}",descriptionNoPoints:"{annotationText}"},endOfChartMarker:"End of interactive chart."},sonification:{playAsSoundButtonText:"Play as sound, {chartTitle}",playAsSoundClickAnnouncement:"Play"},legend:{legendLabelNoTitle:"Toggle series visibility, {chartTitle}",legendLabel:"Chart legend: {legendTitle}",legendItem:"Show {itemName}"},zoom:{mapZoomIn:"Zoom chart",mapZoomOut:"Zoom out chart",resetZoomButton:"Reset zoom"},rangeSelector:{dropdownLabel:"{rangeTitle}",minInputLabel:"Select start date.",maxInputLabel:"Select end date.",clickButtonAnnouncement:"Viewing {axisRangeDescription}"},navigator:{handleLabel:"{#eq handleIx 0}Start, percent{else}End, percent{/eq}",groupLabel:"Axis zoom",changeAnnouncement:"{axisRangeDescription}"},table:{viewAsDataTableButtonText:"View as data table, {chartTitle}",tableSummary:"Table representation of chart."},announceNewData:{newDataAnnounce:"Updated data for chart {chartTitle}",newSeriesAnnounceSingle:"New data series: {seriesDesc}",newPointAnnounceSingle:"New data point: {pointDesc}",newSeriesAnnounceMultiple:"New data series in chart {chartTitle}: {seriesDesc}",newPointAnnounceMultiple:"New data point in chart {chartTitle}: {pointDesc}"},seriesTypeDescriptions:{boxplot:"Box plot charts are typically used to display groups of statistical data. Each data point in the chart can have up to 5 values: minimum, lower quartile, median, upper quartile, and maximum.",arearange:"Arearange charts are line charts displaying a range between a lower and higher value for each point.",areasplinerange:"These charts are line charts displaying a range between a lower and higher value for each point.",bubble:"Bubble charts are scatter charts where each data point also has a size value.",columnrange:"Columnrange charts are column charts displaying a range between a lower and higher value for each point.",errorbar:"Errorbar series are used to display the variability of the data.",funnel:"Funnel charts are used to display reduction of data in stages.",pyramid:"Pyramid charts consist of a single pyramid with item heights corresponding to each point value.",waterfall:"A waterfall chart is a column chart where each column contributes towards a total end value."},chartTypes:{emptyChart:"Empty chart",mapTypeDescription:"Map of {mapTitle} with {numSeries} data series.",unknownMap:"Map of unspecified region with {numSeries} data series.",combinationChart:"Combination chart with {numSeries} data series.",defaultSingle:"Chart with {numPoints} data {#eq numPoints 1}point{else}points{/eq}.",defaultMultiple:"Chart with {numSeries} data series.",splineSingle:"Line chart with {numPoints} data {#eq numPoints 1}point{else}points{/eq}.",splineMultiple:"Line chart with {numSeries} lines.",lineSingle:"Line chart with {numPoints} data {#eq numPoints 1}point{else}points{/eq}.",lineMultiple:"Line chart with {numSeries} lines.",columnSingle:"Bar chart with {numPoints} {#eq numPoints 1}bar{else}bars{/eq}.",columnMultiple:"Bar chart with {numSeries} data series.",barSingle:"Bar chart with {numPoints} {#eq numPoints 1}bar{else}bars{/eq}.",barMultiple:"Bar chart with {numSeries} data series.",pieSingle:"Pie chart with {numPoints} {#eq numPoints 1}slice{else}slices{/eq}.",pieMultiple:"Pie chart with {numSeries} pies.",scatterSingle:"Scatter chart with {numPoints} {#eq numPoints 1}point{else}points{/eq}.",scatterMultiple:"Scatter chart with {numSeries} data series.",boxplotSingle:"Boxplot with {numPoints} {#eq numPoints 1}box{else}boxes{/eq}.",boxplotMultiple:"Boxplot with {numSeries} data series.",bubbleSingle:"Bubble chart with {numPoints} {#eq numPoints 1}bubbles{else}bubble{/eq}.",bubbleMultiple:"Bubble chart with {numSeries} data series."},axis:{xAxisDescriptionSingular:"The chart has 1 X axis displaying {names[0]}. {ranges[0]}",xAxisDescriptionPlural:"The chart has {numAxes} X axes displaying {#each names}{#unless @first},{/unless}{#if @last} and{/if} {this}{/each}.",yAxisDescriptionSingular:"The chart has 1 Y axis displaying {names[0]}. {ranges[0]}",yAxisDescriptionPlural:"The chart has {numAxes} Y axes displaying {#each names}{#unless @first},{/unless}{#if @last} and{/if} {this}{/each}.",timeRangeDays:"Data range: {range} days.",timeRangeHours:"Data range: {range} hours.",timeRangeMinutes:"Data range: {range} minutes.",timeRangeSeconds:"Data range: {range} seconds.",rangeFromTo:"Data ranges from {rangeFrom} to {rangeTo}.",rangeCategories:"Data range: {numCategories} categories.",defaultAxisNames:{categories:"categories",time:"Time",values:"values"}},exporting:{chartMenuLabel:"Chart menu",menuButtonLabel:"View chart menu, {chartTitle}"},series:{summary:{default:"{series.name}, series {seriesNumber} of {chart.series.length} with {series.points.length} data {#eq series.points.length 1}point{else}points{/eq}.",defaultCombination:"{series.name}, series {seriesNumber} of {chart.series.length} with {series.points.length} data {#eq series.points.length 1}point{else}points{/eq}.",line:"{series.name}, line {seriesNumber} of {chart.series.length} with {series.points.length} data {#eq series.points.length 1}point{else}points{/eq}.",lineCombination:"{series.name}, series {seriesNumber} of {chart.series.length}. Line with {series.points.length} data {#eq series.points.length 1}point{else}points{/eq}.",spline:"{series.name}, line {seriesNumber} of {chart.series.length} with {series.points.length} data {#eq series.points.length 1}point{else}points{/eq}.",splineCombination:"{series.name}, series {seriesNumber} of {chart.series.length}. Line with {series.points.length} data {#eq series.points.length 1}point{else}points{/eq}.",column:"{series.name}, bar series {seriesNumber} of {chart.series.length} with {series.points.length} {#eq series.points.length 1}bar{else}bars{/eq}.",columnCombination:"{series.name}, series {seriesNumber} of {chart.series.length}. Bar series with {series.points.length} {#eq series.points.length 1}bar{else}bars{/eq}.",bar:"{series.name}, bar series {seriesNumber} of {chart.series.length} with {series.points.length} {#eq series.points.length 1}bar{else}bars{/eq}.",barCombination:"{series.name}, series {seriesNumber} of {chart.series.length}. Bar series with {series.points.length} {#eq series.points.length 1}bar{else}bars{/eq}.",pie:"{series.name}, pie {seriesNumber} of {chart.series.length} with {series.points.length} {#eq series.points.length 1}slice{else}slices{/eq}.",pieCombination:"{series.name}, series {seriesNumber} of {chart.series.length}. Pie with {series.points.length} {#eq series.points.length 1}slice{else}slices{/eq}.",scatter:"{series.name}, scatter plot {seriesNumber} of {chart.series.length} with {series.points.length} {#eq series.points.length 1}point{else}points{/eq}.",scatterCombination:"{series.name}, series {seriesNumber} of {chart.series.length}, scatter plot with {series.points.length} {#eq series.points.length 1}point{else}points{/eq}.",boxplot:"{series.name}, boxplot {seriesNumber} of {chart.series.length} with {series.points.length} {#eq series.points.length 1}box{else}boxes{/eq}.",boxplotCombination:"{series.name}, series {seriesNumber} of {chart.series.length}. Boxplot with {series.points.length} {#eq series.points.length 1}box{else}boxes{/eq}.",bubble:"{series.name}, bubble series {seriesNumber} of {chart.series.length} with {series.points.length} {#eq series.points.length 1}bubble{else}bubbles{/eq}.",bubbleCombination:"{series.name}, series {seriesNumber} of {chart.series.length}. Bubble series with {series.points.length} {#eq series.points.length 1}bubble{else}bubbles{/eq}.",map:"{series.name}, map {seriesNumber} of {chart.series.length} with {series.points.length} {#eq series.points.length 1}area{else}areas{/eq}.",mapCombination:"{series.name}, series {seriesNumber} of {chart.series.length}. Map with {series.points.length} {#eq series.points.length 1}area{else}areas{/eq}.",mapline:"{series.name}, line {seriesNumber} of {chart.series.length} with {series.points.length} data {#eq series.points.length 1}point{else}points{/eq}.",maplineCombination:"{series.name}, series {seriesNumber} of {chart.series.length}. Line with {series.points.length} data {#eq series.points.length 1}point{else}points{/eq}.",mapbubble:"{series.name}, bubble series {seriesNumber} of {chart.series.length} with {series.points.length} {#eq series.points.length 1}bubble{else}bubbles{/eq}.",mapbubbleCombination:"{series.name}, series {seriesNumber} of {chart.series.length}. Bubble series with {series.points.length} {#eq series.points.length 1}bubble{else}bubbles{/eq}."},description:"{description}",xAxisDescription:"X axis, {name}",yAxisDescription:"Y axis, {name}",nullPointValue:"No value",pointAnnotationsDescription:"{#each annotations}Annotation: {this}{/each}"}}}});let SM=xt,JO=cE();JO.i18nFormat=SM.i18nFormat,JO.A11yChartUtilities=HO,JO.A11yHTMLUtilities=EO,JO.AccessibilityComponent=rT,JO.KeyboardNavigationHandler=PT,JO.SeriesAccessibilityDescriber=mn,SM.compose(JO.Chart,JO.Legend,JO.Point,JO.Series,JO.SVGElement,JO.RangeSelector);let Et=cE();return PN.default})())})(qo)),qo.exports}lP();const pA=NP(iP),kR="cnt",HS="#0d6efd";function CS(G,U,p){for(const f in G)if(f===U&&G[f]===null||f===p&&G[f]===null||f===kR&&G[f]===null||f!==U&&f!==p&&f!==kR&&G[f]!==null)return!1;return!0}function rP(G){const U=Object.keys(G);if(U.filter(p=>G[p]!==null).length!==2)return null;for(const p of U){const f=G[p];if(f!==null&&p!==kR)return{col:p+":"+f,value:parseFloat(G[kR])}}return null}function PP(G,U){return{"progression_bin:PROGRESSION":"#ff9999","progression_bin:STABLE":"#99EE99","symptom_burden_bin:SYMPTOM_PRESENT":"#ffcc99","symptom_burden_bin:NOT_MENTIONED":"#DDDDDD","visual_status_bin:IMPROVING":"#99EE99","visual_status_bin:DECLINING":"#ff9999","clinical_trial_status:AVAILABLE_AND_ELIGIBLE":"#99EE99","clinical_trial_status:AVAILABLE_NOT_ELIGIBLE":"#ff9999"}[G+":"+U]||"#DDDDDD"}function aP({patient:G}){const U=Object.keys(pA[0]||{}),p="tx_modality",f="tx_class",[v,F]=dE.useState("progression_bin"),Q={},sE=pA.reduce((k,_E)=>{const IE=rP(_E);if(IE&&(Q[IE.col]=IE.value),CS(_E,p,f)){const CE=G.treatmentClass.includes(_E[f]);k.push({from:p+":"+_E[p].replace("cumulus__none","NOT_MENTIONED"),to:f+":"+_E[f].replace("cumulus__none","NOT_MENTIONED"),weight:parseFloat(_E[kR]),linkOpacity:CE?1:.3,custom:{selected:CE}})}if(CS(_E,f,v)){const CE=G.treatmentClass.includes(_E[f]);k.push({from:f+":"+_E[f].replace("cumulus__none","NOT_MENTIONED"),to:v+":"+_E[v].replace("cumulus__none","NOT_MENTIONED"),weight:parseFloat(_E[kR]),linkOpacity:CE?1:.3,custom:{selected:CE}})}return k},[]),q={chart:{height:700,margin:[10,0,10,0]},exporting:{enabled:!1},title:{text:""},subtitle:{text:""},credits:{enabled:!1},accessibility:{point:{valueDescriptionFormat:"{index}. {point.from} to {point.to}, {point.weight} patients."}},tooltip:{borderColor:HS,borderWidth:1,headerFormat:null,useHTML:!0,outside:!1,formatter:function(){return console.log(this),this.point.isNode?`<b>${this.point.name}</b><br/>Total: <b>${this.point.custom.weight}</b> patients`+(this.point.linksFrom.length>0?"<hr/><table><tbody>"+this.point.linksFrom.map(k=>`<tr><td style="text-align:right"><b>${k.weight}</b> patients</td><td></td><td style="text-align:left">${k.toNode.name}</td></tr>`).join("")+"</tbody></table>":""):`<b>${this.point.fromNode.name}  ${this.point.toNode.name}</b><br/>${this.point.weight} patients`},shadow:{color:"#0006",size:8}},plotOptions:{sankey:{minLinkWidth:3,linkColorMode:"gradient",linkColor:"#CCCCCC",nodeWidth:"20%",nodeAlignment:"top",nodeDistance:"100%",nodePadding:10,borderRadius:0,color:HS+"60",dataLabels:{enabled:!0,verticalAlign:"middle",allowOverlap:!0,padding:0,style:{textOutline:"1px #FFF8",fontWeight:"bold",fontSize:"13px",fontFamily:"sans-serif"}}}},series:[{keys:["from","to","weight"],nodes:(()=>{const k=[],_E=new Set,IE=new Set,CE=new Set;return pA.forEach(HE=>{if(HE[p]){const fE=HE[f]&&G.treatmentClass.includes(HE[f]);if(!_E.has(HE[p]))_E.add(HE[p]),k.push({id:p+":"+HE[p].replace("cumulus__none","NOT_MENTIONED"),color:"#eae4bf",name:HE[p].replaceAll("_"," "),opacity:fE?1:.5,labelRank:fE?2:0,custom:{weight:Q[p+":"+HE[p].replace("cumulus__none","NOT_MENTIONED")]||0},dataLabels:{style:{color:fE?"#000":"#666666",textOutline:fE?"1px #FFFC":"1px #FFF6"}}});else if(fE){const zE=k.find(wE=>wE.id===p+":"+HE[p].replace("cumulus__none","NOT_MENTIONED"));zE&&(zE.opacity=1,zE.labelRank=2,zE.custom={weight:Q[p+":"+HE[p].replace("cumulus__none","NOT_MENTIONED")]||0},zE.dataLabels={style:{color:"#000",textOutline:"1px #FFFC"}})}}if(HE[f]&&!CE.has(HE[f])){const fE=G.treatmentClass.includes(HE[f]);CE.add(HE[f]),k.push({id:f+":"+HE[f].replace("cumulus__none","NOT_MENTIONED"),color:fE?"#8ac4ff":"#d4e9ff",name:HE[f].replaceAll("_"," "),custom:{weight:Q[f+":"+HE[f].replace("cumulus__none","NOT_MENTIONED")]||0},dataLabels:{labelRank:fE?2:0,style:{color:fE?"#000":"#6382a1",textOutline:fE?"1px #FFFC":"1px #FFF6"}}})}HE[v]&&!IE.has(HE[v])&&(IE.add(HE[v].replace("cumulus__none","NOT_MENTIONED")),k.push({id:v+":"+HE[v].replace("cumulus__none","NOT_MENTIONED"),color:PP(v,HE[v].replace("cumulus__none","NOT_MENTIONED")),name:HE[v].replaceAll("_"," "),custom:{weight:Q[v+":"+HE[v].replace("cumulus__none","NOT_MENTIONED")]||0}}))}),k})(),data:sE,type:"sankey"}]};return oE.jsxs("div",{className:"mt-5",children:[oE.jsxs("div",{className:"d-flex mb-2 gap-5",children:[oE.jsx("div",{className:"col text-start border-bottom border-3",children:oE.jsx("h5",{className:"text-success fw-semibold",children:wR.tx_modality.label})}),oE.jsx("div",{className:"col text-center border-bottom border-3",children:oE.jsx("h5",{className:"text-success fw-semibold",children:wR.tx_class.label})}),oE.jsx("div",{className:"col text-end border-bottom border-3",children:oE.jsx("h5",{className:"text-success fw-semibold",children:oE.jsx("select",{className:"",onChange:k=>{F(k.target.value)},value:v,style:{width:"100%",font:"inherit",color:"inherit",border:"none",background:"transparent",padding:"0 0.2em 0 0",margin:0,cursor:"pointer",outline:"none",textAlign:"inherit"},children:U.filter(k=>k!==p&&k!==f&&k!==kR&&wR[k]?.enabled!==!1).sort((k,_E)=>(wR[_E]?.order??0)-(wR[k]?.order??0)).map(k=>oE.jsx("option",{value:k,title:wR[k]?.description||void 0,children:wR[k]?.label||k.replaceAll("_"," ")},k))})})})]}),oE.jsx(_P,{highcharts:eP,options:q})]})}function DP(){const{id:G}=nr(),U=WS.find(p=>p.mrn===G);return U?oE.jsxs("div",{children:[oE.jsxs(EA,{to:"../",children:[oE.jsx("i",{className:"bi bi-arrow-left-circle me-2"}),"Back to list"]}),oE.jsx(QS,{patient:U}),oE.jsx("div",{className:"table-responsive mt-5",children:oE.jsxs("table",{className:"table table-hover w-100 mb-0",children:[oE.jsxs("thead",{children:[oE.jsxs("tr",{children:[oE.jsx("td",{colSpan:3,rowSpan:2,className:"align-top",children:oE.jsxs("h5",{className:"text-success",children:["Patients matching ",U.firstName,"'s glioma characteristics"]})}),oE.jsxs("td",{colSpan:3,className:"",children:[oE.jsxs("h5",{className:"text-success mb-0",children:["Observed outcome rates for patients like ",U.firstName]}),oE.jsxs("small",{className:"text-muted",children:["Equation: ",oE.jsx("code",{children:"P(outcome | characteristic)"})]})]})]}),oE.jsxs("tr",{children:[oE.jsx("td",{className:"fw-bold text-muted bg-light border-start",children:"Disease Progression"}),oE.jsx("td",{className:"fw-bold text-muted bg-light",children:"Symptoms Present"}),oE.jsx("td",{className:"fw-bold text-muted bg-light border-end",children:"Vision Decline"})]})]}),oE.jsx("tbody",{children:U.characteristics.map((p,f)=>oE.jsxs("tr",{children:[oE.jsx("td",{className:"text-start border-start",onMouseEnter:()=>{document.querySelectorAll("tr td:nth-child(1)").forEach(v=>v.classList.add("col-highlight"))},onMouseLeave:()=>{document.querySelectorAll("tr td:nth-child(1)").forEach(v=>v.classList.remove("col-highlight"))},children:p.label}),oE.jsx("td",{className:"text-start",onMouseEnter:()=>{document.querySelectorAll("tr td:nth-child(2)").forEach(v=>v.classList.add("col-highlight"))},onMouseLeave:()=>{document.querySelectorAll("tr td:nth-child(2)").forEach(v=>v.classList.remove("col-highlight"))},children:p.value}),oE.jsx("td",{className:"text-end text-nowrap",onMouseEnter:()=>{document.querySelectorAll("tr td:nth-child(3)").forEach(v=>v.classList.add("col-highlight"))},onMouseLeave:()=>{document.querySelectorAll("tr td:nth-child(3)").forEach(v=>v.classList.remove("col-highlight"))},children:p.link||null}),oE.jsx("td",{className:"border-start font-monospace whitespace-pre",onMouseEnter:()=>{document.querySelectorAll("tr td:nth-child(4)").forEach(v=>v.classList.add("col-highlight"))},onMouseLeave:()=>{document.querySelectorAll("tr td:nth-child(4)").forEach(v=>v.classList.remove("col-highlight"))},children:p.progressionEvidence.progression?.link?oE.jsx("a",{href:p.progressionEvidence.progression.link,target:"_blank",rel:"noopener noreferrer",className:"text-decoration-none",children:p.progressionEvidence.progression.value}):p.progressionEvidence.progression?.value}),oE.jsx("td",{className:"font-monospace whitespace-pre",onMouseEnter:()=>{document.querySelectorAll("tr td:nth-child(5)").forEach(v=>v.classList.add("col-highlight"))},onMouseLeave:()=>{document.querySelectorAll("tr td:nth-child(5)").forEach(v=>v.classList.remove("col-highlight"))},children:p.progressionEvidence.symptomsPresent?.link?oE.jsx("a",{href:p.progressionEvidence.symptomsPresent.link,target:"_blank",rel:"noopener noreferrer",className:"text-decoration-none",children:p.progressionEvidence.symptomsPresent.value}):p.progressionEvidence.symptomsPresent?.value}),oE.jsx("td",{className:"font-monospace whitespace-pre border-end",onMouseEnter:()=>{document.querySelectorAll("tr td:nth-child(6)").forEach(v=>v.classList.add("col-highlight"))},onMouseLeave:()=>{document.querySelectorAll("tr td:nth-child(6)").forEach(v=>v.classList.remove("col-highlight"))},children:p.progressionEvidence.visionDecline?.link?oE.jsx("a",{href:p.progressionEvidence.visionDecline.link,target:"_blank",rel:"noopener noreferrer",className:"text-decoration-none",children:p.progressionEvidence.visionDecline.value}):p.progressionEvidence.visionDecline?.value})]},f))})]})}),oE.jsx("br",{}),oE.jsxs("h2",{className:"text-center mt-5",children:["Real World Evidence from Children like ",U.firstName]}),oE.jsx(aP,{patient:U})]}):oE.jsx("div",{children:"Patient not found"})}function LP(){return oE.jsx("footer",{className:"mt-5 pt-3",children:oE.jsx("div",{className:"bg-light rounded-bottom px-2 py-4 border-top small text-secondary text-center",children:"This demo app uses sample data to visualize glioma patient scenarios and is intended for demonstration purposes only."})})}function cP(){return oE.jsx(kr,{basename:"/glioma-app/",children:oE.jsxs("div",{className:"container",children:[oE.jsx(TP,{}),oE.jsx("hr",{}),oE.jsxs(ar,{children:[oE.jsx(gA,{path:"/",element:oE.jsx(OP,{})}),oE.jsx(gA,{path:"/:id",element:oE.jsx(DP,{})})]}),oE.jsx(LP,{})]})})}Dl.createRoot(document.getElementById("root")).render(oE.jsx(dE.StrictMode,{children:oE.jsx(cP,{})}));
